Legalize
Legalize / Česká republika / Vyhláška Ministerstva zdravotnictví, kterou se stanoví léčivé přípravky plně hrazené z veřejného zdravotního pojištění a výše úhrad jednotlivých léčivých látek / Historie

Historie novel

Vyhláška Ministerstva zdravotnictví, kterou se stanoví léčivé přípravky plně hrazené z veřejného zdravotního pojištění a výše úhrad jednotlivých léčivých látek

22 verzí · 1997-03-28
2004-01-31
Vyhláška Ministerstva zdravotnictví č. 57/1997 Sb.
Zobrazit změny Text k tomuto datu

Změny ze dne 2004-01-31

@@ -148,14 +148,14 @@
| 1 | A01AA | léčiva k profylaxi zubního kazu (fluorid sodný) | p.o. | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 1.1 | A01AA01 | fluorid sodný | p.o. | 1.1 | MG | 0,88 | |
| 46265 | ZYMAFLUOR 1/4 MG | portblnob200x0.25mg | FAJ | I | | | |
| 64958 | ZYMAFLUOR 1/4 MG | portblnob200x0.25mg | NCH | CH | | | |
| 46265 | ZYMAFLUOR 1/4 MG | portblnob200x0.25mg | FAJ | I | | | |
| 2 | A01AB | protiinfekční léčiva pro lokální aplikaci | lok. | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 2.1 | A01AB10 | natamycin | lok. | 20 | MG | 7,48 | |
| | | | | | | | |
| 2.2 | A01AB03 | chlorhexidin | lok. | 1000 | ML | 178,70 | H |
| 3 | A01AC | koftikosteriody pro lokální aplikaci | lok. | | | | |
| 3 | A01AC | kortikosteriody pro lokální aplikaci | lok. | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 3.1 | A01AC01 | triamcinolon | lok. | 1 | GM | 13,69 | L/DER,STO,OR L |
| | | | | | | | |
@@ -172,122 +172,94 @@
| | | | | | | | |
| 4.5 | A02AD04 | hydrotalcit (pevné lékové formy) | p.o. | 10 | DF | 7,44 | |
| | | | | | | | |
| 4.6 | A02AD04 | hydrotalcit (tekuté lékové formy) | p.o. | 50 ML | 7,44 | | |
| 4.6 | A02AD04 | hydrotalcit (tekuté lékové formy) | p.o. | 50 | ML | 7,44 | |
| 5 | A02BA | antiulceróza ze skupiny H2-antagonistů | p.o. | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| | | | | | | | |
| 5.1 | A02BA01 | cimetidin | p.o. | 0.80 | GM | 4,05 | |
| 64926 | LOCK-2 | tbl obd 100x200mg | CAI | IND | | | |
| 5.2 | A02BA02 | ranitidin nad 75 mg do 150 mg včetně v jedné tabletě | p.o. | 0.30 | GM | 3,80 | |
| 45321 | RANISAN | tbl obd 500x150mg | PMP | CZ | | | |
| 47471 | RANISAN 150 MG | por tblfim60x150mg | PMP | CZ | | | |
| 91280 | RANITAL 150MG | tbl obd 30x150mg | LEK | SLO | | | |
| 96283 | ULCOSAN | tbl obd 30 | IVX | CZ | | | |
| 12346 | HISTAC 150 | tbl obd 20x150mg | RXY | IND | | | |
| 45321 | RANISAN 150 MG | por tblflm500x150mg | PMP | CZ | | | |
| 47471 | RANISAN 150 MG | por tblflm60x150mg | PMP | CZ | | | |
| 91280 | RANITAL 150 MG | tbl obd 30x150mg | LEK | SLO | | | |
| 96283 | ULCOSAN | tbl obd 30x150mg | IVX | CZ | | | |
| 5.3 | A02BA02 | ranitidin nad 150 mg v jedné tabletě | p.o. | 0.30 | GM | 3,70 | |
| 76477 | RANITAL 300MG | tbl obd 30x300mg | LEK | SLO | | | |
| 12347 | HISTAC 300 | tbl obd 10x300mg | RXY | IND | | | |
| 5.4 | A02BA03 | famotidin do 20 mg včetně v 1 tabletě | p.o. | 40 | MG | 3,80 | |
| 59595 | FAMOSAN 20MG | tbl obd 50x20mg | PMP | CZ | | | |
| 5.4 | A02BA03 | famotidin do 20 mg včetně v 1 tabletě | p.o. | 40 | MG | 3.80 | |
| 75832 | APO-FAMOTIDINE 20 MG | tbl obd 100x20mg | APT | CND | | | |
| 96193 | FAMOSAN 20 MG | por tbl flm 20x20mg | PMP | CZ | | | |
| 59595 | FAMOSAN 20 MG | por tbl flm 50x20mg | PMP | CZ | | | |
| 47862 | FAMOSAN 20 MG | por tbl flm100x20mg | PMP | CZ | | | |
| 66194 | FAMOTIDIN 20-SL | tbl obd 30x20mg | SLO | SK | | | |
| 94207 | ULFAMID 20 | tbl 20x20mg | KRK | SLO | | | |
| 96193 | FAMOSAN | tbl obd 20x20mg | PMP | CZ | | | |
| 75832 | APO-FAMOTIDINE 20MG (LEKOVKA) | tbl obd 100x20mg | APT | CND | | | |
| 5.5 | A02BA03 | famotidin nad 20 mg v 1 tabletě | p.o. | 40 | MG | 3,70 | |
| 83206 | FAMOSAN | tbl obd 10x40mg | PMP | CZ | | | |
| 67539 | ULCERAN 40 | tbl obd 500x40mg | MOE | CY | | | |
| 75836 | APO-FAMOTIDINE 40 MG | tbl obd 100x40mg | APT | CND | | | |
| 83206 | FAMOSAN 40 MG | por tbl flm 10x40mg | PMP | CZ | | | |
| 96194 | FAMOSAN 40 MG | por tbl flm 20x40mg | PMP | CZ | | | |
| 59596 | FAMOSAN 40 MG | por tbl flm 50x40mg | PMP | CZ | | | |
| 47863 | FAMOSAN 40 MG | por tbl flm100x40mg | PMP | CZ | | | |
| 47263 | FAMOSAN 40 MG | por tbl flm500x40mg | PMP | CZ | | | |
| 10769 | FAMOTIDIN 40-SL | tbl obd 100x40mg | SLO | SK | | | |
| 66193 | FAMOTIDIN 40-SL | tbl obd 10x40mg | SLO | SK | | | |
| 98035 | ULFAMID 40 | tbl 10x40mg | KRK | SLO | | | |
| 59596 | FAMOSAN 40MG | tbl obd 50x40mg | PMP | CZ | | | |
| 66193 | FAMOTIDIN 40-SL | tbl obd 10x40mg | SLO | SK | | | |
| 75836 | APO-FAMOTIDINE 40MG (LEKOVKA) | tbl obd 100x40mg | APT | CND | | | |
| 67536 | ULCERAN 40 | tbl obd 10x40mg | MOE | CY | | | |
| 47263 | FAMOSAN 40MG | tbl obd 500x40mg | PMP | CZ | | | |
| 10769 | FAMOTIDIN 40-SL | tbl obd 100x40mg | SLO | SK | | | |
| 67537 | ULCERAN 40 | tbl obd 30x40mg | MOE | CY | | | |
| 96194 | FAMOSAN | tbl obd 20x40mg | PMP | CZ | | | |
| 5.6 | A02BA04 | nizatidin | p.o. | 0.30 | GM | 3,80 | |
| | | | | | | | |
| 5.7 | A02BA06 | roxatidin | p.o. | 0.15 | GM | 3,80 | |
| | | | | | | | |
| 5.8 | A02BA07 | ranitidin bismut citrát | p.o. | 0.8 | GM | 28,50 | |
| | | | | | | | |
| 6 | A02BA | antiulceróza ze skupiny H2-antagonistů | parent. | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| | | | | | | | |
| 6 | A02BA | antiulceróza ze skupiny H2-antagonistů | Parent. | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 6.1 | A02BA01 | cimetidin | parent. | 0.80 | GM | 32,06 | H |
| | | | | | | | |
| 6.2 | A02BA02 | ranitidin | parent. | 0.30 | GM | 68,43 | H |
| | | | | | | | |
| 6.3 | A02BA03 | famotidin | parent. | 40 | MG | 68,43 | H |
| | | | | | | | |
| 7 | A02BB | antiulceróza ze skupiny prostaglandinů | p.o. | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| | | | | | | | |
| 7.1 | A02BB01 | misoprostol | p.o. | 0.80 | MG | 47,36 | Z |
| | | | | | | | |
| 8 | A02BC | antiulceróza ze skupiny inhibitorů protonové pumpy | p.o. | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| | | | | | | | |
| 8.1 | A02BC01 | omeprazol (do 10 mg v jedné dávce včetně) | p.o. | 20 | MG | 19,10 | |
| 57408 | HELICID 10 | cps 28x10mg | LEX | CZ | | | |
| 53974 | HELICID 10 | cps 14x10mg | LEX | CZ | | | |
| 8.2 | A02BC01 | omeprazol (nad 10 mg v jedné dávce) | p.o. | 20 | MG | 10,20 | |
| 31511 | OMEPIREX 20 MG | por cps etd 28x20mg | LOT | E | | | |
| 94362 | OMEPROL 20 MG | por cps etd 60x20mg | IIS | TR | | | |
| 94476 | OMEPROL 20 MG | por cps etd 14x20mg | SFS | D | | | |
| 94477 | OMEPROL 20 MG | por cps etd 14x20mg | IIS | TR | | | |
| 94479 | OMEPROL 20 MG | por cps etd 28x20mg | SFS | D | | | |
| 31512 | OMEPIREX 20 MG | por cps etd 56x20mg | LOT | E | | | |
| 94478 | OMEPROL 20 MG | por cps etd 28x20mg | IIS | TR | | | |
| 10245 | OMEPRAZOL AL 20 | por cps etd 30x20mg | APA | D | | | |
| 94360 | OMEPROL 20 MG | por cps etd 15x20mg | IIS | TR | | | |
| 59897 | HELICID 20 | cps 28x20mg | LEX | CZ | | | |
| 53346 | gasec-20 | cps 28x20mg | MHA | CH | | | |
| 10246 | OMEPRAZOL AL 20 | por cps etd100x20mg | APA | D | | | |
| 60160 | ULTOP | cps 14x20mg | KRK | SLO | | | |
| 56500 | HELICID 20 | cps 14x20mg | LEX | CZ | | | |
| 10242 | OMEPRAZOL AL 20 | por cps etd 15x20mg | APA | D | | | |
| 12507 | gasec-20 | cps 14x20mg | MHA | CH | | | |
| 94361 | OMEPROL 20 MG | por cps etd 30x20mg | IIS | TR | | | |
| 58203 | OMEPROL 20 MG | cps 60x20mg | SFS | D | | | |
| 03076 | LOMAC | cps 28x20mg | CIA | IND | | | |
| 75166 | ORTANOL | cps 14x20mg | LEK | SLO | | | |
| 70933 | ORTANOL | cps 28x20mg | LEK | SLO | | | |
| 98625 | OMEPRAZOL-RATIOPHARM 20 MG | por cps etd 15x20mg | MCK | D | | | |
| 58226 | OMEPRAZOL-E | cps ent 28x20mg | EGI | H | | | |
| 58225 | OMEPRAZOL-E | cps ent 14x20mg | EGI | H | | | |
| 98626 | OMEPRAZOL-RATIOPHARM 20 MG | por cps etd 30x20mg | MCK | D | | | |
| 58202 | OMEPROL 20 MG | cps 30x20mg | SFS | D | | | |
| 32419 | LOSEPRAZOL 20 MG | por cps etd 14x20mg | LBB | E | | | |
| 58201 | OMEPROL 20 MG | cps 15x20mg | SFS | D | | | |
| 75974 | LOMAC | cps 14x20mg | CIA | IND | | | |
| 03077 | LOMAC | cps 56x20mg | CIA | IND | | | |
| 32420 | LOSEPRAZOL 20 MG | por cps etd 28x20mg | LBB | E | | | |
| 8.3 | A02BC02 | pantoprazol | p.o. | 40 | mg | 10,20 | |
| | | | | | | | |
| 8.4 | A02BC03 | lansoprazol | p.o. | 30 | mg | 10,20 | |
| | | | | | | | |
| 8.5 | A02BC05 | esomeprazol (do 20mg v jedné dávce včetně) | p.o. | 20 | mg | 12,00 | L/GIT,INT,GER |
| | | | | | | | |
| 8.6 | A02BC05 | esomeprazol (nad 20mg v jedné dávce ) | p.o. | 20 | mg | 6,67 L/GIT,INT,GER | |
| 9 | A02BC | antiulceróza ze skupiny inhibitorů protonové pumpy | parent. | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 8.1 | A02BC01 | omeprazol (do 10 mg v jedné dávce včetně) | p.o. | 20 | MG | 18,20 | |
| 32174 | OMERA 10 | por cps etd 14x10mg | SLO | SK | | | |
| 32175 | OMERA 10 | por cps etd 28x10mg | SLO | SK | | | |
| 8.2 | A02BC01 | omeprazol (nad 10 mg v jedné dávce) | p.o. | 20 | MG | 9,50 | |
| | | | | | | | |
| 8.3 | A02BC02 | pantoprazol | p.o. | 40 | MG | 9,50 | |
| | | | | | | | |
| 8.4 | A02BC03 | lansoprazol | p.o. | 30 | MG | 9,50 | |
| | | | | | | | |
| 8.5 | A02BC05 | esomeprazol (do 20mg v jedné dávce včetně) | p.o. | 20 | MG | 12,00 | L/GIT,INT, GER |
| | | | | | | | |
| 8.6 | A02BC05 | esomeprazol (nad 20mg v jedné dávce ) | p.o. | 20 | MG | 6,67 | L/GIT,INT, GER |
| | | | | | | | |
| 9 | A02BC | antiulceróza ze skupiny inhibitorů protonové pumpy | Parent. | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| | | | | | | | |
| 9.1 | A02BC01 | omeprazol | parent. | 20 | MG | 170,00 | H |
| 31739 | HELICID 40 INF | inf plv sol1x40mg | LEX | CZ | | | |
| 9.2 | A02BC02 | pantoprazol | parent. | 40 | MG | 170,00 | H |
| | | | | | | | |
| 10 | A02BX | ostatní léčiva peptického vředu | p.o. | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| | | | | | | | |
| 10.1 | A02BX02 | sukralfát | p.o. | 4 | GM | 9,88 | |
| 84406 | SUCRALAN | tbl 50x1gm | LAR | A | | | |
| 91217 | VENTER | tbl 50x1gm | KRK | SLO | | | |
| 10.2 | A02BX03 | pirenzepin | p.o. | 0.1 | GM | 8,55 | |
| | | | | | | | |
| 10.3 | A02BX05 | zásaditý citronan bismutitý | p.o. | 0.48 | GM | 23,07 | |
| | | | | | | | |
| 10.4 | A02BX | ostatní léčiva peptického vředu (bismut subsalicylat) | p.o. | 3 | DF | 22,29 | |
| 11 | A02BX | ostatní léčiva peptického vředu | parent. | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| | | | | | | | |
| 11 | A02BX | ostatní léčiva peptického vředu | Parent. | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| | | | | | | | |
| 11.1 | A02BX03 | pirenzepin | parent. | 20 | MG | 105,58 | H |
| | | | | | | | |
| 12 | A02DA | antiflatulencia a spasmolytika ATC skupiny A03A | p.o. | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| | | | | | | | |
| 12.1 | A03AA04 | mebeverin | p.o. | 0.30 | GM | 4,94 | |
| | | | | | | | |
| 12.2 | A03AA05 | trimebutin | p.o. | 0.30 | GM | 4,94 | |
@@ -298,87 +270,98 @@
| 93500 | SAB SIMPLEX | sus 1x30ml | PDA | D | | | |
| 12.5 | A03AX58 | alverin (kombinace se silikony) | p.o. | 0.18 | GM | 7,90 | |
| 67269 | METEOSPASMYL | cps 20x60mg | MSR | F | | | |
| 13 | A03AB | anticholinergika s kvartemí oniovou skupinou | p.o. | | | | |
| 13 | A03AB | anticholinergika s kvarterní oniovou skupinou | p.o. | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 13.1 | A03AB03 | oxyfenon | p.o. | 25 | MG | 2,30 | |
| | | | | | | | |
| 13.2 | A03AB06 | otilonium bromid | p.o. | 0.12 | GM | 12.42 | |
| 13.2 | A03AB06 | otilonium bromid | p.o. | 0.12 | GM | 12,42 | |
| | | | | | | | |
| 13.3 | A03AB11 | poldin | p.o. | 12 | MG | 2,30 | |
| | | | | | | | |
| 13.4 | A03AB20 | trospium chlorid | p.o. | 40 | MG | 11,84 | |
| 12528 | SPASMEX 15 | tbl 50x15mg | PFL | D | | | |
| 12527 | SPASMEX 15 | tbl 30x15mg | PFL | D | | | |
| 12525 | SPASMEX 5 | tbl 30x5mg | PFL | D | | | |
| 14 | A03AD | muskulotropní spasmolytika | p.o. | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| | | | | | | | |
| 14.1 | A03AD01 | papaverin | p.o. | 0.1 | GM | 0,68 | |
| | | | | | | | |
| 14.2 | A03AD02 | drotaverin | p.o. | 0.1 | GM | 4,88 | |
| 02551 | NO-SPA | tbl 20x40mg | CHN | H | | | |
| 46627 | NO-SPA FORTE | tbl 10x80mg | CHN | H | | | |
| 46628 | NO-SPA FORTE | tbl 20x80mg | CHN | H | | | |
| 46627 | NO-SPA FORTE | tbl 10x80mg | CHN | H | | | |
| 15 | A03AD | muskulotropní spasmolytika | parent. | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| | | | | | | | |
| 15.1 | A03AD01 | papaverin | parent. | 0.1 | GM | 17,94 | |
| | | | | | | | |
| 15.2 | A03AD02 | drotaverin | parent. | 0.1 | GM | 25,00 | |
| 59649 | NO-SPA | inj 5x4ml/80mg | CHN | H | | | |
| 16 | A03BA | alkaloidy beladony s terciálni aminovou skupinou | p.o. | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 16 | A03BA | alkaloidy beladony s terciální aminovou skupinou | p.o. | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| | | | | | | | |
| 16.1 | A03BA01 | atropin | p.o. | 1.5 | MG | 0,49 | |
| | | | | | | | |
| 17 | A03BA | alkaloidy beladony s terciální aminovou skupinou | parent. | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| | | | | | | | |
| 17.1 | A03BA01 | atropin (do 1mg v 1 ampuli) | parent. | 1.5 | MG | 15,15 | |
| | | | | | | | |
| 17.2 | A03BA01 | atropin (1 mg a více v 1 ampuli) | parent. | 1.5 | MG | 7,83 | |
| 00394 | ATROPIN BIOTIKA 1MG | inj 10x1ml/1mg | HBS | SK | | | |
| 18 | A03BB | alkaloidy beladony s kvartemí aminovou skupinou | p.o. | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 18 | A03BB | alkaloidy beladony s kvarterní aminovou skupinou | p.o. | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| | | | | | | | |
| 18.1 | A03BB01 | butylskopolamin | p.o. | 60 | MG | 14,10 | |
| 01317 | BUSCOPAN | por tbl obd 20x10mg | BOE | D | | | |
| 19 | A03BB | alkaloidy beladony s kvartemí aminovou skupinou | p.rect. | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 19 | A03BB | alkaloidy beladony s kvarterní aminovou skupinou | p.rect. | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| | | | | | | | |
| 19.1 | A03BB01 | butylskopolamin | p.rect. | 60 | MG | 14,66 | |
| 20 | A03BB | alkaloidy beladony s kvartemí aminovou skupinou | parent. | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| | | | | | | | |
| 20 | A03BB | alkaloidy beladony s kvarterní aminovou skupinou | parent. | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| | | | | | | | |
| 20.1 | A03BB01 | butylskopolamin | parent. | 60 | MG | 37,62 | |
| | | | | | | | |
| 21 | A03DA | syntetická anticholinergika v kombinaci s analgetiky | p.o. | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| | | | | | | | |
| 21.1 | A03DA | syntetická anticholinergika v komb. s analgetiky | p.o. | 2 | DF | 3,96 | |
| | | | | | | | |
| 21.2 | A03DA02 | pitofenon kombinace s analgetiky (pevné lékové formy) | p.o. | 2 | DF | 4,11 | |
| 88708 | ALGIFEN | tbl 20 | | LEX | CZ | | |
| 88708 | ALGIFEN | tbl 20 | LEX | CZ | | | |
| 21.3 | A03DA02 | pitofenon kombinace s analgetiky (tekuté lékové formy) | p.o. | 2 | ML | 5,82 | |
| | | | | | | | |
| 22 | A03DA | syntetická anticholinergika v kombinaci s analgetiky | p.rect. | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| | | | | | | | |
| 22.1 | A03DA02 | pitofenon kombinace s analgetiky | p.rect. | 2 | DF | 13,48 | |
| 91517 | ALGIFEN | sup 5 | LEX | CZ | | | |
| 91517 | ALGIFEN SUP | rct sup 5 | LEX | CZ | | | |
| 23 | A03DA | syntetická anticholinergika v kombinaci s analgetiky | parent. | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| | | | | | | | |
| 23.1 | A03DA02 | pitofenon kombinace s analgetiky | parent. | 2 | DF | 44,25 | |
| 88709 | ALGIFEN | inj 5x5ml | HBS | SK | | | |
| 24 | A03EA | spasmolytika, psycholeptika, analgetika v kombinaci | p.rect. | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| | | | | | | | |
| 24.1 | A03EA | antispasmodika, psycholeptika, analgetika v komb. | p.rect. | 2 | DF | 12,72 | |
| | | | | | | | |
| 25 | A03FA | prokinetika (cisaprid) | p.o. | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 25.1 | A03FA02 | cisaprid (pevné lékové formy, nad 5 mg do 10 mg včetně v 1 tabletě) | p.o. | 30 | MG | 26,00 | L/GIT,INT, PDD,PSY,GER |
| | | | | | | | |
| 25.2 | A03FA02 | cisaprid (pevné lékové formy, nad 10 mg v 1 tabletě) | p.o. | 30 | MG | 22,50 | L/GIT,INT, PDD,PSY,GER |
| | | | | | | | |
| 25.3 | A03FA02 | cisaprid (tekuté lékové formy) s obsahem 1 mg v 1 ml | p.o. | 30 | MG | 57,18 | L/GIT,INT, PDD,PSY,GER |
| 93393 | PREPULSID | sus 1x100ml | JAN | B | | | |
| 25.4 | A03FA02 | cisaprid (tekuté lékové formy dělené - sáčky) | p.o. | 30 | MG | 26,00 | L/GIT,INT, PDD,PSY,GER |
| | | | | | | | |
| 25.1 | A03FA02 | cisaprid (pevné lékové formy, nad 5 mg do 10 mg včetně v 1 tabletě) | p.o. | 30 | MG | 26,00 | L/GIT,INT,PDD, PSY,GER |
| | | | | | | | |
| 25.2 | A03FA02 | cisaprid (pevné lékové formy, nad 10 mg v 1 tabletě) | p.o. | 30 | MG | 22,50 | L/GIT,INT,PDD, PSY, GER |
| | | | | | | | |
| 25.3 | A03FA02 | cisaprid (tekuté lékové formy) s obsahem 1 mg v 1 ml | p.o. | 30 | MG | 57,18 | L/GIT,INT,PDD, PSY, GER |
| 93393 | PREPULSID | por sus 1x100ml | JAN | B | | | |
| 25.4 | A03FA02 | cisaprid (tekuté lékové formy dělené - sáčky) | p.o. | 30 | MG | 26,00 | L/GIT,INT,PDD, PSY, GER |
| 26 | A03FA | prokinetika (ostatní) | p.o. | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| | | | | | | | |
| 26.1 | A03FA01 | metoclopramid hydrochlorid | p.o. | 30 | MG | 4,02 | |
| 56694 | MCP HEXAL 10 | tbl 20x10mg | FST | D | | | |
| 56696 | MCP HEXAL 10 | tbl 100x10mg | FST | D | | | |
| 56695 | MCP HEXAL 10 | tbl 50x10mg | FST | D | | | |
| 03376 | CERUCAL | tbl 50x10mg | VAD | D | | | |
| 56696 | MCP HEXAL 10 | tbl 100x10mg | FST | D | | | |
| 93104 | DEGAN | tbl 40x10mg | LEK | SLO | | | |
| 56698 | MCP HEXAL KAPKY | gtt 1x100ml/400mg | WPH | D | | | |
| 26.2 | A03FA03 | domperidon | p.o. | 30 | MG | 4,02 | |
| | | | | | | | |
| 26.3 | A03FA05 | alizaprid | p.o. | 0.15 | GM | 4,02 | |
@@ -386,36 +369,52 @@
| 26.4 | A03FA | itoprid | p.o. | 0.15 | GM | 28,00 | L/GIT,INT, PDD, PSY,GER |
| | | | | | | | |
| 26.5 | A03AE02 | tegaserod | p.o. | 12 | MG | 30,00 | |
| | | | | | | | |
| 27 | A03FA | prokinetika | p.rect. | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| | | | | | | | |
| 27.1 | A03FA01 | metoclopramid | p.rect. | 30 | MG | 41,50 | |
| | | | | | | | |
| 27.2 | A03FA02 | cisaprid | p.rect. | 30 | MG | 47,57 | |
| | | | | | | | |
| 27.3 | A03FA03 | domperidon | p.rect. | 0.12 | GM | 41,50 | |
| | | | | | | | |
| 28 | A03FA | prokinetika | parent. | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| | | | | | | | |
| 28.1 | A03FA01 | metoclopramid | parent. | 30 | MG | 21,10 | O |
| | | | | | | | |
| 28.2 | A03FA05 | alizaprid | parent. | 0.15 | GM | 16,47 O | |
| 28.2 | A03FA05 | alizaprid | parent. | 0.15 | GM | 16,47 | O |
| | | | | | | | |
| 29 | A04AA | antiemetika ze skupiny serotoninových antagonistů | p.o. | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
Nauzea a zvracení v důsledku silného uvolnění serotoninu, tj. navozené cytotoxickou chemoterapií a radioterapií.
| 29.1 | A04AA01 | ondansetron (pevné lékové formy do 4 mg v jedné tabletě včetně) | p.o. | 16 | MG | 535,50 | P |
| | | | | | | | |
| 84794 | EMESET- 4 | tbl obd (10x6)x4mg | CIA | IND | | | |
| 84744 | EMESET- 4 | tbl obd 6x4mg | CIA | IND | | | |
| 04004 | EMETRON 4 MG | por tbl flm 10x4mg | GED | H | | | |
| 81475 | SETRON 4 | por tbl flm 10x4mg | SLO | SK | | | |
| 29.2 | A04AA01 | ondansetron (pevné lékové formy nad 4 mg v jedné tabletě) | p.o. | 16 | MG | 396,90 | P |
| | | | | | | | |
| 29.3 | A04AA01 | ondansetron (tekuté lékové formy) | p.o. | 16 | MG | 754,65 | P |
| | | | | | | | |
| 29.4 | A04AA01 | ondansetron (léková forma čípků) | p.rect. | 16 | MG | 653,80 | P |
| | | | | | | | |
| 29.5 | A04AA02 | granisetron | p.o. | 2 | MG | 396,90 | P |
| | | | | | | | |
| 29.6 | A04AA03 | tropisetron | p.o. | 5 | MG | 396,90 | P |
| | | | | | | | |
| 29.7 | A04AA04 | dolasetron | p.o. | 200 | MG | 396,90 | P |
| 84793 | EMESET- 8 | tbl obd (10x6)x8mg | CIA | IND | | | |
| 84443 | EMESET- 8 | tbl obd 6x8mg | CIA | IND | | | |
| 04005 | EMETRON 8 MG | por tbl flm 10x8mg | GED | H | | | |
| 03830 | ONDEMET 8 | por tbl flm 10x8mg | LEX | CZ | | | |
| 81476 | SETRON 8 | por tbl flm 10x8mg | SLO | SK | | | |
| 29.3 | A04AA01 | ondansetron (rychle rozpustné pevné lékové formy do 4 mg v jedné tabletě včetně) | p.o. | 16 | MG | 562,30 | P |
| | | | | | | | |
| 29.4 | A04AA01 | ondansetron ((rychle rozpustné pevné lékové formy nad 4 mg v jedné tabletě) | p.o. | 16 | MG | 416,70 | P |
| | | | | | | | |
| 29.5 | A04AA01 | ondansetron (tekuté lékové formy) | p.o. | 16 | MG | 754,65 | P |
| | | | | | | | |
| 29.6 | A04AA01 | ondansetron (léková forma čípků) | p.rect. | 16 | MG | 653,80 | P |
| | | | | | | | |
| 29.7 | A04AA02 | granisetron | p.o. | 2 | MG | 396,90 | P |
| | | | | | | | |
| 29.8 | A04AA03 | tropisetron | p.o. | 5 | MG | 396,90 | P |
| | | | | | | | |
| 29.9 | A04AA04 | dolasetron | p.o. | 200 | MG | 396,90 | P |
| | | | | | | | |
| 30 | A04AA | antiemetika ze skupiny serotoninových antagonistů | parent. | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
@@ -423,67 +422,80 @@
Nauzea a zvracení v důsledku silného uvolnění serotoninu, tj. navozené cytotoxickou chemoterapií a radioterapií.
| 30.1 | A04AA01 | ondansetron (do 4 mg v jedné ampuli včetně) | parent. | 16 | MG | 895,70 | P |
| | | | | | | | |
| 84441 | EMESET | inj 5x2ml/4mg | CIA | IND | | | |
| 04002 | EMETRON 4 MG | inj sol 5x2ml/4mg | GED | H | | | |
| 30.2 | A04AA01 | ondansetron (nad 4 mg v jedné ampuli) | parent. | 16 | MG | 722,40 | P |
| | | | | | | | |
| 84442 | EMESET | inj 5x4ml/8mg | CIA | IND | | | |
| 04003 | EMETRON 8 MG | inj sol 5x4ml/8mg | GED | H | | | |
| 03820 | ONDEMET 8 INJ | inj sol 5x4ml/8mg | LEX | CZ | | | |
| 30.3 | A04AA02 | granisetron | parent. | 3 | MG | 474,20 | P |
| | | | | | | | |
| 30.4 | A04AA03 | tropisetron (do 2,5 mg včetně v jedné ampuli) | parent. | 5 | MG | 816,20 | P |
| | | | | | | | |
| 30.5 | A04AA03 | tropisetron (nad 2,5 mg v jedné ampuli) | parent. | 5 | MG | 474.20 | P |
| | | | | | | | |
| 30.6 | A04AA04 | dolasetron | parent. | 100 | MG 474,20 | P | |
| 30.6 | A04AA04 | dolasetron | parent. | 100 | MG | 474,20 | P |
| | | | | | | | |
| 31 | A04AD | různá antiemetika | p.o. | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 31.1 | A04AD | různá antiemetika (theoklát embraminu) | p.o. | 50 MG | 3,31 | | |
| 88321 | MEDRIN | tbl 20x25mg | LEX | CZ | | | |
| | | | | | | | |
| 31.1 | A04AD | různá antiemetika (theoklát embraminu) | p.o. | 50 | MG | 3,31 | |
| | | | | | | | |
| 31.2 | A04AD | různá antiemetika (theoklát moxastinu) | p.o. | 0.1 | GM | 3,31 | |
| | | | | | | | |
| 31.3 | A04AD | různá antiemetika (meklozin) | p.o. | 50 MG | 3,31 | | |
| 31.3 | A04AD | různá antiemetika (meklozin) | p.o. | 50 | MG | 3,31 | |
| | | | | | | | |
| 32 | A04AD | různá antiemetika | p.rect. | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 32.1 | A04AD01 | různá antiemetika (theoklát moxastinu) | p.rect. | 0.1 GM | 9,38 | | |
| | | | | | | | |
| 32.1 | A04AD01 | různá antiemetika (theoklát moxastinu) | p.rect. | 0.1 | GM | 9,38 | |
| | | | | | | | |
| 33 | A05AA | hepatika ze skupiny žlučových kyselin | p.o. | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 33.1 | A05AA01 | kyselina chenodeoxy-cholová | p.o. | 1 | GM | 21,46 | L/GIT,INF |
| | | | | | | | |
| 33.2 | A05AA02 | kyselina ursodeoxy-cholová | p.o. | 0.75 | GM | 24,10 | L/GIT |
| 97864 | URSOSAN | cps 50x250mg | PMP | CZ | | | |
| | | | | | | | |
| 33.1 | A05AA01 | kyselina chenodeoxycholová | p.o. | 1 | GM | 21,46 | L/GIT,INF |
| | | | | | | | |
| 33.2 | A05AA02 | kyselina ursodeoxycholová | p.o. | 0.75 | GM | 24,10 | L/GIT,INF |
| 91017 | URSOFALK | cps 100x250mg | FAK | D | | | |
| 97864 | URSOSAN | por cps dur50x250mg | PMP | CZ | | | |
| 34 | A05AX | ostatní hepatika | p.o. | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| | | | | | | | |
| 34.1 | A05AX | jiná léčiva onemocnění žlučníku (fenipentol) | p.o. | 3 | DF | 1,55 | |
| 00146 | FEBICHOL | cps 50x100mg | SLO | SK | | | |
| | | | | | | | |
| 34.2 | A05AX02 | hymekromon | p.o. | 1.20 | GM | 5,96 | |
| | | | | | | | |
| 35 | A05BA | léčiva onemocnění jater | p.o. | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 35.1 | A05BA | léčiva onemocnění jater (fosfolipidy) | p.o | 4 | DF | 11,73 | |
| | | | | | | | |
| | | | | | | | |
| 35.1 | A05BA | léčiva onemocnění jater (fosfolipidy) | p.o. | 4 | DF | 11,73 | |
| 35.2 | A05BA | léčiva onemocnění jater (silymarin v kombinaci) | p.o. | 0.21 | GM | 5,68 | |
| | | | | | | | |
| 35.3 | A05BA03 | silymarin (do 70 mg včetně v jedné tabletě) | p.o. | 0.21 | GM | 5,68 | |
| 44143 | SILYGAL | tbl obd 30 | GNO | CZ | | | |
| 01147 | SILYMARIN AL 50 | drg 100x50mg | APA | D | | | |
| 76762 | SILYMARIN AL 50 | drg 30x50mg | APA | | | | |
| 76762 | SILYMARIN AL 50 | drg 30x50mg | APA | D | | | |
| 35.4 | A05BA03 | silymarin (nad 70 mg v jedné tabletě) | p.o. | 0.21 | GM | 4,40 | |
| 36 | A05BA | léčiva onemocněni jater | parent. | H | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| | | | | | | | |
| 36 | A05BA | léčiva onemocnění jater | parent. | H | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| | | | | | | | |
| 36.1 | A05BA | léčiva onemocnění jater (fosfolipidy) | parent. | 1 | DF | 42,72 | H |
| 92325 | ESSENTIALE N | inj 5x5ml | NAT | D | | | |
| 92325 | ESSENTIALE N | inj sol 5x5ml | NAJ | D | | | |
| 36.2 | A05BA03 | silymarin | parent. | 0.35 | GM | 2345,13 | H |
| 31341 | LEGALON SIL | inj sic 4x350mg | MAU | D | | | |
| 37 | A06A | osmoticky působící nevstřebatelné cukry | p.o., p.rect. | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| | | | | | | | |
| 37.1 | A06AD10 | kombinace minerálních solí (k přípravě Golytelyho roztoku) | p.o. | 4 | DF | 242,70 | |
| | | | | | | | |
| 37.2 | A06AD11 | laktulóza | p.o. | 6,7 | GM | 5,45 | L/GIT,INT, GER, PDD,CHI |
| | | | | | | | |
| 37.3 | A06AD12 | laktitol | p.o. | 10 | GM | 3,71 | L/GIT,INT, GER, CHI |
| | | | | | | | |
| 37.4 | A06AG10 | sorbitol v kombinaci s kont. laxativem | p.rect. | 2 DF | 174,01 | | |
| 37.2 | A06AD11 | laktulóza | p.o. | 6,7 | GM | 5,18 | L/GIT,INT,GER, PDD,CHI |
| | | | | | | | |
| 37.3 | A06AD12 | laktitol | p.o. | 10 | GM | 3,71 | L/GIT,INT,GER, CHI |
| | | | | | | | |
| 37.4 | A06AG10 | sorbitol v kombinaci s kont. laxativem | p.rect. | 2 | DF | 174,01 | |
| 92489 | YAL | sol 10x67.5ml | TRM | D | | | |
| 38 | A07AA | střevní antimykotická léčiva | p.o. | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| | | | | | | | |
| 38.1 | A07AA01 | neomycin | p.o. | 5 | GM | 609,91 | H |
| | | | | | | | |
| 38.2 | A07AA02 | nystatin | p.o. | 1.5 | MU | 5,96 | |
@@ -502,10 +514,11 @@
4) bakteriálních infekcí provázejících nespecifická zánětlivá onemocnění střev (Crohnovy choroby a ulcerosní colitidy) citlivých na rifaximin
5) prokázané divertikulitidě tračníku, citlivé na rifaximin.
| 39 | A07EA | kortikosteroidy pro rektální aplikaci nebo působící v tlustém střevu | p.rect., p.o. | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
5) prokázané divertikulitidě tráčniku, citlivé na rifaximin.
| 39 | A07EA | kortikosteroidy pro rektální aplikaci nebo působíci v tlustém střevu | p.rect., p.o. | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| | | | | | | | |
| 39.1 | A07EA06 | budesonid | p.rect. | 2 | MG | 250,00 | L/GIT,INT,GER |
| | | | | | | | |
| 39.2 | A07EA06 | budesonid | p.o. | 9 | MG | 105,35 | P |
@@ -514,7 +527,6 @@
| 64786 | BUDENOFALK | cps ent 50x3mg | FAK | D | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 64787 | BUDENOFALK | cps ent 100x3mg | FAK | D | | | |
| 39.3 | A07EB01 | natrium kromoglykát | p.o. | 800 | MG | 73,58 | P |
Diagnózu prokazuje a léčbu indikuje alergolog a klinický imunolog na základě alergologického vyšetření kožním eventuálně expozičním testem nebo průkazem specifických IgE protilátek: při prokázané potravinové alergii se závažnými místními či celkovými příznaky, které nelze eliminací alergenů z potravy plně upravit.
@@ -522,42 +534,47 @@
| 93797 | NALCROM | cps 100x100mg | FIS | GB | | | |
| 40 | A07EC | aminosalicylová kyselina a její deriváty | p.o. | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| | | | | | | | |
| 40.1 | A07EC01 | sulfasalazin | p.o. | 2 | GM | 16,34 | L/GIT,INT,REV, GER |
| 72968 | SALAZOPYRIN EN | tbl 100x500mg | KBP | S | | | |
| 02159 | SULFASALAZIN K | tbl obd 50x500mg | KRK | SLO | | | |
| 04304 | SULFASALAZIN K-EN | tbl ent 100x500mg | KRK | SLO | | | |
| 02159 | SULFASALAZIN K | por tbl flm50x500mg | KRK | SLO | | | |
| 04304 | SULFASALAZIN K-EN | por tblent100x500mg | KRK | SLO | | | |
| 40.2 | A07EC02 | mesalazin (potahované tablety) | p.o. | 1.5 | GM | 23,43 | L/GIT,INT,GER |
| 75567 | SALOFALK 500 | tblobd ent100x500mg | FAK | D | | | |
| 45835 | SALOFALK 250 | tbl ent 50x250mg | FAK | D | | | |
| 76479 | ASACOL 400 | por tblflm 100x400mg | TLT | CH | | | |
| 93235 | SALOFALK 250 | tbl ent 100x250mg | FAK | D | | | |
| 40.3 | A07EC02 | mesalazin (tablety s řízeným uvolňováním) | p.o. | 1.5 | GM | 44,12 | P |
Mesalazin per os – tablety s řízeným uvolňováním:
Mesalazin per os - tablety s řízeným uvolňováním:
Je aminosalicylátem první volby při idiopatickém střevním zánětu (Crohnově nemoci) postihující horní části trávicího traktu, tenké střevo a přilehlé části tlustého střeva (ileokolitida). Není aminosalicylátem první volby při lokalizaci idiopatického střevního zánětu v tračníku, zde je indikován až při selhání ostatních aminosalicylátů.
| 40.4 | A07EC02 | mesalazin (léková forma - sáčky) | p.o. | 1.5 | GM | 44,12 | P |
| --- | --- | --- | --- | --- | --- | --- | --- |
Mesalazin per os – léková forma-sáčky: Je aminosalicylátem první volby při idiopatickém střevním zánětu (Crohnově nemoci) postihující horní části trávicího traktu, tenké střevo a přilehlé části tlustého střeva (ileokolitida) u děti do 3 let a u pacientů s poruchou polykání. Není aminosalicylátem první volby při lokalizaci idiopatického střevního zánětu v tračníku, zde je indikován až při selhání ostatních aminosalicylátů.
Mesalazin per os - léková forma-sáčky: Je aminosalicylátem první volby při idiopatickém střevním zánětu (Crohnově nemoci) postihující horní části trávicího traktu, tenké střevo a přilehlé části tlustého střeva (ileokolitida) u děti do 3 let a u pacientů s poruchou polykání. Není aminosalicylátem první volby při lokalizaci idiopatického střevního zánětu v tračníku, zde je indikován až při selhání ostatních aminosalicylátů.
| 41 | A07EC | aminosalicylová kyselina a její deriváty | p.rect. | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| | | | | | | | |
| 41.1 | A07EC02 | mesalazin (enm.) | p.rect. | 1.5 | GM | 69,31 | L/GIT |
| 93770 | SALOFALK 4GM | enm 7x60ml/4gm | FAK | D | | | |
| 76700 | ASACOL ENEMA 4 G | sus rec 1x100ml/4gm | TLT | CH | | | |
| 06250 | ASACOL ENEMA 4 G | sus rec 7x100ml/4gm | TLT | CH | | | |
| 93770 | SALOFALK 4 GM | enm 7x60ml/4gm | FAK | D | | | |
| 41.2 | A07EC02 | mesalazin (čípky do 250 mg včetně) | p.rect. | 1.5 | GM | 118,94 | L/GIT |
| 93238 | SALOFALK 250 | sup 10x250mg | FAK | D | | | |
| 93239 | SALOFALK 250 | sup 30x250mg | FAK | D | | | |
| 41.3 | A07EC02 | mesalazin (čípky nad 250 mg) | p.rect. | 1.5 | GM | 102,63 | L/GIT |
| 76704 | ASACOL | sup 20x500mg | TLT | CH | | | |
| 75568 | SALOFALK 500 | sup 10x500mg | FAK | D | | | |
| 75569 | SALOFALK 500 | sup 30x500mg | FAK | D | | | |
| 75568 | SALOFALK 500 | sup 10x500mg | FAK | D | | | |
| 41.4 | A07EC | paraaminosali- cylát sodný | p.rect. | 2 | GM | 46,20 | L/GIT |
| 41.4 | A07EC | paraaminosalicylát sodný | p.rect. | 2 | GM | 46,20 | L/GIT |
| | | | | | | | |
| 42 | A07FA | protiprůjmové mikroorganismy | p.o. | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 42.1 | A07FA01 | organismy produkující kyselinu mléčnou, tekuté lékové formy | p.o. | 2 | ML | 3,61 | L/PDD,GIT, GER |
| 09159 | HYLAK FORTE | gtt 1x100ml | MCK | D | | | |
| 09158 | HYLAK FORTE | gtt 1x30ml | MCK | D | | | |
| 42.2 | A07FA01 | organismy produkující kyselinu mléčnou, pevné lékové formy | p.o. | 4 | DF | 3,86 | L/PDD,GIT, GER |
| | | | | | | | |
| 42.1 | A07FA01 | organismy produkující kyselinu mléčnou, tekuté lékové formy | p.o. | 2 | ML | 3,61 | L/PDD,GIT,GER, INF |
| 09159 | HYLAK FORTE | sol 1x100ml | MCK | D | | | |
| 09158 | HYLAK FORTE | sol 1x30ml | MCK | D | | | |
| 42.2 | A07FA01 | organismy produkující kyselinu mléčnou, pevné lékové formy | p.o. | 4 | DF | 3,86 | L/PDD,GIT,GER, INF |
| | | | | | | | |
| 42.3 | A07FA02 | saccharomyces boulardii sicatus | p.o. | 1 | DF | 5,50 | P |
Přípravek je indikován k léčbě infekčních průjmů, k profylaxi a léčbě průjmů u pacientů živených gastrickou nebo enterální výživou pomocí sondy.Nelze jej předepisovat (a hradit z prostředků veřejného zdravotního pojištění) pro profylaxi a léčbu cestovatelských průjmů.
@@ -567,35 +584,41 @@
Přípravek je indikován k udržovací léčbě u nespecifických střevních zánětů.
| 42.5 | A07FA | protiprůjmové mikroorganismy (Escherichia coli), tekuté lékové formy | p.o. | 1 | DF | 43,99 | L/PDD |
| | | | | | | | |
| 42.6 | A07BC05 | diosmectit (plv. susp.) | p.o. | 1 | DF | 3,86 | L/PDD |
| 42.5 | A07FA | protiprůjmové mikroorganismy (Escherichia coli), tekuté lékové formy | p.o. | 1 | DF | 43,99 | L/PDD, INF |
| | | | | | | | |
| 42.6 | A07BC05 | diosmectit (plv. susp.) | p.o. | 1 | DF | 3,86 | L/PDD, INF |
| | | | | | | | |
| 43 | A09AA | enzymové přípravky | p.o. | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| | | | | | | | |
| 43.1 | A09AA | enzymové přípravky (s pankreatinem, dle lipázy) | p.o. | 5000 | U | 1,03 | |
| 04139 | PANZYNORM FORTE | drg 30 | KRK | SLO | | | |
| 43.2 | A09AA | multienzymy (obsahující pankreatin, trypsin, chymotrypsin, bromelain, papain, amylasu, lipasu, rutosid) | p.o. | 6 | DF | 8,80 | P |
Léčbu multienzymovými přípravky ordinuje onkolog, chirurg, internista nebo dermatolog u lymfedémů v souvislosti s radikální operací nebo s radioterapií pro malignitu, za podmínky, že ke kontrole lymfedému nedostačuje fyzikální léčba, nebo tuto nelze aplikovat.
| 43.3 | A09AA02 | multienzymy (dle lipázy, do 10.000 U v 1 tabletě včetně) | p.o. | 5000 | U | 1.47 | |
| 43.3 | A09AA02 | multienzymy (dle lipázy, do 10.000 U v 1 tabletě včetně) | p.o. | 5000 | U | 1,47 | |
| | | | | | | | |
| 43.4 | A09AA02 | multienzymy (dle lipázy, nad 10.000 do 20.000 U včetně v jedné tabletě) | p.o. | 5000 | U | 1,45 | |
| 56167 | PANGROL 20000 | tbl obd 50 | BCE | D | | | |
| 21362 | PANGROL 400 | tbl obd 48 | BCE | D | | | |
| 56167 | PANGROL 20000 | tbl obd 50 | BCE | D | | | |
| 43.5 | A09AA02 | multienzymy (dle lipázy, nad 10.000 do 20.000 U včetně v jedné tabletě) - formy mikropelet | p.o. | 5000 | U | 1,90 | |
| | | | | | | | |
| 43.6 | A09AA02 | multienzymy (dle lipázy, nad 20.000 U v jedné tabletě) | p.o. | 5000 | U | 1,61 | |
| | | | | | | | |
| 44 | A09AC | pepsin a kyselinotvorné látky | p.o. | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| | | | | | | | |
| 44.1 | A09AC01 | pepsin a kyselinotvorné látky | p.o. | 2 | DF | 2,79 | |
| | | | | | | | |
| 45 | A10A | insuliny (rozpustné humánní) | parent. | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| | | | | | | | |
| 45.1 | A10AB01 | insulin lidský rychle účinkující 100 U/ml, cartridge | parent. | 40 | U | 22,86 | L/DIA |
| | | | | | | | |
| 45.2 | A10AB01 | insulin lidský rychle účinkující, lahv. | parent. | 40 | U | 18,85 | |
| 44576 | HUMULIN R 100 M.J./ML | inj 1x10ml/1ku | LIL | F | | | |
| 40876 | INSULIN-HM R | inj 1x10ml/1ku | LEX | CZ | | | |
| 44576 | HUMULIN R 100 M.J./ML | inj 1x10ml/1ku | LIL | F | | | |
| 45.3 | A10AB01 | insulin lidský rychle účinkující pro aplikaci do insulinových pump | parent. | 40 | U | 27,96 | L/DIA |
| 81496 | VELOSULIN HM (GE) | inj sol1x10ml/100ut | NOO | DK | | | |
| 45.4 | A10AB04 | insulin-lispro krátce působící, lahv. | parent. | 40 | U | 28,28 | |
@@ -605,54 +628,89 @@
| 45.6 | A10AB05 | insulin-aspart krátce působící, lahv. | parent. | 40 | U | 28,28 | |
| | | | | | | | |
| 45.7 | A10AB05 | insulin-aspart krátce působící, cartridge 100U/ML | parent. | 40 | U | 30,49 | L/DIA |
| | | | | | | | |
| 46 | A10A | insuliny (rozpustné monokomponentní) | parent. | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| | | | | | | | |
| 46.1 | A10AB03 | insulin vepřový rychle účinkující - lahv. | parent. | 40 | U | 16,48 | |
| 42366 | HYPURIN PORCINE NEUTRAL | inj 1x10ml/1000ut | CBF | GB | | | |
| 83725 | INSULIN-MONO N | inj 1x10ml/400ut | LEX | CZ | | | |
| 42366 | HYPURIN PORCINE NEUTRAL | inj 1x10ml/1000ut | CBF | GB | | | |
| 46.2 | A10AB03 | insulin vepřový rychle účinkující - cartridge | parent. | 40 | U | 22,86 | L/DIA |
| | | | | | | | |
| 47 | A10A | insuliny (suspenzní humánní) | parent. | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| | | | | | | | |
| 47.1 | A10AC01 | insulin lidský středně dlouze účinkující 100U/ml, cartridge | parent. | 40 | U | 22,86 | L/DIA |
| 47.2 | A10AC01 | insulin lidský středně dlouze účinkující, lahv. | parent. | 40 | U | 18,85 | |
| | | | | | | | |
| 47.2 | A10AC01 | insulin lidský středně dlouze účinkující 100U/ml, cartridge v jednorázovém aplikátoru | parent. | 40 | U | 28,00 | P, L/DIA |
Diabetes mellitus léčený intenzifikovaným inzulínovým režimem u osob s definovanou poruchou zraku stanovenou na základě vyšetření oftalmologem - praktická popř. skutečná nevidomost: pokles zrakové ostrosti pod 3/60 včetně nebo binokulární zorné pole menší než 10 st. kolem centrální fixace.
| 47.3 | A10AC01 | insulin lidský středně dlouze účinkující, lahv. | parent. | 40 | U | 18,85 | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 44567 | HUMULIN N 100 M.J./ML | inj 1x10ml/1ku | LIL | F | | | |
| 40875 | INSULIN-HM NPH | inj 1x10ml/1ku | LEX | CZ | | | |
| 47.3 | A10AD01 | insulin lidský kombinace středně a rychle účinného 100U/ml, cartridge | parent. | 40 | U | 22,86 | L/DIA |
| 47.4 | A10AD01 | insulin lidský kombinace středně a rychle účinného, lahv. | parent. | 40 | U | 18,85 | |
| 47.4 | A10AD01 | insulin lidský kombinace středně a rychle účinného 100U/ml, cartridge | parent. | 40 | U | 22,86 | L/DIA |
| | | | | | | | |
| 47.5 | A10AD01 | insulin lidský kombinace středně a rychle účinného 100U/ml, cartridge v jednorázovém aplikátoru | parent. | 40 | U | 28,00 | P, L/DIA |
Diabetes mellitus léčený intenzifikovaným inzulínovým režimem u osob s definovanou poruchou zraku stanovenou na základě vyšetření oftalmologem - praktická popř. skutečná nevidomost: pokles zrakové ostrosti pod 3/60 včetně nebo binokulární zorné pole menší než 10 st. kolem centrální fixace.
| 47.6 | A10AD01 | insulin lidský kombinace středně a rychle účinného, lahv. | parent. | 40 | U | 18,85 | |
| 40878 | INSULIN-HM MIX 30 | inj 1x10ml/1ku | LEX | CZ | | | |
| 47.5 | A10AE01 | insulin lidský dlouhodobě účinkující | parent. | 40 | U | 18,85 | |
| | | | | | | | |
| 47.6 | A10AD | insulin aspart, kombinace středně a rychle účinného, cartridge | parent. | 40 | U | 30,49 | L/DIA |
| | | | | | | | |
| 47.7 | A10AE04 | insulin glargin, dlouhodobě účinný, cartridge | parent. | 40 | U | 30,49 | L/DIA |
| | | | | | | | |
| 47.8 | A10AE04 | insulin glargin, dlouhodobě účinný, lahv. | parent. | 40 | U | 22,86 | L/DIA |
| 47.7 | A10AE01 | insulin lidský dlouhodobě účinkující | parent. | 40 | U | 18,85 | |
| | | | | | | | |
| 47.8 | A10AD | insulin aspart, kombinace středně a rychle účinného, cartridge | parent. | 40 | U | 30,49 | L/DIA |
| | | | | | | | |
| 47.9 | A10AE04 | insulin glargin, dlouhodobě účinný, cartridge | parent. | 40 | U | 30,49 | L/DIA |
| | | | | | | | |
| 47.10 | A10AE04 | insulin glargin, dlouhodobě účinný, lahv. | parent. | 40 | U | 22,86 | L/DIA |
| | | | | | | | |
| 48 | A10A | insuliny (suspenzní monokomponentní) | parent. | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| | | | | | | | |
| 48.1 | A10AC03 | insulin vepřový středně dlouze účinkující | parent. | 40 | U | 12,64 | |
| | | | | | | | |
| 48.2 | A10AC30 | insulin kombinace zvířecí středně dlouze účinkující | parent. | 40 | U | 12,64 | |
| 83726 | INSULIN-MONO D | inj 1x10ml/400ut | LEX | CZ | | | |
| 83727 | INSULIN-MONO ID | inj 1x10ml/400ut | LEX | CZ | | | |
| 83726 | INSULIN-MONO D | inj 1x10ml/400ut | LEX | | | | |
| 48.3 | A10AE30 | insulin kombinace zvířecí dlouhodobé účinkující | parent. | 40 | U | 12,64 | |
| 48.3 | A10AE30 | insulin kombinace zvířecí dlouhodobě účinkující | parent. | 40 | U | 12,64 | |
| | | | | | | | |
| 48.4 | A10AC02 | insulin hovězí středně dlouze účinkující - lahv. | parent. | 40 | U | 11,99 | |
| 42368 | HYPURIN BOVINE ISOPHANE | inj 1x10ml/1000ut | CBF | GB | | | |
| 48.5 | A10AC02 | insulin hovězí středně dlouze účinkující - cartridge | parent. | 40 | U | 21,60 | L/DIA |
| 48.5 | A10AC02 | insulin hovězí středně dlouze účinkující - cartridge | parent. | 40 U | 21,60 | L/DIA | |
| 42369 | HYPURIN BOVINE ISOPHANE | inj 5x1.5ml/150ut | CBF | GB | | | |
| 48.6 | A10AE02 | insulin hovězí dlouhodobě účinkující - lahv. | parent. | 40 | U | 11,99 | |
| 42370 | HYPURIN BOVINE PROT.ZINC.SULF. | inj 1x10ml/1000ut | CBF | GB | | | |
| 49 | A10BA | léčiva snižující hladinu cukru ze skupiny derivátů biguanidu a inhibitorů alfa-glukosidáz | p.o. | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| | | | | | | | |
| 49.1 | A10BA02 | metformin hydrochlorid | p.o. | 2 | GM | 6,67 | |
| 31957 | GLUFORMIN | | tbl obd 60x850mg | PLI | CHO | | |
| 64642 | ADIMET | | tbl obd 120x850mg | MCK | D | | |
| 49.2 | A10BA03 | buformin | p.o. | 0.2 | gm | 3,47 | |
| 64642 | ADIMET | tbl obd 120x850mg | MCK | D | | | |
| 31957 | GLUFORMIN | tbl obd 60x850mg | PLI | CHO | | | |
| 06668 | METFIREX 500 MG | por tbl flm60x500mg | CHN | H | | | |
| 41507 | METFIREX 500 MG | por tblflm120x500mg | CHN | H | | | |
| 06657 | METFIREX 850 MG | por tbl flm60x850mg | CHN | H | | | |
| 41506 | METFIREX 850 MG | por tblflm 120x850mg | CHN | H | | | |
| 32784 | METFOGAMMA 850 | por tblflm 120x850mg | ARN | D | | | |
| 53960 | METFORMIN 500 LÉČIVA | por tblflm 100x500mg | LEX | CZ | | | |
| 53961 | METFORMIN 850 LÉČIVA | por tbl flm50x850mg | LEX | CZ | | | |
| 05643 | METFORMIN 850 LÉČIVA | por tblflm100x850mg | LEX | CZ | | | |
| 30343 | METFORMIN AL 500 | por tbl flm30x500mg | APA | D | | | |
| 30356 | METFORMIN AL 500 | por tbl flm60x500mg | APA | D | | | |
| 30357 | METFORMIN AL 500 | por tblflm 100x500mg | APA | D | | | |
| 30361 | METFORMIN AL 500 | por tblflm120x500mg | APA | D | | | |
| 40001 | METFORMIN AL 850 | por tbl flm30x850mg | APA | D | | | |
| 40155 | METFORMIN AL 850 | por tbl flm60x850mg | APA | D | | | |
| 40172 | METFORMIN AL 850 | por tblflm100x850mg | APA | D | | | |
| 40174 | METFORMIN AL 850 | por tblflm 120x850mg | APA | D | | | |
| 56503 | SIOFOR 500 | por tbl flm60x500mg | BBE | D | | | |
| 56504 | SIOFOR 850 | por tbl flm60x850mg | BBE | D | | | |
| 49.2 | A10BA03 | buformin | p.o. | 0.2 | GM | 3,47 | |
| 02558 | SILUBIN RETARD | tbl obd 60x100mg | GRU | D | | | |
| 45812 | SILUBIN RETARD | tbl obd 60x100mg | ano | E | | | |
| 49.3 | A10BF01 | akarboza | p.o. | 0.3 | GM | 10,26 | |
| | | | | | | | |
| 49.4 | A10BG02 | rosiglitason s obsahem 4 mg v jedné tabletě | p.o. | 1 | DF | 38,50 P | |
| 49.4 | A10BG02 | rosiglitason s obsahem 4 mg v jedné tabletě | p.o. | 1 | DF | 38,50 | P |
| | | | | | | | |
| 49.5 | A10BG03 | pioglitazon s obsahem 15 mg v jedné tabletě | p.o. | 1 | DF | 34,05 | P |
| | | | | | | | |
@@ -665,17 +723,15 @@
| 50.1 | A10BB01 | glibenklamid (do 1 mg v jedné tabletě včetně) | p.o. | 10 | MG | 2,30 | |
| | | | | | | | |
| 50.2 | A10BB01 | glibenklamid (nad 1 mg v jedné tabletě) | p.o. | 10 | MG | 0,86 | |
| 45107 | BETANASE | tbl 100x5mg | CAI | IND | | | |
| 01791 | BETANASE | tbl 5x(3x10)x5mg | CAI | IND | | | |
| 91880 | MANINIL 5 | tbl 120x5mg | BCE | D | | | |
| 50.3 | A10BB01 | glibenklamid (mikronizované formy, do 1,75 mg včetně v jedné tabletě) | p.o. | 7 | MG | 1.37 | |
| 94523 | GLUCOBENE 1,75MG | tbl 120x1.75mg | MCK | D | | | |
| 50.3 | A10BB01 | glibenklamid (mikronizované formy, do 1,75 mg včetně v jedné tabletě) | p.o. | 7 | MG | 1,37 | |
| 94523 | GLUCOBENE 1.75 MG | tbl 120x1.75mg | MCK | D | | | |
| 50.4 | A10BB01 | glibenklamid (mikronizované formy, nad 1,75 mg v jedné tabletě) | p.o. | 7 | MG | 0,86 | |
| 94525 | GLUCOBENE 3,5MG | tbl 120x3.5mg | MCK | D | | | |
| 94525 | GLUCOBENE 3.5 MG | tbl 120x3.5mg | MCK | D | | | |
| 50.5 | A10BB02 | chlorpropamid | p.o. | 0.37 | GM | 0,78 | |
| | | | | | | | |
| 50.6 | A10BB03 | tolbutamid | p.o. | 1.5 | GM | 2,32 | |
| 00120 | DIRASTAN | tbl 5x10x500mg | SLO | SK | | | |
| 00120 | DIRASTAN | tbl50 (=5x10)x500mg | SLO | SK | | | |
| 50.7 | A10BB04 | glibornurid | p.o. | 38 | MG | 4,79 | |
| | | | | | | | |
| 50.8 | A10BB05 | tolazamid | p.o. | 1 | GM | 2,49 | |
@@ -685,7 +741,7 @@
| 50.10 | A10BB08 | gliquidon | p.o. | 60 | MG | 5,65 | |
| 99336 | GLURENORM | tbl 30x30mg | SLO | SK | | | |
| 50.11 | A10BB09 | gliklazid | p.o. | 0.16 | GM | 6,55 | |
| | | | | | | | |
| 31897 | GLICIREX | por tbl nob 60x80mg | RTT | D | | | |
| 50.12 | A10BB09 | gliklazid, retardované lékové formy | p.o. | 2 | DF | 6,55 | |
| | | | | | | | |
| 50.13 | A10BB12 | glymepirid do 2 mg v jedné tabletě včetně | p.o. | 2 | MG | 6,55 | |
@@ -694,13 +750,15 @@
| | | | | | | | |
| 50.15 | A10BD02 | metformin a glibenklamid - kombinace | p.o. | 3 | DF | 5,85 | |
| | | | | | | | |
| 50.16 | A10BX02 | repaglinid | p.o. | 1 | DF 5,00 | L/DIA | |
| 50.16 | A10BX02 | repaglinid | p.o. | 1 | DF | 5,00 | L/DIA |
| | | | | | | | |
| 50.17 | A10BX03 | nateglinid | p.o. | 1 | DF | 5,00 | L/DIA |
| | | | | | | | |
| 51 | A11CA | vitamin A a jeho deriváty | p.o. | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 51.1 | A11CA01 | retinol (vitamin A) | p.o. | 50 | KU | 1.12 | |
| 00347 | VITAMIN A SLOVAKOFARMA | cps 50x30ku | SLO | SK | | | |
| | | | | | | | |
| 51.1 | A11CA01 | retinol (vitamin A) | p.o. | 50 | KU | 1,12 | |
| 00347 | VITAMIN A-SLOVAKOFARMA | cps 50x30ku | SLO | SK | | | |
| 52 | A11CA | vitamin A a jeho deriváty | parent. | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 52.1 | A11CA01 | retinol (vitamin A) | parent. | 50 | KU | 10,40 | |
@@ -727,15 +785,18 @@
- 5.Léčba hypoparathyreózy rezistentní na léčbu vitaminem D a vápníkem.
| 53.1 | A11CC04 | kalcitriol | p.o. | 1 | RG | 35,10 | P |
| 47583 | ROCALTROL 0.25 MCG | por cpsmol30x0.25rg | RPS | D | | | |
| 58255 | ROCALTROL 0.25 MCG | por cpsmol30x0.25rg | RPS | D | | | |
| 54 | A11CC | vitamin D a jeho deriváty (ostatní) | p.o. | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 54.1 | A11CC01 ergokalciferol (tekuté lékové formy, do 200 U/ml včetně) | p.o. | 6 | KU | 13,10 | | |
| | | | | | | | |
| 54.2 | A11CC01 | ergokalciferol (tekuté lékové formy, nad 200 U/ml) | p.o. | 6 | KU | 0,78 | |
| 00716 | INFADIN | gtt 1x10ml 10mg/1ml | SLO | SK | | | |
| | | | | | | | |
| 54.1 | A11CC01 | ergokalciferol (tekuté lékové formy, do 200 U/ml včetně) | p.o. | 6 KU | 13,10 | | |
| | | | | | | | |
| 54.2 | A11CC01 | ergokalciferol (tekuté lékové formy, nad 200 U/ml) | p.o. | 6 KU | 0,78 | | |
| 00716 | INFADIN | gtt 1x10ml /100mg | SLO | SK | | | |
| 54.3 | A11CC01 | ergocalciferol (pevné lékové formy) | p.o. | 6 | KU | 0,54 | |
| 00353 | VITAMIN D SLOVAKOFARMA | cps 1x300ku | SLO | \| SK | | | |
| 54.4 | A11CC02 | dihydrotachys- terol | p.o. | 1 | MG | 17,13 | |
| 00353 | VITAMIN D SLOVAKOFARMA | cps 1x300ku | SLO | SK | | | |
| 54.4 | A11CC02 | dihydrotachysterol | p.o. | 1 | MG | 17,13 | |
| 94445 | TACHYSTIN | gtt 1x20ml/20mg | CHV | D | | | |
| 54.5 | A11CC03 | alfakalcidol do 0,50 rg včetně | p.o. | 1 | RG | 18,60 | P |
| | | | | | | | |
@@ -759,8 +820,8 @@
- 5.Léčba hypoparathyreózy rezistentní na léčbu vitaminem D a vápníkem.
| 54.7 | A11CC05 | cholekalciferol - tekuté lékové formy | p.o. | 0.5 | MG | 3,84 | |
| 12023 | VIGANTOL OEL | ole 1x10ml 500rg/ml | MEC | D | | | |
| 54.7 | A11CC05 | cholekalciferol – tekuté lékové formy | p.o. | 0.5 | MG | 3,84 | |
| 12023 | VIGANTOL | por gtt sol 1x10ml | MEC | D | | | |
| 54.8 | A11CC05 | cholekalciferol - pevné lékové formy | p.o. | 0.5 | MG | 1,04 | |
| 05877 | VITAMIN D 800-SLOVAKOFARMA | cps 30x800rg | SLO | SK | | | |
| 55 | A11CC | vitamin D a jeho deriváty (kalcitriol) | parent. | | | | |
@@ -788,25 +849,25 @@
| 56 | A11CC | vitamin D a jeho deriváty (ostatní) | parent. | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 56.1 | A11CC01 | ergokalciferol | parent. | 6 | KU | 0,72 | |
| 00405 | CALCIFEROL BIOTIKA FORTE | inj 1x1ml/7.5mg | BTA | SK | | | |
| 56677 | CALCIFEROL BIOTIKA FORTE | inj 5x1ml/7.5mg | BTA | SK | | | |
| 00405 | CALCIFEROL BIOTIKA FORTE | inj sol 1x1ml/7.5mg | BTA | SK | | | |
| 56677 | CALCIFEROL BIOTIKA FORTE | ini sol 5x1ml/7.5mg | BTA | SK | | | |
| 56.2 | A11CC05 | cholekalciferol | parent. | 1 | KU | 0,93 | |
| 11093 | VIGANTOL 50000 | inj 5x1ml/1.25mg | MEC | D | | | |
| 57 | A11DA | vitamin B1 a jeho deriváty | parent. | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| | | | | | | | |
| 57.1 | A11DA | thiamin (vit. B1), prostý | parent. | 75 | MG | 5,50 | H |
| | | | | | | | |
| 57.2 | A11DA01 | thiamin (vit. B1) | parent. | 50 | MG | 5,50 | H |
| 92502 | THIABENE | inj 6x2ml/100mg | MCK | D | | | |
| 58 | A11GA | vitamin C | parent. | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 58.1 | A11GA01 | kyselina askorbová (vitamin C) | parent. | 0.2 | GM | 3.32 | H |
| 92730 | ACIDUM ASCORBICUM BIOTIKA | inj 50x5ml/500mg | HBS | SK | | | |
| 92729 | ACIDUM ASCORBICUM BIOTIKA | inj 5x5mlZ500mg | HBS | SK | | | |
| 58.1 | A11GA01 | kyselina askorbová (vitamin C) | parent. | 0.2 | GM | 3,32 | H |
| 92729 | ACIDUM ASCORBICUM BIOTIKA | inj 5x5ml/500mg | HBS | SK | | | |
| 59 | A11HA | vitamin B2, B6 a E | parent. | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 59.1 | A11HA02 | pyridoxin hydrochlorid (vitamín B6) | parent. | 0.16 | GM | 16,58 | H |
| 00584 | PYRIDOXIN LECIVA | inj 5x1ml/50mg | LEX | CZ | | | |
| 00584 | PYRIDOXIN LÉČIVA INJ. | inj sol 5x1ml/50mg | LEX | CZ | | | |
| 59.2 | A11HA03 | tokoferol (vitamin E, do 30 mg/ml včetně) | parent. | 0.2 | GM | 69,90 | H |
| | | | | | | | |
| 59.3 | A11HA03 | tokoferol (vitamin E, nad 30 mg/ml) | parent. | 0.2 | GM | 7,58 | H |
@@ -817,43 +878,43 @@
| 60.1 | A11JA | kombinace vitamínů | parent. | 10 | ML | 93,80 | H |
| | | | | | | | |
| 60.2 | A11DB | kombinace vitamínů (vitamin B1, B6, B12) | parent. | 10 | ML | 93,80 | H |
| 67074 | MILGAMMA N | inj 100x2ml | WGP | D | | | |
| 11487 | MILGAMMA N | inj 100x2ml | SLH | D | | | |
| 11486 | MILGAMMA N | inj 25x2ml | SLH | D | | | |
| 11488 | MILGAMMA N | inj 500x2ml | SLH | D | | | |
| 67075 | MILGAMMA N | inj 500x2ml | WGP | D | | | |
| 11485 | MILGAMMA N | inj 5x2ml | SLH | D | | | |
| 67075 | MILGAMMA N | inj 500x2ml | WGP | D | | | |
| 11487 | MILGAMMA N | inj 100x2ml | SLH | D | | | |
| 61 | A12A | soli vápníku včetně kombinací vápníku a fluoru | p.o. | | | | |
| 61 | A12A | soli vápníku včetně kombinaci vápníku a fluoru | p.o. | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 61.1 | A12AA03 | glukonát vápenatý (na obsah vápníku) | p.o. | 0.5 | GM | 0,59 | |
| | | | | | | | |
| 61.2 | A12AA04 | uhličitan vápenatý (na obsah vápníku) tablety | p.o. | 0.5 | GM | 2,34 | |
| 70536 | TBL.CALCII CARBON.PRAEC.0.5 MVM | tbl 1000x0.5gm | MVM | CZ | | | |
| 70536 | TBL.CALCII CARBON.PRAEC.0.5 MVM | portblnob1000x0.5gm | MVM | CZ | | | |
| 61.3 | A12AA04 | uhličitan vápenatý (na obsah vápníku), léková forma šumivé tablety | p.o. | 0.5 | GM | 2,34 | |
| | | | | | | | |
| 61.4 | A12AA04 | uhličitan vápenatý(na obsah vápniku), léková forma prášky | p.o. | 0.5 | GM | 2,34 | |
| 61.4 | A12AA04 | uhličitan vápenatý(na obsah vápníku), léková forma prášky | p.o. | 0.5 | GM | 2,34 | |
| | | | | | | | |
| 61.5 | A12AA07 | chlorid vápenatý (na obsah vápníku), tekuté lékové formy, | p.o. | 0.2 | GM | 0,64 | |
| | | | | | | | |
| 00409 | CALCIUM CHLORATUM BIOTIKA | inj 5x10ml 10% | HBS | SK | | | |
| 61.6 | A12AA12 | octan vápenatý (na obsah vápníku) | p.o. | 0.5 | GM | 10,00 | |
| | | | | | | | |
| 61.7 | A12AA20 | vápník (kombinace různých solí, na obsah vápníku) | p.o. | 0.5 | GM | 2,54 | |
| | | | | | | | |
| 61.8 | A12AX | uhličitan vápenatý v kombinaci s cholekalciferolem (na obsah vápníku) do 500 mg vápníku v 1 dávce včetně a do 5 mg cholekalciferolu v 1 dávce včetně | p.o. | 1 | DF | 3,26 | |
| | | | | | | | |
| 61.9 | A12AX | uhličitan vápenatý v kombinaci s cholekalciferolem (na obsah vápníku) do 500 mg vápníku v 1 dávce včetně a nad 5 mg cholekalciferolu v 1 dávce | p.o. | 1 | DF | 4,00 | |
| | | | | | | | |
| 61.10 | A12AX | uhličitan vápenatý v kombinaci s cholekalciferolem (na obsah vápníku) nad 500 mg vápníku v 1 dávce | p.o. | 1 | DF | 6,51 | |
| 61.8 | A12AX | uhličitan vápenatý v kombinaci s cholekalciferolem (na obsah vápníku) do 600 mg vápníku v 1 dávce včetně a do 5 mg cholekalciferolu v 1 dávce včetně | p.o. | 1 | DF | 3,26 | |
| | | | | | | | |
| 61.9 | A12AX | uhličitan vápenatý v kombinaci s cholekalciferolem (na obsah vápníku) do 600 mg vápníku v 1 dávce včetně a nad 5 mg cholekalciferolu v 1 dávce | p.o. | 1 | DF | 4,00 | |
| | | | | | | | |
| 61.10 | A12AX | uhličitan vápenatý v kombinaci s cholekalciferolem (na obsah vápníku) nad 600 mg vápníku v 1 dávce | p.o. | 1 | DF | 6,51 | |
| 46472 | CALTRATE PLUS | tbl obd 30 | JDC | USA | | | |
| 61.11 | A12AX | vápník v kombinaci s fluorem (fluorofosfat sodný) | p.o. | 1 | DF | 5,38 | L/INT,GYN,ORT REV,GER |
| | | | | | | | |
| 61.12 | A12AX | vápník v kombinaci s fluorem (levoglutamid fluorofosfat) | p.o. | 1 | DF | 4,01 | L/INT,GYN,ORT REV,GER |
| 61.13 | A12CX | jiné minerální produkty (na obsah vápníku) | p.o. | 0.5 | GM | 1.14 | |
| 99808 | BIOMIN H | plv 60x3gm(sacky) | BMN | SK | | | |
| | | | | | | | |
| 61.13 | A12CX | jiné minerální produkty (na obsah vápníku) | p.o. | 0.5 | GM | 1,14 | |
| 99808 | BIOMIN H | plv 60x3gm(sÁČky) | BMN | SK | | | |
| 62 | A12AA | soli vápníku | parent. | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 62.1 | A12AA03 | glukonát vápenatý (na obsah vápníku) | parent. | 3 | GM | 59,16 | |
| 00407 | CALCIUM BIOTIKA | inj 10x10ml/1gm | HBS | SK | | | |
| 00407 | CALCIUM BIOTIKA | inj sol 10x10ml/1gm | HBS | SK | | | |
| 62.2 | A12AA07 | chlorid vápenatý (na obsah vápníku) | parent. | 0.2 | GM | 2,85 | |
| 00409 | CALCIUM CHLORATUM BIOTIKA | inj 5x10ml 10% | HBS | SK | | | |
| 63 | A12BA | soli draslíku | p.o. | | | | |
@@ -863,15 +924,13 @@
| 63.2 | A12BA | draslík (na obsah draslíku) | p.o. | 1.5 | GM | 2,44 | |
| | | | | | | | |
| 63.3 | A12BA01 | chlorid draselný (na obsah chloridu draselného) | p.o. | 3 | GM | 2,37 | |
| 91600 | KALNORMIN | tbl 30x1gm | IDA | H | | | |
| 91600 | KALNORMIN | tbl ret 30x1gm | ICN | H | | | |
| 64 | A12BA | soli draslíku | parent. | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 64.1 | A12BA | draslík v kombinaci s hořčíkem | parent. | 1 | DF | 13,20 | O |
| 02132 | CARDI LAN | inj 10x10ml | HBS | SK | | | |
| 64.2 | A12BA01 | chlorid draselný (na obsah chloridu draselného) | parent. | 3 | GM | 52.88 | O |
| 02486 | KALIUM CHLORATUM LECIVA 7.5% | inj 5x10ml 7.5% | LEX | CZ | | | |
| 65 | A12CC | soli hořčíku (na obsah hořčíku) | p.o. | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 02132 | CARDILAN | inj 10x10ml | HBS | SK | | | |
| 64.2 | A12BA01 | chlorid draselný (na obsah chloridu draselného) | parent. | 3 | GM | 52,88 | O |
| 02486 | KALIUM CHLORATUM LÉČIVA 7.5% | inj 5x10ml 7.5% | LEX | CZ | | | |
| 65.1 | A12CC03 | glukonat hořečnatý (na obsah hořčíku) | p.o. | 1 | GM | 11,38 | L/INT,NEU,PSY, GYN,GER |
| | | | | | | | |
| 65.2 | A12CC04 | citronan hořečnatý (na obsah hořčíku) | p.o. | 1 | GM | 11,38 | L/INT,NEU,PSY, GYN,GER |
@@ -883,32 +942,33 @@
| 65.5 | A12CC09 | orotat hořečnatý (na obsah hořčíku) | p.o. | 1 | GM | 11,38 | L/INT,NEU,PSY, GYN,GER |
| | | | | | | | |
| 65.6 | A12CC30 | kombinace hořečnatých solí (na obsah hořčíku) | p.o. | 1 | GM | 11,38 | L/INT,NEU,PSY, GYN,GER |
| 99891 | MAGNESIUM 250 MG PHARMAVIT | por tbl eff 20 | CPW | H | | | |
| 66 | A12CC | soli hořčíku | parent. | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 66.1 | A12CC02 | síran hořečnatý (koncentrace do 10 % včetně) | parent. | 1 | GM | 19,72 | O |
| 00498 | MAGNESIUM SULFURICUM BIOTIKA | inj 5x10ml 10% | HBS | SK | | | |
| 00498 | MAGNESIUM SULFURICUM BIOT.10% | inj 5x10ml 10% | HBS | SK | | | |
| 66.2 | A12CC02 | síran hořečnatý (koncentrace nad 10%) | parent. | 1 | GM | 8,87 | O |
| 00499 | MAGNESIUM SULFURICUM BIOTIKA | inj 5x10ml 20% | HBS | SK | | | |
| 00499 | MAGNESIUM SULFURICUM BIOT.20% | inj 5x10ml 20% | HBS | SK | | | |
| 67 | A12CD | soli fluoru | p.o. | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 67.1 | A12CD01 | fluorid sodný | p.o. | 88 | MG | 4,06 | |
| 09495 | OSSIN RETARD | tbl obd 100x40mg | GRU | D | | | |
| 68 | A14A | anabolické steroidy | parent. | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 68.1 | A14AB01 | nandrolon phenpropionát | parent. | 2 | MG | 3,11 | |
| 00609 | SUPERANABOLON | inj 5x1ml/25mg | SPX | CZ | | | |
| 69 | A16A | ostatní léčiva alimentárního traktu | parent. | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 69.1 | A16AA01 | levokarnitin | parent. | 2 | GM | 356,82 | O |
| | | | | | | | |
| 69.2 | A16AX01 | kyselina tioktová | parent. | 0.2 | GM | 84,42 | O |
| 84382 | THIOGAMMA 600 INJECT | inj 1000x20ml/600mg | SLH | D | | | |
| 84381 | THIOGAMMA 600 INJECT | inj 100x20ml/600mg | SLH | D | | | |
| 84379 | THIOGAMMA 600 INJECT | inj 10x20ml/600mg | SLH | D | | | |
| 55380 | THIOGAMMA 600 INJECT | inj 20x20ml/600mg | SLH | D | | | |
| 55381 | THIOGAMMA 600 INJECT | inj 500x20ml/600mg | SLH | D | | | |
| 84380 | THIOGAMMA 600 INJECT | inj 50x20ml/600mg | SLH | D | | | |
| 84378 | THIOGAMMA 600 INJECT | inj 5x20ml/600mg | SLH | D | | | |
| 84379 | THIOGAMMA 600 INJECT | inj 10x20ml/600mg | SLH | D | | | |
| 55381 | THIOGAMMA 600 INJECT | inj 500x20ml/600mg | SLH | D | | | |
| 84381 | THIOGAMMA 600 INJECT | inj 100x20ml/600mg | SLH | D | | | |
| 84382 | THIOGAMMA 600 INJECT | inj 1000x20ml/600mg | SLH | D | | | |
| 55380 | THIOGAMMA 600 INJECT | inj 20x20ml/600mg | SLH | D | | | |
| 84380 | THIOGAMMA 600 INJECT | inj 50x20ml/600mg | SLH | D | | | |
| 69.3 | A16AA02 | ademetionin | parent. | 0,5 | GM | 94,66 | Z |
| 12319 | TRANSMETIL 500MG INJEKCE | inj sic 5x500mg+5ml | KNO | I | | | |
| 12319 | TRANSMETIL 500 MG INJEKCE | inj pso Iqf 5x500mg | ABT | I | | | |
| 69.4 | A16AA02 | ademetionin | p.o. | 1 | GM | 59,83 | Z |
| | | | | | | | |
| 69.5 | A16AB02 | imiglucerasa | parent. | 200 | U | 40341,80 | Z |
@@ -917,45 +977,51 @@
| | | | | | | | |
| 69.7 | A16AB04 | agalsidáza beta | parent. | 5 | MG | 17700,00 | Z |
| | | | | | | | |
| 69.8 | A08AA10 | sibutramin s obsahem 10 mg v jedné tabletě | p.o. | 15 | MG | 112,70 | P |
| | | | | | | | |
| 69.9 | A08AA10 | sibutramin s obsahem 15 mg v jedné tabletě | p.o. | 15 | MG | 84,90 | P |
| | | | | | | | |
| 69.10 | A08AB01 | orlistat | p.o. | 360 | MG | 84,90 | P |
Sibutramin nebo orlistat předepisuje diabetolog pacientům s diabetes mellitus 2.typu a zároveň BMI vyšším než 35 kg/m2, u nichž je diagnostikována arteriální hypertenze, hyperlipoproteinémie nebo ICHS (u sibutraminu viz kontraindikace) vyžadující farmakologickou léčbu. U pacienta musí současně dojít k poklesu tělesné hmotnosti nejméně o 3 kg v průběhu 6 týdnů za použití pouze režimových (dietních a pohybových) opatření. Tolerance léčby je vyhodnocena po 4 týdnech od zahájení léčby, účinnost po 3 měsících léčby antiobesitikem. Kritériem účinnosti léčby antiobesitikem je pokles aspoň o 5% původní tělesné hmotnosti a současně zlepšení kompenzace diabetu (glykémie na lačno či glykovaného hemoglobinu HbA1c). Neni-li léčba účinná, je podávání antiobesitika po 3 měsících přerušeno. Léčba antiobesitiky je indikována nejdéle na dobu 12 měsíců.
| 69.8 | A08AA10 | sibutramin s obsahem 10 mg v jedné tabletě | p.o. | 15 | MG | 106,20 | P |
| | | | | | | | |
| 69.9 | A08AA10 | sibutramin s obsahem 15 mg v jedné tabletě | p.o. | 15 | MG | 80,00 | P |
| | | | | | | | |
| 69.10 | A08AB01 | orlistat | p.o. | 360 | MG | 80,00 | P |
Sibutramin nebo orlistat předepisuje diabetolog pacientům s diabetes mellitus 2.typu a zároveň BMI vyšším než 35 kg/m2, u nichž je diagnostikována arteriální hypertenze, hyperlipoproteinémie nebo ICHS (u sibutraminu viz kontraindikace) vyžadující farmakologickou léčbu. U pacienta musí současně dojít k poklesu tělesné hmotnosti nejméně o 3 kg v průběhu 6 týdnů za použití pouze režimových (dietních a pohybových) opatření. Tolerance léčby je vyhodnocena po 4 týdnech od zahájení léčby, účinnost po 3 měsících léčby antiobesitikem. Kritériem účinnosti léčby antiobesitikem je pokles aspoň o 5% původní tělesné hmotnosti a současně zlepšení kompenzace diabetu (glykémie na lačno či glykovaného hemoglobinu HbA1c). Není-li léčba účinná, je podávání antiobesitika po 3 měsících přerušeno. Léčba antiobesitiky je indikována nejdéle na dobu 12 měsíců.
| 70 | B01AA | antithrombotika ze skupiny antagonistů vitaminu K | p.o. | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| | | | | | | | |
| 70.1 | B01AA03 | warfarin | p.o. | 7.5 | MG | 3,22 | |
| 12848 | LAWARIN 2 | tbl 100x2mg | PVL | CZ | | | |
| 58161 | LAWARIN 2 | tbl 50x2mg | PVL | CZ | | | |
| 12849 | LAWARIN 5 | tbl 100x5mg | PVL | CZ | | | |
| 58162 | LAWARIN 5 | tbl 50x5mg | PVL | CZ | | | |
| 59674 | WARFARIN 3-SL | por tbl nob 100x3mg | SLO | SK | | | |
| 59675 | WARFARIN 5-SL | por tbl nob 100x5mg | SLO | SK | | | |
| 12848 | LAWARIN 2 | tbl 100x2mg | PVL | CZ | | | |
| 12849 | LAWARIN 5 | tbl 100x5mg | PVL | CZ | | | |
| 58161 | LAWARIN 2 | tbl 50x2mg | PVL | CZ | | | |
| 58162 | LAWARIN 5 | tbl 50x5mg | PVL | CZ | | | |
| 70.2 | B01AA08 | ethylbiskumacetát (do 75 mg v jedné tabletě včetně) | p.o. | 0.6 | GM | 3,60 | |
| | | | | | | | |
| 70.3 | B01AA08 | ethylbiskumacetát (nad 75 mg v jedné tabletě) | p.o. | 0.6 | GM | 4,30 | |
| 71 | B01AB | antithrombotika ze skupiny heparinu a jeho derivátů (antithrombin III) | parent. | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 71.1 | B01AB02 | antithrombin (z tuzemské plazmy zakázkovou frakcionací) | parent. | 2.1 | KU | 25440,00 | U |
| | | | | | | | |
| 71.2 | B01AB02 | antithrombin | parent. 2.1 | KU | 25440,00 | U | |
| 66533 | KYBERNIN P | inj 1x500ut+10ml aq | CTO | A | | | |
| 85772 | KYBERNIN P | inj 1x1ku+20ml aqua | AVN | D | | | |
| 93174 | ANTITHROMBIN III IMMUNO | inj sic 1x1ku+20ml | IMM | A | | | |
| 93173 | ANTITHROMBIN III IMMUNO | inj sic 500ut+10ml | IMM | A | | | |
| 66532 | KYBERNIN P | inj 1x1ku+20ml aqua | i CTO | A | | | |
| 85771 | KYBERNIN P | inj 1x500ut+10ml aq | AVN | D | | | |
| 71.2 | B01AB02 | antithrombin | parent. | 2.1 | KU | 25440,00 | U |
| 72 | B01AB | antithrombotika ze skupiny heparinu a jeho derivátů (heparin) | parent. | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 72.1 | B01AB01 | heparin | parent. | 10 | KU | 15,35 | O |
| 74999 | HEPARIN BIOCHEMIE 25000UT | inj 100x5ml/25ku | BCA | A | | | |
| 93746 | HEPARIN LECIVA | inj 1x10ml/50ku | LEX | CZ | | | |
| 93746 | HEPARIN LÉČIVA | inj 1x10ml/50ku | LEX | CZ | | | |
| 73 | B01AB | antithrombotika ze skupiny heparinu a jeho derivátů (ostatní) | p.o.,parent. | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
Nízkomolekulární hepariny indikovány k léčbě hluboké žilní trombózy, potvrzené dopler. vyšetřením a u pacientek vyžadující antikoagulační léčbu v průběhu gravidity.
Nízkomolekulární hepariny pro ambulantní péči v indikaci:
1) léčby hluboké žilní trombózy potvrzené doplerovským vyšetřením
2) léčby stavů vyžadujících antikoagulační léčbu v průběhu gravidity
3) v období před plánovanou srdeční transplantací
4) prevence a léčby hluboké žilní trombózy u nemocných s prokázaným vrozeným či získaným hyperkoagulačním stavem, u nichž nelze stabilizovat požadované snížení hladiny koagulačních faktorů perorálními antikoagulancii, či s nemožností podat tato antikoagulancia
5) potřeby ambulantního převedení z perorálních antikoagulancií na nízkomolekulární hepariny krátkodobě (max. 5 dnů) před plánovanou operací
| 73.1 | B01AB04 | dalteparin do 2,5 KU včetně v jedné ampuli | parent. | 3 | KU | 64,45 | P |
| | | | | | | | |
@@ -977,13 +1043,13 @@
| | | | | | | | |
| 73.10 | B01AB06 | nadroparin nad 3,8 do 7,6 KU včetně v jedné ampuli | parent. | 3 | KU | 59,74 | P |
| | | | | | | | |
| 73.11 | B01AB06 | nadroparin nad 7,6 KU do 10 KU v jedné ampuli včetně | parent. | 3 | KU | 49.60 | P |
| 73.11 | B01AB06 | nadroparin nad 7,6 KU do 10 KU v jedné ampuli včetně | parent. | 3 | KU | 49,60 | P |
| | | | | | | | |
| 73.12 | B01AB06 | nadroparin nad 10 KU v jedné ampuli | parent. | 3 | KU | 44,00 | P |
| | | | | | | | |
| 73.13 | B01AB07 | parnaparin do 3,2 KU v jedné ampuli včetně | parent. | 3 | KU 64,45 | P | |
| | | | | | | | |
| 73.14 | B01AB07 | parnaparin nad 3,2 do 4,250 KU včetně v jedné ampuli | parent. | 3 | KU 64,40 | P | |
| 73.13 | B01AB07 | parnaparin do 3,2 KU v jedné ampuli včetně | parent. | 3 | KU | 64,45 | P |
| | | | | | | | |
| 73.14 | B01AB07 | parnaparin nad 3,2 do 4,250 KU včetně v jedné ampuli | parent. | 3 | KU | 64,40 | P |
| | | | | | | | |
| 73.15 | B01AB07 | parnaparin nad 4,250 KU v jedné ampuli | parent. | 3 | KU | 59,74 | P |
| | | | | | | | |
@@ -993,11 +1059,10 @@
| | | | | | | | |
| 73.18 | B01AB11 | sulodexid | parent. | 600 | U | 63,44 | O |
| | | | | | | | |
| 73.19 | B01AB11 | sulodexid | p.o. | 250 | U | 12,46 | L/OPH,INT, NEU, DIA,GER |
| 73.19 | B01AB11 | sulodexid | p.o. | 250 | U | 12,46 | L/OPH,INT,NEU, DIA,GER |
| | | | | | | | |
| 73.20 | B01AB | certoparin | parent. | 3 | KU | 76,10 | O |
| 31316 | TROPARIN AMPOULE | inj 10x0.5ml/32mg | BCA | A | | | |
| 53406 | TROPARIN DISPOSABLE SYRINGE | inj 5x0.3ml/32mg | BCA | A | | | |
| 74 | B01AC | antiagregancia trombocytů | p.o. | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
@@ -1007,9 +1072,9 @@
- b) necitlivost na kyselinu acetylsalicylovou zjištěná agregačním vyšetřením v hemokoagulační laboratoři,
- c) podání pacientům po interavaskulárních intervencích (stenty, PTCA, rotablace, atherektomie, laserové atheroplastiky a pod.), podání obvykle v kombinaci s kyselinou acetylsalicylovou po dobu časově omezenou (obvykle jeden měsíc po výkonu).
Léčbu clopidogrelem indikuje kardiolog, internista u nemocných s akutním koronárním syndromem bez elevace úseku ST (nestabilní angina či non-Q infarkt myokardu) obvykle v kombinaci s kyselinou acetylsalicylovou po dobu 12 měsíců od příhody.
- c) podání pacientům po intravaskulárních intervencích (stenty, PTCA, rotablace, atherektomie, laserové atheroplastiky a pod.), podání obvykle v kombinaci s kyselinou acetylsalicylovou po dobu časově omezenou (obvykle jeden měsíc po výkonu).
Léčbu clopidogrelem indikuje kardiolog, internista u nemocných s akutním koronárním syndromem bez elevace úseku ST (nestabilní angina či non-Q infarkt myokardu) obvykle v kombinaci s kyselinou acetylsalicylovou po dobu 6 měsíců od příhody.
Léčbu indobufenem ordinuje internista, kardiolog nebo neurolog:
@@ -1019,22 +1084,21 @@
Léčbu dipyridamolem včetně kombinací indikuje neurolog nebo internista k sekundární prevenci ischemických mozkových příhod u pacientů, kteří netolerují vyšší dávky kyseliny acetylosalicylové nebo při selhání antiagregační léčby, které se projeví cévní mozkovou příhodou.
| 74.1 | B01AC04 | clopidogrel | p.o. | 75 | MG | 33,92 | P |
| 74.1 | B01AC04 | clopidogrel | p.o. | 75 | MG | 39,00 | P |
| | | | | | | | |
| 74.2 | B01AC05 | ticlopidin | p.o. | 0.5 | GM | 23,00 | P |
| 02984 | APO-TIC | por tbl obd30x250mg | APT | CND | | | |
| 02985 | APO-TIC | por tblobd 100x250mg | APT | CND | | | |
| 02518 | IPATON 250 MG | por tbl flm20x250mg | EGI | H | | | |
| 21023 | IPATON 250 MG | por tbl flm60x250mg | EGI | H | | | |
| 66938 | TAGREN | tbl 30x250mg | KRK | SLO | | | |
| 02984 | APO-TIC | por tbl obd30x250mg | APT | CND | | | |
| 02973 | TICLOPIDIN-RATIOPHARM 250 MG | tbl obd 30x250mg | MCK | D | | | |
| 02985 | APO-TIC | por tblobd100x250mg | APT | CND | | | |
| 02974 | TICLOPIDIN-RATIOPHARM 250 MG | tbl obd 90x250mg | MCK | D | | | |
| 74.3 | B01AC06 | kyselina acetylsalicylová (do 30 mg v jedné tabletě včetně) | p.o. | 1 | DF | 0,51 | |
| 72813 | ANOPYRIN 30MG | tbl 20x30mg | SLO | SK | | | |
| 72812 | ANOPYRIN 30MG | tbl 50x30mg | SLO | SK | | | |
| 72813 | ANOPYRIN 30MG | tbl 20x30mg | SLO | SK | | | |
| 74.4 | B01AC06 | kyselina acetylsalicylová (nad 30 mg do 100 mg v jedné tabletě včetně) | p.o. | 1 | DF | 0,51 | |
| 01288 | GODASAL 100 | tbl 50 | PFL | D | | | |
| 99295 | ANOPYRIN 100MG | tbl 20x100mg | SLO | SK | | | |
| 71960 | ANOPYRIN 100MG | tbl 50x100mg | SLO | SK | | | |
| 01286 | GODASAL 100 | tbl 20 | PFL | D | | | |
| | | | | | | | |
| 74.5 | B01AC06 | kyselina acetylsalicylová (nad 100 do 150 mg v jedné tabletě včetně) | p.o. | 1 | DF | 0,98 | |
| | | | | | | | |
| 74.6 | B01AC07 | dipyridamol | p.o. | 400 | MG | 8,65 | P |
@@ -1051,10 +1115,7 @@
| 75.1 | B01AC07 | dipyridamol | parent. | 0.2 | GM | 224,45 | H |
| | | | | | | | |
| 75.2 | B01AC09 | epoprostenol | parent. | 0.5 | MG | 4956,00 | X |
| 41501 | FLOLAN 1.5 MG | inf pso Iqf 1x1.5mg | GWB | GB | | | |
| 41467 | FLOLAN 1.5 MG | inf pso Iqf 1x1.5mg | GOK | GB | | | |
| 58143 | FLOLAN 1.5 MG | inf pso Iqf 1x1.5mg | GOK | GB | | | |
| 41499 | FLOLAN 1.5 MG | inf pso Iqf 1x1.5mg | GWB | GB | | | |
| | | | | | | | |
| 75.3 | B01AC10 | indobufen | parent. | 0.3 | GM | 89,35 | H |
| | | | | | | | |
| 75.4 | B01AC11 | iloprost | parent. | 50 | RG | 660,60 | X |
@@ -1063,7 +1124,7 @@
| | | | | | | | |
| 75.6 | B01AC16 | eptifibatide injekce | parent. | 1 | DF | 930,27 | H |
| | | | | | | | |
| 75.7 | B01AC16 eptifibatide infuze | parent. | 1 | DF | 2930,36 | H | |
| 75.7 | B01AC16 | eptifibatide infuze | parent. | 1 | DF | 2930,36 | H |
| | | | | | | | |
| 75.8 | B01AC17 | tirofiban | parent. | 1 | DF | 5437,00 | H |
| 76 | B01AD | trombolytika | parent. | | | | |
@@ -1080,9 +1141,10 @@
- b) trombolýza akutních a subakutních uzávěrů periferních cév.
| 76.1 | B01AD01 | streptokináza (do 0,75 MU včetně v jedné dávce) | parent. | 1.5 | MU | 3384,60 | U |
| 10937 | STREPTASE | inj sic 1x750ku | HMD | D | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 10937 | STREPTASE | inj sic 1x750ku | AVN | D | | | |
| 76.2 | B01AD01 | streptokináza (nad 0,75 MU v jedné dávce) | parent. | 1.5 | MU | 3214,40 | U |
| 62461 | STREPTASE | inj sic 1x1.5mu | HMD | D | | | |
| 62461 | STREPTASE | inj sic 1x1.5mu | AVN | D | | | |
| 76.3 | B01AD02 | alteplaza | parent. | 0.1 | GM | 43265,44 | U/P |
| | | | | | | | |
| 76.4 | B01AD04 | urokináza (do 100 KU v jedné dávce včetně) | parent. | 3 | MU | 53928,40 | U/P |
@@ -1093,9 +1155,11 @@
| | | | | | | | |
| 76.7 | B01AD07 | retepláza | parent. | 20 | U | 43265,44 | U/P |
| | | | | | | | |
| 76.8 | B01AD10 | drotrecogin alfa (aktivovaný) | parent. | 5 | MG | 6882,00 | H |
| | | | | | | | |
| 76.9 | B01AX03 | lepirudin | parent. 1 | DF | 2300,00 | H | |
| 76.8 | B01AD10 | drotrecogin alfa (aktivovaný) | parent. | 5 | MG | 6882,00 | X |
U pacientů se skórem APACHE II 25 a více, při selhávání dvou a více orgánových systémů, kontrolovaném zdroji sepse a u těch pacientů, kde existuje předpoklad, že po vyléčení bude dostatečná délka a kvalita života, pro vybraná pracoviště.
| 76.9 | B01AX03 | lepirudin | parent. | 1 | DF | 2300,00 | H |
| 77 | B02AA | antifibrinolytika ze skupiny aminokyselin | p.o. | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 77.1 | B02AA01 | kyselina aminokaproová | p.o. | 16 | GM | 38,86 | |
@@ -1103,9 +1167,9 @@
| 77.2 | B02AA02 | kyselina tranexámová (do 250 mg v jedné tabletě včetně) | p.o. | 2 | GM | 40,72 | |
| | | | | | | | |
| 77.3 | B02AA02 | kyselina tranexámová (nad 250 mg v jedné tabletě) | p.o. | 2 | GM | 38,57 | |
| 42613 | EXACYL | por tblflm20x500mg | SBQ | P | | | |
| 42613 | EXACYL | por tblflm20x500mg | SXQ | P | | | |
| 77.4 | B02AA03 | kyselina aminomethylbenzoová | p.o. | 0.25 | GM | 19,31 | |
| 02123 | PAMBA | tbl 10x250mg | CWO | D | | | |
| 02123 | PAMBA | tbl 10x250mg | ABP | D | | | |
| 78 | B02AA | antifibrinolytika ze skupiny aminokyselin | parent. | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 78.1 | B02AA01 | kyselina aminokaproová | parent. | 16 | GM | 65,01 | |
@@ -1113,14 +1177,14 @@
| 78.2 | B02AA02 | kyselina tranexámová | parent. | 2 | GM | 63,74 | |
| 97411 | EXACYL | inj 5x5ml/500mg | SWI | F | | | |
| 78.3 | B02AA03 | kyselina aminomethylbenzoová | parent. | 0.25 | GM | 192,40 | |
| 69793 | PAMBA | inj 5x5ml/50mg | CWO | D | | | |
| 69793 | PAMBA | inj sol 5x5ml/50mg | BGL | D | | | |
| 79 | B02AB | antifibrinolytika ze skupiny inhibitorů proteináz | parent. | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 79.1 | B02AB01 | aprotinin | parent. | 500 | KU | 664,66 | H |
| 80 | B02BA | vitamin K a jeho deriváty a další lokální hemostyptika | p.o. | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 80.1 | B02BA01 | fytomenadion | p.o. | 20 | MG | 10,38 | |
| 00720 | KANAVIT | gtt 1x5ml 20mg/ml | SLO | SK | | | |
| 00720 | KANAVIT | gtt 1x5ml/100mg | SLO | SK | | | |
| 80.2 | B02BX01 | etamsylat | p.o. | 0.75 | GM | 11,30 | L/OPH,HEM,ORL |
| 81 | B02B | vitamin K a jeho deriváty a další lokální hemostyptika | parent. | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
@@ -1130,10 +1194,11 @@
| 00489 | KANAVIT | inj 5x1ml/10mg | HBS | SK | | | |
| 81.3 | B02BX01 | etamsylat | parent. | 0.75 | GM | 80,51 | O |
| 02213 | DICYNONE 250 | inj 100x2ml/250mg | OMR | CH | | | |
| 01821 | DICYNONE 250 | i inj 20x2ml/250mg | OMR | CH | | | |
| 82 | B02BB | lidský fibrinogen | parent. | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 82.1 | B02BB01 | lidský fibrinogen | parent. | 5 | GM | 9452,50 | U |
| 32282 | FIBRINOGEN IMMUNO | inf sic 1000mg+solv | BXG | A | | | |
| 62464 | HAEMOCOMPLETTAN P | inj sic 1x1000mg | CTO | D | | | |
| 83 | B02BC | lokální hemostatika | lok. | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 83.1 | B02BC | lokální hemostatika (rektální lékové formy) | lok. | 1 | DF | 7,19 | |
@@ -1154,40 +1219,42 @@
- b) u nemocných s výskytem inhibitoru proti fakotru VIII v nízkém titru (do 5 Bethesda jednotek),
- c) vepřový faktor VIII je indikován u nemocných s vysokým titrem protilátek proti lidskému faktoru VIII a s nízkým titrem protilátek pr vepřovému faktoru VIII.
- c) vepřový faktor VIII je indikován u nemocných s vysokým titrem protilátek proti lidskému faktoru VIII a s nízkým titrem protilátek proti vepřovému faktoru VIII.
Léčbu koagulačním faktorem IX ordinuje hematolog:
prevence a léčba krvácivých stavů u nemocných s prokázaným deficitem faktoru IX, eventuálně u nemocných s přítomností inhibito faktoru VIII.
prevence a léčba krvácivých stavů u nemocných s prokázaným deficitem faktoru IX, eventuálně u nemocných s přítomností inhibitoru faktoru VIII.
Léčbu aktivitu obcházejícího faktoru VIII ordinuje hematolog. K léčbě krvácivých stavů způsobených prokázaným inhibitorem faktorů koagulačního systému.
Léčbu aptakogem alfa ordinuje hematolog. K léčbě akutního život ohrožujícího krvácení, zejména u nemocných s prokázaným inhibitorem faktorů koagulačního systému.
Léčbu eptakogem alfa ordinuje hematolog. K léčbě akutního život ohrožujícího krvácení, které není prokazatelně zvládnutelné jiným léčivým přípravkem jakož i u nemocných s prokázaným inhibitorem faktorů koagulačního systému.
| 84.1 | B02BD01 | kombinace koagulačních faktorů IX,II,VII a X | parent. | 350 | U | 3284,67 | B/P |
| | | | | | | | |
| 84.2 | B02BD02 | koagulační faktor VIII (středně čištěný) | parent. | 500 | U | 5083,42 | B/P |
| | | | | | | | |
| 84.3 | B02BD02 | koagulační faktor VIII (vysoce čištěný) | parent. | 500 | U | 5818,70 | B/P |
| 53360 | ANTIHEM.F.(LIDSKY),HEMOFIL M | inj sic 1x1000ut+so | BXI | B | | | |
| 53359 | ANTIHEM.F.(LIDSKY),HEMOFIL M | inj sic 1x500ut+sol | BXI | B | | | |
| 53360 | ANTIHEM.F.(LIDSKÝ)HEMOFIL M | inj sic 1x1000ut+so | BXI | B | | | |
| 53359 | ANTIHEM.F.(LIDSKÝ)HEMOFIL M | inj sic 1x500ut+sol | BXI | B | | | |
| 84.4 | B02BD02 | koagulační faktor VIII rekombinantní | parent. | 500 | U | 5818,70 | B/P |
| | | | | | | | |
| 84.5 | B02BD02 | koagulační faktor VIII středně čištěný s von Willebrandovým faktorem | parent. | 500 | U | 7820,64 | B/P |
| | | | | | | | |
| 84.6 | B02BD02 | koagulační faktor VIII vysoce čištěný s von Wilebrandovým faktorem | parent. | 500 | U | 9263,30 | B/P |
| | | | | | | | |
| 88337 | HAEMATE P | inj sic 1x1ku+solv. | AVN | D | | | |
| 88335 | HAEMATE P | inj sic 1x250ut+sol | AVN | D | | | |
| 88336 | HAEMATE P | inj sic 1x500ut+sol | AVN | D | | | |
| 84.7 | B02BD03 | aktivata obcházející inhibitor faktoru VIII | parent. | 10 | KU | 297672,00 | B/P |
| 85676 | FEIBA TIM 4 | inj sic 1x500ut+sol | IMM | A | | | |
| 85677 | FEIBA TIM 4 | inj sic 1x1ku+solv. | IMM | A | | | |
| 84.8 | B02BD04 | koagulační faktor IX (středné čištěný) | parent. | 350 | U | 3284,67 | B/P |
| 85677 | FEIBA TIM 4 1000 J. | inf pso Iqf 1x1ku | BXG | A | | | |
| 85676 | FEIBA TIM 4 500 J. | inf pso Iqf 1x500ut | BXG | A | | | |
| 84.8 | B02BD04 | koagulační faktor IX (středně čištěný) | parent. | 350 | U | 3284,67 | B/P |
| | | | | | | | |
| 84.9 | B02BD04 | koagulační faktor IX (vysoce čištěný) | parent. | 350 | U | 4174,27 | B/P |
| | | | | | | | |
| 84.10 | B02BD08 | eptakog alfa (aktivovaný) | parent. | 2.5 | MU | 1357785,42 | B/P |
| 89826 | NOVOSEVEN 2.4MG(=120KU) | inj sic 1x2.4mg+sol | NOO | DK | | | |
| 89825 | NOVOSEVEN 1.2MG(=60KU) | inj sic 1x1.2mg+sol | NOO | DK | | | |
| 92641 | NOVOSEVEN 4.8MG(=240KU) | inj sic 1x4.8mg+sol | NOO | DK | | | |
| 89826 | NOVOSEVEN 120KIU (2.4MG) | inj pso Iqf 1x2.4mg | NOO | DK | | | |
| 92641 | NOVOSEVEN 240KIU (4.8MG) | inj pso Iqf 1x4.8mg | NOO | DK | | | |
| 89825 | NOVOSEVEN 60KIU (1.2MG) | inj pso Iqf 1x1.2mg | NOO | DK | | | |
| 85 | B02BD | koagulační faktory (ostatní koagulační faktory) | parent. | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 85.1 | B02BD | srážecí faktory | parent. | 350 | U | 2975,02 | X |
@@ -1197,7 +1264,8 @@
| 85.3 | B02BD07 | koagulační faktor XIII | parent. | 350 | U | 2975,02 | X |
| 86 | B03AA | soli dvojmocného železa | p.o. | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 86.1 | B03AA02 | fumarát železnatý (pevné lékové formy) | p.o. | 0.1 | GM | 1.12 | |
| 86.1 | B03AA02 | fumarát železnatý (pevné lékové formy) | p.o. | 0.1 | GM | 1,12 | |
| | | | | | | | |
| 86.2 | B03AA02 | fumarát železnatý (tekuté lékové formy) | p.o. | 0.1 | GM | 2,98 | |
| 00677 | FERRONAT | sus 1x100ml/3gm | GNO | CZ | | | |
| 86.3 | B03AA03 | glukonát železnatý (pevné lékové formy) | p.o. | 0.1 | GM | 1,12 | |
@@ -1215,21 +1283,23 @@
| 86.9 | B03AB | soli trojmocného železa (tekuté lékové formy) | p.o. | 0.1 | GM | 3,20 | |
| | | | | | | | |
| 86.10 | B03AB02 | polymaltosum ferricum (tekuté lékové formy) | p.o. | 0.1 | GM | 10,80 | |
| 02946 | MALTOFER | por gtt sol 30 ml | VII | CH | | | |
| 87 | B03AC | soli trojmocného železa | parent. | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 87.1 | B03AC02 | hydroxid železitý se sacharózou | parent. | 0.1 | GM | 41,70 | O |
| 04084 | FERRUM LEK I.M. | inj 50x2ml/100mg | LEK | SLO | | | |
| 04084 | FERRUM LEK I.M. | inj sol50x2ml/100mg | LEK | SLO | | | |
| 87.2 | B03AC03 | komplex železo-sorbitol-citronová kyselina | parent. | 0.1 | GM | 25,56 | O |
| | | | | | | | |
| 87.3 | B03AC07 | glukonát železito-sodný | parent. | 0.1 | GM | 41,70 | O |
| 03418 | FERRLECIT | inj 5x5ml/62.5mg | NAT | D | | | |
| 03418 | FERRLECIT | inj sol 5x5ml | NAJ | D | | | |
| 70425 | FERRLECIT | inj sol5x5ml/62.5mg | AVT | GB | | | |
| 88 | B03AD | soli dvojmocného železa v kombinaci s kyselinou listovou | p.o. | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 88.1 | B03AD | chlorid železnatý/kyselina listová | p.o. | 0.1 GM | 4,30 | L/GYN,HEM | |
| | | | | | | | |
| 88.2 | B03AD | glukonát železnatý/kyselina listová | p.o. | 0.1 | GM | 4,30 | L/GYN,HEM |
| | | | | | | | |
| 88.3 | B03AD02 | fumarat železnatý/kyselina listová | p.o. | 0.1 | GM | 4,30 | L/GYN,HEM, INT, GER |
| 88.1 | B03AD | chlorid železnatý/kyselina listová | p.o. | 0.1 | GM | 4,30 | L/GYN,HEM |
| | | | | | | | |
| 88.2 | B03AD | glukonat železnatý/kyselina listová | p.o. | 0.1 | GM | 4,30 | L/GYN,HEM |
| | | | | | | | |
| 88.3 | B03AD02 | fumarat železnatý/kyselina listová | p.o. | 0.1 | GM | 4,30 | L/GYN,HEM,INT, GER |
| | | | | | | | |
| 88.4 | B03AD03 | síran železnatý/kyselina listová | p.o. | 0.1 | GM | 4,30 | L/GYN,HEM |
| 89 | B03AE | soli dvojmocného železa v ostatních kombinacích | p.o. | | | | |
@@ -1239,10 +1309,9 @@
| 89.2 | B03AE02 | dvojmocné soli železa/kyselina listová/vitaminy | p.o. | 0.1 | GM | 3,90 | |
| | | | | | | | |
| 89.3 | B03AE10 | chlorid železnatý/kyselina listová | p.o. | 0.1 | GM | 3,90 | |
| | | | | | | | |
| 89.4 | B03AE10 | fumarat železnatý/kyselina listová | p.o. | 0.1 | GM | 3,90 | |
| | | | | | | | |
| 89.5 | B03AE10 | glukonát železnatý/kyselina listová | p.o. | 0.1 | GM | 3,90 | |
| 89.5 | B03AE10 | glukonat železnatý/kyselina listová | p.o. | 0.1 | GM | 3,90 | |
| | | | | | | | |
| 89.6 | B03AE10 | různé kombinace bez kyseliny listové | p.o. | 0.1 | GM | 3,20 | |
| 97402 | SORBIFER DURULES | tbl obd 50x100mg | EGI | H | | | |
@@ -1254,7 +1323,7 @@
| 90 | B03BA | vitamin B12 a jeho deriváty | parent. | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 90.1 | B03BA01 | cyanokobalamin (do 0,3 mg v jedné ampuli včetně) | parent. | 0.02 | MG | 0,51 | |
| 00641 | VITAMIN B12 LECIVA 300RG | inj 5x1ml/300rg | LEX | CZ | | | |
| 00641 | VITAMIN B12 LÉČIVA 300MCG | inj 5x1ml/300rg | LEX | CZ | | | |
| 90.2 | B03BA01 | cyanokobalamin (nad 0,3 mg v jedné ampuli) | parent. | 0.02 | MG | 0,20 | |
| 92503 | NEUROBENE | inj 6x1ml/1000rg | MCK | D | | | |
| 91 | B03BB | kyselina listová a její deriváty | p.o. | | | | |
@@ -1272,7 +1341,7 @@
- c) léčba těžké anémie nezralých dětí.
| 92.1 | B03XA01 | erythropoetin do 500 IU v jedné ampuli včetně | parent. | 1 | KU | 497,40 | K/P |
| 64814 | NEORECORMON 500 IU | inj 6x0.3ml/500iu | ROC | D | | | |
| 64814 | NEORECORMON 500 IU | injsol6x0.3ml/500ut | ROC | D | | | |
| 92.2 | B03XA01 | erythropoetin více než 500 IU do 10 KU v jedné ampuli včetně | parent. | 1 | KU | 455,00 | K/P |
| | | | | | | | |
| 92.3 | B03XA01 | erythropoetin více než 10 KU v jedné ampuli | parent. | 1 | KU | 430,00 | K/P |
@@ -1281,17 +1350,16 @@
| 93.1 | B05AA01 | albumin (z tuzemské plazmy zakázkovou frakcionací) | parent. | 20 | GM | 2676,90 | B |
| | | | | | | | |
| 93.2 | B05AA01 | albumin | parent. | 20 | GM | 2676,90 | B |
| 10124 | HUMAN ALBUMIN 20% BIOTEST | inf 1x100ml | BTP | D | | | |
| 10117 | HUMAN ALBUMIN 20% BIOTEST | inf 1x50ml | BTP | D | | | |
| 62471 | HUMAN ALBUMIN 20% IMMUNO | inf sol 1x100ml 20% | BXG | A | | | |
| 62470 | HUMAN ALBUMIN 20% IMMUNO | inf sol 1x50ml 20% | BXG | A | | | |
| 62472 | HUMAN ALBUMIN 5% IMMUNO | inj 1x250ml 5% | BXG | A | | | |
| 97910 | HUMAN ALBUMIN GRIFOLS 20% | inf sol 1x100ml | GFO | E | | | |
| 42144 | HUMAN ALBUMIN GRIFOLS 20% | inf sol 1x10ml | GFO | E | | | |
| 97909 | HUMAN ALBUMIN GRIFOLS 20% | inf sol 1x50ml | GFO | E | | | |
| 97907 | HUMAN ALBUMIN GRIFOLS 5% | inf sol 1x250ml | GFO | E | | | |
| 97908 | HUMAN ALBUMIN GRIFOLS 5% | inf sol 1x500ml | GFO | E | | | |
| 97910 | HUMAN ALBUMIN GRIFOLS 20% | inf sol 1x100ml | GFO | E | | | |
| 10124 | HUMAN ALBUMIN 20% | inf 1x100ml | BTP | D | | | |
| 97907 | HUMAN ALBUMIN GRIFOLS 5% | inf sol 1x250ml | GFO | E | | | |
| 98147 | ALBUMIN LIDSKY SP 20% SEVAC | inj 5x1ml | USO | CZ | | | |
| 62470 | HUMAN ALBUMIN 20% IMMUNO | inf 1x50ml | IMM | A | | | |
| 97909 | HUMAN ALBUMIN GRIFOLS 20% | inf sol 1x50ml | GFO | E | | | |
| 10117 | HUMAN ALBUMIN 20% | inf 1x50ml | BTP | D | | | |
| 62471 | HUMAN ALBUMIN 20% IMMUNO | inf 1x100ml | IMM | A | | | |
| 42144 | HUMAN ALBUMIN GRIFOLS 20% | inf sol 1x10ml | GFO | E | | | |
| 62472 | HUMAN ALBUMIN 5% IMMUNO | inf 1x250ml | IMM | A | | | |
| 93.3 | B05AA02 | ostatní bílkoviny plasmy užívané jako její náhrady | parent. | 100 | ML | 952,16 | B |
| 94 | B05AA | substituenty plazmy a plazmatické proteiny (ostatní) | parent. | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
@@ -1299,172 +1367,181 @@
| | | | | | | | |
| 94.2 | B05AA05 | dextran (koncentrace 6%) | parent. | 500 | ML | 108,80 | O |
| | | | | | | | |
| 94.3 | B05AA05 | dextran (koncentrace 6% v hyperosmolárním roztoku) | parent. | 500 | ML | 123.86 | O |
| 94.3 | B05AA05 | dextran (koncentrace 6% v hyperosmolárním roztoku) | parent. | 500 | ML | 123,86 | O |
| | | | | | | | |
| 94.4 | B05AA06 | želatinové přípravky | parent. | 500 | ML | 173,90 | O |
| 56412 | GELOFUSINE | inf 1x500ml | BME | CH | | | |
| 94.5 | B05AA07 | hydroxyethylškrob | parent. | 500 | ML | 291,60 | O |
| 44431 | HEMOHES 6% | inf 1x500ml(pe) | BME | D | | | |
| 55897 | HEMOHES 6% | inf 10x500ml(pe) | BME | D | | | |
| 44467 | HEMOHES 10% | inf 1x500ml(pe) | BME | D | | | |
| 95 | B05BA | roztoky k parenteralní výživě (glukóza až do 40% koncentrace) | parent. | | | | |
| 44467 | HEMOHES 10% | inf sol1x500ml(pe) | BMM | D | | | |
| 44431 | HEMOHES 6% | inf sol 1x500ml-pe | BMM | D | | | |
| 55897 | HEMOHES 6% | inf sol10x500ml-pe | BMM | D | | | |
| 95 | B05BA | roztoky k parenterální výživě (glukóza až do 40% koncentrace) | parent. | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 95.1 | B05BA03 | glukóza 10% (nad 100 do 250 ml v jednom balení včetně) | parent. | 100 | ML | 12,71 | O |
| 31433 | 10% DEXTROSE IN WATER FRESENIUS | inf sol 16x250ml-sk | FKI | I | | | |
| 31432 | 10% DEXTROSE IN WATER FRESENIUS | inf sol 1x250ml-skl | FKI | I | | | |
| 43919 | 10% DEXTROSE IN WATER USP SIFRA | inf 16x250ml-sklo | SFR | I | | | |
| 92531 | 10% DEXTROSE IN WATER USP SIFRA | inf 1x250ml-sklo | SFR | I | | | |
| 97735 | GLUCOSE 10%W/V I.V.B.P.BIEFFE | inf 1x250ml(sklo) | BFF | I | | | |
| 59433 | GLUCOSE 10%W/V I.V.B.P.BIEFFE | inf 1x250ml(vak) | BFF | I | | | |
| 59437 | GLUCOSE 10%W/V I.V.B.P.BIEFFE | inf 1x250ml(vak) | BFH | E | | | |
| 92531 | 10% DEXTROSE IN WATER F.INJ.USP | inf 1x250ml(sklo) | SFR | I | | | |
| 62376 | INFUSIO GLUCOSI 10 IMUNA | inf 1x250ml(sklo) | IMA | SK | | | |
| 31433 | 10% DEXTROSE IN WATER FRESENIUS | inf sol 16x250ml-sk | FKI | I | | | |
| 97735 | GLUCOSE 10%W/V I.V.B.P.BIEFFE | inf 1x250ml(sklo) | BFF | I | | | |
| 31432 | 10% DEXTROSE IN WATER FRESENIUS | inf sol 1x250ml-skl | FKI | I | | | |
| 43919 | 10% DEXTROSE IN WATER USP SIFRA | inf 16x250ml(sklo) | SFR | I | | | |
| 59433 | GLUCOSE 10%W/V I.V.B.P.BIEFFE | inf 1x250ml(vak) | BFF | I | | | |
| 66872 | INFUSIO GLUCOSI 10% INFUSIA | inf 1x250ml(sklo) | IHO | CZ | | | |
| 66872 | INFUSIO GLUCOSI 10% INFUSIA | inf sol 1x250ml-skl | IHO | CZ | | | |
| 95.2 | B05BA03 | glukóza 10% (nad 250 do 500 ml v jednom balení včetně) | parent. | 100 | ML | 6,04 | O |
| 92534 | 10% DEXTROSE IN WATER F.INJ.USP | inf 1x500ml(pp) | SFR | I | | | |
| 96877 | GLUKOZA 10 BRAUN | inf 1x500ml(plast) | BMM | D | | | |
| 47017 | GLUKOZA 10 BRAUN | inf 1x500ml(plast) | BME | CH | | | |
| 47000 | GLUKOZA 10 BRAUN | inf 1x500ml(plast) | BME | E | | | |
| 31437 | 10% DEXTROSE IN WATER FRESENIUS | inf sol 1x500ml-pp | FKI | I | | | |
| 92534 | 10% DEXTROSE IN WATER USP SIFRA | inf 1x500ml-pp | SFR | I | | | |
| 97736 | GLUCOSE 10%W/V I.V.B.P.BIEFFE | inf 1x500ml(sklo) | BFF | I | | | |
| 59419 | GLUCOSE 10%W/V.I.V.B.P.BIEFFE | inf 1x500ml(vak) | BFH | E | | | |
| 97737 | GLUCOSE 10%W/V I.V.B.P.BIEFFE | inf 1x500ml(plast) | BFF | I | | | |
| 31437 | 10% DEXTROSE IN WATER FRESENIUS | inf sol 1x500ml-pp | FKI | I | | | |
| 71735 | INFUSIO GLUCOSI 100 G/L MVM G10 | inf 1x500ml | MVM | CZ | | | |
| 59419 | GLUCOSE 10%W/V I.V.B.P.BIEFFE | inf 1x500ml(vak) | BFH | E | | | |
| 97737 | GLUCOSE 10%W/V I.V.B.P.BIEFFE | inf 1x500ml(vak) | BFF | I | | | |
| 47000 | GLUKÓZA 10 BRAUN | inf 1x500ml-pe | BME | E | | | |
| 47017 | GLUKÓZA 10 BRAUN | inf 1x500ml-pe | BME | CH | | | |
| 96877 | GLUKÓZA 10 BRAUN | inf 1x500ml-pe | BMM | D | | | |
| 71735 | INFUSIO GLUCOSI 100 G/L MVM G10 | inf sol 1x500ml | MVM | CZ | | | |
| 95.3 | B05BA03 | glukóza 10% (do 100 ml v jednom balení včetně) | parent. | 100 | ML | 28,00 | O |
| 92530 | 10% DEXTROSE IN WATER F.INJ.USP | inf 1x100ml(sklo) | SFR | I | | | |
| 31430 | 10% DEXTROSE IN WATER FRESENIUS | inf sol 1x100ml-skl | FKI | I | | | |
| 03433 | 10% DEXTROSE IN WATER FRESENIUS | inf sol 20x100ml-sk | FKI | I | | | |
| 31431 | 10% DEXTROSE IN WATER FRESENIUS | inf sol 49x100ml-sk | FKI | I | | | |
| 92530 | 10% DEXTROSE IN WATER USP SIFRA | inf 1x100ml-sklo | SFR | I | | | |
| 43918 | 10% DEXTROSE IN WATER USP SIFRA | inf 49x100ml-sklo | SFR | I | | | |
| 59432 | GLUCOSE 10%W/V I.V.B.P.BIEFFE | inf 1x100ml(vak) | BFF | I | | | |
| 59436 | GLUCOSE 10%W/V I.V.B.P.BIEFFE | inf 1x100ml(vak) | BFH | E | | | |
| 59432 | GLUCOSE 10%W/V I.V.B.P.BIEFFE | inf 1x100ml(vak) | BFF | I | | | |
| 31430 | 10% DEXTROSE IN WATER FRESENIUS | inf sol 1x100ml-skl | FKI | I | | | |
| 43918 | 10% DEXTROSE IN WATER USP SIFRA | inf 49x100ml(sklo) | SFR | I | | | |
| 31431 | 10% DEXTROSE IN WATER FRESENIUS | inf sol 49x100ml-sk | FKI | I | | | |
| 03433 | 10% DEXTROSE IN WATER FRESENIUS | inf sol 20x100ml-sk | FKI | I | | | |
| 95.4 | B05BA03 | glukóza 10% (nad 500 ml v jednom balení) | parent. | 100 | ML | 5,82 | O |
| 92772 | INFUSIO GLUCOSI 10 MEDIEKOS G10 | inf 1x2000ml(vak) | MKS | CZ | | | |
| 43927 | 10% DEXTROSE IN WATER USP SIFRA | inf 4x2000ml(vak) | SFR | I | | | |
| 31439 | 10% DEXTROSE IN WATER FRESENIUS | inf sol 1x1000ml-pp | FKI | I | | | |
| 31436 | 10% DEXTROSE IN WATER FRESENIUS | inf sol 1x1000ml-sk | FKI | I | | | |
| 31447 | 10% DEXTROSE IN WATER FRESENIUS | inf sol 1x1000ml-va | FKI | I | | | |
| 31449 | 10% DEXTROSE IN WATER FRESENIUS | inf sol 1x2000ml-va | FKI | I | | | |
| 31450 | 10% DEXTROSE IN WATER FRESENIUS | inf sol 4x2000ml-va | FKI | I | | | |
| 43922 | 10% DEXTROSE IN WATER USP SIFRA | inf 12x1000ml(pp) | SFR | I | | | |
| 47018 | GLUKOZA 10 BRAUN | inf 1x1000ml(plast) | BME | CH | | | |
| 47001 | GLUKOZA 10 BRAUN | inf 1x1000ml(plast) | BME | E | | | |
| 92533 | 10% DEXTROSE IN WATER F.INJ.USP | inf 1x1000ml(sklo) | SFR | I | | | |
| 31447 | 10% DEXTROSE IN WATER FRESENIUS | inf sol 1x1000ml-va | FKI | I | | | |
| 92535 | 10% DEXTROSE IN WATER F.INJ.USP | inf 1x1000ml(pp) | SFR | I | | | |
| 92539 | 10% DEXTROSE IN WATER F.INJ.USP | inf 1x1000ml(vak) | SFR | I | | | |
| 92540 | 10% DEXTROSE IN WATER F.INJ.USP | inf 1x2000ml(vak) | SFR | I | | | |
| 31440 | 10% DEXTROSE IN WATER FRESENIUS | inf sol 12x1000ml-pp | FKI | I | | | |
| 31449 | 10% DEXTROSE IN WATER FRESENIUS | inf sol 1x2000ml-va | FKI | I | | | |
| 31440 | 10% DEXTROSE IN WATER FRESENIUS | inf sol12x1000ml-pp | FKI | I | | | |
| 43922 | 10% DEXTROSE IN WATER USP SIFRA | inf 12x1000ml-pp | SFR | I | | | |
| 92535 | 10% DEXTROSE IN WATER USP SIFRA | inf 1x1000ml-pp | SFR | I | | | |
| 92533 | 10% DEXTROSE IN WATER USP SIFRA | inf 1x1000ml-sklo | SFR | I | | | |
| 92539 | 10% DEXTROSE IN WATER USP SIFRA | inf 1x1000ml-vak | SFR | I | | | |
| 92540 | 10% DEXTROSE IN WATER USP SIFRA | inf 1x2000ml-vak | SFR | I | | | |
| 43927 | 10% DEXTROSE IN WATER USP SIFRA | inf 4x2000ml-vak | SFR | I | | | |
| 59434 | GLUCOSE 10%W/V I.V.B.P.BIEFFE | inf 1x1000ml(vak) | BFF | I | | | |
| 59438 | GLUCOSE 10%W/V I.V.B.P.BIEFFE | inf 1x1000ml(vak) | BFH | E | | | |
| 96878 | GLUKOZA 10 BRAUN | inf 1x1000ml(plast) | BMM | D | | | |
| 59434 | GLUCOSE 10%W/V I.V.B.P.BIEFFE | inf 1x1000ml(vak) | BFF | I | | | |
| 31436 | 10% DEXTROSE IN WATER FRESENIUS | inf sol 1x1000ml-sk | FKI | I | | | |
| 47001 | GLUKÓZA 10 BRAUN | inf 1x1000ml-pe | BME | E | | | |
| 47018 | GLUKÓZA 10 BRAUN | inf 1x1000ml-pe | BME | CH | | | |
| 96878 | GLUKÓZA 10 BRAUN | inf 1x1000ml-pe | BMM | D | | | |
| 92772 | INFUSIO GLUCOSI 10 MEDIEKOS G10 | inf 1x2000ml(vak) | INK | CZ | | | |
| 95.5 | B05BA03 | glukóza 20% (do 100 ml v jednom balení včetně) | parent. | 100 | ML | 29,10 | O |
| 57750 | GLUCOSE 20% INFUSION-HUMAN | inf 1x100ml | HUA | H | | | |
| 95.6 | B05BA03 | glukóza 20% (nad 100 ml v jednom balení) | parent. | 100 | ML | 6,46 | O |
| 59422 | GLUCOSE 20%W/V I.V.B.P.BIEFFE | inf 1x1000ml(vak) | BFH | E | | | |
| 95.7 | B05BA03 | glukóza 5% (nad 100 do 250 ml v jednom balení včetně) | parent. | 100 | ML | 12,90 | O |
| 97732 | GLUCOSE 5%W/V I.V.B.P.BIEFFE | inf 1x250ml(plast) | BFF | I | | | |
| 92520 | 5% DEXTROSE IN WATER F.INJ.USP | inf 1x250ml(sklo) | SFR | I | | | |
| 31465 | 5% DEXTROSE IN WATER FRESENIUS | inf sol 30x250ml-va | FKI | I | | | |
| 31464 | 5% DEXTROSE IN WATER FRESENIUS | inf sol 1x250ml-vak | FKI | I | | | |
| 66866 | INFUSIO GLUCOSI 5% INFUSIA | inf 1x250ml(sklo) | IHO | CZ | | | |
| 43934 | 5% DEXTROSE IN WATER USP SIFRA | inf 30x250ml(vak) | SFR | I | | | |
| 31454 | 5% DEXTROSE IN WATER FRESENIUS | inf sol 16x250ml-sk | FKI | I | | | |
| 31453 | 5% DEXTROSE IN WATER FRESENIUS | inf sol 1x250ml-skl | FKI | I | | | |
| 43929 | 5% DEXTROSE IN WATER USP SIFRA | inf 16x250ml(sklo) | SFR | I | | | |
| 53818 | INFUSIO GLUCOSI 5% INFUSIA | inf 1x250ml(pvc) | IHO | CZ | | | |
| 46995 | GLUKOZA 5 BRAUN | inf 1x250ml(plast) | BME | E | | | |
| 96872 | GLUKOZA 5 BRAUN | inf 1x250ml(plast) | BMM | D | | | |
| 62372 | INFUSIO GLUCOSI 5 IMUNA | inf 1x250ml(sklo) | IMA | SK | | | |
| 47012 | GLUKOZA 5 BRAUN | inf 1x250ml(plast) | BME | CH | | | |
| 92526 | 5% DEXTROSE IN WATER F.INJ.USP | inf 1x250ml(vak) | SFR | I | | | |
| 31464 | 5% DEXTROSE IN WATER FRESENIUS | inf sol 1x250ml-vak | FKI | I | | | |
| 31465 | 5% DEXTROSE IN WATER FRESENIUS | inf sol 30x250ml-va | FKI | I | | | |
| 43929 | 5% DEXTROSE IN WATER USP SIFRA | inf 16x250ml-sklo | SFR | I | | | |
| 92520 | 5% DEXTROSE IN WATER USP SIFRA | inf 1x250ml-sklo | SFR | I | | | |
| 43934 | 5% DEXTROSE IN WATER USP SIFRA | inf 30x250ml-vak | SFR | I | | | |
| 97729 | GLUCOSE 5%W/V I.V.B.P.BIEFFE | inf 1x250ml(sklo) | BFF | I | | | |
| 59414 | GLUCOSE 5%W/V I.V.B.P.BIEFFE | inf 1x250ml(vak) | BFH | E | | | |
| 97732 | GLUCOSE 5%W/V I.V.B.P.BIEFFE | inf 1x250ml(vak) | BFF | I | | | |
| 46995 | GLUKÓZA 5 BRAUN | inf 1x250ml-pe | BME | E | | | |
| 47012 | GLUKÓZA 5 BRAUN | inf 1x250ml-pe | BME | CH | | | |
| 96872 | GLUKÓZA 5 BRAUN | inf 1x250ml-pe | BMM | D | | | |
| 98894 | GLUKÓZA 5% VIAFLO | inf sol 30x250ml | BFH | E | | | |
| 98893 | GLUKÓZA 5% VIAFLO | inf sol 35x150ml | BFH | E | | | |
| 62372 | INFUSIO GLUCOSI 5 IMUNA | inf 1x250ml(sklo) | IMA | SK | | | |
| 53818 | INFUSIO GLUCOSI 5% INFUSIA | inf sol 1x250ml-pvc | IHO | CZ | | | |
| 66866 | INFUSIO GLUCOSI 5% INFUSIA | inf sol 1x250ml-skl | IHO | CZ | | | |
| 95.8 | B05BA03 | glukóza 5% (nad 250 do 500 ml v jednom balení včetně) | parent. | 100 | ML | 6,89 | O |
| 43931 | 5% DEXTROSE IN WATER USP SIFRA | inf 20x500ml(pp) | SFR | I | | | |
| 43930 | 5% DEXTROSE IN WATER USP SIFRA | inf 12x500ml(sklo) | SFR | I | | | |
| 97733 | GLUCOSE 5%W/V I.V.B.P.BIEFFE | inf 1x500ml(plast) | BFF | I | | | |
| 31456 | 5% DEXTROSE IN WATER FRESENIUS | inf sol 12x500ml-sk | FKI | I | | | |
| 31458 | 5% DEXTROSE IN WATER FRESENIUS | inf sol 1x500ml-pp | FKI | I | | | |
| 31455 | 5% DEXTROSE IN WATER FRESENIUS | inf sol 1x500ml-skl | FKI | I | | | |
| 31466 | 5% DEXTROSE IN WATER FRESENIUS | inf sol 1x500ml-vak | FKI | I | | | |
| 31459 | 5% DEXTROSE IN WATER FRESENIUS | inf sol 20x500ml-pp | FKI | I | | | |
| 31467 | 5% DEXTROSE IN WATER FRESENIUS | inf sol 20x500ml-va | FKI | I | | | |
| 43930 | 5% DEXTROSE IN WATER USP SIFRA | inf 12x500ml-sklo | SFR | I | | | |
| 92523 | 5% DEXTROSE IN WATER USP SIFRA | inf 1x500ml-pp | SFR | I | | | |
| 92521 | 5% DEXTROSE IN WATER USP SIFRA | inf 1x500ml-sklo | SFR | I | | | |
| 92527 | 5% DEXTROSE IN WATER USP SIFRA | inf 1x500ml-vak | SFR | I | | | |
| 43931 | 5% DEXTROSE IN WATER USP SIFRA | inf 20x500ml-pp | SFR | I | | | |
| 43935 | 5% DEXTROSE IN WATER USP SIFRA | inf 20x500ml-vak | SFR | I | | | |
| 97730 | GLUCOSE 5%W/V I.V.B.P.BIEFFE | inf 1x500ml(sklo) | BFF | I | | | |
| 31467 | 5% DEXTROSE IN WATER FRESENIUS | inf sol 20x500ml-va | FKI | I | | | |
| 92521 | 5% DEXTROSE IN WATER F.INJ.USP | inf 1x500ml(sklo) | SFR | I | | | |
| 96873 | GLUKOZA 5 BRAUN | inf 1x500ml(plast) | BMM | D | | | |
| 43935 | 5% DEXTROSE IN WATER USP SIFRA | inf 20x500ml(vak) | SFR | I | | | |
| 31456 | 5% DEXTROSE IN WATER FRESENIUS | inf sol 12x500ml-sk | FKI | I | | | |
| 71734 | INFUSIO GLUCOSI 50 G/L MVM G5 | inf 1x500ml | MVM | CZ | | | |
| 31466 | 5% DEXTROSE IN WATER FRESENIUS | inf sol 1x500ml-vak | FKI | I | | | |
| 47013 | GLUKOZA 5 BRAUN | inf 1x500ml(plast) | BME | CH | | | |
| 92523 | 5% DEXTROSE IN WATER F.INJ.USP | inf 1x500ml(pp) | SFR | I | | | |
| 59415 | GLUCOSE 5%W/V I.V.B.P.BIEFFE | inf 1x500ml(vak) | BFH | E | | | |
| 31455 | 5% DEXTROSE IN WATER FRESENIUS | inf sol 1x500ml-skl | FKI | I | | | |
| 31458 | 5% DEXTROSE IN WATER FRESENIUS | inf sol 1x500ml-pp | FKI | I | | | |
| 31459 | 5% DEXTROSE IN WATER FRESENIUS | inf sol 20x500ml-pp | FKI | I | | | |
| 46996 | GLUKOZA 5 BRAUN | inf 1x500ml(plast) | BME | E | | | |
| 86341 | INFUSIO GLUCOSI 5% INFUSIA | inf 1x500ml(plast) | IHO | CZ | | | |
| 92527 | 5% DEXTROSE IN WATER F.INJ.USP | inf 1x500ml(vak) | SFR | I | | | |
| 97733 | GLUCOSE 5%W/V I.V.B.P.BIEFFE | inf 1x500ml(vak) | BFF | I | | | |
| 46996 | GLUKÓZA 5 BRAUN | inf 1x500ml-pe | BME | E | | | |
| 47013 | GLUKÓZA 5 BRAUN | inf 1x500ml-pe | BME | CH | | | |
| 96873 | GLUKÓZA 5 BRAUN | inf 1x500ml-pe | BMM | D | | | |
| 98901 | GLUKÓZA 5% VIAFLO | inf sol 20x500ml | BFH | E | | | |
| 86341 | INFUSIO GLUCOSI 5% INFUSIA | inf sol 1x500ml-pe | IHO | CZ | | | |
| 71734 | INFUSIO GLUCOSI 50 G/L MVM G5 | inf sol 1x500ml | MVM | CZ | | | |
| 95.9 | B05BA03 | glukóza 5% (do 100 ml v jednom balení včetně) | parent. | 100 | ML | 27,76 | O |
| 43928 | 5% DEXTROSE IN WATER USP SIFRA | inf 49x100ml(sklo) | SFR | I | | | |
| 47011 | GLUKOZA 5 BRAUN | inf 1x100ml(sklo) | BME | CH | | | |
| 31451 | 5% DEXTROSE IN WATER FRESENIUS | inf sol 1x100ml-skl | FKI | I | | | |
| 31462 | 5% DEXTROSE IN WATER FRESENIUS | inf sol 1x100ml-vak | FKI | I | | | |
| 03432 | 5% DEXTROSE IN WATER FRESENIUS | inf sol 20x100ml-sk | FKI | I | | | |
| 46994 | GLUKOZA 5 BRAUN | inf 1x100ml(sklo) | BME | E | | | |
| 31463 | 5% DEXTROSE IN WATER FRESENIUS | inf sol 40x100ml-va | FKI | I | | | |
| 31452 | 5% DEXTROSE IN WATER FRESENIUS | inf sol 49x100ml-sk | FKI | I | | | |
| 92519 | 5% DEXTROSE IN WATER USP SIFRA | inf 1x100ml-sklo | SFR | I | | | |
| 92525 | 5% DEXTROSE IN WATER USP SIFRA | inf 1x100ml-vak | SFR | I | | | |
| 43933 | 5% DEXTROSE IN WATER USP SIFRA | inf 40x100ml-vak | SFR | I | | | |
| 43928 | 5% DEXTROSE IN WATER USP SIFRA | inf 49x100ml-sklo | SFR | I | | | |
| 43933 | 5% DEXTROSE IN WATER USP SIFRA | inf 40x100ml-vak | SFR | I | | | |
| 97728 | GLUCOSE 5%W/V I.V.B.P.BIEFFE | inf 1x100ml(sklo) | BFF | I | | | |
| 96871 | GLUKOZA 5 BRAUN | inf 1x100ml(sklo) | BMM | D | | | |
| 97731 | GLUCOSE 5%W/V I.V.B.P.BIEFFE | inf 1x100ml(plast) | BFF | I | | | |
| 31452 | 5% DEXTROSE IN WATER FRESENIUS | inf sol 49x100ml-sk | FKI | I | | | |
| 59413 | GLUCOSE 5%W/V I.V.B.P.BIEFFE | inf 1x100ml(vak) | BFH | E | | | |
| 43933 | 5% DEXTROSE IN WATER USP SIFRA | inf 40x100ml(vak) | SFR | I | | | |
| 31462 | 5% DEXTROSE IN WATER FRESENIUS | inf sol 1x100ml-vak | FKI | I | | | |
| 31463 | 5% DEXTROSE IN WATER FRESENIUS | inf sol 40x100ml-va | FKI | I | | | |
| 86200 | INFUSIO GLUCOSI 5% INFUSIA | inf 1x100ml(sklo) | IHO | CZ | | | |
| 31451 | 5% DEXTROSE IN WATER FRESENIUS | inf sol 1x100ml-skl | FKI | I | | | |
| 92525 | 5% DEXTROSE IN WATER F.INJ.USP | inf 1x100ml(vak) | SFR | I | | | |
| 97731 | GLUCOSE 5%W/V I.V.B.P.BIEFFE | inf 1x100ml(vak) | BFF | I | | | |
| 46994 | GLUKÓZA 5 BRAUN | inf 1x100ml-sklo | BME | E | | | |
| 47011 | GLUKÓZA 5 BRAUN | inf 1x100ml-sklo | BME | CH | | | |
| 96871 | GLUKÓZA 5 BRAUN | inf 1x100ml-sklo | BMM | D | | | |
| 98886 | GLUKÓZA 5% VIAFLO | inf sol 50x100ml | BFH | E | | | |
| 62370 | INFUSIO GLUCOSI 5 IMUNA | inf 1x100ml(sklo) | IMA | SK | | | |
| 92519 | 5% DEXTROSE IN WATER F.INJ.USP | inf 1x100ml(sklo) | SFR | I | | | |
| 86200 | INFUSIO GLUCOSI 5% INFUSIA | inf sol 1x100ml-skl | IHO | CZ | | | |
| 95.10 | B05BA03 | glukóza 5% (nad 500 ml v jednom balení) | parent. | 100 | ML | 3,96 | O |
| 31468 | 5% DEXTROSE IN WATER FRESENIUS | inf sol 1x1000ml-va | FKI | I | | | |
| 31470 | 5% DEXTROSE IN WATER FRESENIUS | inf sol 1x2000ml-va | FKI | I | | | |
| 31471 | 5% DEXTROSE IN WATER FRESENIUS | inf sol 4x2000ml-va | FKI | I | | | |
| 31469 | 5% DEXTROSE IN WATER FRESENIUS | inf sol10x1000ml-va | FKI | I | | | |
| 43937 | 5% DEXTROSE IN WATER USP SIFRA | inf 4x2000ml(vak) | SFR | I | | | |
| 31468 | 5% DEXTROSE IN WATER FRESENIUS | inf sol 1x1000ml-va | FKI | I | | | |
| 43936 | 5% DEXTROSE IN WATER USP SIFRA | inf 10x1000ml(vak) | SFR | I | | | |
| 31471 | 5% DEXTROSE IN WATER FRESENIUS | inf sol 4x2000ml-va | FKI | I | | | |
| 92528 | 5% DEXTROSE IN WATER F.INJ.USP | inf 1x1000ml(vak) | SFR | I | | | |
| 31470 | 5% DEXTROSE IN WATER FRESENIUS | inf sol 1x2000ml-va | FKI | I | | | |
| 59416 | GLUCOSE 5%W/V I.V.B.P.BIEFFE | inf 1x1000ml(vak) | BFH | E | | | |
| 97734 | GLUCOSE 5%W/V I.V.B.P.BIEFFE | inf 1x1000ml(plast) | BFF | I | | | |
| 92529 | 5% DEXTROSE IN WATER F.INJ.USP | inf 1x2000ml(vak) | SFR | I | | | |
| 43936 | 5% DEXTROSE IN WATER USP SIFRA | inf 10x1000ml-vak | SFR | I | | | |
| 92528 | 5% DEXTROSE IN WATER USP SIFRA | inf 1x1000ml-vak | SFR | I | | | |
| 92529 | 5% DEXTROSE IN WATER USP SIFRA | inf 1x2000ml-vak | SFR | I | | | |
| 43937 | 5% DEXTROSE IN WATER USP SIFRA | inf 4x2000ml-vak | SFR | I | | | |
| 98902 | GLUKÓZA 5% VIAFLO | inf sol 10x1000ml | BFH | E | | | |
| 97734 | GLUCOSE 5%W/V I.V.B.P.BIEFFE | inf 1x1000ml(vak) | BFF | I | | | |
| 95.11 | B05BA03 | glukóza do 10% včetně (do 10 ml v jedné ampuli včetně) | parent. | 100 | ML | 23,90 | O |
| 47241 | GLUKOZA 5 BRAUN | inj 20x10ml(plast) | BMM | D | | | |
| 47241 | GLUKÓZA 5 BRAUN | inf 20x10ml-pla.amp | BMM | D | | | |
| 95.12 | B05BA03 | glukóza nad 10% do 39 % (do 10 ml v jedné ampuli včetně) | parent. | 100 | ML | 98,74 | O |
| | | | | | | | |
| 95.13 | B05BA03 | glukóza nad 20% (nad 100 do 250 ml v jednom balení včetně) | parent. | 100 | ML | 18,18 | O |
| 86972 | ARDEANUTRISOL G 33 | inf 1x250ml | ARD | CZ | | | |
| 55630 | INFUSIO GLUCOSI 40 IMUNA | inf 1x250ml(sklo) | IMA | SK | | | |
| 55630 | INFUSIO GLUCOSI 40 IMUNA | inf 1x250ml | IMA | SK | | | |
| 95.14 | B05BA03 | glukóza nad 20% (do 100 ml v jednom balení včetně) | parent. | 100 | ML | 31,97 | O |
| 55628 | INFUSIO GLUCOSI 40 IMUNA | inf 1x100ml(sklo) | IMA | SK | | | |
| 55628 | INFUSIO GLUCOSI 40 IMUNA | inf 1x100ml | IMA | SK | | | |
| 95.15 | B05BA03 | glukóza nad 20% (nad 250 ml v jednom balení) | parent. | 100 | ML | 8,26 | O |
| | | | | | | | |
| 95.16 | B05BA03 | glukóza inj. 40% (do 10 ml včetně v jedné ampuli) | parent. | 100 | ML | 83,15 | O |
| 02589 | GLUKOZA 40 BRAUN | inf 20x10ml(pla.am) | BME | CH | | | |
| 02587 | GLUKOZA 40 BRAUN | inf 20x10ml(pla.am) | BME | D | | | |
| 96 | B05BA | roztoky k parenterálni výživě (ostatní) | parent. | | | | |
| 95.16 | B05BA03 | glukóza inj. 40% (do 10 ml včetně v jedné ampuli ) | parent. | 100 | ML | 83,15 | O |
| 02587 | GLUKÓZA 40 BRAUN | inf 20x10ml-pla.amp | BMM | D | | | |
| 02589 | GLUKÓZA 40 BRAUN | inf 20x10ml-pla.amp | BME | CH | | | |
| 96 | B05BA | roztoky k parenterální výživě (ostatní) | parent. | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 96.1 | B05BA01 | aminokyseliny (koncentrace do 6% včetně) | parent. | 100 | ML | 38,76 | H |
| | | | | | | | |
| 31989 | CLINIMIX N9G20E | inf sol 4x2000ml | BXF | GB | | | |
| 96.2 | B05BA01 | aminokyseliny (koncentrace nad 14%) | parent. | 100 | ML | 63,44 | H |
| 75521 | AMINOPLASMAL 15% E | inf 1x1000ml | BME | D | | | |
| 96.3 | B05BA01 | aminokyseliny (koncentrace nad 10% do 14% včetně) | parent. | 100 | ML | 70,48 | H |
| 55971 | SALVIAMIN 12.5 E | inf 1x1000ml | CTT | F | | | |
| 55969 | SALVIAMIN 12.5 E | inf 1x500ml | CTT | F | | | |
| 96.4 | B05BA01 | aminokyseliny (koncentrace nad 6% do 10 % včetně) | parent. | 100 | ML | 47,42 | H |
| 31985 | CLINIMIX N14G30E | inf sol 4x2000ml | BXF | GB | | | |
| 31987 | CLINIMIX N17G35E | inf sol 4x2000ml | BXF | GB | | | |
| 92631 | SALVIAMIN 10 E | inf 1x1000ml | CTT | F | | | |
| 96.5 | B05BA02 | tukové emulze (do 10% včetně do 100 ml v jednom balení včetně) | parent. | 100 | ML | 173,20 | H |
| 32004 | INTRALIPID 10 % | inf 10x100ml-vak | FRK | S | | | |
| 45303 | INTRALIPID 10% | inf 1x100ml | PAU | S | | | |
| 04299 | INTRALIPID 10 % | inf 12x100ml-sklo | FRK | S | | | |
| 45303 | INTRALIPID 10 % | inf 1x100ml-sklo | FRK | S | | | |
| 20909 | INTRALIPID 10 % | inf 1x100ml-vak | FRK | S | | | |
| 96.6 | B05BA02 | tukové emulze (nad 10% do 100 ml v jednom balení včetně) | parent. | 100 | ML | 196,40 | H |
| 31526 | SOYACAL 10% | inf eml 20x100ml | GFL | E | | | |
| 96.6 | B05BA02 | tukové emulze (nad 10% do 100 ml v jednom balení včetně) | parent. | 100 | ml | 196,40 | H |
| 31529 | SOYACAL 20% | inf eml 20x100ml | GFL | E | | | |
| 96.7 | B05BA02 | tukové emulze (do 10% včetně nad 100 ml v jednom balerní) | parent. | 100 | ML | 53,83 | H |
| 75442 | INTRALIPID 10 % | inf 12x500ml-sklo | FRK | S | | | |
| 59154 | IVELIP 10% | inf 6x1000ml | CTT | F | | | |
| 75442 | INTRALIPID | inf 12x500ml 10% | PAU | S | | | |
| 96.8 | B05BA02 | tukové emulze (nad 10% nad 100 ml v jednom balení) | parent. | 100 | ML | 67,58 | H |
| 57162 | INTRALIPID 20 % | inf 1x1000ml-sklo | FRK | S | | | |
| 57247 | INTRALIPID 20 % | inf 6x1000ml-sklo | FRK | S | | | |
| 59158 | IVELIP 20% | inf 6x1000ml | CTT | F | | | |
| 57247 | INTRALIPID 20 % | inf 6x1000ml-sklo | FRK | S | | | |
| 57162 | INTRALIPID 20 % | inf 1x1000ml-sklo | FRK | S | | | |
| 96.9 | B05BA03 | fruktóza (koncentrace do 5% včetně) | parent. | 100 | ML | 14,47 | H |
| | | | | | | | |
| 96.10 | B05BA03 | fruktóza (koncentrace nad 10%) | parent. | 100 | ML | 17,74 | H |
@@ -1484,188 +1561,180 @@
| 96.17 | B05BA10 | kombinace bez obsahu aminokyselin | parent. | 100 | ML | 13,20 | H |
| | | | | | | | |
| 96.18 | B05BA10 | kombinace s obsahem aminokyselin | parent. | 100 | ML | 55,76 | H |
| 40178 | AMINOPLASMAL 10% E | inf 1x1000ml | BME | D | | | |
| 45377 | AMINOROZTOK NEO SX 4% INFUSIA | inf 1x500ml | IHO | CZ | | | |
| 45383 | AMINOROZTOK NEO SX 8% INFUSIA | inf 1x500ml | IHO | CZ | | | |
| 47482 | CLINOMEL N4-550 | inf 2x2500ml pe vak | CTT | F | | | |
| 46805 | CLINOMEL N4-550 | inf 4x1500ml pe vak | CTT | F | | | |
| 46804 | CLINOMEL N4-550 | inf 4x2000ml pe vak | CTT | F | | | |
| 47479 | CLINOMEL N5-800 | inf 2x2500ml pe vak | CTT | F | | | |
| 46808 | CLINOMEL N5-800 | inf 4x1500ml pe vak | CTT | F | | | |
| 46807 | CLINOMEL N5-800 | inf 4x2000ml pe vak | CTT | F | | | |
| 47481 | CLINOMEL N6-900 | inf 2x2500ml pe vak | CTT | F | | | |
| 47482 | CLINOMEL N4-550 | inf 2x2500ml pe vak | CTT | F | | | |
| 46811 | CLINOMEL N6-900 | inf 4x1500ml pe vak | CTT | F | | | |
| 46810 | CLINOMEL N6-900 | inf 4x2000ml pe vak | CTT | F | | | |
| 47480 | CLINOMEL N7-1000 | inf 2x2500ml pe vak | CTT | F | | | |
| 46814 | CLINOMEL N7-1000 | inf 4x1500ml pe vak | CTT | F | | | |
| 46813 | CLINOMEL N7-1000 | inf 4x2000ml pe vak | CTT | F | | | |
| 02460 | NUTRIFLEX BASAL | inf 5x1000ml | BMB | CH | | | |
| 02461 | NUTRIFLEX BASAL | inf 5x2000ml | BMB | CH | | | |
| 02454 | NUTRIFLEX PERI | inf 5x1000ml | BMB | CH | | | |
| 02455 | NUTRIFLEX PERI | inf 5x2000ml | BMB | CH | | | |
| 02458 | NUTRIFLEX PLUS | inf 5x1000ml | BMB | CH | | | |
| 02459 | NUTRIFLEX PLUS | inf 5x2000ml | BMB | CH | | | |
| 02452 | NUTRIFLEX SPECIAL | inf 5x1000ml | BMB | CH | | | |
| 02453 | NUTRIFLEX SPECIAL | inf 5x1500ml | BMB | CH | | | |
| 02452 | NUTRIFLEX SPECIAL | inf 5x1000ml | BMB | CH | | | |
| 47480 | CLINOMEL N7-1000 | inf 2x2500ml pe vak | CTT | F | | | |
| 02454 | NUTRIFLEX PERI | inf 5x1000ml | BMB | CH | | | |
| 02461 | NUTRIFLEX BASAL | inf 5x2000ml | BMB | CH | | | |
| 02458 | NUTRIFLEX PLUS | inf 5x1000ml | BMB | CH | | | |
| 47479 | CLINOMEL N5-800 | inf 2x2500ml pe vak | CTT | F | | | |
| 02459 | NUTRIFLEX PLUS | inf 5x2000ml | BMB | CH | | | |
| 02460 | NUTRIFLEX BASAL | inf 5x1000ml | BMB | CH | | | |
| 42557 | OLICLINOMEL N5-800E | inf eml 6x1000ml | BXI | B | | | |
| 98055 | OLICLINOMEL N5-800E | inf eml 6x1000ml | CTT | F | | | |
| 45377 | AMINOROZTOK NEO SX 4% INFUSIA | inf 1x500ml | | CZ | | | |
| 40178 | AMINOPLASMAL 10% E | inf 1x1000ml | BME | D | | | |
| 02455 | NUTRIFLEX PERI | inf 5x2000ml | BMB | CH | | | |
| 46805 | CLINOMEL N4-550 | inf 4x1500ml pe vak | CTT | F | | | |
| 46813 | CLINOMEL N7-1000 | inf 4x2000ml pe vak | CTT | F | | | |
| 46810 | CLINOMEL N6-900 | inf 4x2000ml pe vak | CTT | F | | | |
| 46807 | CLINOMEL N5-800 | inf 4x2000ml pe vak | CTT | F | | | |
| 46804 | CLINOMEL N4-550 | inf 4x2000ml pe vak | CTT | F | | | |
| 42557 | OLICLINOMEL N5-800E | inf eml 6x1000ml | BXI | B | | | |
| 46814 | CLINOMEL N7-1000 | inf 4x1500ml pe vak | CTT | F | | | |
| 46808 | CLINOMEL N5-800 | inf 4x1500ml pe vak | CTT | F | | | |
| 46811 | CLINOMEL N6-900 | inf 4x1500ml pe vak | CTT | F | | | |
| 97 | B05BB | roztoky ovlivňující elektrolytovou rovnováhu (chlorid sodný 0,9% | parent. | | | | |
| 97 | B05BB | roztoky ovlivňující elektrolytovou rovnováhu (chlorid sodný 0,9%) | parent. | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 97.1 | B05BB01 | chlorid sodný 0.9% (nad 100 ml do 250 ml včetně) | parent. | 100 | ML | 7,40 | O |
| 97752 | SODIUM CHLORIDE 0.9%W/V I.V.INF | inf 1x250ml(plast) | BFF | I | | | |
| 97749 | SODIUM CHLORIDE 0.9%W/V I.V.INF | inf 1x250ml(sklo) | BFF | I | | | |
| 57683 | SODIUM CHLORIDE 0.9%W/V I.V.INF | inf 1x250ml(plast) | BFH | E | | | |
| 57683 | SODIUM CHLORIDE 0.9%W/V I.V.INF | inf 1x250ml(vak ii) | BFH | E | | | |
| 97752 | SODIUM CHLORIDE 0.9%W/V I.V.INF | inf 1x250ml(vak ii) | BFF | I | | | |
| 97.2 | B05BB01 | chlorid sodný 0.9% (do 100 ml v balení včetně) | parent. | 100 | ML | 21,08 | O |
| 57681 | SODIUM CHLORIDE 0.9%W/V I.V.INF | inf 1x100ml(plast) | BFH | E | | | |
| 46079 | CHLORID SODNY 0.9% BRAUN | inj 20x20ml(pl.amp) | BME | CH | | | |
| 46075 | CHLORID SODNY 0.9% BRAUN | inf 1x100ml(sklo) | BME | CH | | | |
| 96882 | CHLORID SODNÝ 0.9% BRAUN | inf 1x100ml(sklo) | BMM | D | | | |
| 46065 | CHLORID SODNY 0.9% BRAUN | inf sol 1x100ml-sk | BMR | E | | | |
| 96882 | CHLORID SODNY 0.9% BRAUN | inf sol 1x100ml-sk | BMM | D | | | |
| 46075 | CHLORID SODNY 0.9% BRAUN | inf sol1x100ml-skl | BME | CH | | | |
| 46079 | CHLORID SODNY 0.9% BRAUN | infsol20x20ml-plamp | BME | CH | | | |
| 96887 | CHLORID SODNY 0.9% BRAUN | infsol20x20mlpl.amp | BMM | D | | | |
| 98864 | FYZIOLOGICKÝ ROZTOK VIAFLO | inf sol 50x100ml | BFH | E | | | |
| 97748 | SODIUM CHLORIDE 0.9%W/V I.V.INF | inf 1x100ml(sklo) | BFF | I | | | |
| 97751 | SODIUM CHLORIDE 0.9%W/V I.V.INF | inf 1x100ml(plast) | BFF | I | | | |
| 96887 | CHLORID SODNÝ 0.9% BRAUN | inj 20x20ml(pl.amp) | BMM | D | | | |
| 46065 | CHLORID SODNY 0.9% BRAUN | inf 1x100ml(sklo) | BMR | E | | | |
| 97.3 | B05BB01 | chlorid sodný 0.9% (nad 250 ml v balení) | parent. | 100 | ml | 3,77 | O |
| 75611 | 0.9% SODIUM CHLORIDE I.V.BP | inf 1x1000ml(vak) | BXT | GB | | | |
| 57681 | SODIUM CHLORIDE 0.9%W/V I.V.INF | inf 1x100ml(vak ii) | BFH | E | | | |
| 97751 | SODIUM CHLORIDE 0.9%W/V I.V.INF | inf 1x100ml(vak ii) | BFF | I | | | |
| 97.3 | B05BB01 | chlorid sodný 0.9% (nad 250 ml v balení) | parent. | 100 | ML | 3,77 | O |
| 75611 | 0.9% SODIUM CHLOR.I.V.BP BAXTER | inf 1x1000ml(vak) | BXF | GB | | | |
| 31487 | 0.9%SODIUM CHL.IN WAT.FRESENIUS | inf sol1x1000ml-skl | FKI | I | | | |
| 31500 | 0.9%SODIUM CHL.IN WAT.FRESENIUS | inf sol1x2000ml-vak | FKI | I | | | |
| 31501 | 0.9%SODIUM CHL.IN WAT.FRESENIUS | inf sol4x2000ml-vak | FKI | I | | | |
| 92511 | 0.9%SODIUM CHL.IN WAT.USP SIFRA | inf sol1x1000ml-skl | SFR | I | | | |
| 92518 | 0.9%SODIUM CHL.IN WAT.USP SIFRA | inf sol1x2000ml-vak | SFR | I | | | |
| 43915 | 0.9%SODIUM CHL.IN WAT.USP SIFRA | inf sol4x2000ml-vak | SFR | I | | | |
| 46077 | CHLORID SODNY 0.9% BRAUN | infsol1x1000mlpelah | BME | CH | | | |
| 96885 | CHLORID SODNY 0.9% BRAUN | infsol1x1000mlpelah | BMM | D | | | |
| 98880 | FYZIOLOGICKÝ ROZTOK VIAFLO | inf sol 10x1000ml | BFH | E | | | |
| 03122 | SODIUM CHLORIDE 0.9%W/V I.V.INF | inf 1x1000ml(vak i) | BFH | E | | | |
| 57687 | SODIUM CHLORIDE 0.9%W/V I.V.INF | inf 1 x1000ml(vak ii | BFH | E | | | |
| 97754 | SODIUM CHLORIDE 0.9%W/V I.V.INF | inf 1x1000ml(vak ii | BFF | I | | | |
| 57672 | SODIUM CHLORIDE 0.9%W/V I.V.INF | inf 1x1500ml(vak ii | BFH | E | | | |
| 69180 | SODIUM CHLORIDE 0.9%W/V I.V.INF | inf 1 x1500ml(vak ii | BFF | I | | | |
| 03126 | SODIUM CHLORIDE 0.9%W/V I.V.INF | inf 1x2000ml(vak i) | BFH | E | | | |
| 31500 | 0.9%SODIUM CHL.IN WAT.FRESENIUS | infsol1x2000ml(vak) | FKI | I | | | |
| 69180 | SODIUM CHLORIDE 0.9%W/V I.V.INF | inf 1x1500ml(plast) | BFF | I | | | |
| 57673 | SODIUM CHLORIDE 0.9%W/V I.V.INF | inf 1x2000ml(plast) | BFH | E | | | |
| 92511 | 0.9% SODIUM CHL.IN WATER F.INJ. | inf 1x1000ml(sklo) | SFR | I | | | |
| 96885 | CHLORID SODNÝ 0.9% BRAUN | inf 1x1000ml(plast) | BMM | D | | | |
| 97754 | SODIUM CHLORIDE 0.9%W/V I.V.INF | inf 1x1000ml(plast) | BFF | I | | | |
| 43915 | 0.9% SODIUM CHL.IN WATER F.INJ. | inf 4x2000ml(vak) | SFR | I | | | |
| 57672 | SODIUM CHLORIDE 0.9%W/V I.V.INF | inf 1x1500ml(plast) | BFH | E | | | |
| 31487 | 0.9%SODIUM CHL.IN WAT.FRESENIUS | infsol1x1000ml(skl) | FKI | I | | | |
| 92518 | 0.9% SODIUM CHL.IN WATER F.INJ. | inf 1x2000ml(vak) | SFR | I | | | |
| 03122 | SODIUM CHLORIDE 0.9%W/V I.V.INF | inf 1x1000ml(vak i) | BFH | E | | | |
| 46077 | CHLORID SODNY 0.9% BRAUN | inf 1x1000ml(pe) | BME | CH | | | |
| 31501 | 0.9%SODIUM CHL.IN WAT.FRESENIUS | infsol4x2000ml(vak) | FKI | I | | | |
| 92585 | INFUSIO NATR.CHLOR.ISOT.IMUNA | inf 1x3000ml(vak) | ima | SK | | | |
| 69181 | SODIUM CHLORIDE 0.9%W/V I.V.INF | inf 1x2000ml(plast) | BFF | I | | | |
| 57687 | SODIUM CHLORIDE 0.9%W/V I.V.INF | inf 1x1000ml(plast) | BFH | E | | | |
| 97.4 | B05BB01 | chlorid sodný 0.9% (do 10 ml včetně v jedné ampuli) | parent. | 100 | ml | 39,65 | O |
| 46078 | CHLORID SODNY 0.9% BRAUN | inj 20x10ml(pl.amp) | BME | CH | | | |
| 96886 | CHLORID SODNÝ 0.9% BRAUN | inj 20x10ml(pl.amp) | BMM | D | | | |
| 57673 | SODIUM CHLORIDE 0.9%W/V I.V.INF | inf 1x2000ml(vak ii | BFH | E | | | |
| 69181 | SODIUM CHLORIDE 0.9%W/V I.V.INF | inf 1x2000ml(vak ii | BFF | I | | | |
| 97.4 | B05BB01 | chlorid sodný 0.9% (do 10 ml včetně v jedné ampuli) | parent. | 100 | ML | 39,65 | O |
| 46078 | CHLORID SODNY 0.9% BRAUN | infsol20x10ml-plamp | BME | CH | | | |
| 96886 | CHLORID SODNY 0.9% BRAUN | infsol20x10ml-plamp | BMM | D | | | |
| 98 | B05BB | roztoky ovlivňující elektrolytovou rovnováhu (ostatní) | parent. | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 98.1 | B05BB | roztoky ovlivňující rovnováhu elektrolytů | parent. | 100 | ML | 10,46 | H |
| | | | | | | | |
| 98.2 | B05BB01 | elektrolyty | parent. | 100 | ML | 8,07 | H |
| 44100 | HARTMANNUV ROZTOK BRAUN BP | inf 1x500ml(plast) | BMM | D | | | |
| 93063 | LACTATED RINGER'S INJ.U.S.P.SFR | inf 1x1000ml(sklo) | SFR | I | | | |
| 44103 | HARTMANNUV ROZTOK BRAUN BP | inf 10x1000ml-plast | BMM | D | | | |
| 44102 | HARTMANNUV ROZTOK BRAUN BP | inf 10x500ml-plast | BMM | D | | | |
| 44101 | HARTMANNUV ROZTOK BRAUN BP | inf 1x1000ml-plast | BMM | D | | | |
| 44100 | HARTMANNUV ROZTOK BRAUN BP | inf 1x500ml-plast | BMM | D | | | |
| 70527 | INFUSIO DARROWI MEDICAMEN.D1/1 | inf sol 1x500ml | MVM | CZ | | | |
| 85887 | INFUSIO HARTMANNI IMUNA | inf 1x1000ml(vak) | IMA | SK | | | |
| 92580 | INFUSIO HARTMANNI IMUNA | inf 1x2000ml(vak) | IMA | SK | | | |
| 92581 | INFUSIO HARTMANNI IMUNA | inf 1x3000ml(vak) | IMA | SK | | | |
| 99168 | INFUSIO HARTMANNI IMUNA | inf 1x500ml(sklo) | IMA | SK | | | |
| 87250 | INFUSIO HARTMANNI INFUSIA | inf 1x500ml-sklo | IHO | CZ | | | |
| 70524 | INFUSIO HARTMANNI MEDICAM.H1/1 | inf sol 1x500ml | MVM | CZ | | | |
| 92778 | INFUSIO HARTMANNI MEDIEKOS H1/1 | inf 1x2000ml(vak) | INK | CZ | | | |
| 05870 | INFUSIO HARTMANNI MEDIEKOS H1/1 | inf 1x5000ml(vak) | INK | CZ | | | |
| 92585 | INFUSIO NATR.CHLOR.ISOT.IMUNA | inf 1x3000ml(vak) | IMA | SK | | | |
| 70530 | INFUSIO RINGERI C.NATR.LACT.MVM | inf sol 1x500ml | MVM | CZ | | | |
| 85578 | INFUSIO RINGERI IMUNA | inf 1x1000ml(vak) | IMA | SK | | | |
| 55616 | INFUSIO RINGERI IMUNA | inf 1x2000ml(vak) | IMA | SK | | | |
| 55617 | INFUSIO RINGERI IMUNA | inf 1x3000ml(vak) | IMA | SK | | | |
| 72793 | INFUSIO RINGERI IMUNA | inf 1x500ml(sklo) | IMA | SK | | | |
| 89861 | INFUSIO RINGERI INFUSIA | inf 1x500ml-sklo | IHO | CZ | | | |
| 70529 | INFUSIO RINGERI MEDICAMENTAR1/1 | inf sol 1x500ml | MVM | CZ | | | |
| 92801 | INFUSIO RINGERI MEDIEKOS R1/1 | inf 1x1000ml(vak) | INK | CZ | | | |
| 92802 | INFUSIO RINGERI MEDIEKOS R1/1 | inf 1x2000ml(vak) | INK | CZ | | | |
| 05860 | INFUSIO RINGERI MEDIEKOS R1/1 | inf 1x3000ml(vak) | INK | CZ | | | |
| 05869 | INFUSIO RINGERI MEDIEKOS R1/1 | inf 1x5000ml(vak) | INK | CZ | | | |
| 66833 | PLASMA-LYTE 148 ELECTROLYT.SOL. | inf 1x1000ml | BXF | GB | | | |
| 44102 | HARTMANNUV ROZTOK BRAUN BP | inf 10x500ml(plast) | BMM | D | | | |
| 44101 | HARTMANNUV ROZTOK BRAUN BP | inf 1x1000ml(plast) | BMM | D | | | |
| 97015 | RINGER INFUSION-HUMAN | inf 1x500ml | HUA | H | | | |
| 96892 | RINGER'S BRAUN | inj 1x1000ml(plast) | BMM | D | | | |
| 96891 | RINGER'S BRAUN | inj 1x500ml(plast) | BMM | D | | | |
| 11305 | RINGER'S INJECTION FRESENIUS | inf 10x1000ml-vak | FKI | I | | | |
| 95571 | RINGER'S INJECTION FRESENIUS | inf 12x1000ml-pe | FKI | I | | | |
| 11380 | RINGER'S INJECTION FRESENIUS | inf 12x1000ml-sklo | FKI | I | | | |
| 11376 | RINGER'S INJECTION FRESENIUS | inf 12x500ml-sklo | FKI | I | | | |
| 95579 | RINGER'S INJECTION FRESENIUS | inf 1x1000ml-f | FKI | I | | | |
| 95569 | RINGER'S INJECTION FRESENIUS | inf 1x1000ml-pe | FKI | I | | | |
| 11328 | RINGER'S INJECTION FRESENIUS | inf 1x1000ml-sklo | FKI | I | | | |
| 93051 | RINGER'S INJECTION U.S.P.SIFRA | inf 1x1000ml(sklo) | SFR | I | | | |
| 93054 | RINGER'S INJECTION U.S.P.SIFRA | inf 12x500ml(sklo) | SFR | I | | | |
| 11196 | HARTMANN'S SOL BP FRESENIUS | inf 1x1000ml(sklo) | FKI | I | | | |
| 11197 | HARTMANN'S SOL. BP FRESENIUS | inf 6x1000ml(sklo) | FKI | I | | | |
| 85887 | INFUSIO HARTMANNI IMUNA | inf 1x1000ml(vak) | IMA | SK | | | |
| 11222 | RINGER'S INJECTION FRESENIUS | inf 1x1000ml-vak | FKI | I | | | |
| 11323 | RINGER'S INJECTION FRESENIUS | inf 1x500ml-sklo | FKI | I | | | |
| 59369 | RINGER'S INJECTION U.S.P.BIEFFE | inf 1x1000ml(vak) | BFF | I | | | |
| 59375 | RINGER'S INJECTION U.S.P.BIEFFE | inf 1x1000ml(vak) | BFH | E | | | |
| 69235 | RINGER'S INJECTION U.S.P.BIEFFE | inf 1x500ml(sklo) | BFF | I | | | |
| 11323 | RINGER'S INJECTION FRESENIUS | inf 1x500ml-sklo | FKI | I | | | |
| 44103 | HARTMANNUV ROZTOK BRAUN BP | inf 10x1000ml-plast | BMM | D | | | |
| 85578 | INFUSIO RINGERI IMUNA | inf 1x1000ml(vak) | IMA | SK | | | |
| 93055 | RINGER'S INJECTION U.S.P.SIFRA | inf 12x1000ml(sklo) | SFR | I | | | |
| 87250 | INFUSIO HARTMANNI INFUSIA H 1/1 | inf 1x500ml(sklo) | IHO | CZ | | | |
| 11376 | RINGER'S INJECTION FRESENIUS | inf 12x500ml-sklo | FKI | I | | | |
| 93050 | RINGER'S INJECTION U.S.P.SIFRA | inf 1x500ml(sklo) | SFR | I | | | |
| 59375 | RINGER'S INJECTION U.S.P.BIEFFE | inf 1x1000ml(vak) | BFH | E | | | |
| 11305 | RINGER'S INJECTION FRESENIUS | inf 10x1000ml-vak | FKI | I | | | |
| 05860 | INFUSIO RINGERI MEDIEKOS R1/1 | inf 1x3000ml(vak) | INK | CZ | | | |
| 11154 | HARTMANN'S SOL. BP FRESENIUS | inf 1x1000ml(vak) | FKI | I | | | |
| 93059 | LACTATED RINGER'S INJ.U.S.P.SFR | inf 10x1000ml(vak) | SFR | I | | | |
| 55616 | INFUSIO RINGERI IMUNA | inf 1x2000ml(vak) | IMA | SK | | | |
| 59361 | RINGERUV ROZTOK BRAUN | inf 10x500ml(Idpe) | BME | E | | | |
| 93047 | RINGER'S INJECTION U.S.P.SIFRA | inf 10x1000ml(vak) | SFR | I | | | |
| 70529 | INFUSIO RINGERI MEDICAMENTA | inf 1x500ml | MVM | CZ | | | |
| 59374 | RINGER'S INJECTION U.S.P.BIEFFE | inf 1x500ml(vak) | BFH | E | | | |
| 93047 | RINGER'S INJECTION U.S.P.SIFRA | inf 10x1000ml-vak | SFR | I | | | |
| 93055 | RINGER'S INJECTION U.S.P.SIFRA | inf 12x1000ml-sklo | SFR | I | | | |
| 93054 | RINGER'S INJECTION U.S.P.SIFRA | inf 12x500ml-sklo | SFR | I | | | |
| 93051 | RINGER'S INJECTION U.S.P.SIFRA | inf 1x1000ml-sklo | SFR | I | | | |
| 12610 | RINGER'S INJECTION U.S.P.SIFRA | inf 1x1000ml-vak | SFR | I | | | |
| 93050 | RINGER'S INJECTION U.S.P.SIFRA | inf 1x500ml-sklo | SFR | I | | | |
| 59358 | RINGERUV ROZTOK BRAUN | inf 10x1000ml(Idpe) | BMM | D | | | |
| 72793 | INFUSIO RINGERI IMUNA | inf 1x500ml(sklo) | IMA | SK | | | |
| 59362 | RINGERUV ROZTOK BRAUN | inf 10x1000ml(Idpe) | BME | E | | | |
| 95579 | RINGER'S INJECTION FRESENIUS | inf 1x1000ml-f | FKI | I | | | |
| 92581 | INFUSIO HARTMANNI IMUNA | inf 1x3000ml(vak) | IMA | SK | | | |
| 59357 | RINGERUV ROZTOK BRAUN | inf 10x500ml(Idpe) | BMM | D | | | |
| 05869 | INFUSIO RINGERI MEDIEKOS R1/1 | inf 1x5000ml(vak) | INK | CZ | | | |
| 99168 | INFUSIO HARTMANNI IMUNA | inf 1x500ml(sklo) | IMA | SK | | | |
| 12374 | LACTATED RINGER'S INJ.U.S.P.SFR | inf 1x1000ml(vak) | SFR | I | | | |
| 95571 | RINGER'S INJECTION FRESENIUS | inf 12x1000ml-pe | FKI | I | | | |
| 95569 | RINGER'S INJECTION FRESENIUS | inf 1x1000ml-pe | FKI | I | | | |
| 05870 | INFUSIO HARTMANNI MEDIEKOS H1/1 | inf 1x5000ml(vak) | INK | CZ | | | |
| 92802 ~ | INFUSIO RINGERI MEDIEKOS R1/1 | inf 1x2000ml(vak) | MKS | CZ | | | |
| 92801 | INFUSIO RINGERI MEDIEKOS R1/1 | inf 1x1000ml(vak) | MKS | CZ | | | |
| 89861 | INFUSIO RINGERI INFUSIA R 1/1 | inf 1x500ml(sklo) | IHO | CZ | | | |
| 92580 | INFUSIO HARTMANNI IMUNA | inf 1x2000ml(vak) | IMA | SK | | | |
| 96891 | RINGER'S INJECTION BRAUN | inf 1x500ml | BMM | D | | | |
| 55617 | INFUSIO RINGERI IMUNA | inf 1x3000ml(vak) | IMA | SK | | | |
| 70524 | INFUSIO HARTMANNI MEDICAMENTA | inf 1x500ml | MVM | CZ | | | |
| 59374 | RINGER'S INJECTION U.S.P.BIEFFE | inf 1x500ml(vak) | BFH | E | | | |
| 59369 | RINGER'S INJECTION U.S.P.BIEFFE | inf 1x1000ml(vak) | BFF | I | | | |
| 59366 | RINGERUV ROZTOK BRAUN | inf 10x1000ml(Idpe) | BME | CH | | | |
| 70527 | INFUSIO DARROWI MEDICAMENTA | inf 1x500ml | MVM | CZ | | | |
| 93067 | LACTATED RINGER'S INJ.U.S.P.SFR | inf 6x1000ml(sklo) | SFR | I | | | |
| 70530 | INFUSIO RINGERI C.NATR.LACT.MVM | inf 1x500ml | MVM | CZ | | | |
| 11380 | RINGER'S INJECTION FRESENIUS | inf 12x1000ml-sklo | FKI | I | | | |
| 97015 | RINGER INFUSION-HUMAN | inf 1x500ml | HUA | H | | | |
| 59365 | RINGERUV ROZTOK BRAUN | inf 10x500ml(Idpe) | BME | CH | | | |
| 12610 | RINGER'S INJECTION U.S.P.SIFRA | inf 1x1000ml(vak) | SFR | I | | | |
| 11155 | HARTMANN'S SOL. BP FRESENIUS | inf 10x1000ml(vak) | FKI | I | | | |
| 93527 | ARDEAELYTOSOL R 1/1 | inf 1x500ml | ARD | CZ | | | |
| 92778 | INFUSIO HARTMANNI MEDIEKOS H1/1 | inf 1x2000ml(vak) | MKS | CZ | | | |
| 96892 | RINGER'S BRAUN | inf 1x1000ml | BMM | D | | | |
| 59357 | RINGERUV ROZTOK BRAUN | inf 10x500ml(ldpe) | BMM | D | | | |
| 59361 | RINGERUV ROZTOK BRAUN | inf 10x500ml(ldpe) | BME | E | | | |
| 59365 | RINGERUV ROZTOK BRAUN | inf 10x500ml(ldpe) | BME | CH | | | |
| 98.3 | B05BB02 | elektrolyty se sacharidy | parent. | 100 | ML | 9,04 | H |
| 62369 | INFUSIO NACL ISOT.1/2C.GLUC.5 | inf 1x500ml(sklo) | IMA | SK | | | |
| 69660 | ARDEAELYTOSOL F 1/2 | inf 1x500ml | ARD | CZ | | | |
| 92624 | INFUSIO NACL ISOT.1/2C.GLUC.5 | inf 1x2000ml(vak) | IMA | SK | | | |
| 71733 | INFUSIO NATR.CHL.+GLUC.F1/3 MVM | inf 1x500ml | MVM | CZ | | | |
| 92625 | INFUSIO NACL ISOT.1/2C.GLUC.5 | inf 1x3000ml(vak) | IMA | SK | | | |
| 85566 | INFUSIO NACL ISOT.1/2C.GLUC.5 | inf 1x1000ml(vak) | IMA | SK | | | |
| 85566 | INFUS.NACL ISOT.1/2C.GL.5 IMUNA | inf 1x1000ml(vak) | IMA | SK | | | |
| 92624 | INFUS.NACL ISOT.1/2C.GL.5 IMUNA | inf 1x2000ml(vak) | IMA | SK | | | |
| 92625 | INFUS.NACL ISOT.1/2C.GL.5 IMUNA | inf 1x3000ml(vak) | IMA | SK | | | |
| 62369 | INFUS.NACL ISOT.1/2C.GL.5 IMUNA | inf 1x500ml(sklo) | IMA | SK | | | |
| 56702 | INFUSIO F 1/2 INFUSIA | inf 1x500ml(sklo) | IHO | CZ | | | |
| 70552 | INFUSIO HRS MEDICAMENTA HRS | inf sol 1x500ml | MVM | CZ | | | |
| 71732 | INFUSIO NATR.CHL.+GLUC.F1/2 MVM | inf sol 1x500ml | MVM | CZ | | | |
| 71733 | INFUSIO NATR.CHL.+GLUC.F1/3 MVM | inf sol 1x500ml | MVM | CZ | | | |
| 56706 | INFUSIO R 1/2 INFUSIA | inf 1x500ml(sklo) | IHO | CZ | | | |
| 71732 | INFUSIO NATR.CHL.+GLUC.F1/2 MVM | inf 1x500ml | MVM | CZ | | | |
| 70552 | INFUSIO HRS MEDICAMENTA | inf 1x500ml | MVM | CZ | | | |
| 98.4 | B05BB03 | trometamol | parent. | 100 | ML | 23,02 | H |
| 99 | B05BC | roztoky k osmotické diuréze | parent. | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 99.1 | B05BC01 | mannitol (koncentrace do 10% včetně, nad 250 ml v jednom balení) | parent. | 100 | ML | 12,17 | H |
| 97744 | MANNITOL 10% I.V.INF.BP BIEFFE | inf 1x500ml(sklo) | BFF | I | | | |
| 46027 | MANNITOL 10% I.V.INF.BP BIEFFE | inf 1x500ml(vak) | BFH | E | | | |
| 89155 | INFUSIO MANNITOLI 10% INFUSIA | inf 1x500ml(sklo) | IHO | CZ | | | |
| 74984 | MANNITOL 10% I.V.INF.BP BIEFFE | inf 1x500ml(vak) | BFF | I | | | |
| 46028 | MANNITOL 10% I.V.INF.BP BIEFFE | inf 1x1000ml(vak) | BFH | E | | | |
| 31365 | MANNISOL A INFUSION HUMAN | inf 1x500ml | HUA | H | | | |
| 89155 | INFUSIO MANNITOLI 10% INFUSIA | inf sol1x500ml | IHO | CZ | | | |
| 75517 | INFUSIO MANNITOLI 10 IMUNA | inf 1x500ml(sklo) | IMA | SK | | | |
| 46028 | MANNITOL 10% I.V.INF.BP BEFFE | inf 1x1000ml(vak) | BFH | E | | | |
| 31365 | MANNISOL A INFUSION-HUMAN | inf 1x500ml | HUA | H | | | |
| 74984 | MANNITOL 10% I.V.INF.BP BEFFE | inf 1x500ml(vak) | BFF | I | | | |
| 97744 | MANNITOL 10% I.V.INF.BP BEFFE | inf 1x500ml(sklo) | BFF | I | | | |
| 99.2 | B05BC01 | mannitol (koncentrace do 10% včetně, do 250 ml v jednom balení včetně) | parent. | 100 | ML | 19,31 | H |
| 97743 | MANNITOL 10% I.V.INF.BP BIEFFE | inf 1x250ml(sklo) | BFF | I | | | |
| 46026 | MANNITOL 10% I.V.INF.BP BIEFFE | inf 1x250ml(vak) | BFH | E | | | |
| 74983 | MANNITOL 10% I.V.INF.BP BIEFFE | inf 1x250ml(vak) | BFF | I | | | |
| 80494 | INFUSIO MANNITOLI 100 G/L MVM | inf sol 1x250ml | MVM | CZ | | | |
| 89154 | INFUSIO MANNITOLI 10% INFUSIA | inf sol1x250ml | IHO | CZ | | | |
| 90530 | INFUSIO MANNITOLI 10 IMUNA | inf 1x250ml(sklo) | IMA | SK | | | |
| 80494 | INFUSIO MANNITOLI 100 G/L MVM | inf 1x250ml | MVM | CZ | | | |
| 46026 | MANNITOL 10% I.V.INF.BP BEFFE | inf 1x250ml(vak) | BFH | E | | | |
| 74983 | MANNITOL 10% I.V.INF.BP BEFFE | inf 1x250ml(vak) | BFF | I | | | |
| 97743 | MANNITOL 10% I.V.INF.BP BIEFFE | inf 1x250ml(sklo) | BFF | I | | | |
| 89154 | INFUSIO MANNITOLI 10% INFUSIA | inf 1x250ml(sklo) | IHO | CZ | | | |
| 99.3 | B05BC01 | mannitol (koncentrace nad 10%, nad 250 ml v jednom balení) | parent. | 100 | ML | 13,78 | H |
| 43766 | 20% MANNITOL IN WATER F.INJ.USP | inf 1x1000ml | | SFR | I | | |
| 97747 | MANNITOL 20% I.V.INF.BP BIEFFE | inf 1x500ml(vak) | | BFF | I | | |
| 44383 | INFUSIO MANNITOLI 20% INFUSIA | inf 1x500ml(sklo) | | IHO | CZ | | |
| 97746 | MANNITOL 20% I.V.INF.BP BIEFFE | inf 1x500ml(sklo) | | BFF | I | | |
| 46025 | MANNITOL 20% I.V.INF.BP BIEFFE | inf 1x500ml(vak) | | BFH | E | | |
| 31479 | 20% MANNITOL IN WATER FRESENIUS | inf 1x1000ml | | FKI | I | | |
| 44584 | 20% MANNITOL IN WATER F.INJ.USP | inf 6x1000ml | | SFR | I | | |
| 44583 | 20% MANNITOL IN WATER F.INJ.USP | inf 12x500ml | | SFR | I | | |
| 31480 | 20% MANNITOL IN WATER FRESENIUS | inf 6x1000ml | | FKI | I | | |
| 43765 | 20% MANNITOL IN WATER F.INJ.USP | inf 1x500ml | | SFR | I | | |
| 31478 | 20% MANNITOL IN WATER FRESENIUS | inf 12x500ml | | FKI | I | | |
| 59743 | MANNITOL 20% I.V.INF.BP BIEFFE | inf 1x1000ml(vak) | | BFH | E | | |
| 31477 | 20% MANNITOL IN WATER FRESENIUS | inf 1x500ml | | FKI | I | | |
| 97746 | MANNITOL 20% I.V.INF.BP BIEFFE | inf 1x500ml(sklo) | BFF | I | | | |
| 46025 | MANNITOL 20% I.V.INF.BP BIEFFE | inf 1x500ml(vak) | BFH | E | | | |
| 97747 | MANNITOL 20% I.V.INF.BP BIEFFE | inf 1x500ml(vak) | BFF | I | | | |
| 59743 | MANNITOL 20% I.V.INF.BP BIEFFE | inf 1x1000ml(vak) | BFH | E | | | |
| 44383 | INFUSIO MANNITOLI 20% INFUSIA | inf 1x500ml(sklo) | IHO | CZ | | | |
| 43765 | 20% MANNITOL IN WATER USP SIFRA | inf 1x500ml-sklo | SFR | I | | | |
| 44584 | 20% MANNITOL IN WATER USP SIFRA | inf 6x1000ml-sklo | SFR | I | | | |
| 43766 | 20% MANNITOL IN WATER USP SIFRA | inf 1x1000ml-sklo | SFR | I | | | |
| 31477 | 20% MANNITOL IN WATER FRESENIUS | inf 1x500ml-sklo | FKI | I | | | |
| 31480 | 20% MANNITOL IN WATER FRESENIUS | inf 6x1000ml-sklo | FKI | I | | | |
| 44583 | 20% MANNITOL IN WATER USP SIFRA | inf 12x500ml-sklo | SFR | I | | | |
| 31479 | 20% MANNITOL IN WATER FRESENIUS | inf 1x1000ml-sklo | FKI | I | | | |
| 31478 | 20% MANNITOL IN WATER FRESENIUS | inf 12x500ml-sklo | FKI | I | | | |
| 99.4 | B05BC01 | mannitol (koncentrace nad 10%, do 250 ml v jednom balení včetně) | parent. | 100 | ML | 21,70 | H |
| 97745 | MANNITOL 20% I.V.INF.BP BIEFFE | inf 1x250ml(sklo) | BFF | I | | | |
| 59741 | MANNITOL 20% I.V.INF.BP BIEFFE | inf 1x250ml(vak) | BFH | E | | | |
| 31476 | 20% MANNITOL IN WATER FRESENIUS | inf 16x250ml | FKI | I | | | |
| 59742 | MANNITOL 20% I.V.INF.BP BIEFFE | inf 1x250ml(vak) | BFF | I | | | |
| 80497 | INFUSIO MANNITOLI 200 G/L MVM | inf sol 1x250ml | MVM | CZ | | | |
| 44382 | INFUSIO MANNITOLI 20% INFUSIA | inf 1x250ml(sklo) | IHO | CZ | | | |
| 59742 | MANNITOL 20% I.V.INF.BP BIEFFE | inf 1x250ml(vak) | BFF | I | | | |
| 80497 | INFUSIO MANNITOLI 200 G/L MVM | inf 1x250ml | MVM | CZ | | | |
| 44582 | 20% MANNITOL IN WATER F.INJ.USP | inf 16x250ml | SFR | I | | | |
| 97745 | MANNITOL 20% I.V.INF.BP BIEFFE | inf 1x250ml(sklo) | BFF | I | | | |
| 31475 | 20% MANNITOL IN WATER FRESENIUS | inf 1x250ml | FKI | I | | | |
| 43764 | 20% MANNITOL IN WATER F.INJ.USP | inf 1x250ml | SFR | I | | | |
| 43764 | 20% MANNITOL IN WATER USP SIFRA | inf 1x250ml-sklo | SFR | I | | | |
| 44582 | 20% MANNITOL IN WATER USP SIFRA | inf 16x250ml-sklo | SFR | I | | | |
| 31475 | 20% MANNITOL IN WATER FRESENIUS | inf 1x250ml-sklo | FKI | I | | | |
| 31476 | 20% MANNITOL IN WATER FRESENIUS | inf 16x250ml-sklo | FKI | I | | | |
| 99.5 | B05BC02 | karbamid | parent. | 90 | GM | 1133,11 | H |
| 100 | B05C | roztoky k irigaci | lok. | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
@@ -1681,87 +1750,122 @@
| 101.1 | B05DA | přípravky pro peritoneální dialýzu isotonické | parent. | 1000 | ML | 138,04 | H |
| | | | | | | | |
| 101.2 | B05DB | přípravky pro peritoneální dialýzu hypertonické | parent. | 1000 | ML | 138,04 | H |
| 45645 | GAMBROSOL 10 H GEMINI 10 | sol 4x2500ml(vak) | BJS | I | | | |
| 98265 | CAPD 3 | sol 1x2000ml | FRE | D | | | |
| 65949 | GAMBROSOL 10 M | sol 5x2000ml(sy10) | BJS | I | | | |
| 45668 | GAMBROSOL 10 M SYSTEM 10 | sol 6x1500ml(vak) | BJS | I | | | |
| 65950 | GAMBROSOL 10 M | sol 2x5000ml(sy10) | BJS | I | | | |
| 45674 | GAMBROSOL 10 M SYSTEM 10 | sol 2x4500ml(vak) | BJS | I | | | |
| 45700 | GAMBROSOL 10 L SYSTEM 10 | sol 6x1500ml(vak) | BJS | I | | | |
| 65956 | GAMBROSOL 10 L | sol 3x3000ml(sy10) | BJS | I | | | |
| 65963 | GAMBROSOL 10 L | sol 5x2000ml(ge10) | BJS | I | | | |
| 45711 | GAMBROSOL 10 L GEMINI 10 | sol 4x2500ml(vak) | BJS | I | | | |
| 98254 | CAPD 2 | sol 1x2500ml | FRE | D | | | |
| 01218 | GAMBROSOL TRIO 40 | sol 2x5000ml(sy10) | BJS | I | | | |
| 98253 | CAPD 2 | sol 1x2000ml | FRE | D | | | |
| 95428 | CAPD/DPCA 3 STANDARD | dlp prn sol1x1500ml | FMC | D | | | |
| 98255 | CAPD 2 | sol 1x5000ml | FRE | D | | | |
| 65959 | GAMBROSOL 10 L | sol 2x5000ml(sy10) | BJS | I | | | |
| 65962 | GAMBROSOL 10 L | sol 5x2000ml(sy10) | BJS | I | | | |
| 65946 | GAMBROSOL 10 M | sol 3x3000ml(sy10) | BJS | I | | | |
| 55848 | PERITONEAL DIAL.SOL.+DEXTR.2.5% | sol 1x2500ml(vak) | BFF | I | | | |
| 65967 | GAMBROSOL 10 L | sol 3x3000ml(ge10) | BJS | I | | | |
| 01198 | GAMBROSOL TRIO 10 | sol 4x2500ml(ge10) | BJS | I | | | |
| 45706 | GAMBROSOL 10 L SYSTEM 10 | sol 2x4500ml(vak) | BJS | I | | | |
| 76614 | DIANEAL PD 4(+GLUCOSE 1.36%) | sol 1x2500ml(vak) | BXT | IRL | | | |
| 76634 | DIANEAL PD 4(+GLUCOSE 3.86%) | sol 1x5000ml(vak) | BXT | IRL | | | |
| 95426 | CAPD/DPCA 2 SLEEP SAFE | dlp prn sol1x5000ml | FMC | D | | | |
| 03208 | CAPD/DPCA 17 | sol1x2000ml-stay | FMC | D | | | |
| 03209 | CAPD/DPCA 18 | sol1x2000ml-stay | FMC | D | | | |
| 03210 | CAPD/DPCA 19 | sol1x2000ml-stay | FMC | D | | | |
| 97361 | CAPD/DPCA 2 | sol 1x2000ml-andy | FMC | D | | | |
| 97353 | CAPD/DPCA 2 | sol 1x2000ml-stand | FMC | D | | | |
| 97369 | CAPD/DPCA 2 | sol 1x2000ml-stay | FMC | D | | | |
| 97362 | CAPD/DPCA 2 | sol 1x2500ml-andy | FMC | D | | | |
| 97370 | CAPD/DPCA 2 | sol 1x2500ml-stay | FMC | D | | | |
| 97371 | CAPD/DPCA 2 | sol 1x3000ml-stay | FMC | D | | | |
| 95426 | CAPD/DPCA 2 | sol 1x5000ml-sleep | FMC | D | | | |
| 97355 | CAPD/DPCA 2 | sol 1x5000ml-stand | FMC | D | | | |
| 95427 | CAPD/DPCA 2 | sol 2x5000ml-sleep | FMC | D | | | |
| 97356 | CAPD/DPCA 2 | sol 2x5000ml-stand | FMC | D | | | |
| 97372 | CAPD/DPCA 2 | sol 3x3000ml-stay | FMC | D | | | |
| 97366 | CAPD/DPCA 2 | sol 4x2000ml-andy | FMC | D | | | |
| 97357 | CAPD/DPCA 2 | sol 4x2000ml-stand | FMC | D | | | |
| 95424 | CAPD/DPCA 2 | sol 4x2000ml-stay | FMC | D | | | |
| 97367 | CAPD/DPCA 2 | sol 4x2500ml-andy | FMC | D | | | |
| 95425 | CAPD/DPCA 2 | sol 4x2500ml-stay | FMC | D | | | |
| 97359 | CAPD/DPCA 2 | sol 6x1500ml-stand | FMC | D | | | |
| 30828 | CAPD/DPCA 2 BALANCE | sol 4x2500ml-stay | FMC | D | | | |
| 95428 | CAPD/DPCA 3 | sol 1x1500ml-stand | FMC | D | | | |
| 95437 | CAPD/DPCA 3 | sol 1x2000ml-andy | FMC | D | | | |
| 95429 | CAPD/DPCA 3 | sol 1x2000ml-stand | FMC | D | | | |
| 95445 | CAPD/DPCA 3 | sol 1x2000ml-stay | FMC | D | | | |
| 95438 | CAPD/DPCA 3 | sol 1x2500ml-andy | FMC | D | | | |
| 95430 | CAPD/DPCA 3 | sol 1x2500ml-stand | FMC | D | | | |
| 95446 | CAPD/DPCA 3 | sol 1x2500ml-stay | FMC | D | | | |
| 95447 | CAPD/DPCA 3 | sol 1x3000ml-stay | FMC | D | | | |
| 95491 | CAPD/DPCA 3 | sol 1x5000ml-sleep | FMC | D | | | |
| 95431 | CAPD/DPCA 3 | sol 1x5000ml-stand | FMC | D | | | |
| 95492 | CAPD/DPCA 3 | sol 2x5000ml-sleep | FMC | D | | | |
| 95432 | CAPD/DPCA 3 | sol 2x5000ml-stand | FMC | D | | | |
| 95487 | CAPD/DPCA 3 | sol 3x3000ml-stay | FMC | D | | | |
| 95442 | CAPD/DPCA 3 | sol 4x2000ml-andy | FMC | D | | | |
| 95433 | CAPD/DPCA 3 | sol 4x2000ml-stand | FMC | D | | | |
| 95489 | CAPD/DPCA 3 | sol 4x2000ml-stay | FMC | D | | | |
| 95443 | CAPD/DPCA 3 | sol 4x2500ml-andy | FMC | D | | | |
| 95490 | CAPD/DPCA 3 | sol 4x2500ml-stay | FMC | D | | | |
| 95435 | CAPD/DPCA 3 | sol 6x1500ml-stand | FMC | D | | | |
| 30848 | CAPD/DPCA 3 BALANCE | sol 4x2500ml-stay | FMC | D | | | |
| 95501 | CAPD/DPCA 4 | sol 1x2000ml-andy | FMC | D | | | |
| 95494 | CAPD/DPCA 4 | sol 1x2000ml-stand | FMC | D | | | |
| 95509 | CAPD/DPCA 4 | sol 1x2000ml-stay | FMC | D | | | |
| 95502 | CAPD/DPCA 4 | sol 1x2500ml-andy | FMC | D | | | |
| 95495 | CAPD/DPCA 4 | sol 1x2500ml-stand | FMC | D | | | |
| 95510 | CAPD/DPCA 4 | sol 1x2500ml-stay | FMC | D | | | |
| 95511 | CAPD/DPCA 4 | sol 1x3000ml-stay | FMC | D | | | |
| 95516 | CAPD/DPCA 4 | sol 1x5000ml-sleep | FMC | D | | | |
| 95496 | CAPD/DPCA 4 | sol 1x5000ml-stand | FMC | D | | | |
| 95517 | CAPD/DPCA 4 | sol 2x5000ml-sleep | FMC | D | | | |
| 95497 | CAPD/DPCA 4 | sol 2x5000ml-stand | FMC | D | | | |
| 95512 | CAPD/DPCA 4 | sol 3x3000ml-stay | FMC | D | | | |
| 95506 | CAPD/DPCA 4 | sol 4x2000ml-andy | FMC | D | | | |
| 95498 | CAPD/DPCA 4 | sol 4x2000ml-stand | FMC | D | | | |
| 95514 | CAPD/DPCA 4 | sol 4x2000ml-stay | FMC | D | | | |
| 95507 | CAPD/DPCA 4 | sol 4x2500ml-andy | FMC | D | | | |
| 95515 | CAPD/DPCA 4 | sol 4x2500ml-stay | FMC | D | | | |
| 95499 | CAPD/DPCA 4 | sol 6x1500ml-stand | FMC | D | | | |
| 30852 | CAPD/DPCA 4 BALANCE | sol 4x2500ml-stay | FMC | D | | | |
| 46907 | DIANEAL PD1 GL.1.36%/13.6MG/ML | sol 1x2500ml(vak) | BXI | IRL | | | |
| 46909 | DIANEAL PD1 GL.1.36%/13.6MG/ML | sol 1x5000ml(vak) | BXI | IRL | | | |
| 12854 | CAPD 4 ANDY PLUS | sol 1x2500ml | FRC | D | | | |
| 46916 | DIANEAL PD1 GL.2.27%/22.7MG/ML | sol 1x2500ml(vak) | BXI | IRL | | | |
| 46918 | DIANEAL PD1 GL.2.27%/22.7MG/ML | sol 1x5000ml(vak) | BXI | IRL | | | |
| 46925 | DIANEAL PD1 GL.3.86%/38.6MG/ML | sol 1x2500ml(vak) | BXI | IRL | | | |
| 46927 | DIANEAL PD1 GL.3.86%/38.6MG/ML | sol 1x5000ml(vak) | BXI | IRL | | | |
| 76614 | DIANEAL PD4 GL.1.36%/13.6MG/ML | sol 1x2500ml(vak) | BXI | IRL | | | |
| 76616 | DIANEAL PD4 GL.1.36%/13.6MG/ML | sol 1x5000ml(vak) | BXI | IRL | | | |
| 76623 | DIANEAL PD4 GL.2.27%/22.7MG/ML | sol 1x2500ml(vak) | BXI | IRL | | | |
| 76625 | DIANEAL PD4 GL.2.27%/22.7MG/ML | sol 1x5000ml(vak) | BXI | IRL | | | |
| 76632 | DIANEAL PD4 GL.3.86%/38.6MG/ML | sol 1x2500ml(vak) | BXI | IRL | | | |
| 76634 | DIANEAL PD4 GL.3.86%/38.6MG/ML | sol 1x5000ml(vak) | BXI | IRL | | | |
| 45640 | GAMBROSOL 10 H | sol 2x4500ml(sy10) | BJS | I | | | |
| 68515 | GAMBROSOL 10 H | sol 2x5000ml(sy10) | BJS | I | | | |
| 69318 | GAMBROSOL 10 H | sol 3x3000ml(ge10) | BJS | I | | | |
| 68321 | GAMBROSOL 10 H | sol 3x3000ml(sy10) | BJS | I | | | |
| 45645 | GAMBROSOL 10 H | sol 4x2500ml(ge10) | BJS | I | | | |
| 45638 | GAMBROSOL 10 H | sol 4x2500ml(sy10) | BJS | I | | | |
| 69304 | GAMBROSOL 10 H | sol 5x2000ml(ge10) | BJS | I | | | |
| 68460 | GAMBROSOL 10 H | sol 5x2000ml(sy10) | BJS | I | | | |
| 45632 | GAMBROSOL 10 H | sol 6x1500ml(sy10) | BJS | I | | | |
| 45706 | GAMBROSOL 10 L | sol 2x4500ml(sy10) | BJS | l | | | |
| 65959 | GAMBROSOL 10 L | sol 2x5000ml(sy10) | BJS | I | | | |
| 65967 | GAMBROSOL 10 L | sol 3x3000ml(ge10) | BJS | I | | | |
| 65956 | GAMBROSOL 10 L | sol 3x3000ml(sy10) | BJS | I | | | |
| 45711 | GAMBROSOL 10 L | sol 4x2500ml(ge10) | BJS | I | | | |
| 45704 | GAMBROSOL 10 L | sol 4x2500ml(sy10) | BJS | I | | | |
| 65963 | GAMBROSOL 10 L | sol 5x2000ml(ge10) | BJS | I | | | |
| 65962 | GAMBROSOL 10 L | sol 5x2000ml(sy10) | BJS | I | | | |
| 45700 | GAMBROSOL 10 L | sol 6x1500ml(sy10) | BJS | I | | | |
| 45674 | GAMBROSOL 10 M | sol 2x4500ml(sy10) | BJS | I | | | |
| 65950 | GAMBROSOL 10 M | sol 2x5000ml(sy10) | BJS | I | | | |
| 65936 | GAMBROSOL 10 M | sol 3x3000ml(ge10) | BJS | I | | | |
| 65946 | GAMBROSOL 10 M | sol 3x3000ml(sy10) | BJS | I | | | |
| 45677 | GAMBROSOL 10 M | sol 4x2500ml(ge10) | BJS | I | | | |
| 45672 | GAMBROSOL 10 M | sol 4x2500ml(sy10) | BJS | I | | | |
| 65937 | GAMBROSOL 10 M | sol 5x2000ml(ge10) | BJS | I | | | |
| 65949 | GAMBROSOL 10 M | sol 5x2000ml(sy10) | BJS | I | | | |
| 45668 | GAMBROSOL 10 M | sol 6x1500ml(sy10) | BJS | I | | | |
| 01186 | GAMBROSOL TRIO 10 | sol 2x5000ml(sy10) | BJS | I | | | |
| 46918 | DIANEAL PD1 GL.2.27%/22.7MG/ML | sol 1x5000ml(vak) | BXI | IRL | | | |
| 45672 | GAMBROSOL 10 M SYSTEM 10 | sol 4x2500ml(vak) | BJS | I | | | |
| 55846 | PERITONEAL DIAL.SOL+DEXTR.4.25% | sol 1x2500ml(vak) | BFF | I | | | |
| 46925 | DIANEAL PD1 GL.3.86%Z38.6MGZML | sol 1x2500ml(vak) | BXI | IRL | | | |
| 46927 | DIANEAL PD1 GL3.86%/38.6MG/ML | sol 1x5000ml(vak) | BXI | IRL | | | |
| 01198 | GAMBROSOL TRIO 10 | sol 4x2500ml(ge10) | BJS | I | | | |
| 01184 | GAMBROSOL TRIO 10 | sol 4x2500ml(sy10) | BJS | I | | | |
| 01218 | GAMBROSOL TRIO 40 | sol 2x5000ml(sy10) | BJS | I | | | |
| 01236 | GAMBROSOL TRIO 40 | sol 4x2500ml(ge10) | BJS | I | | | |
| 95516 | CAPD/DPCA 4 SLEEP SAFE | dlp prn sol1x5000ml | FMC | D | | | |
| 98277 | CAPD 4 | sol 1x5000ml | FRE | D | | | |
| 65936 | GAMBROSOL 10 M | sol 3x3000ml(ge10) | BJS | I | | | |
| 98267 | CAPD 3 | sol 1x5000ml | FRE | D | | | |
| 45640 | GAMBROSOL 10 H SYSTEM 10 | sol 2x4500ml(vak) | BJS | I | | | |
| 30828 | CAPD/DPCA 2 BALANCE STAY SAFE | dlp prn sol4x2500ml | FMC | D | | | |
| 45677 | GAMBROSOL 10 M GEMINI 10 | sol 4x2500ml(vak) | BJS | I | | | |
| 95446 | CAPD/DPCA 3 STAY SAFE | dlp prn sol 1x2500ml | FMC | D | | | |
| 98275 | CAPD 4 | sol 1x2000ml | FRE | D | | | |
| 12805 | CAPD 3 ANDY PLUS | sol 1x2500ml | FRC | D | | | |
| 55847 | PERITONEAL DIAL.SOL.+DEXTR.1.5% | sol 1x2500ml(vak) | BFF | I | | | |
| 95491 | CAPD/DPCA 3 SLEEP SAFE | dlp prn sol1x5000ml | FMC | D | | | |
| 97371 | CAPD/DPCA 2 STAY SAFE | dlp prn sol1x3000ml | FMC | D | | | |
| 59059 | NUTRINEAL PD4 WITH 1.1%AMINOAC. | sol 4x2500ml(vak) | BXI | IRL | | | |
| 95447 | CAPD/DPCA 3 STAY SAFE | dlp prn sol1x3000ml | FMC | D | | | |
| 65937 | GAMBROSOL 10 M | sol 5x2000ml(ge10) | BJS | I | | | |
| 95511 | CAPD/DPCA 4 STAY SAFE | dlp prn sol1x3000ml | FMC | D | | | |
| 30852 | CAPD/DPCA 4 BALANCE STAY SAFE | dlp prn sol4x2500ml | FMC | D | | | |
| 45632 | GAMBROSOL 10 H SYSTEM 10 | sol 6x1500ml(vak) | BJS | I | | | |
| 45638 | GAMBROSOL 10 H SYSTEM 10 | sol 4x2500ml(vak) | BJS | I | | | |
| 76616 | DIANEAL PD 4(+GLUCOSE 1.36%) | sol 1x5000ml(vak) | BXT | IRL | | | |
| 52994 | pERITON.DIAL+dext.2.5%+0.18CA | sol 4x2000ml(vak) | BFF | I | | | |
| 69318 | GAMBROSOL 10 H | sol 3x3000ml(ge10) | BJS | I | | | |
| 69304 | GAMBROSOL 10 H | sol 5x2000ml(ge10) | BJS | I | | | |
| 52995 | PERITON.DIAL.+dext.2.5%+0.18CA | sol 4x2500ml(vak) | BFF | I | | | |
| 01215 | GAMBROSOL TRIO 40 | sol 4x2500ml(sy10) | BJS | I | | | |
| 69183 | PERITONEAL DIAL.SOL.+DEXTR.1.5% | sol 1x5000ml(vak) | BFF | I | | | |
| 52992 | periton.dial.+dext.1.5%+0.18ca | sol 4x2000ml | BFF | I | | | |
| 03208 | CAPD/DPCA 17 STAY SAFE | dlp prn sol1x2000ml | FMC | D | | | |
| 59059 | NUTRINEAL PD4 WITH 1.1%AMINOAC. | dlp prn sol4x2500ml | BXI | IRL | | | |
| 52992 | PERITON.DIAL.+DEXT.1.5%+0.18CA | sol 4x2000ml | BFF | I | | | |
| 52993 | PERITON.DIAL.+DEXT.1.5%+0.18CA | sol 4x2500ml | BFF | I | | | |
| 45704 | GAMBROSOL 10 L SYSTEM 10 | sol 4x2500ml(vak) | BJS | I | | | |
| 03209 | CAPD/DPCA 18 STAY SAFE | dlp prn sol1x2000ml | FMC | D | | | |
| 68515 | GAMBROSOL 10 H | sol 2x5000ml(sy10) | BJS | I | | | |
| 68460 | GAMBROSOL 10 H | sol 5x2000ml(sy10) | BJS | I | | | |
| 68321 | GAMBROSOL 10 H | sol 3x3000ml(sy10) | BJS | I | | | |
| 95430 | CAPD/DPCA 3 STANDARD | dlp prn sol1x2500ml | FMC | D | | | |
| 85924 | PERITONEAL DIAL.SOL.+DEXTR.2.5% | sol 1x5000ml(vak) | BFF | I | | | |
| 85926 | PERITONEAL DIAL.SOL+DEXTR.4.25% | sol 1x5000ml(vak) | BFF | I | | | |
| 30848 | CAPD/DPCA 3 BALANCE STAY SAFE | dlp prn sol4x2500ml | FMC | D | | | |
| 76625 | DIANEAL PD 4(+GLUCOSE 2.27%) | sol 1x5000ml(vak) | BXT | IRL | | | |
| 03210 | CAPD/DPCA 19 STAY SAFE | dlp prn sol1x2000ml | FMC | D | | | |
| 76623 | DIANEAL PD 4(+GLUCOSE 2.27%) | sol 1x2500ml(vak) | BXT | IRL | | | |
| 01184 | GAMBROSOL TRIO 10 | sol 4x2500ml(sy10) | BJS | I | | | |
| 76632 | DIANEAL PD 4(+GLUCOSE 3.86%) | sol 1x2500ml(vak) | BXT | IRL | | | |
| 11497 | CAPD 2 ANDY PLUS | sol 1x2500ml | FRC | D | | | |
| 52994 | PERITON.DIAL.+DEXT.2.5%+0.18CA | sol 4x2000ml(vak) | BFF | I | | | |
| 52995 | PERITON.DIAL.+DEXT.2.5%+0.18CA | sol 4x2500ml(vak) | BFF | I | | | |
| 55847 | PERITON.DIAL.SOL+DEXT.BFF 1.5% | sol 2500ml(vak-Šr.) | BFF | I | | | |
| 69183 | PERITON.DIAL.SOL+DEXT.BFF 1.5% | sol 5000ml(vak-Šr.) | BFF | I | | | |
| 55848 | PERITON.DIAL.SOL+DEXT.BFF 2.5% | sol 2500ml(vak-Šr.) | BFF | I | | | |
| 85924 | PERITON.DIAL.SOL+DEXT.BFF 2.5% | sol 5000ml(vak-Šr.) | BFF | I | | | |
| 55846 | PERITON.DIAL.SOL+DEXT.BFF4.25% | sol 2500ml(vak-Šr.) | BFF | I | | | |
| 85926 | PERITON.DIAL.SOL+DEXT.BFF4.25% | sol 5000ml(vak-Šr.) | BFF | I | | | |
| 102 | B05X | přídavky do nitrožilně podávaných roztoků (hydrogenuhličitan sodný) | parent. | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 102.1 | B05XA02 | hydrogenuhličitan sodný (do 20 ml v jedné ampuli včetně) | parent. | 100 | ML | 124,74 | O |
@@ -1770,8 +1874,8 @@
| 103 | B05X | přídavky do nitrožilně podávaných roztoků (ostatní) | parent. | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 103.1 | B05XA01 | chlorid draselný (koncentrace 7,45%) | parent. | 100 | ML | 17,40 | H |
| 70523 | INFUSIO KALII CHLORATI CONC.MVM | inf 1x250ml | MVM | CZ | | | |
| 103.2 | B05XA03 | chlorid sodný (koncentrace do 5,85% včetně) | parent | 100 | ML | 20,30 | H |
| 70523 | INFUSIO KALII CHL.CONC.MVM 7.45 | inf sol 1x250ml | MVM | CZ | | | |
| 103.2 | B05XA03 | chlorid sodný (koncentrace do 5,85% včetně) | parent. | 100 | ML | 20,30 | H |
| 44171 | CHLORID SODNY 5.85% BRAUN | inf 1x100ml | BME | D | | | |
| 103.3 | B05XA03 | chlorid sodný (koncentrace nad 5,85%) | parent. | 100 | ML | 18,55 | H |
| 01695 | NATRII CHLORIDI 10% MEDVIR | inf 1x100ml | VYS | CZ | | | |
@@ -1782,13 +1886,13 @@
| 103.6 | B05XA30 | kombinace elektrolytů (stopové prvky) | parent. | 10 | ML | 12,46 | H |
| | | | | | | | |
| 103.7 | B05XA31 | elektrolyty v kombinaci s jinými léčivy | parent. | 100 | ML | 33,26 | H |
| 75101 | KALIUM-L-MALATLOSUNG | inf 10x20ml | LPD | A | | | |
| 75101 | KALIUM-L-MALATLÖS.ELO-MEL INF. | inf cnc sol 10x20ml | LPD | A | | | |
| 103.8 | B05XB01 | chlorid argininu (koncentrace 21%) | parent. | 100 | ML | 233,08 | H |
| 86797 | ARDEAELYTOSOL L-ARGININCHL.21% | inf 1x200ml | ARD | CZ | | | |
| 86798 | ARDEAELYTOSOL L-ARGININCHL.21% | inf 1x250ml | ARD | CZ | | | |
| 69596 | ARDEAELYTOSOL L-ARGININCHL.21% | inf 1x300ml | ARD | CZ | | | |
| 86799 | ARDEAELYTOSOL L-ARGININCHL.21 % | inf 1x400ml | ARD | CZ | | | |
| 69597 | ARDEAELYTOSOL L-ARGININCHL.21% | inf 1x500ml | ARD | CZ | | | |
| 86797 | ARDEAELYTOSOL L-ARGININCHL.21% | inf 1x200ml | ARD | CZ | | | |
| 86799 | ARDEAELYTOSOL L-ARGININCHL.21% | inf 1x400ml | ARD | CZ | | | |
| 69596 | ARDEAELYTOSOL L-ARGININCHL.21% | inf 1x300ml | ARD | CZ | | | |
| 103.9 | B05XB02 | alanylglutamin | parent. | 1 | ML | 4,39 | H |
| | | | | | | | |
| 103.10 | B05XC | vitamíny | parent. | 1 | DF | 43,99 | H |
@@ -1801,8 +1905,8 @@
| 104.2 | B05ZA | hemodialytika, koncentráty | lok. | 1000 | ML | 125,72 | H |
| | | | | | | | |
| 104.3 | B05ZB | hemofiltráty | lok. | 1000 | ML | 94,50 | H |
| 89174 | SOLUTION FOR HAEMOFILTRATION E2 | i sol 1x5000ml | BFF | I | | | |
| 98825 | ROZTOK PRO HEMOFILTRACI HF 11 | sol 2x4500ml | FMC | D | | | |
| 89174 | SOLUTION FOR HAEMOFILTRATION E2 | sol 1x5000ml | BFF | I | | | |
| 105 | C01AA | kardioglykosidy z náprstníku | p.o. | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 105.1 | C01AA02 | acetyldigoxin | p.o. | 0.5 | MG | 1,03 | |
@@ -1810,8 +1914,9 @@
| 105.2 | C01AA04 | digitoxin | p.o. | 0.1 | MG | 1,03 | |
| | | | | | | | |
| 105.3 | C01AA05 | digoxin | p.o. | 0.25 | MG | 1,27 | |
| 03542 | DIGOXIN 0.250 LECIVA | tbl 30x0.25mg | LEX | CZ | | | |
| 00705 | DIGOXIN | gtt 1x10ml 0.5mg/ml | IVX | CZ | | | |
| 83318 | DIGOXIN 0.125 LÉČIVA | tbl 30x0.125mg | LEX | CZ | | | |
| 03542 | DIGOXIN 0.250 LÉČIVA | tbl 30x0.25mg | LEX | CZ | | | |
| 00705 | DIGOXIN-GALENA | porgttsol1x10ml/5mg | IVX | CZ | | | |
| 105.4 | C01AA08 | metildigoxin | p.o. | 0.2 | MG | 1,03 | |
| 106 | C01AA | kardioglykosidy z náprstníku | parent. | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
@@ -1823,19 +1928,19 @@
| 107 | C01BA | antiarytmika, třída la | p.o. | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 107.1 | C01BA | detajmii bitartras | p.o. | 75 | MG | 14,07 | |
| 23113 | TACHMALCOR | drg 50x25mg | VAD | D | | | |
| 107.2 | C01BA01 | chinidin | p.o. | 1.2 | GM | 13,48 | |
| 70549 | TBL.CHINIDINI SULFURICI 0.2 MVM | tbl 1000x0.2gm | MVM | CZ | | | |
| 107.3 | C01BA01 | Chinidin (retardované lékové formy) | p.o. | 1.2 | GM | 21,80 | |
| 23113 | TACHMALCOR | por tbl obd 50x25mg | AWD | D | | | |
| 107.2 | C01BA01 | chinidin (neretardované lékové formy) | p.o. | 1.2 | GM | 10,80 | |
| | | | | | | | |
| 107.3 | C01BA01 | chinidin (retardované lékové formy) | p.o. | 1.2 | GM | 17,40 | |
| | | | | | | | |
| 107.4 | C01BA02 | prokainamid | p.o. | 3 | GM | 38,61 | |
| | | | | | | | |
| 107.5 | C01BA03 | disopyramid | p.o. | 0.4 | GM | 12,37 | |
| | | | | | | | |
| 107.6 | C01BA08 | prajmalin | p.o. | 30 | MG | 13,56 | |
| 90992 | NEO-GILURYTMAL | tbl obd 50x20mg | SVP | D | | | |
| 107.6 | C01BA08 | prajmalin | p.o. | 30 | MG | 10,80 | |
| | | | | | | | |
| 107.7 | C01CA | ipratropium | p.o. | 30 | MG | 53,77 | |
| 88433 | ITROP | tbl fc 20x10mg | BOE | F | | | |
| 88433 | ITROP | tbl obd 20x10mg | BOE | F | | | |
| 108 | C01BA | antiarytmika, třída la | parent. | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 108.1 | C01B | ipratropium | parent. | 3 | MG | 782,94 | O |
@@ -1845,53 +1950,50 @@
| 108.3 | C01BA03 | disopyramid | parent. | 0.4 | GM | 251,87 | O |
| | | | | | | | |
| 108.4 | C01BA05 | ajmalin | parent. | 0.3 | GM | 251,87 | O |
| 109 | C01BB | antiarytmika, trida Ib | p.o. | | | | |
| 109 | C01BB | antiarytmika, třída Ib | p.o. | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 109.1 | C01BB02 | mexiletin | p.o. | 0.8 | GM | 9,41 | |
| 93311 | KATEN RETARD | tbl 50x400mg | SLO | SK | | | |
| 93311 | KATEN RETARD 400MG | tbl ret 50x400mg | SLO | SK | | | |
| 109.2 | C01BB03 | tocainid | p.o. | 1.2 | GM | 10,22 | |
| 110 | C01BB | antiarytmika, třída Ib | parent. | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 110.1 | C01BB01 | lidokain | parent. | 1 | ML | 1,22 | O/INT,KAR, GER |
| | | | | | | | |
| 110.2 | C01BB02 | mexiletin | parent. | 0.8 | GM | 351,64 | O/INT,KAR, GER |
| | | | | | | | |
| 110.3 | C01BB03 | tocainid | parent. | 1.2 | GM | 351,64 | O/INT,KAR, GER |
| 111 | C01BC | antiarytmika, třida Ic | p.o. | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 111.1 | C01BC03 | propafenon (méně než 100 mg v jedné tabletě) | p.o. | 0.3 | gm | 17,16 | |
| | | | | | | | |
| 111.2 | C01BC03 | propafenon (od 100 mg do 150 mg včetně v jedné tabletě) | p.o. | 0.3 | gm | 6,70 | |
| 53535 | PROPAFENON AL 150 | tbl obd 50x150mg | APA | D | | | |
| 59942 | PROPANORM 150MG | tbl obd 50x150mg | PMP | CZ | | | |
| 91276 | PROLEKOFEN | tbl fc 50x150mg | LEK | SLO | | | |
| 111.3 | C01BC03 | propafenon (nad 150 mg v jedné tabletě) | p.o. | 0.3 | GM | 5,70 | |
| 110.1 | C01BB01 | lidokain | parent. | 1 | ML | 1,22 | O/INT,KAR,GER |
| | | | | | | | |
| 110.2 | C01BB02 | mexiletin | parent. | 0.8 | GM | 351,64 | O/INT,KAR,GER |
| | | | | | | | |
| 110.3 | C01BB03 | tocainid | parent. | 1.2 | GM | 351,64 | O/INT,KAR,GER |
| 111 | C01BC | antiarytmika, třída Ic | p.o. | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 111.1 | C01BC03 | propafenon (méně než 100 mg v jedné tabletě) | p.o. | 0.3 | GM | 17,16 | |
| | | | | | | | |
| 111.2 | C01BC03 | propafenon (od 100 mg do 150 mg včetně v jedné tabletě) | p.o. | 0.3 | GM | 6,40 | |
| | | | | | | | |
| 111.3 | C01BC03 | propafenon (nad 150 mg v jedné tabletě) | p.o. | 0.3 | GM | 5,40 | |
| 112 | C01BC | antiarytmika, třída Ic | parent. | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 112.1 | C01BC03 | propafenon | parent. | 0.3 | GM | 174,00 | O/INT,KAR, GER |
| | | | | | | | |
| 112.2 | C01BC07 | lorcainid | parent. | 0.2 | GM | 139,01 | O/INT,KAR, GER |
| 112.1 | C01BC03 | propafenon | parent. | 0.3 | GM | 174,00 | O/INT,KAR,GER |
| | | | | | | | |
| 112.2 | C01BC07 | lorcainid | parent. | 0.2 | GM | 139,01 | O/INT,KAR,GER |
| 113 | C01BD | antiarytmika, třída III | p.o. | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 113.1 | C01BD01 | amiodaron | p.o. | 0.2 | GM | 4,20 | |
| 113.1 | C01BD01 | amiodaron | p.o. | 0.2 | GM | 4,00 | |
| 59286 | AMIOHEXAL 200 | tbl 100x200mg | SFS | D | | | |
| 59284 | AMIOHEXAL 200 | tbl 20x200mg | SFS | D | | | |
| 59285 | AMIOHEXAL 200 | tbl 50x200mg | SFS | D | | | |
| 59284 | AMIOHEXAL 200 | tbl 20x200mg | SFS | D | | | |
| 59655 | AMIOKORDIN | tbl 60x200mg | KRK | SLO | | | |
| 114 | C01BD | antiarytmika, třída III a adenosin | parent. | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 114.1 | C01BD01 | amiodaron | parent. | 0.2 | GM | 19,28 | O/INT,KAR, GER |
| 96600 | SEDACORON | inj 5x3ml/150mg | EBW | A | | | |
| 59659 | AMIOKORDIN | inj 5x3ml/150mg | KRK | SLO | | | |
| 114.2 | C01BD02 | bretylium tosilát | parent. | 100 | MG | 139,01 | O/INT,KAR, GER |
| | | | | | | | |
| 114.3 | C01EB10 | adenosin | parent. | 15 | MG | 695,63 | O/INT,KAR, GER |
| 91615 | ADENOCOR | inj 6x2ml/6mg | SWI | F | | | |
| 55662 | ADENOSIN EBEWE | inj 6x2ml/6mg | EBP | A | | | |
| 114.1 | C01BD01 | amiodaron | parent. | 0.2 | GM | 19,28 | O/INT,KAR,GER |
| 59659 | AMIOKORDIN | inj sol 5x3ml/150mg | KRK | SLO | | | |
| 96600 | SEDACORON | inj sol 5x3ml/150mg | EBP | A | | | |
| 114.2 | C01BD02 | bretylium tosilát | parent. | 100 | MG | 139,01 | O/INT,KAR,GER |
| | | | | | | | |
| 114.3 | C01EB10 | adenosin | parent. | 15 | MG | 695,63 | O/INT,KAR,GER |
| 91615 | ADENOCOR | inj 6x2ml/6mg | SWJ | F | | | |
| 55662 | ADENOSIN EBEWE | inj sol 6x2ml/6mg | EBP | A | | | |
| 115 | C01CA | adrenergní a dopaminergní léčiva (norepinefrin a dopamin) | parent. | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 115.1 | C01CA03 | norepinefrin | parent. | 6 | mg | 79,56 | O |
| 00536 | NORADNRENALIN LECIVA | inj 5x1ml/1mg | LEX | CZ | | | |
| 115.1 | C01CA03 | norepinefrin | parent. | 6 | MG | 79,56 | O |
| 00536 | NORADRENALIN LÉČIVA | inj 5x1ml/1mg | LEX | CZ | | | |
| 115.2 | C01CA04 | dopamin | parent. | 0.5 | GM | 114,50 | O |
| 116 | C01CA | adrenergní a dopaminergní léčiva (ostatní) | parent. | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
@@ -1900,7 +2002,6 @@
| 116.2 | C01CA05 | norfenefrin | parent. | 25 | MG | 23,76 | H |
| | | | | | | | |
| 116.3 | C01CA07 | dobutamin | parent. | 0.5 | GM | 324,00 | H |
| 86762 | DOBUJECT | inf 5x5ml/250mg | LOY | SF | | | |
| 01639 | DOBUTAMIN GIULINI | inj sic 10x250mg | WAU | D | | | |
| 84361 | DOBUTAMIN GIULINI | inj sic 1x250mg | WAU | D | | | |
| 116.4 | C01CA09 | metaraminol | parent. | 50 | MG | 191,26 | H |
@@ -1908,7 +2009,6 @@
| 116.5 | C01CA10 | metoxamin | parent. | 30 | MG | 40,91 | H |
| | | | | | | | |
| 116.6 | C01CA11 | mepentermin | parent. | 30 | MG | 101,67 | H |
| | | | | | | | |
| 116.7 | C01CA17 | midodrin | parent. | 7.5 | MG | 83,44 | H |
| | | | | | | | |
| 116.8 | C01CA24 | epinefrin (lékové formy autoinjektoru) | parent. | 1 | DF | 684,31 | P |
@@ -1934,72 +2034,73 @@
| 118.3 | C01DA02 | glycerol trinitrát (nad 2,5 mg v jedné tabletě) | p.o. | 5 | MG | 2,12 | |
| 31089 | NITROMINT 2.6MG | tbl ret 60x2.6mg | EGI | H | | | |
| 118.4 | C01DA08 | isosorbid dinitrát (do 20 mg v jedné tabletě včetně) | p.o. | 60 | MG | 3,50 | |
| 02405 | DINISAN RETARD 20MG | cps ret 30x20mg | ETS | F | | | |
| 02405 | DINISAN RETARD 20MG | por cps pro 30x20mg | ETS | F | | | |
| 32840 | DINISAN RETARD 20MG | por cps pro 30x20mg | PMP | CZ | | | |
| 118.5 | C01DA08 | isosorbid dinitrát (nad 20 do 80 mg v jedné tabletě včetně) neretardované lékové formy | p.o. | 60 | MG | 1,25 | |
| | | | | | | | |
| 118.6 | C01DA08 | isosorbid dinitrát (nad 20 do 80 mg v jedné tabletě včetně) retardované lékové formy | p.o. | 60 | MG | 2,50 | |
| 02379 | DINISAN RETARD 40MG | por cps pro 30x40mg | ETS | F | | | |
| 32843 | DINISAN RETARD 40MG | por cps pro 30x40mg | PMP | CZ | | | |
| 02379 | DINISAN RETARD 40MG | cps ret 30x40mg | ETS | F | | | |
| 118.7 | C01DA08 | isosorbid dinitrát (nad 80 mg v jedné tabletě) | p.o. | 60 | MG | 4,20 | |
| 91591 | CARDIKET RETARD 120 | cps ret 20x120mg | SWP | D | | | |
| 118.8 | C01DA14 | isosorbid mononitrát do 20 mg včetně v jedné tabletě | p.o. | 40 | MG | 2,75 | |
| 96187 | MONOSAN 20MG | tbl 50x20mg | PMP | CZ | | | |
| 59898 | ISMN AL 20 | tbl 30x20mg | APA | D | | | |
| 61467 | ISMN AL 20 | tbl 100x20mg | APA | D | | | |
| 96190 | MONOSAN 20MG | tbl 30x20mg | PMP | CZ | | | |
| 47685 | ISMIN AL 20 | por tbl nob 30x20mg | APA | D | | | |
| 47686 | ISMIN AL 20 | por tbl nob 60x20mg | APA | D | | | |
| 76402 | SORBIMON 20MG | tbl 100x20mg | MCK | D | | | |
| 76401 | SORBIMON 20MG | tbl 50x20mg | MCK | D | | | |
| 76400 | SORBIMON 20MG | tbl 20x20mg | MCK | D | | | |
| 92568 | ISMN AL 20 | tbl 60x20mg | APA | D | | | |
| 47685 | ISMIN AL 20 | por tbl nob 30x20mg | APA | D | | | |
| 47687 | ISMIN AL 20 | por tbl nob100x20mg | APA | D | | | |
| 87184 | MONO MACK 20MG | tbl 30x20mg | ICS | CZ | | | |
| 59898 | ISMN AL 20 | por tbl nob 30x20mg | APA | D | | | |
| 92568 | ISMN AL 20 | por tbl nob 60x20mg | APA | D | | | |
| 61467 | ISMN AL 20 | por tbl nob100x20mg | APA | D | | | |
| 87184 | MONO MACK 20MG | por tbl nob 30x20mg | ICS | CZ | | | |
| 96190 | MONOSAN 20 MG | por tbl nob 30x20mg | PMP | CZ | | | |
| 96187 | MONOSAN 20 MG | por tbl nob 50x20mg | PMP | CZ | | | |
| 23305 | MONOSAN 20 MG | por tbl nob100x20mg | PMP | CZ | | | |
| 76402 | SORBIMON 20 MG | tbl 100x20mg | MCK | D | | | |
| 76400 | SORBIMON 20 MG | tbl 20x20mg | MCK | D | | | |
| 76401 | SORBIMON 20 MG | tbl 50x20mg | MCK | D | | | |
| 118.9 | C01DA14 | isosorbid mononitrát nad 20 mg v jedné tabletě | p.o. | 40 | MG | 2,49 | |
| 92569 | ISMN AL 40 | tbl 60x40mg | APA | D | | | |
| 61469 | ISMN AL 40 | tbl 100x40mg | APA | D | | | |
| 96188 | MONOSAN 40MG | tbl 50x40mg | PMP | CZ | | | |
| 47688 | ISMIN AL 40 | por tbl nob 30x40mg | APA | D | | | |
| 47689 | ISMIN AL 40 | por tbl nob 60x40mg | APA | D | | | |
| 59899 | ISMN AL 40 | tbl 30x40mg | APA | D | | | |
| 47690 | ISMIN AL 40 | por tbl nob100x40mg | APA | D | | | |
| 87185 | MONO MACK 40MG | tbl 30x40mg | ICS | CZ | | | |
| 96191 | MONOSAN 40MG | tbl 30x40mg | PMP | CZ | | | |
| 76405 | SORBIMON 40MG | tbl 100x40mg | MCK | D | | | |
| 76404 | SORBIMON 40MG | tbl 50x40mg | MCK | D | | | |
| 76403 | SORBIMON 40MG | tbl 20x40mg | MCK | D | | | |
| 59899 | ISMN AL 40 | por tbl nob 30x40mg | APA | D | | | |
| 92569 | ISMN AL 40 | por tbl nob 60x40mg | APA | D | | | |
| 61469 | ISMN AL 40 | por tbl nob100x40mg | APA | D | | | |
| 87185 | MONO MACK 40MG | por tbl nob 30x40mg | ICS | CZ | | | |
| 96191 | MONOSAN 40 MG | por tbl nob 30x40mg | PMP | CZ | | | |
| 96188 | MONOSAN 40 MG | por tbl nob 50x40mg | PMP | CZ | | | |
| 23306 | MONOSAN 40 MG | por tbl nob100x40mg | PMP | CZ | | | |
| 76405 | SORBIMON 40 MG | tbl 100x40mg | MCK | D | | | |
| 76403 | SORBIMON 40 MG | tbl 20x40mg | MCK | D | | | |
| 76404 | SORBIMON 40 MG | tbl 50x40mg | MCK | D | | | |
| 119 | C01DA | vazodilatancia ze skupiny organických nitrátů | parent. | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 119.1 | C01DA02 | glycerol trinitrát | parent. | 2.5 | MG | 13,18 | H |
| 83538 | NITRO POHL INFUS. | inf 1x50ml/50mg | PLB | D | | | |
| 83539 | NITRO POHL INFUS. | inf 10x50ml/50mg | PLB | D | | | |
| 02640 | NITRO MACK AMPULE | inj 10x5ml/5mg | PHH | D | | | |
| 04307 | NITRO POHL INFUS. | inf 10x10ml/10mg | PLB | D | | | |
| 83538 | NITRO POHL INFUS. | inf 1x50ml/50mg | PLB | D | | | |
| 119.2 | C01DA08 | isosorbid dinitrát | parent. | 20 | MG | 123,96 | H |
| 120 | C01DA | vazodilatancia ze skupiny organických nitrátů | spr. | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 120.1 | C01DA02 | glycerol trinitrát | spr. | 5 | DF | 2,36 | |
| 60032 | MAYCOR NITROSPRAY-PUMPSPRAY | spr 1x11.8gm=14.5ml | PDA | D | | | |
| 31407 | NITROMINT | aer dos 1x10gm | EGI | H | | | |
| | | | | | | | |
| 120.2 | C01DA08 | isosorbid dinitrát (mimo přípravků určených k transdermální aplikaci) | spr. | 20 | MG | 8,80 | |
| 121 | C01DA | vazodilatancia ze skupiny organických nitrátů | sublng. | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 121.1 | C01DA02 | glycerol trinitrát | sublng. | 2.5 | MG | 5,93 | |
| 00231 | NITROGLYCERIN SLOVAKOFARMA | tbl 20x0.5mg | SLO | SK | | | |
| 00231 | NITROGLYCERIN-SLOVAKOFARMA | tbl 20x0.5mg | SLO | SK | | | |
| 121.2 | C01DA08 | isosorbid dinitrát | sublng. | 20 | MG | 3,03 | |
| 122 | C01DX | ostatní vazodilatancia | p.o. | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 122.1 | C01DX03 | oxifedrin | p.o. | 40 | MG | 4,79 | |
| | | | | | | | |
| 122.2 | C01DX12 | molsidomin (do 2 mg v jedné tabletě včetně) | p.o. | 6 | MG | 4,46 | |
| 49553 | MOLSIHEXAL 2MG | tbl 100x2mg | SFS | D | | | |
| 49553 | MOLSIHEXAL 2 MG | tbl 100x2mg | SFS | D | | | |
| 122.3 | C01DX12 | molsidomin (nad 2 do 4 mg v jedné tabletě včetně) | p.o. | 6 | MG | 2,72 | |
| 49554 | MOLSIHEXAL 4MG | tbl 100x4mg | SFS | D | | | |
| 49554 | MOLSIHEXAL 4 MG | tbl 100x4mg | SFS | D | | | |
| 122.4 | C01DX12 | molsidomin (nad 4 mg v jedné tabletě) | p.o. | 6 | MG | 2,10 | |
| 49561 | MOLSIHEXAL RETARD | tbl ret 60x8mg | SFS | D | | | |
| 49559 | MOLSIHEXAL RETARD | tbl ret 100x8mg | SFS | D | | | |
| 49560 | MOLSIHEXAL RETARD | tbl ret 30x8mg | SFS | D | | | |
| 122.5 | C01EB15 | trimetazidin | p.o. | 40 | MG | 6,50 | L/INT,KAR, GER |
| 49561 | MOLSIHEXAL RETARD | tbl ret 60x8mg | SFS | D | | | |
| 122.5 | C01EB15 | trimetazidin | p.o. | 40 | MG | 6,50 | L/INT, KAR,GER |
| 123 | C01DX | ostatní vazodilatancia | parent. | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 123.1 | C01DX03 | oxifedrin | parent. | 40 | MG | 13,78 | H |
@@ -2008,11 +2109,11 @@
| 124 | C01EA | prostaglandiny | parent. | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 124.1 | C01EA01 | alprostadil | parent. | 0,5 | MG | 3090,40 | X |
| 44169 | ALPROSTAPINT 500MCG/ML | inf 5x1ml/500rg | BGD | D | | | |
| 92305 | ALPROSTAN | inf 10x0.2ml/100rg | LEX | CZ | | | |
| 92305 | ALPROSTAN | inf sol 10x0.2ml | LEX | CZ | | | |
| 44169 | ALPROSTAPINT 500 MCG/ML | inf cnc sol 5x1ml | BGD | D | | | |
| 124.2 | C01EA01 | alprostadil (vázaný na cyklodextrin) | parent. | 20 | RG | 634,27 | X |
| 91731 | PROSTAVASIN | inj sic 10x20rg | SWP | D | | | |
| 125 | C02 | antihypertenziva působící na centrální atfa-2 receptory a jejich kombinace s diuretiky | p.o. | | | | |
| 91731 | PROSTAVASIN | inj sic 10x5ml | SWP | D | | | |
| 125 | C02 | antihypertenziva působící na centrální alfa-2 receptory a jejich kombinace s diuretiky | p.o. | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 125.1 | C02AB01 | methyldopa (levotočivá) | p.o. | 1 | GM | 6,80 | |
| | | | | | | | |
@@ -2021,6 +2122,7 @@
| 125.3 | C02AC02 | guanfacin | p.o. | 3 | MG | 7,00 | |
| | | | | | | | |
| 125.4 | C02AC05 | moxonidin do 0,2 mg v 1 tabletě včetně | p.o. | 0.3 | MG | 7,80 | |
| | | | | | | | |
| 125.5 | C02AC05 | moxonidin nad 0,2 mg v 1 tabletě | p.o. | 0.3 | MG | 7,00 | |
| | | | | | | | |
| 125.6 | C02AC06 | rilmenidin | p.o. | 1 | MG | 7,00 | |
@@ -2047,29 +2149,30 @@
| | | | | | | | |
| 127.5 | C02CA04 | doxazosin-retardované formy nad 4 mg v jedné tabletě | p.o. | 4 | MG | 10,20 | L/URN |
| | | | | | | | |
| 127.6 | C02CA04 | doxazosin - neretardované formy | p.o. | 4 | MG | 16,80 | L/URN |
| 45215 | ZOXON 4 | tbl 30x4mg | LEX | CZ | | | |
| 127.6 | C02CA04 | doxazosin – neretardované formy | p.o. | 4 | MG | 16,80 | L/URN |
| 64798 | KAMIREN 2 | tbl 30x2mg | KRK | SLO | | | |
| 64797 | KAMIREN 4 | tbl 30x4mg | KRK | SLO | | | |
| 64798 | KAMIREN 2 | tbl 30x2mg | KRK | SLO | | | |
| 95243 | ZOXON 4 | tbl 100x4mg | LEX | CZ | | | |
| 45215 | ZOXON 4 | por tbl nob 30x4mg | LEX | CZ | | | |
| 95243 | ZOXON 4 | por tbl nob100x4mg | LEX | CZ | | | |
| 127.7 | C02CA06 | urapidil | p.o. | 50 | MG | 6,89 | |
| 128 | C02CA | antihypertenziva působící na periferní alfa-1 receptory | parent. | O | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 128.1 | C02CA06 | urapidil | parent. | 50 | MG | 217,84 | O |
| 90763 | EBRANTIL I.V.25 | inj 5x5ml/25mg | BGL | D | | | |
| 90765 | EBRANTIL I.V.50 | inj 5x10ml/50mg | BGL | D | | | |
| 90763 | EBRANTIL I.V. 25 | inj sol 5x5ml/25mg | AKZ | D | | | |
| 90765 | EBRANTIL I.V. 50 | inj sol 5x10ml/50mg | AKZ | D | | | |
| 129 | C02D | antihypertenziva působící přímou vazodilataci | p.o. | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 129.1 | C02DB01 | dihydralazin | p.o. | 75 | MG | 2,00 | |
| | | | | | | | |
| 129.2 | C02DB03 | endralazin | p.o. | 10 | MG | 9,43 | |
| | | | | | | | |
| 129.3 | C02DC01 | minoxidil | p.o. | 20 | MG | 20,14 | L/INT,KAR, GER |
| 130 | C02D | antihypertenziva působící přímou vazodilataci | parent. | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 130.1 | C02DA01 | diazoxid | parent. | 300 | MG | 283,99 | H |
| | | | | | | | |
| 130.2 | C02DB01 | dihydralazin | parent. | 25 | MG | 29,88 | H |
| 90484 | NEPRESOL | inj 5x25mg+solv. | CGC | CH | | | |
| | | | | | | | |
| 130.3 | C02DD01 | nitroprusid sodný | parent. | 50 | MG | 265,63 | H |
| 21221 | NIPRUSS | inf plv sol 5x60mg | SWP | D | | | |
| 131 | C03AA | thiazidová diuretika | p.o. | | | | |
@@ -2081,10 +2184,10 @@
| | | | | | | | |
| 132.2 | C03BA10 | xipamid | p.o. | 20 | MG | 1,03 | |
| | | | | | | | |
| 132.3 | C03BA11 | indapamid | p.o. | 2.5 | MG | 1.12 | |
| 132.3 | C03BA11 | indapamid | p.o. | 2.5 | MG | 1,12 | |
| 96696 | INDAP | por cps dur30x2.5mg | PMP | CZ | | | |
| 46635 | INDAPAMID HF | tbl obd 30x2.5mg | HMF | YU | | | |
| 96696 | INDAP | cps 30x2.5mg | PMP | CZ | | | |
| 132.4 | C03BA11 | indapamid s řízeným uvolňováním | p.o. | 1.5 | MG | 1,12 | |
| 132.4 | C03BA11 | indapamid s řízeným uvolňováním | p.o. | 1,5 | MG | 1,12 | |
| | | | | | | | |
| 132.5 | C03BA | metipamid | p.o. | 2.5 | MG | 1,03 | |
| | | | | | | | |
@@ -2092,37 +2195,40 @@
| 133 | C03CA | kličková diuretika | p.o. | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 133.1 | C03CA01 | furosemid (méně než 125 mg v jedné tabletě) | p.o. | 40 | MG | 0,88 | |
| 56347 | APO-FUROSEMIDE 40MG | tbl 100x40mg | APT | CND | | | |
| 96738 | APO-FUROSEMIDE 80MG | tbl 100x80mg | APT | CND | | | |
| 98219 | FURON 40 MG | por tbl nob 50x40mg | MCK | D | | | |
| 56805 | FURORESE 40 | tbl 100x40mg | FST | D | | | |
| 56802 | FURORESE 40 | tbl 20x40mg | FST | D | | | |
| 56804 | FURORESE 40 | tbl 50x40mg | FST | D | | | |
| 56802 | FURORESE 40 | tbl 20x40mg | FST | D | | | |
| 98219 | FURON 40MG | tbl 50x40mg | MCK | D | | | |
| 56347 | APO-FUROSEMIDE 40MG | tbl 100x40mg | APT | CND | | | |
| 02079 | FUROSEMID SLOVAKOFARMA | tbl 2x10x40mg | SLO | SK | | | |
| 02079 | FUROSEMID-SLOVAKOFARMA | tbl 20x40mg | SLO | SK | | | |
| 133.2 | C03CA01 | furosemid (125 mg a více v jedné tabletě) | p.o. | 40 | MG | 1,08 | |
| 56812 | FURORESE 250 | tbl 100x250mg | FST | D | | | |
| 02785 | FUROSEMID SLOVAKOFARMA FORTE | tbl 10x250mg | SLO | SK | | | |
| 56809 | FURORESE 125 | tbl 100x125mg | FST | D | | | |
| 56807 | FURORESE 125 | tbl 30x125mg | FST | D | | | |
| 56808 | FURORESE 125 | tbl 50x125mg | FST | D | | | |
| 98937 | FURORESE 250 | por tbl nob10x250mg | FST | D | | | |
| 56810 | FURORESE 250 | por tbl nob20x250mg | FST | D | | | |
| 56811 | FURORESE 250 | por tbl nob50x250mg | FST | D | | | |
| 56812 | FURORESE 250 | por tblnob100x250mg | FST | D | | | |
| 56815 | FURORESE 500 | tbl 100x500mg | FST | D | | | |
| 68632 | FURORESE 500 | tbl 20x500mg | FST | D | | | |
| 55809 | FURORESE 125 | tbl 100x125mg | FST | D | | | |
| 56811 | FURORESE 250 | tbl 50x250mg | FST | D | | | |
| 56814 | FURORESE 500 | tbl 50x500mg | FST | D | | | |
| 56815 | FURORESE 500 | tbl 100x500mg | FST | D | | | |
| 56810 | FURORESE 250 | tbl 20x250mg | FST | D | | | |
| 98937 | FURORESE 250 | por tbl nob 10x250mg | FST | D | | | |
| 81497 | FUROSEMID AL 500 | por tbl nob20x500mg | APA | D | | | |
| 81498 | FUROSEMID AL 500 | por tbl nob50x500mg | APA | D | | | |
| 81499 | FUROSEMID AL 500 | por tblnob100x500mg | APA | D | | | |
| 02785 | FUROSEMID SLOVAKOFARMA FORTE | tbl 10x250mg | SLO | SK | | | |
| 133.3 | C03CA04 | torasemid (do 10 mg v jedné tabletě včetně) | p.o. | 15 | MG | 0,88 | |
| | | | | | | | |
| 133.4 | C03CA04 | torasemid (nad 10 mg v jedné tabletě) | p.o. | 15 | MG | 1,08 | |
| 134 | C03CA | kličková diuretika | | parent. | | | |
| 134 | C03CA | kličková diuretika | parent. | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 134.1 | C03CA01 | furosemid (méně než 125 mg v jedné ampuli) | parent. | 40 | MG | 15,04 | O |
| 56818 | FURORESE 20 INJEKT | inj 25x2ml/20mg | PHH | D | | | |
| 56817 | FURORESE 20 INJEKT | inj 5x2ml/20mg | PHH | D | | | |
| 56818 | FURORESE 20 INJEKT | inj 25x2ml/20mg | PHH | D | | | |
| 02133 | FUROSEMID BIOTIKA | inj 5x2ml/20mg | HBS | SK | | | |
| 134.2 | C03CA01 | furosemid (125 mg a více v jedné ampuli) | parent. | 40 | MG | 7,36 | O |
| 56820 | FURORESE ROZTOK | inf 25x25ml/250mg | PHH | D | | | |
| 56819 | FURORESE ROZTOK | inf 5x25ml/250mg | PHH | D | | | |
| 56820 | FURORESE ROZTOK | inf 25x25ml/250mg | PHH | D | | | |
| 99333 | FUROSEMID BIOTIKA FORTE | inj 10x10ml/125mg | HBS | SK | | | |
| 134.3 | C03CA04 | torasemid (do 10 mg v jedné ampuli včetně) | parent. | 15 | MG | 16,03 | O |
| | | | | | | | |
@@ -2141,14 +2247,15 @@
| 136.1 | C03EA06 | chlorthalidon a kalium šetřící látky | p.o. | 1 | DF | 1,17 | |
| 88518 | AMICLOTON | tbl 30 | SLO | SK | | | |
| 136.2 | C03EA01 | hydrochlorothiazid a kalium šetřící látky | p.o. | 0.5 | DF | 0,54 | |
| 83718 | AMILORID/HCT AL | tbl 100 | APA | D | | | |
| 83717 | AMILORID/HCT AL | tbl 50 | APA | D | | | |
| 47478 | LORADUR MITE | por tbl nob 50 | MCK | D | | | |
| 83717 | AMILORID HCT AL | tbl 50 | APA | D | | | |
| 76380 | RHEFLUIN | tbl 30 | LEX | CZ | | | |
| 83718 | AMILORID HCT AL | tbl 100 | APA | D | | | |
| 136.3 | C03EA14 | spironolakton/butizid | p.o. | 1 | DF | 9,78 | |
| 137 | C04AB | periferní vazodilatancia ze skupiny derivátů imidazolu | parent. | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 137.1 | C04AB01 | fentolamin | parent. | 10 | MG | 20,82 | O |
| | | | | | | | |
| 137.2 | C04AB02 | tolazolin | parent. | 75 | MG | 87,00 | O |
| 138 | C04A | periferní vazodilatancia ze skupiny derivátů purinu a kyseliny nikotinové | p.o. | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
@@ -2158,16 +2265,19 @@
| | | | | | | | |
| 138.3 | C04AD03 | pentoxifyllin (do 100 mg v jedné tabletě včetně) | p.o. | 1 | GM | 4,30 | |
| | | | | | | | |
| 138.4 | C04AD03 | Pentoxifyllin (nad 100 mg do 400 mg v jedné tabletě včetně) | p.o. | 1 | GM | 6,70 | |
| 47085 | PENTOMER RETARD 400MG | tbl obd 100x400mg | MCK | D | | | |
| 89991 | PENTOXIFYLLIN AL 400 RETARD | tbl obd 50x400mg | APA | D | | | |
| 89992 | PENTOXIFYLLIN AL 400 RETARD | tbl obd 100x400mg | APA | D | | | |
| 54247 | APO-PENTOXIFYLLINE SR | tbl ret 100x400mg | APT | CND | | | |
| 138.4 | C04AD03 | pentoxifyllin (nad 100 mg do 400 mg v jedné tabletě včetně) | p.o. | 1 | GM | 6,70 | |
| 54247 | APO-PENTOXIFYLLINE SR | por tblpro100x400mg | APT | CND | | | |
| 47085 | PENTOMER RETARD 400MG | tbl ret 100x400mg | MCK | D | | | |
| 89992 | PENTOXIFYLLIN AL 400 RETARD | tbl ret 100x400mg | APA | D | | | |
| 66513 | PENTOXIFYLLIN AL 400 RETARD | tbl ret 30x400mg | APA | D | | | |
| 89991 | PENTOXIFYLLIN AL 400 RETARD | tbl ret 50x400mg | APA | D | | | |
| 53479 | TRENTAL 400 | por tbl ret20x400mg | HBS | SK | | | |
| 53480 | TRENTAL 400 | por tblret100x400mg | HBS | SK | | | |
| 66513 | PENTOXIFYLLIN AL 400 RETARD | tbl obd 30x400mg | APA | D | | | |
| 53479 | TRENTAL 400 | por tblret20x400mg | HBS | SK | | | |
| 138.5 | C04AD03 | pentoxifyllin (nad 400 mg v jedné tabletě) | p.o. | 1 | GM | 7,50 | |
| 97702 | PENTOMER RETARD 600MG | tbl obd 20x600mg | MCK | D | | | |
| 49600 | PENTOHEXAL 600 | tbl ret 30x600mg | SFS | D | | | |
| 49601 | PENTOHEXAL 600 | tbl ret 50x600mg | SFS | D | | | |
| 97702 | PENTOMER RETARD 600MG | tbl ret 20x600mg | MCK | D | | | |
| 84413 | VASONIT RETARD 600MG | tbl obd 20x600mg | LAR | A | | | |
| 138.6 | C04AD04 | etophyllin nikotinát | p.o. | 0.3 | GM | 1,65 | |
| 00243 | OXYPHYLLIN | tbl 50x100mg | SLO | SK | | | |
| 139 | C04A | periferní vazodilatancia ze skupiny derivátů purinu a kyseliny nikotinové | parent. | | | | |
@@ -2179,18 +2289,18 @@
| 139.3 | C04AD02 | xantinol nikotinát | parent. | 0.9 | GM | 4,25 | |
| | | | | | | | |
| 139.4 | C04AD03 | pentoxifyllin | parent. | 0.3 | GM | 28,40 | |
| 53200 | AGAPURIN | inj 5x5ml/100mg | SLO | SK | | | |
| 69241 | PENTILIN INJEKCE 100MG/5ML | inj 5x5ml/100mg | KRK | SLO | | | |
| 49603 | PENTOHEXAL 300 | inf 10x15ml/300mg | PHH | D | | | |
| 53200 | AGAPURIN | inj 5x5ml/100mg | SLO | SK | | | |
| 43709 | TRENTAL | inf 10x15ml/300mg | HBS | SK | | | |
| 69241 | PENTILIN 100 | inj 5x5ml/100mg | KRK | SLO | | | |
| 140 | C04AE | periferní vazodilatancia ze skupiny derivátů námelových alkaloidů | p.o. | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 140.1 | C04AE01 | hydrogenované ergotové akaloidy | p.o. | 3 | MG | 2,11 | |
| 91032 | SECATOXIN FORTE | gtt 1x25ml/62.5mg | GNO | CZ | | | |
| 140.1 | C04AE01 | hydrogenované ergotové alkaloidy | p.o. | 3 | MG | 2,11 | |
| 91032 | SECATOXIN FORTE | por gtt sol 1x25ml | IVX | CZ | | | |
| 140.2 | C04AE02 | nicergolin | p.o. | 30 | MG | 8,50 | |
| 05742 | ERGOTOP 30 | tbl obd 28x30mg | GNO | CZ | | | |
| 05742 | ERGOTOP 30 | por tbl flm 28x30mg | IVX | CZ | | | |
| 140.3 | C04AE54 | dihydroergokristin, kombinace | p.o. | 2 | ML | 1,87 | |
| 88088 | ERSILAN | gtt 50ml | GNO | CZ | | | |
| 88088 | ERSILAN | gtt 1x50ml | GNO | CZ | | | |
| 141 | C04AE | periferní vazodilatancia ze skupiny derivátů námelových alkaloidů | parent. | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 141.1 | C04AE01 | hydrogenované ergotové alkaloidy | parent. | 3 | MG | 69,21 | |
@@ -2199,13 +2309,12 @@
| 142.1 | C04AX | jiná periferní vasodilatancia | p.o. | 3 | DF | 5,66 | |
| | | | | | | | |
| 142.2 | C04AX02 | fenoxybenzamin | p.o. | 30 | MG | 15,54 | |
| | | | | | | | |
| 142.3 | C04AX19 | sulkotidil | p.o. | 0.3 | GM | 5,66 | |
| | | | | | | | |
| 142.4 | C04AX20 | buflomedil | p.o. | 0.6 | GM | 5,66 | |
| | | | | | | | |
| 142.5 | C04AX21 | naftidrofuryl | p.o. | 0.2 | GM | 5,66 | |
| 66015 | ENELBIN 100 RETARD | tbl ret 100x100mg | LEX | CZ | | | |
| 66015 | ENELBIN 100 RETARD | por tblret100x100mg | LEX | CZ | | | |
| 143 | C04AX | jiná periferní vasodilatancia | parent. | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 143.1 | C04AX | jiná periferní vasodilatancia | parent. | 2 | DF | 14,86 | |
@@ -2214,7 +2323,7 @@
| | | | | | | | |
| 143.3 | C04AX21 | naftidrofuryl | parent. | 0.2 | GM | 53,95 | |
| 98049 | ENELBIN | inj 10x5ml/40mg | LEX | CZ | | | |
| 144 | C05AD | anthemorhoidalia obsa | hující lokální anestetika | lok. | | | |
| 144 | C05AD | antihemorhoidalia obsahující lokální anestetika | lok. | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 144.1 | C05AD | přípravky obsahující lokální anestetika (lékové formy čípků) | lok. | 1 | DF | 0,98 | |
| | | | | | | | |
@@ -2229,7 +2338,7 @@
| 144.6 | C05AD04 | cinchokain (lékové formy mastí) | lok. | 1 | GM | 0,84 | |
| 145 | C05AX | jiná antihemorrhoidalia k zevnímu použití | lok. | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 145.1 | C05AX02 | bismutové přípravky, kombinace (lékové formy masti) | lok. | 1 | GM | 0,78 | |
| 145.1 | C05AX02 | bismutové přípravky, kombinace (lékové formy mastí) | lok. | 1 | GM | 0,78 | |
| | | | | | | | |
| 145.2 | C05AX02 | bismutové přípravky, kombinace (lékové formy čípků) | lok. | 1 | DF | 0,98 | |
| | | | | | | | |
@@ -2242,7 +2351,7 @@
| | | | | | | | |
| 146.2 | C05BA03 | heparin k zevnímu použití | lok. | 1 | GM | 0,87 | |
| 86044 | HEPARIN AL GEL 30000 | gel 1x100gm | APA | D | | | |
| 86042 | HEPARIN AL SALBE 30000 | ung 1x100gm | APA | D | | | |
| 86042 | HEPARIN AL MAST 30000 | ung 1x100gm | APA | D | | | |
| 146.3 | C05BA53 | heparin, kombinace k zevnímu použití | lok. | 1 | GM | 0,87 | |
| 147 | C05CA | kapiláry stabilizující léčiva ze skupiny flavonoidů | p.o. | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
@@ -2250,8 +2359,8 @@
| | | | | | | | |
| 147.2 | C05CA51 | rutosidy (kombinace, pevné lékové formy) | p.o. | 3 | DF | 1,30 | |
| 96303 | ASCORUTIN | tbl obd 50 | SLO | SK | | | |
| 147.3 | C05CA51 | rutosidy (kombinace, tekuté lékové formy) | p.o. | 2 | ml | 3,03 | |
| 02635 | ANAVENOL | gtt 1x25ml | GNO | CZ | | | |
| 147.3 | C05CA51 | rutosidy (kombinace, tekuté lékové formy) | p.o. | 2 | ML | 3,03 | |
| 02635 | ANAVENOL | por gtt sol 1x25ml | IXP | CZ | | | |
| 147.4 | C05CA53 | diosmin, kombinace | p.o. | 2 | DF | 4,50 | |
| | | | | | | | |
| 147.5 | C05CA54 | troxerutin, kombinace | p.o. | 2 | DF | 4,50 | |
@@ -2262,47 +2371,38 @@
| 148.2 | C05CX01 | tribenosid | p.o. | 0.8 | GM | 4,50 | |
| | | | | | | | |
| 148.3 | C05CX | jiné kapiláry stabilizující látky (escin) | p.o. | 60 | MG | 6,33 | |
| 94327 | YELLON | cps 30x20mg | SLO | SK | | | |
| 31000 | YELLON | cps 30x20mg-blistr | SLO | SK | | | |
| 31000 | YELLON | cps 30x20mg-bli | SLO | SK | | | |
| 94327 | YELLON | cps 30x20mg-lah | SLO | SK | | | |
| 149 | C05 | jiné kapiláry stabilizující látky | parent. | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 149.1 | C05CX | jiné kapiláry stabilizující látky (escin) | parent. | 5 | MG | 54,26 | H |
| | | | | | | | |
| 149.2 | C05BB02 | polidokanol (do 0,5% včetně) | parent. | 1 | ML | 14,16 | O |
| 08512 | AETHOXYSKLEROL 0,5% | inj 1x30ml 0,5% | KRS | D | | | |
| 08510 | AETHOXYSKLEROL 0,5% | inj 5x2ml 0.5% | KRS | D | | | |
| 08512 | AETHOXYSKLEROL 0.5% | inj 1x30ml | KRS | D | | | |
| 08510 | AETHOXYSKLEROL 0.5% | inj 5x2ml | KRS | D | | | |
| 149.3 | C05BB02 | polidokanol (nad 0,5 do 1 % včetně) | parent. | 1 | ML | 16,30 | O |
| 20034 | AETHOXYSKLEROL 1% | inj 1x30ml 1% | KRS | D | | | |
| 20033 | AETHOXYSKLEROL 1% | inj 5x2ml 1% | KRS | D | | | |
| 20034 | AETHOXYSKLEROL 1% | inj 1x30ml | KRS | D | | | |
| 20033 | AETHOXYSKLEROL 1% | inj 5x2ml | KRS | D | | | |
| 149.4 | C05BB02 | polidokanol (nad 1% do 3 % včetně) | parent. | 1 | ML | 18,16 | O |
| 08511 | AETHOXYSKLEROL 2% | inj 5x2ml 2% | KRS | D | | | |
| 02529 | AETHOXYSKLEROL 3% | inj 5x2ml 3% | KRS | D | | | |
| 149.5 | C05BB02 | polidokanol (vice než 3 %) | parent. | 1 | ML | 19,64 | O |
| 90799 | AETHOXYSKLEROL 4% | inj 5x2ml 4% | KRS | D | | | |
| 08511 | AETHOXYSKLEROL 2% | inj 5x2ml | KRS | D | | | |
| 02529 | AETHOXYSKLEROL 3% | inj 5x2ml | KRS | D | | | |
| 149.5 | C05BB02 | polidokanol (více než 3 %) | parent. | 1 | ML | 19,64 | O |
| 90799 | AETHOXYSKLEROL 4% | inj 5x2ml | KRS | D | | | |
| 149.6 | C05BB04 | natrium tetradecyl sulfat (koncentrace do 1% včetně) | parent. | 1 | ML | 14,16 | O |
| | | | | | | | |
| 149.7 | C05BB04 | natrium tetradecyl sulfat (koncentrace nad 1% ) | parent. | 1 ML | 19,64 | O | |
| 149.7 | C05BB04 | natrium tetradecyl sulfat (koncentrace nad 1% ) | parent. | 1 | ML | 19,64 | O |
| 150 | C07AA | beta-blokátory, bez beta-1 selektivity (sotalol) | p.o. | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 150.1 | C07AA07 | sotalol | p.o. | 0.16 | GM | 4,75 | L/KAR,INT,GER |
| 83668 | SOTAHEXAL 80 | tbl 50x80mg | HEX | D | | | |
| 54128 | SOTALOL AL 80 | tbl 20x80mg | APA | D | | | |
| 54132 | SOTALOL AL 160 | tbl 50x160mg | APA | D | | | |
| 46608 | SOTALOL 80-SL | tbl 30x80mg | SLO | SK | | | |
| 54131 | SOTALOL AL 160 | tbl 20x160mg | APA | D | | | |
| 46744 | SOTALOL 160-SL | tbl 30x160mg | SLO | SK | | | |
| 83669 i | SOTAHEXAL 80 | tbl 100x80mg | HEX | D | | | |
| 83671 | SOTAHEXAL 160 | tbl 100x160mg | HEX | D | | | |
| 150.1 | C07AA07 | sotalol | p.o. | 0.16 | GM | 4,75 | L/KAR,INT, GER |
| 83481 | SOTAHEXAL 160 | tbl 20x160mg | HEX | D | | | |
| 83670 | SOTAHEXAL 160 | tbl 50x160mg | HEX | D | | | |
| 83481 | SOTAHEXAL 160 | tbl 20x160mg | HEX | D | | | |
| 83480 | SOTAHEXAL 80 | tbl 20x80mg | HEX | D | | | |
| 54129 | SOTALOL AL 80 | tbl 50x80mg | APA | D | | | |
| 151 | C07AA | beta-blokátory, bez beta-1 selektivity (ostatní) | p.o. | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 151.1 | C07AA | metipranolol (do 5 mg včetně v 1 tabletě) | p.o. | 10 | MG | 0,78 | |
| | | | | | | | |
| 151.2 | C07AA | metipranolol (nad 5 do 10 mg včetně v 1 tabletě) | p.o. | 10 | MG | 0,66 | |
| 02483 | TRIMEPRANOL | tbl 50x10mg | SLO | SK | | | |
| 02483 | TRIMEPRANOL 10MG | tbl 50x10mg | SLO | SK | | | |
| 151.3 | C07AA | metipranolol (nad 10 mg v 1 tabletě) | p.o. | 10 | MG | 0,29 | |
| | | | | | | | |
| 151.4 | C07AA02 | oxprenolol | p.o. | 0.1 | GM | 2,74 | |
@@ -2324,97 +2424,101 @@
| --- | --- | --- | --- | --- | --- | --- | --- |
| 152.1 | C07AA | metipranolol | parent. | 10 | MG | 62,70 | O |
| 85886 | TRIMEPRANOL | inj 10x1ml/1mg | HBS | SK | | | |
| 152.2 | C07AA | taiinolol | parent. | 50 | MG | 93,65 | O |
| 152.2 | C07AA | talinolol | parent. | 50 | MG | 93,65 | O |
| | | | | | | | |
| 152.3 | C07AA02 | oxprenolol | parent. | 0.1 | GM | 99,13 | O |
| | | | | | | | |
| 152.4 | C07AA03 | pindolol | parent. | 15 | MG | 99.13 | O |
| 152.4 | C07AA03 | pindolol | parent. | 15 | MG | 99,13 | O |
| | | | | | | | |
| 152.5 | C07AA07 | sotalol | parent. | 0.16 | GM | 900,64 | O |
| 153 | C07AB | beta-blokátory, s beta-1 selektivitou | p.o. | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 153.1 | C07AB02 | metoprolol (do 50 mg včetně v jedné tabletě) | p.o. | 0.15 | GM | 2,93 | |
| 96753 | APO-METOPROLOL 50 | tbl 100x50mg | APT | CND | | | |
| 54152 | EGILOK 50MG | tbl 200x50mg | EGI | H | | | |
| 54151 | EGILOK 50MG | tbl 60x50mg | EGI | H | | | |
| 50080 | VASOCARDIN 50 | tbl 50x50mg | SLO | SK | | | |
| 54151 | EGILOK 50MG | tbl 60x50mg | EGI | H | | | |
| 54152 | EGILOK 50MG | tbl 200x50mg | EGI | H | | | |
| 96753 | APO-METOPROLOL 50 | tbl 100x50mg | APT | CND | | | |
| 153.2 | C07AB02 | metoprolol (nad 50 mg v jedné tabletě) | p.o. | 0.15 | GM | 2,74 | |
| 96755 | APO-METOPROLOL 100 | tbl 100x100mg | APT | CND | | | |
| 45555 | BETALOC 100 MG | tbl 100x100mg | AZC | S | | | |
| 59894 | EGILOK 100 MG | tbl 200x100mg | EGI | H | | | |
| 59893 | EGILOK 100 MG | tbl 60x100mg | EGI | H | | | |
| 32674 | METOPROLOL AL 100 | por tbl nob20x100mg | SDB | D | | | |
| 47673 | METOPROLOL AL 100 | por tbl nob20x100mg | APA | D | | | |
| 47674 | METOPROLOL AL 100 | por tbl nob60x100mg | APA | D | | | |
| 96755 | APO-METOPROLOL 100 | tbl 100x100mg | APT | CND | | | |
| 32675 | METOPROLOL AL 100 | por tblnob100x100mg | SDB | D | | | |
| 47675 | METOPROLOL AL 100 | por tblnob100x100mg | APA | D | | | |
| 45592 | VASOCARDIN 100 | tbl 50x100mg-blistr | SLO | SK | | | |
| 47673 | METOPROLOL AL 100 | por tbl nob20x100mg | APA | D | | | |
| 59893 | EGILOK 100MG | tbl 60x100mg | EGI | H | | | |
| 59894 | EGILOK 100MG | tbl 200x100mg | EGI | H | | | |
| 45555 | BETALOC 100MG | tbl 100x100mg | APN | S | | | |
| 47675 | METOPROLOL AL 100 | por tblnob100x100mg | APA | D | | | |
| 153.3 | C07AB02 | metoprolol - retardované lékové formy | p.o. | 0.15 | GM | 3,52 | |
| 46980 | BETALOC SR 200MG | tbl ret 100x200mg | APN | S | | | |
| 46980 | BETALOC SR 200MG | tbl ret 100x200mg | AZC | S | | | |
| 46981 | BETALOC SR 200MG | tbl ret 30x200mg | AZC | S | | | |
| 03201 | EMZOK 200 MG | por tbl pro30x200mg | IXP | CZ | | | |
| 32673 | METOPROLOL AL 200 RETARD | por tbl pro50x200mg | APA | D | | | |
| 46981 | BETALOC SR 200MG | tbl ret 30x200mg | APN | S | | | |
| 47501 | METOPROLOL AL 200 RETARD | por tblpro100x200mg | APA | D | | | |
| 32707 | VASOCARDIN SR 200 | por tbl pro30x0.2gm | SLO | SK | | | |
| 32711 | VASOCARDIN SR 200 | por tblpro100x0.2gm | SLO | SK | | | |
| 153.4 | C07AB02 | metoprolol (léková forma tablety s řízeným uvolňováním) do 25 mg v jedné tabletě včetně | p.o. | 0.15 | GM | 26,20 | P |
Metoprolol v lékové formě tablet s řízeným uvolňováním je ordinován k léčbě srdečního selhání; v dávce 25 mg je určen k zahájení léčby, pouze v případech kdy není pacientem tolerována dávka vyšší, je možné podávat v dávce 25 mg dlouhodobě. Cílová dávka metoprololu v lékové formě tablet s řízeným uvolňováním v indikaci srdečního selhání je 200 mg denně, k této udržovací dávce je možné předepisovat tablety s obsahem 100 mg. V indikaci léčby hypertenze, arytmií a sekundární prevence nelze hradit ze zdravotního pojištění.
Metoprolol v lékové formě tablet s řízeným uvolňováním je ordinován k léčbě srdečního selhání; v dávce 25 mg je určen k zahájení léčby, pouze v případech kdy není pacinetem tolerována dávka vyšší, je možné podávat v dávce 25 mg dlouhodobě. Cílová dávka metoprololu v lékové formě tablet s řízeným uvolňováním v indikaci srdečního selhání je 200 mg denně, k této udržovací dávce je možné předepisovat tablety s obsahem 100 mg. V indikaci léčby hypertenze, arytmií a sekundární prevence nelze hradit ze zdravotního pojištění.
| 31536 | BETALOC ZOK 25 MG | tbl ret 100x25mg | AZC | S | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 153.5 | C07AB02 | metoprolol (léková forma tablety s řízeným uvolňováním) nad 25 mg v jedné tabletě | p.o. | 0.15 | GM | 6,00 | P |
| 49935 | BETALOC ZOK 25 MG | tbl ret 100x25mg | AZC | D | | | |
| 153.5 | C07AB02 | metoprolol (léková forma tablety s řízeným uvolňováním) nad 25 mg v jedné tabletě | p.o. | 0.15 | GM | 8,00 | P |
| | | | | | | | |
| 153.6 | C07AB03 | atenolol do 50 mg v jedné tabletě včetně | p.o. | 75 | MG | 3,35 | |
| 62857 | ATENOBENE 50MG | tbl obd 50x50mg | MCK | D | | | |
| 42453 | ATEHEXAL 25 | por tbl flm 30x25mg | SFS | D | | | |
| 83638 | ATEHEXAL 25 | por tbl flm 30x25mg | HEX | D | | | |
| 42454 | ATEHEXAL 25 | por tbl flm 50x25mg | SFS | D | | | |
| 83639 | ATEHEXAL 25 | por tbl flm 50x25mg | HEX | D | | | |
| 42455 | ATEHEXAL 25 | por tbl flm100x25mg | SFS | D | | | |
| 83640 | ATEHEXAL 25 | por tbl flm100x25mg | HEX | D | | | |
| 42456 | ATEHEXAL 50 | por tbl flm 30x50mg | SFS | D | | | |
| 83642 | ATEHEXAL 50 | por tbl flm 30x50mg | HEX | D | | | |
| 42457 | ATEHEXAL 50 | por tbl flm 50x50mg | SFS | D | | | |
| 83643 | ATEHEXAL 50 | por tbl flm 50x50mg | HEX | D | | | |
| 42458 | ATEHEXAL 50 | por tbl flm100x50mg | SFS | D | | | |
| 83644 | ATEHEXAL 50 | por tbl flm100x50mg | HEX | D | | | |
| 62861 | ATENOBENE 25 MG | por tbl flm 30x25mg | MCK | D | | | |
| 62856 | ATENOBENE 50 MG | por tbl flm 20x50mg | MCK | D | | | |
| 62857 | ATENOBENE 50 MG | por tbl flm 50x50mg | MCK | D | | | |
| 58659 | ATENOLOL AL 25 | por tbl nob 30x25mg | APA | D | | | |
| 58660 | ATENOLOL AL 25 | por tbl nob 50x25mg | APA | D | | | |
| 62856 | ATENOBENE 50MG | tbl obd 20x50mg | MCK | D | | | |
| 83638 | ATEHEXAL 25 | tbl obd 30x25mg | HEX | D | | | |
| 58661 | ATENOLOL AL 25 | por tbl nob100x25mg | APA | D | | | |
| 89254 | ATENOLOL AL 25 | tbl obd 100x25mg | APA | D | | | |
| 89253 | ATENOLOL AL 25 | tbl obd 50x25mg | APA | D | | | |
| 89252 | ATENOLOL AL 25 | tblobd 30x25mg | APA | D | | | |
| 02949 | ATENOLOL AL 50 | por tbl nob 30x50mg | APA | D | | | |
| 02950 | ATENOLOL AL 50 | por tbl nob 50x50mg | APA | D | | | |
| 62861 | ATENOBENE 25MG | tbl obd 30x25mg | MCK | D | | | |
| 83639 | ATEHEXAL 25 | tbl obd 50x25mg | HEX | D | | | |
| 58659 | ATENOLOL AL 25 | por tbl nob 30x25mg | APA | D | | | |
| 42453 | ATEHEXAL 25 | por tbl flm 30x25mg | SFS | D | | | |
| 58661 | ATENOLOL AL 25 | por tbl nob100x25mg | APA | D | | | |
| 89253 | ATENOLOL AL 25 | tbl obd 50x25mg | APA | D | | | |
| 89254 | ATENOLOL AL 25 | tbl obd 100x25mg | APA | D | | | |
| 02951 | ATENOLOL AL 50 | por tbl nob100x50mg | APA | D | | | |
| 89257 | ATENOLOL AL 50 | tbl obd 100x50mg | APA | D | | | |
| 89255 | ATENOLOL AL 50 | tbl obd 30x50mg | APA | D | | | |
| 89256 | ATENOLOL AL 50 | tbl obd 50x50mg | APA | D | | | |
| 89257 | ATENOLOL AL 50 | tbl obd 100x50mg | APA | D | | | |
| 02951 | ATENOLOL AL 50 | por tbl nob100x50mg | APA | D | | | |
| 42458 | ATEHEXAL 50 | por tbl flm 100x50mg | SFS | D | | | |
| 42457 | ATEHEXAL 50 | por tbl flm 50x50mg | SFS | D | | | |
| 83640 | ATEHEXAL 25 | tbl obd 100x25mg | HEX | D | | | |
| 89252 | ATENOLOL AL 25 | tbl obd 30x25mg | APA | D | | | |
| 42454 | ATEHEXAL 25 | por tbl flm 50x25mg | SFS | D | | | |
| 83643 | ATEHEXAL 50 | tbl obd 50x50mg | HEX | D | | | |
| 83642 | ATEHEXAL 50 | tbl obd 30x50mg | HEX | D | | | |
| 42456 | ATEHEXAL 50 | por tbl flm 30x50mg | SFS | D | | | |
| 02949 | ATENOLOL AL 50 | por tbl nob 30x50mg | APA | D | | | |
| 42455 | ATEHEXAL 25 | por tbl flm 100x25mg | SFS | D | | | |
| 83644 | ATEHEXAL 50 | tbl obd 100x50mg | HEX | D | | | |
| 153.7 | C07AB03 | atenolol nad 50 mg v jedné tabletě | p.o. | 75 | MG | 3,10 | |
| 65389 | TENORMIN | tbl obd 28x100mg | ZNC | GB | | | |
| 54419 | ATEBLOCOR 100 | por tbl flm30x100mg | PMP | CZ | | | |
| 42459 | ATEHEXAL 100 | por tbl flm30x100mg | SFS | D | | | |
| 83646 | ATEHEXAL 100 | por tbl flm30x100mg | HEX | D | | | |
| 42460 | ATEHEXAL 100 | por tbl flm50x100mg | SFS | D | | | |
| 83648 | ATEHEXAL 100 | tbl obd 100x100mg | HEX | D | | | |
| 83647 | ATEHEXAL 100 | tbl obd 50x100mg | HEX | D | | | |
| 83647 | ATEHEXAL 100 | por tbl flm50x100mg | HEX | D | | | |
| 42461 | ATEHEXAL 100 | por tblflm100x100mg | SFS | D | | | |
| 83648 | ATEHEXAL 100 | por tblflm100x100mg | HEX | D | | | |
| 02710 | ATENOLOL AL 100 | por tblnob 50x100mg | APA | D | | | |
| 83646 | ATEHEXAL 100 | tbl obd 30x100mg | HEX | D | | | |
| 02720 | ATENOLOL AL 100 | por tblnob100x100mg | APA | D | | | |
| 42459 | ATEHEXAL 100 | por tbl flm30x100mg | SFS | D | | | |
| 42461 | ATEHEXAL 100 | por tblflm100x100mg | SFS | D | | | |
| 54419 | ATEBLOCOR 100 | tbl obd 30x100mg | PMP | CZ | | | |
| 89260 | ATENOLOL AL 100 | tbl obd 100x100mg | APA | D | | | |
| 89259 | ATENOLOL AL 100 | tbl obd 50x100mg | APA | D | | | |
| 65389 | TENORMIN 100 | tbl obd 28x100mg | AZC | GB | | | |
| 153.8 | C07AB04 | acebutolol | p.o. | 0.4 | GM | 5,12 | |
| 75939 | ACECOR 400 | tbl obd 30x400mg | SPA | I | | | |
| 75939 | ACECOR 400 | por tbl flm30x400mg | DAQ | I | | | |
| 153.9 | C07AB05 | betaxolol | p.o. | 20 | MG | 5,12 | |
| | | | | | | | |
| 153.10 | C07AB07 | bisoprolol | p.o. | 10 | MG | 5,12 | |
| 32970 | BISOPROLOL-RATIOPHARM 10 MG | por tbl nob 30x10mg | MCK | D | | | |
| 32974 | BISOPROLOL-RATIOPHARM 10 MG | por tbl nob100x10mg | MCK | D | | | |
| 32967 | BISOPROLOL-RATIOPHARM 5 MG | por tbl nob 100x5mg | MCK | D | | | |
| 32963 | BISOPROLOL-RATIOPHARM 5 MG | por tbl nob 30x5mg | MCK | D | | | |
| 32970 | BISOPROLOL-RATIOPHARM 10 MG | por tbl nob 30x10mg | MCK | D | | | |
| 153.11 | C07AB07 | bisoprolol hemifumarát do 2,5 mg v jedné tabletě včetně | p.o. | 10 | MG | 13,37 | P |
| 03801 | CONCOR COR 2.5 MG | tbl obd 28x2.5mg | MEC | D | | | |
| 153.12 | C07AB07 | bisoprolol hemifumarát nad 2,5 mg v jedné tabletě | p.o. | 10 | MG | 6,00 | P |
| 153.12 | C07AB07 | bisoprolol hemifumarát nad 2,5 mg v jedné tabletě | p.o. | 10 | MG | 8,00 | P |
Bisoprolol je ordinován k léčbě srdečního selhání; v dávce 2,5 mg je určen k zahájení léčby, pouze v případech, kdy není pacientem tolerována dávka vyšší, je možné podávat v dávce 2,5 mg dlouhodobě. Cílová dávka bisoprololu v této indikaci je 10 mg denně a k udržovací léčbě možno předpisovat bisoprolol v tabletách s obsahem 10 mg. V indikaci léčby hypertenze, arytmií a sekundární prevence nelze hradit ze zdravotního pojištění.
@@ -2426,26 +2530,29 @@
| 154.1 | C07AB02 | metoprolol | parent. | 0.15 | GM | 1398,18 | O |
| | | | | | | | |
| 154.2 | C07AB03 | atenolol | parent. | 75 | MG | 1840,83 | O |
| 65387 | TENORMIN | inj 10x10ml/5mg | ZNC | GB | | | |
| 65387 | TENORMIN | inj sol 10x10ml/5mg | AZC | GB | | | |
| 154.3 | C07AB04 | acebutolol | parent. | 0.4 | GM | 1398,18 | O |
| | | | | | | | |
| 154.4 | C07AB09 | esmolol | parent. | 2,5 | GM | 4673,10 | H |
| 58412 | BREVIBLOC 250MG/ML | inf cnc sol 1x10ml | BXT | GB | | | |
| 154.4 | C07AB09 | esmolol | parent. | 2,5 | GM | 4205,00 | O |
| 58412 | BREVIBLOC 250 MG/ML | inf cnc sol 1x10ml | BXT | GB | | | |
| 155 | C07AG | alfa, beta-blokátory | p.o. | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 155.1 | C07AG01 | Iabetalol | p.o. | 0.6 | GM | 19,50 | L/KAR,INT,GER |
| | | | | | | | |
| 155.2 | C07AG02 | karvedilol (do 6,25 mg v 1 tabletě včetně) | p.o. | 37.5 | MG | 46,00 | P |
| 155.1 | C07AG01 | labetalol | p.o. | 0.6 | GM | 19,50 | L/KAR,INT,GER |
| | | | | | | | |
| 155.2 | C07AG02 | karvedilol (do 6,25 mg v 1 tabletě včetně) | p.o. | 37.5 | MG | 21,00 | P |
| 98922 | ATRAM 6.25 | por tblnob30x6.25mg | LEX | CZ | | | |
Léčbu karvedilolem zahajuje kardiolog nebo internista k léčbě srdečního selhání s prokázaným snížením ejekční frakce levé srdeční komory na 35% a níže. Karvedilol v dávce 6,25 mg je určen k zavedení léčby na dobu nezbytně nutnou a je možno jej předepsat maximálně v množství 3 balení na nemocného. Pouze v případech, že není vyšší dávka tolerována, je možno podávat dávku 6,25 mg dlouhodobě. Cílová dávka karvedilolu v této indikaci je 25 - 50 mg denně. V indikaci léčby hypertenze nelze hradit z prostředků zdravotního pojištění.
| 155.3 | C07AG02 | karvedilol (nad 6,25 mg v 1 tabletě) | p.o. | 37.5 | MG | 21,00 | P |
| 155.3 | C07AG02 | karvedilol (nad 6,25 mg v 1 tabletě) | p.o. | 37.5 | MG | 16,00 | P |
| 98925 | ATRAM 25 | por tblnob30x25mg | LEX | CZ | | | |
| 156 | C07AG | alfa, beta-blokátory | parent. | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 156.1 | C07AG01 | labetalol | parent. | 0.6 | GM | 1027,60 | H |
| 157 | C07F | beta-blokátory v kombinaci s jinými antihypertenzivy | p.o. | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 157.1 | C07BB03 | atenolol a thiazidy | p.o. | 1 | DF | 4,34 | |
| 76715 | TENORETIC | tbl obd 28 | ZNC | GB | | | |
| 76715 | TENORETIC | por tbl flm 28 | AZC | GB | | | |
| 157.2 | C07CA17 | bopindolol a thiazidy | p.o. | 1 | DF | 4,34 | |
| | | | | | | | |
| 157.3 | C07FA | beta-blokátory, neselektivní, a jiná antihypertensiva | p.o. | 0.5 | DF | 0,73 | |
@@ -2456,50 +2563,55 @@
| 158.1 | C08CA01 | amlodipin | p.o. | 5 | MG | 5,53 | |
| 02954 | AGEN 10 | por tbl nob 30x10mg | LEX | CZ | | | |
| 02945 | AGEN 5 | por tbl nob 30x5mg | LEX | CZ | | | |
| 58876 | AMLOZEK 10 | por tbl nob 30x10mg | ADD | PL | | | |
| 58874 | AMLOZEK 5 | por tbl nob 30x5mg | ADD | PL | | | |
| 03999 | CARDILOPIN 10 MG | por tbl nob 30x10mg | EGI | H | | | |
| 03997 | CARDILOPIN 2.5 MG | por tbl nob30x2.5mg | EGI | H | | | |
| 03998 | CARDILOPIN 5 MG | por tbl nob 30x5mg | EGI | H | | | |
| 03994 | NORMODIPINE 10 MG | por tbl nob 30x10mg | GED | H | | | |
| 03993 | NORMODIPINE 5 MG | por tbl nob 30x5mg | GED | H | | | |
| 58417 | ORCAL 10MG | tbl 30x10mg | LEK | SLO | | | |
| 58415 | ORCAL 5MG | tbl 30x5mg | LEK | SLO | | | |
| 03993 | NORMODIPINE 5 MG | por tbl nob 30x5mg | GED | H | | | |
| 03994 | NORMODIPINE 10 MG | por tbl nob 30x10mg | GED | H | | | |
| 158.2 | C08CA02 | felodipin | p.o. | 5 | MG | 5,53 | |
| 03963 | AURONAL 5 MG RETARD | por tbl ret30x5mg | EGI | H | | | |
| 03965 | AURONAL 10 MG RETARD | por tbl ret 30x10mg | EGI | H | | | |
| 03961 | AURONAL 2.5 MG RETARD | por tbl ret30x2.5mg | EGI | H | | | |
| 02961 | PRESID 2.5 MG | tbl ret 30x2.5mg | IVX | CZ | | | |
| 02959 | PRESID 10 MG | tbl ret 30x10mg | IVX | CZ | | | |
| 02957 | PRESID 5 MG | tbl ret 30x5mg | IVX | CZ | | | |
| 03963 | AURONAL 5 MG RETARD | por tbl ret30x5mg | EGI | H | | | |
| 02959 | PRESID 10 MG | por tbl ret 30x10mg | IVX | CZ | | | |
| 02961 | PRESID 2.5 MG | por tbl ret30x2.5mg | IVX | CZ | | | |
| 02957 | PRESID 5 MG | por tbl ret 30x5mg | IVX | CZ | | | |
| 158.3 | C08CA03 | isradipin | p.o. | 5 | MG | 5,28 | |
| | | | | | | | |
| 158.4 | C08CA03 | isradipin (retardované lékové formy) | p.o. | 5 | MG | 5,53 | |
| | | | | | | | |
| 158.5 | C08CA05 | nifedipin | p.o. | 30 | MG | 1,45 | |
| 91634 | CORDAFEN | tbl obd 50x10mg | ZPF | PL | | | |
| 91634 | CORDAFEN | por tbl flm 50x10mg | ZPF | PL | | | |
| 158.6 | C08CA05 | nifedipin (retardované lékové formy s obsahem 20 mg) | p.o. | 30 | MG | 2,10 | |
| 59937 | CORINFAR 20 RETARD | tbl ret 30x20mg | VAD | D | | | |
| 93460 | CORDIPIN RETARD | tbl ret 30x20mg | KRK | SLO | | | |
| 47490 | CORINFAR 20 RETARD | por tbl pro 30x20mg | AWD | D | | | |
| 158.7 | C08CA05 | nifedipin (retardované lékové formy s obsahem 40 mg) | p.o. | 30 | MG | 1,37 | |
| | | | | | | | |
| 158.8 | C08CA05 | nifedipin (lékové formy s retardací 24 hodin) | p.o. | 1 | DF | 5,53 | |
| 03033 | CORDIPIN XL | tbl ret 30x40mg | KRK | SLO | | | |
| 53372 | NIFECARD XL 30MG | tbl obd 30x30mg | LEK | SLO | | | |
| 53372 | NIFECARD XL 30MG | tbl ret 30x30mg | LEK | SLO | | | |
| 158.9 | C08CA06 | nimodipin | p.o. | 0.3 | GM | 136,08 | X |
| 94189 | DILCEREN | tbl obd 50x30mg | SLO | SK | | | |
| 158.10 | C08CA07 | nisoldipin | p.o. | 20 | MG | 5,53 | |
| | | | | | | | |
| 158.11 | C08CA08 | nitrendipin | p.o. | 20 | MG | 5,53 | |
| 94688 | NITRENDIPIN-RATIOPHARM 20MG | por tbl nob 30x20mg | MCK | D | | | |
| 30965 | NITRENDIPIN-RATIOPHARM 20MG | por tbl nob100x20mg | MCK | D | | | |
| 66496 | NITREPRESS 10 | tbl 100x10mg | HEX | D | | | |
| 66469 | NITREPRESS 10 | por tbl nob 20x10mg | HHO | D | | | |
| 95584 | NITREPRESS 10 | por tbl nob 28x10mg | HHO | D | | | |
| 95585 | NITREPRESS 10 | por tbl nob 30x10mg | HHO | D | | | |
| 66495 | NITREPRESS 10 | por tbl nob 50x10mg | HHO | D | | | |
| 66496 | NITREPRESS 10 | por tbl nob100x10mg | HHO | D | | | |
| 66499 | NITREPRESS 20 | por tbl nob 20x20mg | HHO | D | | | |
| 95586 | NITREPRESS 20 | por tbl nob 28x20mg | HHO | D | | | |
| 95587 | NITREPRESS 20 | por tbl nob 30x20mg | HHO | D | | | |
| 66498 | NITREPRESS 20 | por tbl nob 50x20mg | HHO | D | | | |
| 66497 | NITREPRESS 20 | por tbl nob100x20mg | HHO | D | | | |
| 03079 | UNIPRES 10 | tbl 30x10mg | KRK | SLO | | | |
| 95586 | NITREPRESS 20 | por tbl nob 28x20mg | HHO | D | | | |
| 66499 | NITREPRESS 20 | tbl 20x20mg | HEX | D | | | |
| 66498 | NITREPRESS 20 | tbl 50x20mg | HEX | D | | | |
| 66497 | NITREPRESS 20 | tbl 100x20mg | HEX | D | | | |
| 95585 | NITREPRESS 10 | por tbl nob 30x10mg | HHO | D | | | |
| 66495 | NITREPRESS 10 | tbl 50x10mg | HEX | D | | | |
| 94688 | NITRENDIPIN-RATIOPHARM 20MG | por tbl nob 30x20mg | MCK | D | | | |
| 03078 | UNIPRES 20 | tbl 30x20mg | KRK | SLO | | | |
| 66469 | NITREPRESS 10 | tbl 20x10mg | HEX | D | | | |
| 158.12 | C08CA09 | lacidipin | p.o. | 4 | MG | 5,53 | |
| | | | | | | | |
| 158.13 | C08CA10 | nilvadipin | p.o. | 8 | MG | 5,53 | |
@@ -2507,7 +2619,6 @@
| 158.14 | C08CA12 | barnidipin | p.o. | 10 | MG | 5,53 | |
| | | | | | | | |
| 158.15 | C08CA13 | lercanidipin | p.o. | 10 | MG | 5,53 | |
| | | | | | | | |
| 158.16 | C08CX01 | mibefradil | p.o. | 50 | MG | 13,20 | L/INT,KAR,GER |
| 159 | C08CA | antagonisté vápníku dihydropyridinové řady | parent. | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
@@ -2516,48 +2627,48 @@
| 159.2 | C08CA05 | nifedipin | parent. | 30 | MG | 3074,59 | H |
| | | | | | | | |
| 159.3 | C08CA06 | nimodipin | parent. | 50 | MG | 3066,90 | X |
| 94535 | NIMOTOP S | inf 5x50ml/10mg | BAY | D | | | |
| 94535 | NIMOTOP S | inf sol 5x50ml/10mg | BAY | D | | | |
| 160 | C08DA | antagonisté vápníku fenylalkylaminové řady | p.o. | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 160.1 | C08DA01 | verapamil neretardované lékové formy do 240 mg v jedné tabletě včetně | p.o. | 0.24 | GM | 5,00 | |
| 86045 | VERAPAMIL AL 120 | tbl obd 50x120mg | APA | D | | | |
| 77037 | VERAPAMIL AL 80 | tbl obd 100x80mg | APA | D | | | |
| 56160 | VERAHEXAL 120 | tbl obd 100x120mg | FST | D | | | |
| 77034 | VERAPAMIL AL 40 | tbl obd 50x40mg | APA | D | | | |
| 77036 | VERAPAMIL AL 80 | tbl obd 50x80mg | APA | D | | | |
| 56158 | VERAHEXAL 120 | tbl obd 30x120mg | FST | D | | | |
| 56159 | VERAHEXAL 120 | tbl obd 50x120mg | FST | D | | | |
| 56154 | VERAHEXAL 40 | tbl obd 100x40mg | FST | D | | | |
| 56152 | VERAHEXAL 40 | tbl obd 30x40mg | FST | D | | | |
| 56153 | VERAHEXAL 40 | tbl obd 50x40mg | FST | D | | | |
| 56157 | VERAHEXAL 80 | tbl obd 100x80mg | FST | D | | | |
| 56155 | VERAHEXAL 80 | tbl obd 30x80mg | FST | D | | | |
| 56156 | VERAHEXAL 80 | tbl obd 50x80mg | FST | D | | | |
| 56163 | VERAHEXAL KHK RETARD | tbl ret 100x120mg | FST | D | | | |
| 56161 | VERAHEXAL KHK RETARD | tbl ret 30x120mg | FST | D | | | |
| 56162 | VERAHEXAL KHK RETARD | tbl ret 50x120mg | FST | D | | | |
| 56163 | VERAHEXAL KHK RETARD | tbl ret 100x120mg | FST | D | | | |
| 77035 | VERAPAMIL AL 40 | tbl obd 100x40mg | APA | D | | | |
| 56155 | VERAHEXAL 80 | tbl obd 30x80mg | FST | D | | | |
| 86046 | VERAPAMIL AL 120 | tbl obd 100x120mg | APA | D | | | |
| 56159 | VERAHEXAL 120 | tbl obd 50x120mg | FST | D | | | |
| 56153 | VERAHEXAL 40 | tbl obd 50x40mg | FST | D | | | |
| 56158 | VERAHEXAL 120 | tbl obd 30x120mg | FST | D | | | |
| 56154 | I VERAHEXAL 40 | tbl obd 100x40mg | FST | D | | | |
| 56157 | VERAHEXAL 80 | tbl obd 100x80mg | FST | D | | | |
| 56152 | VERAHEXAL 40 | tbl obd 30x40mg | FST | D | | | |
| 99305 | VERAPAMIL 40-SLOVAKOFARMA | tbl obd 30x40mg | SLO | SK | | | |
| 56156 | VERAHEXAL 80 | tbl obd 50x80mg | FST | D | | | |
| 99306 | VERAPAMIL 80-SLOVAKOFARMA | tbl obd 30x80mg | SLO | SK | | | |
| 86045 | VERAPAMIL AL 120 | por tbl flm50x120mg | APA | D | | | |
| 86046 | VERAPAMIL AL 120 | por tblflm100x120mg | APA | D | | | |
| 77034 | VERAPAMIL AL 40 | por tbl flm50x40mg | APA | D | | | |
| 77035 | VERAPAMIL AL 40 | por tblflm100x40mg | APA | D | | | |
| 77036 | VERAPAMIL AL 80 | por tbl flm50x80mg | APA | D | | | |
| 77037 | VERAPAMIL AL 80 | por tblflm100x80mg | APA | D | | | |
| 160.2 | C08DA01 | verapamil (retardované lékové formy s obsahem 240 mg v jedné tabletě včetně) | p.o. | 0.24 | GM | 5,53 | |
| 93679 | LEKOPTIN RETARD | tbl ret 20x240mg | LEK | SLO | | | |
| 56166 | VERAHEXAL RR | tbl ret 100x240mg | FST | D | | | |
| 56164 | VERAHEXAL RR | tbl ret 30x240mg | FST | D | | | |
| 54034 | VERAPAMIL AL 240 RETARD | tbl ret 100x240mg | APA | D | | | |
| 54032 | VERAPAMIL AL 240 RETARD | tbl ret 50x240mg | APA | D | | | |
| 56165 | VERAHEXAL RR | tbl ret 50x240mg | FST | D | | | |
| 56166 | VERAHEXAL RR | tbl ret 100x240mg | FST | D | | | |
| 43879 | VEROGALID ER 240MG | tbl ret 100x240mg | GNO | CZ | | | |
| 43877 | VEROGALID ER 240MG | tbl ret 30x240mg | GNO | CZ | | | |
| 93679 | LEKOPTIN RETARD | tbl obd 20x240mg | LEK | SLO | | | |
| 54032 | VERAPAMIL AL 240 RETARD | por tbl ret50x240mg | APA | D | | | |
| 54034 | VERAPAMIL AL 240 RETARD | por tblret100x240mg | APA | D | | | |
| 43877 | VEROGALID ER 240 MG | por tblpro 30x240mg | IVX | CZ | | | |
| 43879 | VEROGALID ER 240 MG | portblpro 100x240mg | IVX | CZ | | | |
| 160.3 | C08DA02 | gallopamil | p.o. | 0.1 | GM | 5,00 | |
| 161 | C08DA | antagonisté vápníku fenylalkyiaminové řady | parent. | | | | |
| 161 | C08DA | antagonisté vápníku fenylalkylaminové řady | parent. | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 161.1 | C08DA01 | verapamil | parent. | 0.24 | GM | 355,24 | H |
| 162 | C08DB | antagonisté vápníku benzothlazepinové řady | p.o. | | | | |
| 162 | C08DB | antagonisté vápníku benzothiazepinové řady | p.o. | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 162.1 | C08DB01 | diltiazem | p.o. | 0.24 | GM | 5,28 | |
| 93186 | BLOCALCIN 60 | por tbl nob 50x60mg | PVL | CZ | | | |
| 94321 | BLOCALCIN 90 RETARD | por tbl ret 30x90mg | PVL | CZ | | | |
| 93186 | BLOCALCIN 60 | por tbl nob 50x60mg | PVL | CZ | | | |
| 162.2 | C08DB01 | diltiazem (retardované lékové formy s obsahem 120 mg a více) | p.o. | 0.24 | GM | 5,53 | |
| 163 | C08DB | antagonisté vápníku benzothiazepinové řady | parent. | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
@@ -2565,117 +2676,151 @@
| 164 | C09AA | inhibitory angiotenzin konvertujícího enzymu | p.o. | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 164.1 | C09AA01 | kaptopril (do 12,5 mg v 1 tabletě včetně) | p.o. | 50 | MG | 4,29 | |
| 96903 | APO-CAPTO | tbl 100x12.5mg | APT | CND | | | |
| 97873 | ALKADIL 25MG | tbl 40x25mg | ALK | MAC | | | |
| 96903 | APO-CAPTO 12.5 MG | tbl 100x12.5mg | APT | CND | | | |
| 68839 | APO-CAPTO 25 MG | tbl 100x25mg | APT | CND | | | |
| 56200 | CAPOTEN 12.5MG | tbl 90x12.5mg | BMS | AUS | | | |
| 12150 | CAPTOPRIL AL 12.5 | tbl 100x12.5mg | APA | D | | | |
| 12148 | CAPTOPRIL AL 12.5 | tbl 30x12.5mg | APA | D | | | |
| 56200 | CAPOTEN 12.5MG | tbl 90x12.5mg | BMS | AUS | | | |
| 12149 | CAPTOPRIL AL 12.5 | tbl 50x12.5mg | APA | D | | | |
| 12150 | CAPTOPRIL AL 12.5 | tbl 100x12.5mg | APA | D | | | |
| 164.2 | C09AA01 | kaptopril (nad 12,5 mg do 25 mg v 1 tabletě včetně) | p.o. | 50 | MG | 4,00 | |
| 59381 | CAPTOPRIL 25 SVUS | tbl 100x25mg | SVS | CZ | | | |
| 32253 | CAPTOPRIL AL 25 | tbl 100x25mg | APA | D | | | |
| 68839 | APO-CAPTO 25MG | tbl 100x25mg | APT | CND | | | |
| 32251 | CAPTOPRIL AL 25 | tbl 30x25mg | APA | D | | | |
| 32252 | CAPTOPRIL AL 25 | tbl 50x25mg | APA | D | | | |
| 97873 | ALKADIL 25 MG | tbl 40x25mg | ALK | MAC | | | |
| 59381 | CAPTOPRIL 25 SVUS | tbl 100x25mg | SVS | CZ | | | |
| 32251 | CAPTOPRIL AL 25 | tbl 30x25mg | APA | D | | | |
| 164.3 | C09AA01 | kaptopril (nad 25 mg v 1 tabletě) | p.o. | 50 | MG | 3,80 | |
| 59386 | CAPTOPRIL 50 SVUS | tbl 100x50mg | SVS | CZ | | | |
| 59384 | CAPTOPRIL 50 SVUS | tbl 30x50mg | SVS | CZ | | | |
| 59385 | CAPTOPRIL 50 SVUS | tbl 50x50mg | SVS | CZ | | | |
| 84143 | CAPTOPRIL AL 50 | tbl 100x50mg | APA | D | | | |
| 84141 | CAPTOPRIL AL 50 | tbl 30x50mg | APA | D | | | |
| 84142 | CAPTOPRIL AL 50 | tbl 50x50mg | APA | D | | | |
| 84141 | CAPTOPRIL AL 50 | tbl 30x50mg | APA | D | | | |
| 59386 | CAPTOPRIL 50 SVUS | tbl 100x50mg | SVS | CZ | | | |
| 59385 | CAPTOPRIL 50 SVUS | tbl 50x50mg | SVS | CZ | | | |
| 59384 | CAPTOPRIL 50 SVUS | tbl 30x50mg | SVS | CZ | | | |
| 49563 | TENSIOMIN 50MG | tbl 90x50mg | EGI | H | | | |
| 164.4 | C09AA02 | enalapril hydrogenmaleát (do 5 mg v jedné tabletě včetně) | p.o. | 10 | MG | 4,95 | |
| 83508 | EDNYT 5MG | tbl 100x5mg-lahv GED | H | | | | |
| 32277 | EDNYT 5 MG | tbl 100x5mg-blistr GED | H | | | | |
| 83503 | APO-ENALAPRIL 5 MG | tbl 100x5mg | APQ | MEX | | | |
| 59108 | BERLIPRIL 5 | tbl 100x5mg | BCE | D | | | |
| 84651 | BERLIPRIL 5 | tbl 30x5mg | BCE | D | | | |
| 32179 | E-COR 2.5 | por tbl nob30x2.5mg | SLO | SK | | | |
| 32183 | E-COR 5 | por tbl nob 100x5mg | SLO | SK | | | |
| 32182 | E-COR 5 | por tbl nob 30x5mg | SLO | SK | | | |
| 11991 | EDNYT 2.5 MG | tbl 30x2.5mg | GED | H | | | |
| 32277 | EDNYT 5 MG | tbl 100x5mg-blistr | GED | H | | | |
| 12087 | EDNYT 5 MG | tbl 30x5mg-blistr | GED | H | | | |
| 66115 | ENALAPRIL 2.5-SL | tbl 100x2.5mg(bli.) | SLO | SK | | | |
| 66067 | ENALAPRIL 2.5-SL | tbl 30x2.5mg(blis.) | SLO | SK | | | |
| 66197 | ENALAPRIL 5-SL | tbl 100x5mg(blis.) | SLO | SK | | | |
| 66148 | ENALAPRIL 5-SL | tbl 30x5mg(blistr) | SLO | SK | | | |
| 32758 | ENALEK 5 MG | por tbl nob 30x5mg | LEK | SLO | | | |
| 06550 | ENAP 2.5MG | tbl 100x2.5mg | KRK | SLO | | | |
| 59878 | ENAPRIL 5 | tbl 50x5mg | SFS | D | | | |
| 59976 | ENAP 2.5MG | tbl 30x2.5mg | KRK | SLO | | | |
| 45273 | ENAP 5 MG | por tbl nob 30x5mg | KRK | SLO | | | |
| 59643 | ENAP 5 MG | por tbl nob100x5mg | KRK | SLO | | | |
| 30478 | ENAPIREX 5 MG | por tbl nob 28x5mg | CHN | H | | | |
| 42632 | ENAPIREX 5 MG | por tbl nob 70x5mg | CHN | H | | | |
| 30478 | ENAPIREX 5MG | tbl 28 | CHN | H | | | |
| 59976 | ENAP 2.5MG | tbl30x2.5mg | KRK | SLO | | | |
| 59643 | ENAP 5MG | tbl 100x5mg | KRK | SLO | | | |
| 59879 | ENAPRIL 5 | tbl 100x5mg | SFS | D | | | |
| 59877 | ENAPRIL 5 | tbl 30x5mg | SFS | D | | | |
| 59878 | ENAPRIL 5 | tbl 50x5mg | SFS | D | | | |
| 164.5 | C09AA02 | enalapril hydrogenmaleát (nad 5 do 10 mg v jedné tabletě včetně) | p.o. | 10 | MG | 3,90 | |
| 64839 | APO-ENALAPRIL 10 MG | tbl 100x10mg | APQ | MEX | | | |
| 32185 | E-COR 10 | por tbl nob 30x10mg | SLO | SK | | | |
| 32186 | E-COR 10 | por tblnob100x10mg | SLO | SK | | | |
| 32276 | EDNYT 10 MG | tbl 100x10mg-blistr | GED | H | | | |
| 12156 | EDNYT 10 MG | tbl 30x10mg-blistr | GED | H | | | |
| 58052 | ENALAPRIL 10-SL | tbl 100x10mg(blis.) | SLO | SK | | | |
| 58055 | ENALAPRIL 10-SL | tbl 30x10mg(blistr) | SLO | SK | | | |
| 58367 | ENALAPRIL-RATIOPHARM 10 MG | tbl 50x10mg | MCK | D | | | |
| 30479 | ENAPIREX 10MG | tbl 28 | CHN | H | | | |
| 59642 | ENAP 10MG | tbl 100x10mg | KRK | SLO | | | |
| 32276 | EDNYT 10 MG | tbl 100x10mg-blistr | GED | H | | | |
| 32759 | ENALEK 10 MG | por tbl nob 30x10mg | LEK | SLO | | | |
| 45274 | ENAP 10 MG | por tbl nob 30x10mg | KRK | SLO | | | |
| 59642 | ENAP 10 MG | por tbl nob100x10mg | KRK | SLO | | | |
| 30479 | ENAPIREX 10 MG | por tbl nob 28x10mg | CHN | H | | | |
| 42636 | ENAPIREX 10 MG | por tbl nob 70x10mg | CHN | H | | | |
| 59882 | ENAPRIL 10 | tbl 100x10mg | SFS | D | | | |
| 59880 | ENAPRIL 10 | tbl 30x10mg | SFS | D | | | |
| 59881 | ENAPRIL 10 | tbl 50x10mg | SFS | D | | | |
| 59882 | ENAPRIL 10 | tbl 100x10mg | SFS | D | | | |
| 164.6 | C09AA02 | enalapril hydrogenmaleát (nad 10 mg v jedné tabletě) | p.o. | 10 | MG | 2,85 | |
| 164.6 | C09AA02 | enalapril hydrogenmaleát (nad 10 mg v jedné tabletě) | p.o. | 10 MG | 2,85 | | |
| 64840 | APO-ENALAPRIL 20 MG | tbl 100x20mg | APQ | MEX | | | |
| 32188 | E-COR 20 | por tbl nob 30x20mg | SLO | SK | | | |
| 32189 | E-COR 20 | por tblnob100x20mg | SLO | SK | | | |
| 12212 | EDNYT 20 MG | tbl 30x20mg | GED | H | | | |
| 58061 | ENALAPRIL 20-SL | tbl 30x20mg(blistr) | SLO | SK | | | |
| 58369 | ENALAPRIL-RATIOPHARM 20 MG | tbl 30x20mg | MCK | D | | | |
| 32760 | ENALEK 20 MG | por tbl nob 30x20mg | LEK | SLO | | | |
| 45275 | ENAP 20 MG | por tbl nob 30x20mg | KRK | SLO | | | |
| 30480 | ENAPIREX 20 MG | por tbl nob 28x20mg | CHN | | | | |
| 42640 | ENAPIREX 20 MG | por tbl nob 70x20mg | CHN | | | | |
| 59885 | ENAPRIL 20 | tbl 100x20mg | SFS | D | | | |
| 59883 | ENAPRIL 20 | tbl 30x20mg | SFS | D | | | |
| 59884 | ENAPRIL 20 | tbl 50x20mg | SFS | D | | | |
| 59883 | ENAPRIL 20 | tbl 30x20mg | SFS | D | | | |
| 58369 | ENALAPRIL-RATIOPHARM 20 MG | tbl 30x20mg | MCK | D | | | |
| 59885 | ENAPRIL 20 | tbl 100x20mg | SFS | D | | | |
| 164.7 | C09AA03 | lisinopril | p.o. | 10 | MG | 5,40 | |
| 32502 | DAPRIL 10 | | por tbl nob 60x10mg | MOE | CY | | |
| 32500 | DAPRIL 5 | | por tbl nob 60x5mg | MOE | CY | | |
| 32505 | DAPRIL 20 | | por tbl nob 60x20mg | MOE | CY | | |
| 67562 | DAPRIL 10 | | tbl 30x10mg | MOE | CY | | |
| 32503 | DAPRIL 10 | | por tbl nob 100x10mg | MOE | CY | | |
| 11006 | DIROTON 10 MG | | tbl 100x10mg | GED | H | | |
| 67561 | DAPRIL 5 | | tbl 30x5mg | MOE | CY | | |
| 32501 | DAPRIL 5 | | por tbl nob100x5mg | MOE | CY | | |
| 32504 | DAPRIL 20 | | por tbl nob 30x20mg | MOE | CY | | |
| 164.8 | C09AA04 | perindopril | p.o. | 4 | MG | 6,50 | |
| | | | | | | | |
| 164.9 | C09AA05 | ramipril do 2,5 mg v jedné tabletě včetně | p.o. | 2.5 | MG | 6,50 | |
| | | | | | | | |
| 164.10 | C09AA05 | ramipril nad 2,5 mg v jedné tabletě | p.o. | 2.5 | MG | 5,85 | |
| | | | | | | | |
| 164.11 | C09AA06 | quinapril do 15 mg v jedné tabletě včetně | p.o. | 15 | MG | 6,50 | |
| | | | | | | | |
| 164.12 | C09AA06 | quinapril nad 15 mg v jedné tabletě | p.o. | 15 | MG | 6,20 | |
| | | | | | | | |
| 164.13 | C09AA07 | benazepril | p.o. | 7.5 | MG | 6,50 | |
| | | | | | | | |
| 164.14 | C09AA08 | cilazapril | p.o. | 2.5 | MG | 6,50 | |
| | | | | | | | |
| 164.15 | C09AA09 | fosinopril | p.o. | 1 | DF | 6,50 | |
| | | | | | | | |
| 164.16 | C09AA10 | trandolapril | p.o. | 2 | MG | 6,50 | |
| 164.17 | C09AA11 | spirapril | p.o. | 6 | MG | 6,50 | |
| | | | | | | | |
| 164.18 | C09AA12 | delapril | p.o. | 30 | MG | 6,50 | |
| | | | | | | | |
| 164.19 | C09AA13 | moexipril | p.o. | 15 | MG | 6,50 | |
| | | | | | | | |
| 164.20 | C09AA16 | imidapril do 5 mg v jedné tabletě včetně | p.o. | 5 | MG | 6,50 | |
| | | | | | | | |
| 164.21 | C09AA16 | imidapril nad 5 mg v jedné tabletě | p.o. | 5 | MG | 5,85 | |
| 165 | C09AA | inhibitory angiotenzin konvertujího enzymu | parent. | | | | |
| 164.7 | C09AA03 | lisinopril | p.o. | 10 | MG | 5,13 | |
| 10685 | LISINOPRIL-RATIOPHARM 10 MG | por tbl nob100x10mg | MCK | D | | | |
| 10629 | LISINOPRIL-RATIOPHARM 5 MG | por tbl nob 100x5mg | MCK | D | | | |
| 164.8 | C09AA04 | perindopril | p.o. | 4 | MG | 6,00 | |
| 164.9 | C09AA05 | ramipril do 2,5 mg v jedné tabletě včetně | p.o. | 2.5 | MG | 6,00 | |
| 13469 | RAMIL 1.25 | por tblnob30x1.25mg | LEX | CZ | | | |
| 13470 | RAMIL 1.25 | por tblnob90x1.25mg | LEX | CZ | | | |
| 13472 | RAMIL 2.5 | por tblnob 30x2.5mg | LEX | CZ | | | |
| 13473 | RAMIL 2.5 | por tblnob 90x2.5mg | LEX | CZ | | | |
| 164.10 | C09AA05 | ramipril nad 2,5 mg v jedné tabletě | p.o. | 2.5 | MG | 4,80 | |
| 13477 | RAMIL 10 | por tblnob 30x10mg | LEX | CZ | | | |
| 13478 | RAMIL 10 | por tblnob 90x10mg | LEX | CZ | | | |
| 164.11 | C09AA06 | quinapril do 15 mg v jedné tabletě včetně | p.o. | 15 | MG | 6,00 | |
| | | | | | | | |
| 164.12 | C09AA06 | quinapril nad 15 mg v jedné tabletě | p.o. | 15 | MG | 4,80 | |
| | | | | | | | |
| 164.13 | C09AA07 | benazepril | p.o. | 7.5 | MG | 6,00 | |
| | | | | | | | |
| 164.14 | C09AA08 | cilazapril | p.o. | 2.5 | MG | 6,00 | |
| | | | | | | | |
| 164.15 | C09AA09 | fosinopril | p.o. | 15 | MG | 4,80 | |
| | | | | | | | |
| 164.16 | C09AA10 | trandolapril | p.o. | 2 | MG | 6,00 | |
| | | | | | | | |
| 164.17 | C09AA11 | spirapril | p.o. | 6 | MG | 6,00 | |
| | | | | | | | |
| 164.18 | C09AA12 | delapril | p.o. | 30 | MG | 6,00 | |
| | | | | | | | |
| 164.19 | C09AA13 | moexipril | p.o. | 15 | MG | 6,00 | |
| | | | | | | | |
| 164.20 | C09AA16 | imidapril do 5 mg v jedné tabletě včetně | p.o. | 5 | MG | 6,00 | |
| | | | | | | | |
| 164.21 | C09AA16 | imidapril nad 5 mg v jedné tabletě | p.o. | 5 | MG | 4,80 | |
| 165 | C09AA | inhibitory angiotenzin konvertujíciho enzymu | parent. | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 165.1 | C09AA02 | enalaprilát | parent. | 1.25 | MG | 26,30 | H |
| 62597 | ENAP I.V. | inj 5x1ml/1.25mg | KRK | SLO | | | |
| 166 | C09BA | inhibitory angiotenzin konvertujícího enzymu v kombinaci s diuretiky | p.o. | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 166.1 | C09BA01 | kaptopril a diuretika | p.o. | 1 | DF | 4,78 | |
| 53252 | CAPTOHEXAL COMP.25/12.5 | tbl 100x25mg/12.5mg | SFS | D | | | |
| 53250 | CAPTOHEXAL COMP.25/12.5 | tbl 20x25mg/12.5mg | SFS | D | | | |
| 53251 | CAPTOHEXAL COMP.25/12.5 | tbl 50x25mg/12.5mg | SFS | D | | | |
| 53245 | CAPTOHEXAL COMP.25/25 | tbl 100x25mg/25mg | SFS | D | | | |
| 53242 | CAPTOHEXAL COMP.25/25 | tbl 20x25mg/25mg | SFS | D | | | |
| 53243 | CAPTOHEXAL COMP.25/25 | tbl 50x25mg/25mg | SFS | D | | | |
| 53242 | CAPTOHEXAL COMP.25/25 | tbl 20x25mg/25mg | SFS | D | | | |
| 53250 | CAPTOHEXAL COMP.25/12.5 | tbl 20x25mg/12.5mg | SFS | D | | | |
| 53248 | CAPTOHEXAL COMP.50/25 | tbl 50x50mg/25mg | SFS | D | | | |
| 53249 | CAPTOHEXAL COMP.50/25 | tbl 100x50mg/25mg | SFS | D | | | |
| 53246 | CAPTOHEXAL COMP.50/25 | tbl 20x50mg/25mg | SFS | D | | | |
| 53252 | CAPTOHEXAL COMP.25/12.5 | tbl 100x25mg/12.5mg | SFS | D | | | |
| 53251 | CAPTOHEXAL COMP.25/12.5 | tbl 50x25mg/12.5mg | SFS | D | | | |
| 53245 | CAPTOHEXAL COMP.25/25 | tbl 100x25mg/25mg | SFS | D | | | |
| 53248 | CAPTOHEXAL COMP.50/25 | tbl 50x50mg/25mg | SFS | D | | | |
| 166.2 | C09BA02 | enalapril a diuretika | p.o. | 1 | DF | 4,37 | |
| | | | | | | | |
| 166.3 | C09BA06 | quinapril s obsahem 10 mg v jedné tabletě a diuretikum | p.o. | 1 | DF | 4,80 | |
| | | | | | | | |
| 166.4 | C09BA06 | quinapril s obsahem 20 mg v jedné tabletě a diuretikum | p.o. | 1 | DF | 8,74 | |
| 66506 | ENAP-H | por tbl nob 30 | KRK | SLO | | | |
| 55429 | ENAP-HL | por tbl nob 30 | KRK | SLO | | | |
| 166.3 | C09BA06 | quinapril s obsahem 10 mg v jedné tabletě a diuretikum | p.o. | 1 | DF | 4,47 | |
| | | | | | | | |
| 166.4 | C09BA06 | quinapril s obsahem 20 mg v jedné tabletě a diuretikum | p.o. | 1 | DF | 6,87 | |
| | | | | | | | |
| 166.5 | C09BA07 | benazepril a diuretika | p.o. | 1 | DF | 5,06 | |
| | | | | | | | |
| 166.6 | C09BB05 | felodipin a ramipril | p.o. | 1 | DF | 9,27 | |
| | | | | | | | |
| 166.7 | C09BB10 | trandolapril/verapamil | p.o. | 1 | DF | 10,25 | |
| 166.6 | C09BA08 | cilazapril a diuretika | p.o. | 1 | DF | 10,07 | |
| | | | | | | | |
| 166.7 | C09BB05 | felodipin a ramipril | p.o. | 1 | DF | 8,77 | |
| | | | | | | | |
| 166.8 | C09BB10 | trandolapril/verapamil | p.o. | 1 | DF | 9,75 | |
| 167 | C09CA | antagonisté angiotensinu II | p.o. | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 167.1 | C09CA01 | losartan do 50 mg v jedné tabletě včetně | p.o. | 50 | MG | 6,50 | |
| | | | | | | | |
| 10604 | LORISTA | por tblflm 28x50mg | KRK | SLO | | | |
| 47610 | LORISTA | por tblflm 84x50mg | KRK | SLO | | | |
| 10618 | LOZAP 12.5 | portblflm 30x12.5mg | LEX | CZ | | | |
| 10620 | LOZAP 50 | por tbl flm 30x50mg | LEX | CZ | | | |
| 167.2 | C09CA01 | losartan nad 50 mg v jedné tabletě včetně | p.o. | 50 | MG | 5,20 | |
| | | | | | | | |
| 167.3 | C09CA02 | eprosartan | p.o. | 600 | MG | 6,50 | |
@@ -2684,9 +2829,9 @@
| | | | | | | | |
| 167.5 | C09CA03 | valsartan nad 80 mg v jedné tabletě | p.o. | 80 | MG | 5,20 | |
| | | | | | | | |
| 167.6 | C09CA04 | irbesartan do 150 mg v jedné tabletě včetně | p.o. | 150 | MG | 12,00 | P |
| | | | | | | | |
| 167.7 | C09CA04 | irbesartan nad 150 mg v jedné tabletě | p.o. | 150 | MG | 9,60 | P |
| 167.6 | C09CA04 | irbesartan do 150 mg v jedné tabletě včetně | p.o. | 150 | MG | 9,00 | P |
| | | | | | | | |
| 167.7 | C09CA04 | irbesartan nad 150 mg v jedné tabletě | p.o. | 150 | MG | 7,20 | P |
Irbesartan je indikován u pacientů s:
@@ -2700,16 +2845,15 @@
| | | | | | | | |
| 167.10 | C09CA07 | telmisartan do 40 mg v jedné tabletě včetně | p.o. | 40 | MG | 6,50 | |
| | | | | | | | |
| 167.11 | C09CA07 | telmisartan nad 40 mg v jedné tabletě | p.o. | 40 | MG | 5.20 | |
| | | | | | | | |
| 167.12 | C09DA01 | losartan v kombinaci s thiazidy | p.o. | 1 | DF | 6,27 | |
| | | | | | | | |
| 167.13 | C09DA03 | valsartan v kombinaci s thiazidy s obsahem 80 mg vaisartanu v jedné tabletě včetně | p.o. | 1 | DF | 6,97 | |
| | | | | | | | |
| 167.14 | C09DA03 | valsartan v kombinaci s thiazidy s obsahem 160 mg vaisartanu a 12,5 mg hydrochlorothiazidu v jedné tabletě včetně | p.o. | 1 | DF | 10,87 | |
| 167.11 | C09CA07 | telmisartan nad 40 mg v jedné tabletě | p.o. | 40 | MG | 5,20 | |
| | | | | | | | |
| 167.12 | C09DA01 | losartan v kombinaci s thiazidy | p.o. | 1 | DF | 6,97 | |
| 03701 | LOZAP H | por tbl flm 28 | LEX | CZ | | | |
| 167.13 | C09DA03 | valsartan v kombinaci s thiazidy s obsahem 80 mg valsartanu v jedné tabletě včetně | p.o. | 1 | DF | 6,97 | |
| | | | | | | | |
| 167.14 | C09DA03 | valsartan v kombinaci s thiazidy s obsahem 160 mg valsartanu a 12,5 mg hydrochlorothiazidu v jedné tabletě včetně | p.o. | 1 | DF | 10,87 | |
| | | | | | | | |
| 167.15 | C09DA03 | valsartan v kombinaci s thiazidy s obsahem 160 mg valsartanu a 25 mg hydrochlorothiazidu v jedné tabletě včetně | p.o. | 1 | DF | 11,34 | |
| | | | | | | | |
| 167.16 | C09DA06 | kandesartan v kombinaci s thiazidy s obsahem 8 mg kandesartanu v jedné tabletě | p.o. | 1 | DF | 6,97 | |
| | | | | | | | |
| 167.17 | C09DA06 | kandesartan v kombinaci s thiazidy s obsahem 16 mg kandesartanu v jedné tabletě | p.o. | 1 | DF | 10,87 | |
@@ -2722,7 +2866,7 @@
Simvastatin, lovastatin: léčba nemocných s manifestní aterosklerózou (sekundární prevence) s izolovanou hypercholesterolémií nebo se smíšenou hyperlipidémií s převahou hypercholesterolémie, možno předepsat vždy jen jedno hypolipidemikum (nelze kombinovat statiny a fibráty). U pacientů s diabetes mellitus s hypercholesterolémií též indikován v primární prevenci.
Léčbu atorvastatinem, cerivastatinem, fluvastatinem a pravastatinem ordinuje kardiolog, internista, diabetolog nebo lékař pracující v poradnách pro poruchy metabolizmu lipidů:
Léčba atorvastatinem, cerivastatinem, fluvastatinem a pravastatinem ordinuje kardiolog, internista, diabetolog nebo lékař pracující v poradnách pro poruchy metabolizmu lipidů:
- a) léčba nemocných s familiární hypercholesterolémií (atorvastatin v dávce 40mg denně je hrazen pouze v léčbě nemocných s isolovanou familiární hypercholesterolemií)
@@ -2731,47 +2875,97 @@
- c) léčba nemocných s kumulací rizikových faktorů (s vysokým rizikem kardiovaskulární příhody vyjádřeným absolutním desetiletým rizikem 20% a více ) s izolovanou hypercholesterolémií či s kombinovanou hyperlipidémií s převahou hypercholesterolémie
| 168.1 | C10AA01 | simvastatin (do 10 mg v jedné tabletě včetně) | p.o. | 1 | DF | 10,00 | P |
| 59727 | SIMGAL 10 MG | por tbl flm 28x10mg | IVX | CZ | | | |
| 10390 | SIMIREX 10 MG | por tbl flm 30x10mg | SYH | E | | | |
| 10398 | SIMIREX 10 MG | por tbl flm 50x10mg | SYH | E | | | |
| 58773 | SIMVACARD 10 | tbl obd 28x10mg | LEX | CZ | | | |
| 31844 | SIMVASTATIN-RATIOPHARM 10 MG | por tbl flm 30x10mg | SYH | E | | | |
| 31847 | SIMVASTATIN-RATIOPHARM 10 MG | por tbl flm100x10mg | SYH | E | | | |
| 49919 | SIMVAX 10 | por tbl flm 28x10mg | SFS | D | | | |
| 49923 | SIMVAX 10 | por tbl flm 28x10mg | SFS | D | | | |
| 81479 | SIMVAX 10 | por tbl flm 28x10mg | GEA | DK | | | |
| 81481 | SIMVAX 10 | portblflm50x10mgbli | GEA | DK | | | |
| 31847 | SIMVASTATIN-RATIOPHARM 10 MG | por tbl flm 100x10mg | SYH | E | | | |
| 81480 | SIMVAX 10 | portblflm30x10mgbli | GEA | DK | | | |
| I97069 | SIMVAX 10 | portblflm50x10mglah | GEA | DK | | | |
| 10390 | SIMIREX 10 MG | por tbl flm 30x10mg | SYH | E | | | |
| 97067 | SIMVAX 10 | por tbl flm 28x10mg | GEA | DK | | | |
| 10398 | SIMIREX 10 MG | por tbl flm 50x10mg | SYH | E | | | |
| 49920 | SIMVAX 10 | por tbl flm 30x10mg | SFS | D | | | |
| 49924 | SIMVAX 10 | por tbl flm 30x10mg | SFS | D | | | |
| 81480 | SIMVAX 10 | por tbl flm 30x10mg | GEA | DK | | | |
| 97068 | SIMVAX 10 | por tbl flm 30x10mg | GEA | DK | | | |
| 49921 | SIMVAX 10 | por tbl flm 50x10mg | SFS | D | | | |
| 49925 | SIMVAX 10 | por tbl flm 50x10mg | SFS | D | | | |
| 81481 | SIMVAX 10 | por tbl flm 50x10mg | GEA | DK | | | |
| 97069 | SIMVAX 10 | por tbl flm 50x10mg | GEA | DK | | | |
| 49922 | SIMVAX 10 | por tbl flm100x10mg | SFS | D | | | |
| 49926 | SIMVAX 10 | por tbl flm100x10mg | SFS | D | | | |
| 66024 | SIMVOR 10MG | tbl obd 30x10mg | RXY | IND | | | |
| 58136 | VASILIP 10 | tbl obd 28x10mg | KRK | SLO | | | |
| 95250 | VASILIP 10 | tbl obd 84x10mg | KRK | SLO | | | |
| 168.2 | C10AA01 | simvastatin (nad 10 do 20 mg v jedné tabletě včetně) | p.o. | 1 | DF | 16,00 | P |
| 81485 | SIMVAX 20 | portblflm50x20mgbli | GEA | DK | | | |
| g7072 | SIMVAX 20 | portblflm30x20mglah | GEA | DK | | | |
| 97073 | SIMVAX 20 | portblfim50x20mglah | GEA | DK | | | |
| 81484 | SIMVAX 20 | portblflm30x20mgbli | GEA | DK | | | |
| 59728 | SIMGAL 20 MG | por tbl flm 28x20mg | IVX | CZ | | | |
| 10422 | SIMIREX 20 MG | por tbl flm 30x20mg | SYH | E | | | |
| 58775 | SIMVACARD 20 | tbl obd 28x20mg | LEX | CZ | | | |
| 47731 | SIMVACARD 20 | tbl obd 84x20mg | LEX | CZ | | | |
| 31851 | SIMVASTATIN-RATIOPHARM 20 MG | por tbl flm 30x20mg | SYH | E | | | |
| 31856 | SIMVASTATIN-RATIOPHARM 20 MG | por tbl flm 100x20mg | SYH | E | | | |
| 49911 | SIMVAX 20 | por tbl flm 28x20mg | SFS | D | | | |
| 49915 | SIMVAX 20 | por tbl flm 28x20mg | SFS | D | | | |
| 81483 | SIMVAX 20 | por tbl flm 28x20mg | GEA | DK | | | |
| 97071 | SIMVAX 20 | por tbl flm 28x20mg | GEA | DK | | | |
| 31856 | SIMVASTATIN-RATIOPHARM 20 MG | por tbl flm100x20mg | SYH | E | | | |
| 49912 | SIMVAX 20 | por tbl flm 30x20mg | SFS | D | | | |
| 49916 | SIMVAX 20 | por tbl flm 30x20mg | SFS | D | | | |
| 81484 | SIMVAX 20 | por tbl flm 30x20mg | GEA | DK | | | |
| 97072 | SIMVAX 20 | por tbl flm 30x20mg | GEA | DK | | | |
| 49913 | SIMVAX 20 | por tbl flm 50x20mg | SFS | D | | | |
| 49917 | SIMVAX 20 | por tbl flm 50x20mg | SFS | D | | | |
| 81485 | SIMVAX 20 | por tbl flm 50x20mg | GEA | DK | | | |
| 97073 | SIMVAX 20 | por tbl flm 50x20mg | GEA | DK | | | |
| 49914 | SIMVAX 20 | por tbl flm100x20mg | SFS | D | | | |
| 49918 | SIMVAX 20 | por tbl flm100x20mg | SFS | D | | | |
| 66026 | SIMVOR 20MG | tbl obd 30x20mg | RXY | IND | | | |
| 58064 | VASILIP 20 | tbl obd 28x20mg | KRK | SLO | | | |
| 95251 | VASILIP 20 | tbl obd 84x20mg | KRK | SLO | | | |
| 168.3 | C10AA01 | simvastatin (nad 20 mg do 40mg v jedné tabletě včetně) | p.o. | 1 | DF | 25,60 | P |
| 59729 | SIMGAL 40 MG | por tbl flm 28x40mg | IVX | CZ | | | |
| 10459 | SIMIREX 40 MG | por tbl flm 30x40mg | SYH | E | | | |
| 58777 | SIMVACARD 40 | tbl obd 28x40mg | LEX | CZ | | | |
| 31859 | SIMVASTATIN-RATIOPHARM 40 MG | por tbl flm 30x40mg | SYH | E | | | |
| 49901 | SIMVAX 40 | por tbl flm 28x40mg | SFS | D | | | |
| 49905 | SIMVAX 40 | por tbl flm 28x40mg | SFS | D | | | |
| 81487 | SIMVAX 40 | por tbl flm 28x40mg | GEA | DK | | | |
| 97077 | SIMVAX 40 | portblflm50x40mglah | GEA | DK | | | |
| 81488 | SIMVAX 40 | portblflm30x40mgbli | GEA | DK | | | |
| 97076 | SIMVAX 40 | portblflm30x40mglah | GEA | DK | | | |
| 81489 | SIMVAX 40 | portblflm50x40mgbli | GEA | DK | | | |
| 97075 | SIMVAX 40 | por tbl flm 28x40mg | GEA | DK | | | |
| 49902 | SIMVAX 40 | por tbl flm 30x40mg | SFS | D | | | |
| 49906 | SIMVAX 40 | por tbl flm 30x40mg | SFS | D | | | |
| 81488 | SIMVAX 40 | por tbl flm 30x40mg | GEA | DK | | | |
| 97076 | SIMVAX 40 | por tbl flm 30x40mg | GEA | DK | | | |
| 49903 | SIMVAX 40 | por tbl flm 50x40mg | SFS | D | | | |
| 49907 | SIMVAX 40 | por tbl flm 50x40mg | SFS | D | | | |
| 81489 | SIMVAX 40 | por tbl flm 50x40mg | GEA | DK | | | |
| 97077 | SIMVAX 40 | por tbl flm 50x40mg | GEA | DK | | | |
| 49904 | SIMVAX 40 | por tbl flm100x40mg | SFS | D | | | |
| 49908 | SIMVAX 40 | por tbl flm100x40mg | SFS | D | | | |
| 66028 | SIMVOR 40MG | tbl obd 30x40mg | RXY | IND | | | |
| 66028 | SIMVOR 40MG | tbl obd 30x40mg | RXY | IND | | | |
| 42929 | VASILIP 40 | por tbl obd 28x40mg | KRK | SLO | | | |
| 168.4 | C10AA01 | simvastatin (nad 40 mg v jedné tabletě) | p.o. | 1 | DF | 40,90 | P |
| | | | | | | | |
| 168.5 | C10AA02 | lovastatin (do 20 mg v jedné tabletě včetně) | p.o. | 1 | DF | 9,00 | P |
| 53286 | APO-LOVASTATIN 20 | tbl 100x20mg | APT | CND | | | |
| 01300 | APO-LOVASTATIN 20 | tbl 30x20mg | APT | CND | | | |
| 58799 | HOLETAR 20 | tbl 30x20mg | KRK | SLO | | | |
| 53507 | MEDOSTATIN 20MG | tbl 100x20mg | MOE | CY | | | |
| 53506 | MEDOSTATIN 20MG | tbl 30x20mg | MOE | CY | | | |
| 168.6 | C10AA02 | lovastatin (nad 20 mg v jedné tabletě do 40 mg v jedné tabletě včetně) | p.o. | 1 | DF | 14,40 | P |
| | | | | | | | |
| 53287 | APO-LOVASTATIN 40 | tbl 100x40mg | APT | CND | | | |
| 01254 | APO-LOVASTATIN 40 | tbl 30x40mg | APT | CND | | | |
| 168.7 | C10AA03 | pravastatin (do 10 mg v jedné tabletě včetně) | p.o. | 1 | DF | 10,00 | P |
| | | | | | | | |
| 168.8 | C10AA03 | pravastatin (nad 10 mg do 20 mg v jedné tabletě včetně) | p.o. | 1 | DF | 16,00 | P |
| | | | | | | | |
| 168.9 | C10AA03 | pravastatin (nad 20 mg v jedné tabletě ) | p.o. | 1 | DF | 25,60 | P |
| 168.9 | C10AA03 | pravastatin (nad 20 mg v jedné tabletě) | p.o. | 1 | DF | 25,60 | P |
| | | | | | | | |
| 168.10 | C10AA04 | fluvastatin (do 20 mg v jedné tabletě včetně) | p.o. | 1 | DF | 10,00 | P |
| | | | | | | | |
| 168.11 | C10AA04 | fluvastatin (nad 20 mg do 40 mgv jedné tabletě včetně) | p.o. | 1 | DF | 16,00 | P |
| | | | | | | | |
| 168.12 | C10AA04 | fluvastatin (nad 40 MG v jedné tabletě ) | p.o. | 1 | DF | 30,55 | P |
| 168.12 | C10AA04 | fluvastatin (nad 40 MG v jedné tabletě ) | p.o. | 1 | DF | 27,50 | P |
| | | | | | | | |
| 168.13 | C10AA05 | atorvastatin (do 10 MG včetně v jedné tabletě) | p.o. | 1 | DF | 21,40 | P |
| | | | | | | | |
@@ -2781,14 +2975,23 @@
| 169 | C10A | hypolipidemika ze skupiny fibrátů a některých dalších skupin | p.o. | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 169.1 | C10AB | klofibrát (etofylin) | p.o. | 0.5 | GM | 4,55 | |
| 49609 | DUOLIP FORTE | tbl obd 100x500mg | MCK | A | | | |
| 49609 | DUOLIP FORTE | tbl obd 100x500mg | MCK | D | | | |
| 169.2 | C10AB02 | bezafibrát | p.o. | 0.6 | GM | 6,50 | |
| | | | | | | | |
| 169.3 | C10AB04 | gemfibrozil | p.o. | 1.2 | GM | 6,50 | |
| | | | | | | | |
| 169.4 | C10AB05 | fenofibrát | p.o. | 0.3 | GM | 6,50 | |
| | | | | | | | |
| 169.5 | C10AB05 | fenofibrát (mikronisované lékové formy) | p.o. | 1 | DF | 8,10 | |
| | | | | | | | |
| 04143 | APO-FENO | por cpsdur 30x200mg | APT | CND | | | |
| 04145 | APO-FENO | por cpsdur100x200mg | APT | CND | | | |
| 32652 | FEBIRA 200 | por cps dur30x200mg | SLO | SK | | | |
| 32653 | FEBIRA 200 | por cps dur60x200mg | SLO | SK | | | |
| 32654 | FEBIRA 200 | por cps dur90x200mg | SLO | SK | | | |
| 41797 | LIPIREX 200MG | por cps dur60x200mg | SGY | B | | | |
| 99839 | LIPIREX S 160 MG | por cps dur60x160mg | SGY | B | | | |
| 47872 | SUPRELIP | por cps dur30x200mg | CPW | H | | | |
| 47873 | SUPRELIP | por cpsdur100x200mg | CPW | H | | | |
| 169.6 | C10AB05 | fenofibrát (supramikronisované lékové formy) | p.o. | 1 | DF | 9,00 | |
| | | | | | | | |
| 169.7 | C10AB08 | ciprofibrát | p.o. | 0.1 | GM | 8,10 | |
@@ -2804,13 +3007,12 @@
- b) léčba pacientů s pruritem při biliární cirhóze.
| 170.1 | C10AC01 | cholestyramin | p.o. | 14 | GM | 31,09 | P |
| | | | | | | | |
| 170.2 | C10AC02 | colestipol | p.o. | 20 | GM | 59,39 | P |
| 94764 | COLESTID | plv 50x5gm | UPJ | B | | | |
| 171 | D01AA | antimykotika pro lokální podání ze skupiny antibiotik | lok. | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 171.1 | D01AA01 | nystatin | lok. | 1 | GM | 2,66 | |
| 01069 | FUNGICIDIN LECIVA | ung 1x10gm | LEX | CZ | | | |
| 01069 | FUNGICIDIN LÉČIVA | ung 1x10gm | LEK | CZ | | | |
| 171.2 | D01AA02 | natamycin | lok. | 1 | GM | 1,96 | |
| 172 | D01AC | antimykotika pro lokální podání ze skupiny derivátu imidazolu | lok. | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
@@ -2831,12 +3033,13 @@
| 172.8 | D01AC08 | ketokonazol | lok. | 1 | GM | 1,83 | |
| | | | | | | | |
| 172.9 | D01AC10 | bifonazol | lok. | 1 | GM | 2,49 | |
| 05969 | BIFONAZOL-SL CRM. | drm crm1x15gm/150mg | SLO | SK | | | |
| 05969 | BIFONAZOL-SL CRM. | drmcrm 1x15gm/150mg | SLO | SK | | | |
| 05976 | BIFONAZOL-SL SOL. | drm sol1x15ml/150mg | SLO | SK | | | |
| 05977 | BIFONAZOL-SL SOL. | drm sol1x20ml/200mg | SLO | SK | | | |
| 172.10 | D01AC11 | oxikonazol | lok. | 1 | GM | 2,49 | |
| | | | | | | | |
| 172.11 | D01AC12 | fenticonazol | lok. | 1 | GM | 1,83 | |
| | | | | | | | |
| 172.12 | D01AC16 | flutrimazol, lékové forma krém a spray | lok. | 1 | GM | 4,70 | |
| | | | | | | | |
| 172.13 | D01AC16 | flutrimazol, lékové forma gelu | lok. | 1 | GM | 3,06 | |
@@ -2851,34 +3054,37 @@
Léčbu ordinuje dermatolog u onychomykóz, doložených kultivačním vyšetřením.
| 99142 | MYCOSPOR NAGELSET | ung 10gm+pla 15ks | BAY | D | | | |
| 173 | D01AE | antimykotika pro lokální podání ostatních skupin | lok. | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 173.1 | D01AE | jiná antimykotika k zevnímu použití | lok. | 1 | ML | 0,78 | |
| 00799 | NITROFUNGIN | liq 1x25ml | GNO | CZ | | | |
| 00799 | NITROFUNGIN | drm sol 1x25ml | GNO | CZ | | | |
| 173.2 | D01AE04 | kyselina undecylenová | lok. | 1 | GM | 0,93 | |
| | | | | | | | |
| 173.3 | D01AE14 | ciclopirox | lok. | 1 | GM | 3,79 | |
| 76152 | BATRAFEN | liq 1x20ml | HBS | SK | | | |
| 76150 | BATRAFEN | crm 1x20gm | HBS | SK | | | |
| 173.4 | D01AE15 | terbinafin | lok. | | GM | 3,79 | |
| | | | | | | | |
| 173.5 | D01AE16 | amorolfin | lok. | | MG | 3,35 | |
| | | | | | | | |
| 173.6 | D01AE18 | tolnaftat | lok. | | GM | 1,83 | |
| | | | | | | | |
| 173.7 | D01AE19 | tolciklát | lok. | | GM | 1,83 | |
| | | | | | | | |
| 173.8 | D01AE20 | kombinace antimykotik (tolnaftat/cetrimid) | lok. | | GM | 1,83 | |
| | | | | | | | |
| 173.9 | D01AE20 | kombinace antimykotik (ostatní kombinace) | lok. | | GM | 0,64 | |
| | | | | | | | |
| 173.10 | D01AE | naftini hydrochlorid | lok. | | GM | 2,93 | |
| 76150 | BATRAFEN KRÉM | crm 1x20gm/200mg | HBS | SK | | | |
| 76152 | BATRAFEN ROZTOK | liq 1x20ml | HBS | SK | | | |
| 173.4 | D01AE15 | terbinafin | lok. | 1 | GM | 3,79 | |
| | | | | | | | |
| 173.5 | D01AE16 | amorolfin | lok. | 1 | MG | 3,35 | |
| | | | | | | | |
| 173.6 | D01AE18 | tolnaftat | lok. | 1 | GM | 1,83 | |
| | | | | | | | |
| 173.7 | D01AE19 | tolciklát | lok. | 1 | GM | 1,83 | |
| | | | | | | | |
| 173.8 | D01AE20 | kombinace antimykotik (tolnaftat/cetrimid) | lok. | 1 | GM | 1,83 | |
| | | | | | | | |
| 173.9 | D01AE20 | kombinace antimykotik (ostatní kombinace) | lok. | 1 | GM | 0,64 | |
| | | | | | | | |
| 173.10 | D01AE | naftini hydrochlorid | lok. | 1 | GM | 2,93 | |
| 174 | D01BA | antimykotika pro celkové podání | p.o. | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 174.1 | D01BA01 | griseofulvin | p.o. | 0.5 | GM | 9,97 | |
| | | | | | | | |
| 174.2 | D01BA02 | terbinafin | p.o. | 0.25 | GM | 60,00 | P |
| 174.2 | D01BA02 | terbinafin do 125 mg v jedné tabletě včetně | p.o. | 0.25 | GM | 60,00 | P |
| 58429 | ONYCHON 125 | tbl 14x125mg bli | LEX | CZ | | | |
| 30766 | ONYCHON 125 | tbl 14x125mg lah | LEX | CZ | | | |
| 10144 | TERBISIL KID | por tblnob 14x125mg | GED | H | | | |
| 174.3 | D01BA02 | terbinafin nad 125 mg v jedné tabletě včetně | p.o. | 0.25 | GM | 57,00 | P |
Léčbu terbinafinem ordinuje dermatolog:
@@ -2894,25 +3100,16 @@
Podmínkou zahájení léčby ad b) je pozitivní mikroskopický nález a provedený odběr na mykologickou kultivaci.
| 10148 | TERBISIL 250 MG | por tblnob 28x250mg | GED | H | | | |
| 10147 | TERBISIL 250 MG | por tblnob 14x250mg | GED | H | | | |
| 32370 | BRINAF 250 | por tbl nob14x250mg | SLO | SK | | | |
| 10144 | TERBISIL KID | por tblnob 14x125mg | GED | H | | | |
| 58429 | ONYCHON 125 | tbl 14x125mg bli | LEX | CZ | | | |
| 58430 | ONYCHON 250 | tbl 14x250mg bli | LEX | CZ | | | |
| 30766 | ONYCHON 125 | tbl 14x125mg lah | LEX | CZ | | | |
| 30769 | ONYCHON 250 | tbl 14x250mg lah | LEX | CZ | | | |
| 175 | D02AB | emolliencia obsahující oxid zinečnatý | lok. | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 175.1 | D02AB | přípravky obsahující oxid zinečnatý (do 120 g v jednom balení včetně) | lok. | 1 | GM | 0,56 | |
| 88780 | SUSPENSIO ZINCI OXYD.CSL4 PROF. | sus 1x100gm | PSR | CZ | | | |
| 176 | D02AC | emolliencia obsah | ující měkký parafin a tukové produkty | lok. | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 176.1 | D02AC | měkký parafin a tukové produkty (do 250 ml v 1 balení včetně) - tekuté lékové formy | lok. | 1 | ML | 0.59 | L/DER,PDD |
| | | | | | | | |
| 176.2 | D02AC | měkký parafin a tukové produkty (nad 250 ml v 1 balení) - tekuté lékové formy | lok. | 1 | ML | 0,43 | L/DER.PDD |
| | | | | | | | |
| 176.3 | D02AC | měkký parafin s polydekanolem (do 250 ml v 1 balení včetně) | lok. | 1 | ML | 0.65 | L/DER,PDD |
| 176 | D02AC | emolliencia obsahující měkký parafin a tukové produkty | lok. | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 176.1 | D02AC | měkký parafin a tukové produkty (do 250 ml v 1 balení včetně) - tekuté lékové formy | lok. | 1 | ML | 0,59 | L/DER,PDD |
| 176.2 | D02AC | měkký parafin a tukové produkty (nad 250 ml v 1 balení) - tekuté lékové formy | lok. | 1 | ML | 0,43 | L/DER,PDD |
| | | | | | | | |
| 176.3 | D02AC | měkký parafin s polydekanolem (do 250 ml v 1 balení včetně) | lok. | 1 | ML | 0,65 | L/DER,PDD |
| | | | | | | | |
| 176.4 | D02AC | měkký parafin s polydekanolem (nad 250 ml v 1 balení) | lok. | 1 | ML | 0,47 | L/DER,PDD |
| | | | | | | | |
@@ -2921,23 +3118,23 @@
| 176.6 | D02AC | měkký parafin a tukové produkty (nad 250 gm v 1 balení) | lok. | 1 | GM | 0,43 | L/DER,PDD |
| | | | | | | | |
| 176.7 | D02AE01 | měkký parafin a tukové produkty s obsahem močoviny -tekuté lékové formy | lok. | 1 | ML | 0,50 | L/DER,PDD |
| 97153 | EXCIPIAL U HYDROLOTIO | lot 1x200ml | SEG | CH | | | |
| 97153 | EXCIPIAL U HYDROLOTIO | drm eml 1x200ml | SEG | CH | | | |
| 176.8 | D02AE51 | kombinace kyseliny salicylové s ureou | lok. | 1 | GM | 1,00 | |
| 177 | D02AX | jiná emolliencia a protektiva | lok. | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 177.1 | D02AX | jiná emolliencia a protektiva (do 50 g v balení včetně) | lok. | | GM | 1,71 | |
| | | | | | | | |
| 177.2 | D02AX | jiná emolliencia a protektiva (nad 50 g v balení) | lok. | | GM | 0,64 | |
| | | | | | | | |
| 177.3 | D03AX | jiná léčiva podporující tvorbu jizev (chlorofyl) | lok. | | ML | 0,49 | |
| | | | | | | | |
| 177.4 | D03AX | jiná léčiva podporující zajizvení (kombinace celulosa + karboxycelulosa, na obsah karboxycelulosy) | lok. | | GM | 15,40 | |
| | | | | | | | |
| 177.5 | D03AX | jiná léčiva podporující zajizvení (zinci hyaluronas -lékové formy gelu) | lok. | | GM | 1,42 | |
| | | | | | | | |
| 177.6 | D03AX | jiná léčiva podporující zajizvení (zinci hyaluronas -lékové formy roztoku) | lok. | | ML | 3,91 | |
| | | | | | | | |
| 177.7 | D03AX02 | dextranomer | lok. | | GM | 3,91 | |
| 177.1 | D02AX | jiná emolliencia a protektiva (do 50 g v balení včetně) | lok. | 1 | GM | 1,71 | |
| | | | | | | | |
| 177.2 | D02AX | jiná emolliencia a protektiva (nad 50 g v balení) | lok. | 1 | GM | 0,64 | |
| | | | | | | | |
| 177.3 | D03AX | jiná léčiva podporující tvorbu jizev (chlorofyl) | lok. | 1 | ML | 0,49 | |
| | | | | | | | |
| 177.4 | D03AX | jiná léčiva podporující zajizvení (kombinace celulosa + karboxycelulosa, na obsah karboxycelulosy) | lok. | 1 | GM | 15,40 | |
| | | | | | | | |
| 177.5 | D03AX | jiná léčiva podporující zajizvení (zinci hyaluronas -lékové formy gelu) | lok. | 1 | GM | 1,42 | |
| | | | | | | | |
| 177.6 | D03AX | jiná léčiva podporující zajizvení (zinci hyaluronas -lékové formy roztoku) | lok. | 1 | ML | 3,91 | |
| | | | | | | | |
| 177.7 | D03AX02 | dextranomer | lok. | 1 | GM | 3,91 | |
| 178 | D03BA | proteolytické enzymy | lok. | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
@@ -2972,8 +3169,8 @@
| 179.1 | D05AA | dehty | lok. | 1 | GM | 0,73 | |
| 66502 | ICHTOXYL | ung 1x30gm | HEO | CZ | | | |
| 66262 | SALOXYL | ung 1x30gm | HEO | CZ | | | |
| 85950 | SUSPENSIO VIŠNĚVSKI+PICE LIQUID | sus 1x1000gm | HEO | CZ | | | |
| 05994 | UNGUENTUM ICHTHAMMOLI 10% H.-B. | drm ung 1x30gm | HEO | CZ | | | |
| 85950 | SUSPENSIO VISNEVSKI+PICE LIQUID | sus 1x1000gm | HEO | CZ | | | |
| 55290 | UNGUENTUM ICHTHAMOLI 10% MVM | drm ung 1x100gm | MVM | CZ | | | |
| 179.2 | D05AA | dehty (odbarvený dehet) | lok. | 1 | GM | 1,17 | |
| | | | | | | | |
@@ -2981,11 +3178,13 @@
| 90618 | OXSORALEN | liq 1x50ml 0.15% | GER | A | | | |
| 179.4 | D05AC01 | dithranol | lok. | 1 | GM | 3,91 | |
| | | | | | | | |
| 179.5 | D05AX02 | kalcipotriol | lok. | 1 | GM | 9,00 | P |
| | | | | | | | |
| 179.6 | D05AX04 | tacalcitol | lok. | 1 | GM | 18,00 | P |
| | | | | | | | |
| 179.7 | D05AX05 | tazaroten | lok. | 1 | GM | 18,00 | P |
| 179.5 | D05AX02 | calcipotriol | lok. | 1 | GM | 9,00 | P |
| | | | | | | | |
| 179.6 | D05AX03 | calcitriol | lok. | 1 | GM | 9,00 | P |
| | | | | | | | |
| 179.7 | D05AX04 | tacalcitol | lok. | 1 | GM | 18,00 | P |
| | | | | | | | |
| 179.8 | D05AX05 | tazaroten | lok. | 1 | GM | 18,00 | P |
| 180 | D05BB | retinoidy pro celkové podání | p.o. | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
@@ -3008,8 +3207,7 @@
| 181.1 | D06AA | tetracyklin a deriváty | lok. | 1 | GM | 2,93 | |
| | | | | | | | |
| 181.2 | D06AX | neomycin/bacitracin (k přípravě roztoku) | lok. | 1 | ML | 3,83 | |
| 55762 | PAMYCON NA PRIPRAVU STER.ROZT. | plv 10x1lahv. | BTA | SK | | | |
| 55759 | PAMYCON NA PRIPRAVU KAPEK | plv 1x1lahv | BTA | SK i | | | |
| 55759 | PAMYCON NA PŘÍPRAVU KAPEK | plv 1x1lahv | BTA | SK | | | |
| 181.3 | D06AX | neomycin/bacitracin (zásyp do 2 g včetně) | lok. | 1 | GM | 13,69 | |
| | | | | | | | |
| 181.4 | D06AX | neomycin/bacitracin (zásyp nad 2 do 5 g v jednom balení včetně) | lok. | 1 | GM | 7,63 | |
@@ -3017,7 +3215,6 @@
| 181.5 | D06AX | neomycin/bacitracin (mast) | lok. | 1 | GM | 2,93 | |
| | | | | | | | |
| 181.6 | D06AX | primycin | lok. | 1 | GM | 2,44 | |
| | | | | | | | |
| 181.7 | D06AX02 | chloramfenikol | lok. | 1 | GM | 2,88 | |
| | | | | | | | |
| 181.8 | D06AX09 | mupirocin (do 5 g v jednom balení včetně) | lok. | 1 | GM | 8,31 | |
@@ -3046,18 +3243,15 @@
| 182.9 | D06BX01 | metronidazol | lok. | 1 | GM | 2,25 | L/DER,CHI |
| 183 | D07AA | kortikosteroidy třídy I, slabě účinné | lok. | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 183.1 | D07AA02 | hydrokortison | lok. | 1 | GM | 3.31 | |
| | | | | | | | |
| 183.2 | D07AA03 | Prednisolon | lok. | 1 | GM | 3,18 | |
| 183.1 | D07AA02 | hydrokortison | lok. | 1 | GM | 3,31 | |
| | | | | | | | |
| 183.2 | D07AA03 | prednisolon | lok. | 1 | GM | 3,18 | |
| 184 | D07AB | kortikosteroidy třídy II, středně účinné | lok. | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 184.1 | D07AB01 | klobetazon | lok. | 1 | GM | 3,08 | |
| | | | | | | | |
| 184.2 | D07AB02 | hydrokortison butyrát | lok. | 1 | GM | 3,08 | |
| 62047 | LOCOID LIPOCREAM | crm 1x30gm 0.1% | YEU | NL | | | |
| 09310 | LOCOID 0.1% | ung 1x30gm 0.1% | YEU | NL | | | |
| 09307 | LOCOID 0.1% LOTION | lot 1x30ml | YEU | NL | | | |
| 09305 | LOCOID 0.1% | crm 1x30gm 0.1% | YEU | NL | | | |
| | | | | | | | |
| 184.3 | D07AB03 | flumetason | lok. | 1 | GM | 3,08 | |
| | | | | | | | |
| 184.4 | D07AB07 | flupredniden | lok. | 1 | GM | 3,08 | |
@@ -3065,24 +3259,23 @@
| 184.5 | D07AB09 | triamcinolon (lékové formy mastí a krémů) | lok. | 1 | GM | 2,55 | |
| | | | | | | | |
| 184.6 | D07AB09 | triamcinolon (lékové formy lotia) | lok. | 1 | ML | 2,83 | |
| 66167 | TRIAMCINOLON-GALENA | lot 1x30gm | GNO | CZ | | | |
| 66167 | TRIAMCINOLON-GALENA | drm sol 1x30gm | IVX | CZ | | | |
| 184.7 | D07AB09 | triamcinolon (lékové formy spreje) | lok. | 1 | GM | 0,73 | |
| | | | | | | | |
| 184.8 | D07AB09 | triamcinolon (lékové formy tinktury) | lok. | 1 | ML | 0,98 | |
| | | | | | | | |
| 184.9 | D07AB10 | alclomethason | lok. | 1 | GM | 3,08 | |
| | | | | | | | |
| 184.10 | D07AB19 | dexamethason acetát | lok. | 1 | GM | 3,09 | |
| 02415 | DEXAMETHAZON LECIVA | crm 10gm 0.01% | LEX | CZ | | | |
| 02415 | DEXAMETHAZON LÉČIVA CRM | drm crm 1x10gm | LEX | CZ | | | |
| 185 | D07AC | kortikosteroidy třídy III, účinné (fluorované) | lok. | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 185.1 | D07AC01 | betamethason dipropionát | lok. | 1 | GM | 2,49 | |
| 88489 | KUTERID | crm 20gm | LEK | SLO | | | |
| 88495 | KUTERID | ung 20gm | LEK | SLO | | | |
| 80206 | BELODERM | drm crm1x30gm 0.05% | BLU | CHO | | | |
| 80204 | BELODERM | drm ung1x30gm 0.05% | BLU | CHO | | | |
| 98034 | DIPROSONE | crm 1x30gm | SCH | B | | | |
| 80206 | BELODERM | crm 1x30gm 0.05% | BLU | CHO | | | |
| 80204 | BELODERM | ung 1x30gm 0.05% | BLU | CHO | | | |
| 98032 | DIPROSONE | ung 1x30gm | SCH | B | | | |
| 88489 | KUTERID | drm crm 1x20gm | LEK | SLO | | | |
| 88495 | KUTERID | drm ung 1x20gm | LEK | SLO | | | |
| 185.2 | D07AC01 | betamethason valerát | lok. | 1 | GM | 3,32 | |
| | | | | | | | |
| 185.3 | D07AC02 | fluklorolon | lok. | 1 | GM | 3,32 | |
@@ -3090,7 +3283,7 @@
| 185.4 | D07AC04 | fluocinolon gel | lok. | 1 | GM | 2,44 | |
| | | | | | | | |
| 185.5 | D07AC04 | fluocinolon mast a krém (koncentrace do 0,025% včetně) | lok. | 1 | GM | 2,93 | |
| 92285 | GELARGIN UNG | ung 1x20gm/5mg | LEX | CZ | | | |
| | | | | | | | |
| 185.6 | D07AC04 | fluocinolon mast a krém (koncentrace nad 0,025%) | lok. | 1 | GM | 3,91 | |
| | | | | | | | |
| 185.7 | D07AC04 | fluocinolon lotio (koncentrace do 0,025% včetně) | lok. | 1 | GM | 2,93 | |
@@ -3108,43 +3301,43 @@
| --- | --- | --- | --- | --- | --- | --- | --- |
| 186.1 | D07AC09 | budesonid | lok. | 1 | GM | 3,18 | L/DER |
| | | | | | | | |
| 186.2 | D07AC13 | mometazon do 10g v 1 balení včetně | lok. | 1 | GM | 6,70 | L/DER,ALG, PDD |
| | | | | | | | |
| 186.3 | D07AC13 | mometazon nad 10g v jednom balení | lok. | 1 | GM | 5,00 | L/DER,ALG, PDD |
| | | | | | | | |
| 186.4 | D07AC14 | methylprednisoloni aceponas | lok. | 1 | GM | 5,87 | L/DER,ALG, PDD |
| | | | | | | | |
| 186.5 | D07AC18 | prednikarbat (do 10 g v 1 balení včetně) | lok. | 1 | GM | 6,70 | L/DER,ALG, PDD |
| 83156 | DERMATOP | ung 1x10gm 2.5mg/gm | HBS | SK | | | |
| 83154 | DERMATOP | crm 1x10gm 2.5mg/gm | HBS | SK | | | |
| 186.6 | D07AC18 | prednikarbat (nad 10 g v 1 balení) | lok. | 1 | GM | 5,87 | L/DER,ALG, PDD |
| 186.2 | D07AC13 | mometazon do 10g v 1 balení včetně | lok. | 1 | GM | 6,70 | L/DER,ALG,PDD |
| | | | | | | | |
| 186.3 | D07AC13 | mometazon nad 10g v jednom balení | lok. | 1 | GM | 5,00 | L/DER,ALG,PDD |
| | | | | | | | |
| 186.4 | D07AC14 | methylprednisoloni aceponas | lok. | 1 | GM | 5,87 | L/DER,ALG,PDD |
| | | | | | | | |
| 186.5 | D07AC18 | prednikarbat (do 10 g v 1 balení včetně) | lok. | 1 | GM | 6,70 | L/DER,ALG,PDD |
| 83154 DERMATOP | crm 1x10gm/25mg | HBS | SK | | | | |
| 83156 DERMATOP | ung 1x10gm/25mg | HBS | SK | | | | |
| 186.6 | D07AC18 | prednikarbat (nad 10 g v 1 balení) | lok. | 1 | GM | 5,87 | L/DER,ALG,PDD |
| 187 | D07AD | kortikosteroidy třídy IV, vysoce účinné | lok. | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 187.1 | D07AD01 | klobetasol | lok. | 1 | GM | 4,40 | L/DER |
| | | | | | | | |
| 187.2 | D07AD02 | halcinonid | lok. | 1 | ML | 4,41 | L/DER |
| 97020 | BETACORTON | liq 1x100ml | SEG | CH | | | |
| 97019 | BETACORTON | liq 1x25ml | SEG | CH | | | |
| 97020 | BETACORTON | drm sol 1x100ml | SEG | CH | | | |
| 97019 | BETACORTON | drm sol 1x25ml | SEG | CH | | | |
| 188 | D07BB | kortikosteroidy, středně účinné, kombinace s antiseptiky | lok. | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 188.1 | D07BA01 | prednisolon/cloroxin | lok. | 1 | GM | 1,96 | |
| | | | | | | | |
| 188.2 | D07BB01 | flumetason a antiseptika | lok. | 1 | GM | 3,32 | |
| | | | | | | | |
| 188.3 | D07BB03 | triamcinolon a antiseptika (lékové formy pěny) | lok. | 1 | GM | 1.42 | |
| | | | | | | | |
| 188.4 | D07BB03 | triamcinolon a antiseptika (lékové formy spreje) | lok. | 1 GM | 0,59 | | |
| 188.3 | D07BB03 | triamcinolon a antiseptika (lékové formy pěny) | lok. | 1 | GM | 1,42 | |
| | | | | | | | |
| 188.4 | D07BB03 | triamcinolon a antiseptika (lékové formy spreje) | lok. | 1 | GM | 0,59 | |
| | | | | | | | |
| 188.5 | D07BB03 | triamcinolon a antiseptika (lékové formy tinktury) | lok. | 1 | ML | 1,60 | |
| 02827 | TRIAMCINOLON | tct 1x10ml | GNO | CZ | | | |
| 188.6 | D07BB03 | triamcinolon a antiseptika (lékové formy mastí a krémů) | lok. 1 | GM | 1,87 | | |
| 02827 | TRIAMCINOLON-GALENA | drm gtt sol 1x10ml | IVX | CZ | | | |
| 188.6 | D07BB03 | triamcinolon a antiseptika (lékové formy mastí a krémů) | lok. | 1 | GM | 1,87 | |
| | | | | | | | |
| 188.7 | D07BA01 | prednisolon/hexamidin diisothionát | lok. | 1 | GM | 1,96 | |
| | | | | | | | |
| 188.8 | D07CC01 | betamethason a gentamycin | lok. | 1 | GM | 2,50 | L/DER |
| 189 | D07X | kortikosteroidy, jiné kombinace | lok. | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 189.1 | D07XA01 | hydrokortison | lok. | 1 | ML | 1.96 | |
| 189.1 | D07XA01 | hydrokortison | lok. | 1 | ML | 1,96 | |
| | | | | | | | |
| 189.2 | D07XA02 | prednisolon/kyselina salicylová | lok. | 1 | ML | 1,32 | |
| | | | | | | | |
@@ -3157,8 +3350,8 @@
| 189.6 | D07XC | diflucortolon/isoconasol | lok. | 1 | GM | 2,61 | |
| | | | | | | | |
| 189.7 | D07XC01 | betamethason (lékové formy mastí a krémů) | lok. | 1 | GM | 2,61 | |
| | | | | | | | |
| 189.8 | D07XC01 | betamethason (lékové formy tinktur) | lok. | | ML | 2,61 | |
| 85864 | BELOSALIC | drm ung 1x30gm | BLU | CHO | | | |
| 189.8 | D07XC01 | betamethason (lékové formy tinktur) | lok. | 1 | ML | 2,61 | |
| | | | | | | | |
| 189.9 | D07XD | halcinonid/kyselina salicylová | lok. | 1 | ML | 3,57 | |
| | | | | | | | |
@@ -3172,26 +3365,26 @@
| 190.1 | D08AC02 | chlorhexidin | lok. | 1000 | ML | 178,70 | |
| | | | | | | | |
| 190.2 | D08AD | kyselina boritá (lékové formy mastí) | lok. | 1 | GM | 0,43 | |
| 65998 | UNG.AC.BORICI 3% HERB.-BOFARMA | ung 1x1000gm (dóza) | HEO | CZ | | | |
| 65997 | UNG.AC.BORICI 3% HERB.-BOFARMA | ung 1x500gm (dóza) | HEO | CZ | | | |
| 65998 | UNG.AC.BORICI 3% HERB.-BOFARMA | ung 1x1000gm (dÓza) | HEO | CZ | | | |
| 65997 | UNG.AC.BORICI 3% HERB.-BOFARMA | ung 1x500gm (dÓza) | HEO | CZ | | | |
| 190.3 | D08AD | kyselina boritá (lékové formy roztoků) | lok. | 10 | GM | 1,32 | |
| | | | | | | | |
| 190.4 | D08AG02 | polyvidon-jód (do 200 ml včetně roztoku v jednom balení) | lok. | 1 | ML | 0,98 | |
| 96605 | JODISOL SPRAY S MECH.ROZPRASOV. | spr 1x75gm | LDN | CZ | | | |
| 46054 | BRAUNOL | liq 1x100ml | BMB | CH | | | |
| 02981 | JODISOL ROZTOK | liq 1x80gm | LDN | CZ | | | |
| 190.5 | D08AG02 | polyvidon-jód (nad 200 ml roztoku v jednom balení) | lok. 1 | ML | 0,49 | | |
| 02981 | JODISOL ROZTOK | liq 1x80gm | SDH | CZ | | | |
| 96605 | JODISOL SPRAY S MECH.ROZPRAŠOV. | drm spr sol1x75gm | SDH | CZ | | | |
| 190.5 | D08AG02 | polyvidon-jód (nad 200 ml roztoku v jednom balení) | lok. | 1 | ML | 0,49 | |
| 62317 | BETADINE | liq 1x1000ml | EGI | H | | | |
| 62319 | BETADINE | liq chir 1x1000ml | EGI | H | | | |
| 80553 | BRAUNOL | liq 1x1000ml | BMB | CH | | | |
| 46055 | BRAUNOL | liq 1x250ml | BMB | CH | | | |
| 46056 | BRAUNOL | liq 1x500ml | BMB | CH | | | |
| 62319 | BETADINE (CHIRURG.) | liq 1x1000ml | EGI | H | | | |
| 80553 | BRAUNOL | liq 1x1000ml | BMB | CH | | | |
| 62317 | BETADINE | liq 1x1000ml | EGI | H | | | |
| 02983 | JODISOL ROZTOK | liq 1x760gm | LDN | CZ | | | |
| 02983 | JODISOL ROZTOK | liq 1x760gm | SDH | CZ | | | |
| 190.6 | D08AG02 | polyvidon-jód (do 200 g masti v jednom balení včetně) | lok. | 1 | GM | 1,96 | |
| 84421 | BRAUNOVIDON MAST | ung 100gm (pe tuba) | BMB | CH | | | |
| 84421 | BRAUNOVIDON MAST | ung 1x100gm-tuba | BMB | CH | | | |
| 190.7 | D08AG02 | polyvidon-jód nad 200 g masti v jednom balení) | lok. | 1 | GM | 0,98 | |
| 46052 | BRAUNOVIDON MAST | ung 250gm (pe nad.) | BMB | CH | | | |
| 84422 | BRAUNOVIDON MAST | ung 250gm (pe tuba) | BMB | CH | | | |
| 46052 | BRAUNOVIDON MAST | ung 1x250gm-kelímek | BMB | CH | | | |
| 84422 | BRAUNOVIDON MAST | ung 1x250gm-pe tuba | BMB | CH | | | |
| 190.8 | D08AH | kloroxin | lok. | 1 | GM | 0,78 | |
| | | | | | | | |
| 190.9 | D08AJ | bromid benzododecinia (tinktura a roztok do 50 ml v jednom balení včetně) | lok. | 1 | ML | 0,29 | |
@@ -3211,39 +3404,40 @@
| 192 | D10A | lokálně podávaná léčiva k léčbě akne | lok. | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 192.1 | D10AD01 | tretinoin (lékové formy krémů a gelů do koncentrace 0,05% včetně) | lok. | 1 | GM | 3,75 | |
| 97573 | RETIN-A KREM 0.025% | crm 1x30gm | CIL | CH | | | |
| 66170 | LOCACID | crm 1x30gm 0.05% | PFH | F | | | |
| 192.2 | D10AD01 | tretinoin (lékové formy krémů a gelů koncentrace nad 0,05%) | lok. | 1 | GM | 4,40 | |
| | | | | | | | |
| 97573 | RETIN-A KRÉM 0.025% | drm crm 1x30gm | CIL | CH | | | |
| 192.3 | D10AD01 | tretinoin (lékové formy roztoků do koncentrace 0,05% včetně) | lok. | 1 | ML | 4,00 | |
| 64956 | AIROL | lot 1x50ml 0.05% | PRH | F | | | |
| 192.4 | D10AD01 | tretinoin (lékové formy roztoků koncentrace nad 0,05%) | lok. | 1 | ML | 4,40 | |
| | | | | | | | |
| 192.5 | D10AD03 | adapalen - léková forma krémů a gelů | lok. | 1 | GM | 4,00 | |
| | | | | | | | |
| 192.6 | D10AE01 | benzoyl peroxid (lékové formy krémů a gelů) | lok. | 1 | GM | 1,42 | |
| 47279 | ECLARAN 5 | gel 1x45gm | PFG | F | | | |
| 192.7 | D10AE01 | benzoyl peroxid (lékové formy roztoků a lotií) | lok. | 1 | ML | 0,39 | |
| | | | | | | | |
| 192.8 | D10AE01 | benzoyl peroxid (koncentrace 20%) | lok. | 1 | ML | 2,54 | |
| | | | | | | | |
| 192.9 | D10AF01 | klindamycin | lok. | 1 | ML | 1,96 | |
| | | | | | | | |
| 192.10 | D10AF02 | erythromycin (lékové formy krémů a masti) | lok. | 1 | GM | 2,93 | |
| | | | | | | | |
| 192.11 | D10AF02 | erythromycin (lékové formy roztoků) do 60 ml včetně v jednom balení | lok. | 1 | ML | 2,13 | |
| 98204 | ERYFLUID | sol 1x30ml | PFB | F | | | |
| 192.12 | D10AF02 | erythromycin (lékové formy roztoků) nad 60 ml v jednom balení | lok. | 1 | ML | 1,72 | |
| 75285 | ERYFLUID | sol 1x100ml | PFB | F | | | |
| 192.13 | D10AF52 | erythromycin v kombinaci | lok. | 1 | ML | 2,93 | |
| | | | | | | | |
| 192.14 | D10AX03 | kyselina azelaová | lok. | 1 | GM | 1,96 | |
| 192.6 | D10AD54 | isotretinoin a erythromycin v kombinaci | lok. | 1 | GM | 2,93 | |
| | | | | | | | |
| 192.7 | D10AE01 | benzoyl peroxid (lékové formy krémů a gelů) | lok. | 1 | GM | 1,42 | |
| 47279 | ECLARAN 5 | drm gel 1x45gm | PFG | F | | | |
| 192.8 | D10AE01 | benzoyl peroxid (lékové formy roztoků a lotií) | lok. | 1 | ML | 0,39 | |
| | | | | | | | |
| 192.9 | D10AE01 | benzoyl peroxid (koncentrace 20%) | lok. | 1 | ML | 2,54 | |
| | | | | | | | |
| 192.10 | D10AF01 | klindamycin | lok. | 1 | ML | 1,96 | |
| | | | | | | | |
| 192.11 | D10AF02 | erythromycin (lékové formy krémů a mastí) | lok. | 1 | GM | 2,93 | |
| | | | | | | | |
| 192.12 | D10AF02 | erythromycin (lékové formy roztoků) do 60 ml včetně v jednom balení | lok. | 1 | ML | 2,13 | |
| 98204 | ERYFLUID | sol 1x30ml | PFH | F | | | |
| 192.13 | D10AF02 | erythromycin (lékové formy roztoků) nad 60 ml v jednom balení | lok. | 1 | ML | 1,72 | |
| 75285 | ERYFLUID | sol 1x100ml | PFH | F | | | |
| 192.14 | D10AF52 | erythromycin v kombinaci | lok. | 1 | ML | 2,93 | |
| | | | | | | | |
| 192.15 | D10AX03 | kyselina azelaová | lok. | 1 | GM | 1,96 | |
| 193 | D10B | celkově podávaná léčiva k léčbě akné | p.o. | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 193.1 | D10BA01 | isotretinoin (do 10 MG včetně v jedné kapsli ) | p.o. | 30 | MG | 83,53 | X |
| 11685 | ROACCUTANE ROCHE | cps 30x10mg | HLR | CH | | | |
| 11685 | ROACCUTANE 10MG | cps 30x10mg | HLR | CH | | | |
| 193.2 | D10BA01 | isotretinoin (nad 10 MG v jedné kapsli) | p.o. | 30 | MG | 75,39 | X |
| 91843 | ROACCUTANE ROCHE | cps 30x20mg | HLR | CH | | | |
| 91843 | ROACCUTANE 20MG | cps 30x20mg | HLR | CH | | | |
| 194 | D11AX | jiná dermatologika | lok. | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 194.1 | D11AX | celulóza (lékové formy zásypů) | lok. | 1 | GM | 9,78 | L/DER |
@@ -3252,9 +3446,22 @@
Léčbu pimecrolimem indikuje dermatovenerolog u dětí ve věku od 3. měsíců do 6.ti let na akutní a subakutní projevy atopické dermatitidy bez mokvání a superinfekce v obličeji a krku, které při použití emoliencií trvají alespoň 14 dnů. Maximální délka kontinuálního podávání je 6 měsíců.
| 194.3 | D11AF | fluorouracil (lékové formy roztoků) | lok. | 1 | ML | 16,51 | L/DER |
| 194.3 | D11AX14 | tacrolimus v koncentraci 0,03% | lok. | 1 | GM | 32,00 | P |
| --- | --- | --- | --- | --- | --- | --- | --- |
| | | | | | | | |
| 194.4 | D11AX14 | tacrolimus v koncentraci 0,1% | lok. | 1 | GM | 35,00 | P |
Léčbu atopické dermatitidy tacrolimem ordinuje dermatolog u pacientů, u kterých selhala léčba emolienciemi, kteří netolerují konvenční léčbu nebo na ni nereagují, v následujících indikacích:
- a) u dětí ve věku 2-6 let, které trpí středně těžkou či těžkou atopickou dermatitidou na hlavě a krku (klasifikace dle Rajky a Langelanda: středně těžká forma = 4,5-7,5 bodů, těžká forma = 8-9 bodů);
- b) u dětí nad 6 let věku a u dospělých, kteří trpí těžkou formou atopické dermatitidy na hlavě a krku (8-9 bodů výše uvedené klasifikace).
| 194.5 | D11AF | fluorouracil (lékové formy roztoků) | lok. | 1 | ML | 16,51 | L/DER |
| 60890 | VERRUMAL | liq 1x13ml | HEM | D | | | |
| 194.4 | D11AF | fluorouracil (lékové formy mastí) | lok. | 1 | GM | 13,15 | L/DER,ONK |
| 194.6 | D11AF | fluorouracil (lékové formy mastí) | lok. | 1 | GM | 13,15 | L/DER,ONK |
| | | | | | | | |
| 194.7 | D06BB04 | podophylotoxin | lok. | 1 | GM | 15,00 | L/DER |
| 195 | G01AA | vaginálně podávaná antimykotika a antibiotika | vag. | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
@@ -3279,21 +3486,21 @@
| 195.7 | G01AA51 | nystatin kombinace s nifuratelem (lékové formy vag. krémů) | vag. | 5 | GM | 33,95 | |
| 196 | G01AF | vaginálně podávané imidazolové deriváty | vag. | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 196.1 | G01AF20 | kombinace imidazolových derivátů - mikonazol a metronidazol ( lékové formy vag. tablet) | vag. | 1 | DF | 6,35 | |
| 196.1 | G01AF20 | kombinace imidazolových derivátů - mikonazol a metronidazol (lékové formy vag. tablet) | vag. | 1 | DF | 6,35 | |
| | | | | | | | |
| 196.2 | G01AF01 | metronidazol | vag. | 0.5 | GM | 3,35 | |
| 02430 | ENTIZOL | tbl vag 10x500mg | POL | PL | | | |
| 02430 | ENTIZOL | tbl vag 10x500mg | ZPF | PL | | | |
| 196.3 | G01AF02 | klotrimazol (lékové formy vaginálních tablet) | vag. | 0.1 | GM | 8,25 | |
| 62862 | CANDIBENE 100MG | tbl vag 6x100mg | MCK | D | | | |
| 62863 | CANDIBENE 200MG | tbl vag 3x200mg | MCK | D | | | |
| 62862 | CANDIBENE 100 MG | tbl vag 6x100mg | MCK | D | | | |
| 62863 | CANDIBENE 200 MG | tbl vag 3x200mg | MCK | D | | | |
| 196.4 | G01AF02 | klotrimazol (lékové formy vaginálních krémů) | vag. | 0.1 | GM | 12,78 | |
| 68917 | JENAMAZOL 2% | crm vag 20gm+aplik. | VJP | D | | | |
| 196.5 | G01AF04 | mikonazol | vag. | 0.1 | GM | 8,70 | |
| | | | | | | | |
| 196.6 | G01AF05 | ekonazol (lékové formy vaginálních krémů) | vag. | 0.1 | GM | 12.78 | |
| | | | | | | | |
| 196.7 | G01AF05 | ekonazol (lékové formy vaginálních tablet, globuli a čípků) | vag. | 0.1 | GM | 30,99 | |
| 06095 | GYNO-PEVARYL 50 | glo vag 15x50mg | CIL | CH | | | |
| 196.6 | G01AF05 | ekonazol (lékové formy vaginálních krémů) | vag. | 0.1 | GM | 12,78 | |
| | | | | | | | |
| 196.7 | G01AF05 | ekonazol (lékové formy vaginálních tablet, globulí a čípků) | vag. | 0.1 | GM | 30,99 | |
| 06095 | GYNO-PEVARYL 50 | sup vag 15x50mg | CIL | CH | | | |
| 196.8 | G01AF11 | ketoconazol | vag. | 0.4 | GM | 13,44 | |
| | | | | | | | |
| 196.9 | G01AF12 | fenticonazol | vag. | 0.1 | GM | 13,44 | |
@@ -3311,13 +3518,14 @@
| | | | | | | | |
| 197.3 | G01AX | nifuratel/nystatin (lékové formy vaginálních krémů) | vag. | 5 | GM | 35,19 | |
| | | | | | | | |
| 197.4 | G01AX | nitrofurantoin | vag. | 0.2 | GM | 2.97 | |
| 03629 | FURANTOIN LECIVA | tbl vag 30x100mg | LEX | CZ | | | |
| 197.5 | G01AX | sulfathiazol | vag. | 1 | DF | 6.60 | |
| 197.4 | G01AX | nitrofurantoin | vag. | 0.2 | GM | 2,97 | |
| 03629 | FURANTOIN LÉČIVA | tbl vag 30x100mg | LEX | CZ | | | |
| 197.5 | G01AX | sulfathiazol | vag. | 1 | DF | 6,60 | |
| | | | | | | | |
| 197.6 | G01AX | jiná antiinfektiva a antiseptika (tetraboritan sodný) | vag. | 1 | DF | 6,40 | |
| | | | | | | | |
| 197.7 | G01AX03 | polykresulen | vag. | 90 | MG | 0,35 | |
| | | | | | | | |
| 197.8 | G01AX05 | nifuratel | p.o. | 0.6 | GM | 12,50 | |
| | | | | | | | |
| 197.9 | G01AX11 | polyvidon-jód (vaginální čípky) | vag. | 0.2 | GM | 8,94 | |
@@ -3332,9 +3540,9 @@
| | | | | | | | |
| 197.14 | G01AX12 | ciclopirox (vaginální čípky) | vag. | 1 | DF | 31,28 | |
| | | | | | | | |
| 197.15 | G01AX14 | laktobacilus a estriol - vaginální tablety | vag. | 1 | DF | 16,13 | |
| | | | | | | | |
| 197.16 | G02CC03 | benzydamin hydrochlorid | vag. | 1 | DF | 8,00 | |
| 197.15 | G01AX14 | laktobacilus a estriol – vaginální tablety | vag. | 1 | DF | 16,13 | |
| | | | | | | | |
| 197.16 | G02CC3 | benzydamin hydrochlorid | vag. | 1 | DF | 8,00 | |
| 198 | G02AB | uterotonika ze skupiny námelových alkaloidů | p.o. | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 198.1 | G02AB02 | ergotové alkaloidy | p.o. | 0.2 | MG | 1,12 | |
@@ -3348,7 +3556,7 @@
| 200 | G02AD | uterotonika ze skupiny prostaglandinů | p.o. | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 200.1 | G02AD02 | dinoproston | p.o. | 0.5 | MG | 84,02 | H |
| 57150 | PROSTIN E2 | tbl 10x0.5mg | PAU | B | | | |
| 57150 | PROSTIN E 2 | tbl 10x0.5mg | PPU | B | | | |
| 201 | G02AD | uterotonika ze skupiny prostaglandinů | vag. | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
@@ -3367,7 +3575,7 @@
| 201.2 | G02AD02 | dinoproston (nad 0,5 do 2 mg v jedné dávce včetně) | vag. | 1 | DF | 1111,90 | K/P |
| | | | | | | | |
| 201.3 | G02AD02 | dinoproston (nad 2 mg v jedné dávce) | vag. | 1 | DF | 386,78 | K/P |
| 02289 | PROSTIN E2 | tbl vag 4x3mg | PAU | B | | | |
| 02289 | PROSTIN E2 | tbl vag 4x3mg | PPU | B | | | |
| 201.4 | G02AD02 | dinoproston (pesar) | vag. | 1 | DF | 2200,00 | K/P |
| 202 | G02AD | uterotonika ze skupiny prostaglandinů | parent. | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
@@ -3397,7 +3605,7 @@
pouze jako pokračování parenterální aplikace tokolytik.
| 203.1 | G02CA | hexoprenalin | p.o. | 1.5 | MG | 10,14 | P |
| 75173 | GYNIPRAL 0.5MG | tbl 20x0.5mg | HNP | A | | | |
| 75173 | GYNIPRAL 0.5 MG | por tbl nob20x0.5mg | NYC | A | | | |
| 203.2 | G02CA01 | ritodrin | p.o. | 40 | MG | 23,14 | P |
| | | | | | | | |
| 203.3 | G02CA03 | fenoterol | p.o. | 20 | MG | 23,14 | P |
@@ -3413,40 +3621,44 @@
- c) intrapartální akutní tokolýza.
| 204.1 | G02CA | hexoprenalin | parent. | 25 | RG | 45,36 | U/P |
| 75464 | GYNIPRAL 25RG KONCENTR.ZUR INF. | inf 5x5ml/25rg | HNP | A | | | |
| 75463 | GYNIPRAL 10RG/2ML | inj 5x2ml/10rg | HNP | A | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 75463 | GYNIPRAL 10 MCG/2ML | inj sol 5x2ml/10rg | NYC | A | | | |
| 46293 | GYNIPRAL 25MCG KONC.PRO PŘ.INF. | inf cnc sol 5x5ml | NYC | A | | | |
| 75464 | GYNIPRAL 25MCG KONCEN.ZUR INF. | inf 5x5ml/25rg | HNP | A | | | |
| 204.2 | G02CA01 | ritodrin | parent. | 40 | MG | 45,36 | U/P |
| | | | | | | | |
| 204.3 | G02CA03 | fenoterol | parent. | 0.5 | MG | 45,36 | U/P |
| 58242 | PARTUSISTEN | inf 25x10ml/0.5mg | BOE | E | | | |
| 03399 | PARTUSISTEN | inf 25x10ml/0.5mg | BGP | D | | | |
| 204.4 | G02CX01 | atosiban infuse | parent. | 1 | DF | 3500,00 | H |
| | | | | | | | |
| 204.5 | G02CX01 | atosiban injekce | parent. | 1 | DF | 1300,00 | H |
| | | | | | | | |
| 204.4 | G02CX01 | atosiban infuse | parent. | 1 | DF | 3500,00 | U/P |
| | | | | | | | |
| 204.5 | G02CX01 | atosiban injekce | parent. | 1 | DF | 1150,00 | U/P |
Atosiban se používá při předčasné děložní činnosti u těhotných od 24. týdne gestace do ukončeného 33. týdne těhotenství při následujících patologiích: diabetes mellitus matky, kardiopatie matky, těhotné s primární hypotenzí a tendencí ke kolapsovým stavům, těhotné s thyreopatií, těhotné se srdeční arytmií, těhotné u nichž byla indikována parenterální tokolýza v kontinuálním podání delším než 48 hodin.
| 205 | G02CB | inhibitory prolaktinu | p.o. | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 205.1 | G02CB | tergurid | p.o. | 1 | MG | 5,46 | |
| 91979 | MYSALFON | tbl obd 30x0.5mg | LEX | CZ | | | |
| 205.2 | G02CB01 | bromokriptin | p.o. | 5 | MG | 12,03 | |
| 67512 | MEDOCRIPTINE | tbl 30x2.5mg | MOE | CY | | | |
| 67514 | MEDOCRIPTINE | tbl 500x2.5mg | MOE | CY | | | |
| 67514 | MEDOCRIPTINE | tbl 500x2.5mg-l | MOE | CY | | | |
| 205.3 | G02CB02 | lisurid | p.o. | 0.6 | MG | 2,49 | |
| | | | | | | | |
| 205.4 | G02CB03 | kabergolin | p.o. | 70 | RG | 24,77 | P |
Nesnášenlivost a nedostatečná účinnost jiných léků ze skupiny dopaminergních agonistů (terguridu a přípravků bromokriptinu) u nemocných s hyperprolaktinémií a prolaktin secernujícími adenomy a u nemocných s akromegalií, která je citlivá na tuto léčbu.
| 66746 | DOSTINEX 0.5MG | tbl 8x0.5mg | PHA | I | | | |
| 66746 | DOSTINEX 0.5MG | tbl 8x0.5mg | PAU | I | | | |
| 205.5 | G02CB04 | quinagolid | p.o. | 75 | RG | 24,77 | Z |
| 206 | G03B | androgeny | p.o. | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 206.1 | G03BA0 | testosteron | p.o. | 0.12 | GM | 27,37 | L/END,ONK, GYN,SEX,URN |
| | | | | | | | |
| 206.2 | G03BB01 | mesterolon | p.o. | 50 | MG | 20,04 | L/END,ONK, GYN, SEX,URN |
| 09591 | PROVIRON 25 | tbl 20x25mg | SAG | D | | | |
| 09592 | PROVIRON 25 | tbl 50x25mg | SAG | D | | | |
| 206.1 | G03BA03 | testosteron | p.o. | 0.12 | GM | 27,37 | L/END,ONK,GYN, SEX,URN |
| 206.2 | G03BB01 | mesterolon | p.o. | 50 | MG | 20,04 | L/END,ONK,GYN, SEX,URN |
| 09591 | PROVIRON-25 | por tbl nob 20x25mg | SAG | D | | | |
| 09592 | PROVIRON-25 | por tbl nob 50x25mg | SAG | D | | | |
| 207 | G03B | androgeny | parent. | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 207.1 | G03BA03 | testosteron | parent. | 18 | MG | 8.11 | L/END,ONK, GYN, SEX,URN |
| 207.1 | G03BA03 | testosteron | parent. | 18 | MG | 8,11 | L/END,ONK,GYN, SEX,URN |
| 00373 | AGOVIRIN-DEPOT | inj 5x2ml/50mg | BTA | SK | | | |
| 208 | G03CA | přirozené a semisyntetické estrogeny | p.o. | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
@@ -3463,7 +3675,7 @@
Estriol a promestrien k vaginalní aplikaci indikuje gynekolog, urolog a dermatovenerolog k léčbě lokálních změn u postmenopausálního vegetativního a estrogen-deficitního syndromu.
| 208.1 | G03CA | přirozené a semisyntetické estrogeny prosté, mestranol | p.o. | 0.15 | MG | 3,76 | P |
| 208.1 | G03CA | přírozené a semisyntetické estrogeny prosté, mestranol | p.o. | 0.15 | MG | 3,76 | P |
| | | | | | | | |
| 208.2 | G03CA03 | estradiol (do 1 mg v jedné tabletě včetně) | p.o. | 2 | MG | 8,55 | P |
| | | | | | | | |
@@ -3472,14 +3684,15 @@
| 208.4 | G03CA03 | estradiol (nad 2 mg v jedné tabletě) | p.o. | 2 | MG | 4,18 | P |
| | | | | | | | |
| 208.5 | G03CA03 | estradiol (s uvolněním méně než 50 RG/den, v rámci 28. denního cyklu) | transd. | 1 | DF | 4,18 | P |
| 47045 | ESTRAHEXAL 25 | tts emp 6x2mg | HEX | D | | | |
| 208.6 | G03CA03 | estradiol (s uvolněním od 50 do 99 rg včetně/den, v rámci 28. denního cyklu) | transd. | 1 | DF | 5,70 | P |
| | | | | | | | |
| 208.7 | G03CA03 | estradiol (s uvolněním 100 a více rg/den, v rámci 28. denního cyklu) | transd. | 1 | DF | 8,55 | P |
| 47045 | ESTRAHEXAL 25 | drm emp tdr 6x2mg | HEX | D | | | |
| 208.6 | G03CA03 | estradiol (s uvolněním od 50 do 99 rg včetně /den, v rámci 28. denního cyklu) | transd. | 1 | DF | 5,70 | P |
| | | | | | | | |
| 208.7 | G03CA03 | estradiol (s uvolněním 100 a více rg /den, v rámci 28. denního cyklu) | transd. | 1 | DF | 8,55 | P |
| | | | | | | | |
| 208.8 | G03CA03 | estradiol (lékové formy gelů) | transd. | 1,5 | MG | 5,57 | P |
| 76922 | OESTROGEL | gel 1x80gm | LBE | F | | | |
| 53753 | ESTREVA | gel 1x50gm/0.05gm | THL | MC | | | |
| 76922 | OESTROGEL | gel 1x80gm | LSB | F | | | |
| 76927 | OESTROGEL DISPENSOR | gel 1x80gm | LSB | F | | | |
| 208.9 | G03CA03 | estradiol | vag. | 25 | RG | 9,79 | P |
| | | | | | | | |
| 208.10 | G03CA03 | estradiol (lékové formy vaginálních krémů) | vag. | 0.2 | MG | 3,08 | P |
@@ -3493,7 +3706,7 @@
| 208.14 | G03CA04 | estriol (lékové formy vaginálních tablet, do 0,5 mg včetně) | vag. | 0.2 | MG | 2,67 | P |
| | | | | | | | |
| 208.15 | G03CA04 | estriol (lékové formy vaginálních tablet, nad 0,5 mg) | vag. | 0.2 | MG | 1,16 | P |
| 97590 | ORTHO-GYNEST D | sup vag 6 | CIL | CH | | | |
| 97590 | ORTHO-GYNEST D | sup vag dep.6x3.5mg | CIL | CH | | | |
| 208.16 | G03CA09 | promestrien (lékové formy vaginálních krémů) | vag. | 10 | MG | 4,70 | P |
| | | | | | | | |
| 208.17 | G03CA09 | promestrien (lékové formy vaginálních tobolek) | vag. | 10 | MG | 5,00 | P |
@@ -3502,48 +3715,47 @@
| 83387 | OESTROFEMINAL 0.6 | cps 21x0.6mg | MAC | D | | | |
| 208.19 | G03CA57 | přírodní konj. estrogeny (nad 625 rg v jedné tabletě nebo tobolce) | p.o. | 625 | RG | 4,12 | P |
| 09467 | OESTROFEMINAL 1.25 | cps 21x1.25mg | MAC | D | | | |
| 208.20 | G03CC | promestrien a chlorquinaldol v kombinaci | vag. | 1 | DF | 5,50 | |
| 208.20 | G03CC | promestrien a chlorquinaldol v kombinací | vag. | 1 | DF | 5,50 | |
| 209 | G03CA | přirozené a semisyntetické estrogeny | parent. | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 209.1 | G03CA03 | estradiol | parent. | 1 | MG | 4,35 | |
| 00364 | AGOFOLLIN | inj sol 5x1ml/5mg | BTA | SK | | | |
| 00365 | AGOFOLLIN-DEPOT | inj 1x2ml/10mg | BTA | SK | | | |
| 00364 | AGOFOLLIN | inj 5x1ml/5mg | BTA | SK | | | |
| 209.2 | G03CA03 | estradiol valerat | parent. | 1 | MG | 2,57 | |
| 00529 | NEOFOLLIN | inj 5x1ml/5mg | BTA | SK | | | |
| 00529 | NEOFOLLIN | inj sol 5x1ml/5mg | BTA | SK | | | |
| 209.3 | G03CA03 | estradiol implantát | parent. | 1 | DF | 1095,00 | |
| | | | | | | | |
| 209.4 | G03CA04 | estriol | parent. | 2 | MG | 4,30 | |
| 210 | G03D | progestiny | p.o. | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 210.1 | G03DA02 | medroxyprogesteron | p.o. | 5 | MG | 3,52 | L/GYN,URN, END, INT,SEX,GER |
| 91231 | PROVERA | tbl 24x5mg | UPJ | B | | | |
| 210.2 | G03DA04 | progesteron | p.o. | 0.3 | GM | 15,60 | L/GYN,URN, END, INT,SEX,GER |
| | | | | | | | |
| 210.3 | G03DB01 | dydrogesteron | p.o. | 10 | MG | 5,20 | L/GYN,URN, END, INT,SEX,GER |
| | | | | | | | |
| 210.4 | G03DB04 | nomegestrol | p.o. | 5 | MG | 5,20 | L/GYN,URN, END, INT,SEX,GER |
| | | | | | | | |
| 210.5 | G03DC02 | norethisteron | p.o. | 5 | MG | 2,81 | L/GYN,URN, END, INT,SEX,GER |
| 210.1 | G03DA02 | medroxyprogesteron | p.o. | 5 | MG | 3,52 | L/GYN,URN,END, INT,SEX,GER |
| 91231 | PROVERA 5 MG | por tbl nob 24x5mg | PPU | B | | | |
| 210.2 | G03DA04 | progesteron | p.o. | 0.3 | GM | 15,60 | L/GYN,URN,END, INT,SEX,GER |
| | | | | | | | |
| 210.3 | G03DB01 | dydrogesteron | p.o. | 10 | MG | 5,20 | L/GYN,URN,END, INT,SEX,GER |
| | | | | | | | |
| 210.4 | G03DB04 | nomegestrol | p.o. | 5 | MG | 5,20 | L/GYN,URN,END, INT,SEX,GER |
| | | | | | | | |
| 210.5 | G03DC02 | norethisteron | p.o. | 5 | MG | 2,81 | L/GYN,URN,END, INT,SEX,GER |
| 01939 | NORETHISTERON SLOVAKOFARMA | tbl 30x5mg | SLO | SK | | | |
| 210.6 | G03DC03 | lynestrenol | p.o. | 5 | MG | 2,81 | L/GYN,URN, END, INT,SEX,GER |
| | | | | | | | |
| 210.7 | G03DC05 | tibolon | p.o. | 2.5 | MG | 18.00 | P |
Léčbu tibolonem ordinuje gynekolog k léčbě estrogen deficitního syndromu tam, kde jsou jiné hormonální přípravky kontraindikován nebo kde jiné hormonální přípravky pacientka objektivně nesnáší.
| 210.6 | G03DC03 | lynestrenol | p.o. | 5 | MG | 2,81 | L/GYN,URN,END, INT,SEX,GER |
| | | | | | | | |
| 210.7 | G03DC05 | tibolon | p.o. | 2.5 | MG | 18,00 | P |
Léčbu tibolonem ordinuje gynekolog k léčbě estrogen deficitního syndromu tam, kde jsou jiné hormonální přípravky kontraindikovány nebo kde jiné hormonální přípravky pacientka objektivně nesnáší.
| 211 | G03D | progestiny | parent. | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 211.1 | G03DA03 | hydroxyprogesteron | parent. | 10 | MG | 1,76 | L/GYN,URN, SEX |
| 00531 | NEOLUTIN FORTE | inj 5x1ml/125mg | SPX | CZ | | | |
| 211.2 | G03DA04 | progesteron (depotní lékové formy) | parent. | 5 | MG | 3,85 | L/GYN,URN, SEX |
| 00367 | AGOLUTIN-DEPOT | inj 1x2ml/50mg | BTA | \ SK | | | |
| 211.3 | G03DA04 | progesteron | parent. | 5 | MG | 1,00 | L/GYN,URN, SEX |
| 02094 | AGOLUTIN | inj 5x2ml/60mg | BTA | SK | | | |
| 211.1 | G03DA03 | hydroxyprogesteron | parent. | 10 | MG | 1,76 | L/GYN,URN,SEX |
| 00531 | NEOLUTIN FORTE INJ. | inj 5x1ml/125mg | SPX | CZ | | | |
| 211.2 | G03DA04 | progesteron (depotní lékové formy) | parent. | 5 | MG | 3,85 | L/GYN,URN,SEX |
| 00367 | AGOLUTIN-DEPOT | inj 1x2ml/50mg | BTA | SK | | | |
| 211.3 | G03DA04 | progesteron | parent. | 5 | MG | 1,00 | L/GYN,URN,SEX |
| 212 | G03E | androgeny a ženské pohlavní hormony | parent. | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 212.1 | G03EA02 | testosteron a estrogen | parent. | 1 | DF | 21,62 | L/GYN,END, SEX |
| 212.1 | G03EA02 | testosteron a estrogen | parent. | 1 | DF | 21,62 | L/GYN,END,SEX |
| 00464 | FOLIVIRIN | inj 5x2ml | BTA | SK | | | |
| 212.2 | G03EA03 | prasteron enantat/estradiol valerat | parent. | 1 | DF | 73.32 | L/GYN,END, SEX |
| 212.2 | G03EA03 | prasteron enantat/estradiol valerat | parent. | 1 | DF | 73,32 | L/GYN,END,SEX |
| 213 | G03F | progestiny a estrogeny | p.o. | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
@@ -3557,34 +3769,38 @@
| | | | | | | | |
| 213.3 | G03FA01 | norethisteron a estrogen, fixní kombinace | transd. | 1 | DF | 6,43 | P |
| | | | | | | | |
| 213.4 | G03FA12 | medroxyprogesteron a estrogen, fixní kombinace | p.o. | 1 | DF | 6,43 | P |
| | | | | | | | |
| 213.5 | G03FA14 | dydrogesteron a estradiol, fixní kombinace | p.o. | 1 | DF | 6,43 | P |
| | | | | | | | |
| 213.6 | G03FA15 | dienogest a estradiol, fixní kombinace | p.o. | 1 | DF | 6,43 | P |
| | | | | | | | |
| 213.7 | G03FB | gestageny a estrogeny, sekvenční přípravky | p.o. | 0.75 | DF | 4,82 | P |
| | | | | | | | |
| 213.8 | G03FB05 | norethisteron a estrogen, sekvenční přípravky | p.o. | 1 | DF | 6,43 | P |
| | | | | | | | |
| 213.9 | G03FB05 | norethisteron a estrogen, sekvenční přípravky | transd. | 1 | DF | 6,43 | P |
| | | | | | | | |
| 213.10 | G03FB06 | medroxyprogesteron a estrogen, sekvenční přípravky | p.o. | 0.75 | DF | 4,82 | P |
| 54310 | DIVINA | tbl 3x21 (=63) | ORN | DK | | | |
| 213.11 | G03FB08 | dydrogesteron a estrogen, sekvenční kombinace | p.o. | 0.75 | DF | 4,82 | P |
| | | | | | | | |
| 213.12 | G03FB09 | levonorgestrel a estrogen, sekvenční přípravky | transd. | 1 | DF | 6,43 | P |
| | | | | | | | |
| 213.13 | G03FB09 | levonorgestrel a estrogen, sekvenční kombinace | p.o. | 0,75 | DF | 4,82 | P |
| | | | | | | | |
| 213.14 | G03HB01 | cyproteron/estradiol | p.o. | 0.75 | DF | 4,82 | P |
| 213.4 | G03FA12 | medroxyprogesteron a estrogen, fixní kombinace s obsahem nad 1 mg estrogenu | p.o. | 1 | DF | 6,43 | P |
| | | | | | | | |
| 213.5 | G03FA12 | medroxyprogesteron a estrogen, fixní kombinace s obsahem do1 mg estrogenu včetně | p.o. | 1 | DF | 5,17 | P |
| | | | | | | | |
| 213.6 | G03FA14 | dydrogesteron a estradiol, fixní kombinace | p.o. | 1 | DF | 6,43 | P |
| | | | | | | | |
| 213.7 | G03FA15 | dienogest a estradiol, fixní kombinace | p.o. | 1 | DF | 6,43 | P |
| | | | | | | | |
| 213.8 | G03FB | gestageny a estrogeny, sekvenční přípravky | p.o. | 0.75 | DF | 4,82 | P |
| | | | | | | | |
| 213.9 | G03FB05 | norethisteron a estrogen, sekvenční přípravky | p.o. | 1 | DF | 6,43 | P |
| | | | | | | | |
| 213.10 | G03FB05 | norethisteron a estrogen, sekvenční přípravky | transd. | 1 | DF | 6,43 | P |
| | | | | | | | |
| 213.11 | G03FB06 | medroxyprogesteron a estrogen, sekvenční přípravky | p.o. | 0.75 | DF | 4,82 | P |
| 54310 | DIVINA | tbl 3x21(=63) | ORN | DK | | | |
| 213.12 | G03FB08 | dydrogesteron a estrogen, sekvenční kombinace | p.o. | 0.75 | DF | 4,82 | P |
| | | | | | | | |
| 213.13 | G03FB09 | levonorgestrel a estrogen, sekvenční přípravky | transd. | 1 | DF | 6,43 | P |
| | | | | | | | |
| 213.14 | G03FB09 | levonorgestrel a estrogen, sekvenční kombinace | p.o. | 0,75 | DF | 4,82 | P |
| | | | | | | | |
| 213.15 | G03HB01 | cyproteron/estradiol | p.o. | 0.75 | DF | 4,82 | P |
| 214 | G03GA | gonadotrofin (choriový) | parent. | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 214.1 | G03GA01 | choriový gonadotrofin (do 500 U v 1 ampuli včetně) | parent. | 250 | U | 24,59 | L/GYN,END, PDD, SEX |
| | | | | | | | |
| 214.2 | G03GA01 | choriový gonadotrofin (nad 500 U do 1500 U v 1 ampuli včetně) | parent. | 250 | U | 14,98 | L/GYN,END, PDD, SEX |
| | | | | | | | |
| 214.3 | G03GA01 | choriový gonadotrofin (nad 1500 U v 1 ampuli) | parent. | 250 | U | 10,71 | L/GYN,END, PDD, SEX |
| 214.1 | G03GA01 | choriový gonadotrofin (do 500 U v 1 ampuli včetně) | parent. | 250 | U | 24,59 | L/GYN,END,PDD, SEX |
| | | | | | | | |
| 214.2 | G03GA01 | choriový gonadotrofin (nad 500 U do 1500 U v 1 ampuli včetně) | parent. | 250 | U | 14,98 | L/GYN,END,PDD, SEX |
| | | | | | | | |
| 214.3 | G03GA01 | choriový gonadotrofin (nad 1500 U v 1 ampuli) | parent. | 250 | U | 10,71 | L/GYN,END,PDD, SEX |
| | | | | | | | |
| 214.4 | G03GA01 | rekombinantní choriový gonadotrofin (nad 1500 U v 1 ampuli) | parent. | 250 | U | 19,60 | L/GYN,END,PDD, SEX |
| 215 | G03GA | gonadotrofin (lidský) | parent. | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 215.1 | G03GA02 | gonadotrofin lidský | parent. | 75 | U | 329,64 | Z |
@@ -3593,49 +3809,44 @@
| 43727 | MERIONAL 75 M.J. | inj sic 1x75ut+solv | IBS | CH | | | |
| 215.2 | G03GA04 | urofollitrofin | parent. | 75 | U | 381,82 | Z |
| 43724 | FOSTIMON 75 M.J | inj sic 10x75ut+sol | IBS | CH | | | |
| 43723 | FOSTIMON 75 M.J. | inj sic 1x75ut+solv | IBS | CH | | | |
| 43723 | FOSTIMON 75 M.J. | inj sic 1x75ut+solv | IBS | | | | |
| 215.3 | G03GA04 | urofollitrofin vysoce čištěný | parent. | 75 | U | 488,79 | Z |
| | | | | | | | |
| 215.4 | G03GA05 | folitrofin alfa | parent. | 75 | U | 733,19 | Z |
| | | | | | | | |
| 215.5 | G03GA06 | folitrofin beta | parent. | 75 | U | 733,19 | Z |
| | | | | | | | |
| 215.6 | G03GA07 | lutropin alfa ( rekombinantní lidský luteinizační hormon) | parent. | 75 | U | 733,19 | z |
| 215.6 | G03GA07 | lutropin alfa ( rekombinantní lidský luteinizační hormon) | parent. | 75 | U | 733,19 | Z |
| 216 | G03GB | syntetické stimulátory ovulace | p.o. | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 216.1 | G03GB02 | klomifen | p.o. | 9 | MG | 1,24 | L/GYN,END, SEX, URN |
| 216.1 | G03GB02 | klomifen | p.o. | 9 | MG | 1,24 | L/GYN,END,SEX, URN |
| 217 | G03HA | antiandrogeny | p.o. | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 217.1 | G03HA01 | cyproteron (do 10 mg v jedné tabletě včetně) | p.o. | 0.1 | GM | 166,20 | |
| 77006 | ANDROCUR 10MG | tbl 15x10mg | SAG | D | | | |
| 77006 | ANDROCUR-10 | tbl 15x10mg | SAG | D | | | |
| 217.2 | G03HA01 | cyproteron (nad 10 mg v jedné tabletě) | p.o. | 0.1 | GM | 55,60 | |
| 59354 | ANDROCUR 100 | tbl obd 50x100mg | SUE | F | | | |
| 03783 | ANDROCUR | tbl 50x50mg | SAG | D | | | |
| 03783 | ANDROCUR-50 | tbl 50x50mg | SAG | D | | | |
| 218 | G03HA | antiandrogeny | parent. | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 218.1 | G03HA01 | cyproteron | parent. | 0.1 | GM | 122,72 | L/PSY,SEX, URN |
| 23342 | ANDROCUR-DEPOT | inj 3x3ml/300mg | SAG | D | | | |
| 23342 | ANDROCUR DEPOT | inj sol 3x3ml/300mg | SAG | D | | | |
| 219 | G03XA | antigonadotrofiny a podobná léčiva | p.o. | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 219.1 | G03XA01 | danazol | p.o. | 0.6 | GM | 78,16 | L/GYN,END, HEM, ALG,SEX |
| 58424 | ANARGIL 200 MG | cps 500x200mg-blis. | MOE | CY | | | |
| 58423 | ANARGIL 200 MG | cps 200x200mg-blis. | MOE | CY | | | |
| 58419 | ANARGIL 100 MG | cps 100x100mg-blis. | MOE | CY | | | |
| 58420 | ANARGIL 100 MG | cps 200x100mg-blis. | MOE | CY | | | |
| 58421 | ANARGIL 100 MG | cps 500x100mg-blis. | MOE | CY | | | |
| 58422 | ANARGIL 200 MG | cps 100x200mg-blis. | MOE | CY | | | |
| 219.2 | G03XA02 | gestrinon | p.o. | 0.7 | MG | 46,26 | L/GYN,END,HEM,ALG,SEX |
| 83580 | NEMESTRAN | cps 8x2.5mg | ROU | GB | | | |
| 219.3 | G03XC01 | raloxifen | p.o. | 60 | MG | 35,50 | P |
Raloxifen: léčbu ordinuje internista, endokrinolog, revmatolog, ortoped, gynekolog: Postmenopauzální osteoporoza žen dokumentovaná denzitometricky (méně než -2,5 SD) nebo u žen s osteoporotickou zlomeninou, u kterých selhala hormonální substituční léčba (HRT) nebo z objektivních důvodů nelze použít HRT. Léčba je dlouhodobá, trvá nejméně dva roky. Terapie delší ne dva roky pouze u pacientek s prokazatelnou zástavou úbytku kostní hmoty.
| 220 | G04AB | chinolonová chemoterapeutika močových infekci | p.o. | | | | |
| 219.1 | G03XA01 | danazol | p.o. | 0.6 | GM | 78,16 | L/GYN,END,HEM, ALG,SEX |
| | | | | | | | |
| 219.2 | G03XA02 | gestrinon | p.o. | 0.7 | MG | 46,26 | L/GYN,END,HEM, ALG,SEX |
| | | | | | | | |
| 219.3 | G03XC01 | raloxifen | p.o. | 60 | MG | 33,70 | P |
Raloxifen: léčbu ordinuje internista, endokrinolog, revmatolog, ortoped, gynekolog: Postmenopauzální osteoporoza žen dokumentovaná denzitometricky (méně než -2,5 SD) nebo u žen s osteoporotickou zlomeninou, u kterých selhala hormonální substituční léčba (HRT) nebo z objektivních důvodů nelze použít HRT. Léčba je dlouhodobá, trvá nejméně dva roky. Terapie delší než dva roky pouze u pacientek s prokazatelnou zástavou úbytku kostní hmoty.
| 220 | G04AB | chinolonová chemoterapeutika močových infekcí | p.o. | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 220.1 | G04AB01 | kyselina nalidixová | p.o. | 4 | GM | 8,55 | |
| | | | | | | | |
| 220.2 | G04AB03 | kyselina pipemidová | p.o. | 0.8 | GM | 19,55 | |
| 221 | G04AC | nitrofuranová chemoterapeutika močových infekci | p.o. | | | | |
| 221 | G04AC | nitrofuranová chemoterapeutika močových infekcí | p.o. | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 221.1 | G04AC02 | nifurtinol | p.o. | 0.16 | GM | 2,58 | |
| 222 | G04BC | rozpouštědla močových kamenů | p.o. | | | | |
@@ -3645,21 +3856,19 @@
| 222.2 | G04BC | rozpouštědla močových kamenů (ve formě eff. tablet) | p.o. | 4 | DF | 5,97 | |
| 223 | G04BD | spasmolytika močových cest | p.o. | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 223.1 | G04BD02 | flavoxat | p.o. | 0.8 | GM | 12,96 | L/URN,GYN, SEX GER |
| | | | | | | | |
| 223.2 | G04BD04 | oxybutynin | p.o. | 15 | MG | 12,96 | L/URN,GYN, SEX GER |
| 66791 | DITROPAN | tbl 30x5mg | SSF | F | | | |
| 223.3 | G04BD06 | propiverin (do 5 mg v jedné tabletě včetně) | p.o. | 15 | MG | 11,80 | L/URN,GYN, SEX PDD,GER |
| 223.1 | G04BD02 | flavoxat | p.o. | 0.8 | GM | 12,96 | L/URN,GYN,SEX GER |
| | | | | | | | |
| 223.2 | G04BD04 | oxybutynin | p.o. | 15 | MG | 12,96 | L/URN,GYN,SEX GER |
| 66791 | DITROPAN | por tbl nob 30x5mg | SWH | F | | | |
| 223.3 | G04BD06 | propiverin (do 5 mg v jedné tabletě včetně) | p.o. | 15 | MG | 11,80 | L/URN,GYN,SEX PDD, GER |
| 66820 | MICTONETTEN | drg 100x5mg | APG | D | | | |
| 92255 | MICTONETTEN | drg 30x5mg | APG | D | | | |
| 66819 | MICTONETTEN | drg 50x5mg | APG | D | | | |
| 66820 | MICTONETTEN | drg 100x5mg | APG | D | | | |
| 223.4 | G04BD06 | propiverin (nad 5 mg v jedné tabletě) | p.o. | 15 | MG | 5,40 | L/URN,GYN, SEX,GER |
| 66818 | MICTONORM | drg 100x15mg | APG | D | | | |
| 66817 | MICTONORM | drg 50x15mg | APG | D | | | |
| 92254 | MICTONORM | drg 30x15mg | APG | D | | | |
| 223.4 | G04BD06 | propiverin (nad 5 mg v jedné tabletě) | p.o. | 15 | MG | 4,32 | L/URN,GYN,SEX, GER |
| | | | | | | | |
| 223.5 | G04BD07 | tolterodin | p.o. | 4 | MG | 35,00 | P |
Tolterodin je indikován urologem, gynekologem, sexuologem a geriatrem při nesnášenlivosti nebo nedostatečné účinnosti jiných léků ze skupiny anticholinergik a spazmolytik (oxybutynin, propiverin) u nemocných postižených hyperaktivním měchýřem a nebo případy s těžkou hyperaktivitou měchýře. Po 3 měsících terapie tolterodinem bude přehodnocen stav pacienta na základě anamnestických údajů před zahájením terapie antimuskariniky. Pokud bude frekvence inkontinentních episod snížena o 30% a více bude terapie tolterodinem dále hrazena z prostředků veřejného zdravotního pojištění. Pokud bude frekvence inkontinentních episod snížena o méně než 30%, nebude dále hrazena z prostředků veřejného zdravotního pojištění.
Tolterodin je indikován urologem, gynekologem, sexuologem a geriatrem při nesnášenlivosti nebo nedostatečné účinnosti jiných léků ze skupiny anticholinergik a spazmolytik (oxybutynin, propiverin) u nemocných postižených hyperaktivním měchýřem a nebo případy s těžkou hyperaktivitou měchýře. Po 3 měsících terapie tolterodinem bude přehodnocen stav pacienta na základě anamnestických údajů před zahájením terapie antimuskariniky. Pokud bude frekvence inkontinentních episod snížena o 30% a více, bude terapie tolterodinem dále hrazena z prostředků veřejného zdravotního pojištění. Pokud bude frekvence inkontinentních episod snížena o méně než 30%, nebude dále hrazena z prostředků veřejného zdravotního pojištění.
| 224 | G04BX | jiná urologika, k léčbě benigní hyperplasie prostaty | p.o. | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
@@ -3670,30 +3879,30 @@
| 224.3 | G04CA02 | tamsulosin | p.o. | 0.4 | MG | 20,00 | L/URN |
| | | | | | | | |
| 224.4 | G04CA03 | terazosin | p.o. | 5 | MG | 16,80 | L/URN |
| 44311 | KORNAM 2MG | tbl 30x2mg | LEK | SLO | | | |
| 44312 | KORNAM 5MG | tbl 30x5mg | LEK | SLO | | | |
| 44311 | KORNAM 2 MG | por tbl nob30x2mg | LEK | SLO | | | |
| 44312 | KORNAM 5 MG | por tbl nob 30x5mg | LEK | SLO | | | |
| 224.5 | G04CB01 | finasterid | p.o. | 5 | MG | 20,00 | L/URN |
| 81493 | FINEX | por tbl flm 100x5mg | GEA | DK | | | |
| 81491 | FINEX | por tbl flm 30x5mg | GEA | DK | | | |
| 81492 | FINEX | por tbl flm 50x5mg | GEA | DK | | | |
| 81491 | FINEX | por tbl flm 30x5mg | GEA | DK | | | |
| 81493 | FINEX | por tbl flm 100x5mg | GEA | DK | | | |
| 224.6 | G04CX01 | extrakt Pyg. africanum | p.o. | 2 | DF | 16,00 | L/URN |
| | | | | | | | |
| 224.7 | G04CX02 | extrakt Serenoa repens včetně kombinací (pevné lékové formy dávkované 2 a víckrát denně) | p.o. | 2 | DF | 16,00 | L/URN |
| 57898 | SPALDA SABAL 160MG | cps 200x160mg | KKA | D | | | |
| 57897 | SPALDA SABAL 160MG | cps 120x160mg | KKA | D | | | |
| 57896 | SPALDA SABAL 160MG | cps 60x160mg | KKA | D | | | |
| 57897 | SPALDA SABAL 160 MG | cps 120x160mg | KKA | D | | | |
| 57898 | SPALDA SABAL 160 MG | cps 200x160mg | KKA | D | | | |
| 57896 | SPALDA SABAL 160 MG | cps 60x160mg | KKA | D | | | |
| 224.8 | G04CX02 | extrakt Serenoa repens včetně kombinací (pevné lékové formy dávkované 1x denně) | p.o. | 1 | DF | 16,00 | L/URN |
| 59710 | PROSTAMOL UNO | cps 30x320mg | BCE | D | | | |
| 57893 | SPALDA SABAL 320MG | cps 60x320mg | KKA | D | | | |
| 57894 | SPALDA SABAL 320MG | cps 120x320mg | KKA | D | | | |
| 57895 | SPALDA SABAL 320MG | cps 200x320mg | KKA | D | | | |
| 57894 | SPALDA SABAL 320 MG | cps 120x320mg | KKA | D | | | |
| 57895 | SPALDA SABAL 320 MG | cps 200x320mg | KKA | D | | | |
| 57893 | SPALDA SABAL 320 MG | cps 60x320mg | KKA | D | | | |
| 224.9 | G04CX03 | mepartricin | p.o. | 150 | KU | 20,00 | L/URN |
| 225 | H01A | hormony předního laloku hypofýzy | parent. | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 225.1 | H01AA02 | tetrakosaktid (nedepotní lékové formy) | parent. | 0.25 | MG | 59,93 | L/END |
| | | | | | | | |
| 225.2 | H01AC01 | somatropin | parent. | 2 | U | 660,39 | L/J5 |
| 61229 | GENOTROPIN KABI VIAL MULTIDOSE | inj sic 5x16ut+solv | KBP | S | | | |
| 66752 | GENOTROPIN KABI VIAL MULTIDOSE | inj 5x36ut/ml+solv. | KBP | S | | | |
| 66752 | GENOTROPIN 36 M.J.(12MG) | inj pso Iqf 5x36ut | PHA | S | | | |
| 226 | H01BA | vasopresin a jeho deriváty | parent. | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 226.1 | H01BA02 | desmopresin | parent. | 4 | RG | 82,41 | O |
@@ -3720,21 +3929,18 @@
| 229.1 | H01CA01 | gonadorelin (nasálně) | lok. | 1.2 | MG | 203,34 | Z |
| | | | | | | | |
| 229.2 | H01CA02 | nafarelin do 4 ml včetně v jednom balení (nasálně) | lok. | 0,4 | MG | 147,61 | Z |
| 45481 | SYNAREL | spr nas 1x4ml | SEA | POR | | | |
| 45481 | SYNAREL | spr nas 1x4ml/30dav | SEA | POR | | | |
| 229.3 | H01CA02 | nafarelin nad 4 ml v jednom balení (nasálně) | lok. | 0,4 | MG | 116,04 | Z |
| 83795 | SYNAREL | spr nas 1x8ml | SEA | POR | | | |
| 229.4 | H01CC01 | ganirelix (antagonista gonadotropin releasing hormonu ) | parent. | 0,25 | MG | 1600,00 | Z |
| 05981 | ORGALUTRAN 0.25MG/0.5ML INJ.ROZ | inj sol 1x0.5ml | ORG | IRL | | | |
| 05980 | ORGALUTRAN 0.25MG/0.5ML INJ.ROZ | inj sol 1x0.5ml | ORG | NL | | | |
| 05979 | ORGALUTRAN 0.25MG/0.5ML INJ.ROZ | inj sol 5x0.5ml | ORG | NL | | | |
| 05982 | ORGALUTRAN 0.25MG/0.5ML INJ.ROZ | inj sol 5x0.5ml | ORG | IRL | | | |
| 229.5 | H01CC02 | cetrorelix s obsahem 0,25 mg v 1 ampuli | parent. | 0,25 | MG | 1600,00 | Z |
| | | | | | | | |
| 229.6 | H01CC02 | cetrorelix s obsahem 3 mg v 1 ampuli | parent. | 0,25 | MG | 667,00 | Z |
| 83795 | SYNAREL | spr nas 1x8ml/60dav | SEA | POR | | | |
| 229.4 | H01CC01 | ganirelix (antagonista gonadotropin releasing hormonu ) | parent. | 0,25 | MG | 1440,00 | Z |
| | | | | | | | |
| 229.5 | H01CC02 | cetrorelix s obsahem 0,25 mg v 1 ampuli | parent. | 0,25 | MG | 1440,00 | Z |
| | | | | | | | |
| 229.6 | H01CC02 | cetrorelix s obsahem 3 mg v 1 ampuli | parent. | 0,25 | MG | 600,30 | Z |
| 230 | H01CB | somatostatin a jeho deriváty | parent. | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 230.1 | H01CB01 | somatostatin | parent. | 6 | MG | 7688,40 | X |
| 66824 | SOMATOSTATIN | inj sic 1x3mg+solv. | UCB | B | | | |
| 66824 | SOMATOSTATIN-UCB 3 MG | inf pso Iqf 1x3mg | UCB | B | | | |
| 230.2 | H01CB02 | oktreotid | parent. | 1 | MG | 4000,00 | H |
| | | | | | | | |
| 230.3 | H01CB02 | oktreotid s podáváním 1x měsíčně s obsahem 10 mg | parent. | 357 | RG | 1276,70 | X |
@@ -3746,14 +3952,15 @@
| 230.6 | H01CB03 | lantreotid s obsahem 30mg | parent. | 2,14 | MG | 1557,00 | X |
| | | | | | | | |
| 230.7 | H01CB03 | lantreotid s obsahem 60mg | parent. | 2,14 | MG | 1557,00 | X |
| | | | | | | | |
| 230.8 | H01CB03 | lantreotid s obsahem 90mg | parent. | 3.21 | MG | 1832,00 | X |
| | | | | | | | |
| 46342 | SOMATULINE AUTOGEL 60 MG | inj sol1x0.3ml/60mg | BFN | F | | | |
| 230.8 | H01CB03 | lantreotid s obsahem 90mg | parent. | 3,21 | MG | 1832,00 | X |
| 46341 | SOMATULINE AUTOGEL 90 MG | inj sol1x0.3ml/90mg | BFN | F | | | |
| 230.9 | H01CB03 | lantreotid s obsahem 120mg | parent. | 4,29 | MG | 2109,00 | X |
| 46343 | SOMATULINE AUTOGEL 120 MG | injsol1x0.5ml/120mg | BFN | F | | | |
| 231 | H02AA | mineralokortikoidy | p.o. | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 231.1 | H02AA02 | fludrokortison | p.o. | 0.1 | MG | 4,76 | |
| 58644 | FLUDROCORTISON SQUIBB | tbl 100x0.1mg | BMS | D | | | |
| 58644 | FLUDROCORTISON SQUIBB | tbl 100x0.1mg | HAG | D | | | |
| 232 | H02AB | glukokortikoidy | p.o. | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 232.1 | H02AB01 | betamethason | p.o. | 1.5 | MG | 3,42 | |
@@ -3765,15 +3972,14 @@
| 232.4 | H02AB04 | methylprednisolon (do 8 mg v jedné tabletě včetně) | p.o. | 7.5 | MG | 3,42 | |
| | | | | | | | |
| 232.5 | H02AB04 | methylprednisolon (nad 8 mg v jedné tabletě) | p.o. | 7.5 | MG | 4,79 | |
| 86606 | MEDROL 16MG | tbl 50x16mg(blistr) | PAU | B | | | |
| 86607 | MEDROL 32MG | tbl 20x32mg(blistr) | PAU | B | | | |
| 86606 | MEDROL 16 MG | por tblnob50x16mg-b | PPU | B | | | |
| 232.6 | H02AB07 | prednison | p.o. | 10 | MG | 2,80 | |
| 00269 | PREDNISON 5 LECIVA | tbl 20x5mg | LEX | CZ | | | |
| 02963 | PREDNISON 20 LECIVA | tbl 20x20mg(blistr) | LEX | CZ | | | |
| 02963 | PREDNISON 20 LÉČIVA | tbl 20x20mg-blistr | LEX | CZ | | | |
| 00269 | PREDNISON 5 LÉČIVA | tbl 20x5mg | LEX | CZ | | | |
| 232.7 | H02AB08 | triamcinolon | p.o. | 7.5 | MG | 2,74 | |
| | | | | | | | |
| 232.8 | H02AB09 | hydrokortison | p.o. | 30 | MG | 7,07 | |
| 76205 | HYDROCORTISON 10MG JENAPHARM | tbl 20x10mg | VJP | D | | | |
| 76205 | HYDROCORTISON 10 MG JENAPHARM | por tbl nob 20x10mg | VJP | D | | | |
| 232.9 | H02AB10 | kortison | p.o. | 37.5 | MG | 5,07 | |
| | | | | | | | |
| 232.10 | H02AB07 | prednison (do 10 mg včetně) | p.rect. | 10 | MG | 17,30 | |
@@ -3786,8 +3992,10 @@
| 233.1 | H02AB | mazipredon | parent. | 30 | MG | 17,79 | O |
| | | | | | | | |
| 233.2 | H02AB01 | betamethason (depotní lékové formy) | parent. | 0.4 | MG | 3,28 | O |
| 86187 | DIPROPHOS | inj 1x1ml | SCH | F | | | |
| 89870 | DIPROPHOS | inj 1x1ml | SCH | B | | | |
| 78257 | DIPROPHOS | inj 5x1ml | SCH | F | | | |
| 89869 | DIPROPHOS | inj 5x1ml | SCH | B | | | |
| 78257 | DIPROPHOS | inj 5x1ml | SCH | F | | | |
| 233.3 | H02AB02 | dexamethason (do 8 mg v jedné ampuli včetně) | parent. | 1.5 | MG | 1,99 | O |
| 01673 | DEXAMED | inj 100x2ml/8mg | MOE | CY | | | |
| 84090 | DEXAMED | inj 10x2ml/8mg | MOE | CY | | | |
@@ -3796,46 +4004,45 @@
| 233.4 | H02AB02 | dexamethason (40 mg v jedné ampuli) | parent. | 1.5 | MG | 24,50 | O |
| 99479 | FORTECORTIN MONO 40(AMPULE) | inj 1x5ml/40mg | MEC | D | | | |
| 233.5 | H02AB04 | methylprednisolon (do 80 mg v jedné ampuli včetně) | parent. | 20 | MG | 31,90 | O |
| 09709 | SOLU-MEDROL | inj sic 1x40mg+1ml | UPJ | B | | | |
| 85790 | DEPO-MEDROL DISPOS.SYRINGE | inj 1x1ml/40mg | UPJ | B | | | |
| 09709 | SOLU-MEDROL | inj sic 1x40mg+1ml | PAU | B | | | |
| 233.6 | H02AB04 | methylprednisolon (nad 80 do 500 mg v jedné ampuli včetně) | parent. | 20 | MG | 22,11 | O |
| 09711 | SOLU-MEDROL | inj sic 1x500mg+8ml | UPJ | B | | | |
| 09711 | SOLU-MEDROL | inj sic 500mg+7.8ml | PAU | B | | | |
| 233.7 | H02AB04 | methylprednisolon (nad 500 mg v jedné ampuli) | parent. | 20 | MG | 15,25 | O |
| | | | | | | | |
| 233.8 | H02AB06 | prednisolon (do 50 mg v jedné ampuli včetně) | parent. | 10 | MG | 17,46 | O |
| 09705 | SOLU-DECORTIN H 50 | inj sic 1x50mg+1ml | MEC | D | | | |
| | | | | | | | |
| 233.9 | H02AB06 | prednisolon (nad 50 mg v jedné ampuli) | parent. | 10 | MG | 12,51 | O |
| 09707 | SOLU-DECORTIN H 250 | inj sic 1x250mg+2ml | MEC | D | | | |
| | | | | | | | |
| 233.10 | H02AB08 | triamcinolon | parent. | 7.5 | MG | 13,64 | O |
| | | | | | | | |
| 233.11 | H02AB09 | hydrokortison | parent. | 30 | MG | 11,19 | O |
| 234 | H03AA | hormony štítné žlázy | p.o. | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 234.1 | H03AA | hormony štítné žlázy | p.o. | 1 | DF | 2,15 | |
| 61161 | JODTHYROX | tbl 100 | MEC | D | | | |
| 61160 | JODTHYROX | tbl 50 | MEC | D | | | |
| 61161 | JODTHYROX | tbl 100 | MEC | D | | | |
| 234.2 | H03AA01 | levothyroxin sodný (do 50 rg v 1 tabletě včetně) | p.o. | 0.15 | MG | 1,96 | |
| 69189 | EUTHYROX 50 | tbl 100x50rg | MEC | D | | | |
| 47141 | LETROX 50 | tbl 100x50rg | BCE | D | | | |
| 234.3 | H03AA01 | levothyroxin sodný (nad 50 rg do 100 rg včetně v 1 tabletě) | p.o. | 0.15 | MG | 1,37 | |
| 97186 | EUTHYROX 100 | tbl 100x100rg | 97186 | EUTHY | | | |
| 47144 | LETROX 100 | tbl 100x100rg | BCE | D | | | |
| 97186 | EUTHYROX 100 | tbl 100x100rg | MEC | D | | | |
| 234.4 | H03AA01 | levothyroxin sodný (nad 100 rg v 1 tabletě) | p.o. | 0.15 | MG | 1.12 | |
| 234.4 | H03AA01 | levothyroxin sodný (nad 100 rg v 1 tabletě) | p.o. | 0.15 | MG | 1,12 | |
| 69191 | EUTHYROX 150 | tbl 100x150rg | MEC | D | | | |
| 47133 | LETROX 150 | tbl 100x150rg | BCE | D | | | |
| 234.5 | H03AA02 | liothyronin sodný | p.o. | 0.06 | MG | 4,40 | |
| 09805 | TERTROXIN | tbl 100x0.02mg | GLA | ZA | | | |
| | | | | | | | |
| 234.6 | H03AA03 | kombinace levothyroxinu a liothyroninu | p.o. | 1 | DF | 1,81 | |
| 03875 | THYREOTOM | tbl 60x50rg | BCE | D | | | |
| 234.7 | H03CA | jodová terapie | p.o. | 200 | RG | 1.81 | |
| 234.7 | H03CA | jódová terapie | p.o. | 200 | RG | 1,81 | |
| 61158 | JODID 100 | tbl 100 | MEC | D | | | |
| 61159 | JODID 200 | tbl 100 | MEC | D | | | |
| 235 | H03B | thyreostatika | p.o. | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 235.1 | H03BA02 | propylthiouracil | p.o. | 0.1 | GM | 7,04 | |
| 09577 | PROPYCIL 50 | tbl 100x50mg | | SVP | D | | |
| 09577 | PROPYCIL 50 | tbl 100x50mg | SVP | D | | | |
| 235.2 | H03BB01 | karbimazol | p.o. | 15 | MG | 2,91 | |
| 00066 | CARBIMAZOL SLOVAKOFARMA | tbl 100x5mg | SLO | SK | | | |
| 00066 | CARBIMAZOL-SLOVAKOFARMA | tbl 100x5mg | SLO | SK | | | |
| 235.3 | H03BB02 | thiamazol | p.o. | 10 | MG | 2,83 | |
| | | | | | | | |
| 235.4 | H03BC01 | perchlorát draselný | p.o. | 0.2 | GM | 1,66 | |
@@ -3847,11 +4054,11 @@
| 237.1 | H04AA01 | glukagon | parent. | 1 | MG | 404,62 | L/DIA |
| | | | | | | | |
| 237.2 | H04AA01 | glukagon (ve formě hypokit) | parent. | 1 | MG | 811,39 | L/DIA |
| 83741 | GLUCAGEN 1MG HYPOKIT | inj sic 1mg+strik. | NOO | DK | | | |
| 83741 | GLUCAGEN 1 MG HYPOKIT | inj sic 1mg+sol+stŘ | NOO | DK | | | |
| 238 | H05BA | kalcitonin | inhal. | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
Kalcitonin předepisuje intemista,ortoped, gynekolog a endokrinolog:
Kalcitonin předepisuje internista,ortoped, gynekolog a endokrinolog:
u osteoporozy dokumentované denzitometricky (méně než -2,5 SD) nebo osteoporotické patologické zlomeniny pokud jsou tyto stavy spojené s výrazným algickým (bolestivým) syndromem, nereagujícím na běžnou analgetickou terapii.
@@ -3861,12 +4068,12 @@
Dále je indikován u: hyperkalcemické krize, Pagetova choroba s bolestmi v kostech,neurodystrofické stavy
| 238.1 | H05BA01 | kalcitonin (lososí, do 100 U včetně v jedné dávce) | inhal. | 200 U | 104,13 | P | |
| 64662 | TONOCALCIN 100I.U.NOSNI SPREJ | spr nas 1x3.5ml | MCI | CZ | | | |
| 238.1 | H05BA01 | kalcitonin (lososí, do 100 U včetně v jedné dávce) | inhal. | 200 | U | 104,13 | P |
| 30967 | OSTEODON 100 I.U. | sprnas1x3.5ml/28dÁv | LEX | CZ | | | |
| 64662 | TONOCALCIN 100I.U.NOSNÍ SPREJ | spr nas 1x3.5ml | MCI | CZ | | | |
| 238.2 | H05BA01 | kalcitonin (lososí, nad 100 U v jedné dávce) | inhal. | 200 | U | 83,00 | P |
| 30968 | OSTEODON 200 I.U. | sprnas1x2.1ml/14dÁv | LEX | CZ | | | |
| 10146 | TONOCALCIN 200 I.U.NOSNÍ SPREJ | spr nas 1x3.5ml | MCI | CZ | | | |
| 30968 | OSTEODON 200 I.U. | sprnas1x2.1ml/14dÁv | LEX | CZ | | | |
| 239 | H05BA | kalcitonin | parent. | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 239.1 | H05BA01 | kalcitonin (lososí) | parent. | 100 | U | 118,09 | L/INT,ORT, END,GER |
@@ -3876,16 +4083,19 @@
| 239.3 | H05BA03 | kalcitonin (lidský, nad 50 U v jedné ampuli) | parent. | 100 | U | 157,39 | L/INT,ORT, END,GER |
| 240 | J01AA | tetracyklinová antibiotika | p.o. | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 240.1 | J01AA02 | doxycyklin | p.o. | 0.1 | GM | 3.92 | |
| 47720 | DOXYCYCLIN AL 200 | tbl 10x200mg | APA | D | | | |
| 12735 | DOXYHEXAL 200 TABS | tbl 10x200mg | hex | D | | | |
| 12737 | DOXYHEXAL 200 TABS | tbl 10x200mg | SFS | D | | | |
| 12741 | DOXYHEXAL TABS | tbl 10x100mg | hex | D | | | |
| 12742 | DOXYHEXAL TABS | tbl 20x100mg | hex | D | | | |
| 47719 | DOXYCYCLIN AL 100 | tbl 20x100mg | APA | D | | | |
| 240.1 | J01AA02 | doxycyklin | p.o. | 0.1 | GM | 3,92 | |
| 97654 | DOXYBENE 100MG | cps 10x100mg | MCK | D | | | |
| 04013 | DOXYBENE 200 MG TABLETY | por tbl nob10x200mg | MCK | D | | | |
| 47718 | DOXYCYCLIN AL 100 | tbl 10x100mg | APA | D | | | |
| 47719 | DOXYCYCLIN AL 100 | tbl 20x100mg | APA | D | | | |
| 47720 | DOXYCYCLIN AL 200 | tbl 10x200mg | APA | D | | | |
| 12735 | DOXYHEXAL 200 TABS | tbl 10x200mg | HEX | D | | | |
| 12737 | DOXYHEXAL 200 TABS | tbl 10x200mg | SFS | D | | | |
| 12738 | DOXYHEXAL 200 TABS | tbl 20x200mg | SFS | D | | | |
| 12741 | DOXYHEXAL TABS | tbl 10x100mg | HEX | D | | | |
| 32953 | DOXYHEXAL TABS | tbl 10x100mg | SFS | D | | | |
| 12742 | DOXYHEXAL TABS | tbl 20x100mg | HEX | D | | | |
| 32954 | DOXYHEXAL TABS | tbl 20x100mg | SFS | D | | | |
| 240.2 | J01AA04 | lymecyklin | p.o. | 0.6 | GM | 3,92 | |
| | | | | | | | |
| 240.3 | J01AA06 | oxytetracyklin | p.o. | 1 | GM | 3,92 | |
@@ -3903,8 +4113,8 @@
| 241.2 | J01AA09 | rolitetracyklin | parent. | 0.35 | GM | 94,63 | K |
| 242 | J01BA | amfenikolová antibiotika | p.o. | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 242.1 | J01BA01 | chloramfenikol | p.o. | 3 | GM | 25.88 | |
| 71951 | CHLORAMPHENICOL LECIVA | cps 30x250mg | LEX | CZ | | | |
| 242.1 | J01BA01 | chloramfenikol | p.o. | 3 | GM | 25,88 | |
| 71951 | CHLORAMPHENICOL LÉČIVA | cps 30x250mg | LEX | CZ | | | |
| 243 | J01BA | amfenikolová antibiotika | parent. | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 243.1 | J01BA01 | chloramfenikol | parent. | 3 | GM | 267,93 | K |
@@ -3917,40 +4127,40 @@
| 244.2 | J01CA01 | ampicilin (tekuté lékové formy) | p.o. | 2 | GM | 17,20 | |
| | | | | | | | |
| 244.3 | J01CA04 | amoxicilin (pevné lékové formy) do 0,5 gm v 1tabletě včetně | p.o. | 1 | GM | 10,12 | |
| 66828 | AMOCLEN 250 | cps 30x250mg | LEX | CZ | | | |
| 66829 | AMOCLEN 500 | cps 30x500mg | LEX | CZ | | | |
| 53681 | AMOXICILLIN 250-SLOVAKOFARMA | cps 30x250mg | SLO | SK | | | |
| 53682 | AMOXICILLIN 500-SLOVAKOFARMA | cps 30x500mg | SLO | SK | | | |
| 44337 | AMOXIHEXAL 500 | tbl obd 10x500mg | HHC | D | | | |
| 44338 | AMOXIHEXAL 500 | tbl obd 20x500mg | HHC | D | | | |
| 62053 | DUOMOX 375 | tbl 20x375mg | YEU | NL | | | |
| 62050 | DUOMOX 500 | tbl 20x500mg | YEU | NL | | | |
| 66364 | OSPAMOX 250MG | cps 12x250mg | BCA | A | | | |
| 53682 | AMOXICILLIN 500-SLOVAKOFARMA | cps 30x500mg | SLO | SK | | | |
| 44337 | AMOXIHEXAL 500 | tbl obd 10x500mg HHC | D | | | | |
| 66828 | AMOCLEN 250 | cps 30x250mg | LEX | CZ | | | |
| 44338 | AMOXIHEXAL 500 | tbl obd 20x500mg | HHC | D | | | |
| 66829 | AMOCLEN 500 | cps 30x500mg | LEX | CZ | | | |
| 32557 | OSPAMOX 500 MG | por tbl obd14x500mg | BCA | A | | | |
| 66368 | OSPAMOX 500MG | tbl obd 12x500mg | BCA | A | | | |
| 53681 | AMOXICILLIN 250-SLOVAKOFARMA | cps 30x250mg | SLO | SK | | | |
| 244.4 | J01CA04 | amoxicilin (pevné lékové formy) nad 0,5 gm v 1 tabletě | p.o. | 1 | GM | 9,06 | |
| 66370 | OSPAMOX 1000MG | tbl obd 12x1000mg | BCA | A | | | |
| 66369 | OSPAMOX 750MG | tbl obd 12x750mg | BCA | A | | | |
| 66368 | OSPAMOX 500 MG | por tbl flm12x500mg | BCA | A | | | |
| 32557 | OSPAMOX 500 MG | por tbl flm14x500mg | BCA | A | | | |
| 244.4 | J01CA04 | amoxicilin (pevné lékové formy) nad 0,5 gm v 1tabletě | p.o. | 1 | GM | 9,06 | |
| 65929 | AMOXICILLIN AL 1000 | tbl obd 10x1000mg | APA | D | | | |
| 65958 | AMOXICILLIN AL 1000 | tbl obd 20x1000mg | APA | D | | | |
| 44342 | AMOXIHEXAL 1000 | tbl obd 10x1000mg | HHC | D | | | |
| 44343 | AMOXIHEXAL 1000 | tbl obd 20x1000mg | HHC | D | | | |
| 44344 | AMOXIHEXAL 1000 | tbl obd 50x1000mg | HHC | D | | | |
| 44342 | AMOXIHEXAL 1000 | tbl obd 10x1000mg | HHC | D | | | |
| 44339 | AMOXIHEXAL 750 | tbl obd 10x750mg | HHC | D | | | |
| 44341 | AMOXIHEXAL 750 | tbl obd 50x750mg | HHC | D | | | |
| 44343 | AMOXIHEXAL 1000 | tbl obd 20x1000mg | HHC | D | | | |
| 65958 | AMOXICILLIN AL 1000 | tbl obd 20x1000mg | APA | D | | | |
| 32559 | OSPAMOX 1000 MG | por tblobd14x1000mg | BCA | A | | | |
| 32558 | OSPAMOX 750 MG | por tbl obd14x750mg | BCA | A | | | |
| 66370 | OSPAMOX 1000 MG | por tblflm12x1000mg | BCA | A | | | |
| 32559 | OSPAMOX 1000 MG | por tblflm14x1000mg | BCA | A | | | |
| 66369 | OSPAMOX 750 MG | por tbl flm12x750mg | BCA | A | | | |
| 32558 | OSPAMOX 750 MG | por tbl flm 14x750mg | BCA | A | | | |
| 244.5 | J01CA04 | amoxicilin (tekuté lékové formy do 0,5 gm včetně v 5 mililitrech) | p.o. | 1 | GM | 13,05 | |
| 62050 | DUOMOX 500 | tbl 20x500mg | YEU | NL | | | |
| 84510 | AMOCLEN 250 | sir sic 1x100ml/5gm | LEX | CZ | | | |
| 44345 | AMOXIHEXAL | plv sus 1x100ml | AAG | D | | | |
| 44347 | AMOXIHEXAL FORTE | plv sus 1x100ml | AAG | D | | | |
| 66366 | OSPAMOX 250MG/5ML | gra sus 1x60ml | BCA | A | | | |
| 62053 | DUOMOX 375 | tbl 20x375mg | YEU | NL | | | |
| 44345 | AMOXIHEXAL | plv sus 1x100ml | AAG | D | | | |
| 84510 | AMOCLEN 250 | sir sic 1x5gm/100ml | LEX | CZ | | | |
| 66367 | OSPAMOX 375MG/5ML | gra sus 1x60ml | BCA | A | | | |
| 44347 | AMOXIHEXAL FORTE | plv sus 1x100ml | AAG | D | | | |
| 244.6 | J01CA04 | amoxicilin (tekuté lékové formy nad 0,5 gm v 5 mililitrech) | p.o. | 1 | GM | 10,00 | |
| 44335 | AMOXIHEXAL 1000 TABS | tbl sol 12x1000mg | HHC | D | | | |
| 44336 | AMOXIHEXAL 1000 TABS | tbl sol 24x1000mg | HHC | D | | | |
| 44335 | AMOXIHEXAL 1000 TABS | tbl sol 12x1000mg | HHC | D | | | |
| 44333 | AMOXIHEXAL 750 TABS | tbl sol 12x750mg | HHC | D | | | |
| 44334 | AMOXIHEXAL 750 TABS | tbl sol 24x750mg | HHC | D | | | |
| 44333 | AMOXIHEXAL 750 TABS | tbl sol 12x750mg | HHC | D | | | |
| 244.7 | J01CA06 | bakampicilin | p.o. | 1.2 | GM | 16,62 | |
| 245 | J01CA | aminopenicilinová antibiotika | parent. | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
@@ -3965,54 +4175,54 @@
| 247 | J01CE | na beta-laktamázu citlivé peniciliny | p.o. | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 247.1 | J01CE02 | fenoxymethylpenicilin (méně než 500 KU v jedné tabletě) | p.o. | 2 | GM | 21,02 | |
| 92805 | V-PENICILIN 250MG SLOVAKOFARMA | tbl 30x250mg-blistr | SLO | SK | | | |
| 92434 | V-PENICILIN 0.4MEGA BIOTIKA | tbl 30x400ku | BTA | SK | | | |
| 92434 | V-PENICILIN 0.4 MEGA BIOTIKA | por tbl nob30x400ku | BTA | SK | | | |
| 92805 | V-PENICILIN 250 MG SLOVAKOFARMA | tbl 30x250mg-blistr | SLO | SK | | | |
| 247.2 | J01CE02 | fenoxymethylpenicilin (od 500 KU včetně do 900 KU včetně v jedné tabletě) | p.o. | 2 | GM | 19,11 | |
| 92806 | V-PENICILIN 500MG SLOVAKOFARMA | tbl 30x500mg-blistr | SLO | SK | | | |
| 45996 | OSPEN 500 | tbl obd 30x500ku | BCA | A | | | |
| 56831 | OSPEN 500 | tbl obd 12x500ku | BCA | A | | | |
| 92435 | V-PENICILIN 0.8MEGA BIOTIKA | tbl 30x800ku | BTA | SK | | | |
| 56831 | OSPEN 500 | por tblflm12x500ku | BCA | A | | | |
| 45996 | OSPEN 500 | por tblflm30x500ku | BCA | A | | | |
| 92435 | V-PENICILIN 0.8 MEGA BIOTIKA | por tbl nob30x800ku | BTA | SK | | | |
| 92805 | V-PENICILIN 250 MG SLOVAKOFARMA | tbl 30x250mg-blistr | SLO | SK | | | |
| 247.3 | J01CE02 | fenoxymethylpenicilin (nad 900 KU v jedné tabletě) | p.o. | 2 | GM | 19,65 | |
| 49513 | PENBENE | tbl obd 30x1mu | MCK | D | | | |
| 66359 | OSPEN 1000 | tbl obd 12x1000ku | BCA | A | | | |
| 66360 | OSPEN 1500 | tbl obd 12x1500ku | BCA | A | | | |
| 92436 | V-PENICILIN 1.2MEGA BIOTIKA | tbl 30x1.2mu | BTA | SK | | | |
| 05960 | V-PENICILIN 750MG SLOVAKOFARMA | tbl 20x750mg-blistr | SLO | SK | | | |
| 57778 | PENBENE 1500000 | tbl obd 21 | MCK | D | | | |
| 45998 | OSPEN 1500 | tbl obd 30x1500ku | BCA | A | | | |
| 66359 | OSPEN 1000 | por tblflm12x1000ku | BCA | A | | | |
| 45997 | OSPEN 1000 | por tblflm30x1000ku | BCA | A | | | |
| 66360 | OSPEN 1500 | por tblflm12x1500ku | BCA | A | | | |
| 45998 | OSPEN 1500 | por tblflm30x1500ku | BCA | A | | | |
| 65356 | PENBENE 1 000 000 | tbl obd 12x1mu | MCK | D | | | |
| 01881 | PENBENE 1 000 000 | tbl obd 21x1mu | MCK | D | | | |
| 49513 | PENBENE 1 000 000 | tbl obd 30x1mu | MCK | D | | | |
| 57778 | PENBENE 1 500 000 | tbl obd 21 | MCK | D | | | |
| 64937 | PENCID 1000 | tbl obd 20x1mu | LEX | CZ | | | |
| 30069 | PENCID 1000 | tbl obd 30x1mu | LEX | CZ | | | |
| 45997 | OSPEN 1000 | tbl obd 30x1000ku | BCA | A | | | |
| 64937 | PENCID 1000 | tbl obd 20x1mu | LEX | CZ | | | |
| 44708 | V-PENICILIN 750MG SLOVAKOFARMA | tbl 30x750mg-blistr | SLO | SK | | | |
| 64936 | PENCID 1500 | tbl obd 20x1.5mu | LEX | CZ | | | |
| 01881 | PENBENE 1 000 000 | tbl obd 21x1mu | MCK | D | | | |
| 65356 | PENBENE | tbl obd 12x1mu | MCK | D | | | |
| 92436 | V-PENICILIN 1.2 MEGA BIOTIKA | por tbl nob30x1.2mu | BTA | SK | | | |
| 05960 | V-PENICILIN 750MG SLOVAKOFARMA | tbl 20x750mg-bli | SLO | SK | | | |
| 44708 | V-PENICILIN 750MG SLOVAKOFARMA | tbl 30x750mg-bli | SLO | SK | | | |
| 247.4 | J01CE02 | fenoxymethylpenicilin (tekuté lékové formy do 250 KU v 5 ml včetně) | p.o. | 2 | GM | 69.99 | |
| | | | | | | | |
| 247.5 | J01CE02 | fenoxymethylpenicilin (tekuté lékové formy nad 250 KU v 5 ml) | p.o. | 2 | GM | 26,30 | |
| | | | | | | | |
| 247.6 | J01CE06 | penamecilin | p.o. | 1.05 | GM | 15,05 | |
| 56442 | PENCLEN | tbl 30x350mg-blistr | SLO | SK | | | |
| 56442 | PENCLEN | tbl 30x350mg-bli | SLO | SK | | | |
| 247.7 | J01CE10 | benzathin fenoxymethylpenicilin | p.o. | 2 | GM | 29,43 | |
| 76213 | OSPEN 750 | sir 60ml 750mg/5ml | KRK | SLO | | | |
| 49549 | OSPEN 400MG | sir 1x150ml | BCA | A | | | |
| 76213 | OSPEN 750 KRKA | por sus 1x60ml/9gm | KRK | SLO | | | |
| 248 | J01CE | na beta-laktamázu citlivé peniciliny | parent. | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 248.1 | J01CE01 | benzylpenicilin (do 1 MU v jedné ampuli včetně) | parent. | 3.6 | GM | 123,86 | K |
| 01093 | PENICILIN G DRASEL.SOL BIOTIKA | inj sic 10x1mu | BTA | SK | | | |
| 02136 | PENICILIN G DRASEL.SOL BIOTIKA | inj sic 10x500ku | BTA | SK | | | |
| 02136 | PENICILIN G 0.5 DRAS.SOL BIOT. | inj sic 10x500ku | BTA | SK | | | |
| 01093 | PENICILIN G 1.0 DRAS.SOL BIOT. | inj sic 10x1mu | BTA | SK | | | |
| 248.2 | J01CE01 | benzylpenicilin (nad 1 MU v jedné ampuli) | parent. | 3.6 | GM | 49,32 | K |
| 93405 | PENICILIN G DRASEL.SOL BIOTIKA | inj sic 10x5mu | BTA | SK | | | |
| 93405 | PENICILIN G 5.0 DRAS.SOL BIOT. | inj sic 10x5mu | BTA | SK | | | |
| 248.3 | J01CE08 | benzathin benzylpenicilin (do 0,6 MU v jedné ampuli včetně) | parent. | 2 | MU | 70,63 | K |
| | | | | | | | |
| 248.4 | J01CE08 | benzathin benzylpenicilin (nad 0,6 MU v jedné ampuli) | parent. | 2 | MU | 27,83 | K |
| 62050 | DUOMOX 500 | tbl 20x500mg | YEU | NL | | | |
| 01764 | RETARPEN 2.4 M.U.I. | inj sic 50x2.4mu | BCA | A | | | |
| 248.5 | J01CE09 | prokain penicilin (do 0,6 MU v jedné dávce včetně) | parent. | 2 | MU | 79,58 | K |
| | | | | | | | |
| 248.6 | J01CE09 | prokain penicilin (nad 0,6 MU v jedné dávce) | parent. | 2 | MU | 39,05 | K |
| 01102 | PROKAIN PENICILIN G BIOTIKA | inj 10x1.5mu | BTA | SK | | | |
| 01102 | PROKAIN PENICILIN G 1.5 BIOTIKA | inj sic 10x1.5mu | BTA | SK | | | |
| 248.7 | J01CE30 | kombinace | parent. | 0.5 | DF | 10,36 | K |
| 02723 | PENDEPON COMPOSITUM | inj 10x1.5mu | BTA | SK | | | |
| 02723 | PENDEPON COMPOSITUM | inj sic 10x1.5mu | BTA | SK | | | |
| 249 | J01CF | vůči beta-laktamáze stabilní peniciliny | p.o. | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 249.1 | J01CF02 | cloxacilin (pevné lékové formy) | p.o. | 2 | GM | 28,74 | |
@@ -4032,54 +4242,62 @@
| 251.2 | J01CR04 | sultamicilin (tekuté lékové formy) | p.o. | 1.5 | GM | 80,90 | |
| | | | | | | | |
| 251.3 | J01CR02 | amoxicilin a inhibitor beta-laktamázy (pevné lékové formy, do 375 mg v 1 tabletě včetně) | p.o. | 1 | GM | 31,80 | |
| 97657 | AUGMENTIN 375MG | tbl obd 21x375mg | LEX | CZ | | | |
| 85524 | AMOKSIKLAV 375MG | tbl obd 21x375mg | LEK | SLO | | | |
| 86026 | AUGMENTIN 375 MG | tbl obd 21x375mg | SKW | GB | | | |
| 86147 | AUGMENTIN 375 MG | tbl obd 21x375mg | LEX | CZ | | | |
| 93709 | AUGMENTIN 375 MG | tbl obd 21x375mg | SKW | GB | | | |
| 95213 | AUGMENTIN 375 MG | tbl obd 21x375mg | LEX | CZ | | | |
| 46093 | ENHANCIN 250/125MG | tbl obd 21x250mg | RXY | IND | | | |
| 85524 | AMOKSIKLAV | tbl obd 21x375mg | LEK | SLO | | | |
| 93709 | AUGMENTIN 375MG | tbl obd 21x375mg | SKB | GB | | | |
| 251.4 | J01CR02 | amoxicilin a inhibitor beta-laktamázy (pevné lékové formy, nad 375 mg do 625 mg včetně v 1 tabletě) | p.o. | 1 | GM | 28,98 | |
| 83738 | AUGMENTIN 625MG | tbl obd 21x625mg | LEX | CZ | | | |
| 85525 | AMOKSIKLAV 625MG | tbl obd 21x625mg | LEK | SLO | | | |
| 96459 | AMOXICILLIN-RATIOPH COMP.625 MG | por tbl flm21x625mg | MCK | D | | | |
| 85446 | AUGMENTIN 625 MG | tbl obd 21x625mg | LEX | CZ | | | |
| 86148 | AUGMENTIN 625 MG | tbl obd 21x625mg | SKW | GB | | | |
| 86149 | AUGMENTIN 625 MG | tbl obd 21x625mg | LEX | CZ | | | |
| 89852 | AUGMENTIN 625 MG | tbl obd 21x625mg | SKW | GB | | | |
| 32389 | BETAKLAV | por tblnob21x625mg | KRK | SLO | | | |
| 53577 | CURAM 625MG | tbl obd 21x625mg | BCA | A | | | |
| 85525 | AMOKSIKLAV | tbl obd 21x625mg | LEK | SLO | | | |
| 46094 | ENHANCIN 500/125MG | tbl obd 21x500mg | RXY | IND | | | |
| 89852 | AUGMENTIN 625MG | tbl obd 21x625mg | SKB | GB | | | |
| 251.5 | J01CR02 | amoxicilin a inhibitor beta-laktamázy (pevné lékové formy, nad 625 mg v 1 tabletě) | p.o. | 1 | GM | 27,18 | |
| 05951 | AMOKSIKLAV 1G | tbl obd 14x1gm | LEA | SLO | | | |
| 12494 | AUGMENTIN 1GM | tbl 14x1gm | SKB | GB | | | |
| 53959 | AUGMENTIN 1GM | tbl obd 14x1gm | LEX | CZ | | | |
| 12494 | AUGMENTIN 1 G | tbl obd 14x1gm | SKW | GB | | | |
| 94933 | AUGMENTIN 1 G | tbl obd 14x1gm | SKW | GB | | | |
| 94934 | AUGMENTIN 1 G | tbl obd 14x1gm | LEX | CZ | | | |
| 95137 | AUGMENTIN 1 G | tbl obd 14x1gm | LEX | CZ | | | |
| 251.6 | J01CR02 | amoxicilin a inhibitor beta-laktamázy (tekuté lékové formy do 156 mg v 5 ml včetně) | p.o. | 1 | GM | 47,44 | |
| 74991 | AMOKSIKLAV | plv sus 1x100ml | LEK | SLO | | | |
| 53567 | CURAM 156.25MGZ5ML | plv sus 1x100ml | BCA | A | | | |
| 97658 | AUGMENTIN 156MG/5ML | sir sic 1x100ml | LEX | CZ | | | |
| 53567 | CURAM 156.25MG/5ML | plv sus 1x100ml | BCA | A | | | |
| 251.7 | J01CR02 | amoxicilin a inhibitor beta-laktamázy (tekuté lékové formy, nad 156 mg v 5 ml) | p.o. | 1 | GM | 31,12 | |
| 83739 | AUGMENTIN 312MG/5ML | sir sic 1x100ml | LEX | CZ | | | |
| 96416 | AMOKSIKLAV FORTE | plv sus 1x100ml | LEK | SLO | | | |
| 94875 | AUGMENTIN DUO | por plv sus 1x140ml | LEX | CZ | | | |
| 84792 | AUGMENTIN DUO | por plv sus 1x70ml | SKW | GB | | | |
| 94873 | AUGMENTIN DUO | por plv sus 1x70ml | LEX | CZ | | | |
| 53571 | CURAM 312.5MG/5ML | plv sus 1x100ml | BCA | A | | | |
| 84792 | AUGMENTIN DUO | plv sus 1x70ml | SKW | GB | | | |
| 252 | J01CR | kombinace inhibitoru beta-laktamázy s peniciliny, nebo kombinace penicilinů | parent. | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 252.1 | J01CR01 | ampicilin a enzymový inhibitor | parent. | 2 | GM | 162,17 | U/ATB |
| | | | | | | | |
| 252.2 | J01CR02 | amoxicilin a inhibitor beta-laktamázy | parent. | 1 | GM | 109,88 | U/ATB |
| 97660 | AUGMENTIN 1.2GM | inj sic 5x1.2gm | LEX | CZ | | | |
| 72972 | AMOKSIKLAV 1.2GM | inj sic 5x1.2gm | LEK | SLO | | | |
| 32279 | AMOKSIKLAV 600 MG | inj sic 5x600mg | LEA | SLO | | | |
| 72973 | AMOKSIKLAV 600MG | inj sic 5x600mg | LEK | SLO | | | |
| 32280 | AMOKSIKLAV 1.2 G | inj sic 5x1.2gm | LEA | SLO | | | |
| 252.3 | J01CR03 | tikarcilin a inhibitor beta-laktamázy | parent. | 15 | GM | 1820,84 U/ATB | |
| 32280 | AMOKSIKLAV 1.2 G | inj plv sol 5x1.2gm | LEA | SLO | | | |
| 72972 | AMOKSIKLAV 1.2 G | inj plv sol 5x1.2gm | LEK | SLO | | | |
| 32279 | AMOKSIKLAV 600 MG | inj plv sol 5x600mg | LEA | SLO | | | |
| 72973 | AMOKSIKLAV 600 MG | inj plv sol 5x600mg | LEK | SLO | | | |
| 94808 | AUGMENTIN 1.2 GM | inj sic 5x1.2gm | LEX | CZ | | | |
| 252.3 | J01CR03 | tikarcilin a inhibitor beta-laktamázy | parent. | 15 | GM | 1820,84 | U/ATB |
| | | | | | | | |
| 252.4 | J01CR05 | piperacilin a inhibitor beta-laktamázy | parent. | 14 | GM | 1980,92 | U/ATB |
| | | | | | | | |
| 252.5 | J01CR50 | kombinace penicilinů | parent. | 3 | DF | 71.80 | U |
| 252.5 | J01CR50 | kombinace penicilinů | parent. | 3 | DF | 71,80 | U |
| | | | | | | | |
| 252.6 | J01DA | cefoperazon a inhibitor beta-laktamázy | parent. | 2 | GM | 397,00 | U/ATB |
| 253 | J01DA | cefalosporinová antibiotika | p.o. | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 253.1 | J01DA01 | cefalexin (pevné lékové formy) | p.o. | 2 | GM | 38,13 | |
| 06158 | ORACEF | cps 16x500mg | KRK | SLO | | | |
| 55779 | CEFACLEN 250 | cps 30x250mg | SLO | SK | | | |
| 55782 | CEFACLEN 500 | cps 30x500mg | SLO | SK | | | |
| 06158 | ORACEF 500MG | cps 16x500mg | KRK | SLO | | | |
| 66357 | OSPEXIN 1000MG | tbl obd 12x1000mg | BCA | A | | | |
| 55782 | CEFACLEN 500 | cps 30x500mg | SLO | SK | | | |
| 66356 | OSPEXIN 500MG | tbl obd 12x500mg | BCA | A | | | |
| 55779 | CEFACLEN 250 | cps 30x250mg | SLO | SK | | | |
| 253.2 | J01DA01 | cefalexin (tekuté lékové formy) | p.o. | 2 | GM | 44,33 | |
| 66354 | OSPEXIN 250MG/5ML | gra sus 1x60ml | BCA | A | | | |
| 66355 | OSPEXIN 375MG/5ML | gra sus 1x60ml | BCA | A | | | |
@@ -4088,39 +4306,40 @@
| 253.4 | J01DA06 | cefuroxim axetil (tekuté lékové formy) | p.o. | 1 | GM | 141,75 | |
| | | | | | | | |
| 253.5 | J01DA08 | cefaklor (pevné lékové formy do 375 mg v 1 tabletě včetně) | p.o. | 1.5 | GM | 71,43 | |
| 53153 | VERCEF 250MG | cps 7x3(blistr) | RXY | IND | | | |
| 01665 | CEFACLOR 250-SL | cps 21x250mg | SLO | SK | | | |
| 58765 | SERVICLOR 250 MG | cps 21x250mg | BCA | A | | | |
| 47210 | VERCEF MR 375 MG | port blret 14x375mg | RXY | IND | | | |
| 253.6 | J01DA08 | cefaklor (pevné lékové formy nad 375 mg v 1 tabletě) | p.o. | 1.5 | GM | 66,03 | |
| 53153 | VERCEF 250MG | cps 7x3(blistr) | RXY | IND | | | |
| 47210 | VERCEF MR 375 MG | por tblret 14x375mg | RXY | IND | | | |
| 253.6 | J01DA08 | cefaklor (pevné lékové formy nad 375 mg v 1 tabletě) | p.o. 1.5 | GM | 66,03 | | |
| 45193 | CEC 500 | tbl obd 10x500mg | SFS | D | | | |
| 45194 | CEC 500 | tbl obd 20x500mg | SFS | D | | | |
| 01667 | CEFACLOR 500-SL | cps 21x500mg | SLO | SK | | | |
| 32156 | SERVICLOR 500 MG | cps 21x500mg | BCA | A | | | |
| 45194 | CEC 500 | tbl obd 20x500mg | SFS | D | | | |
| 45193 | CEC 500 | tbl obd 10x500mg | SFS | D | | | |
| 01667 | CEFACLOR 500-SL | cps 21x500mg | SLO | SK | | | |
| 53157 | VERCEF 500MG | cps 7x3(blistr) | RXY | IND | | | |
| 53157 | VERCEF 500MG | cps 7x3-bli | RXY | IND | | | |
| 253.7 | J01DA08 | cefaklor (tekuté lékové formy, do 125 mg/5 ml včetně) | p.o. | 1.5 | GM | 103,11 | |
| 45195 | CEC SIRUP | plv sus 100ml/2.5gm | SFS | D | | | |
| 58763 | SERVICLOR 125 MG/5ML | por gra sus 1x100ml | BCA | A | | | |
| 53151 | VERCEF 125MG/5ML | plv sus 1x100ml | RXY | IND | | | |
| 253.8 | J01DA08 | cefaklor (tekuté lékové formy, nad 125 mg/5 ml) | p.o. | 1.5 | GM | 86,27 | |
| 45196 | CEC FORTE SIRUP | plv sus 100ml/5gm | SES | D | | | |
| 45196 | CEC FORTE SIRUP | plv sus 100ml/5gm | SFS | D | | | |
| 66282 | CEFACLOR AL SUSP. | gra sus 1x100ml/5gm | APA | D | | | |
| 58764 | SERVICLOR 250 MG/5ML | por gra sus 1x100ml | BCA | A | | | |
| 53152 | VERCEF 250MG/5ML | plv sus 1x100ml | RXY | IND | | | |
| 253.9 | J01DA09 | Cefadroxil (pevné lékové formy) | p.o. | 2 | GM | 40,00 | |
| 253.9 | J01DA09 | cefadroxil (pevné lékové formy) | p.o. | 2 | GM | 40,00 | |
| 44799 | BIODROXIL | cps 12x500mg | BCA | A | | | |
| 44802 | BIODROXIL | tbl obd 12x1000mg | BCA | A | | | |
| 44799 | BIODROXIL | cps 12x500mg | BCA | A | | | |
| 253.10 | J01DA09 | Cefadroxil (tekuté lékové formy) | p.o. | 2 | GM | 63,30 | |
| | | | | | | | |
| 253.11 | J01DA23 | Cefixim | p.o. | 0.4 | GM | 107,35 | ATB |
| | | | | | | | |
| 253.12 | J01DA26 | Cefetamet | p.o. | 1 | GM | 107,53 | ATB |
| | | | | | | | |
| 253.13 | J01DA33 | Cefpodoxim | p.o. | 0.4 | GM | 92,35 | ATB |
| | | | | | | | |
| 253.14 | J01DA39 | Ceftibuten | p.o. | 0.4 | GM | 92,35 | ATB |
| 253.10 | J01DA09 | cefadroxil (tekuté lékové formy) | p.o. | 2 | GM | 63,30 | |
| | | | | | | | |
| 253.11 | J01DA23 | cefixim | p.o. | 0.4 | GM | 107,35 | ATB |
| | | | | | | | |
| 253.12 | J01DA26 | cefetamet | p.o. | 1 | GM | 107,53 | ATB |
| | | | | | | | |
| 253.13 | J01DA33 | cefpodoxim | p.o. | 0.4 | GM | 92,35 | ATB |
| | | | | | | | |
| 253.14 | J01DA39 | ceftibuten | p.o. | 0.4 | GM | 92,35 | ATB |
| | | | | | | | |
| 253.15 | J01DA41 | cefprozil (pevné lékové formy) | p.o. | 1 | GM | 92,35 | |
| | | | | | | | |
| 253.16 | J01DA41 | cefprozil (tekuté lékové formy) | p.o. | 1 | GM | 141,75 | |
| 254 | J01DA | cefalosporinová antibiotika | parent. | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
@@ -4134,25 +4353,25 @@
- c) léčba nekomplikované akutní kapavky (jednorázová nitrosvalová aplikace 250 mg ceftriaxonu).
| 254.1 | J01DA03 | cefalotin | parent. | 4 | GM | 188,18 | U/ATB |
| 85512 | CEFALOTIN BIOTIKA | inj sic 50x1gm | BTA | SK | | | |
| 85512 | CEFALOTIN 1.0 BIOTIKA | inj sic 50x1gm | BTA | SK | | | |
| 254.2 | J01DA04 | cefazolin | parent. | 3 | GM | 128,71 | U/ATB |
| 02205 | CEFAZOLINE PANPHARMA | inj sic 25x1gm | LPA | F | | | |
| 84018 | CEFAZOLINE PANPHARMA | inj sic 50x1gm | LPA | F | | | |
| 85510 | VULMIZOLIN 1.0 | inj sic 50x1gm | BTA | SK | | | |
| 02205 | CEFAZOLINE PANPHARMA | inj sic 25x1gm | LPA | F | | | |
| 83111 | ORIZOLIN 1000 | inj sic 1x1000mg | CAI | IND | | | |
| 91148 | VULMIZOLIN 1.0 | inj sic 10x1gm | BTA | SK | | | |
| 85510 | VULMIZOLIN 1.0 | inj sic 50x1gm | BTA | SK | | | |
| 254.3 | J01DA05 | cefoxitin | parent. | 6 | GM | 937,79 | U/ATB |
| | | | | | | | |
| 254.4 | J01DA06 | cefuroxim | parent. | 4 | GM | 439,20 | U/ATB |
| 64833 | AXETINE 1.5GM | inj sic 100x1.5gm | MOE | CY | | | |
| 64831 | AXETINE 1.5GM | inj sic 10x1.5gm | MOE | CY | | | |
| 64833 | AXETINE 1.5GM | inj sic 100x1.5gm | MOE | CY | | | |
| 64837 | AXETINE 750MG | inj sic 100x750mg | MOE | CY | | | |
| 64835 | AXETINE 750MG | inj sic 10x750mg | MOE | CY | | | |
| 64837 | AXETINE 750 MG | inj sic 100x750mg | MOE | CY | | | |
| 64835 | AXETINE 750 MG | inj sic 10x750mg | MOE | CY | | | |
| 254.5 | J01DA07 | cefamandol | parent. | 6 | GM | 615,68 | U/ATB |
| 99332 | MANDOL | inj sic 1x1gm | LIL | I | | | |
| 99332 | MANDOL 1G | inj sic 1x1gm | LIL | I | | | |
| 254.6 | J01DA10 | cefotaxim do 1 g včetně v jedné ampuli | parent. | 6 | GM | 524,01 | U/ATB |
| 94176 | CEFOTAXIME LEK 1 G | inj sic 1x1gm | LEK | SLO | | | |
| 05770 | TAXCEF | inj sic 1x1gm | RXY | IND | | | |
| 94176 | CEFOTAXIME | inj 1x1gm | LEK | SLO | | | |
| 254.7 | J01DA10 | cefotaxim nad 1 g v jedné ampuli | parent. | 6 | GM | 459,00 | U/ATB |
| 05748 | TAXCEF 2G | inj sic 1x2gm | RXY | IND | | | |
| 254.8 | J01DA11 | ceftazidim do 500 mg včetně v jedné ampuli | parent. | 6 | GM | 1736,18 | U/ATB |
@@ -4162,46 +4381,46 @@
| 254.10 | J01DA12 | cefsulodin | parent. | 6 | GM | 615,68 | U/ATB |
| | | | | | | | |
| 254.11 | J01DA13 | ceftriaxon | parent. | 2 | GM | 555,00 | ambulantně: K/P ústavně: U/ATB |
| 58756 | CEFTRIAXON TORREX 2 G | inj plv sol 1x2gm | TRX | A | | | |
| 80662 | LENDACIN 1G | inj sic 5x1gm | LEK | SLO | | | |
| 64638 | OFRAMAX 1 G | inj sic 1x1gm | RXY | IND | | | |
| 80662 | LENDACIN 1GM | inj sic 5x1gm | LEK | SLO | | | |
| 254.12 | J01DA22 | ceftizoxim | parent. | 4 | GM | 615,68 | U/ATB |
| | | | | | | | |
| 254.13 | J01DA24 | cefepim | parent. | 4 | GM | 1605,91 | U/ATB |
| | | | | | | | |
| 254.14 | J01DA30 | cefapirin | parent. | 4 | GM | 194,73 | U/ATB |
| | | | | | | | |
| 254.15 | J01DA32 | cefoperazon | parent. | 6 | GM | 1526,24 | U/ATB |
| | | | | | | | |
| 254.16 | J01DA37 | cefpirom | parent. | 4 | GM | 1638,40 | U/ATB |
| 86598 | CEFROM 2GM | inj sic 1x2gm | ROU | F | | | |
| 255 | J01DF | monobaktámová antibiotika | parent. | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 255.1 | J01DF01 | aztreonam | parent. | 4 | GM | 1645.60 | U/ATB |
| 255.1 | J01DF01 | aztreonam | parent. | 4 | GM | 1645,60 | U/ATB |
| 256 | J01DH | karbapenemová antibiotika | parent. | U/ATB | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 256.1 | J01DH | ertapenem | parent. | 1 | GM | 1980,00 | U/ATB |
| | | | | | | | |
| 256.2 | J01DH02 | meropenem | parent. | 2 | GM | 2194,52 | U/ATB |
| | | | | | | | |
| 256.3 | J01DH51 | imipenem a inhibitor enzymu | parent. | 2 | GM | 2238,99 | U/ATB |
| 12091 | TIENAM I.M. | inj sic 1x500/500mg | MSD | CH | | | |
| 12091 | TIENAM I.M.500 MG | inj sic 1x500/500mg | MSD | CH | | | |
| 257 | J01EB | krátkodobě působící sulfonamidy | p.o. | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 257.1 | J01EA01 | trimethoprim (do 100 mg v jedné tabletě včetně) | p.o. | 0.4 | GM | 11,88 | |
| 89812 | TRIPRIM 100MG | tbl 10x100mg | MCK | D | | | |
| 89813 | TRIPRIM 100MG | tbl 20x100mg | MCK | D | | | |
| 89812 | TRIPRIM 100MG | tbl 10x100mg | MCK | D | | | |
| 257.2 | J01EA01 | trimethoprim (nad 100 mg v jedné tabletě) | p.o. | 0.4 | GM | 8,94 | |
| 89815 | TRIPRIM 200MG | tbl 10x200mg | MCK | D | | | |
| 89816 | TRIPRIM 200MG | tbl 20x200mg | MCK | D | | | |
| 89815 | TRIPRIM 200MG | tbl 10x200mg | MCK | D | | | |
| 257.3 | J01EB05 | sulfafurazol | p.o. | 4 | GM | 13,64 | |
| 258 | J01EE | sulfonamidy kombinované s trimetoprimem | p.o. | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 258.1 | J01EE01 | sulfamethoxazol a trimethoprim (pevné lékové formy, do 120 mg v jedné tabletě včetně) | p.o. | 1.92 | GM | 17,06 | |
| | | | | | | | |
| 258.2 | J01EE01 | sulfamethoxazol a trimethoprim (pevné lékové formy nad 120 mg v jedné tabletě) | p.o. | 1.92 | GM | 6,84 | |
| 87758 | ORIPRIM | tbl 100x480mg | CAI | IND | | | |
| 12917 | BISMORAL 480 | tbl 20x480mg | SLO | SK | | | |
| 75022 | COTRIMOXAZOL AL FORTE | tbl 10x960mg | APA | D | | | |
| 75023 | COTRIMOXAZOL AL FORTE | tbl 20x960mg | APA | D | | | |
| 87758 | ORIPRIM | tbl 100x480mg | CAI | IND | | | |
| 97868 | ORIPRIM | tbl 20x480mg | CAI | IND | | | |
| 258.3 | J01EE01 | sulfamethoxazol a trimethoprim (tekuté lékové formy) | p.o. | 1.92 | GM | 22,39 | |
| | | | | | | | |
@@ -4224,8 +4443,8 @@
| 260.2 | J01FA01 | erythromycin (pevné lékové formy) | p.o. | 1 | GM | 19,09 | |
| | | | | | | | |
| 260.3 | J01FA01 | erythromycin (tekuté lékové formy) | p.o. | 1 | GM | 43,33 | |
| 55585 | MEROMYCIN 200MG/5ML | plv sus 1x100ml | MCK | D | | | |
| 97508 | ERYTHROMYCIN-RATIO.TS 200MG/5ML | plv sus 1x100ml | MCK | D | | | |
| 97508 | ERYTHROMYCIN-RATIOPHARM TS | plv sus 1x100ml | MCK | D | | | |
| 55585 | MEROMYCIN | plv sus 1x100ml | MCK | D | | | |
| 260.4 | J01FA02 | spiramycin | p.o. | 3 | GM | 42,75 | |
| | | | | | | | |
| 260.5 | J01FA05 | oleandomycin | p.o. | 1 | GM | 14,59 | |
@@ -4233,19 +4452,26 @@
| 260.6 | J01FA06 | roxithromycin (do 100 mg v jedné tabletě včetně) | p.o. | 0.3 | GM | 38,67 | |
| | | | | | | | |
| 260.7 | J01FA06 | roxithromycin (nad 100 mg v jedné tabletě) | p.o. | 0.3 | GM | 33,44 | |
| | | | | | | | |
| 10855 | ROXITHROMYCIN-RATIOPHARM 150 MG | por tbl flm10x150mg | MCK | D | | | |
| 10857 | ROXITHROMYCIN-RATIOPHARM 150 MG | por tbl flm14x150mg | MCK | D | | | |
| 10875 | ROXITHROMYCIN-RATIOPHARM 300 MG | por tbl flm10x300mg | MCK | D | | | |
| 260.8 | J01FA07 | josamycin (pevné lékové formy) | p.o. | 2 | GM | 30,08 | |
| | | | | | | | |
| 260.9 | J01FA07 | josamycin (tekuté lékové formy) | p.o. | 1 | GM | 40,45 | |
| | | | | | | | |
| 260.10 | J01FA09 | klarithromycin (pevné lékové formy) | p.o. | 0.5 | GM | 42,75 | |
| | | | | | | | |
| 53282 | FROMILID 250 | tbl obd 14x250mg | KRK | SLO | | | |
| 53283 | FROMILID 500 | tbl obd 14x500mg | KRK | SLO | | | |
| 03750 | LEKOKLAR 250 MG | por tbl flm14x250mg | LEK | SLO | | | |
| 03751 | LEKOKLAR 500 MG | por tbl flm14x500mg | LEK | SLO | | | |
| 260.11 | J01FA09 | klarithromycin (tekuté lékové formy) | p.o. | 0.5 | GM | 66,50 | |
| | | | | | | | |
| 58491 | FROMILID | por gra sus 1x60ml | KRK | SLO | | | |
| 260.12 | J01FA10 | azithromycin (pevné lékové formy do 125 mg v 1 tabletě nebo tobolce včetně) | p.o. | 0.25 | GM | 56,34 | |
| | | | | | | | |
| 260.13 | J01FA10 | azithromycin (pevné lékové formy nad 125 mg v 1 tabletě nebo tobolce) | p.o. | 0.25 | GM | 55,86 | |
| | | | | | | | |
| 10380 | AZITROX 250 | por tbl flm 3x250mg | LEX | CZ | | | |
| 10381 | AZITROX 250 | por tbl flm 6x250mg | LEX | CZ | | | |
| 10382 | AZITROX 500 | por tbl flm 3x500mg | LEX | CZ | | | |
| 260.14 | J01FA10 | azithromycin (tekuté lékové formy) | p.o. | 0.25 | GM | 82,27 | |
| | | | | | | | |
| 260.15 | J01FA13 | dirythromycin | p.o. | 0.5 | GM | 42,75 | |
@@ -4256,13 +4482,15 @@
| 261.1 | J01FA01 | erythromycin | parent. | 1 | GM | 717,50 | K |
| | | | | | | | |
| 261.2 | J01FA02 | spiramycin | parent. | 4,5 | MU | 663,67 | K |
| 78174 | ROVAMYCINE 1.5 M.I.U. | plv inf 1x1.5mu | RSL | F | | | |
| 78174 | ROVAMYCINE PLV.PRO INF.1.5 MIU | plv inf 1x1.5mu | RSL | F | | | |
| 261.3 | J01FA09 | klaritromycin | parent. | 1 | GM | 861,00 | K |
| | | | | | | | |
| 261.4 | J01FA10 | azitromycin | parent. | 0,5 | GM | 474,33 | K |
| 262 | J01FF | linkosamidová antibiotika | p.o. | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 262.1 | J01FF01 | klindamycin (pevné lékové formy) | p.o. | 1.2 | GM | 55,46 | |
| 83458 | DALACIN C | cps 16x300mg | UPJ | B | | | |
| 03365 | DALACIN C | cps 16x150mg | UPJ | B | | | |
| 03365 | DALACIN C 150MG | cps 16x150mg | PAU | B | | | |
| 83458 | DALACIN C 300MG | cps 16x300mg | PAU | B | | | |
| 262.2 | J01FF01 | klindamycin (tekuté lékové formy) | p.o. | 1.2 | GM | 136,53 | |
| | | | | | | | |
| 262.3 | J01FF02 | linkomycin (pevné lékové formy) | p.o. | 1.8 | GM | 29,08 | ATB |
@@ -4280,15 +4508,13 @@
| 264 | J01GA | streptomycin a jeho deriváty | parent. | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 264.1 | J01GA01 | streptomycin | parent. | 1 | GM | 117,10 | |
| 59732 | STREPTOMYCIN GRUNENTHAL 1.0 G | inj sic 1x1gm+solv. | GRU | D | | | |
| 265 | J01GB | aminoglykosidová antibiotika | parent. | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| | | | | | | | |
| 265.1 | J01GB01 | tobramycin (do 40 mg v jedné ampuli včetně) | parent. | 0.24 | GM | 43,84 | U/ATB |
| | | | | | | | |
| 265.2 | J01GB01 | tobramycin (nad 40 mg v jedné ampuli) | parent. | 0.24 | GM | 23,02 | U/ATB |
| | | | | | | | |
| 265.3 | J01GB01 | tobramycin (léková forma - inhalační roztok) | inhal. | 0.6 | GM | 2975,00 | P |
| 265.3 | J01GB01 | tobramycin (léková forma – inhalační roztok) | inhal. | 0.6 | GM | 2975,00 | P |
Tobramycin v inhalační formě je indikován pacientům s cystickou fibrózou infikovaných Pseudomonas aeruginosa, starších 6-ti let.
@@ -4298,7 +4524,7 @@
| | | | | | | | |
| 265.6 | J01GB03 | gentamicin (lékové formy pěny) | lok. | 130 | MG | 2411,98 | U/ATB |
| | | | | | | | |
| 265.7 | J01GB03 | gentamicin (lékové formy kuliček k impiantaci) | imp. | 1 | DF | 152,06 | U/ATB |
| 265.7 | J01GB03 | gentamicin (lékové formy kuliček k implantaci) | imp. | 1 | DF | 152,06 | U/ATB |
| | | | | | | | |
| 265.8 | J01GB05 | neomycin | parent. | 1 | GM | 122,34 | U/ATB |
| | | | | | | | |
@@ -4309,7 +4535,6 @@
| 265.11 | J01GB07 | netilmicin (do 50 mg v jedné ampuli včetně) | parent. | 0.35 | GM | 519,93 | U/ATB |
| | | | | | | | |
| 265.12 | J01GB07 | netilmicin (nad 50 mg v jedné ampuli) | parent. | 0.35 | GM | 304,57 | U/ATB |
| | | | | | | | |
| 265.13 | J01GB11 | isepamicin (do 250 mg včetně v jedné ampuli) | parent. | 1 | GM | 620,27 | U/ATB |
| | | | | | | | |
| 265.14 | J01GB11 | isepamicin (nad 250 mg v jedné ampuli) | parent. | 1 | GM | 516,90 | U/ATB |
@@ -4321,29 +4546,29 @@
| 266.1 | J01MA01 | ofloxacin | p.o. | 0.4 | GM | 24,50 | |
| 12349 | ZANOCIN 200MG | tbl obd 10x200mg | RXY | IND | | | |
| 266.2 | J01MA02 | ciprofloxacin | p.o. | 1 | GM | 24,50 | |
| 69196 | CIPROBID 500 | tbl obd 10x500mg | CAI | IND | | | |
| 87104 | CIFLOXINAL | tbl obd 10x250mg | PMP | CZ | | | |
| 53715 | CIFLOXINAL | tbl obd 200x250mg | PMP | CZ | | | |
| 69195 | CIPROBID 250 | tbl obd 10x250mg | CAI | IND | | | |
| 94453 | CIPRINOL 250 | tbl obd 10x250mg | KRK | SLO | | | |
| 87104 | CIFLOXINAL | tbl obd 10x250mg | PMP | CZ | | | |
| 53202 | CIPHIN 500 | tbl obd 10x500mg | SLO | SK | | | |
| 53201 | CIPHIN 250 | tbl obd 10x250mg | SLO | SK | | | |
| 44988 | CIPLOX 250 | tbl obd 10x250mg | CIA | IND | | | |
| 44986 | CIPLOX 500 | tbl obd 50x500mg | CIA | IND | | | |
| 87105 | CIFLOXINAL | tbl obd 20x250mg | PMP | CZ | | | |
| 64825 | CIFRAN 250 MG | tbl obd 10x250mg | RXS | IND | | | |
| 64827 | CIFRAN 500 MG | tbl obd 10x500mg | RXS | IND | | | |
| 87105 | CIFLOXINAL | tbl obd 20x250mg | PMP | CZ | | | |
| 53201 | CIPHIN 250 | tbl obd 10x250mg | SLO | SK | | | |
| 53202 | CIPHIN 500 | tbl obd 10x500mg | SLO | SK | | | |
| 44988 | CIPLOX 250 | tbl obd 10x250mg | CIA | IND | | | |
| 44989 | CIPLOX 250 | tbl obd 50x250mg | CIA | IND | | | |
| 44985 | CIPLOX 500 | tbl obd 10x500mg | CIA | IND | | | |
| 44986 | CIPLOX 500 | tbl obd 50x500mg | CIA | IND | | | |
| 94453 | CIPRINOL 250 | tbl obd 10x250mg | KRK | SLO | | | |
| 96039 | CIPRINOL 500 | tbl obd 10x500mg | KRK | SLO | | | |
| 44989 | CIPLOX 250 | tbl obd 50x250mg | CIA | IND | | | |
| 69195 | CIPROBID 250 | tbl obd 10x250mg | CAI | IND | | | |
| 69196 | CIPROBID 500 | tbl obd 10x500mg | CAI | IND | | | |
| 266.3 | J01MA03 | pefloxacin | p.o. | 0.8 | GM | 24,50 | |
| 94156 | ABAKTAL | tbl obd 10x400mg | LEK | SLO | | | |
| 266.4 | J01MA04 | enoxacin | p.o. | 0.8 | GM | 20,50 | |
| | | | | | | | |
| 266.5 | J01MA06 | norfloxacin | p.o. | 0.8 | GM | 20,50 | |
| 44091 | GYRABLOCK 400 | tbl obd 1000x400mg | MOE | CY | | | |
| 44090 | GYRABLOCK 400 | tbl obd 500x400mg | MOE | CY | | | |
| 93465 | NOLICIN | tbl 20x400mg | KRK | SLO | | | |
| 44090 | GYRABLOCK 400 | por tblflm500x400mg | MOE | CY | | | |
| 44091 | GYRABLOCK 400 | portblflm1000x400mg | MOE | CY | | | |
| 93465 | NOLICIN | tbl obd 20x400mg | KRK | SLO | | | |
| 266.6 | J01MA07 | lomefloxacin | p.o. | 0.8 | GM | 24,50 | |
| | | | | | | | |
| 266.7 | J01MA08 | fleroxacin | p.o. | 0.4 | GM | 24,50 | |
@@ -4364,10 +4589,10 @@
| --- | --- | --- | --- | --- | --- | --- | --- |
| 267.1 | J01MA01 | ofloxacin | parent. | 0.4 | GM | 212,23 | U/ATB |
| 66137 | OFLOXIN INF | inf 1x100ml/200mg | LEX | CZ | | | |
| 267.2 | J01MA02 | ciprofloxacin - infúze | parent. | 0.5 | GM | 212,23 | U/ATB |
| 59829 | CIPRINOL 100MGZ50ML | inf 1x50ml/100mg | KRK | SLO | | | |
| 267.2 | J01MA02 | ciprofloxacin – infúze | parent. | 0.5 | GM | 212,23 | U/ATB |
| 59829 | CIPRINOL 100MG/50ML | inf 1x50ml/100mg | KRK | SLO | | | |
| 59830 | CIPRINOL 200MG/100ML | inf 1x100ml/200mg | KRK | SLO | | | |
| 267.3 | J01MA02 | ciprofloxacin - injekce | parent. | 0.5 | GM | 190,00 | U/ATB |
| 267.3 | J01MA02 | ciprofloxacin – injekce | parent. | 0.5 | GM | 190,00 | U/ATB |
| | | | | | | | |
| 267.4 | J01MA03 | pefloxacin | parent. | 0.8 | GM | 93,26 | U/ATB |
| 94155 | ABAKTAL | inj 10x5ml/400mg | LEK | SLO | | | |
@@ -4379,12 +4604,12 @@
| 268 | J01XA | ostatní antibiotika | parent. | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 268.1 | J01XA01 | vankomycin | parent. | 2 | GM | 1265,30 | U/ATB |
| 92290 | EDICIN 1GM | inj.sicc.1x1gm | LEK | SLO | | | |
| 92289 | EDICIN 0,5GM | inj.sicc. 1x500mg | LEK | SLO | | | |
| 92289 | EDICIN 0.5 GM | inj plv sol 1x500mg | LEK | SLO | | | |
| 92290 | EDICIN 1GM | inj plv sol 1x1gm | LEK | SLO | | | |
| 268.2 | J01XA02 | teikoplanin | parent. | 0.4 | GM | 2492,83 | U/ATB |
| | | | | | | | |
| 268.3 | J01XB01 | kolistin | parent. | 3 | MU | 109,34 | U/ATB |
| 61178 | COLIMYCINE | inj sic 50x1mu | RBE | F | | | |
| 61178 | COLIMYCINE | inj sic 50x1mu | RDG | GB | | | |
| 268.4 | J01XB02 | polymyxin | parent. | 0.15 | GM | 103,09 | U/ATB |
| | | | | | | | |
| 268.5 | J01XX08 | linezolid | p.o. | 1,2 | GM | 4958,00 | U/ATB |
@@ -4400,7 +4625,7 @@
| 270.2 | J01XD03 | ornidazol | parent. | 1 | GM | 50,44 | U |
| | | | | | | | |
| 270.3 | J01XE01 | nitrofurantoin | p.o. | 0.2 | GM | 3,65 | |
| 90510 | FURANTOIN LECIVA | tbl ent 20x100mg | LEX | CZ | | | |
| 90510 | FURANTOIN LÉČIVA TBL FLM | por tbl ent20x100mg | LEX | CZ | | | |
| 271 | J02AA | antimykotická antibiotika | parent. | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 271.1 | J02AA01 | amfotericin | parent. | 35 | MG | 279,36 | U |
@@ -4443,34 +4668,36 @@
- e) itrakonazol tekuté lékové formy - léčba orální a oesophageální kandidózy a profylakticky u imunokompromitovaných pacientů
| 274.1 | J02AC01 | flukonazol ( pevné lékové formy 150 mg v 1 tabletě ) | p.o. | 0.15 | GM | 203,85 | P |
| 66039 | MYCOMAX 150 | cps 1x150mg | LEX | CZ | | | |
| 59788 | DIFLAZON 150 | cps 1x150mg | KRK | SLO | | | |
| 53917 | FLUCONAZOL 150-SLOVAKOFARMA | cps 1x150mg | SLO | SK | | | |
| 10689 | FORCAN - 150 | por cps dur 1x150mg | CIA | IND | | | |
| 66039 | MYCOMAX 150 | por cps dur 1x150mg | LEX | CZ | | | |
| 47439 | MYCOMAX 150 | por cps dur 3x150mg | LEX | CZ | | | |
| 53917 | FLUCONAZOL 150-SLOVAKOFARMA | cps 1x150mg | SLO | SK | | | |
| 59875 | MYCOSYST 150MG | cps 1x150mg | GED | H | | | |
| 59876 | MYCOSYST 150MG | cps 2x150mg | GED | H | | | |
| 59875 | MYCOSYST 150 MG | cps 1x150mg | GED | H | | | |
| 59876 | MYCOSYST 150 MG | cps 2x150mg | GED | H | | | |
| 10743 | MYCOSYST 150 MG | cps 4x150mg | GED | H | | | |
| 274.2 | J02AC01 | flukonazol - ostatní pevné lékové formy jiné než 150 mg v jedné tabletě | p.o. | 0.2 | GM | 262,18 | P |
| 274.2 | J02AC01 | flukonazol – ostatní pevné lékové formy jiné než 150 mg v jedné tabletě | p.o. | 0.2 | GM | 262,18 | P |
| 59787 | DIFLAZON 100 | cps 28x100mg | KRK | SLO | | | |
| 59790 | DIFLAZON 200 | cps 20x200mg | KRK | SLO | | | |
| 59789 | DIFLAZON 200 | cps 7x200mg | KRK | SLO | | | |
| 59786 | DIFLAZON 50 | cps 7x50mg | KRK | SLO | | | |
| 59790 | DIFLAZON 200 | cps 20x200mg | KRK | SLO | | | |
| 66036 | MYCOMAX 100 | cps 28x100mg | LEX | CZ | | | |
| 66033 | MYCOMAX 50 | cps 28x50mg | LEX | CZ | | | |
| 66037 | MYCOMAX 100 | cps 7x100mg | LEX | CZ | | | |
| 59787 | DIFLAZON 100 | cps 28x100mg | KRK | SLO | | | |
| 55397 | FLUCONAZOL 50-SLOVAKOFARMA | cps 14x50mg | SLO | SK | | | |
| 55396 | FLUCONAZOL 50-SLOVAKOFARMA | cps 7x50mg | SLO | SK | | | |
| 30084 | FORCAN - 50 | por cps dur 7x50mg | CIA | IND | | | |
| 66036 | MYCOMAX 100 | cps 28x100mg | LEX | CZ | | | |
| 66037 | MYCOMAX 100 | cps 7x100mg | LEX | CZ | | | |
| 66033 | MYCOMAX 50 | cps 28x50mg | LEX | CZ | | | |
| 66032 | MYCOMAX 50 | cps 7x50mg | LEX | CZ | | | |
| 59789 | DIFLAZON 200 | cps 7x200mg | I KRK | SLO | | | |
| 274.3 | J02AC01 | flukonazol (do 50 mg v 5 ml sirupu včetně) | p.o. | 0.2 | GM | 479,01 | P |
| 64950 | DIFLUCAN 50MG/5ML | plv sus 1x35ml | PFC | F | | | |
| 66031 | MYCOMAX SIR | sir 1x100ml/500mg | LEX | CZ | | | |
| 64950 | DIFLUCAN 50MG/5ML | plv pro sus 1x35ml | PFC | F | | | |
| 274.4 | J02AC01 | flukonazol (nad 50 do 100mg v 5 ml sirupu včetně) | p.o. | 0.2 | GM | 436,59 | P |
| | | | | | | | |
| 274.5 | J02AC01 | flukonazol - tekuté lékové formy nad 100 mg v 5 ml sirupu | p.o. | 0.2 | GM | 349,25 | P |
| 274.5 | J02AC01 | flukonazol – tekuté lékové formy nad 100 mg v 5 ml sirupu | p.o. | 0.2 | GM | 349,25 | P |
| | | | | | | | |
| 274.6 | J02AC02 | itrakonazol (pevné lékové formy do 400 mg včetně v jednom balení) | p.o. | 0.2 | GM | 95,60 | P |
| | | | | | | | |
| 274.7 | J02AC02 | itrakonazol (pevné lékové formy) nad 400 mg v jednom balení | p.o. | 0.2 | GM | 120,00 | P |
| 274.7 | J02AC02 | itrakonazol (pevné lékové formy) nad 400 mg v jednom balení | p.o. | 0.2 | GM | 114,00 | P |
| | | | | | | | |
| 274.8 | J02AC02 | itrakonazol (tekuté lékové formy) | p.o. | 0.2 | GM | 391,27 | P |
| 56067 | SPORANOX | sol 1x150ml/1.5gm | JAN | B | | | |
@@ -4487,9 +4714,9 @@
| 275.1 | J02AC03 | vorikonazol | parent. | 0.4 | GM | 9.857,80 | U/ATB |
| | | | | | | | |
| 275.2 | J02AC01 | flukonazol | parent. | 0.2 | GM | 550,00 | U/P |
| 58431 | DIFLAZON | inf sol 1x100ml | KRK | SLO | | | |
| 46979 | FLUCONAZOL-SLOVAKOFARMA PRO INF | inf 1x100ml/200mg | SLO | SK | | | |
| 58431 | DIFLAZON | inf 1x100ml/200mg | KRK | SLO | | | |
| 65989 | MYCOMAX INF. | inf 1x100ml/200mg | LEX | CZ | | | |
| 65989 | MYCOMAX INF | inf 1x100ml/200mg | LEX | CZ | | | |
| 275.3 | J02AC02 | itrakonazol | parent. | 0.2 | GM | 3.520,00 | U/ATB |
| | | | | | | | |
| 275.4 | J02AX01 | flucytosin | parent. | 10 | GM | 2710,83 | U/P |
@@ -4503,12 +4730,13 @@
Léčbu rifabutinem ordinuje pneumolog nebo infekcionista: léčba tuberkulózy vyvolané atypickými mykobakteriemi.
| 276.1 | J04AB02 | rifampicin | p.o. | 0.6 | GM | 12,76 | |
| 96780 | ARFICIN | cps 100x300mg | BLU | CHO | | | |
| 96780 | ARFICIN 300 MG | cps 100x300mg | BLU | CHO | | | |
| 276.2 | J04AB04 | rifabutin | p.o. | 0.15 | GM | 125,72 | P |
| 91946 | MYCOBUTIN 150 | cps 30x150mg | PHA | I | | | |
| 277 | J04AB | antibiotika k léčbě tuberkulózy | parent. | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 277.1 | J04AB03 | rifamycin | parent. | 0.6 | GM | 244,40 | |
| | | | | | | | |
| 277.2 | J04AB30 | kapreomycin | parent. | 1 | GM | 553,11 | |
| 278 | J04AC | hydrazidy k léčbě tuberkulózy | p.o. | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
@@ -4520,8 +4748,8 @@
| 279.2 | J04AK02 | ethambutol | p.o. | 1.2 | GM | 12,22 | |
| 280 | J04BA | chemoterapeutika k léčbě lepry | p.o. | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 280.1 | J04BA02 | dapson | p.o. | 50 | MG | 1.37 | |
| 91888 | DISULONE 100 AU PROTOXAL.DE FER | tbl 100x100mg | LVN | F | | | |
| 280.1 | J04BA02 | dapson | p.o. | 50 | MG | 1,37 | |
| 91888 | DISULONE 100MG | tbl 100x100mg+200mg | LVN | F | | | |
| 281 | J05A | antivirotika | p.o. | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
@@ -4539,7 +4767,7 @@
Léčbu inosin pranobexem ordinuje alergolog nebo imunolog u pacientů s prokázanou poruchou imunity.
Léčbu antiretrovirovými léčivy (zidovudin, didanosin, zalcitabin, saquinavir, ritonavir, indavir, stavudin, efavirenz, nevirapin, nelfinav lamivudin a abacavir) indikuje infekcionista pracující v AIDS centrech.
Léčbu antiretrovirovými léčivy (zidovudin, didanosin, zalcitabin, saquinavir, ritonavir, indavir, stavudin, efavirenz, nevirapin, nelfinavir, lamivudin a abacavir) indikuje infekcionista pracující v AIDS centrech.
Léčbu lamivudinem dále indikuje ošetřující lékař u chronické virové hepatitidy typu B.
@@ -4555,55 +4783,56 @@
| --- | --- | --- | --- | --- | --- | --- | --- |
| | | | | | | | |
| 281.2 | J05AB01 | acyklovir do 200 mg včetně | p.o. | 4 | GM | 272,00 | P |
| 84127 | HERPESIN 200 | tbl 25x200mg | LCM | CZ | | | |
| 57068 | ACICLOVIRAL 200 | tbl 25x200mg | APA | D | | | |
| 84127 | HERPESIN 200 | tbl 25x200mg | PVL | CZ | | | |
| 54031 | PROVIRSAN | tbl 30x200mg | PMP | CZ | | | |
| 54213 | RANVIR 200 | tbl 25x200mg | RXG | IND | | | |
| 53608 | XOROX 200MG | tbl 25x200mg | KWI | A | | | |
| 57068 | ACICLOVIR AL 200 | tbl 25x200mg | APA | D | | | |
| 54213 | RANVIR 200 | tbl 25x200mg | RXG | IND | | | |
| 281.3 | J05AB01 | acyklovir nad 200 mg | p.o. | 4 | GM | 225,30 | P |
| 56079 | ACICLOVIR AL 400 | tbl 35x400mg | APA | D | | | |
| 54216 | RANVIR 400 | tbl 25x400mg | RXG | IND | | | |
| 53610 | XOROX 400MG | tbl 60x400mg | KWI | A | | | |
| 53611 | XOROX 800MG | tbl 35x800mg | KWI | A | | | |
| 53610 | XOROX 400MG | tbl 60x400mg | KWI | A | | | |
| 281.4 | J05AB04 | ribavirin | p.o. | 1 | GM | 730,83 | X |
| | | | | | | | |
| 281.4 | J05AB04 | ribavirin | p.o. | 1 | GM | 604,96 | X |
| 58274 | REBETOL 200 MG | por cpsdur168x200mg | SCH | B | | | |
| 281.5 | J05AB06 | gancyklovir | p.o. | 3 | GM | 1960,07 | P |
| 59653 | CYMEVENE 250MG | cps 84x250mg | RPE | GB | | | |
| 59653 | CYMEVENE 250 MG | por cpsdur84x250mg | RPE | GB | | | |
| 281.6 | J05AB09 | famcyklovir | p.o. | 0.75 | GM | 458,88 | P |
| | | | | | | | |
| 281.7 | J05AB11 | valacyklovir | p.o. | 3 | GM | 374,00 | P |
| | | | | | | | |
| 281.8 | J05AB14 | valgancyklovir | p.o. | 0,9 | GM | 2000,00 | P |
| | | | | | | | |
| 97249 | VALCYTE 450 MG | por tbl flm60x450mg | HLR | D | | | |
| 281.9 | J05AE01 | saquinavir | p.o. | 1,8 | GM | 453,70 | P |
| 59463 | FORTOVASE 200 MG | cps 180x200mg | HLR | D | | | |
| 281.10 | J05AE02 | indinavir | p.o. | 2,4 | GM | 453,70 | P |
| | | | | | | | |
| 281.11 | J05AE03 | ritonavir | p.o. | 1.2 | GM | 453,70 | P |
| 281.11 | J05AE03 | ritonavir | p.o. | 1,2 | GM | 453,70 | P |
| 02940 | NORVIR | cps 2x84=168x100mg | ABB | GB | | | |
| 281.12 | J05AE04 | nelfinavir | p.o. | 2,25 | GM | 453,70 | P |
| | | | | | | | |
| 281.13 | J05AE | inhibitory proteáz (lopinavir.ritonavir v kombinaci) | p.o. | 6 | DF | 564,00 | P |
| 281.13 | J05AE | inhibitory proteáz (lopinavir,ritonavir v kombinaci) | p.o. | 6 | DF | 564,00 | P |
| | | | | | | | |
| 281.14 | J05AF01 | zidovudin | p.o. | 1.5 | GM | 685,28 | P |
| | | | | | | | |
| 281.15 | J05AF02 | didanosin | p.o. | 0.4 | GM | 236,43 | P |
| | | | | | | | |
| 281.16 | J05AF03 | zalcitabin | p.o. | 2.25 | MG | 235,25 | P |
| 66734 | HIVID 0.75MG | tbl obd 100x0.75mg | HLR | CH | | | |
| 66733 | HIVID 0.375MG | tbl obd 100x0.375mg | HLR | CH | | | |
| 66733 | HIVID 0.375 MG | tblobd100x0.375mg-b | HLR | CH | | | |
| 66734 | HIVID 0.75 MG | tblobd100x0.75mg-b | HLR | CH | | | |
| 281.17 | J05AF04 | stavudin | p.o. | 80 | MG | 302,07 | P |
| 53209 | ZERIT 40MG | cps 56x40mg | BMS | F | | | |
| 53209 | ZERIT 40 MG | cps 56x40mg | BMS | F | | | |
| 281.18 | J05AF05 | lamivudin do 100 mg v jedné tabletě včetně respektive do 5 mg v jednom mililitru včetně | p.o. | 0,3 | GM | 292,03 | P |
| 02085 | ZEFFIX 100 MG | tbl obd 28x100mg | GOW | GB | | | |
| 02086 | ZEFFIX 100 MG | tbl obd 84x100mg | GOW | GB | | | |
| 02087 | ZEFFIX 5MG/ML | sol 1x240ml/1.2g | GWL | GB | | | |
| 02086 | ZEFFIX 100 MG | tbl obd 84x100mg | GOW | GB | | | |
| 281.19 | J05AF05 | lamivudin nad 100 mg v jedné tabletě respektive nad 5 mq v jednom mililitru | p.o. | 0,3 | GM | 248,01 | P |
| 94802 | ZEFFIX 5MG/ML | sol 1x240ml/1.2g | GWE | D | | | |
| 281.19 | J05AF05 | lamivudin nad 100 mg v jedné tabletě respektive nad 5 mg v jednom mililitru | p.o. | 0,3 | GM | 248,01 | P |
| | | | | | | | |
| 281.20 | J05AF06 | abacavir | p.o. | 600 | MG | 360,00 | P |
| | | | | | | | |
| 281.21 | J05AF30 | abacavir, lamivudin a zidovudin v kombinaci | p.o. | 2 | DF | 852,04 | P |
| 30158 | TRIZIVIR | por tbl flm 1x60 | GOW | GB | | | |
| 30158 | TRIZIVIR | por tbl flm 60 | GOW | GB | | | |
| 281.22 | J05AF30 | jiné kombinace antiretrovirových virostatik (lamivudin a zidovudin) | p.o. | 2 | DF | 522,13 | P |
| | | | | | | | |
| 281.23 | J05AG01 | nevirapin | p.o. | 0,4 | GM | 343,34 | P |
@@ -4625,7 +4854,7 @@
| 281.26 | J05AH02 | oseltamivir | p.o. | 150 | MG | 130,00 | P |
| --- | --- | --- | --- | --- | --- | --- | --- |
Oseltamivir je indikován pro léčbu influenzy A a B u pacientů, kteří z důvodů kontraindikace nebyli očkováni proti influenze nebo tam kde očkování selhalo, u následujících skupin pacientů:
Oseltamivir je indikován pro léčbu influenzy A a B u pacientů, kteří z důvodů kontraindikace nebyli očkování proti influenze nebo tam, kde očkování selhalo, u následujících skupin pacientů:
- 1. děti starší 1 roku s cystickou fibrózou, děti s onkologickým onemocněním na imunosupresivní léčbě
@@ -4636,7 +4865,7 @@
Z veřejného zdravotního pojištění je pro jednu terapeutickou kůru hrazeno jedno balení určené k pětidenní léčbě. Oseltamivir u výše uvedených skupin ordinuje ošetřující lékař pouze v době chřipkové epidemie vyhlášené krajskou hygienickou stanicí.
| 281.27 | J05AX05 | inosin pranobex | p.o. | 1 | GM | 30,55 | P |
| 88174 | ISOPRINOSINE | tbl 5x10(=50)x500mg | EWO | CH | | | |
| 88174 | ISOPRINOSINE | tbl 50x500mg | EWO | CH | | | |
| 282 | J05AB | antivirotika ze skupiny nukloeosidů | parent. | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
@@ -4663,8 +4892,8 @@
- c) profylaxe a léčba CMV infekcí u pacientů u orgánových transplantací.
| 282.1 | J05AB01 | acyklovir | parent. | 4 | GM | 1551,47 | U/P |
| 93260 | HERPESIN 250 | inf sic 10x250mg | PVL | CZ | | | |
| 53607 | XOROX 250MG | inf sic 5x250mg | KWI | A | | | |
| 93260 | HERPESIN 250 | inf sic 10x250mg | PVL | CZ | | | |
| 282.2 | J05AB06 | gancyklovir | parent. | 0.5 | GM | 1568,70 | U/P |
| 02064 | CYMEVENE | inf sic 1x500mg | HLR | CH | | | |
| 282.3 | J05AB12 | cidofovir | parent. | 375 | MG | 33556,50 | U/P |
@@ -4692,27 +4921,27 @@
| 283.2 | J06AA01 | sérum proti záškrtu | parent. | | | plně | K/P |
| | | | | | | | |
| 283.3 | J06AA03 | sérum proti hadímu jedu | parent. | | | plně | K/P |
| 83330 | IPSER EUROPE PASTEUR(ANTIVEN.) | inj 1x5ml | PMX | F | | | |
| 93005 | VIPER VENOM ANTITOXIN | inj 1x5ml/500ut | BIM | PL | | | |
| 283.4 | J06AA04 | sérum proti botulinu | parent. | | | plně | K/P |
| 01190 | BOSEA | inj 1x35ml | SVF | CZ | | | |
| 283.5 | J06AA05 | sérum proti plynaté sněti | parent. | | | plně | K/P |
| 01195 | GASEA | inj 1x20ml/25ku | SVF | CZ | | | |
| 283.6 | J06AA06 | sérum proti vzteklině | parent. | | | plně K/P | |
| 46295 | FAVIRAB | inj sol 1x5ml/1ku | AVS | F | | | |
| 283.6 | J06AA06 | sérum proti vzteklině | parent. | | | plně | K/P |
| 46295 | FAVIRAB | inj 1x5ml/1ku | AVS | F | | | |
| 284 | J06BA | imunoglobuliny, normální lidské | parent. | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 284.1 | J06BA01 | imunoglobuliny, norm. lidské, k extravasální aplikaci do velikosti méně než 5 ml v jedné ampuli | parent. | 1 | DF | 245,80 | O |
| | | | | | | | |
| 57669 | PASTEUR.HUM.IMMUNOGL.GRIFOLS 16 | inj 1x2ml/320mg | GFO | E | | | |
| 284.2 | J06BA01 | imunoglobuliny, norm. lidské, k extravasální aplikaci 5 ml a více v jedné ampuli | parent. | 1 | DF | 600,00 | O |
| | | | | | | | |
| 284.3 | J06BA02 | imunoglobuliny normální lidské pro i.v. aplikaci | parent. | 1 | GM | 956,88 | B |
| 62553 | INTRAGLOBIN F PRO INFUS. | inf 1x50ml | BTP | D | | | |
| 62554 | INTRAGLOBIN F PRO INFUS. | inf 1x100ml | BTP | D | | | |
| 62555 | INTRAGLOBIN F PRO INFUS. | inf 1x200ml | BTP | D | | | |
| 62554 | INTRAGLOBIN F | inf 1x100ml | BTP | D | | | |
| 62555 | INTRAGLOBIN F | inf 1x200ml | BTP | D | | | |
| 62553 | INTRAGLOBIN F | inf 1x50ml | BTP | D | | | |
| 284.4 | J06BA02 | imunoglobuliny normální lidské pro i.v. aplikaci (s obsahem IgM) | parent. | 1 | GM | 1955,16 | U |
| | | | | | | | |
| 284.5 | J06BA | imunoglobuliny, norm. lidské ( k extravasální aplikaci), kombinace s histaminem | parent. | 1 | DF | 89,40 | O |
| 87736 | HISTAGLOBIN | inj sic 3x12mg+sol. | BBL | CH | | | |
| 87736 | HISTAGLOBIN | inj 3x12mg+sol. | BBL | CH | | | |
| 285 | J06BB | specifické imunoglobuliny | parent. | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
@@ -4737,61 +4966,61 @@
Imunoglobulin proti tetanu je hrazen dle symbolu B.
| 285.1 | J06BB12 | protiencefalický globulin | parent. | 1 | ML | 300,65 | K |
| 95084 | FSME-BULIN I.M. | inj 1x5ml | IMM | A | | | |
| 95082 | FSME-BULIN I.M. | inj 1x1ml | IMM | A | | | |
| 95083 | FSME-BULIN I.M. | inj 1x2ml | IMM | A | | | |
| 95082 | FSME-BULIN | inj 1x1ml | BXG | A | | | |
| 95083 | FSME-BULIN | inj 1x2ml | BXG | A | | | |
| 95084 | FSME-BULIN | inj 1x5ml | BXG | A | | | |
| 285.2 | J06BB01 | anti-d (rh) imunoglobulin (do 100 rg v jedné ampuli včetně) | parent. | 250 | RG | 1407,96 | K |
| | | | | | | | |
| 285.3 | J06BB01 | anti-d (rh) imunoglobulin (nad 100 rg v jedné ampuli) | parent. | 250 | RG | 1320,40 | K |
| 57573 | PARTOBULIN S/D | inj 1x1ml/250rg | OIH | A | | | |
| 57573 | PARTOBULIN S/D | inj 1x1ml/250rg | BXG | A | | | |
| 285.4 | J06BB02 | imunoglobulin proti tetanu | parent. | | | plně | B |
| 57804 | PASTEURISED HUM.ANTITET.IG.GRIF | inj 1x1ml/250ut-str | GFO | E | | | |
| 83607 | TETABULIN | inj 250ut/ml | IMM | A | | | |
| 44669 | i PASTEURISED HUM.ANTITET.IG.GRIF | inj sic 1x500ut+2ml | GFO | E | | | |
| 57805 | PASTEURISED HUM.ANTITET.IG.GRIF | inj 1x2ml/500ut-str | GFO | E | | | |
| 44668 | PASTEURISED HUM.ANTITET.IG.GRIF | inj sic 1x250ut+2ml | GFO | E | | | |
| 57805 | PASTEURISED HUM.ANTITET.IG.GRIF | inj 1x2mlZ500ut-str | GFO | E | | | |
| 285.5 | J06BB03 | imunoglobulin proti neštovicím a pásovému oparu | parent. | 1 | KU | 32724,00 | K/P |
| 97894 | VARITECT(R) | inj 1x5ml | BTP | D | | | |
| 97896 | VARITECT(R) | inj 1x50ml | BTP | D | | | |
| 97895 | VARITECT(R) | inj 1x20ml | BTP | D | | | |
| 44669 | PASTEURISED HUM.ANTITET.IG.GRIF | inj sic 1x500ut+2ml | GFO | E | | | |
| 83607 | TETABULIN S/D | injsol1x1ml/250ut+s | BXG | A | | | |
| 285.5 | J06BB03 | imunoglobulin proti neštovícím a pásovému oparu | parent. | 1 | KU | 32724,00 | K/P |
| 97895 | VARITECT | inj 1x20ml/500ut | BTP | D | | | |
| 97896 | VARITECT | inj 1x50ml/1.25ku | BTP | D | | | |
| 97894 | VARITECT | inj 1x5ml/125ut | BTP | D | | | |
| 285.6 | J06BB04 | imunoglobulin proti hepatitidě B | parent. | | | plně | K |
| 97898 | HEPATECT | inj 1x10ml | BTP | D | | | |
| 97897 | HEPATECT | inj 1x2ml | BTP | D | | | |
| 57419 | PASTEURISED HUM.ANTIHEP.B GFO | inj 1x3ml/600ut | GFO | E | | | |
| 57420 | PASTEURISED HUM.ANTIHEP.B GFO | inj 1x5ml/1000ut | GFO | E | | | |
| 57419 | PASTEURISED HUM.ANTIHEP.B GFO | inj 1x3mlZ600ut | GFO | E | | | |
| 97898 | HEPATECT(R) | inj 1x10ml | BTP | D | | | |
| 97897 | HEPATECT(R) | inj 1x2ml | BTP | D | | | |
| 285.7 | J06BB05 | imunoglobulin proti rabies | parent. | plně | K/P | | |
| 46731 | IMOGAM RABIES PASTEURIZED | | inj 1x10ml/1500ut | AVS | F | | |
| 53163 | IMOGAM RABIES PASTEURIZED | | inj 1x2ml/300ut | AVS | F | | |
| 285.7 | J06BB05 | imunoglobulin proti rabies | parent. | | | plně | K/P |
| 46731 | IMOGAM RABIES PASTEURIZED | inj 1x10ml/1500ut | AVS | F | | | |
| 53163 | IMOGAM RABIES PASTEURIZED | inj 1x2ml/300ut | AVS | F | | | |
| 285.8 | J06BB09 | imunoglobulin proti cytomegalovirové infekci | parent. | 1 | GM | 4817,20 | U/P |
| 94864 | CYTOTECT | inf 1x50ml 100mg/ml | BTP | D | | | |
| 94863 | CYTOTECT | inj 1x20ml 100mg/ml | BTP | D | | | |
| 94862 | CYTOTECT | inj 1x10ml 100mg/ml | BTP | D | | | |
| 285.9 | J06BB16 | palivizumab do 50 mg v jedné ampuli včetně | parent. | 1 | DF | 27.645 | X |
| 02106 | SYNAGIS 50MG | inj sic 1x50mg+sol | ABB | I | | | |
| 94862 | CYTOTECT BIOTEST | inf sol 1x10ml-amp | BTP | D | | | |
| 94863 | CYTOTECT BIOTEST | inf sol 1x20ml-amp | BTP | D | | | |
| 94864 | CYTOTECT BIOTEST | inf sol 1x50ml-lah | BTP | D | | | |
| 285.9 | J06BB16 | palivizumab do 50 mg v jedné ampuli včetně | parent | 1 | DF | 27.645 | X |
| 02106 | SYNAGIS 50 MG | inj sic 1x50mg+sol | ABB | I | | | |
| 285.10 | J06BB16 | palivizumab nad 50 mg v jedné ampuli | parent. | 1 | DF | 45.568,00 | X |
| 02143 | SYNAGIS 100MG | inj sic 1x100mg+sol | ABB | I | | | |
| 02143 | SYNAGIS 100 MG | inj sic 1x100mg+sol | ABB | I | | | |
| 286 | J07AM | očkovací látky proti tetanu | parent. | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 286.1 | J07AM01 | tetanový toxoid | parent. | | | plně | K |
| 83445 | TETAVAX | inj 1x10ml | PMX | F | | | |
| 83447 | TETAVAX | inj 10x20ml | PMX | F | | | |
| 83443 | TETAVAX | inj 1x0.5ml-strik. | PMX | F | | | |
| 83525 | TETAVAX | inj 20x0.5ml-ampule | PMX | F | | | |
| 83526 | TETAVAX | inj 10x10ml | PMX | F | | | |
| 83622 | ALTEANA | inj 10x0.5ml | SVF | CZ | | | |
| 83444 | TETAVAX | i inj 20x0.5ml-strik. | PMX | F | | | |
| 83622 | ALTEANA | inj 10x0.5ml/40ut | SVF | CZ | | | |
| 83526 | TETAVAX | inj 10x10ml-lahv. | AVS | F | | | |
| 83447 | TETAVAX | inj 10x20ml-lahv. | AVS | F | | | |
| 83443 | TETAVAX | inj 1x0.5ml-stŘ. | AVS | F | | | |
| 83445 | TETAVAX | inj 1x10ml-lahv. | AVS | F | | | |
| 83525 | TETAVAX | inj 20x0.5ml-amp. | AVS | F | | | |
| 83444 | TETAVAX | inj 20x0.5ml-stŘ. | AVS | F | | | |
| 287 | J07AN | očkovací látky proti tuberkulóze | parent. | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 287.1 | J07AN01 | tuberkulosa, živé atenuované mykobakterium | parent. | 1 | DF | 229,40 | H |
| 58227 | BCG VACCINE SSI | inj sic 10x10dav+so | SST | DK | | | |
| 58228 | BCG VACCINE SSI | inj sic 10x20dav+so | SST | DK | | | |
| 58227 | BCG VACCINE SSI | inj sic 10x10dÁv+so | SST | DK | | | |
| 58228 | BCG VACCINE SSI | inj sic 10x20dÁv+so | SST | DK | | | |
| 288 | J07AX | jiné bakteriální očkovací látky | parent. | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 288.1 | J07AX | jiné bakteriální vakcíny (protistafylokoková vakcína) | parent. | | | plně | K |
| 94269 | POLYSTAFANA | inj 10x0.5ml | SVF | CZ | | | |
| 94269 | POLYSTAFANA | inj 10x0.5ml/5.4ut | SVF | CZ | | | |
| 288.2 | J07AX | jiné bakteriální vakcíny (směs bakterinů) | parent. | 1 | DF | 26,15 | K |
| | | | | | | | |
| 288.3 | J07AX | jiné bakteriální vakcíny (protipseudomonádová vakcína) | parent. | 1 | DF | 206,02 | O |
| 288.3 | J07AX | jiné bakteriální vakcíny (protipseudomo-nádová vakcína) | parent. | 1 | DF | 206,02 | O |
| | | | | | | | |
| 288.4 | J07AX | jiné bakteriální vakcíny (uropatogenní vakcína) | parent. | 1 | DF | 280,47 | O |
@@ -4806,78 +5035,72 @@
| 288.7 | J07AL01 | pneumokoková vakcína | parent. | 1 | DF | 208,70 | O/P |
| | | | | | | | |
| 288.8 | J07AM51 | tetanový anatoxin, kombinace s anatoxinem záškrtu | parent. | 1 | DF | 11,67 | O/P |
| 01221 | ALDITEANA SEVAC | inj 10x0.5ml | SEV | CZ | | | |
| 288.9 | J07BB02 | chřipka, čištěný antigen | parent. | 1 | DF | 188,90 | O/P |
| 12877 | INFLUVAC | injsus10x0.5ml/1dáv | SOO | NL | | | |
| 83429 | VAXIGRIP | inj 1x0.5ml | PMX | F | | | |
| 49482 | INFLUVAC | injsus1x0.5ml/dav. | SOO | NL | | | |
| 01221 | ALDITEANA | inj 10x0.5ml | SVF | CZ | | | |
| 288.9 | J07BB02 | chřipka, čištěný antigen | parent. | 1 | DF | 160,00 | O/P |
| | | | | | | | |
| 288.10 | J07BF03 | dětská obrna, trivalentní, inaktivovaný celý virus | parent. | 1 | DF | 95,30 | O/P |
| | | | | | | | |
| 288.11 | J07BJ01 | zarděnky, živý oslabený virus | parent. | 1 | DF | 74,00 | O/P |
| 88548 | ERVEVAX RUBELLA VACCINE S.C. | inj sic 10dav.+solv | SKX | B | | | |
| 88548 | ERVEVAX RUBELLA VACCINE | inj pso Iqf 10dÁv. | SKX | B | | | |
| 88549 | ERVEVAX RUBELLA VACCINE | inj pso Iqf 50dÁv. | SKX | B | | | |
| 288.12 | J07AH03 | meningokokus, bivalentni čištěný polysacharidový antigen | parent. | 1 | DF | 115,10 | O/P |
| 76063 | MENINGOCOCCAL POLYS.A+C VACCINE | inj 1x1dav.+strik. | PMX | F | | | |
| 288.12 | J07AH03 | meningokokus, bivalentní čištěný polysacharidový antigen | parent. | 1 | DF | 115,10 | O/P |
| 76063 | MENINGOCOCCAL POLYS.A+C VACCINE | inj sic 1x1dav+str | AVS | F | | | |
| 289 | J07BG | očkovací látky proti vzteklině | parent. | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 289.1 | J07BG01 | inaktivovaný celý virus vztekliny | parent. | | | plně | K |
| 93706 | VERORAB | inj sic 1dav.+0.5ml | PMX | F | | | |
| 90996 | RABIPUR | inj sic 5x2.5ut | CBG | D | | | |
| 75379 | RABIPUR | inj sic 1x2.5ut | CBG | D | | | |
| 75379 | RABIPUR | inj sic 1x2.5ut+sol | CBG | D | | | |
| 90996 | RABIPUR | inj sic 5x2.5ut+sol | CBG | D | | | |
| 93706 | VERORAB | inj sic 1dav.+0.5ml | AVS | F | | | |
| 290 | L01AA | alkylační cytostatika | p.o. | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 290.1 | L01AA01 | cyklofosfamid | p.o. | 0.1 | GM | 5,44 | |
| 94174 | CYCLOPHOSPHAMIDE ORION | tbl obd 50x50mg | ONA | SF | | | |
| | | | | | | | |
| 290.2 | L01AA02 | chlorambucil (do 2 mg v jedné tabletě včetně) | p.o. | 1 | MG | 4,50 | |
| 11244 | LEUKERAN | tbl obd 25x2mg | GWE | GB | | | |
| | | | | | | | |
| 290.3 | L01AA02 | chlorambucil (nad 2 mg v jedné tabletě) | p.o. | 1 | MG | 3,72 | |
| | | | | | | | |
| 290.4 | L01AA03 | melfalan (do 2 mg v jedné tabletě včetně) | p.o. | 1 | MG | 4,30 | |
| 32213 | ALKERAN 2 MG | por tbl obd 25x2mg | GOK | GB | | | |
| | | | | | | | |
| 290.5 | L01AA03 | melfalan (nad 2 mg v jedné tabletě) | p.o. | 1 | MG | 2,88 | |
| | | | | | | | |
| 290.6 | L01AA08 | prednimustin | p.o. | 1 | MG | 3,62 | |
| | | | | | | | |
| 290.7 | L01AX03 | temozolomid | p. o. | 370 | MG | 15992,78 | X |
| 66104 | TEMODAL 100MG | cps 5x100mg | SCH | B | | | |
| 66109 | TEMODAL 20MG | cps 5x20mg | SCH | B | | | |
| 66106 | TEMODAL 250MG | cps 5x250mg | SCH | B | | | |
| 290.7 | L01AX03 | temozolomid | p.o. | 370 | MG | 15193,15 | X |
| 291 | L01AA | alkylační cytostatika | parent. | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 291.1 | L01AA01 | cyklofosfamid | parent. | 10 | MG | 3,52 | B |
| 10777 | CYTOXAN 1 G | inj sic 6x1gm | BMS | POR | | | |
| 10776 | CYTOXAN 500 MG | inj sic 12x500mg | BMS | POR | | | |
| | | | | | | | |
| 291.2 | L01AA03 | melfalan | parent. | 1 | MG | 12,61 | B/ONK,HEM |
| 32508 | ALKERAN | inj pso Iqf 50mg | GOK | GB | | | |
| 32507 | ALKERAN | inj pso lqf 50mg | GXW | I | | | |
| | | | | | | | |
| 291.3 | L01AA05 | chlormethin | parent. | 1 | MG | 34,22 | B/ONK,HEM |
| | | | | | | | |
| 291.4 | L01AA06 | ifosfamid (do 500 mg v jedné ampuli včetně) | parent. | 1 | MG | 1,42 | B/ONK,HEM |
| | | | | | | | |
| 291.5 | L01AA06 | ifosfamid (nad 500 mg v jedné ampuli) | parent. | 1 | MG | 1,32 | B/ONK,HEM |
| 32275 | HOLOXAN 2 G | inj sic 1x2gm | HOD | D | | | |
| 70469 | HOLOXAN 2GM | inj sic 1x2gm | ASD | D | | | |
| 32275 | HOLOXAN 2 G | inj plv sol 1x2gm | HOD | D | | | |
| 70469 | HOLOXAN 2 G | inj plv sol 1x2gm | ASD | D | | | |
| 291.6 | L01AC01 | thiotepa | parent. | 1 | MG | 21,31 | B/ONK,HEM |
| | | | | | | | |
| 291.7 | L01AX04 | dakarbazin | parent. | 10 | MG | 7.90 | B/ONK,HEM |
| 89999 | DACARBAZIN LACHEMA 1000 | inj sic 1x1000mg | LCM | CZ | | | |
| 88560 | DACARBAZIN LACHEMA 500 | inj sic 1x500mg | LCM | CZ | | | |
| 88441 | DACARBAZIN LACHEMA 200 | inj sic 10x200mg | LCM | CZ | | | |
| 88561 | DACARBAZIN LACHEMA 500 | inj sic 5x500mg | LCM | CZ | | | |
| 88440 | DACARBAZIN LACHEMA 100 | inj sic 10x100mg | LCM | CZ | | | |
| 90000 | DACARBAZIN LACHEMA 1000 | inj sic 5x1000mg | LCM | CZ | | | |
| 292 | L01AB | alkylsulfaty p.o. | | | | | |
| 291.7 | L01AX04 | dakarbazin | parent. | 10 | MG | 7,90 | B/ONK,HEM |
| 88440 | DACARBAZIN LACHEMA 100 | inj sic 10x100mg | PVL | CZ | | | |
| 89999 | DACARBAZIN LACHEMA 1000 | inj sic 1x1000mg | PVL | CZ | | | |
| 90000 | DACARBAZIN LACHEMA 1000 | inj sic 5x1000mg | PVL | CZ | | | |
| 88441 | DACARBAZIN LACHEMA 200 | inj sic 10x200mg | PVL | CZ | | | |
| 88560 | DACARBAZIN LACHEMA 500 | inj sic 1x500mg | PVL | CZ | | | |
| 88561 | DACARBAZIN LACHEMA 500 | inj sic 5x500mg | PVL | CZ | | | |
| 292 | L01AB | alkylsulfaty | p.o. | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 292.1 | L01AB01 | busulfán (do 0,5 mg v jedné tabletě včetně) | p.o. | 1 | MG | 14,86 | L/ONK,HEM |
| | | | | | | | |
| 292.2 | L01AB01 | busulfán (nad 0,5 mg v jedné tabletě) | p.o. | 1 MG | 4,89 | L/ONK,HEM | |
| 292.2 | L01AB01 | busulfán (nad 0,5 mg v jedné tabletě) | p.o. | 1 | MG | 4,89 | L/ONK,HEM |
| 293 | L01AD | nitrosomočoviny | p.o. | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 293.1 | L01AD02 | lomustin (do 10 mg v jedné tabletě včetně) | p.o. | 1 | MG | 5,72 | L/ONK,HEM |
| | | | | | | | |
| 293.2 | L01AD02 | lomustin (nad 10 do 40 mg v jedné tabletě včetně) | p.o. | 1 | MG | 5,63 | L/ONK,HEM |
| | | | | | | | |
| 64652 | CEENU LOMUSTINE (CCNU) 40 MG | cps 20x40mg | BMS | I | | | |
| 293.3 | L01AD02 | lomustin (nad 40 mg v jedné tabletě) | p.o. | 1 | MG | 4,39 | L/ONK,HEM |
| 64653 | CEENU LOMUSTINE (CCNU) 100 MG | cps 20x100mg | BMS | I | | | |
| 294 | L01AD | nitrosomočoviny | parent. | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 294.1 | L01AD01 | karmustin | parent. | 1 | MG | 9,92 | B/ONK,HEM |
@@ -4888,43 +5111,43 @@
| 295 | L01BA | antimetabolity ze skupiny analog kyseliny listové | p.o. | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 295.1 | L01BA01 | metotrexát | p.o. | 1 | MG | 1,52 | |
| 91922 | METHOTREXAT LACHEMA 10 | tbl 100x10mg | LCM | CZ | | | |
| 91065 | METHOTREXAT LACHEMA 2.5 | tbl 100x2.5mg | LCM | CZ | | | |
| 91922 | METHOTREXAT LACHEMA 10 | tbl 100x10mg | PVL | CZ | | | |
| 91065 | METHOTREXAT LACHEMA 2.5 | tbl 100x2.5mg | PVL | CZ | | | |
| 296 | L01BA | antimetabolity ze skupiny analog kyseliny listové | parent. | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 296.1 | L01BA01 | metotrexát (do 5 mg v jedné ampuli včetně) | parent. | 1 | MG | 9,09 | B |
| 91025 | METHOTREXAT LACHEMA 5 | inj 10x2ml/5mg | LCM | CZ | | | |
| 10827 | METHOTREXATE-TEVA 2.5MG/ML | inj 5x2ml/5mg | PHM | NL | | | |
| 91922 | METHOTREXAT LACHEMA 10 | tbl 100x10mg | PVL | CZ | | | |
| 91065 | METHOTREXAT LACHEMA 2.5 | tbl 100x2.5mg | PVL | CZ | | | |
| 296.2 | L01BA01 | metotrexát (nad 5 do 500 mg v jedné ampuli včetně) | parent. | 1 | MG | 3,23 | B |
| 87564 | METHOTREXAT LACHEMA 50 | inj sic 10x50mg | LCM | CZ | | | |
| 64784 | METHOTREXAT EBEWE | inf 1x5ml/500mg | EBW | A | | | |
| 64784 | METHOTREXAT EBEWE | inf 1x5ml/500mg | EBP | A | | | |
| 93963 | METHOTREXAT LACHEMA 20 | inj 10x2ml/20mg | PVL | CZ | | | |
| 91025 | METHOTREXAT LACHEMA 5 | inj 10x2ml/5mg | PVL | CZ | | | |
| 93964 | METHOTREXAT LACHEMA 50 | inj 10x5ml/50mg | PVL | CZ | | | |
| 87564 | METHOTREXAT LACHEMA 50 | inj sic 10x50mg | PVL | CZ | | | |
| 87761 | METHOTREXAT LACHEMA 500 | inj sic 10x500mg | LCM | CZ | | | |
| 11195 | METHOTREXATE-TEVA 25MG/ML | inj 1x20ml/500mg-la | PHM | NL | | | |
| 11191 | METHOTREXATE-TEVA 25MG/ML | inj 1x2ml/50mg-lah | PHM | NL | | | |
| 11193 | METHOTREXATE-TEVA 25MG/ML | inj 1x4ml/100mg-lah | PHM | NL | | | |
| 11194 | METHOTREXATE-TEVA 25MG/ML | inj 1x8ml/200mg-lah | PHM | NL | | | |
| 93963 | METHOTREXAT LACHEMA 20 | inj 10x2ml/20mg | LCM | CZ | | | |
| 93964 | METHOTREXAT LACHEMA 50 | inj 10x5ml/50mg | LCM | CZ | | | |
| 11191 | METHOTREXATE-TEVA 25MG/ML | inj 1x2ml/50mg-lahv | PHM | NL | | | |
| 11193 | METHOTREXATE-TEVA 25MG/ML | inj 1x4ml/100mg-lah | PHM | NL | | | |
| 11192 | METHOTREXATE-TEVA 25MG/ML | inj 5x2ml/50mg-amp. | PHM | NL | | | |
| 11192 | METHOTREXATE-TEVA 25MG/ML | inj 5x2ml/50mg-amp | PHM | NL | | | |
| 296.3 | L01BA01 | metotrexát (nad 500 mg v jedné ampuli) | parent. | 10 | MG | 4,89 | B |
| 93965 | METHOTREXAT LACHEMA 1000 | inj 10x20ml/1000mg | LCM | CZ | | | |
| 93965 | METHOTREXAT LACHEMA 1000 | inj 10x20ml/1000mg | PVL | CZ | | | |
| 296.4 | L01BA03 | raltitrexed | parent. | 1 | DF | 7498,20 | X |
| 65351 | TOMUDEX | inj sic 1x2mg | AZC | GB | | | |
| 297 | L01BB | antimetabolity ze skupiny analog purinů | p.o. | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 297.1 | L01BB02 | merkaptopurin | p.o. | 10 | MG | 6,21 | L/ONK,HEM |
| 94241 | PURI-NETHOL | tbl 25x50mg | BWE | GB | | | |
| 297.2 | L01BB03 | tioguanin | p.o. | 10 | MG | 9.34 | L/ONK,HEM |
| 297.2 | L01BB03 | tioguanin | p.o. | 10 | MG | 9,34 | L/ONK,HEM |
| | | | | | | | |
| 297.3 | L01BB05 | fludarabin | p.o. | 1 | MG | 87,20 | L/ONK,HEM |
| 58897 | FLUDARA | tbl obd 15x10mg | SAG | D | | | |
| 58898 | FLUDARA | tbl obd 20x10mg | SAG | D | | | |
| 58897 | FLUDARA | tbl obd 15x10mg | SAG | D | | | |
| 298 | L01BB | antimetabolity ze skupiny analog purinů | parent. | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 298.1 | L01BB04 | cladribin | parent. | 1 | MG | 884,61 | B/ONK,HEM |
| | | | | | | | |
| 298.2 | L01BB05 | fludarabin | parent. | 1 | MG | 126,51 | B/ONK,HEM |
| 77008 | FLUDARA I.V. | inj sic 5x50mg | SAG | D | | | |
| 77008 | FLUDARA | inj sic 5x50mg | SAG | D | | | |
| 299 | L01BC | antimetabolity ze skupiny analog pyrimidinu | p.o. | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 299.1 | L01BC | azaribin | p.o. | 1 | MG | 8,50 | L/ONK,HEM |
@@ -4940,33 +5163,26 @@
| 300 | L01BC | antimetabolity ze skupiny analog pyrimidinu | parent. | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 300.1 | L01BC01 | cytarabin (do 100 mg v jedné ampuli včetně) | parent. | 1 | MG | 1,27 | B/ONK,HEM |
| 99483 | ALEXAN (LAHVICKY) | inj 10x5ml/100mg | MAC | D | | | |
| 99484 | ALEXAN (LAHVICKY) | inj 30x2ml/40mg | MAC | D | | | |
| 08796 | CYTOSAR 100MG | inj sic 1x100mg+5ml | UPJ | B | | | |
| 99483 | ALEXAN 100MG/5ML | inj 10x5ml/100mg | PFC | F | | | |
| 99484 | ALEXAN 40MG/2ML | inj 30x2ml/40mg | PFC | F | | | |
| 08796 | CYTOSAR 100 MG | inj sic 1x100mg+sol | PPU | B | | | |
| 300.2 | L01BC01 | cytarabin (nad 100 mg v jedné ampuli) | parent. | 1 | MG | 1,03 | B/ONK,HEM |
| 65423 | CYTOSAR 1GM | inj sic 1x1000mg | UPJ | B | | | |
| 96990 | ALEXAN (LAHVICKY) | inj 1x20ml/1000mg | MAC | D | | | |
| 85837 | CYTOSAR 500MG | inj sic 500mg+10ml | UPJ | B | | | |
| 96990 | ALEXAN 1000MG/20ML | inj 1x20ml/1000mg | UPJ | B | | | |
| 65423 | CYTOSAR 1 G | inj sic 1x1gm | PPU | B | | | |
| 85837 | CYTOSAR 500 MG | inj sic 1x500mg+sol | PPU | B | | | |
| 300.3 | L01BC02 | fluorouracil | parent. | 10 | MG | 2,66 | B/ONK,HEM |
| 32753 | FLUORO-URACIL ICN | injsol 1x100ml/5gm | SOC | CH | | | |
| 12667 | 5-FLUOROURACIL EBEWE | inj 1x100ml/5000mg | EBP | A | | | |
| 12665 | 5-FLUOROURACIL EBEWE | inj 1x10ml/500mg | EBP | A | | | |
| 12666 | 5-FLUOROURACIL EBEWE | inj 1x20ml/1000mg | EBP | A | | | |
| 56055 | 5-FLUOROURACIL EBEWE | inj 1x5ml/250mg | EBP | A | | | |
| 11175 | FLUOROURACIL-TEVA | inj 1x20ml/1000mg | PHM | NL | | | |
| 32752 | FLUORO-URACIL ICN | injsol 5x20ml/1gm | SOC | CH | | | |
| 11173 | FLUOROURACIL-TEVA | inj 1x10ml/500mg | PHM | NL | | | |
| 11394 | LA-FU 50 MG/ML | inj 10x10ml/500mg | PVL | CZ | | | |
| 11117 | LA-FU 50 MG/ML | inj 1x20ml/1000mg | PVL | CZ | | | |
| 32750 | FLUORO-URACIL ICN | injsol 10x5ml/250mg | SOC | CH | | | |
| 11171 | FLUOROURACIL-TEVA | inj 1x5ml/250mg | PHM | NL | | | |
| 32752 | FLUORO-URACIL ICN | inj sol 5x20ml/1gm | IAB | CH | | | |
| 32753 | FLUORO-URACIL ICN | inj sol1x100ml/5gm | IAB | CH | | | |
| 32761 | FLUOROURACIL-TEVA | inj sol 1x100ml/5gm | PHM | NL | | | |
| 11393 | LA-FU 50 MG/ML | inj 1x10ml/500mg | PVL | CZ | | | |
| 32751 | FLUORO-URACIL ICN | injsol 5x10ml/500mg | SOC | CH | | | |
| 11100 | LA-FU 50 MG/ML | inj 10x5ml/250mg | PVL | CZ | | | |
| 58240 | FLUORO-URACIL ICN | inj sol 5x5ml/250mg | SOC | CH | | | |
| 11173 | FLUOROURACIL-TEVA | inj sol1x10ml/500mg | PHM | NL | | | |
| 11175 | FLUOROURACIL-TEVA | injsol1x20ml/1000mg | PHM | NL | | | |
| 11394 | LA-FU 50 MG/ML | inj sol 10x10ml | PVL | CZ | | | |
| 11393 | LA-FU 50 MG/ML | inj sol 1x10ml | PVL | CZ | | | |
| 57650 | LA-FU 500 | inj 1x10ml/500mg | LCM | CZ | | | |
| 11101 | LA-FU 50 MG/ML | inj 5x20ml/1000mg | PVL | CZ | | | |
| 12665 | 5-FLUOROURACIL EBEWE | inj 1x10ml/500mg | EBP | A | | | |
| 12667 | 5-FLUOROURACIL EBEWE | inj 1x100ml/5000mg | EBP | A | | | |
| 12666 | 5-FLUOROURACIL EBEWE | inj 1x20ml/1000mg | EBP | A | | | |
| 300.4 | L01BC03 | tegafur | parent. | 10 | MG | 2,83 | B/ONK,HEM |
| | | | | | | | |
| 300.5 | L01BC05 | gemcitabin | parent. | 1 | MG | 5,87 | X |
@@ -4975,83 +5191,88 @@
| 301.1 | L01CA01 | vinblastin | parent. | 1 | MG | 26,54 | B/ONK,HEM |
| | | | | | | | |
| 301.2 | L01CA02 | vinkristin | parent. | 1 | MG | 165,00 | B/ONK,HEM |
| 11420 | VINCRISTINE-TEVA | inj 1x1ml/1mg | PHM | NL | | | |
| 11421 | VINCRISTINE-TEVA | inj 1x2ml/2mg | PHM | NL | | | |
| 11422 | VINCRISTINE-TEVA | inj 1x5ml/5mg | PHM | NL | | | |
| 11420 | VINCRISTINE-TEVA | inj 1x1ml/1mg | PHM | NL | | | |
| 301.3 | L01CA04 | vinorelbin | parent. | 1 | MG | 108,27 | X |
| 98203 | NAVELBINE | inj 10x5ml/50mg | PFB | F | | | |
| 98203 | NAVELBINE | inj sol 10x5ml/50mg | PFD | F | | | |
| 301.4 | L01CA04 | vinorelbin | p.o. | 1 | MG | 114,06 | X |
| 05924 | NAVELBINE ORAL 20 MG | por cps mol 1x20mg | PFD | F | | | |
| 05925 | NAVELBINE ORAL 30 MG | por cps mol 1x30mg | PFD | F | | | |
| 05926 | NAVELBINE ORAL 40 MG | por cps mol 1x40mg | PFD | F | | | |
| 05927 | NAVELBINE ORAL 80 MG | por cps mol 1x80mg | PFD | F | | | |
| 05926 | NAVELBINE ORAL 40 MG | por cps mol 1x40mg | PFD | F | | | |
| 05924 | NAVELBINE ORAL 20 MG | por cps mol 1x20mg | PFD | F | | | |
| 302 | L01CB | podofylotoxinové deriváty | p.o. | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 302.1 | l01cb01 | etoposid | p.o. | 1 | MG | 3,05 | L/ONK,HEM |
| 97401 | VEPESID | cps 20x50mg | | BMS | I | | |
| 86710 | VEPESID | cps 10x100mg | | BMS | I | | |
| 93697 | LASTET | cps 20x50mg | | NKU | J | | |
| 93696 | LASTET | cps 40x25mg | | NKU | J | | |
| 93698 | LASTET | cps 10x100mg | | NKU | J | | |
| 302.1 | L01CB01 | etoposid | p.o. | 1 | MG | 3,05 | L/ONK,HEM |
| 93698 | LASTET 100 | cps 10x100mg | NKU | J | | | |
| 93696 | LASTET 25 | cps 40x25mg | NKU | J | | | |
| 93697 | LASTET 50 | cps 20x50mg | NKU | J | | | |
| 86710 | VEPESID 100MG | cps 10x100mg | BMS | I | | | |
| 97401 | VEPESID 50MG | cps 20x50mg | BMS | I | | | |
| 303 | L01CB | podofylotoxinové deriváty | parent. | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 303.1 | L01CB01 | etoposid | parent. | 1 | MG | 3,02 | B/ONK,HEM |
| 11389 | ETOPOSIDE-TEVA | inf cnc 1x5ml/100mg | PHM | NL | | | |
| 11390 | ETOPOSIDE-TEVA | inf cnc1x10ml/200mg | PHM | NL | | | |
| 11389 | ETOPOSIDE-TEVA | inf cnc 1x5ml/100mg | PHM | NL | | | |
| 86709 | VEPESID | inf cnc10x5ml/100mg | BMS | I | | | |
| 303.2 | L01CB02 | teniposid | parent. | 1 | MG | 6,06 | B/ONK,HEM |
| 304 | L01CD | taxany | parent. | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 304.1 | L01CD01 | paclitaxel | parent. | 1 | MG | 140,25 | X |
| 45155 | PAXENE | inf cnc 25ml/150mg | IVX | CZ | | | |
| 05952 | PAXENE | inf cnc16.7ml/100mg | IVX | CZ | | | |
| 05953 | PAXENE | inf cnc 50ml/300mg | IVX | CZ | | | |
| 45154 | PAXENE | inf cnc 1x5ml/30mg | IVX | CZ | | | |
| 45155 | PAXENE | inf cnc sol 1x25ml | IVX | CZ | | | |
| 05953 | PAXENE | inf cnc sol 1x50ml | IVX | CZ | | | |
| 45154 | PAXENE | inf cnc sol 1x5ml | IVX | CZ | | | |
| 05952 | PAXENE | inf cnc sol1x16.7ml | IVX | CZ | | | |
| 304.2 | L01CD02 | docetaxel | parent. | 1 | MG | 245,83 | X |
| 305 | L01DA | aktinomyciny | parent. | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 305.1 | L01DA01 | daktinomycin | parent. | 1 | MG | 664,85 | B/ONK,HEM |
| 306 | L01DB | antracykliny a jejich deriváty | p.o. | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 306.1 | L01DB06 | idarubicin | p.o. | 1 | MG | 274.70 | X |
| 78814 | ZAVEDOS 25MG | cps 1x25mg | FAR | I | | | |
| 78813 | ZAVEDOS 10MG | cps 1x10mg | FAR | I | | | |
| 78812 | ZAVEDOS 5MG | cps 1x5mg | FAR | I | | | |
| 306.1 | L01DB06 | idarubicin | p.o. | 1 | MG | 274,70 | X |
| 78813 | ZAVEDOS 10 MG | por cps dur 1x10mg | PAU | I | | | |
| 78814 | ZAVEDOS 25 MG | por cps dur 1x25mg | PAU | I | | | |
| 78812 | ZAVEDOS 5 MG | por cps dur 1x5mg | PAU | I | | | |
| 307 | L01DB | antracykliny a jejich deriváty | parent. | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 307.1 | L01DB01 | doxorubicin (do 40 mg včetně v jedné ampuli) | parent. | 1 | MG | 33,58 | B/ONK,HEM |
| 12663 | DOXORUBICIN EBEWE 10 MG | inj 1x5ml/10mg | EBP | A | | | |
| 30949 | DOXORUBICIN LACHEMA 10 | inj plv sol 1x10mg | PVL | CZ | | | |
| 12663 | DOXORUBICIN EBEWE 10MG | inj 1x5ml/10mg | EBW | A | | | |
| 32975 | DOXORUBICIN-TEVA 0.2% | inj sol 1x10mg/5ml | PHM | NL | | | |
| 307.2 | L01DB01 | doxorubicin (nad 40 mg v jedné ampuli) | parent. | 1 | MG | 32,18 | B/ONK,HEM |
| 12664 | DOXORUBICIN EBEWE 50 MG | inj 1x25ml/50mg | EBP | A | | | |
| 30950 | DOXORUBICIN LACHEMA 50 | inj plv sol 1x50mg | PVL | CZ | | | |
| 12664 | DOXORUBICIN EBEWE 50MG | inj 1x25ml/50mg | EBW | A | | | |
| 307.3 | L01DB02 | daunorubicin | parent. | 1 | MG | 19.21 | B/ONK,HEM |
| | | | | | | | |
| 307.4 | L01DB03 | epirubicin | parent. | 1 | MG | 35.85 | B/ONK,HEM |
| 58289 | FARMORUBICIN PFS | inj 1x25ml/50mg | PUH | I | | | |
| 307.5 | L01DB04 | aklarubicin | parent. | 1 | MG | 19.21 | B/ONK,HEM |
| 32977 | DOXORUBICIN-TEVA 0.2% | inj sol 1x50mg/25ml | PHM | NL | | | |
| 32978 | DOXORUBICIN-TEVA 0.2% | injsol1x200mg/100ml | PHM | NL | | | |
| 307.3 | L01DB02 | daunorubicin | parent. | 1 | MG | 19,21 | B/ONK,HEM |
| | | | | | | | |
| 307.4 | L01DB03 | epirubicin | parent. | 1 | MG | 35,85 | B/ONK,HEM |
| | | | | | | | |
| 307.5 | L01DB04 | aklarubicin | parent. | 1 | MG | 19,21 | B/ONK,HEM |
| | | | | | | | |
| 307.6 | L01DB05 | zorubicin | parent. | 1 | MG | 19,21 | B/ONK,HEM |
| | | | | | | | |
| 307.7 | L01DB06 | idarubicin | parent. | 1 | MG | 753,57 | B/ONK,HEM |
| | | | | | | | |
| 01181 | ZAVEDOS | inj sic 1x10mg | PIR | I | | | |
| 307.8 | L01DB07 | mitoxantron | parent. | 1 | MG | 53,96 | B/ONK,HEM |
| 54033 | REFADOR | inj cnc 1x15ml/30mg | PVL | CZ | | | |
| 54033 | REFADOR 2MG/ML | inf cnc1x15ml/30mg | PVL | CZ | | | |
| 308 | L01DC | ostatní cytotoxická antibiotika | parent. | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 308.1 | L01DC01 | bleomycin | parent. | 1 | MG | 66,36 | B/ONK,HEM |
| 03404 | BLEOCIN | inj 1x15mg | NKU | J | | | |
| 308.2 | L01DC03 | mitomycin (do 2 mg v jedné ampuli včetně) | parent. | 1 | MG | 76,25 | B/ONK,HEM |
| | | | | | | | |
| 308.3 | L01DC03 | mitomycin (nad 2 mg v jedné ampuli) | parent. | 1 | MG | 70,36 | B/ONK,HEM |
| 308.1 | L01DC01 | bleomycin | parent. | 1 | MG | 56,93 | B/ONK,HEM |
| 03404 | BLEOCIN | inj sic 1x15mg | NKU | J | | | |
| 308.2 | L01DC03 | mitomycin (do 2 mg v jedné ampuli včetně) | parent. | 1 | MG | 75,46 | B/ONK,HEM |
| 10630 | MITOMYCIN C KYOWA | inj plv sol 10x2mg | KYA | J | | | |
| 308.3 | L01DC03 | mitomycin (nad 2 mg v jedné ampuli) | parent. | 1 | MG | 67.07 | B/ONK,HEM |
| 83440 | MITOMYCIN C KYOWA | inj plv sol 5x20mg | KYA | J | | | |
| 309 | L01XA | platinová cytostatika | parent. | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 309.1 | L01XA01 | cisplatina | parent. | 1 | MG | 8,21 | B/ONK,HEM |
| 96454 | PLATIDIAM | inj 5x25mg/50ml | LCM | CZ | | | |
| 92302 | CISPLATIN EBEWE | inf 1x100ml/50mg | EBW | A | | | |
| 96453 | PLATIDIAM | inj 10x10mg/20ml | LCM | CZ | | | |
| 96455 | PLATIDIAM | inj 1x50mg/100ml | LCM | CZ | | | |
| 92302 | CISPLATIN EBEWE | inf cnc sol 1x100ml | EBP | A | | | |
| 96453 | PLATIDIAM 10 | inf cnc sol 10x20ml | PVL | CZ | | | |
| 96454 | PLATIDIAM 25 | inf cnc sol 5x50ml | PVL | CZ | | | |
| 96455 | PLATIDIAM 50 | inf cnc sol 1x100ml | PVL | CZ | | | |
| 309.2 | L01XA02 | karboplatina (do 50 mg v jedné ampuli včetně) | parent. | 1 | MG | 6,70 | B/ONK,HEM |
| 10828 | CARBOPLATIN-TEVA | inj 1x5ml/50mg | PHM | NL | | | |
| 75010 | CYCLOPLATIN 50 | inf cnc sol 1x5ml | PVL | CZ | | | |
| 90777 | CYCLOPLATIN 50 | inf plv sol 10x50mg | PVL | CZ | | | |
| 309.3 | L01XA02 | karboplatina (nad 50 mg v jedné ampuli) | parent. | 1 | MG | 3,86 | B/ONK,HEM |
@@ -5059,47 +5280,56 @@
| 93665 | CYCLOPLATIN 200 | inf plv sol 5x200mg | PVL | CZ | | | |
| 310 | L01XB | methylhydrazinová cytostatika | p.o. | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 310.1 | L01XB01 | prokarbazin | p.o. | 10 | MG | 2.44 | L/ONK,HEM |
| 310.1 | L01XB01 | prokarbazin | p.o. | 10 | MG | 2,44 | L/ONK,HEM |
| 311 | L01XX | ostatní cytostatika | p.o. | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 311.1 | L01XX05 | hydroxymočovina | p.o. | 0.1 | GM | 2,23 | L/ONK,HEM, URN |
| | | | | | | | |
| 311.2 | L01XX11 | estramustin | p.o. | 10 | MG | 3,91 | L/ONK,HEM, URN |
| 58742 | ESTRACYT | cps 100x140mg | PUA | I | | | |
| 08921 | ESTRACYT | cps 100x140mg | PHA | S | | | |
| 311.3 | L01XX14 | tretinoin | p.o. | 10 | MG | 101,68 | L/ONK,HEM, URN |
| 84009 | VESANOID | cps 100x10mg | HLR | CH | | | |
| 311.1 | L01XX05 | hydroxymočovina | p.o. | 0.1 | GM | 2,23 | L/ONK,HEM,URN |
| | | | | | | | |
| 311.2 | L01XX11 | estramustin | p.o. | 10 | MG | 3,45 | L/ONK,HEM,URN |
| | | | | | | | |
| 311.3 | L01XX14 | tretinoin | p.o. | 10 | MG | 98,65 | L/ONK,HEM,URN |
| | | | | | | | |
| 311.4 | L01XX28 | imatinib | p.o. | 400 | MG | 2672,95 | X |
| 40199 | GLIVEC 100MG | cps 120x100mg | NPF | CH | | | |
| 40199 | GLIVEC 100 MG | por cpsdur120x100mg | NPA | CH | | | |
| 312 | L01XX | ostatní cytostatika | parent. | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 312.1 | L01XC04 | alemtuzumab | parent. | 1 | MG | 442.20 | X |
| 312.2 | L01XC02 | rituximab | parent. | 10 | MG | 1234,71 | X |
| 59839 | MABTHERA 100MG | inf 2x10ml/100mg | HLR | D | | | |
| 46130 | MABTHERA 500MG | inf 1x50ml/500mg | HLR | D | | | |
| 312.3 | L01XC03 | trastuzumab | parent. | 1 | DF | 25.414,00 | X |
| | | | | | | | |
| 312.4 | L01XD02 | verteporfin | parent. | 15 | MG | 44000.00 | X |
| | | | | | | | |
| 312.1 | L01XC02 | rituximab | parent. | 10 | MG | 1234,71 | X |
| 59839 | MABTHERA 100 MG | inf cnc sol 2x10ml | HLR | D | | | |
| 46130 | MABTHERA 500 MG | inf cnc sol 1x50ml | HLR | D | | | |
| 312.2 | L01XC03 | trastuzumab | parent. | 1 | DF | 25.414,00 | X |
| | | | | | | | |
| 312.3 | L01XC04 | alemtuzumab | parent. | 1 | MG | 442,20 | X |
| | | | | | | | |
| 312.4 | L01XD02 | verteporfin | parent. | 15 | MG | 23000,00 | O/P |
Verteporfin k fotodynamické terapii /PDT/ ordinuje oftalmolog u nemocných se subfoveálně lokalizovanou převážně klasickou chorioideální neovaskularizací objektivizovanou angiografickým vyšetřením.
Standardní postup PDT je indikován u klasických a čistě okultních subfoveálních chorioideálních neovaskulárních membrán /CHNVM/, u věkem podmíněné makulární degenerace /VPMD/, dále u patologické myopie, angioidních pruhů, po traumatech, u syndromu histoplasmózy, u zánětlivých a idiopatických membrán, i při komplikacích makulárních dystrofií / morbus Best/.
PDT je indikována i tam, kde by další pokles ZO jediného prakticky vidoucího oka pod 0,1 měl nepříznivý dopad na kvalitu života nemocného u komplikovaných případů nemocných se subfoveální CHNVM u VPMD, patologické myopie. Velikost léze je omezena: největší průměr je 5,4 mm. Funkce oka musí být rovna nebo lepší než 0,1. Podkladem pro indikaci je podrobné biomikroskopické a angiografické vyšetření /fluorescenční, event. indocyaninová angiografie /, někdy i optická koherentní tomografie /OCT/.
Indikace k PDT musí být potvrzena vedoucím příslušného centra. PDT bude prováděna na pracovištích, která splní nutné personální i přístrojové podmínky k zajištění dostupnosti pro nemocné.
| 312.5 | L01XX01 | amsakrin | parent. | 1 | MG | 25,80 | B/ONK,HEM |
| | | | | | | | |
| 312.6 | L01XX02 | asparagináza | parent. | 1 | MG | 2784,54 | B/ONK,HEM |
| 93503 | AMSIDYL | inf cnc sol 6x75mg | GOD | D | | | |
| 312.6 | L01XX02 | asparagináza | parent. | 1 | MG | 2784,54 | B/ ONK,HEM |
| 58319 | KIDROLASE | inj sic 10x10ku | THN | B | | | |
| 94058 | ERWINASE | inj sic 20x10ku | POT | GB | | | |
| 312.7 | L01XX11 | estramustin | parent. | 1 | MG | 1,03 | B/ONK,HEM, UR N |
| | | | | | | | |
| 312.8 | L01XX17 | topotekan | parent. | 1 | MG | 3066,38 | X |
| | | | | | | | |
| 312.9 | L01XX19 | irinotekan | parent. | 1 | MG | 72,40 | X |
| | | | | | | | |
| 312.10 | L01XX09 | miltefosin | lok. | 60 | MG | 9,78 | |
| 312.7 | L01XX09 | miltefosin | lok. | 60 | MG | 9,78 | |
| | | | | | | | |
| 312.8 | L01XX11 | estramustin | parent. | 1 | MG | 1,03 | B/ONK,HEM,UR N |
| 58800 | ESTRACYT | inj sic 10x300mg+so | PIR | I | | | |
| 312.9 | L01XX17 | topotekan | parent. | 1 | MG | 2913,06 | X |
| | | | | | | | |
| 312.10 | L01XX19 | irinotekan | parent. | 1 | MG | 72,40 | X |
| 56005 | CAMPTO | inf cnc 1x2ml/40mg | AVT | GB | | | |
| 56006 | CAMPTO | inf cnc 1x5ml/100mg | AVT | GB | | | |
| 313 | L02AA | estrogeny | p.o. | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 313.1 | L02AA01 | diethylstilbestrol | p.o. | 10 | MG | 3,32 | L/ONK,HEM, URN GYN,SEX |
| | | | | | | | |
| 313.2 | L02AA03 | ethinylestradiol | p.o. | 1 | MG | 4,06 | L/ONK,HEM, URN GYN,SEX |
| | | | | | | | |
| 313.3 | L02AA04 | fosfestrol | p.o. | 0.1 | GM | 3,32 | L/ONK,HEM, URN GYN,SEX |
| 313.1 | L02AA01 | diethylstilbestrol | p.o. | 10 | MG | 3,32 | L/ONK,HEM,URN GYN,SEX |
| | | | | | | | |
| 313.2 | L02AA03 | ethinylestradiol | p.o. | 1 | MG | 4,06 | L/ONK,HEM,URN GYN,SEX |
| | | | | | | | |
| 313.3 | L02AA04 | fosfestrol | p.o. | 0.1 | GM | 3,32 | L/ONK,HEM,URN GYN,SEX |
| 314 | L02AA | estrogeny | parent. | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 314.1 | L02AA01 | diethylstilbestrol | parent. | 10 | MG | 6,55 | B/ONK,HEM, URN,SEX |
@@ -5109,24 +5339,27 @@
| 314.3 | L02AA04 | fosfestrol | parent. | 0.1 | GM | 4,79 | B/ONK,HEM, URN,SEX |
| 315 | L02AB | progestiny | p.o. | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 315.1 | L02AB01 | megestrol (pevné lékové formy) | p.o. | 160 | MG | 39,89 | L/ONK,HEM, URN GYN,SEX |
| | | | | | | | |
| 315.1 | L02AB01 | megestrol (pevné lékové formy) | p.o. | 160 | MG | 39,89 | L/ONK,HEM,URN GYN,SEX |
| 58936 | MEGACE 160 MG | tbl 100x160mg | HAG | D | | | |
| 58935 | MEGACE 40 MG | tbl 100x40mg | HAG | D | | | |
| 32103 | MEGAPLEX 160 MG | por tblnob30x160mg | PHM | NL | | | |
| 32098 | MEGAPLEX 40 MG | por tbl nob 30x40mg | PHM | NL | | | |
| 315.2 | L02AB01 | megestrol (tekuté lékové formy) | p.o. | 160 | MG | 70,97 | P |
Indikováno v případech kachexie u manifestního AIDS a v případech, kdy nádorová kachexie je kontraindikací kurativní protinádorové terapie.
| 315.3 | L02AB02 | medroxyprogesteron | p.o. | 1 | GM | 149,59 | L/ONK,HEM, URN GYN,SEX |
| 58390 | PROVERA 500MG | tbl 20x500mg | PUA | I | | | |
| 58392 | PROVERA 100MG | tbl 100x100mg | PUA | I | | | |
| 315.3 | L02AB02 | medroxyprogesteron | p.o. | 1 | GM | 149,59 | L/ONK,HEM,URN GYN,SEX |
| 32121 | MEDROPLEX 100 MG | por tblnobl 00x100mg | PHM | NL | | | |
| 32124 | MEDROPLEX 500 MG | por tbl nob30x500mg | PHM | NL | | | |
| 316 | L02AB | progestiny | parent. | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 316.1 | L02AB02 | medroxyprogesteron | parent. | 1 | GM | 692,00 | L/ONK,GYN, SEX |
| 87805 | DEPO-PROVERA 150MG/ML | inj 1x1ml/150mg | UPJ | B | | | |
| 316.2 | L02AB03 | gestonoron | parent. | 1 | MG | 1,12 | L/ONK,GYN, SEX |
| 316.1 | L02AB02 | medroxyprogesteron | parent. | 1 | GM | 692,00 | L/ONK,GYN,SEX |
| 87805 | DEPO-PROVERA | inj sus 1x1ml-lag | PPU | B | | | |
| 316.2 | L02AB03 | gestonoron | parent. | 1 | MG | 1,12 | L/ONK,GYN,SEX |
| 317 | L02AE | hormon uvolňující gonadotrofin a jeho deriváty | inhal. | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 317.1 | L02AE01 | buserelin | inhal. | 1 | MG | 233,29 | Z |
| 58107 | SUPRECUR | sol 2x10gm/15mg+apl | AVT | D | | | |
| 58107 | SUPRECUR | spr nas2x10gm/15mg | AVT | D | | | |
| 318 | L02AE | hormon uvolňující gonadotrofin a jeho deriváty | parent. | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
@@ -5149,8 +5382,8 @@
| 318.2 | L02AE01 | buserelin (depotní lékové formy aplikované 1x měsíčně) | parent. | 1 | MG | 1719,80 | K/P |
| 75018 | SUPREFACT DEPOT | imp 1ks=2x3.15mg+ap | AVT | D | | | |
| 318.3 | L02AE01 | buserelin (depotní lékové formy aplikované 1x za tři měsíce) | parent. | 1 | MG | 1576,70 | K/P |
| | | | | | | | |
| 318.4 | L02AE02 | leuprorelin | parent. | | MG | 253,00 | K/P |
| 66042 | SUPREFACT DEPOT 3 MĚSÍCE | imp 1x9.45mg=3xstl | AVT | D | | | |
| 318.4 | L02AE02 | leuprorelin | parent. | 1 | MG | 253,00 | K/P |
| | | | | | | | |
| 318.5 | L02AE02 | leuprorelin (depotní lékové formy aplikované 1x měsíčně) | parent. | 1 | MG | 1522,80 | K/P |
| | | | | | | | |
@@ -5161,57 +5394,52 @@
| 318.8 | L02AE03 | goserelin (depotní lékové formy aplikované 1x za tři měsíce) | parent. | 1 | MG | 1379,60 | K/P |
| | | | | | | | |
| 318.9 | L02AE04 | triptorelin | parent. | 1 | DF | 251,89 | K/P |
| 58623 | DIPHERELINE 0.1 MG | inj sic 7x0.1mg+sol | PBE | F | | | |
| 318.10 | L02AE04 | triptorelin (depotní lékové formy aplikované 1x měsíčné) | parent. | 1 | MG | 1516,13 | K/P |
| 58623 | DIPHERELINE 0.1 MG | inj psu Iqf 7x0.1 mg | IAA | F | | | |
| 318.10 | L02AE04 | triptorelin (depotní lékové formy aplikované 1x měsíčně) | parent. | 1 | MG | 1516,13 | K/P |
| 01656 | DIPHERELINE S.R. 3 MG | inj psu Iqf 1x3mg | IAA | F | | | |
| 318.11 | L02AE04 | triptorelin (depotní lékové formy aplikované 1x za tři měsíce) | parent. | 1 | MG | 1324,50 | K/P |
| 01656 | DIPHERELINE S.R. 3 MG | inj psulqf1x3mg+sol | PBE | F | | | |
| 319 | L02BA | antiestrogeny | p.o. | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 319.1 | L02BA01 | tamoxifen (do 20 mg v 1 tabletě včetně) | p.o. | 20 | MG | 6,00 | |
| 44056 | TAMOXIFEN EBEWE 10 | tbl 30x10mg | EBP | A | | | |
| 64810 | NOLVADEX D | por tbl flm 30x20mg | AZC | GB | | | |
| 67039 | TAMIFEN 10 | por tbl nob 30x10mg | MOE | CY | | | |
| 10703 | TAMIFEN 10 | por tbl nob100x10mg | MOE | CY | | | |
| 44056 | TAMOXIFEN EBEWE 10 MG | por tbl nob30x10mg | EBP | A | | | |
| 58701 | TAMOXIFEN EBEWE 10 MG | por tblnob100x10mg | EBP | A | | | |
| 44057 | TAMOXIFEN EBEWE 20 MG | por tbl nob30x20mg | EBP | A | | | |
| 58702 | TAMOXIFEN EBEWE 20 MG | por tblnob100x20mg | EBP | A | | | |
| 88392 | TAMOXIFEN LACHEMA 10 | tbl 100x10mg | PVL | CZ | | | |
| 12446 | TAMOXIFEN-RATIOPHARM 10 | tbl 100x10mg | MCK | D | | | |
| 67039 | TAMIFEN 10 | tbl 30x10mg | MOE | CY | | | |
| 44057 | TAMOXIFEN EBEWE 20 | tbl 30x20mg | EBP | A | | | |
| 58701 | TAMOXIFEN EBEWE 10MG | tbl 100x10mg | EBP | A | | | |
| 64810 | NOLVADEX D | tbl obd 30x20mg | AZC | GB | | | |
| 88392 | TAMOXIFEN LACHEMA 10 | tbl 100x10mg | LCM | CZ | | | |
| 58702 | TAMOXIFEN EBEWE 20MG | tbl 100x20mg | EBP | A | | | |
| 10703 | TAMIFEN 10 | tbl 100x10mg | MOE | CY | | | |
| 319.2 | L02BA01 | tamoxifen (nad 20 mg v 1 tabletě) | p.o. | 20 | MG | 4,40 | |
| 44059 | TAMOXIFEN EBEWE 40 | tbl 30x40mg | EBW | A | | | |
| 44058 | TAMOXIFEN EBEWE 30 | tbl 30x30mg | EBW | A | | | |
| 44058 | TAMOXIFEN EBEWE 30 MG | por tbl nob30x30mg | EBP | A | | | |
| 44059 | TAMOXIFEN EBEWE 40 MG | por tbl nob30x40mg | EBP | A | | | |
| 320 | L02BB | antiandrogeny | p.o. | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 320.1 | L02BB01 | flutamid | p.o. | 0.75 | GM | 81,21 | L/ONK,URN, SEX,END |
| 31736 | FLUTAPLEX | portblnob 100x250mg | PHM | NL | | | |
| 320.1 | L02BB01 | flutamid | p.o. | 0,75 | GM | 81,21 | L/ONK,URN,SEX,END |
| 54521 | ANDRAXAN | tbl obd 100x250mg | MCI | CZ | | | |
| 58741 | APO-FLUTAMIDE | tbl obd 100x250mg | APT | CND | | | |
| 83392 | FLUCINOM | tbl 100x250mg | SCH | B | | | |
| 83392 | FLUCINOM | por tblnob100x250mg | SCH | B | | | |
| 31736 | FLUTAPLEX | portblnob100x250mg | PHM | NL | | | |
| 47084 | PROSTANDRIL | tbl 100x250mg | PLI | CHO | | | |
| 54521 | ANDRAXAN | tbl obd 100x250mg | MCI | CZ | | | |
| 320.2 | L02BB02 | nilutamid | p.o. | 0,3 | GM | 162,42 | L/ONK,URN, SEX |
| 93259 | ANANDRON 150MG | tbl 30x150mg | LBU | F | | | |
| 320.3 | L02BB03 | bicalutamid | p.o. | 50 | MG | 107,14 | L/ONK,URN, SEX |
| 320.2 | L02BB02 | nilutamid | p.o. | 0,3 | GM | 162,42 | L/ONK,URN,SEX |
| 93259 | ANANDRON 150 MG | tbl 30x150mg | LBU | F | | | |
| 320.3 | L02BB03 | bicalutamid | p.o. | 50 | MG | 107,14 | L/ONK,URN,SEX |
| 321 | L02BG | inhibitory tvorby steroidních hormonů | p.o. | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 321.1 | L02BG01 | aminogluthetimid | p.o. | 1 | GM | 62,45 | L/ONK,END |
| 07510 | ORIMETEN | tbl 100x250mg | CGC | CH | | | |
| 321.2 | L02BG03 | anastrozol | p.o. | 1 | MG | 162,14 | X |
| | | | | | | | |
| 321.3 | L02BG04 | letrozol | p.o. | 2,5 | MG | 162,14 | X |
| 56509 | FEMARA | tbl obd 30x2.5mg | NPA | CH | | | |
| 321.4 | L02BG06 | exemestan | p.o. | 25 | MG | 162,14 | X |
| | | | | | | | |
| 321.2 | L02BG03 | anastrozol | p.o. | 1 | MG | 160,00 | X |
| | | | | | | | |
| 321.3 | L02BG04 | letrozol | p.o. | 2,5 | MG | 160,00 | X |
| 321.4 | L02BG06 | exemestan | p.o. | 25 | MG | 160,00 | X |
| 322 | L02BG | inhibitory tvorby steroidních hormonů | parent. | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 322.1 | L02BG02 | formestan | parent. | 18 | MG | 233,77 | X |
| 92361 | LENTARON DEPOT 250MG I.M. | inj sic 1x250mg+2ml | CGC | CH | | | |
| 92361 | LENTARON DEPOT 250MG I.M. | inj sic 1x250mg+sol | NPA | CH | | | |
| 323 | L03AA | cytokiny | parent. | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 323.1 | L03AA02 | filgrastim | parent. | 1 | MG | 10.608,50 | X |
| 69026 | NEUPOGEN | inj 5x1ml | HLR | CH | | | |
| 57863 | NEUPOGEN | inj 5x1ml | AMG | POR | | | |
| 578641 | NEUPOGEN | inj 5x1.6ml | AMG | POR | | | |
| 98297 | NEUPOGEN | inj 5x1.6ml | HLR | CH | | | |
| 323.1 | L03AA02 | filgrastim | parent. | 1 | MG | 9548,00 | X |
| | | | | | | | |
| 323.2 | L03AA03 | molgramostim (do 0,3 mgG včetně v jedné ampuli) | parent. | 1 | MG | 13613,27 | X |
| | | | | | | | |
| 323.3 | L03AA03 | molgramostim (nad 0,3 mg v jedné ampuli) | parent. | 1 | MG | 11843,67 | X |
@@ -5226,17 +5454,17 @@
| 54402 | ROFERON-A 18 MIU/0.6ML | inj 3x0.6ml/18mu | HLR | CH | | | |
| 323.8 | L03AB04 | interferon alfa-2a do 10 MU v 1 ampuli vč. - jiné aplikační formy | parent. | 1 | MU | 230,63 | X |
| 10647 | ROFERON-A 6 MIU/0.5 ML | sol inj1x6miu/0,5ml | HLR | CH | | | |
| 10648 | ROFERON-A 6 MIU/0.5 ML | sol inj5x6miu/0,5ml | HLR | CH | | | |
| 10664 | ROFERON-A 9 MIU/0.5 ML | sol inj1x9miu/0,5ml | HLR | CH | | | |
| 10668 | ROFERON-A 9 MIU/0.5 ML | sol inj5x9miu/0,5ml | HLR | CH | | | |
| 10648 | ROFERON-A 6 MIU/0.5 ML | sol inj5x6miu/0,5ml | HLR | CH | | | |
| 323.9 | L03AB04 | interferon alfa-2a nad 10 MU v 1 ampuli vč. - jiné aplikační formy | parent. | 1 | MU | 213,15 | X |
| | | | | | | | |
| 323.10 | L03AB05 | interferon alfa-2b - aplikční forma „pera“ | parent. | 1 | MU | 230,63 | X |
| 32573 | INTRONA 18 MIU REDIPEN | inj sol 1.2ml/6x3mu | SCH | IRL | | | |
| 32572 | INTRONA 30 MIU REDIPEN | inj sol 1.2ml/6x5mu | SCH | IRL | | | |
| 32574 | INTRONA 60 MIU REDIPEN | inj sol1.2ml/6x10mu | SCH | IRL | | | |
| 32573 | INTRONA 18 MIU REDIPEN | inj sol 1.2ml/6x3mu | SCH | IRL | | | |
| 323.11 | L03AB05 | interferon alfa-2b do 10 MU v 1 ampuli včetně - jiné aplikační formy | parent. | 1 | MU | 230,63 | X |
| 32575 | INTRONA 10 MIU | inj sol 1ml/10mu | SH | IRL | | | |
| 32575 | INTRONA 10 MIU | inj sol 1ml/10mu | SCH | IRL | | | |
| 323.12 | L03AB05 | interferon alfa-2b nad 10 MU v 1 ampuli - jiné aplikační formy | parent. | 1 | MU | 213,15 | X |
| | | | | | | | |
| 323.13 | L03AB06 | interferon alfa-n 1 do 9MU v 1 ampuli včetně | parent. | 1 | MU | 230,63 | X |
@@ -5244,17 +5472,26 @@
| 323.14 | L03AB06 | interferon alfa-n1 více než 9MU v 1 ampuli | parent. | 1 | MU | 213,15 | X |
| | | | | | | | |
| 323.15 | L03AB07 | interferon beta - 1a | parent. | 1 | MU | 409,37 | X |
| 01795 | REBIF 44 | inj 12x0.5ml/44rg | IFB | I | | | |
| 01793 | REBIF 44 | inj 1x0.5ml/44rg | IFB | I | | | |
| 01794 | REBIF 44 | inj 3x0.5mlZ44rg | IFB | I | | | |
| 01795 | REBIF 44 | inj 12x0.5ml/44rg | IFB | I | | | |
| 323.16 | L03AB07 | interferon beta - 1a výhradně pro intramuskulámí podání | parent. | 1 | DF | 5932,25 | X |
| 01794 | REBIF 44 | inj 3x0.5ml/44rg | IFB | I | | | |
| 323.16 | L03AB07 | interferon beta - 1a výhradně pro intramuskulární podání | parent. | 1 | DF | 5932,25 | X |
| 06241 | AVONEX | inj sic 4x30rg+solv | BHF | NL | | | |
| 323.17 | L03AB08 | interferon beta - 1 b | parent. | 1 | MU | 276,80 | X |
| | | | | | | | |
| 323.18 | L03AB09 | interferon alfacon - 1 | parent. | 1 | MU | 230,63 | X |
| | | | | | | | |
| 323.19 | L03AB10 | peginterferon alfa 2-b | parent. | 1 | RG | 72,83 | X |
| 10187 | PEGINTRON 80 | injsic 1x80rgsolset | SCH | IRL | | | |
| 10132 | PEGINTRON 50 | inj pso Iqf 1x50rg | SCH | IRL | | | |
| 10187 | PEGINTRON 80 | inj pso Iqf 1x80rg | SCH | IRL | | | |
| 95705 | PEGINTRON REDIPEN 100 MCG | inj pso Iqf 1x100rg | SCH | IRL | | | |
| 95706 | PEGINTRON REDIPEN 100 MCG | inj pso Iqf 4x100rg | SCH | IRL | | | |
| 95709 | PEGINTRON REDIPEN 120 MCG | inj pso Iqf 1x120rg | SCH | IRL | | | |
| 95710 | PEGINTRON REDIPEN 120 MCG | inj pso Iqf 4x120rg | SCH | IRL | | | |
| 95707 | PEGINTRON REDIPEN 150 MCG | inj pso Iqf 1x150rg | SCH | IRL | | | |
| 95708 | PEGINTRON REDIPEN 150 MCG | inj pso Iqf 4x150rg | SCH | IRL | | | |
| 95703 | PEGINTRON REDIPEN 80 MCG | inj pso Iqf 1x80rg | SCH | IRL | | | |
| 95704 | PEGINTRON REDIPEN 80 MCG | inj pso Iqf 4x80rg | SCH | IRL | | | |
| 323.20 | L03AB11 | peginterferon alfa 2-a | parent. | 1 | RG | 47,40 | X |
| | | | | | | | |
| 323.21 | L03AC01 | aldesleukin | parent. | 1 | MG | 7517,20 | X |
@@ -5270,8 +5507,8 @@
| 325 | L03AX | ostatní imunostimulační léčiva | parent. | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 325.1 | L03AX03 | BCG vakcína | parent. | 1 | MG | 37,00 | O/ONK,URN |
| 68908 | IMMUCYST BCG IMMUNOTHERAPEUT. | inj sic 3x27mg+1ml | CNG | CND | | | |
| 53968 | IMMUCYST | inj sic 1x81mg+solv | APZ | CND | | | |
| 68908 | IMMUCYST | inj sic 3x27mg+solv | APZ | CND | | | |
| 325.2 | L03AX | dialyzát lidských leukocytů | parent. | 1 | DF | 844,00 | P |
Dialyzát lidských leukocytů předepisuje lékař odbornosti alergolog a klinický imunolog nemocným se středně těžkou a těžkou primární nebo sekundární poruchou celulární imunity, prokázanou laboratorním imunologickým vyšetřením.
@@ -5283,7 +5520,7 @@
| 325.5 | L03AX | bac. propionibacterii acnes | parent. | 1 | MG | 72,83 | O/ONK |
| | | | | | | | |
| 325.6 | L03AX | laktobacillus acidophilus | parent. | 3 | DF | 602,00 | O/GYN |
| 86711 | SOLCOTRICHOVAC | inj 3x0.5ml | SOC | CH | | | |
| 86711 | SOLCOTRICHOVAC | inj sus 3x0.5ml | IAB | CH | | | |
| 325.7 | L03AX | vaccin. staphyl. phagolys. | parent. | 1 | DF | 72,98 | O |
| | | | | | | | |
| 325.8 | L03AX13 | glatirameracetat kopolymer | parent. | 20 | MG | 1106,56 | X |
@@ -5332,53 +5569,59 @@
Léčbu leflunomidem ordinuje revmatolog.
Léčba je indikována u pacientů s revmatoidní artritídou (RA),která je stále aktivní a progreduje vzdor léčbě minimálně 2 léky ze skupiny tzv.léků druhé řady (jedním z nich musí být metotrexat).Tyto léky musí být podávány prokazatelně dostatečně dlouhou dobu (nejméně 6 měsíců) a v dostatečné dávce (sulfasalazin 3 g/denně,metotrexát 25 mg/týdně).
Léčba je indikována u pacientů s revmatoidní artritídou (RA),která je stále aktivní a progreduje vzdor léčbě minimálně 2 léky ze skupiny tzv.léků druhé řady (jednim z nich musí být metotrexat).Tyto léky musí být podávány prokazatelně dostatečně dlouhou dobu (nejméně 6 měsíců) a v dostatečné dávce (sulfasalazin 3 g/denně,metotrexát 25 mg/týdně).
Aktivita RA musí být hodnocena jako vysoká (DAS ≥5,1 metodikou formuláře DAS 28) nebo kombinace 5 oteklých kloubů a CRP > 10 mg/l.
Efekt léčby musí být průkazný do 6 měsíců po začátku léčby, kvantifikován jako pokles DAS > 1,2.
Efekt léčby musí být průkazný do 6 měsíců po začátku léčby,kvantifikován jako pokles DAS > 1,2.
Průběh léčby leflunomidem bude dokumentován v dotazníku České revmatologické společnosti,které budou kontrolovány a vyhodnocovány.
| 326.1 | L04AA01 | cyklosporin | p.o. | 250 | MG | 253,40 | P |
| | | | | | | | |
| 326.2 | L04AA05 | tacrolimus | p.o. | 5 | MG | 346,70 | P |
| | | | | | | | |
| 326.3 | L04AA06 | mophetil mycophenolát | p.o. | 2 | GM | 420,00 | P |
| | | | | | | | |
| 326.4 | L04AA10 | sirolimus | p.o. | 6 | MG | 663,38 | P |
| | | | | | | | |
| 326.5 | L04AA13 | leflunomid | p.o. | 15 | MG | 67,40 | P |
| 326.2 | L04AA05 | tacrolimus do 0,5 mg v jedné tabletě včetně | p.o. | 5 | MG | 428,70 | P |
| | | | | | | | |
| 326.3 | L04AA05 | tacrolimus nad 0,5 mg v jedné tabletě | p.o. | 5 | MG | 346,70 | P |
| 57628 | PROGRAF 1 MG | por cps dur 60x1mg | FUJ | IRL | | | |
| 57629 | PROGRAF 5 MG | por cps dur 30x5mg | FUJ | IRL | | | |
| 326.4 | L04AA06 | mophetil mycophenolát | p.o. | 2 | GM | 420,00 | P |
| 31960 | CELLCEPT 250 MG | por cpsdur100x250mg | HLR | D | | | |
| 32892 | CELLCEPT 500 MG | por tbl flm50x500mg | HLR | D | | | |
| 326.5 | L04AA10 | sirolimus | p.o. | 6 | MG | 663,38 | P |
| | | | | | | | |
| 326.6 | L04AA13 | leflunomid | p.o. | 15 | MG | 67,40 | P |
| 327 | L04AA | selektivní imunosupresivní léčiva | parent. | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 327.1 | L04AA09 | basiliximab | parent. | 20 | MG | 53004,39 | H |
| | | | | | | | |
| 327.2 | L04AA01 | cyklosporin | parent. | 1 | MG | 2,58 | U/J10 |
| 88514 | SANDIMMUN KONZENTRAT | inf 10x5ml 50mg/1ml | SAN | CH | | | |
| 327.3 | L04AA02 | muromonab-CD3 | parent. | 5 | MG | 11129,25 | U/J10 |
| | | | | | | | |
| 327.4 | L04AA03 | antilymfocytární IG | parent. | 10 | MG | 103,87 | U/J10 |
| | | | | | | | |
| 327.5 | L04AA04 | antithymocytární IG | parent. | 1 | MG | 121,46 | U/J10 |
| 44491 | ATG-FRESENIUS S | inj 1x5ml/100mg | FRE | D | | | |
| 44492 | ATG-FRESENIUS S | inj 10x5ml/100mg | FRE | D | | | |
| 327.6 | L04AA05 | tacrolimus | parent. | 5 | MG | 1578,09 | H |
| 57631 | PROGRAF 5MG/ML | inf cnc 10x1ml/5mg | FUJ | IRL | | | |
| 327.7 | L04AA08 | daclizumab | parent. | 350 | MG | 139608,00 | U/J10 |
| 327.8 | L04AA11 | etanerceptum | parent. | 7 | MG | 1538,35 | Z |
| 327.1 | L04AA01 | cyklosporin | parent. | 1 | MG | 2,58 | U/J10 |
| 88514 | SANDIMMUN | inf cnc sol 10x5ml | NPA | CH | | | |
| 327.2 | L04AA02 | muromonab-CD3 | parent. | 5 | MG | 11129,25 | U/J10 |
| 98815 | CEDETRIN-T | inj 10x3ml/3mg | IVX | CZ | | | |
| 327.3 | L04AA03 | antilymfocytární IG | parent. | 10 | MG | 103,87 | U/J10 |
| | | | | | | | |
| 327.4 | L04AA04 | antithymocytární IG | parent. | 1 | MG | 121,46 | U/J10 |
| 44492 | ATG-FRESENIUS S | inf 10x5ml/100mg | FHC | D | | | |
| 44491 | ATG-FRESENIUS S | inf 1x5ml/100mg | FHC | D | | | |
| 327.5 | L04AA05 | tacrolimus | parent. | 5 | MG | 1578,09 | H |
| 57631 | PROGRAF 5 MG/ML | infcncsol10x1ml/5mg | FUJ | IRL | | | |
| 327.6 | L04AA08 | daclizumab | parent. | 350 | MG | 139608,00 | U/J10 |
| | | | | | | | |
| 327.7 | L04AA09 | basiliximab | parent. | 20 | MG | 50354,15 | H |
| | | | | | | | |
| 327.8 | L04AA11 | etanerceptum | parent. | 7 | MG | 1391,80 | X |
| | | | | | | | |
| 327.9 | L04AA12 | infliximab | parent. | 375 | MG | 70500,00 | X |
| | | | | | | | |
| 327.10 | L04AA | adalimumabum | parent. | 1 | DF | 49459,00 | X |
| 21064 | HUMIRA=D2E7 | inj 2x0.8ml/40mg | ABK | D | | | |
| 328 | L04AX | ostatní imunosupresiva | p.o. | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 328.1 | L04AX01 | azathioprin (do 25 mg v jedné tabletě včetně) | p.o. | 10 | MG | 1.81 | |
| 328.1 | L04AX01 | azathioprin (do 25 mg v jedné tabletě včetně) | p.o. | 10 | MG | 1,81 | |
| 58498 | IMURAN 25MG | tbl obd 100x25mg | GOK | GB | | | |
| 328.2 | L04AX01 | azathioprin (nad 25 mg v jedné tabletě) | p.o. | 10 | MG | 1.12 | |
| 328.2 | L04AX01 | azathioprin (nad 25 mg v jedné tabletě) | p.o. | 10 | MG | 1,12 | |
| 329 | L04AX | ostatní imunosupresiva | parent. | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 329.1 | L04ax01 | azathioprin | parent. | 1 | MG | 9,82 | U/J10 |
| 32819 | IMURAN | inj sic 1x50mg | GXW | I | | | |
| 329.1 | L04AX01 | azathioprin | parent. | 1 | MG | 9,82 | U/J10 |
| 32819 | IMURAN | inj sic 1x50mg | GAK | I | | | |
| 58678 | IMURAN | inj sic 1x50mg | GOK | GB | | | |
| 330 | M01AA | protizánětlivá léčiva ze skupiny butylpyrazolidinů | p.o. | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
@@ -5388,88 +5631,82 @@
| 331 | M01AA | protizánětlivá léčiva ze skupiny butylpyrazolidinů | parent. | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 331.1 | M01AA | butylpyrazolidiny | parent. | 1 | DF | 6,89 | |
| 332 | M01AB | protjzánětlivá léčiva ze skupiny derivátů kyseliny octové | p.o. | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 332.1 | M01AB | deriváty kyseliny octové | p.o. | 70 | mg | 1.76 | |
| 332 | M01AB | protizánětlivá léčiva ze skupiny derivátů kyseliny octové | p.o. | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 332.1 | M01AB | deriváty kyseliny octové | p.o. | 70 | MG | 1,76 | |
| | | | | | | | |
| 332.2 | M01AB01 | indometacin | p.o. | 0.1 | GM | 2,65 | |
| 77078 | APO-INDOMETHACIN 50MG | cps 100x50mg | APT | CND | | | |
| 97713 | APO-INDOMETHACIN 25MG | cps 100x25mg | APT | CND | | | |
| 97713 | APO-INDOMETHACIN 25 | cps 100x25mg | APT | CND | | | |
| 77078 | APO-INDOMETHACIN 50 | cps 100x50mg | APT | CND | | | |
| 332.3 | M01AB02 | sulindac | p.o. | 0.4 | GM | 4,69 | |
| | | | | | | | |
| 332.4 | M01AB03 | tolmetin | p.o. | 0.7 | GM | 4,69 | |
| | | | | | | | |
| 332.5 | M01AB05 | diklofenak | p.o. | 0.1 | GM | 4,29 | |
| 89024 | DICLOFENAC AL 50 | tbl obd 20x50mg | APA | D | | | |
| 98144 | VERAL 25MG | tbl 30x25mg | SLO | SK | | | |
| 67541 | ALMIRAL 50 | tbl obd 20x50mg | MOE | CY | | | |
| 96740 | APO-DICLO 25MG | tbl obd 100x25mg | APT | CND | | | |
| 96742 | APO-DICLO 50MG | tbl obd 100x50mg | APT | CND | | | |
| 53640 | APO-DICLO SR 100 | tbl ret 100x100mg | APT | CND | | | |
| 59396 | APO-DICLO SR 100 | tbl ret 30x100mg | APT | CND | | | |
| 45519 | DICLOFEN 25 SVUS | tbl obd 20x25mg | SVS | CZ | | | |
| 05714 | DICLOFEN 25 SVUS | tbl obd 30x25mg | SVS | CZ | | | |
| 45521 | DICLOFEN 25 SVUS | tbl obd 50x25mg | SVS | CZ | | | |
| 75605 | DICLOFENAC AL 25 | tbl obd 100x25mg | APA | D | | | |
| 75604 | DICLOFENAC AL 25 | tbl obd 50x25mg | APA | D | | | |
| 89024 | DICLOFENAC AL 50 | por tbl flm 20x50mg | APA | D | | | |
| 89025 | DICLOFENAC AL 50 | por tbl flm 50x50mg | APA | D | | | |
| 89026 | DICLOFENAC AL 50 | por tbl flm100x50mg | APA | D | | | |
| 75633 | DICLOFENAC AL RETARD | tbl ret 100x100mg | APA | D | | | |
| 75631 | DICLOFENAC AL RETARD | tbl ret 20x100mg | APA | D | | | |
| 75632 | DICLOFENAC AL RETARD | tbl ret 50x100mg | APA | D | | | |
| 58880 | DOLMINA 100 SR | tbl ret 20x100mg | LEX | CZ | | | |
| 59134 | MYOGIT 25 | tbl ent 20x25mg | PFL | D | | | |
| 59137 | MYOGIT 50 | tbl ent 20x50mg | PFL | D | | | |
| 98108 | NAKLOFEN | tbl ent 20x50mg | KRK | SLO | | | |
| 98111 | NAKLOFEN RETARD | tbl ret 20x100mg | KRK | SLO | | | |
| 98108 | NAKLOFEN | tbl ent 20x50mg | KRK | SLO | | | |
| 96740 | APO-DICLO 25MG | tbl ent 100x25mg | APT | CND | | | |
| 89025 | DICLOFENAC AL 50 | tbl obd 50x50mg | APA | D | | | |
| 89026 | DICLOFENAC AL 50 | tbl obd 100x50mg | APA | D | | | |
| 96742 | APO-DICLO 50MG | tbl ent 100x50mg | APT | CND | | | |
| 75631 | DICLOFENAC AL RETARD | tbl obd 20x100mg | APA | D | | | |
| 58880 | DOLMINA 100 SR | tbl ret 20x100mg | LEX | CZ | | | |
| 66049 | VERAL 100 RETARD | tbl ret 30x100mg | SLO | SK | | | |
| 98144 | VERAL 25 MG | por tbl ent 30x25mg | SLO | SK | | | |
| 83518 | VERAL 50 MG | tbl ent 20x50mg | SLO | SK | | | |
| 83519 | VERAL 50 MG | tbl ent 50x50mg | SLO | SK | | | |
| 66050 | VERAL 75 RETARD | tbl ret 20x75mg | SLO | SK | | | |
| 59396 | APO-DICLO SR 100 | tbl ret 30x100mg | APT | CND | | | |
| 05714 | DICLOFEN 25 SVUS | tbl obd 30x25mg | SVS | CZ | | | |
| 53640 | APO-DICLO SR 100 | tbl ret 100x100mg | APT | CND | | | |
| 83518 | VERAL 50MG | tbl ent 20x50mg | SLO | SK | | | |
| 83519 | VERAL 50MG | tbl ent 50x50mg | SLO | SK | | | |
| 45521 | DICLOFEN 25 SVUS | tbl obd 50x25mg | SVS | CZ | | | |
| 75604 | DICLOFENAC AL 25 | tbl obd 50x25mg | APA | D | | | |
| 75605 | DICLOFENAC AL 25 | tbl obd 100x25mg | APA | D | | | |
| 45519 | DICLOFEN 25 SVUS | tbl obd 20x25mg | SVS | CZ | | | |
| 59137 | MYOGIT 50 | tbl ent 20x50mg | PFL | D | | | |
| 66049 | VERAL 100 RETARD | tbl ret 30x100mg | SLO | SK | | | |
| 75633 | DICLOFENAC AL RETARD | tbl obd 100x100mg | APA | D | | | |
| 59134 | MYOGIT 25 | tbl ent 20x25mg | PFL | D | | | |
| 75632 | DICLOFENAC AL RETARD | tbl obd 50x100mg | APA | D | | | |
| 67541 | ALMIRAL 50 | tbl ent 20x50mg | MOE | CY | | | |
| 332.6 | M01AB05 | diklofenak lékové formy s rychlým nástupem účinku (do 100 mg v jedné tabletě včetně) | p.o. | 0.1 | GM | 4,52 | |
| | | | | | | | |
| 332.7 | M01AB05 | diklofenak lékové formy s rychlým nástupem účinku (nad 100 mg v jedné tabletě) | p.o. | 0.1 | GM | 4,20 | |
| 46621 | UNO | tbl obd 20x150mg | MCK | D | | | |
| 46620 | UNO | tbl obd 10x150mg | MCK | D | | | |
| 46620 | UNO | tbl ret 10x150mg | MCK | D | | | |
| 46621 | UNO | tbl ret 20x150mg | MCK | D | | | |
| 332.8 | M01AB06 | alclofenak | p.o. | 1.25 | GM | 4,29 | |
| | | | | | | | |
| 332.9 | M01AB09 | lonazolak | p.o. | 0.6 | GM | 4,29 | |
| | | | | | | | |
| 332.10 | M01AB16 | aceklofenak | p.o. | 0.2 | GM | 4,29 | |
| | | | | | | | |
| 332.11 | M01AB55 | diklofenak/ misoprostol (na obsah diklofenaku) | p.o. | 0.1 | GM | 29,33 | Z |
| 332.11 | M01AB55 | diklofenak/misoprostol (na obsah diklofenaku) | p.o. | 0.1 | GM | 29,33 | Z |
| 333 | M01AB | protizánětlivá léčiva ze skupiny derivátů kyseliny octové | p.rect. | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 333.1 | M01AB01 | indometacin | p.rect. | 0.1 | GM | 3,27 | |
| 93724 | INDOMETACIN 100 BERLIN-CHEMIE | sup 10x100mg | BCE | D | | | |
| 333.2 | M01AB03 | tolmetin | p.rect. | 0.7 | GM | 10,56 | |
| | | | | | | | |
| 333.3 | M01AB05 | diklofenak | p.rect. | 0.1 | GM | 10,56 | |
| 98110 | NAKLOFEN | sup 10x50mg | KRK | SLO | | | |
| 42611 | MONOFLAM 50 MG | rct sup 10x50mg | AAN | D | | | |
| 42612 | MONOFLAM 100 MG | ret sup 10x100mg | AAN | D | | | |
| 87206 | VERAL 100MG | sup 10x100mg | SLO | SK | | | |
| 333.3 | M01AB05 | diklofenak | p.rect. | 0.1 | GM | 8,50 | |
| | | | | | | | |
| 333.4 | M01AB09 | lonazolak | p.rect. | 0.6 | GM | 10,56 | |
| 334 | M01AB | protizánětlivá léčiva ze skupiny derivátů kyseliny octové | parent. | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 334.1 | M01AB01 | indometacin | parent. | 0.1 | GM | 12,66 | |
| | | | | | | | |
| 334.2 | M01AB05 | diklofenak | parent. | 0.1 | GM | 12,90 | |
| 54539 | DOLMINA INJ. | inj 5x3ml/75mg | LEX | CZ | | | |
| 67547 | ALMIRAL | inj 10x3ml/75mg | MOE | CY | | | |
| 54539 | DOLMINA INJ | inj sol5x3ml/75mg | LEX | CZ | | | |
| 98109 | NAKLOFEN | inj 5x3ml/75mg | KRK | SLO | | | |
| 10600 | VERAL 75 | inj sol 5x3ml/75mg | SLO | SK | | | |
| 98109 | NAKLOFEN | inj 5x3ml/75mg | KRK | SLO | | | |
| 67548 | ALMIRAL | inj 100x3ml/75mg | MOE | CY | | | |
| 67547 | ALMIRAL | inj 10x3ml/75mg | MOE | CY | | | |
| 335 | M01AC | protizánětlivá léčiva ze skupiny oxikamů | p.o. | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 335.1 | M01AC01 | piroxikam | p.o. | 20 | MG | 2,49 | |
| 97710 | APO-PIROXICAM 20 | cps 100x20mg | APT | CND | | | |
| 68581 | PIROX 10 VON CT | tbl 50x10mg | CTA | D | | | |
| 47112 | PIROX 20 | tbl 20x20mg | MCK | D | | | |
| 68582 | PIROX 20 VON CT | tbl 50x20mg | CTA | D | | | |
| 11068 | PIROXICAM AL 20 | tbl 20x20mg | APA | D | | | |
| 53744 | PRO-ROXIKAM 10MG | tbl 20x10mg | PMP | CZ | | | |
| 68582 | PIROX 20 | tbl 50x20mg | CTA | D | | | |
| 47112 | PIROX 20 | tbl 20x20mg | MCK | D | | | |
| 68581 | PIROX 10 | tbl 50x10mg | CTA | D | | | |
| 71947 | ARTHREMIN 20 | cps 30x20mg | LEX | CZ | | | |
| 53745 | PRO-ROXIKAM 20MG | tbl 20x20mg | PMP | CZ | | | |
| 335.2 | M01AC01 | piroxikam (lékové formy s rychlým nástupem účinku) | p.o. | 20 | MG | 4,52 | |
| | | | | | | | |
@@ -5483,11 +5720,14 @@
| 336 | M01AC | protizánětlivá léčiva ze skupiny oxikamů | p.rect. | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 336.1 | M01AC01 | piroxikam | p.rect. | 20 | MG | 10,75 | |
| 67172 | PIROX 20 | sup 10x20mg | CTA | D | | | |
| 336.1 | M01AC01 | piroxikam | p.rect. | 20 | MG | 8,50 | |
| | | | | | | | |
| 336.2 | M01AC02 | tenoxikam | p.rect. | 20 | MG | 10,75 | |
| | | | | | | | |
| 336.3 | M01AC06 | meloxikam | p.rect. | 15 | MG | 16,50 | L/ORT,REV, NEU |
| 336.3 | M01AC06 | meloxikam | p.rect. | 15 | MG | 13,00 | P |
Léčba akutní a chronické bolesti a zánětu u muskuloskeletálních onemocnění u pacientů, kteří prokazatelně v minulosti měli subjektivně příznaky NSA indukované gastropatie po 2 různých COX neselektivních NSA, kvůli kterým musela být léčba přerušena.
| 337 | M01AC | protizánětlivá léčiva ze skupiny oxikamů | parent. | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 337.1 | M01AC01 | piroxikam | parent. | 20 | MG | 11,73 | |
@@ -5495,14 +5735,18 @@
| 337.2 | M01AC02 | tenoxikam | parent. | 20 | MG | 11,73 | |
| | | | | | | | |
| 337.3 | M01AC05 | lornoxikam | parent. | 12 | MG | 11,73 | |
| 337.4 | M01AC06 | meloxikam | parent. | 15 | MG | 39,00 | P |
Léčbu akutní a chronické bolesti a zánětu u muskuloskeletálních onemocnění u pacientů, kteří prokazatelně v minulosti měli subjektivně příznaky NSA indukované gastropatie po 2 různých COX neselektivních NSA, kvůli kterým musela být léčba přerušena v případě, že nelze použít tabletovou a čípkovou formu.
| 338 | M01AE | protizánětlivá léčiva ze skupiny derivátů kyseliny propionové | p.o. | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 338.1 | M01AE01 | ibuprofen | p.o. | 1.2 | GM | 3,79 | |
| 97989 | APO-IBUPROFEN 400 MG | tbl obd 100x400mg | APT | CND | | | |
| 66990 | DOLGIT 800 | por tbl flm20x800mg | DLR | D | | | |
| 32020 | IBUPROFEN AL 400 | tbl obd 100x400mg | APA | D | | | |
| 32018 | IBUPROFEN AL 400 | tbl obd 30x400mg | APA | D | | | |
| 32019 | IBUPROFEN AL 400 | tbl obd 50x400mg | APA | D | | | |
| 32018 | IBUPROFEN AL 400 | tbl obd 30x400mg | APA | D | | | |
| 66990 | DOLGIT 800 | tbl obd 20x800mg | DLR | D | | | |
| 97989 | APO-IBUPROFEN 400MG | tbl 100x400mg | APT | CND | | | |
| 338.2 | M01AE01 | ibuprofen (lékové formy sirupu) | p.o. | 1.2 | GM | 19,55 | |
| | | | | | | | |
| 338.3 | M01AE02 | naproxen (pevné lékové formy) | p.o. | 0.5 | GM | 4,29 | |
@@ -5521,11 +5765,11 @@
| | | | | | | | |
| 338.10 | M01AE11 | kyselina tiaprofenová | p.o. | 0.6 | GM | 6,00 | |
| | | | | | | | |
| 338.11 | M01AE12 | oxaprozin | p.o. | 0.9 | GM | 11,00 | P |
Léčba akutní a chronické bolesti a zánětu u muskuloskeletálních onemocnění u pacientů,kteří prokazatelně v minulosti měli subjektivně příznaky NSA indukované gastropatie po 2 různých COX neselektivních NSA, kvůli kterým musela být léčba přerušena.
| 338.12 | M01AE17 | dexketoprofen | p.o. | 75 | MG | 15,60 | |
| 338.11 | M01AE12 | oxaprozin | p.o. | 0.9 | GM | 8,25 | P |
Léčba akutní a chronické bolesti a zánětu u muskuloskeletálních onemocnění u pacientů,k teří prokazatelně v minulosti měli subjektivně příznaky NSA indukované gastropatie po 2 různých COX neselektivních NSA, kvůli kterým musela být léčba přerušena.
| 338.12 | M01AE17 | dexketoprofen | p.o. | 75 | MG | 4,52 | |
| | | | | | | | |
| 338.13 | M01AG02 | kyselina tolfenámová | p.o. | 0.3 | GM | 4,29 | |
| 339 | M01AE | protizánětlivá léčiva ze skupiny derivátů kyseliny propionové | p.rect. | | | | |
@@ -5544,11 +5788,12 @@
| 340.2 | M01AE02 | naproxen | parent. | 0.5 | GM | 13,73 | |
| | | | | | | | |
| 340.3 | M01AE03 | ketoprofen | parent. | 0.15 | GM | 15,45 | |
| 76657 | KETONAL I.M. | inj 10x2ml/100mg | LEK | SLO | | | |
| 76657 | KETONAL | inj 10x2ml/100mg | LEK | SLO | | | |
| 340.4 | M01AG | etofenamat | parent. | 1 | GM | 13,73 | |
| 341 | M01AX | ostatní protizánétlivá léčiva | p.o. | | | | |
Léčba akutní a chronické bolesti a zánětu u muskuloskeletálních onemocnění u pacientů,kteří prokazatelně v minulosti měli subjektivné příznaky NSA indukované gastropatie po 2 různých COX neselektivních NSA, kvůli kterým musela být léčba přerušena.
| 341 | M01AX | ostatní protizánětlivá léčiva | p.o. | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
Léčba akutní a chronické bolesti a zánětu u muskuloskeletálních onemocnění u pacientů,k teří prokazatelně v minulosti měli subjektivně příznaky NSA indukované gastropatie po 2 různých COX neselektivních NSA, kvůli kterým musela být léčba přerušena.
| 341.1 | M01AX01 | nabumeton | p.o. | 1 | GM | 11,00 | P |
| --- | --- | --- | --- | --- | --- | --- | --- |
@@ -5560,8 +5805,9 @@
| 341.4 | M01AX13 | proquazon | p.o. | 0.9 | GM | 11,78 | |
| | | | | | | | |
| 341.5 | M01AX17 | nimesulid | p.o. | 0.2 | GM | 11,00 | P |
| | | | | | | | |
| 341.6 | M01AX17 | nimesulid | p.rect. | 0.2 | GM | 14,32 | L/REV,ORT, NEU |
| 32486 | COXTRAL | por tbl nob10x100mg | LEX | CZ | | | |
| 32487 | COXTRAL | por tbl nob30x100mg | LEX | CZ | | | |
| 341.6 | M01AX17 | nimesulid | p.rect. | 0.2 | GM | 14,32 | L/REV,ORT,NEU |
| | | | | | | | |
| 341.7 | M01AX21 | diacerein | p.o. | 100 | MG | 10,50 | L/REV, ORT |
| | | | | | | | |
@@ -5579,14 +5825,14 @@
- a) revmatoidní artritida dospělých ve všech stadiích onemocnění.
- b) osteoartróza nosných kloubů rentgenologicky III. – IV. stadia dle Kellgrena ve stadiu bolestivé dekompenzace či zánětlivé iritace.
Z prostředků veřejného zdravotního pojištění je hrazena v indikaci osteoartróza denní dávka celecoxibu do 200 mg včetně nebo den dávka rofecoxibu do 25 mg včetně; v indikaci revmatoidní artriris denní dávka celecoxibu do 400 mg včetně nebo denní dávka rofecoxibu do 25 mg včetně.
| 341.9 | M01AH01 | celecoxib | p.o. | 0.2 | GM | 27,00 | P |
| --- | --- | --- | --- | --- | --- | --- | --- |
| | | | | | | | |
| 341.10 | M01AH02 | rofecoxib (pevné lékové formy s obsahem do 25 mg rofecoxibu včetně) | p.o. | 1 | DF | 36,00 | P |
- b) osteoartróza nosných kloubů rentgenologicky III. - IV. stadia dle Kellgrena ve stadiu bolestivé dekompenzace či zánětlivé iritace.
Z prostředků veřejného zdravotního pojištění je hrazena v indikaci osteoartróza denní dávka celecoxibu do 200 mg včetně nebo denní dávka rofecoxibu do 25 mg včetně; v indikaci revmatoidní artriris denní dávka celecoxibu do 400 mg včetně nebo denní dávka rofecoxibu do 25 mg včetně.
| 341.9 | M01AH01 | celecoxib | p.o. | 0.2 | GM | 28,00 | P |
| --- | --- | --- | --- | --- | --- | --- | --- |
| | | | | | | | |
| 341.10 | M01AH02 | rofecoxib (pevné lékové formy s obsahem do 25 mg rofecoxibu včetně) | p.o. | 1 | DF | 32,00 | P |
| | | | | | | | |
| 341.11 | M01AH02 | rofecoxib (pevné lékové formy s obsahem 50 mg rofecoxibu) | p.o. | 1 | DF | 30,00 | P |
@@ -5603,12 +5849,41 @@
Rofecoxib v tekuté lékové formě je indikován pediatrem a revmatologem u pacientů s juvenilní idiopatickou revmatoidní artritidou do 8. let věku při nesnášenlivosti na ibuprofen.
| 341.13 | M01AH | parecoxib | parent. | 80 | MG | 558,00 | H |
| 341.13 | M01AH03 | valdecoxib 10 mg | p.o. | 1 | DF | 28,00 | P |
| --- | --- | --- | --- | --- | --- | --- | --- |
| | | | | | | | |
| 341.14 | M01AH03 | valdecoxib 20 mg | p.o. | 1 | DF | 32,00 | P |
| | | | | | | | |
| 341.15 | M01AH03 | valdecoxib 40 mg | p.o. | 1 | DF | 36,00 | P |
Léčiva skupiny specifických COX 2 inhibitorů jsou předepisována revmatologem, ortopedem nebo gynekologem osobám s níže uvedeným rizikem:
1) prodělaná vředová choroba žaludku či duodena, ověřená fibroskopicky, v předchozích 20 letech života nebo současně, nebo
2) současná dlouhodobá celková léčba kortikoidy (t.j. déle než 6 - 8 týdnů), nebo
3) současná léčba antikoagulačními léky warfarinového typu.
Osobám s výše uvedeným rizikem jsou tato léčiva předepisována u následujících diagnóz:
- a) revmatoidní artritida dospělých ve všech stadiích onemocnění.
- b) osteoartróza nosných kloubů rentgenologicky III. - IV. stadia dle Kellgrena ve stadiu bolestivé dekompenzace či zánětlivé iritace.
- c) primární dysmenorea
Z prostředků veřejného zdravotního pojištění je hrazena v indikaci osteoartróza denní dávka valdekoxibu do 20 mg včetně, v indikaci revmatoidní artritis denní dávka valdekoxibu do 20 mg včetně, v indikaci primární dysmenorea denní dávka valdekoxibu v prvním dni do 80 mg včetně a následující dny do 40 mg včetně.
| 341.16 | M01AH04 | parecoxib | parent. | 80 | MG | 334,00 | O/P |
| --- | --- | --- | --- | --- | --- | --- | --- |
Parecoxib je hrazen pro léčbu pooperační bolesti u pacientů s nesnášenlivostí opioidních analgetik nebo u pacientů s vředovou chorobou nebo krvácením do GIT v anamnéze.
| 342 | M01CB | léčiva obsahující zlato | parent. | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 342.1 | M01CB01 | aurothiomalát sodný | parent. | 2.4 | MG | 6,15 | L/REV |
| 02780 | TAUREDON | inj 10x0.5ml/50mg | BGL | D | | | |
| 02781 | TAUREDON | inj 10x0.5ml/20mg | BGL | D | | | |
| 02781 | TAUREDON 20 | injsol10x0.5ml/20mg | AKZ | D | | | |
| 02780 | TAUREDON 50 | injsol10x0.5ml/50mg | AKZ | D | | | |
| 343 | M01C | penicilamin a ostatní chorobu modifikující léčiva včetně skupiny M09 | p.o., parent. | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
@@ -5617,13 +5892,12 @@
součást léčby primární osteoarthrózy kolenních kloubů, rentgenologicky II. a III. stádium dle Kellgrena, při pravidelných bolestech větší intenzity, nebo u pacientů, u kterých je léčba nesteroidními antirevmatiky kontraindikována.
| 343.1 | M01CC01 | penicilamin (do 150 mg v jedné tabletě včetně) | p.o. | 0.5 | GM | 27,51 | |
| 66755 | METALCAPTASE | tbl obd 50x150mg | KNO | D | | | |
| 66755 | METALCAPTASE 150 | tbl obd 50x150mg | HEL | D | | | |
| 343.2 | M01CC01 | penicilamin (nad 150 mg v jedné tabletě) | p.o. | 0.5 | GM | 22,76 | |
| 66753 | METALCAPTASE | tbl obd 50x300mg | KNO | D | | | |
| 66753 | METALCAPTASE 300 | tbl obd 50x300mg | HEL | D | | | |
| 343.3 | M09AX01 | kyselina hyaluronová | parent. | 3.6 | MG | 195,52 | P |
| 344 | M02AA | nesteroidní protizánětlivá léčiva k zevnímu podání | lok. | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| | | | | | | | |
| 344.1 | M02AA | protizánětlivé přípr., nesteroidní, k zevnímu použití, nad 50 g masti v jednom balení | lok. | 1 | GM | 0,70 | |
| | | | | | | | |
| 344.2 | M02AA | ketofenylbutazon do 50 g masti včetně v jednom balení | lok. | 1 | GM | 0,85 | |
@@ -5635,11 +5909,10 @@
| 344.5 | M02AA06 | etofenamát do 50 g masti včetně v jednom balení | lok. | 1 | GM | 0,85 | |
| | | | | | | | |
| 344.6 | M02AA06 | etofenamát nad 50 g masti v jednom balení | lok. | 1 | GM | 0,70 | |
| | | | | | | | |
| 344.7 | M02AA07 | piroxikam do 50 g masti včetně v jednom balení | lok. | 1 | GM | 0,85 | |
| | | | | | | | |
| 344.8 | M02AA07 | piroxikam nad 50 g masti v jednom balení | lok. | 1 | GM | 0,70 | |
| 01780 | REUMADOR | gel 1x100gm | SLO | SK | | | |
| 01780 | REUMADOR | gel 1x100gm/500mg | SLO | SK | | | |
| 344.9 | M02AA10 | ketoprofen do 50 g masti včetně v jednom balení | lok. | 1 | GM | 0,85 | |
| | | | | | | | |
| 344.10 | M02AA10 | ketoprofen nad 50 g masti v jednom balení | lok. | 1 | GM | 0,70 | |
@@ -5648,7 +5921,7 @@
| | | | | | | | |
| 344.12 | M02AA13 | ibuprofen do 50 g masti včetně v jednom balení | lok. | 1 | GM | 0,85 | |
| | | | | | | | |
| 344.13 | M02AA13 | ibuprofen nad 50 g mastí v jednom balení | lok. | 1 | GM | 0,70 | |
| 344.13 | M02AA13 | ibuprofen nad 50 g masti v jednom balení | lok. | 1 | GM | 0,70 | |
| | | | | | | | |
| 344.14 | M02AA15 | diklofenak do 50 g masti včetně v jednom balení | lok. | 1 | GM | 0,85 | |
| | | | | | | | |
@@ -5671,7 +5944,7 @@
| 345 | M02AC | deriváty kyseliny salicylové k lokálnímu podání | lok. | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 345.1 | M02AC | přípravky s deriváty kyseliny salicylové | lok. | 1 | GM | 0,85 | |
| 346 | M02AX | jiná léčiva k léčbé kloubů a svalů k zevnímu podání | lok. | | | | |
| 346 | M02AX | jiná léčiva k léčbě kloubů a svalů k zevnímu podání | lok. | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 346.1 | M02AX | jiné přípr. k léč. kloubů a svalů k zevnímu použ. | lok. | 1 | GM | 0,85 | |
| | | | | | | | |
@@ -5698,27 +5971,28 @@
| 349.3 | M03AC03 | vekuronium | parent. | 10 | MG | 113,59 | H |
| | | | | | | | |
| 349.4 | M03AC04 | atrakurium | parent. | 50 | MG | 98,58 | H |
| 53619 | ATRACURIUM BESYL.GENTH.10MG/ML | inj 10x10ml/100mg | GNN | D | | | |
| 53617 | ATRACURIUM BESYL.GENTH.10MG/ML | inj 10x2.5ml/25mg | GNN | D | | | |
| 53620 | ATRACURIUM BESYL.GENTH.10MG/ML | inj 10x25ml/250mg | GNN | D | | | |
| 53618 | ATRACURIUM BESYL.GENTH.10MG/ML | inj 10x5ml/50mg | GNN | D | | | |
| 53616 | ATRACURIUM BESYL.GENTH.10MG/ML | inj 2x25ml/250mg | GNN | D | | | |
| 53614 | ATRACURIUM BESYL.GENTH.10MG/ML | inj 5x10ml/100mg | GNN | D | | | |
| 53612 | ATRACURIUM BESYL.GENTH.10MG/ML | inj 5x2.5ml/25mg | GNN | D | | | |
| 53615 | ATRACURIUM BESYL.GENTH.10MG/ML | inj 5x25ml/250mg | GNN | D | | | |
| 53613 | ATRACURIUM BESYL.GENTH.10MG/ML | inj 5x5ml/50mg | GNN | D | | | |
| 53616 | ATRACURIUM BESYL.GENTH.10MG/ML | inj 2x25ml/250mg | GNN | D | | | |
| 53618 | ATRACURIUM BESYL.GENTH.10MG/ML | inj 10x5ml/50mg | GNN | D | | | |
| 53615 | ATRACURIUM BESYL.GENTH.10MG/ML | inj 5x25ml/250mg | GNN | D | | | |
| 53617 | ATRACURIUM BESYL.GENTH.10MG/ML | inj 10x2.5ml/25mg | GNN | D | | | |
| 53620 | ATRACURIUM BESYL.GENTH.10MG/ML | inj 10x25ml/250mg | GNN | D | | | |
| 53619 | ATRACURIUM BESYL.GENTH.10MG/ML | inj 10x10ml/100mg | GNN | D | | | |
| 349.5 | M03AC06 | pipekuronium | parent. | 10 | MG | 103,48 | H |
| | | | | | | | |
| 349.6 | M03AC09 | rokuroniumbromid | parent. | 50 | MG | 200,00 | H |
| | | | | | | | |
| 349.7 | M03AC10 | mivacuronium | parent. | 10 | MG | 129,58 | H |
| | | | | | | | |
| 349.8 | M03AC11 | cisatracurium | parent. | 10 | MG | 208.40 | H |
| 56517 | NIMBEX FORTE | inj 1x30ml/150mg | GWE | GB | | | |
| 349.8 | M03AC11 | cisatracurium | parent. | 10 | MG | 208,40 | H |
| 56517 | NIMBEX FORTE | inj sol1x30ml/150mg | GWE | GB | | | |
| 99581 | NIMBEX FORTE | inj sol1x30ml/150mg | GAK | I | | | |
| 350 | M03AX | ostatní svalová relaxancia | parent. | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 350.1 | M03AX01 | botulotoxin (do 100 U v jedné ampuli včetně) | parent. | 100 | U | 9.075,20 | X |
| 75241 | BOTOX | inj sic 1x100ut | ALL | IRL | | | |
| 75241 | BOTOX | inj plv sol 1x100ut | AGW | IRL | | | |
| 350.2 | M03AX01 | botulotoxin (nad 100 U v jedné ampuli) | parent. | 100 | U | 2.268,80 | X |
| 32074 | DYSPORT | inj sic 1x500ut | IPW | GB | | | |
| 32075 | DYSPORT | inj sic 2x500ut | IPW | GB | | | |
@@ -5728,13 +6002,13 @@
| | | | | | | | |
| 351.2 | M03BX01 | baklofen (nad 10 mg v jedné tabletě) | p.o. | 50 | MG | 6,31 | |
| | | | | | | | |
| 351.3 | M03BX02 | tizanidin (do 2 mg v jedné tabletě včetně) | p.o. | 12 | MG | 21,50 | L/NEU,ORT, REV |
| | | | | | | | |
| 351.4 | M03BX02 | tizanidin (nad 2 mg v jedné tabletě) | p.o. | 12 | MG | 15,84 | L/NEU,ORT, REV |
| 351.3 | M03BX02 | tizanidin (do 2 mg v jedné tabletě včetně) | p.o. | 12 | MG | 21,50 | L/NEU,ORT,REV |
| | | | | | | | |
| 351.4 | M03BX02 | tizanidin (nad 2 mg v jedné tabletě) | p.o. | 12 | MG | 15,84 | L/NEU,ORT,REV |
| | | | | | | | |
| 351.5 | M03BX04 | tolperison | p.o. | 200 | MG | 4,38 | |
| 57785 | MYDOCALM 50MG | tbl obd 30x50mg-ie. | GED | H | | | |
| 00208 | MYDOCALM 50MG | tbl obd 30x50mg-bl. | GED | H | | | |
| 00208 | MYDOCALM 50 MG | por tbl flm 30x50mg | GED | H | | | |
| 57785 | MYDOCALM 50 MG | por tbl flm 30x50mg | GED | H | | | |
| 351.6 | M03BX04 | tolperison | parent. | 200 | MG | 9,58 | |
| | | | | | | | |
| 351.7 | M03BX05 | thiocolchicosid | p.o. | 12 | MG | 9,97 | |
@@ -5746,9 +6020,9 @@
| 351.10 | M03BA52 | carisoprodol a paracetamol v kombinaci | p.o. | 3 | DF | 2,50 | |
| 352 | M03CA | přímo působící svalová relaxancia | parent. | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 352.1 | M03CA01 | dantrolen | parent. | 0.1 | GM | 7008,60 | T |
| 91583 | DANTROLEN | inj sic3x12x20mg+so | RHA | D | | | |
| 353 | M04AA | antiuratika inhibující tvorbu kyseliny močové | p.o. | | | | |
| 352.1 | M03CA1 | dantrolen | parent. | 0.1 | GM | 7008,60 | T |
| 91583 | DANTROLEN I.V. | inf sic 36x20mg+sol | PGA | D | | | |
| 353 | M04AA | antiuratika inhibujicí tvorbu kyseliny močové | p.o. | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 353.1 | M04AA01 | allopurinol | p.o. | 0.4 | GM | 3,28 | |
| 354 | M04AB | antiuratika zvyšující vylučování kyseliny močové | p.o. | | | | |
@@ -5775,20 +6049,18 @@
- a) Denzitometricky dokumentovaná osteoporóza (méně než -2,5 SD) nebo osteoporotická patologická zlomenina.
- b) Ženy s osteoporózou, u kterých nelze z objektivních důvodů použít hormonální substituční terapii nebo ženy s osteoporotickou zlomeninou, u kterých selhala hormonální substituční léčba (HRT)
Léčba je dlouhodobá, trvá nejméně dva roky. Terapie delší než dva roky pouze u pacientek s prokazatelnou zástavou úbytku kostní hmoty.
- b) Ženy s osteoporózou, u kterých nelze z objektivních důvodů použít hormonální substituční terapii nebo ženy s osteoporotickou zlomeninou, u kterých selhala hormonální substituční léčba (HRT) Léčba je dlouhodobá, trvá nejméně dva roky. Terapie delší než dva roky pouze u pacientek s prokazatelnou zástavou úbytku kostní hmoty.
| 356.1 | M05BA02 | kyselina klodronová do 400 mg v jedné tabletě včetně | p.o. | 1.6 | GM | 197,94 | P |
| 94460 | BONEFOS 400 MG | cps 100x400mg | LOY | SF | | | |
| 93985 | LODRONAT | cps 60x400mg | ROC | D | | | |
| 94460 | BONEFOS 400MG | cps 100x400mg | LOY | SF | | | |
| 356.2 | M05BA02 | kyselina klodronová nad 400 mg do 520 mg v jedné tabletě včetně | p.o. | 1.6 | GM | 304,54 | P |
| | | | | | | | |
| 356.3 | M05BA02 | kyselina klodronová nad 520 mg do 800 mg v jedné tabletě včetně | p.o. | 1.6 | GM | 197,94 | P |
| 56638 | BONEFOS 800MG | tbl obd 60x800mg | LOY | SF | | | |
| 356.4 | M05BA04 | kyselina alendronová | p.o. | 10 | MG | 37,40 | P |
| | | | | | | | |
| 356.5 | M05BA07 | kyselina risedronová | p.o. | 5 | MG | 37,40 | P |
| 56638 | BONEFOS 800 MG | tbl obd 60x800mg | LOY | SF | | | |
| 356.4 | M05BA04 | kyselina alendronová | p.o. | 10 | MG | 35,50 | P |
| | | | | | | | |
| 356.5 | M05BA07 | kyselina risedronová | p.o. | 5 | MG | 35,50 | P |
| 357 | M05BA | bisfosfonáty | parent. | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
@@ -5808,8 +6080,7 @@
| 357.1 | M05BA02 | kyselina klodronová | parent. | 1.5 | GM | 2348,73 | O/P |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 57452 | LODRONAT AMPULE | inj 5x10ml/300mg | ROC | D | | | |
| 94548 | BONEFOS | inj 5x5ml 60mg/ml | LOY | SF | | | |
| 94548 | BONEFOS | inf cnc 5x5ml/300mg | LOY | SF | | | |
| 357.2 | M05BA03 | kyselina pamidronová | parent. | 60 | MG | 3758,01 | O/P |
| | | | | | | | |
| 357.3 | M05BA06 | kyselina ibandronová | parent. | 2 | MG | 9384,77 | O/P |
@@ -5830,9 +6101,9 @@
| 359.1 | N01AB01 | halotan | inhal. | 100 | ML | 304,96 | H |
| | | | | | | | |
| 359.2 | N01AB06 | isofluran | inhal. | 100 | ML | 1852,76 | H |
| 10722 | ISOFLURAN RHODIA | inh 1x250ml | ROD | GB | | | |
| 55404 | AERRANE | inh sol 1x100ml | BXI | B | | | |
| 55405 | AERRANE | inh sol 1x250ml | BXI | B | | | |
| 10722 | ISOFLURAN RHODIA | inh sol 1x250ml | ROD | GB | | | |
| 359.3 | N01AB07 | desfluran | inhal. | 100 | ML | 1407,00 | H |
| | | | | | | | |
| 359.4 | N01AB08 | sevofluoran | inhal. | 100 | ML | 2290,62 | H |
@@ -5843,7 +6114,7 @@
| 360.2 | N01AF03 | thiopental (do 500 mg v jedné ampuli včetně) | parent. | 0.5 | GM | 60,41 | H |
| | | | | | | | |
| 360.3 | N01AF03 | thiopental (nad 500 mg v jedné ampuli) | parent. | 0.5 | GM | 38,85 | H |
| 361 | N01AH | opioidní anestetika (fentanyi) | parent. | | | | |
| 361 | N01AH | opioidní anestetika (fentanyl) | parent. | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 361.1 | N01AH01 | fentanyl (do 2 ml roztoku v ampuli včetně) | parent. | 1 | MG | 137,80 | O |
| 30101 | FENTANYL TORREX 50MCG/ML | inj 5x2ml/100rg | TRX | A | | | |
@@ -5852,14 +6123,17 @@
| 362 | N01AH | opioidní anestetika (ostatní) | parent. | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 362.1 | N01AH02 | alfentanyl | parent. | 1.5 | MG | 46,89 | H |
| 87721 | RAPIFEN | inj 5x2ml | JAN | B | | | |
| 87721 | RAPIFEN | inj sol 5x2ml/1mg | JAN | B | | | |
| 362.2 | N01AH03 | sufentanyl (do 10 rg v ampuli včetně) | parent. | 0.6 | MG | 1344,54 | H |
| 93701 | SUFENTA I.V. | inj 5x2ml/10rg | JAN | B | | | |
| 93701 | SUFENTA | inj 5x2ml/10rg | JAN | B | | | |
| 362.3 | N01AH03 | sufentanyl (nad 10 do 50 rg v ampuli včetně) | parent. | 0.6 | MG | 644,02 | H |
| 85526 | SUFENTA FORTE I.V. | inj 5x1ml/50rg | JAN | B | | | |
| 85526 | SUFENTA FORTE | inj 5x1ml/50rg | JAN | B | | | |
| 30779 | SUFENTANIL TORREX 5 MCG/ML | inj sol 5x10ml/50rg | TRX | A | | | |
| 21043 | SUFENTANIL TORREX 5 MCG/ML | inj sol10x10ml/50rg | TRX | A | | | |
| 21044 | SUFENTANIL TORREX 5 MCG/ML | inj sol20x10ml/50rg | TRX | A | | | |
| 362.4 | N01AH03 | sufentanyl (nad 50 rg v ampuli) | parent. | 0.6 | MG | 718,96 | H |
| 93702 | SUFENTA FORTE I.V. | inj 5x5ml/250rg | JAN | B | | | |
| 362.5 | N01AH51 | fentanyi v kombinacích | parent. | 4 | ML | 38.22 | H |
| 93702 | SUFENTA FORTE | inj 5x5ml/250rg | JAN | B | | | |
| 362.5 | N01AH51 | fentanyl v kombinacích | parent. | 4 | ML | 38,22 | H |
| | | | | | | | |
| 362.6 | N01AH06 | remifentanyl | parent. | 1 | MG | 264,29 | H |
| 363 | N01AX | ostatní celková anestetika | parent. | | | | |
@@ -5872,20 +6146,22 @@
| | | | | | | | |
| 363.4 | N01AX07 | etomidát | parent. | 50 | MG | 162,72 | O |
| | | | | | | | |
| 363.5 | N01AX10 | propofol - koncentrace do 1% včetně | parent. | 10 | ML | 87,00 | O |
| 56663 | PROPOFOL GENTHON 10MG/ML | inj 1x20ml/200mg | GNN | D | | | |
| 56669 | PROPOFOL GENTHON 10MG/ML | inj 1x100ml/1gm | GNN | D | | | |
| 56670 | PROPOFOL GENTHON 10MG/ML | inj 5x100ml/1gm | GNN | D | | | |
| 56671 | PROPOFOL GENTHON 10MG/ML | inj 10x100ml/1gm | GNN | D | | | |
| 53444 | PROPOFOL ABBOTT | inj 1x100ml/1gm | ABN | USA | | | |
| 56668 | PROPOFOL GENTHON 10MG/ML | inj 10x50ml/500mg | GNN | D | | | |
| 53442 | PROPOFOL ABBOTT | inj 5x20ml/200mg-la | ABN | USA | | | |
| 56666 | PROPOFOL GENTHON 10MG/ML | inj 1x50ml/500mg | GNN | D | | | |
| 56665 | PROPOFOL GENTHON 10MG/ML | inj 10x20ml/200mg | GNN | D | | | |
| 56664 | PROPOFOL GENTHON 10MG/ML | inj 5x20ml/200mg | GNN | D | | | |
| 53441 | PROPOFOL ABBOTT | inj 5x20ml/200mg-am | ABN | USA | | | |
| 56667 | PROPOFOL GENTHON 10MG/ML | inj 5x50ml/500mg | GNN | D | | | |
| 363.6 | N01AX10 | propofol - 2% koncentrace | parent. | 10 | ML | 139,00 | O |
| 363.5 | N01AX10 | propofol – koncentrace do 1% včetně | parent. | 10 | ML | 87,00 | O |
| 53444 | PROPOFOL ABBOTT | inj eml 1x100ml | ABN | USA | | | |
| 53441 | PROPOFOL ABBOTT | inj eml 5x20ml-am | ABN | USA | | | |
| 53442 | PROPOFOL ABBOTT | inj eml 5x20ml-la | ABN | USA | | | |
| 56671 | PROPOFOL GENTHON 10 MG/ML | injeml10x100ml/1gm | GNN | D | | | |
| 56665 | PROPOFOL GENTHON 10 MG/ML | injeml10x20ml/200mg | GNN | D | | | |
| 56668 | PROPOFOL GENTHON 10 MG/ML | injeml10x50ml/500mg | GNN | D | | | |
| 56669 | PROPOFOL GENTHON 10 MG/ML | injeml1x100ml/1gm | GNN | D | | | |
| 56663 | PROPOFOL GENTHON 10 MG/ML | injeml1x20ml/200mg | GNN | D | | | |
| 56666 | PROPOFOL GENTHON 10 MG/ML | injeml1x50ml/500mg | GNN | D | | | |
| 56670 | PROPOFOL GENTHON 10 MG/ML | injeml5x100ml/1gm | GNN | D | | | |
| 56664 | PROPOFOL GENTHON 10 MG/ML | injeml5x20ml/200mg | GNN | D | | | |
| 56667 | PROPOFOL GENTHON 10 MG/ML | injeml5x50ml/500mg | GNN | D | | | |
| 44163 | RECOFOL | inj 1x50ml/500mg | LOY | SF | | | |
| 75180 | RECOFOL | inj 5x20ml/200mg | LOY | SF | | | |
| 363.6 | N01AX10 | propofol – 2% koncentrace | parent. | 10 | ML | 139,00 | O |
| 364 | N01BA | lokální anestetika ze skupiny esterů kyseliny aminobenzoové | parent. | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 364.1 | N01BA | estery aminobenzoové kyseliny | parent. | 100 | ML | 19,55 | O |
@@ -5893,43 +6169,45 @@
| 364.2 | N01BA02 | prokain (do 10 ml v jedné ampuli včetně) | parent. | 1 | ML | 1,37 | O |
| | | | | | | | |
| 364.3 | N01BA02 | prokain (nad 10 ml v jedné ampuli) | parent. | 1 | ML | 0,49 | O |
| 69670 | INJECTIO PROCAIN.CHLOR.0.2% ARD | inj 1x250ml 0.2% | ARD | CZ | | | |
| 69673 | INJECTIO PROCAIN.CHLOR.0.5% ARD | inj 1x250ml 0.5% | ARD | CZ | | | |
| 69674 | INJECTIO PROCAIN CHLOR.0,5% ARD | inj 1x500ml 0.5% | ARD | CZ | | | |
| 89212 | INJECTIO PROCAIN.CHLOR.0.2% ARD | inj 1x200ml 0.2% | ARD | CZ | | | |
| 69671 | INJECTIO PROCAIN.CHLOR.0.2% ARD | inj 1x500ml 0.2% | ARD | CZ | | | |
| 69676 | INJECTIO PROCAIN.CHLOR.1% ARD. | inj 1x250ml 1% | ARD | CZ | | | |
| 89214 | INJECTIO PROCAIN CHLOR.0,5% ARD | inj 1x200ml 0.5% | ARD | CZ | | | |
| 89216 | INJECTIO PROCAIN.CHLOR.1% ARD. | inj 1x200ml 1% | ARD | CZ | | | |
| 69677 | INJECTIO PROCAIN.CHLOR.1% ARD. | inj 1x500ml 1% | ARD | CZ | | | |
| 89212 | INJECTIO PROCAIN.CHLOR.0.2% ARD | inj 1x200ml | ARD | CZ | | | |
| 69670 | INJECTIO PROCAIN.CHLOR.0.2% ARD | inj 1x250ml/500mg | ARD | CZ | | | |
| 69671 | INJECTIO PROCAIN.CHLOR.0.2% ARD | inj 1x500ml/1gm | ARD | CZ | | | |
| 89214 | INJECTIO PROCAIN.CHLOR.0.5% ARD | inj 1x200ml | ARD | CZ | | | |
| 69673 | INJECTIO PROCAIN.CHLOR.0.5% ARD | inj 1x250ml/1.25gm | ARD | CZ | | | |
| 69674 | INJECTIO PROCAIN.CHLOR.0.5% ARD | inj 1x500ml/2.5gm | ARD | CZ | | | |
| 89216 | INJECTIO PROCAIN.CHLOR.1% ARD. | inj 1x200ml | ARD | CZ | | | |
| 69676 | INJECTIO PROCAIN.CHLOR.1% ARD. | inj 1x250ml | ARD | CZ | | | |
| 69677 | INJECTIO PROCAIN.CHLOR.1% ARD. | inj 1x500ml/5gm | ARD | CZ | | | |
| 365 | N01BB | lokální anestetika ze skupiny amidů | lok. | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 365.1 | N01BB | trimekain | lok. | 1 | GM | 1,18 | O |
| 02684 | MESOCAIN | gel 1x20gm | SLO | SK | | | |
Autokatetrizace močových cest prováděná pacientem v domácí péči.
| 02684 | MESOCAIN | gel 1x20gm/200mg | SLO | SK | | | |
| 365.2 | N01BB02 | lidokain (obsah 6 ml) | lok. | 1 | ML | 5,60 | P |
| | | | | | | | |
| 365.3 | N01BB02 | lidokain (obsah 11 ml) | lok. | 1 | ML | 3,90 | P |
| 366 | N01BB | lokální anestetika ze skupiny amidů | parent. | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 366.1 | N01BB | trimekain (koncentrace 0,5%) | parent. | 1 | ML | 0,73 | O |
| 69705 | INJECTIO TRIMECAIN.CHL.0.5% ARD | inj 1x250ml 0.5% | ARD | CZ | | | |
| 69706 | INJECTIO TRIMECAIN.CHL.0.5% ARD | inj 1x500ml 0.5% | ARD | CZ | | | |
| 69705 | INJECTIO TRIMECAIN.CHL.0.5% ARD | inj 1x250ml 0.5% | ARD | CZ | | | |
| 366.2 | N01BB | trimekain (koncentrace 1%, do 10 ml v jedné ampuli včetně) | parent. | 1 | ML | 1,43 | O |
| | | | | | | | |
| 366.3 | N01BB | trimekain (koncentrace 1%, nad 10 ml v jedné ampuli) | parent. | 1 | ML | 0,78 | O |
| 69708 | INJECTIO TRIMECAIN.CHL.1% ARD. | inj 1x250ml 1% | ARD | CZ | | | |
| 69709 | INJECTIO TRIMECAIN.CHL.1% ARD. | inj 1x500ml 1% | ARD | CZ | | | |
| 69708 | INJECTIO TRIMECAIN.CHL.1% ARD. | inj 1x250ml 1% | ARD | CZ | | | |
| 366.4 | N01BB | trimekain (koncentrace 2%) | parent. | 1 | ML | 1,22 | O |
| | | | | | | | |
| 366.5 | N01BB | trimekain/adrenalin | parent. | 1 | ML | 2,35 | O |
| | | | | | | | |
| 366.6 | N01BB01 | bupivakain | parent. | 1 | ML | 3,52 | O |
| | | | | | | | |
| 06624 | BUPIVACAINE HYDROCHLORIDE 0.25% | inj sol 10x50ml | SLH | D | | | |
| 06623 | BUPIVACAINE HYDROCHLORIDE 0.25% | inj sol 1x50ml | SLH | D | | | |
| 06625 | BUPIVACAINE HYDROCHLORIDE 0.25% | inj sol 50x50ml | SLH | D | | | |
| 06634 | BUPIVACAINE HYDROCHLORIDE 0.5% | inj sol 10x50ml | SLH | D | | | |
| 06635 | BUPIVACAINE HYDROCHLORIDE 0.5% | inj sol 50x50ml | SLH | D | | | |
| 366.7 | N01BB01 | bupivakain (lékové formy spinal) | parent. | 1 | ML | 48,84 | O |
| 92836 | MARCAINE SPINAL 0.5% HEAVY | inj 5x4ml/20mg | AST | S | | | |
| 06640 | BUPIVACAINE HYDROCH0.5%HYPERBAR | inj sol 10x4ml | SLH | D | | | |
| 92836 | MARCAINE SPINAL 0.5% HEAVY | inj sol 5x4ml/20mg | AZC | D | | | |
| 366.8 | N01BB02 | lidokain | parent. | 1 | ML | 1,22 | O |
| | | | | | | | |
| 366.9 | N01BB03 | mepivakain | parent. | 1 | ML | 3,52 | O |
@@ -5945,11 +6223,11 @@
| 366.14 | N01BB58 | artikain/adrenalin | parent. | 1 | ML | 4,15 | O |
| | | | | | | | |
| 366.15 | N01BB10 | ropivacain | parent. | 1 | ML | 14,00 | O |
| 46610 | NAROPIN 2MG/ML | inf 5x100ml/200mg | APN | S | | | |
| 56038 | NAROPIN 2MG/ML | inj 5x10ml/20mg | APN | s | | | |
| 03755 | CHIROCAINE 2.5 MG/ML | inj sol 10x10ml | ABB | I | | | |
| 03761 | CHIROCAINE 5 MG/ML | inj sol 10x10ml | ABB | I | | | |
| 366.16 | N01BB09 | levobupivacain | parent. | 1 | ML | 14,00 | O |
| 03761 | CHIROCAINE 5 MG | inj cnc sol 10x10ml | ABB | I | | | |
| 03755 | CHIROCAINE 2.5 MG | inj cnc sol 10x10ml | ABB | I | | | |
| 46610 | NAROPIN 2 MG/ML | infsol5x100ml/200mg | AZC | S | | | |
| 56038 | NAROPIN 2 MG/ML | inj sol5x10ml/20mg | AZC | S | | | |
| 367 | N01BX | ostatní lokální anestetika | lok. | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 367.1 | N01BX01 | ethylchlorid | lok. | 100 | ML | 93,36 | O |
@@ -5957,29 +6235,30 @@
| --- | --- | --- | --- | --- | --- | --- | --- |
| 368.1 | N02AA01 | morfin (do 10 mg v jedné tabletě včetně) | p.o. | 0.1 | GM | 79,40 | |
| 55940 | M-ESLON SR 10 | cps ret 100x10mg | ETP | F | | | |
| 80405 | VENDAL RETARD | tbl fc 30x10mg | LAR | D | | | |
| 94309 | MST CONTINUS | tbl ret 60x10mg | NPP | GB | | | |
| 88834 | M-ESLON SR 10 | cps ret 20x10mg | ETP | F | | | |
| 94309 | MST CONTINUS 10MG | tbl ret 60x10mg | NPP | GB | | | |
| 46256 | SKENAN L.P.10 MG | por cps rdr 14x10mg | EAD | F | | | |
| 80405 | VENDAL RETARD 10MG | tbl obd 30x10mg | LAR | A | | | |
| 368.2 | N02AA01 | morfin (nad 10 mg do 30 mg včetně v jedné tabletě) | p.o. | 0.1 | GM | 53,20 | |
| 80406 | VENDAL RETARD | tbl fc 30x30mg | LAR | D | | | |
| 55942 | M-ESLON SR 30 | cps ret 100x30mg | ETP | F | | | |
| 94310 | MST CONTINUS 30MG | tbl ret 60x30mg | NPP | GB | | | |
| 46258 | SKENAN L.P.30 MG | por cps rdr 14x30mg | EAD | F | | | |
| 12919 | SLOVALGIN 30 RETARD | tbl obd 10x30mg | SLO | SK | | | |
| 55942 | M-ESLON SR 30 | cps ret 100x30mg | ETP | F | | | |
| 47265 | SLOVALGIN 30 RETARD | tbl obd 60x30mg | SLO | SK | | | |
| 94310 | MST CONTINUS | tbl 60x30mg | NPP | GB | | | |
| 55941 | M-ESLON SR 30 | cps ret 50x30mg | ETP | F | | | |
| 80406 | VENDAL RETARD 30MG | tbl obd 30x30mg | LAR | A | | | |
| 368.3 | N02AA01 | morfin (nad 30 mg do 99 mg včetně v jedné tabletě) | p.o. | 0.1 | GM | 50,39 | |
| 88839 | M-ESLON SR 60 | cps ret 20x60mg | ETP | F | | | |
| 94311 | MST CONTINUS | tbl 60x60mg | NPP | GB | | | |
| 80407 | VENDAL RETARD | tbl fc 30x60mg | LAR | D | | | |
| 55944 | M-ESLON SR 60 | cps ret 100x60mg | ETP | F | | | |
| 55944 | M-ESLON SR 60 | cps ret 100x60mg | ETP | F | | | |
| 94311 | MST CONTINUS 60MG | tbl ret 60x60mg | NPP | GB | | | |
| 46260 | SKENAN L.P.60 MG | por cps rdr 14x60mg | EAD | F | | | |
| 46977 | SLOVALGIN 60 RETARD | tbl ret 30x60mg | SLO | SK | | | |
| 46978 | SLOVALGIN 60 RETARD | tbl ret 60x60mg | SLO | SK | | | |
| 55944 | M-ESLON SR 60 | cps ret 100x60mg | ETP | F | | | |
| 46977 | SLOVALGIN 60 RETARD | tbl ret 30x60mg | SLO | SK | | | |
| 80407 | VENDAL RETARD 60MG | tbl obd 30x60mg | LAR | A | | | |
| 368.4 | N02AA01 | morfin (100 a více mg v jedné tabletě) | p.o. | 0.1 | GM | 46,55 | |
| 46262 | SKENAN L.P.100 MG | por cps rdr14x100mg | EAD | F | | | |
| 46975 | SLOVALGIN 100 RETARD | tbl ret 30x100mg | SLO | SK | | | |
| 46976 | SLOVALGIN 100 RETARD | tbl ret 60x100mg | SLO | SK | | | |
| 80408 | VENDAL RETARD | tbl fc 30x100mg | LAR | D | | | |
| 46975 | SLOVALGIN 100 RETARD | tbl ret 30x100mg | SLO | SK | | | |
| 94312 | MST CONTINUS | tbl 60x100mg | NPP | GB | | | |
| 80409 | VENDAL RETARD | tbl fc 30x200mg | LAR | D | | | |
| 80408 | VENDAL RETARD 100MG | tbl obd 30x100mg | LAR | A | | | |
| 80409 | VENDAL RETARD 200MG | tbl obd 30x200mg | LAR | A | | | |
| 368.5 | N02AA01 | morfin (tekuté lékové formy s retardovaným uvolňováním, do 30 mg v jedné dávce včetně) | p.o. | 0.1 | GM | 61,60 | |
| | | | | | | | |
| 368.6 | N02AA01 | morfin (tekuté lékové formy s retardovaným uvolňováním, nad 30 mg do 99 mg v jedné dávce včetně) | p.o. | 0.1 | GM | 58,36 | |
@@ -5997,13 +6276,13 @@
| 368.12 | N02AA05 | oxycodon více než 40 mg v jedné tabletě | p.o. | 30 | MG | 52,20 | |
| | | | | | | | |
| 368.13 | N02AA08 | dihydrocodein (do 90 mg v jedné tabletě včetně) | p.o. | 0.15 | GM | 32,71 | |
| 80452 | DHC CONTINUS 90MG | tbl ret 56x90mg | NPP | GB | | | |
| 56874 | DHC CONTINUS 90MG | tbl ret 20x90mg | NPP | GB | | | |
| 56873 | DHC CONTINUS 60MG | tbl ret 20x60mg | NPP | GB | | | |
| 80451 | DHC CONTINUS 60MG | tbl ret 56x60mg | NPP | GB | | | |
| 56873 | DHC CONTINUS 60 MG | por tbl ret 20x60mg | NPP | GB | | | |
| 80451 | DHC CONTINUS 60 MG | por tbl ret 56x60mg | NPP | GB | | | |
| 56874 | DHC CONTINUS 90 MG | por tbl ret 20x90mg | NPP | GB | | | |
| 80452 | DHC CONTINUS 90 MG | por tbl ret 56x90mg | NPP | GB | | | |
| 368.14 | N02AA08 | dihydrocodein (nad 90 mg v jedné tabletě) | p.o. | 0.15 | GM | 27,86 | |
| 56875 | DHC CONTINUS 120MG | tbl ret 20x120mg | NPP | GB | | | |
| 80453 | DHC CONTINUS 120MG | tbl ret 56x120mg | NPP | GB | | | |
| 56875 | DHC CONTINUS 120 MG | por tbl ret20x120mg | NPP | GB | | | |
| 80453 | DHC CONTINUS 120 MG | por tbl ret56x120mg | NPP | GB | | | |
| 369 | N02AA | analgetika ze skupiny přírodních opioidů | parent. | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 369.1 | N02AA01 | morfin (do 10 mg v jedné ampuli včetně) | parent. | 30 | MG | 15,45 | O |
@@ -6014,13 +6293,13 @@
| --- | --- | --- | --- | --- | --- | --- | --- |
| 370.1 | N02AB02 | pethidin | p.o. | 0.4 | GM | 41,30 | |
| | | | | | | | |
| 370.2 | N02AB03 | fentanyl (s řízeným uvolňováním 25 mikrogramu za hodinu) | transd. | 1 | DF | 241,46 | P |
| | | | | | | | |
| 370.3 | N02AB03 | fentanyl (s řízeným uvolňováním 50 mikrogramu za hodinu) | transd. | 1 | DF | 458,80 | P |
| | | | | | | | |
| 370.4 | N02AB03 | fentanyl (s řízeným uvolňováním 75 mikrogramu za hodinu) | transd. | 1 | DF | 667,24 | P |
| | | | | | | | |
| 370.5 | N02AB03 | fentanyl (s řízeným uvolňováním 100 mikrogramu za hodinu) | transd. | 1 | DF | 807,50 | P |
| 370.2 | N02AB03 | fentanyl (s řízeným uvolňováním 25 mikrogramu za hodinu) | transd. | 1 | DF | 229,40 | P |
| | | | | | | | |
| 370.3 | N02AB03 | fentanyl (s řízeným uvolňováním 50 mikrogramu za hodinu) | transd. | 1 | DF | 435,90 | P |
| | | | | | | | |
| 370.4 | N02AB03 | fentanyl (s řízeným uvolňováním 75 mikrogramu za hodinu) | transd. | 1 | DF | 633,85 | P |
| | | | | | | | |
| 370.5 | N02AB03 | fentanyl (s řízeným uvolňováním 100 mikrogramu za hodinu) | transd. | 1 | DF | 767,15 | P |
Fentanyl s řízeným uvolňováním ve formě náplasti je indikován v případě, kdy jiné opiody nejsou pro pacienta vhodné.
@@ -6037,7 +6316,7 @@
| 373 | N02AD | analgetika ze skupiny benzomorfanových derivátů | p.o. | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 373.1 | N02AD01 | pentazocin | p.o. | 0.2 | GM | 25,90 | |
| 08968 | FORTRAL | tbl 100x50mg | KRK | SK | | | |
| 08968 | FORTRAL | tbl 100x50mg | KRK | SLO | | | |
| 374 | N02AD | analgetika ze skupiny benzomorfanových derivátů | parent. | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 374.1 | N02AD01 | pentazocin | parent. | 0.2 | GM | 101,10 | O |
@@ -6045,6 +6324,7 @@
| 375 | N02AX | analgetika ze skupiny ostatních opioidů | p.o., subling. | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 375.1 | N02AE01 | buprenorfin | subling. | 1.2 | MG | 80,00 | |
| | | | | | | | |
| 375.2 | N02AE01 | buprenorfin (s řízeným uvolňováním 35 mikrogramu za hodinu) | transd. | 1 | DF | 254,00 | P |
| | | | | | | | |
| 375.3 | N02AE01 | buprenorfin (s řízeným uvolňováním 50,5 mikrogramu za hodinu) | transd. | 1 | DF | 370,00 | P |
@@ -6054,43 +6334,25 @@
Buprenorfin s řízeným uvolňováním ve formě náplasti je indikován v případě, kdy jiné opiody nejsou pro pacienta vhodné.
| 375.5 | N02AX01 | tilidin | p.o. | 0.2 | GM | 19,78 | |
| 03558 | VALORON | gtt 10ml 10% | IVX | CZ | | | |
| 375.6 | N02AX02 | tramadol hydrochlorid (pevné lékové formy neretardované) | p.o. | 0.3 | GM | 21,80 | |
| 03558 | VALORON | por gtt sol 1x10ml | IVX | CZ | | | |
| 375.6 | N02AX02 | tramadol hydrochlorid (pevné lékové formy neretardované) | p.o. | 0.3 | GM | 17,44 | |
| 67568 | MABRON 50MG | cps 10x50mg | MOE | CY | | | |
| 67569 | MABRON 50MG | cps 20x50mg | MOE | CY | | | |
| 84375 | PROTRADON | cps 10x50mg | PMP | CZ | | | |
| 84376 | PROTRADON | cps 20x50mg | PMP | CZ | | | |
| 53716 | PROTRADON | cps 500x50mg | PMP | CZ | | | |
| 12475 | TRAMABENE 50 TOBOLKY | cps 30x50mg | MCK | D | | | |
| 54082 | TRAMADOL 50 HF | cps 20x50mg | HMF | YU | | | |
| 84631 | TRAMADOL-K | cps 20x50mg | KRK | SLO | | | |
| 84376 | PROTRADON | cps 20x50mg | PMP | CZ | | | |
| 84375 | PROTRADON | cps 10x50mg | PMP | CZ | | | |
| 83094 | TRAMAL | cps 20x50mg | LEX | CZ | | | |
| 12475 | TRAMABENE 50 TOBOLKY | cps 30x50mg | MCK | D | | | |
| 67569 | MABRON 50MG | cps 20x50mg | MOE | CY | | | |
| 67568 | MABRON 50MG | cps 10x50mg | MOE | CY | | | |
| 375.7 | N02AX02 | tramadol hydrochlorid (pevné lékové formy retardované) | p.o. | 0.3 | GM | 29,40 | |
| 43712 | TRAMAL RETARD 100 | tbl obd 30x100mg | LEX | CZ | | | |
| 59672 | TRALGIT SR 100 | por tbl ret30x100mg | SLO | SK | | | |
| 59673 | TRALGIT SR 100 | por tbl ret50x100mg | SLO | SK | | | |
| 59671 | TRALGIT SR 100 | por tbl ret10x100mg | SLO | SK | | | |
| 81423 | TRAMADOL LANNACHER RET.100 | por tbl ret20x100mg | LAR | A | | | |
| 43711 | TRAMAL RETARD 100 | tbl obd 10x100mg | LEX | CZ | | | |
| 32197 | TRAMADOL-K RETARD | por tbl ret30x100mg | KRK | SLO | | | |
| 12687 | TRAMAL RETARD 100 | tbl obd 30x100mg | GRU | D | | | |
| 41022 | TRAMADOL LANNACHER RET.200 MG | por tbl ret50x200mg | LAR | A | | | |
| 53368 | TRAMAL RETARD 200 | tbl ret 10x200mg | LEX | CZ | | | |
| 53366 | TRAMAL RETARD 150 | tbl ret 10x150mg | LEX | CZ | | | |
| 40912 | TRAMADOL LANNACHER RET.150 MG | por tbl ret20x150mg | LAR | A | | | |
| 40939 | TRAMADOL LANNACHER RET.150 MG | por tbl ret50x150mg | LAR | A | | | |
| 81424 | TRAMADOL LANNACHER RET.100 | por tbl ret50x100mg | LAR | A | | | |
| 41000 | TRAMADOL LANNACHER RET.200 MG | por tbl ret20x200mg | LAR | A | | | |
| 375.8 | N02AX02 | tramadol hydrochlorid ( tekuté lékové formy) | p.o. | 0.3 | GM | 29,30 | |
| 83095 | TRAMAL | gtt 1x10ml/1gm | LEX | CZ | | | |
| 59077 | TRAMADOL AL | gtt 1x50ml/5gm | SDB | D | | | |
| 53555 | PROTRADON KAPKY | gtt 1x10ml/1gm | PMP | CZ | | | |
| 59076 | TRAMADOL AL | gtt 1x20ml/2gm | SDB | D | | | |
| 04306 | TRAMAL | por cps dur 20x50mg | GRU | D | | | |
| 83094 | TRAMAL LÉČIVA | por cps dur 20x50mg | LEX | CZ | | | |
| 375.7 | N02AX02 | tramadol hydrochlorid (pevné lékové formy retardované) | p.o. | 0.3 | GM | 23,52 | |
| | | | | | | | |
| 375.8 | N02AX02 | tramadol hydrochlorid (tekuté lékové formy) | p.o. | 0.3 | GM | 24,44 | |
| 12473 | TRAMABENE KAPKY | gtt 1x100ml/10gm | MCK | D | | | |
| 56036 | TRAMAL | gtt 1x96ml/9.6gm | LEX | CZ | | | |
| 12472 | TRAMABENE KAPKY | gtt 1x30ml/3gm | MCK | D | | | |
| 84630 | TRAMADOL-K | gtt 1x10ml/1gm | KRK | SLO | | | |
| 376 | N02AX | analgetika ze skupiny ostatních opioidů | p.rect, parent. | | | | |
| 32069 | TRAMADOL AL KAPKY | gtt 1x50ml/5gm | APA | D | | | |
| 59077 | TRAMADOL AL KAPKY | gtt 1x50ml/5gm | SDB | D | | | |
| 376 | N02AX | analgetika ze skupiny ostatních opioidů | p.rect., parent. | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 376.1 | N02AE01 | buprenorfin | parent. | 1.2 | MG | 200,40 | O |
| | | | | | | | |
@@ -6100,28 +6362,35 @@
| | | | | | | | |
| 376.4 | N02AX01 | tilidin | parent. | 0.2 | GM | 16,37 | O |
| | | | | | | | |
| 376.5 | N02AX02 | tramadol hydrochlorid | p.rect. | 0.3 | GM | 52,00 | |
| 83096 | TRAMAL | sup 5x100mg | LEX | CZ | | | |
| 376.6 | N02AX02 | tramadol hydrochlorid (do 50 mg v jedné ampuli včetně) | parent. | 0.3 | GM | 102,84 | O |
| 376.5 | N02AX02 | tramadol hydrochlorid | p.rect. | 0.3 | GM | 41,60 | |
| 06201 | TRAMAL | sup 5x100mg | GRU | D | | | |
| 83096 | TRAMAL LÉČIVA | rct sup 5x100mg | LEX | CZ | | | |
| 376.6 | N02AX02 | tramadol hydrochlorid (do 50 mg v jedné ampuli včetně) | parent. | 0.3 | GM | 82,30 | O |
| 12477 | TRAMABENE 50 INJEKCE | inj 5x1ml/50mg | MCK | D | | | |
| 84628 | TRAMADOL-K 50MG/1ML | inj 5x1ml/50mg | KRK | SLO | | | |
| 83097 | TRAMAL 50 | inj 5x1 mlZ50mg | LEX | CZ | | | |
| 376.7 | N02AX02 | tramadol hydrochlorid (nad 50 mg v jedné ampuli) | parent. | 0.3 | GM | 53,76 | O |
| 67560 | MABRON | inj 100x2ml/100mg | MOE | CY | | | |
| 58994 | TRAMADOL AL | inj 20x2ml/100mg | SDB | D | | | |
| 58993 | TRAMADOL AL | inj 10x2ml/100mg | SDB | D | | | |
| 84628 | TRAMADOL-K 50MG/1 ML | inj 5x1 ml/50mg | KRK | SLO | | | |
| 06200 | TRAMAL 50 | inj 5x1ml/50mg | GRU | D | | | |
| 83097 | TRAMAL 50 LÉČIVA | inj sol 5x1ml/50mg | LEX | CZ | | | |
| 376.7 | N02AX02 | tramadol hydrochlorid (nad 50 mg v jedné ampuli) | parent. | 0.3 | GM | 43,00 | O |
| 67560 | MABRON | inj sol 100x2ml | MOE | CY | | | |
| 67558 | MABRON | inj sol 5x2ml | MOE | CY | | | |
| 58198 | PROTRADON INJEKCE 100 MG | inj sol 5x2ml/100mg | FIP | I | | | |
| 58199 | PROTRADON INJEKCE 100 MG | inj sol10x2ml/100mg | FIP | I | | | |
| 58200 | PROTRADON INJEKCE 100 MG | injsol100x2ml/100mg | FIP | I | | | |
| 12478 | TRAMABENE 100 INJEKCE | inj 5x2ml/100mg | MCK | D | | | |
| 32049 | TRAMADOL AL 100 INJ. | inj 10x2ml/100mg | APA | D | | | |
| 58993 | TRAMADOL AL 100 INJ. | inj 10x2ml/100mg | SDB | D | | | |
| 58994 | TRAMADOL AL 100 INJ. | inj 20x2ml/100mg | SDB | D | | | |
| 32048 | TRAMADOL AL 100 INJ. | inj 5x2ml/100mg | APA | D | | | |
| 76389 | TRAMADOL AL 100 INJ. | inj 5x2ml/100mg | SDB | D | | | |
| 92364 | TRAMADOL LANNACHER 100MG/2ML | inj 5x2ml/100mg | LAR | A | | | |
| 76389 | TRAMADOL AL | inj 5x2ml/100mg | SDB | D | | | |
| 83098 | TRAMAL 100 | inj 5x2ml/100mg | LEX | CZ | | | |
| 67558 | MABRON | inj 5x2ml/100mg | MOE | CY | | | |
| 12478 | TRAMABENE 100 INJEKCE | inj 5x2ml/100mg | MCK | D | | | |
| 84629 | TRAMADOL-K 100MG/2ML | inj 5x2ml/100mg | KRK | SLO | | | |
| 53678 | TRAMADOL-SLOVAKOFARMA 100MG/2ML | inj 5x2ml/100mg | SLO | SK | | | |
| 90719 | TRAMAL 100 | inj 5x2ml/100mg | GRU | D | | | |
| 83098 | TRAMAL 100 LÉČIVA | inj sol 5x2ml/100mg | LEX | CZ | | | |
| 377 | N02BA | analgetika ze skupiny kyseliny salicylové a jejich derivátů | p.o. | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 377.1 | N02BA01 | kyselina acetylsalicylová | p.o. | 3 | GM | 6,45 | |
| 00011 | ACYLPYRIN | tbl 10x500mg | SLO | SK | | | |
| 70487 | APO-ASA 325MG | tbl obd 100x325mg | APT | CND | | | |
| 377.2 | N02BA02 | aloxiprin | p.o. | 3 | GM | 6,45 | |
| | | | | | | | |
| 377.3 | N02BA03 | cholin salicylát | p.o. | 3 | GM | 8,65 | |
@@ -6143,6 +6412,7 @@
| 379.1 | N02BE01 | paracetamol (pevné lékové formy do 125 mg v jedné tabletě včetně) | p.o. | 3 | GM | 8,67 | |
| 97656 | PARALEN 125 | tbl 20x125mg | LEX | CZ | | | |
| 379.2 | N02BE01 | paracetamol (pevné lékové formy nad 125 mg v jedné tabletě) | p.o. | 3 | GM | 4,94 | |
| 05097 | APO-ACETAMINOPHEN 500MG | tbl 100x500mg | TOP | CND | | | |
| 83608 | APO-ACETAMINOPHEN 500MG | tbl 100x500mg | APT | CND | | | |
| 84749 | MEDIPYRIN 500 | tbl 10x500mg | SLO | SK | | | |
| 03837 | PARALEN 500 | tbl 10x500mg | LEX | CZ | | | |
@@ -6150,20 +6420,20 @@
| 380 | N02BE | analgetika ze skupiny anilidů | p.rect. | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 380.1 | N02BE01 | paracetamol (do 150 mg v jednom čípku včetně) | p.rect. | 3 | GM | 90,96 | |
| 86010 | BEN-U-RON 125MG | sup 10x125mg | BNC | D | | | |
| 86009 | BEN-U-RON 125MG | sup 5x125mg | BNC | D | | | |
| 86010 | BEN-U-RON 125MG | sup 10x125mg | BNC | D | | | |
| 380.2 | N02BE01 | paracetamol (nad 150 mg v jednom čípku) | p.rect. | 3 | GM | 26,98 | |
| 94982 | MEXALEN | sup 6x1000mg | MCK | D | | | |
| 59869 | MEDIPYRIN 250 | sup 10x250mg | SLO | SK | | | |
| 86015 | BEN-U-RON 1000MG | sup 10x1000mg | BNC | D | | | |
| 86014 | BEN-U-RON 500MG | sup 10x500mg | BNC | D | | | |
| 86013 | BEN-U-RON 500MG | sup 5x500mg | BNC | D | | | |
| 59869 | MEDIPYRIN 250 | sup 10x250mg | SLO | SK | | | |
| 94982 | MEXALEN 1000 MG | rct sup 6x1000mg | MCK | D | | | |
| 381 | N02B | ostatní analgetika | parent. | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 381.1 | N02BB02 | metamizol sodný (do 1 g v 1 ampuli včetně) | parent. | 3 | GM | 44,53 | O |
| 07981 | NOVALGIN | inj 10x2ml/1000mg | HBS | SK | | | |
| 07981 | NOVALGIN INJEKCE | inj sol 10x2ml/1gm | HBS | SK | | | |
| 381.2 | N02BB02 | metamizol sodný (nad 1 g v 1 ampuli) | parent. | 3 | GM | 18,48 | O |
| 55824 | NOVALGIN | inj 5x5ml/2500mg | HBS | SK | | | |
| 55824 | NOVALGIN INJEKCE | inj sol 5x5ml/2.5gm | HBS | SK | | | |
| 381.3 | N02BB73 | aminophenazon v kombinaci s psycholeptiky | parent. | 1 | DF | 8,10 | O |
| 00457 | EUNALGIT | inj 5x2ml | LEX | CZ | | | |
| 381.4 | N02BE05 | propacetamol | parent. | 1 | GM | 41,84 | O |
@@ -6177,7 +6447,7 @@
| 383 | N02CA | antimigrenika ze skupiny derivátů námelových alkaloidů | parent. | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 383.1 | N02CA01 | dihydroergotamin | parent. | 4 | MG | 111,52 | |
| 90795 | DIHYDERGOT | inj 5x1ml 1 mg/ml | SAN | CH | | | |
| 90795 | DIHYDERGOT | inj 5x1ml/1mg | NPA | CH | | | |
| 383.2 | N02CA01 | dihydroergotamin nosní spray | inhal. | 1 | MG | 50,00 | |
| 384 | N02C | jiná antimigrenika | p.o. | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
@@ -6205,26 +6475,26 @@
| | | | | | | | |
| 384.11 | N02CX06 | oxetoron | p.o. | 0.12 | GM | 5,87 | |
| | | | | | | | |
| 384.12 | N02CX | lysin acetylsalicylát v kombinaci s metokloprami dem | p.o. | 1 | DF | 21,66 | |
| 384.12 | N02CX | lysin acetylsalicylát v kombinaci s metoklopramidem | p.o. | 1 | DF | 21,66 | |
| | | | | | | | |
| 384.13 | N02CX | pipethiaden | p.o. | 3 | DF | 2,54 | |
| 385 | N03AA | antiepileptika ze skupiny barbiturátů a jejích derivátů | p.o. | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 385.1 | N03AA | fenobarbital pseudonorefedr. | p.o. 0.1 | GM | 2,05 | | |
| | | | | | | | |
| 385.2 | N03AA02 | fenobarbital (do 15 mg v jedné tabletě včetně) | p.o. | 0.1 | GM 6,08 | | |
| 385 | N03AA | antiepileptika ze skupiny barbiturátů a jejich derivátů | p.o. | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 385.1 | N03AA | fenobarbital pseudonorefedr. | p.o. | 0.1 | GM | 2,05 | |
| | | | | | | | |
| 385.2 | N03AA02 | fenobarbital (do 15 mg v jedné tabletě včetně) | p.o. | 0.1 | GM | 6,08 | |
| 68578 | PHENAEMALETTEN | tbl 50x15mg | DET | D | | | |
| 385.3 | N03AA02 | fenobarbital (nad 15 mg v jedné tabletě) | p.o. | 0.1 | GM | 2,27 | |
| 68579 | PHENAEMAL 0.1 | tbl 50x100mg | DET | D | | | |
| 385.4 | N03AA03 | primidon (pevné lékové formy) | p.o. | 1.25 GM | 4.72 | | |
| 01365 | MYSOLINE | tbl 100x250mg | ZNC | GB | | | |
| 385.4 | N03AA03 | primidon (pevné lékové formy) | p.o. | 1.25 | GM | 4,72 | |
| 01365 | MYSOLINE | por tblnob100x250mg | AZC | GB | | | |
| 385.5 | N03AA03 | primidon (tekuté lékové formy) | p.o. | 1.25 | GM | 45,51 | |
| 386 | N03AA | antiepileptika ze skupiny barbiturátů a jejích derivátů | parent. | | | | |
| 386 | N03AA | antiepileptika ze skupiny barbiturátů a jejich derivátů | parent. | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 386.1 | N03AA02 | fenobarbital (do 40 mg včetně v jedné ampuli) | parent. | 0.1 | GM | 126,25 | O |
| 66845 | GARDENAL | inj sic 1x40mg+solv | RPC | F | | | |
| 66845 | GARDENAL | inj sic 1x40mg+solv | AVM | F | | | |
| 386.2 | N03AA02 | fenobarbital (nad 40 mg v jedné ampuli) | parent. | 0.1 | GM | 13,46 | O |
| 84449 | LUMINAL | inj 5x1 ml/219mg | DET | D | | | |
| 84449 | LUMINAL | inj 5x1ml/200mg | DET | D | | | |
| 387 | N03AB | antiepileptika ze skupiny hydantoinů | p.o. | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 387.1 | N03AB02 | fenytoin | p.o. | 0.3 | GM | 2,81 | |
@@ -6241,77 +6511,65 @@
| 389 | N03AD | antiepileptika ze skupiny sukcinimidů | p.o. | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 389.1 | N03AD01 | ethosuximid (pevné lékové formy) | p.o. | 1.25 | GM | 16,78 | |
| 92041 | PETINIMID | cps 100x250mg | GER | A | | | |
| 92041 | PETINIMID | por cpsmol100x250mg | GER | A | | | |
| 389.2 | N03AD01 | ethosuximid (tekuté lékové formy) | p.o. | 1.25 | GM | 22,69 | |
| 02110 | PETINIMID | sir 1x250ml/12.5gm | GER | A | | | |
| 02035 | SUXILEP | gtt 50gm 50% | GMD | D | | | |
| 11037 | SUXILEP | gtt 50gm 50% | PHW | D | | | |
| 02110 | PETINIMID | sir 250ml 12.5gm | GER | A | | | |
| 02035 | SUXILEP | gtt 50gm 50% | GMD | D | | | |
| 389.3 | N03AD03 | mesuximid | p.o. | 0.9 | GM | 24,78 | |
| 390 | N03AE | antiepileptika ze skupiny benzodiazepinů | p.o. | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 390.1 | N03AE01 | klonazepam (tekuté lékové formy) | p.o. | 8 | MG | 33,60 | |
| 59908 | RIVOTRIL 2.5MG/ML | gtt 1x10ml/25mg | ROX | I | | | |
| 390.2 | N03AE01 | klonazepam (pevné lékové formy do 0,5 mg v jedné tabletě včetně) | p.o. | 8 | MG | 24,15 | |
| 03031 | RIVOTRIL | tbl 50x0.5mg | HLR | CH | | | |
| 03031 | RIVOTRIL 0.5 MG | tbl 50x0.5mg | HLR | CH | | | |
| 390.3 | N03AE01 | klonazepam (pevné lékové formy nad 0,5 mg v jedné tabletě) | p.o. | 8 | MG | 12,71 | |
| 391 | N03AE antiepileptika ze skupiny benzodiazepinů | parent. | | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 391.1 | N03AE01 | klonazepam | parent. | 8 | MG | 230,32 | |
| 391 | N03AE | antiepileptika ze skupiny benzodiazepinů | parent. | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 391.1 | N03AE01 | klonazepam | parent. | 8 | MG | 230,32 | O |
| 03030 | RIVOTRIL | inj 5x1ml/1mg+solv. | HLR | CH | | | |
| 392 | N03AF | antiepileptika ze skupiny derivátů karboxamidu | p.o. | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 392.1 | N03AF01 | karbamazepin (pevné lékové formy) | p.o. | 1 | GM | 12,16 | |
| 62309 | APO-CARBAMAZEPINE 200MG | tbl 100x200mg | APT | CND | | | |
| 62309 | APO-CARBAMAZEPINE | tbl 100x200mg | APT | CND | | | |
| 98080 | NEUROTOP | tbl 50x200mg | GER | A | | | |
| 392.2 | N03AF01 | karbamazepin (retardované pevné lékové formy) | p.o. | 1 | GM | 16,94 | |
| 71954 | TIMONIL RETARD | tbl 50x150mg | DET | D | | | |
| 60164 | TIMONIL RETARD | tbl 50x300mg | DET | D | | | |
| 60165 | TIMONIL RETARD | tbl 100x300mg | DET | D | | | |
| 60166 | TIMONIL RETARD | tbl 50x600mg | DET | D | | | |
| 96305 | NEUROTOP RETARD 300 | tbl 50x300mg | GER | A | | | |
| 96306 | NEUROTOP RETARD 600 | tbl 50x600mg | GER | A | | | |
| 96305 | NEUROTOP RETARD 300 | tbl ret 50x300mg | GER | A | | | |
| 96306 | NEUROTOP RETARD 600 | tbl ret 50x600mg | GER | A | | | |
| 71954 | TIMONIL 150 RETARD | tbl 50x150mg | DET | D | | | |
| 60165 | TIMONIL 300 RETARD | tbl 100x300mg | DET | D | | | |
| 60164 | TIMONIL 300 RETARD | tbl 50x300mg | DET | D | | | |
| 60166 | TIMONIL 600 RETARD | tbl 50x600mg | DET | D | | | |
| 392.3 | N03AF01 | karbamazepin (tekuté lékové formy) | p.o. | 1 | GM | 42,52 | |
| | | | | | | | |
| 392.4 | N03AF02 | oxcarbazepin | p.o. | 1 | GM | 11,10 | |
| 393 | N03AG | antiepileptika ze skupiny derivátů mastných kyselin (natrium valproát) | p.o. | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 393.1 | N03AG01 | natrium valproát (pevné lékové formy, do 150 mg v 1 tabletě včetně) | p.o. | 1.5 | GM | 19,06 | |
| 08768 | CONVULEX | cps 100x150mg | GER | A | | | |
| 393.1 | N03AG01 | natrium valproát (pevné lékové formy, do 150 mg v 1 tabletě včetně) | p.o. | 1.5 | GM | 17,68 | |
| 61183 | ORFIRIL 150 | drg 50x150mg | DET | D | | | |
| 393.2 | N03AG01 | natrium valproát (pevné lékové formy, nad 150 mg v 1 tabletě) | p.o. | 1.5 | GM | 15,64 | |
| 61185 | ORFIRIL 600 | drg 50x600mg | DET | D | | | |
| 75296 | CONVULEX | cps 100x500mg | GER | A | | | |
| 93334 | EVERIDEN | tbl 100x300mg | SLO | SK | | | |
| 08769 | CONVULEX | cps 100x300mg | i GER | A | | | |
| 61184 | ORFIRIL 300 | drg 50x300mg | DET | D | | | |
| 393.3 | N03AG01 | natrium valproát (retardované pevné lékové formy do 300 mg v jedné tabletě včetně) | p.o. | 1.5 | GM | 26,88 | |
| 57712 | ORFIRIL LONG 300MG | cps ret 50x300mg | DET | D | | | |
| 57713 | ORFIRIL LONG 300MG | cps ret 100x300mg | DET | D | | | |
| 393.2 | N03AG01 | natrium valproát (pevné lékové formy, nad 150 mg v 1 tabletě) | p.o. | 1.5 | GM | 15,35 | |
| 08769 | CONVULEX 300 | por cpsdur100x300mg | GER | A | | | |
| 393.3 | N03AG01 | natrium valproát (retardované pevné lékové formy do 300 mg v jedné tabletě včetně) | p.o. | 1.5 | GM | 24,97 | |
| 58785 | CONVULEX CR 300 MG | tbl ret 50x300mg | GER | A | | | |
| 393.4 | N03AG01 | natrium valproát (retardované pevné lékové formy nad 300 mg v jedné tabletě) | p.o. | 1.5 | GM | 28,46 | |
| 58787 | CONVULEX CR 500 MG | tbl ret 50x500mg | GER | A | | | |
| 57719 | ORFIRIL LONG 1000MG | tbl ret 100x1000mg | DET | D | | | |
| 57718 | ORFIRIL LONG 1000MG | tbl ret 50x1000mg | DET | D | | | |
| 57716 | ORFIRIL LONG 500MG | tbl ret 100x500mg | DET | D | | | |
| 57715 | ORFIRIL LONG 500MG | tbl ret 50x500mg | DET | D | | | |
| 393.5 | N03AG01 | natrium valproát a kyselina valproová (retardované pevné lékové formy do 300 mg v jedné tabletě) | p.o. | 1.5 | GM | 31,90 | |
| | | | | | | | |
| 393.6 | N03AG01 | natrium valproát a kyselina valproová (retardované pevné lékové formy nad 300 mg v jedné tabletě) | p.o. | 1.5 | GM | 29,41 | |
| 44997 | DEPAKINE CHRONO 500MG SECABLE | tbl ret 100x500mg | SWI | F | | | |
| 393.4 | N03AG01 | natrium valproát (retardované pevné lékové formy nad 300 mg v jedné tabletě) | p.o. | 1.5 | GM | 25,00 | |
| | | | | | | | |
| 393.5 | N03AG01 | natrium valproát a kyselina valproová (retardované pevné lékové formy do 300 mg v jedné tabletě) | p.o. | 1.5 | GM | 30,30 | |
| | | | | | | | |
| 393.6 | N03AG01 | natrium valproát a kyselina valproová (retardované pevné lékové formy nad 300 mg v jedné tabletě) | p.o. | 1.5 | GM | 27,90 | |
| | | | | | | | |
| 393.7 | N03AG01 | natrium valproát (tekuté lékové formy) | p.o. | 1.5 | GM | 25,63 | |
| 08770 | CONVULEX | gtt 100ml 300mg/ml | GER | A | | | |
| 08770 | CONVULEX | gtt 100ml | GER | A | | | |
| 394 | N03AG | antiepileptika ze skupiny derivátů mastných kyselin (ostatní) | p.o. | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 394.1 | N03AG02 | valpromid | p.o. | 1.5 | GM | 25,61 | L/PSY,NEU |
| | | | | | | | |
| 394.2 | N03AG04 | vigabatrin | p.o. | 2 | GM | 135,36 | L/PSY,NEU |
| 80370 | SABRIL | portblflm 100x500mg | MDD | GB | | | |
| 46408 | SABRIL | portblflm 100x500mg | PBH | F | | | |
| 394.3 | N03AG06 | tiagabin | p.o. | 30 | MG | 135,36 | L/PSY,NEU |
| 394.2 | N03AG04 | vigabatrin | p.o. | 2 | GM | 131,30 | L/PSY,NEU |
| 46408 | SABRIL | portblflm100x500mg | PBH | F | | | |
| 80370 | SABRIL | portblflm100x500mg | MDD | GB | | | |
| 394.3 | N03AG06 | tiagabin | p.o. | 30 | MG | 131,30 | L/PSY,NEU |
| 395 | N03AG | antiepileptika ze skupiny derivátů mastných kyselin | parent. | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 395.1 | N03AG01 | natrium valproát | parent. | 1.5 | GM | 1201,85 | K |
| 54238 | ORFIRIL INJEKTIONSLOSUNG | inj 5x3ml/300mg | DET | D | | | |
| 54238 | ORFIRIL 100 MG/ML INJEKTIONSLÖ. | inj sol 5x3ml/300mg | DET | D | | | |
| 396 | N03AX | ostatní antiepileptika | p.o. | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 396.1 | N03AX03 | sultiam | p.o. | 0.4 | GM | 16,11 | L/PSY,NEU |
@@ -6324,20 +6582,18 @@
| | | | | | | | |
| 396.3 | N03AX09 | lamotrigin (disperzní forma nad 2 mg do 5 mg v jedné tabletě včetně) | p.o. | 0.3 | GM | 300,00 | P |
| 42584 | LAMICTAL 5 MG | por tbl mnd 30x5mg | GOW | GB | | | |
| 396.4 | N03AX09 | lamotrigin (disperzní forma nad 5 mg do 25mg včetně v jedné tabletě) | p.o. | 0.3 | GM | 185,00 | P |
| 396.4 | N03AX09 | lamotrigin ( disperzní forma nad 5 mg do 25mg včetně v jedné tabletě) | p.o. | 0.3 | GM | 185,00 | P |
| 42585 | LAMICTAL 25 MG | por tbl mnd 30x25mg | GOW | GB | | | |
| 396.5 | N03AX09 | lamotrigin (disperzní forma nad 50 mg v jedné tabletě) | p.o. | 0.3 | GM | 144,00 | P |
| 42586 | LAMICTAL 100 MG | por tbl mnd30x100mg | GOW | GB | | | |
| 396.6 | N03AX09 | lamotrigin (nad 5 mg do 25mg včetně v jedné tabletě) | p.o. | 0.3 | GM | 168,54 | L/PSY,NEU |
| | | | | | | | |
| 396.7 | N03AX09 | lamotrigin (nad 25mg do 50 mg včetně v jedné tabletě) | p.o. | 0.3 | GM | 150,58 | L/PSY,NEU |
| | | | | | | | |
| 396.8 | N03AX09 | lamotrigin (nad 50 mg v jedné tabletě) | p.o. | 0.3 | GM | 139,90 | L/PSY,NEU |
| 42491 | LAMICTAL 100 MG | portblnob100x100mg | GOK | GB | | | |
| 396.9 | N03AX10 | felbamat | p.o. | 2.4 | GM | 283,03 | L/PSY,NEU |
| 77005 | TALOXA 600MG | tbl 100x600mg | SCH | B | | | |
| 396.6 | N03AX09 | lamotrigin (nad 5 mg do 25mg včetně v jedné tabletě) | p.o. | 0.3 | GM | 155,30 | L/PSY,NEU |
| | | | | | | | |
| 396.7 | N03AX09 | lamotrigin (nad 25mg do 50 mg včetně v jedné tabletě) | p.o. | 0.3 | GM | 138,75 | L/PSY,NEU |
| | | | | | | | |
| 396.8 | N03AX09 | lamotrigin (nad 50 mg v jedné tabletě) | p.o. | 0.3 | GM | 128,91 | L/PSY,NEU |
| | | | | | | | |
| 396.9 | N03AX10 | felbamat | p.o. | 2.4 | GM | 274,54 | L/PSY,NEU |
| 77003 | TALOXA | sus 230ml 120mg/ml | SCH | B | | | |
| 77004 | TALOXA 400MG | tbl 100x400mg | SCH | B | | | |
Topiramat - léková forma tobolky: předepisuje psychiatr, neurolog pro děti do 15. let, které nemohou být, z jakýchkoliv důvodů, léčeny tabletovou formou.
@@ -6345,19 +6601,15 @@
| | | | | | | | |
| 396.11 | N03AX11 | topiramat tobolky (nad 15 mg do 25 mg včetně v jedné tobolce) | p.o. | 0.3 | GM | 185,00 | P |
| | | | | | | | |
| 396.12 | N03AX11 | topiramat tablety (do 25 mg včetně v jedné tabletě) | p.o. | 0.3 | GM | 168,54 | L/PSY,NEU |
| 44671 | TOPAMAX 25MG | tbl obd 28x25mg-bl. | CIL | CH | | | |
| 396.13 | N03AX11 | topiramat tablety (nad 25 mg do 50 mg včetně v jedné tabletě) | p.o. | 0.3 | GM | 150,58 | L/PSY,NEU |
| 44675 | TOPAMAX 50MG | tbl obd 28x50mg-bl. | CIL | CH | | | |
| 396.14 | N03AX11 | topiramat tablety (nad 50 mg v jedné tabletě) | p.o. | 0.3 | GM | 139,90 | L/PSY,NEU |
| | | | | | | | |
| 396.15 | N03AX12 | gabapentin | p.o. | 1.8 | GM | 135,36 | L/PSY,NEU |
| 84401 | NEURONTIN 400MG | cps 50x400mg | PDA | D | | | |
| 84396 | NEURONTIN 100MG | cps 20x100mg | PDA | D | | | |
| 84400 | NEURONTIN 300MG | cps 100x300mg | PDA | D | | | |
| 84399 | NEURONTIN 300MG | cps 50x300mg | PDA | D | | | |
| 84398 | NEURONTIN 100MG | cps 100x100mg | PDA | D | | | |
| 396.16 | N03AX14 | levetiracetam | p.o. | 2 | GM | 135,36 | L/PSY,NEU |
| 396.12 | N03AX11 | topiramat tablety (do 25 mg včetně v jedné tabletě) | p.o. | 0.3 | GM | 163,48 | L/PSY,NEU |
| | | | | | | | |
| 396.13 | N03AX11 | topiramat tablety (nad 25 mg do 50 mg včetně v jedné tabletě) | p.o. | 0.3 | GM | 146,06 | L/PSY,NEU |
| | | | | | | | |
| 396.14 | N03AX11 | topiramat tablety (nad 50 mg v jedné tabletě) | p.o. | 0.3 | GM | 135,70 | L/PSY,NEU |
| | | | | | | | |
| 396.15 | N03AX12 | gabapentin | p.o. | 1.8 | GM | 131,30 | L/PSY,NEU |
| | | | | | | | |
| 396.16 | N03AX14 | levetiracetam | p.o. | 2 | GM | 131,30 | L/PSY, NEU |
| 397 | N04AA | antiparkinsonika ze skupiny terciárních aminů | p.o. | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 397.1 | N04AA | hydrochlorid diethazinia | p.o. | 0.25 | GM | 7,15 | |
@@ -6367,13 +6619,15 @@
| 397.3 | N04AA03 | metixen | p.o. | 40 | MG | 18,09 | |
| | | | | | | | |
| 397.4 | N04AA04 | procyklidin | p.o. | 25 | MG | 8,80 | |
| 57783 | KEMADRIN | tbl 100x5mg | ACA | GB | | | |
| 01337 | KEMADRIN | tbl 100x5mg | BWE | GB | | | |
| 01337 | KEMADRIN | por tbl nob 100x5mg | GWE | GB | | | |
| 03481 | KEMADRIN | por tbl nob 100x5mg | GWE | D | | | |
| 03483 | KEMADRIN | por tbl nob 100x5mg | WFD | GB | | | |
| 57783 | KEMADRIN | por tbl nob 100x5mg | ACA | GB | | | |
| 398 | N04AA | antiparkinsonika ze skupiny terciárních aminů | parent. | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 398.1 | N04AA02 | biperiden | parent. | 10 MG | 58,52 | O | |
| 20056 | AKINETON PRO INFUS. | inj 5x1ml/5mg | KNO | D | | | |
| 398.1 | N04AA02 | biperiden | parent. | 10 | MG | 58,52 | O |
| 01973 | AKINETON | inj 5x1ml/5mg | EBW | A | | | |
| 20056 | AKINETON | inj 5x1ml/5mg | KNO | D | | | |
| 398.2 | N04AA08 | dexetimid | parent. | 0.12 | MG | 1,71 | O |
| 399 | N04AC | antiparkinsonika ze skupiny esterů tropinu | p.o. | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
@@ -6383,48 +6637,46 @@
| 400.1 | N04BA01 | levodopa | p.o. | 3.5 | GM | 24,64 | |
| | | | | | | | |
| 400.2 | N04BA02 | levodopa/karbidopa (do 125 mg v 1 tabletě včetně) | p.o. | 0.6 | GM | 29,62 | |
| 45241 | ISICOM 100MG | tbl 100x125mg | DET | D | | | |
| 400.3 | N04BA02 | levodopa/karbidopa (nad 125 mg v 1 tabletě) | p.o. | 0.6 | GM | 19,31 | |
| 03591 | NAKOM | tbl 100x275mg | LEK | SLO | | | |
| 45244 | ISICOM 250MG | tbl 100x275mg | DET | D | | | |
| 45241 | ISICOM 100 MG | tbl 100x100mg | DET | D | | | |
| 400.3 | N04BA02 | levodopa/ karbidopa (nad 125 mg v 1 tabletě) | p.o. | 0.6 | GM | 19,31 | |
| 45244 | ISICOM 250 MG | tbl 100x275mg | DET | D | | | |
| 03591 | NAKOM | por tblnob100x275mg | LEK | SLO | | | |
| 400.4 | N04BA02 | levodopa/benserazid | p.o. | 0.6 | GM | 22,00 | |
| 31026 | MADOPAR 250 | por tblnob100x250mg | HLR | CH | | | |
| 400.5 | N04BA02 | levodopa a inhibitory dekarboxylázy (retardované lékové formy do 0,125 gm včetně v jedné tabletě) | p.o. | 0.6 | GM | 32,75 | |
| 12073 | MADOPAR HBS | cps 30x125mg | HLR | CH | | | |
| 400.6 | N04BA02 | levodopa a inhibitory dekarboxylázy (retardované lékové formy nad 0,125 gm v jedné tabletě) | p.o. | 0.6 | GM | 26,69 | |
| 400.5 | N04BA02 | levodopa a inhibitory dekarboxylázy (retardováné lékové formy do 0,125 gm včetně v jedné tabletě) | p.o. | 0.6 | GM | 32,75 | |
| 12073 | MADOPAR HBS | por cps rdr30x125mg | HLR | CH | | | |
| 400.6 | N04BA02 | levodopa a inhibitory dekarboxylázy (retardováné lékové formy nad 0,125 gm v jedné tabletě) | p.o. | 0.6 | GM | 26,69 | |
| 401 | N04BB | antiparkinsonika ze skupiny amantadinu a jeho derivátů | p.o. | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 401.1 | N04BB01 | amantadin hydrochlorid | p.o. | 0.2 | GM | 5,52 | L/NEU,PSY, GER |
| 401.1 | N04BB01 | amantadin hydrochlorid | p.o. | 0.2 | GM | 5,52 | L/NEU,PSY,GER |
| 02871 | VIREGYT-K | cps 50x100mg | EGI | H | | | |
| 401.2 | N04BB01 | amantadin sulfát | p.o. | 0.2 | GM | 7,33 | L/NEU,PSY, GER |
| 401.2 | N04BB01 | amantadin sulfát | p.o. | 0.2 | GM | 7,33 | L/NEU,PSY,GER |
| | | | | | | | |
| 401.3 | N04BB01 | amantadin | parent. | 0,2 | GM | 4,25 | H |
| 402 | N04BD | antiparkinsonika ze skupiny inhibitorů MAO | p.o. | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 402.1 | N04BD01 | Selegilin do 5 mg v 1 tabletě včetně | p.o. | 5.0 | MG | 5,49 | L/NEU,PSY, GER |
| 59279 | SELEGILIN-RATIOPHARM 5 MG | tbl 50x5mg | MCK | D | | | |
| 03073 | APO-SELEG | por tbl nob100x5mg | APT | CND | | | |
| 402.1 | N04BD01 | selegilin do 5 mg v 1 tabletě včetně | p.o. | 5.0 | MG | 5,49 | L/NEU,PSY,GER |
| 03073 | APO-SELEG | por tbl nob 100x5mg | APT | CND | | | |
| 03074 | APO-SELEG | por tbl nob 50x5mg | APT | CND | | | |
| 13017 | NIAR | tbl 30x5mg | KNO | D | | | |
| 402.2 | N04BD01 | Selegilin nad 5 mg v 1 tabletě | p.o. | 5.0 | MG | 5,10 | L/NEU,PSY, GER |
| | | | | | | | |
| 13017 | NIAR | por tbl nob 30x5mg | AAW | D | | | |
| 59279 | SELEGILIN-RATIOPHARM 5 MG | por tbl nob 50x5mg | MCK | D | | | |
| 402.2 | N04BD01 | selegilin nad 5 mg v 1 tabletě | p.o. | 5.0 | MG | 5,10 | L/NEU,PSY,GER |
| 402.3 | N04BX01 | tolkapon | p.o. | 0,3 | GM | 116,72 | X |
| | | | | | | | |
| 402.4 | N04BC02 | pergolidi mesilas (do 0,05 mg včetně v jedné tabletě) | p.o. | 3 | MG | 176,94 | X |
| | | | | | | | |
| 402.5 | N04BC02 | pergolidi mesilas (nad 0,05 mg do 0,25 mg včetně v jedné tabletě) | p.o. | 3 | MG | 145,66 | X |
| | | | | | | | |
| 402.6 | N04BC02 | pergolidi mesilas (nad 0,25 mg v jedné tabletě) | p.o. | 3 | MG | 132,95 | X |
| 402.4 | N04BC02 | pergolidi mesilas (do 0,05 mg včetně v jedné tabletě) | p.o. | 3 | MG | 159,40 | X |
| 23138 | HIZEST 0.05 MG | portblnob100x0.05mg | IXP | CZ | | | |
| 402.5 | N04BC02 | pergolidi mesilas (nad 0,05 mg do 0,25 mg včetně v jedné tabletě) | p.o. | 3 | MG | 131,12 | X |
| 23136 | HIZEST 0.25 MG | portblnob100x0.25mg | IXP | CZ | | | |
| 402.6 | N04BC02 | pergolidi mesilas (nad 0,25 mg v jedné tabletě) | p.o. | 3 | MG | 119,66 | X |
| 23140 | HIZEST 1 MG | portblnob100x1mg | IXP | CZ | | | |
| 402.7 | N04BC03 | dihydroergokriptin | p.o. | 10 | MG | 16,11 | X |
| 64928 | ALMIRID | tbl 20x20mg | MON | I | | | |
| 64928 | ALMIRID | por tbl nob 20x20mg | DAQ | I | | | |
| 402.8 | N04BC04 | ropinirol do 2 mg v jedné tabletě včetně | p.o. | 6 | MG | 72,83 | X |
| | | | | | | | |
| 402.9 | N04BC04 | ropinirol nad 2 mg v jedné tabletě | p.o. | 6 | MG | 66,50 | X |
| | | | | | | | |
| 402.10 | N04BC05 | pramipexol | p.o. | 2,5 | MG | 110,79 | X |
| | | | | | | | |
| 402.11 | N04BX02 | entacapon | p.o. | 1 | GM | 175,00 | X |
| 54466 | COMTAN | tbl obd 30x200mg | NPA | D | | | |
| 402.11 | N04BX02 | entacapon | p.o. | 1 | GM | 160,00 | X |
| 403 | N05AA | neuroleptika ze skupiny dimethylaminopropyl fenothiazinů | p.o. | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 403.1 | N05AA01 | chlorpromazin (pevné lékové formy do 50 mg v jedné tabletě včetně) | p.o. | 0.3 | GM | 12,19 | |
@@ -6436,34 +6688,33 @@
| 403.4 | N05AA02 | levomepromazin | p.o. | 0.3 | GM | 16,94 | |
| | | | | | | | |
| 403.5 | N05AA03 | promazin | p.o. | 0.3 | GM | 13,49 | |
| 404 | N05AA | neuroteptika ze skupiny dimethylaminopropyl fenothiazinů | parent. | | | | |
| 404 | N05AA | neuroleptika ze skupiny dimethylaminopropyl fenothiazinů | parent. | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 404.1 | N05AA01 | chlorpromazin | parent. | 0.1 | GM | 25,37 | O |
| 00560 | PLEGOMAZIN 0.5% | inj 10x5ml/25mg | EGI | H | | | |
| 404.2 | N05AA02 | levomepromazin | parent. | 0.1 | GM | 30,89 | O |
| 01845 | TISERCIN | inj 10x1ml/25mg | EGI | H | | | |
| 01845 | TISERCIN | inj 10x1 ml/25mg | EGI | H | | | |
| 405 | N05AB | neuroleptika ze skupiny piperazinových derivátů fenothiazinu | p.o. | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 405.1 | N05AB03 | perfenazin | p.o. | 30 | MG | 1.83 | |
| 00262 | PERFENAZIN LECIVA | tbl obd 50x8mg | LEX | CZ | | | |
| 405.1 | N05AB03 | perfenazin | p.o. | 30 | MG | 1,83 | |
| 00262 | PERFENAZIN LÉČIVA | tbl obd 50x8mg | LEX | CZ | | | |
| 405.2 | N05AB04 | prochlorperazin | p.o. | 0.1 | GM | 12,42 | |
| | | | | | | | |
| 405.3 | N05AB06 | trifluoperazin | p.o. | 20 | MG | 6,99 | |
| | | | | | | | |
| 405.4 | N05AB08 | thioproperazin | p.o. | 75 | MG | 6,70 | |
| 406 | N05AB | neuroleptika ze skupiny piperazinových derivátů fenothiazinu | parent. | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 406.1 | N05AB02 | flufenazin | parent. | 1 | MG | 3,77 | O |
| 03514 | MODITEN DEPOT | inj 5x1ml/25mg | BTA | SK | | | |
| 407 | N05AC | neuroleptika ze skupiny piperidinových derivátů fenothlazinu | p.o. | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 407.1 | N05AC01 | periciazin (tekuté lékové formy) | p.o. | 50 | MG | 5,19 | L/NEU,PSY, GER |
| | | | | | | | |
| 407.2 | N05AC01 | periciazin (pevné lékové formy) | p.o. | 50 | MG | 5,72 | L/NEU,PSY, GER |
| 407 | N05AC | neuroleptika ze skupiny piperidinových derivátů fenothiazinu | p.o. | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 407.1 | N05AC01 | periciazin (tekuté lékové formy) | p.o. | 50 | MG | 5,19 | L/NEU,PSY,GER |
| | | | | | | | |
| 407.2 | N05AC01 | periciazin (pevné lékové formy) | p.o. | 50 | MG | 5,72 | L/NEU,PSY,GER |
| | | | | | | | |
| 407.3 | N05AC02 | thioridazin | p.o. | 0.3 | GM | 12,34 | |
| 00324 | THIORIDAZIN 25 LECIVA | drg 50x25mg | LEX | CZ | | | |
| 00325 | THIORIDAZIN 100 LECIVA | drg 20x100mg | LEX | CZ | | | |
| 00325 | THIORIDAZIN 100 LÉČIVA | drg 20x100mg | LEX | CZ | | | |
| 00324 | THIORIDAZIN 25 LÉČIVA | drg 50x25mg | LEX | CZ | | | |
| 408 | N05AD | neuroleptika ze skupiny derivátů butyrofenonu | p.o. | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 408.1 | N05AD01 | haloperidol (pevné lékové formy) | p.o. | 8 | MG | 6,06 | |
@@ -6479,9 +6730,9 @@
| --- | --- | --- | --- | --- | --- | --- | --- |
| 409.1 | N05AD01 | haloperidol (depotní lékové formy) | parent. | 3.3 | MG | 9,82 | O |
| | | | | | | | |
| 409.2 | N05AD01 | haloperidol | parent. | 8 | MG | 16,72 | O |
| | | | | | | | |
| 409.3 | N05AD02 | trifluperidol | parent. | 2 | MG | 5,52 | O |
| 409.2 | N05AD01 | haloperidol | parent. | 8 | MG | 16.72 | O |
| | | | | | | | |
| 409.3 | N05AD02 | trifluperidol | parent. | 2 | MG | 5.52 | O |
| | | | | | | | |
| 409.4 | N05AD03 | melperon | parent. | 0.3 | GM | 50,10 | O |
| | | | | | | | |
@@ -6495,11 +6746,11 @@
| 410.3 | N05AF03 | chlorprothixen (do 5 mg v jedné tabletě včetně) | p.o. | 0.3 | GM | 26,39 | |
| | | | | | | | |
| 410.4 | N05AF03 | chlorprothixen (nad 5 do 15 mg v jedné tabletě včetně) | p.o. | 0.3 | GM | 13,27 | |
| 75433 | CHLORPROTHIXEN 15 LECIVA | tbl obd 30x15mg | LEX | CZ | | | |
| 75433 | CHLORPROTHIXEN 15 LÉČIVA | por tbl flm 30x15mg | LEX | CZ | | | |
| 410.5 | N05AF03 | chlorprothixen (nad 15 mg v jedné tabletě) | p.o. | 0.3 | GM | 8,18 | |
| 75428 | CHLORPROTHIXEN 50 LECIVA | tbl obd 30x50mg | LEX | CZ | | | |
| 75428 | CHLORPROTHIXEN 50 LÉČIVA | por tbl flm 30x50mg | LEX | CZ | | | |
| 410.6 | N05AF05 | zuklopenthixol | p.o. | 30 | MG | 13,27 | |
| 57827 | CISORDINOL 25MG | tbl obd 50x25mg-pp | LUN | DK | | | |
| 57827 | CISORDINOL 25 MG | por tbl flm 50x25mg | LUN | DK | | | |
| 411 | N05AF | neuroleptika ze skupiny derivátů thioxanthenu | parent. | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 411.1 | N05AF | oxyprotepin | parent. | 1 | MG | 2,55 | O |
@@ -6511,28 +6762,28 @@
| 411.4 | N05AF05 | zuklopenthixol | parent. | 30 | MG | 94,25 | O |
| 93253 | CISORDINOL-ACUTARD | inj 10x2ml/100mg | LUN | DK | | | |
| 411.5 | N05AF05 | zuklopenthixol (depotní formy) | parent. | 15 | MG | 11,78 | O |
| 412 | N05AG | neuroleptika ze skupiny difenylbutytpiperidinových derivátů | p.o. | | | | |
| 412 | N05AG | neuroleptika ze skupiny difenylbutylpiperidinových derivátů | p.o. | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 412.1 | N05AG02 | pimozid | p.o. | 4 | MG | 10,76 | |
| | | | | | | | |
| 412.2 | N05AG03 | penfluridol | p.o. | 6 | MG | 6,01 | |
| 01637 | SEMAP | tbl 12x20mg | JAN | P | | | |
| 01637 | SEMAP | tbl 12x20mg | JAG | P | | | |
| 413 | N05AG | neuroleptika ze skupiny difenylbutylpiperidinových derivátů | parent. | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 413.1 | N05AG01 | fluspirilen | parent. | 0.7 | MG | 12,39 | O |
| 413.1 | N05AG01 | fluspirilesn | parent. | 0.7 | MG | 12,39 | O |
| 414 | N05AH | neuroleptika ze skupiny dibenzodiazepinů a jejich derivátů | p.o. | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 414.1 | N05AH01 | loxapin | p.o. | 0,1 | GM | 52,20 | L/PSY |
| | | | | | | | |
| 414.2 | N05AH02 | klozapin (do 25 mg v jedné tabletě včetně) | p.o. | 0.3 | GM | 57.16 | L/PSY,NEU |
| 414.2 | N05AH02 | klozapin (do 25 mg v jedné tabletě včetně) | p.o. | 0.3 | GM | 57,16 | L/PSY,NEU |
| 42824 | CLOZAPIN DESITIN 25 MG | por tbl nob 30x25mg | SBV | NL | | | |
| 414.3 | N05AH02 | klozapin (nad 25 do 50 mg v jedné tabletě včetně) | p.o. | 0.3 | GM | 50,20 | L/PSY,NEU |
| | | | | | | | |
| 414.4 | N05AH02 | klozapin (nad 50 mg v jedné tabletě) | p.o. | 0.3 | GM | 46,03 | L/PSY |
| 42825 | CLOZAPIN DESITIN 100 MG | por tbl nob30x100mg | SBV | NL | | | |
| 414.5 | N05AH03 | olanzapin | p.o. | 10 | MG | 131,70 | P |
Olanzapin, quetiapin v dávce nad 25 mg v jedné tabletě indikuje psychiatr pacientům, u kterých selhala předchozí léčba atypickými antipsychotiky, a to v případech:
| 414.5 | N05AH03 | olanzapin | p.o. | 10 | MG | 120,00 | P |
Olanzapin, quetiapin v dávce nad 25 mg v jedné tabletě indikuje psychiatr pacientům, u kterých selhala předchozi léčba atypickými antipsychotiky, a to v případech:
- a) výskytu extrapyramidových příznaků v anamnéze nebo v současnosti (pozitivní příznak ozubeného kola, akutní nebo tardivní dyskinesy, akathisie, ztráta souhybů),
@@ -6543,7 +6794,7 @@
Quetiapin v dávce do 25 mg v jedné tabletě indikuje neurolog u pacientů s psychotickými komplikacemi dopaminergní léčby Parkinsonovy nemoci.
| 414.7 | N05AH04 | quetiapin nad 25 mg v jedné tabletě | p.o. | 0,4 | GM | 131,70 | P |
| 414.7 | N05AH04 | quetiapin nad 25 mg v jedné tabletě | p.o. | 0,4 | GM | 120,00 | P |
| | | | | | | | |
| 414.8 | N05AX11 | zotepin | p.o. | 0,2 | GM | 76,90 | L/PSY |
| 415 | N05AH | neuroleptika ze skupiny dibenzodiazepinů a jejich derivátů | parent. | | | | |
@@ -6551,32 +6802,33 @@
| 415.1 | N05AH02 | klozapin | parent. | 0.3 | GM | 86,22 | H |
| | | | | | | | |
| 415.2 | N05AH03 | olanzapin | parent. | 10 | MG | 177,00 | H |
| 32601 | ZYPREXA INTRAMUSCULAR | inj plv sol 1x10mg | LPF | D | | | |
| 416 | N05AL | neuroleptika ze skupiny benzamidů | p.o. | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 416.1 | N05AL01 | sulpirid (do 50 mg v jedné tabletě včetně) | p.o. | 0.8 | GM | 35,00 | |
| 54432 | PROSULPIN 50MG | tbl 30x50mg | PMP | CZ | | | |
| 54432 | PROSULPIN 50 MG | tbl 30x50mg | PMP | CZ | | | |
| 11468 | PROSULPIN 50 MG | tbl 60x50mg | PMP | CZ | | | |
| 46749 | SULPIROL 50 | por cps dur 20x50mg | SFS | D | | | |
| 46750 | SULPIROL 50 | por cps dur 50x50mg | SFS | D | | | |
| 46751 | SULPIROL 50 | por cps dur100x50mg | SFS | D | | | |
| 46750 | SULPIROL 50 | por cps dur 50x50mg | SFS | D | | | |
| 46749 | SULPIROL 50 | por cps dur 20x50mg | SFS | D | | | |
| 11468 | PROSULPIN 50MG | tbl 60x50mg | PMP | CZ | | | |
| 416.2 | N05AL01 | sulpirid (nad 50 mg v jedné tabletě) | p.o. | 0.8 | GM | 20,83 | L/PSY,NEU |
| 46743 | SULPIROL 200 | por tblnob100x200mg | HEX | D | | | |
| 11149 | PROSULPIN 200MG | tbl 60x200mg | PMP | CZ | | | |
| 07387 | PROSULPIN 200 MG | por tbl nob30x200mg | PMP | CZ | | | |
| 11149 | PROSULPIN 200 MG | por tbl nob60x200mg | PMP | CZ | | | |
| 46741 | SULPIROL 200 | por tbl nob20x200mg | HEX | D | | | |
| 46748 | SULPIROL 200 | por tbl nob20x200mg | SFS | D | | | |
| 46746 | SULPIROL 200 | por tblnob100x200mg | SFS | D | | | |
| 46741 | SULPIROL 200 | por tbl nob20x200mg | HEX | D | | | |
| 07387 | PROSULPIN | tbl 30x200mg | PMP | CZ | | | |
| 46742 | SULPIROL 200 | por tbl nob50x200mg | HEX | D | | | |
| 46747 | SULPIROL 200 | por tbl nob50x200mg | SFS | D | | | |
| 46743 | SULPIROL 200 | por tblnob100x200mg | HEX | D | | | |
| 46746 | SULPIROL 200 | por tblnob100x200mg | SFS | D | | | |
| 416.3 | N05AL03 | tiaprid (pevné lékové formy) | p.o. | 0.4 | GM | 27,00 | |
| | | | | | | | |
| 416.4 | N05AL03 | tiaprid (tekuté lékové formy) | p.o. | 0.4 | GM | 41,87 | |
| | | | | | | | |
| 416.5 | N05AL05 | amisulprid (pevné lékové formy)do 50 mg v jedné tabletě včetně | p.o. | 1 | DF | 16,70 | L/PSY,NEU |
| | | | | | | | |
| 416.6 | N05AL05 | amisulprid (pevné lékové formy) nad 50 mg v jedné tabletě | p.o. | 600 | MG | 131,70 | P |
Amisulprid v dávce nad 50 mg v jedné tabletě indikuje psychiatr pacientům, u kterých selhala předchozí léčba atypickými antipsychotiky, a to v případech:
| 416.6 | N05AL05 | amisulprid (pevné lékové formy) nad 50 mg v jedné tabletě | p.o. | 600 | MG | 120,00 | P |
Amisulprid v dávce nad 50 mg v jedné tabletě indikuje psychiatr pacientům, u kterých selhala předchozi léčba atypickými antipsychotiky, a to v případech:
- a) výskytu extrapyramidových příznaků v anamnéze nebo v současnosti (pozitivní příznak ozubeného kola, akutní nebo tardivní dyskinesy, akathisie, ztráta souhybů),
@@ -6585,22 +6837,22 @@
| 417 | N05AL | neuroleptika ze skupiny benzamidů | parent. | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 417.1 | N05AL01 | sulpirid | parent. | 0.8 | GM | 71,33 | O/PSY,NEU |
| 89922 | DOGMATIL 100 | inj 6x2ml/100mg | SSJ | F | | | |
| 89922 | DOGMATIL 100 MG | inj sol 6x2ml/100mg | SBN | F | | | |
| 417.2 | N05AL03 | tiaprid | parent. | 0.4 | GM | 55,43 | O |
| 47628 | TIAPRIDAL | injsol 12x2ml/100mg | SBN | F | | | |
| 418 | N05AN | lithium | p.o. | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 418.1 | N05AN01 | lithium do 0,3 g včetně v jedné tabletě | p.o. | 1 | GM | 6,95 | |
| 02481 | LITHIUM CAERBONICUM SLOVAKOFARMA | tbl 100x300mg | SLO | SK | | | |
| 02481 | LITHIUM CARBONICUM SLOVAKOFARMA | tbl 100x300mg | SLO | SK | | | |
| 418.2 | N05AN01 | lithium nad 0,3 g v jedné tabletě | p.o. | 1 | GM | 4,67 | |
| 04385 | CONTEMNOL | tbl 100x500mg | SLO | SK | | | |
| 04385 | CONTEMNOL | tbl ret 100x500mg | SLO | SK | | | |
| 419 | N05AX | ostatní antipsychotika | p.o. | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 419.1 | N05AX08 | risperidon (s obsahem do 1 mg včetně) | p.o. | 5 | MG | 92,00 | L/PSY, NEU, GER, INT |
| 419.1 | N05AX08 | risperidon (s obsahem do 1 mg včetně) | p.o. | 5 | MG | 64,40 | L/PSY, NEU, GER, INT |
| 10527 | RISPEN 1 | por tbl flm 20x1mg | LEX | CZ | | | |
| 42525 | RISPEN 1 | por tbl flm 50x1mg | LEX | CZ | | | |
| 419.2 | N05AX08 | risperidon (s obsahem nad 1 mg ) | p.o. | 5 | MG | 94,60 | L/PSY, NEU, GER, INT |
| 42529 | RISPEN 3 | por tbl flm 50x3mg | LEX | CZ | | | |
| 42527 | RISPEN 2 | por tbl flm 50x2mg | LEX | CZ | | | |
| 419.2 | N05AX08 | risperidon (s obsahem nad 1 mg ) | p.o. | 5 | MG | 66,20 | L/PSY, NEU, GER, INT |
| | | | | | | | |
| 419.3 | N05AX08 | risperidon (tekuté lékové formy) | p.o. | 5 | MG | 115,00 | L/PSY, NEU, GER, INT |
| | | | | | | | |
| 419.4 | N05AX08 | risperidon s obsahem do 25 mg v jedné ampuli včetně | parent. | 1.8 | MG | 303,26 | O/P |
@@ -6609,13 +6861,12 @@
Risperidon ve formě depotní injekce je indikován psychiatrem u schizofrenních pacientů s dobrou prognózou po opakované hospitalizaci z důvodů nedodržování léčby za vzniku relapsu s agresivitou. Je indikován pouze u pacientů, kteří netolerují klasická antipsychotika nebo jsou tato u nich neúčinná. Léčba se ukončí pokud pacient relabuje během 12 měsíců terapie a to i přes optimalizaci dávky nebo u pacientů, kteří nespolupracují.
| 419.6 | N05AE03 | sertindol | p.o. | 1 | DF | 131,70 | P |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 13039 | SERDOLECT 4MG | tbl obd 30x4mg | LUN | DK | | | |
| 419.7 | N05AE04 | ziprasidon | p.o. | 80 | MG | 131,70 | P |
| 44645 | ZELDOX 80MG | cps 30x80mg | MAC | D | | | |
Sertindol a ziprasidon indikuje psychiatr pacientům, u kterých selhala předchozí léčba atypickými antipsychotiky, a to v případech:
| 419.6 | N05AE03 | sertindol | p.o. | 1 | DF | 120,00 | P |
| --- | --- | --- | --- | --- | --- | --- | --- |
| | | | | | | | |
| 419.7 | N05AE04 | ziprasidon | p.o. | 80 | MG | 120,00 | P |
Sertindol a ziprasidon indikuje psychiatr pacientům, u kterých selhala předchozi léčba atypickými antipsychotiky, a to v případech:
- a) výskytu extrapyramidových příznaků v anamnéze nebo v současnosti (pozitivní příznak ozubeného kola, akutní nebo tardivní dyskinesy, akathisie, ztráta souhybů),
@@ -6627,7 +6878,7 @@
| 420.1 | N05BA23 | tofisopam | p.o. | 0.15 | GM | 0,68 | |
| | | | | | | | |
| 420.2 | N05BA01 | diazepam | p.o. | 10 | MG | 0,68 | |
| 02478 | DIAZEPAM SLOVAKOFARMA | tbl 20x10mg | SLO | SK | | | |
| 02478 | DIAZEPAM SLOVAKOFARMA 10 MG | tbl 20x10mg | SLO | SK | | | |
| 420.3 | N05BA02 | chlordiazepoxid | p.o. | 30 | MG | 0,68 | |
| | | | | | | | |
| 420.4 | N05BA03 | medazepam | p.o. | 20 | MG | 0,68 | |
@@ -6650,21 +6901,20 @@
Léčbu alprazolamem ordinuje psychiatr, neurolog nebo internista: léčba panické úzkosti.
| 59759 | FRONTIN 1.0MG | tbl 100x1mg | EGI | H | | | |
| 59758 | FRONTIN 1.0MG | tbl 30x1mg | EGI | H | | | |
| 59759 | FRONTIN 1.0MG | tbl 100x1mg | EGI | H | | | |
| | | | | | | | |
| 421 | N05BA | anxiolytjka ze skupiny derivátů benzodiazepinu | p.rect. | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 421.1 | N05BA01 | diazepam (do 5 mg v jednom čípku včetně) | p.rect. | 10 | MG | 108,16 | L/NEU,PSY, PDD |
| 04326 | STESOLID 5MG | enm 5x2.5ml/5mg | ALO | N | | | |
| 69417 | DIAZEPAM DESITIN RECTAL TUBE | enm 5x2.5ml/5mg | DET | D | | | |
| 421.2 | N05BA01 | diazepam (nad 5 mg v jednom čípku) | p.rect. | 10 | MG | 67,14 | L/NEU,PSY, PDD |
| 04327 | STESOLID 10MG | enm 5x2.5ml/10mg | ALO | N | | | |
| 69418 | DIAZEPAM DESITIN RECTAL TUBE | enm 5x2.5ml/10mg | DET | D | | | |
| 421 | N05BA | anxiolytika ze skupiny derivátů benzodiazepinu | p.rect. | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 421.1 | N05BA01 | diazepam (do 5 mg v jednom čípku včetně) | p.rect. | 10 | MG | 108,16 | L/NEU,PSY,PDD |
| 69417 | DIAZEPAM DESITIN RECT.TUBE 5MG | enm 5x2.5ml/5mg | DET | D | | | |
| 04326 | STESOLID 5 MG | enm 5x2.5ml/5mg | ALO | N | | | |
| 421.2 | N05BA01 | diazepam (nad 5 mg v jednom čípku) | p.rect. | 10 | MG | 67,14 | L/NEU,PSY,PDD |
| 69418 | DIAZEPAM DESITIN RECT.TUBE 10MG | enm 5x2.5ml/10mg | DET | D | | | |
| 04327 | STESOLID 10 MG | enm 5x2.5ml/10mg | ALO | N | | | |
| 422 | N05BA | anxiolytika ze skupiny derivátů benzodiazepinu | parent. | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 422.1 | N05BA01 | diazepam | parent. | 10 | MG | 7,53 | |
| 96610 | APAURIN | inj 10x2ml/10mg | KRK | SLO | | | |
| 96610 | APAURIN | inj sol10x2ml/10mg | KRK | SLO | | | |
| 422.2 | N05BA05 | klorazepát draselný | parent. | 20 | MG | 14,66 | |
| 423 | N05BX | ostatní anxiolytika | p.o. | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
@@ -6673,7 +6923,7 @@
| 423.2 | N05BC01 | meprobamat | p.o. | 1.2 | GM | 0,68 | |
| | | | | | | | |
| 423.3 | N05BX01 | mefenoxalon | p.o. | 1.2 | GM | 16,38 | |
| 85656 | DORSIFLEX | tbl 30x200mg | LEK | SLO | | | |
| 85656 | DORSIFLEX 200MG | tbl 30x200mg | LEK | SLO | | | |
| 423.4 | N05BE01 | buspiron | p.o. | 30 | MG | 2,49 | |
| 424 | N05CA | hypnotika ze skupiny barbiturátů | parent. | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
@@ -6683,16 +6933,16 @@
| 425 | N05CD | hypnotika ze skupiny benzodiazepinů | parent. | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 425.1 | N05CD03 | flunitrazepam | parent. | 1 | MG | 6,61 | O |
| 90559 | ROHYPNOL INJ | inj 5x1ml+5x1ml sol | LEX | CZ | | | |
| 90559 | ROHYPNOL INJ | inj 5x1ml/2mg+solv. | LEX | CZ | | | |
| 425.2 | N05CD08 | midazolam (do 5 mg v jedné ampuli včetně) | parent. | 15 | MG | 105,75 | O |
| 58163 | FULSED | inj sol10x1ml/5mg | RXY | IND | | | |
| 53631 | MIDAZOLAM SYNTHON 1MG/ML | inj 10x5ml/5mg | ANN | IRL | | | |
| 53633 | MIDAZOLAM SYNTHON 5MG/ML | inj 10x1ml/5mg | ANN | IRL | | | |
| 02922 | MIDAZOLAM SYNTHON 5MG/ML | inj 10x1ml/5mg | SOO | NL | | | |
| 00903 | MIDAZOLAM SYNTHON 1MG/ML | inj 10x5ml/5mg | SOO | NL | | | |
| 00903 | MIDAZOLAM SYNTHON 1 MG/ML | inj 10x5ml/5mg | SOO | NL | | | |
| 53631 | MIDAZOLAM SYNTHON 1 MG/ML | inj 10x5ml/5mg | ANN | IRL | | | |
| 02922 | MIDAZOLAM SYNTHON 5 MG/ML | inj 10x1ml/5mg | SOO | NL | | | |
| 53633 | MIDAZOLAM SYNTHON 5 MG/ML | inj 10x1ml/5mg | ANN | IRL | | | |
| 425.3 | N05CD08 | midazolam (nad 5 mg v jedné ampuli) | parent. | 15 | MG | 72,90 | O |
| 02924 | MIDAZOLAM SYNTHON 5MG/ML | inj 10x3ml/15mg | SOO | NL | | | |
| 53635 | MIDAZOLAM SYNTHON 5MG/ML | inj 10x3ml/15mg | ANN | IRL | | | |
| 02924 | MIDAZOLAM SYNTHON 5 MG/ML | inj 10x3ml/15mg | SOO | NL | | | |
| 53635 | MIDAZOLAM SYNTHON 5 MG/ML | inj 10x3ml/15mg | ANN | IRL | | | |
| 426 | N06AA | antidepresiva ze skupiny neselektivních inhibitorů reuptake monoaminů | p.o. | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 426.1 | N06AA01 | desipramin | p.o. | 0.1 | GM | 17,11 | |
@@ -6700,138 +6950,120 @@
| 426.2 | N06AA02 | imipramin | p.o. | 0.1 | GM | 9,90 | |
| | | | | | | | |
| 426.3 | N06AA04 | klomipramin | p.o. | 0.1 | GM | 14,49 | |
| 08557 | ANAFRANIL | drg 30x25mg | CGC | CH | | | |
| 93828 | ANAFRANIL SR GEIGY 75 | tbl obd 20x75mg | CGC | CH | | | |
| 93828 | ANAFRANIL SR 75 | por tbl ret 20x75mg | NPA | CH | | | |
| 426.4 | N06AA05 | opipramol | p.o. | 0.15 | GM | 12,02 | |
| | | | | | | | |
| 426.5 | N06AA07 | lofepramin | p.o. | 105 | MG | 14,66 | |
| | | | | | | | |
| 426.6 | N06AA08 | dibenzepin | p.o. | 0.3 | GM | 15,24 | |
| 02641 | NOVERIL 240 | tbl 20x240mg | WAN | CH | | | |
| | | | | | | | |
| 426.7 | N06AA09 | amitriptylin | p.o. | 75 | MG | 2,85 | |
| 87167 | AMITRIPTYLIN SLOVAKOFARMA | tbl obd 50x28.3mg | SLO | SK | | | |
| 87167 | AMITRIPTYLIN-SLOVAKOFARMA | tbl obd 50x28.3mg | SLO | SK | | | |
| 426.8 | N06AA10 | nortriptylin | p.o. | 75 | MG | 9,10 | |
| | | | | | | | |
| 426.9 | N06AA16 | dosulepin | p.o. | 150 | MG | 9,78 | |
| 04207 | PROTHIADEN 25 | drg 30x25mg | LEX | CZ | | | |
| 77047 | PROTHIADEN 75 | tbl obd 30x75mg | LEX | CZ | | | |
| 426.10 | N06AA21 | maprotilin | p.o. | 100 | MG | 12,28 | |
| 45757 | MAPROTIBENE 25MG | tbl obd 20x25mg | MCK | D | | | |
| 45759 | MAPROTIBENE 50MG | tbl obd 20x50mg | MCK | D | | | |
| 45757 | MAPROTIBENE 25 MG | por tbl flm 20x25mg | MCK | D | | | |
| 45759 | MAPROTIBENE 50 MG | por tbl flm 20x50mg | MCK | D | | | |
| 427 | N06AA | antidepresiva ze skupiny neselektivních inhibitorů reuptake monoaminů | parent. | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 427.1 | N06AA01 | desipramin | parent. | 0.1 | GM | 96,44 | O |
| | | | | | | | |
| 427.2 | N06AA02 | imipramin | parent. | 0.1 | GM | 48,39 | O |
| | | | | | | | |
| 427.3 | N06AA04 | klomipramin | parent. | 0.1 | GM | 95,76 | O |
| 02884 | ANAFRANIL | inj 10x2ml 25mg | CGC | CH | | | |
| 02884 | ANAFRANIL | inj 10x2ml/25mg | NPA | CH | | | |
| 427.4 | N06AA08 | dibenzepin | parent. | 0.3 | GM | 96,44 | O |
| | | | | | | | |
| 427.5 | N06AA09 | amitriptylin | parent. | 75 | MG | 30,79 | O |
| | | | | | | | |
| 427.6 | N06AA21 | maprotilin | parent. | 100 | MG | 108,64 | O |
| 94560 | LUDIOMIL | inj 10x5ml/25mg | CGC | CH | | | |
| 428 | N06AB | antidepresiva ze skupiny selektivních inhibitorů reuptake serotoninu | p.o. | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 428.1 | N06AB03 | fluoxetin | p.o. | 20 | MG | 14,00 | |
| 54073 | FLOXET 20MG | cps 14x20mg | EGI | H | | | |
| 94560 | LUDIOMIL | inj 10x5ml/25mg | NPA | CH | | | |
| 428 | N06AB | antidepresiva ze skupiny selektivních inhibitorů reuptake serotoninu | p.o. | O | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 428.1 | N06AB03 | fluoxetin | p.o. | 20 | MG | 13,00 | |
| 95458 | FLUOXETIN-RATIOPHARM 20 MG | por cpsdur100x20mg | MCK | D | | | |
| 64656 | FLUOXIN | por cps dur 20x20mg | SFS | D | | | |
| 98779 | FLUOXIN | por cps dur 30x20mg | SFS | D | | | |
| 64657 | FLUOXIN | por cps dur 50x20mg | SFS | D | | | |
| 64658 | FLUOXIN | por cps dur100x20mg | SFS | D | | | |
| 56471 | FLUVAL | cps 14x20mg | KRK | SLO | | | |
| 56472 | FLUVAL | cps 28x20mg | KRK | SLO | | | |
| 54422 | MAGRILAN | cps 10x20mg | MOE | CY | | | |
| 54423 | MAGRILAN | cps 30x20mg | MOE | CY | | | |
| 64657 | FLUOXIN | por cps dur 50x20mg | SFS | D | | | |
| 56471 | FLUVAL | cps 14x20mg | KRK | SLO | | | |
| 56472 | FLUVAL | cps 28x20mg | KRK | SLO | | | |
| 54074 | FLOXET 20MG | cps 28x20mg | EGI | H | | | |
| 13022 | PORTAL | cps 14x20mg | LEK | SLO | | | |
| 98791 | DEPREX LÉČIVA | por cps dur 30x20mg | LEX | CZ | | | |
| 98779 | FLUOXIN | por cps dur 30x20mg | SFS | D | | | |
| 95458 | FLUOXETIN-RATIOPHARM 20 MG | por cpsdur100x20mg | MCK | D | | | |
| 95457 | FLUOXETIN-RATIOPHARM 20 MG | por cps dur30x20mg | MCK | D | | | |
| 92346 | DEPREX | cps 30x20mg | LEX | CZ | | | |
| 13023 | PORTAL | cps 28x20mg | LEK | SLO | | | |
| 64658 | FLUOXIN | por cps dur100x20mg | SFS | D | | | |
| 64656 | FLUOXIN | por cps dur 20x20mg | SFS | D | | | |
| 44397 | APO-FLUOXETINE | cps 30x20mg | APT | CND | | | |
| 44398 | APO-FLUOXETINE | cps 100x20mg | APT | CND | | | |
| 59274 | FLUMIREX | cps 30x20mg | CHN | H | | | |
| 428.2 | N06AB04 | citalopram do 10 mg v jedné tabletě včetně | p.o. | 20 | MG | 18,00 | L/PSY,SEX, NEU, INT,GER |
| 03976 | CITALEC 10 | tbl obd30x10mg-bli | LEX | CZ | | | |
| 428.3 | N06AB04 | citalopram nad 10 mg v jedné tabletě | p.o. | 20 | MG | 16,70 | L/PSY,SEX, NEU, INT,GER |
| 03978 | CITALEC 20 | tbl obd30x20mg | LEX | CZ | | | |
| 30956 | CITALEC 40 | tbl obd30x40mg(bli) | LEX | CZ | | | |
| 428.4 | N06AB04 | citalopram, tekuté lékové formy | p.o. | 20 | MG | 18,00 | L/PSY,SEX, NEU, INT,GER |
| | | | | | | | |
| 428.5 | N06AB05 | paroxetin | p.o. | 20 | MG | 16,70 | L/PSY,SEX, NEU, INT,GER |
| 41158 | PAROLEX 20 | por tbl flm 60x20mg | AAZ | DK | | | |
| 41239 | PAROLEX 20 | por tbl flm 60x20mg | AAZ | DK | | | |
| 41242 | PAROLEX 40 | por tbl flm 20x40mg | AAZ | DK | | | |
| 41243 | PAROLEX 40 | por tbl flm 60x40mg | AAZ | DK | | | |
| 41244 | PAROLEX 40 | por tbl flm 100x40mg | AAZ | DK | | | |
| 41245 | PAROLEX 40 | por tbl flm 20x40mg | AAZ | DK | | | |
| 41253 | PAROLEX 40 | por tbl flm 60x40mg | AAZ | DK | | | |
| 41262 | PAROLEX 40 | por tbl flm 100x40mg | AAZ | DK | | | |
| 96217 | PAROLEX 40 | por tbl flm 30x40mg | AAZ | DK | | | |
| 96216 | PAROLEX 40 | por tbl flm 30x40mg | AAZ | DK | | | |
| 96215 | PAROLEX 20 | por tbl flm 30x20mg | AAZ | DK | | | |
| 96214 | PAROLEX 20 | por tbl flm 30x20mg | AAZ | DK | | | |
| 428.6 | N06AB06 | sertralin | p.o. | 50 | MG | 16.70 | L/PSY,SEX, NEU, INT,GER |
| 59556 | SERLIFT 50 MG | por tblflm 30x50mg | RXY | IND | | | |
| 47325 | SERTRALIN IREX 100 MG | por tblflm 28x100mg | OMA | IS | | | |
| 59560 | SERLIFT 100 MG | por tbl flm30x100mg | RXY | IND | | | |
| 32743 | SERTRALIN IREX 50 MG | por tbl flm 28x50mg | OMA | IS | | | |
| 428.7 | N06AB08 | fluvoxamin (do 50 mg v jedné tabletě včetně) | p.o. | 100 | MG | 18,00 | L/PSY,SEX, NEU, INT,GER |
| | | | | | | | |
| 428.8 | N06AB08 | fluvoxamin (nad 50 mg v jedné tabletě) | p.o. | 100 | MG | 16,70 | L/PSY,SEX, NEU, INT,GER |
| | | | | | | | |
| 428.9 | N06AB10 | escitalopram | p.o. | 10 | MG | 16,70 | L/PSY,SEX, NEU, INT,GER |
| 428.2 | N06AB04 | citalopram do 10 mg v jedné tabletě včetně | p.o. | 20 | MG | 15,10 | |
| | | | | | | | |
| 428.3 | N06AB04 | citalopram nad 10 mg v jedné tabletě | p.o. | 20 | MG | 14,00 | |
| | | | | | | | |
| 428.4 | N06AB04 | citalopram, tekuté lékové formy | p.o. | 20 | MG | 15,10 | |
| | | | | | | | |
| 428.5 | N06AB05 | paroxetin | p.o. | 20 | MG | 14,00 | |
| 96215 | PAROLEX 20 | por tblflm30x20mg-b | AAZ | DK | | | |
| 96214 | PAROLEX 20 | por tblflm30x20mg-l | AAZ | DK | | | |
| 41158 | PAROLEX 20 | por tblflm60x20mg-b | AAZ | DK | | | |
| 41239 | PAROLEX 20 | por tblflm60x20mg-l | AAZ | DK | | | |
| 96217 | PAROLEX 40 | por tblflm30x40mg-b | AAZ | DK | | | |
| 96216 | PAROLEX 40 | por tblflm30x40mg-l | AAZ | DK | | | |
| 41243 | PAROLEX 40 | por tblflm60x40mg-b | AAZ | DK | | | |
| 41253 | PAROLEX 40 | por tblflm60x40mg-l | AAZ | DK | | | |
| 428.6 | N06AB06 | sertralin | p.o. | 50 | MG | 14,00 | |
| | | | | | | | |
| 428.7 | N06AB08 | fluvoxamin (do 50 mg v jedné tabletě včetně) | p.o. | 100 | MG | 18,00 | L/PSY,SEX,NEU, INT,GER |
| | | | | | | | |
| 428.8 | N06AB08 | fluvoxamin (nad 50 mg v jedné tabletě) | p.o. | 100 | MG | 16,70 | L/PSY,SEX,NEU, INT,GER |
| | | | | | | | |
| 428.9 | N06AB10 | escitalopram | p.o. | 10 | MG | 16,70 | L/PSY,SEX,NEU, INT,GER |
| 429 | N06AB | antidepresiva ze skupiny selektivních inhibitorů reuptake serotoninu | parent. | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 429.1 | N06AB04 | citalopram | parent. | 20 | MG | 228,29 | O/PSY,SEX |
| 60113 | SEROPRAM | inf 10x1ml/40mg | LUN | DK | | | |
| 60113 | SEROPRAM | inf cnc sol 10x1ml | LUN | DK | | | |
| 430 | N06A | ostatní antidepresiva | p.o. | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 430.1 | N06AF01 | isocarbaxazid | p.o. | 15 | MG | 4,30 | L7PSY,SEX, NEU, |
| | | | | | | | |
| 430.2 | N06AF04 | tranylcypromin | p.o. | 10 | MG | 5.03 | L/PSY,SEX, NEU |
| | | | | | | | |
| 430.3 | N06AG02 | moklobemid do 150mg v jedné tabletě včetně | p.o. | 0.3 | GM | 18.00 | L/PSY,SEX, NEU, INT,GER |
| | | | | | | | |
| 430.4 | N06AG02 | moklobemid nad 150 mg v jedné tabletě | p.o. | 0.3 | GM | 16,70 | L/PSY,SEX, NEU, INT,GER |
| | | | | | | | |
| 430.5 | N06AX03 | mianserin do 10 mg v jedné tabletě včetně | p.o. | 60 | MG | 16,70 | L/PSY,SEX, NEU |
| | | | | | | | |
| 430.6 | N06AX03 | mianserin nad 10 mg v jedné tabletě | p.o. | 60 | MG | 17,35 | L7PSY.SEX. NEU |
| 45771 | MIABENE 30MG | tbl obd 20x30mg | MCK | D | | | |
| 430.7 | N06AX05 | trazodon | p.o. | 0.3 | GM | 14,22 | L/PSY,SEX, NEU |
| | | | | | | | |
| 430.8 | N06AX05 | trazodon, tablety s řízeným uvolňováním | p.o. | 0.3 | GM | 17,60 | L/PSY,SEX, NEU |
| | | | | | | | |
| 430.9 | N06AX06 | nefazodon hydrochlorid | p.o. | 400 | MG | 20,70 | L/PSY,SEX, NEU |
| | | | | | | | |
| 430.10 | N06AX09 | viloxazin | p.o. | 0.2 | GM | 14,22 | L/PSY,SEX, NEU |
| | | | | | | | |
| 430.11 | N06AX11 | mirtazapin | p.o. | 30 | MG | 22,25 | L/PSY,SEX, NEU |
| | | | | | | | |
| 430.12 | N06AX12 | bupropion | p.o. | 200 | MG | 18,00 | L/PSY,SEX, NEU |
| | | | | | | | |
| 430.13 | N06AX14 | tianeptin | p.o. | 37.5 | MG | 16,70 | L/PSY,SEX, NEU, INT,GER |
| | | | | | | | |
| 430.14 | N06AX16 | venlafaxin | p.o. | 100 | MG | 22,25 | L/NEU,PSY, SEX |
| | | | | | | | |
| 430.15 | N06AX17 | milnacipran | p.o. | 100 | MG | 22,25 | L/NEU,PSY, SEX |
| | | | | | | | |
| 430.16 | N06AX18 | reboxetin | p.o. | 8 | MG | 22,25 | L/NEU,PSY, SEX |
| | | | | | | | |
| 430.17 | V11 | hyperici extractum siccum normatum (LI 160) | p.o. | 900 | MG | 10,80 | |
| 430.1 | N06AF01 | isocarbaxazid | p.o. | 15 | MG | 4,30 | L/PSY,SEX,NEU, |
| | | | | | | | |
| 430.2 | N06AF04 | tranylcypromin | p.o. | 10 | MG | 5,03 | L/PSY,SEX,NEU |
| | | | | | | | |
| 430.3 | N06AG02 | moklobemid do 150mg v jedné tabletě včetně | p.o. | 0.3 | GM | 18,00 | L/PSY,SEX,NEU, INT,GER |
| | | | | | | | |
| 430.4 | N06AG02 | moklobemid nad 150 mg v jedné tabletě | p.o. | 0.3 | GM | 16,70 | L/PSY,SEX,NEU, INT,GER |
| | | | | | | | |
| 430.5 | N06AX03 | mianserin do 10 mg v jedné tabletě včetně | p.o. | 60 | MG | 16,70 | L/PSY,SEX,NEU |
| | | | | | | | |
| 430.6 | N06AX03 | mianserin nad 10 mg v jedné tabletě | p.o. | 60 | MG | 17,35 | L/PSY,SEX,NEU |
| 45771 | MIABENE 30 MG | por tbl flm 20x30mg | MCK | D | | | |
| 430.7 | N06AX05 | trazodon | p.o. | 0.3 | GM | 14,22 | L/PSY,SEX,NEU |
| | | | | | | | |
| 430.8 | N06AX05 | trazodon, tablety s řízeným uvolňováním | p.o. | 0.3 | GM | 17,60 | L/PSY,SEX,NEU |
| | | | | | | | |
| 430.9 | N06AX06 | nefazodon hydrochlorid | p.o. | 400 | MG | 20,70 | L/PSY,SEX,NEU |
| | | | | | | | |
| 430.10 | N06AX09 | viloxazin | p.o. | 0.2 | GM | 14,22 | L/PSY,SEX,NEU |
| | | | | | | | |
| 430.11 | N06AX11 | mirtazapin | p.o. | 30 | MG | 22,25 | L/PSY,SEX,NEU |
| | | | | | | | |
| 430.12 | N06AX12 | bupropion | p.o. | 200 | MG | 18,00 | L/PSY,SEX,NEU |
| | | | | | | | |
| 430.13 | N06AX14 | tianeptin | p.o. | 37.5 | MG | 16,70 | L/PSY,SEX,NEU, INT,GER |
| | | | | | | | |
| 430.14 | N06AX16 | venlafaxin | p.o. | 100 | MG | 22,25 | L/NEU,PSY,SEX |
| | | | | | | | |
| 430.15 | N06AX17 | milnacipran | p.o. | 100 | MG | 22,25 | L/NEU,PSY,SEX |
| | | | | | | | |
| 430.16 | N06AX18 | reboxetin | p.o. | 8 | MG | 22,25 | L/NEU,PSY,SEX |
| | | | | | | | |
| 430.17 | V11 | hyperici extractum siccum (LI 160) | p.o. | 900 | MG | 6,50 | |
| | | | | | | | |
| 430.18 | V11 | hyperici extractum siccum normatum (ostatní) | p.o. | 900 | MG | 2,00 | |
| 431 | N06BA | centrálně působící stimulancia | p.o. | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 431.1 | N06BA04 | methylphenidat | p.o. | 30 | MG | 9,00 | L/NEU,PSY, PDD, SEX |
| 83328 | RITALIN | tbl 30x10mg | CGC | CH | | | |
| 431.2 | N06BA07 | modafinil | p.o. | 300 | MG | 9,00 | L/NEU,PSY, PDD, SEX |
| 431.1 | N06BA04 | methylphenidat | p.o. | 30 | MG | 9,00 | L/NEU,PSY,PDD, SEX |
| 83328 | RITALIN | tbl 30x10mg | NPA | CH | | | |
| 431.2 | N06BA07 | modafinil | p.o. | 300 | MG | 9,00 | L/NEU,PSY,PDD, SEX |
| 432 | N06BX | ostatní psychostimulancia a nootropika | p.o. | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
Pyritinol, piracetam a vinpocetin indikuje neurolog a psychiatr pacientům s nejméně jedou z následujících diagnóz:
Pyritinol a piracetam, tekuté lékové formy, indikuje neurolog a psychiatr v uvedených indikacích u dětí. U dospělých neurolog, psychiatr a geriatr pouze při současné poruše polykání, s nejméně jedou z následujících diagnóz:
1) afasie cévního původu a poruchy kognitivních funkcí po prodělané CPM,
@@ -6843,92 +7075,72 @@
5) DMO.
Dále je psychiatrem, neurologem a othorynolaryngologem vinpocetin indikován pacientům s vertigem a tinitem.
Tekuté lékové formy jsou indikovány pacientům ve výše uvedených indikacích, postižených současně poruchou polykání.
| 432.1 | N06BX02 | pyritinol (pevné lékové formy) | p.o. | 0.3 | GM | 6,50 | P |
| --- | --- | --- | --- | --- | --- | --- | --- |
| | | | | | | | |
| 432.2 | N06BX02 | pyritinol (tekuté lékové formy) | p.o. | 0.3 | GM | 18,12 | P |
| | | | | | | | |
| 432.3 | N06BX03 | piracetam (pevné lékové formy) | p.o. | 2.4 | GM | 5,85 | P |
| 81598 | PIRABENE 800MG | tbl obd 100x800mg | MCK | D | | | |
| 64864 | PIRACETAM AL 1200 | por tblflm30x1200mg | APA | D | | | |
| 64865 | PIRACETAM AL 1200 | por tblflm60x1200mg | APA | D | | | |
| 66646 | PIRACETAM AL 800 | tbl obd 30x800mg | APA | D | | | |
| 66648 | PIRACETAM AL 800 | tbl obd 100x800mg | APA | D | | | |
| 81600 | PIRABENE 1200MG | tbl obd 60x1200mg | MCK | D | | | |
| 10032 | PIRACETAM AL 800 | tbl obd 60x800mg | APA | D | | | |
| 66647 | PIRACETAM AL 800 | tbl obd 50x800mg | APA | D | | | |
| 432.4 | N06BX03 | piracetam (tekuté lékové formy) | p.o. | 2.4 | GM | 18,12 | P |
| 88156 | NOOTROPIL 20% ORAL | sol 1x125ml 20% | UCB | B | | | |
| 04289 | NOOTROPIL 33% ORAL | sol 1x125ml 33% | UCB | B | | | |
| 432.5 | N06BX18 | vinpocetin | p.o. | 15 | MG | 6,50 | P |
Léčbu inhibitory acetylcholinesterázy (IAchE) ordinuje neurolog nebo psychiatr pacientům, u kterých je diagnosticky vyloučena demence jiného typu než Alzheimerova a potvrzena diagnóza Alzheimerovy demence (ACH) se stupněm postižení vyjádřeným dle škály MMSE (Mini-Mental State Examination) v rozmezí dosaženého skóre 20 – 13 bodů včetně.
Po 12.týdnech (3 měsíce) od zahájení podávání IAchE je provedeno další vyšetření pacienta škálou MMSE. Léčba IAchE je hrazena z prostředků zdravotního pojištění při setrvání skóre, nebo jeho poklesu o nejvíce 2 body ve srovnání s hodnotou MMSE dosahovanou pacientem před zahájením léčby IAchE). Další kontroly MMSE jsou prováděny nejméně po každých 3 měsících léčby.
Léčba IAchE není hrazena u pacientů, u nichž po 6/9 atd. měsících od zahájení léčby nedojde k objektivně prokazatelnému terapeutickému účinku (tj. zastaveni progrese anebo pokles menší než 2 body dle škály MMSE oproti původnímu stavu) a dále při zjištěném skóre škály MMSE 12 bodů. Tato kritéria se vztahují i na léčbu pacientů trvající v rámci stanovených kritérií déle než 9 měsíců.
Léčbu memantinem indikuje neurolog nebo psychiatr pacientům, u kterých je potvrzena diagnóza Alzheimerovy demence (ACH) se stupněm postižení vyjádřeným dle škály MMSE (Mini-Mental State Examination) v rozmezí dosaženého skóre 6 – 17 bodů včetně.
Léčba memantinem není hrazena u pacientů, u nichž poklesne zjištěné skóre škály MMSE pod 6 bodů.
| 432.6 | N06DA02 | donepezil do 5mg v jedné tabletě včetně | p.o. | 1 | DF | 58,00 | P |
| | | | | | | | |
| 432.7 | N06DA02 | donepezil nad 5 mg v jedné tabletě | p.o. | 1 | DF | 113,00 | P |
| | | | | | | | |
| 432.8 | N06DA03 | rivastigmin do 1,5 mg v jedné tabletě včetně | p.o. | 2 | DF | 58,00 | P |
| | | | | | | | |
| 432.9 | N06DA03 | rivastigmin nad 1,5 mg v jedné tabletě | p.o. | 2 | DF | 113,00 | P |
| | | | | | | | |
| 432.10 | N06DA04 | galantamin do 4 mg v jedné tabletě včetně | p.o. | 2 | DF | 58,00 | P |
| | | | | | | | |
| 432.11 | N06DA04 | galantamin nad 4 mg v jedné tabletě | p.o. | 2 | DF | 113,00 | P |
| | | | | | | | |
| 432.12 | N06DX01 | memantin | p.o. | 20 | MG | 85,00 | P |
| | | | | | | | |
| 432.13 | N06DX02 | extrakty z Ginkgo biloba (pevné i tekuté lékové formy) | p.o. | 120 | MG | 8,10 | L/PSY, NEU, INT, OPH, ORL,GER |
| 58478 | GINGIUM ROZTOK | por gttsol2x100ml | SFS | D | | | |
| 58477 | GINGIUM ROZTOK | por gttsol1x100ml | SFS | D | | | |
| 58791 | GINGIUM TABLETY | por tbl flm100x40mg | SFS | D | | | |
| 42483 | GINGIUM TABLETY | por tbl flm120x40mg | SFS | D | | | |
| 432.1 | N06BX02 | pyritinol (pevné lékové formy) | p.o. | 0.3 | GM | 3,90 | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| | | | | | | | |
| 432.2 | N06BX02 | pyritinol (tekuté lékové formy) | p.o. | 0.3 | GM | 17,80 | P |
| | | | | | | | |
| 432.3 | N06BX03 | piracetam (pevné lékové formy) | p.o. | 2.4 | GM | 3,50 | |
| | | | | | | | |
| 432.4 | N06BX03 | piracetam (tekuté lékové formy) | p.o. | 2.4 | GM | 17,80 | P |
| 04289 | NOOTROPIL 33% ORAL SOLUTION | por sol 1x125ml | UAG | B | | | |
| 432.5 | N06BX18 | vinpocetin | p.o. | 15 | MG | 3,90 | |
Léčbu inhibitory acetylcholinesterázy (lAchE) a memantinem ordinuje neurolog, psychiatr nebo geriatr pacientům, u kterých je diagnosticky vyloučena demence jiného typu než Alzheimerova a potvrzena diagnóza Alzheimerovy demence (ACH) se stupněm postižení vyjádřeným dle škály MMSE (Mini-Mental State Examination) v rozmezí dosaženého skóre 20 – 13 bodů včetně a v případě memantinu 17-6 bodů.
Po 12.týdnech (3 měsíce) od zahájení podávání lachE a memantinu je provedeno další vyšetření pacienta škálou MMSE. Léčba lachE a memantinem je hrazena z prostředků zdravotního pojištění při setrvání skóre, nebo jeho poklesu o nejvíce 2 body ve srovnání s hodnotou MMSE dosahovanou pacientem před zahájením léčby lAchE a memantinem. Další kontroly MMSE jsou prováděny nejméně po každých 3 měsících léčby. Léčba lAchE a memantinem není hrazena u pacientů, u nichž po 6/9 atd. měsících od zahájení léčby nedojde k objektivně prokazatelnému terapeutickému účinku (tj. zastavení progrese anebo pokles menší než 2 body dle škály MMSE oproti původnímu stavu) a dále při zjištěném skóre škály MMSE 12 bodů, v případě memantinu pod 6 bodů škály MMSE. Tato kritéria se vztahují i na léčbu pacientů trvající v rámci stanovených kritérií déle než 9 měsíců.
| 432.6 | N06DA02 | donepezil do 5mg v jedné tabletě včetně | p.o. | 1 | DF | 51,30 | P |
| | | | | | | | |
| 432.7 | N06DA02 | donepezil nad 5 mg v jedné tabletě | p.o. | 1 | DF | 100,00 | P |
| | | | | | | | |
| 432.8 | N06DA03 | rivastigmin do 1,5 mg v jedné tabletě včetně | p.o. | 2 | DF | 51,30 | P |
| | | | | | | | |
| 432.9 | N06DA03 | rivastigmin nad 1,5 mg v jedné tabletě | p.o. | 2 | DF | 100,00 | P |
| | | | | | | | |
| 432.10 | N06DA04 | galantamin do 4 mg v jedné tabletě včetně | p.o. | 2 | DF | 51,30 | P |
| | | | | | | | |
| 432.11 | N06DA04 | galantamin nad 4 mg v jedné tabletě | p.o. | 2 | DF | 100,00 | P |
| | | | | | | | |
| 432.12 | N06DX01 | memantin | p.o. | 20 | MG | 100,00 | P |
| | | | | | | | |
| 432.13 | N06DX02 | extrakty z Ginkgo biloba (pevné i tekuté lékové formy) | p.o. | 120 | MG | 5,66 | |
| 433 | N06BX | ostatní psychostimulancia a nootropika | parent. | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 433.1 | N06BX01 | meklofenoxat | parent. | 0.5 | GM | 83,53 | H |
| | | | | | | | |
| 433.2 | NO6BX02 | pyritinol | parent. | 0.3 | GM | 57,25 | H |
| 433.2 | N06BX02 | pyritinol | parent. | 0.3 | GM | 57,25 | H |
| | | | | | | | |
| 433.3 | N06BX03 | piracetam | parent. | 6 | GM | 57,25 | H |
| 11337 | GERATAM 3G | inj 4x15ml/3gm | UCB | B | | | |
| 11337 | GERATAM 3 G | inj 4x15ml/3gm | UCB | B | | | |
| 433.4 | N06BX18 | vinpocetin | parent. | 15 | MG | 24,98 | H |
| 434 | N07AA | parasympatomimetika ze skupiny inhibitorů cholinesterázy | p.o. | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 434.1 | N07AA01 | neostigmin | p.o. | 60 | MG | 19,75 | |
| 53946 | SYNTOSTIGMIN | tbl 20x15mg(blistr) | SLO | SK | | | |
| 00612 | SYNTOSTIGMIN | inj 10x1ml/0.5mg | HBS | SK | | | |
| 434.2 | N07AA02 | pyridostigmin (do 10 mg v jedné tabletě včetně) | p.o. | 180 | MG | 25,86 | |
| | | | | | | | |
| 434.3 | N07AA02 | pyridostigmin (nad 10 mg v jedné tabletě) | p.o. | 180 | MG | 16,81 | |
| 434.3 | N07AA02 | pyridostigmin (nad 10 mg v jedné tabletě) | p.o. | 180 | MG | 17,65 | L/NEU |
| | | | | | | | |
| 434.4 | N07AA03 | distigmin | p.o. | 5 | MG | 5,82 | |
| 02360 | UBRETID | tbl 20x5mg | HNP | A | | | |
| 02130 | UBRETID | tbl 50x5mg | HNP | A | | | |
| 02360 | UBRETID 5 MG | por tbl nob 20x5mg | NYC | A | | | |
| 02130 | UBRETID 5 MG | por tbl nob 50x5mg | NYC | A | | | |
| 434.5 | N07AA30 | ambenonium | p.o. | 60 | MG | 18,04 | |
| 435 | N07AA | parasympatomimetika ze skupiny inhibitorů cholinesterázy | parent. | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 435.1 | N07AA01 | neostigmin | parent. | 2 | MG | 18,04 | |
| 00612 | SYNTOSTIGMIN | inj 10x1ml/0.5mg | HBS | SK | | | |
| 53940 | SYNTOSTIGMIN | tbl 20x15mg(blistr) | SLO | SK | | | |
| 435.2 | N07AA02 | pyridostigmin | parent. | 10 | MG | 113,20 | |
| | | | | | | | |
| 435.3 | N07AA03 | distigmin | parent. | 0.25 | MG | 5,62 | |
| 435.3 | N07AA03 | dlstigmin | parent. | 0.25 | MG | 5,62 | |
| 436 | N07CA | léčiva proti vertigu | p.o. | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 436.1 | N07CA52 | cinarizin, kombinace (s dimenhydrinátem) | p.o. | 3 | DF | 4,79 | |
| | | | | | | | |
| 436.2 | N07CA01 | betahistin | p.o. | 24 | MG | 8,76 | |
| | | | | | | | |
| 42932 | AVERTIN 16 | por tbl nob 60x16mg | LBL | D | | | |
| 42935 | AVERTIN 8 | por tbl nob 60x8mg | LBL | D | | | |
| 31522 | BETAHIREX 8 MG | por tbl nob120x8mg | SFW | GB | | | |
| 436.3 | N07CA02 | cinarizin (do 25 mg včetně v jedné tabletě) | p.o. | 90 | MG | 1,86 | |
| | | | | | | | |
| 436.4 | N07CA02 | cinarizin (nad 25 mg v jedné tabletě) | p.o. | 90 | MG | 1,56 | |
@@ -6962,7 +7174,7 @@
Léčbu meflochinem ordinuje infekcionista: léčba tropické malárie (z oblastí s vysokou rezistencí vůči chlorochinu na Plasmodium falciparum).
| 439.1 | P01BA01 | chlorochin | p.o. | 0.5 | GM | 2,79 | |
| 00098 | DELAGIL | tbl 30x250mg | IDA | H | | | |
| 00098 | DELAGIL | tbl 30x250mg | IHU | H | | | |
| 439.2 | P01BA02 | hydroxychlorochin | p.o. | 0.4 | GM | 17,66 | P |
| 54424 | PLAQUENIL | tbl obd 60x200mg | SWC | GB | | | |
| 439.3 | P01BC02 | meflochin | p.o. | 1 | GM | 308,40 | P |
@@ -6975,7 +7187,7 @@
| 441 | P01CX | ostatní léčiva k léčbě protozoóz | parent. | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 441.1 | P01CX01 | pentamidin isethionát | parent. | 0.28 | GM | 1047,13 | X |
| 442 | P02CA | anthelmintika ze skupiny benzimtoazolových derivátů | p.o. | | | | |
| 442 | P02CA | anthelmintika ze skupiny benzimidazolových derivátů | p.o. | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 442.1 | P02CA01 | mebendazol | p.o. | 0.2 | GM | 13,60 | |
| | | | | | | | |
@@ -6988,22 +7200,21 @@
| 444 | P02CE | anthelmintika ze skupiny imidazothiazolových derivátů | p.o. | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 444.1 | P02CE01 | levamizol | p.o. | 0.15 | GM | 29,55 | |
| 04030 | DECARIS | tbl 2x50mg | GED | H | | | |
| 04030 | DECARIS 50MG | tbl 2x50mg | GED | H | | | |
| 445 | P02CX | ostatní anthelmintika | p.o. | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 445.1 | P02CX01 | pyrvinium | p.o. | 0.3 | GM | 17,69 | |
| 02139 | PYRVINIUM | sus 1x100ml | GNO | CZ | | | |
| 02139 | PYRVINIUM | sus 1x100ml/1.5gm | IXP | CZ | | | |
| 446 | P02DA | anticestodika ze skupiny derivátů kyseliny salicylové | p.o. | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 446.1 | P02DA01 | niklosamid | p.o. | 2 | GM | 131,19 | |
| 447 | P03AB | ektoparazitika ze skupiny halogenovaných léčiv | lok. | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 447.1 | P03AB02 | lindan (lékové formy gelu) | lok. | 1 | GM | 2,54 | |
| | | | | | | | |
| 447.2 | P03AB02 | lindan (lékové formy lotia) | lok. | 1 | ML | 1,08 | |
| 62364 | JACUTIN | eml 1x100ml/300mg | HEM | D | | | |
| 97547 | JACUTIN | eml 1x200ml/600mg | HEM | D | | | |
| 92765 | SKABICID | drm eml 1x100gm/gm | AVE | CZ | | | |
| 97547 | JACUTIN | lot 1x200ml | HEM | D | | | |
| 62364 | JACUTIN | lot 1x100ml | HEM | D | | | |
| 447.3 | P03AB02 | lindan (lékové formy spreje) | lok. | 1 | ML | 1,17 | |
| 448 | P03AC | ektoparazitika ze skupiny pyrethrinů | lok. | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
@@ -7012,38 +7223,38 @@
| 448.2 | P03AC04 | permerthrin | lok. | 1 | ML | 1,17 | |
| 449 | R01AC | protialergická léčiva k lokálnímu podání | lok. | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 449.1 | R01AC01 | natrium kromoglykát (do 15 mililitrů včetně v jednom balení) | lok. | 40 | MG | 13,88 | L/ALG,TRN, ORL |
| 449.1 | R01AC01 | natrium kromoglykát (do 15 mililitrů včetně v jednom balení) | lok. | 40 | MG | 13,88 | L/ALG,TRN,ORL |
| 53742 | ALLERGO-COMOD NOSNÍ SPREJ | spr nas 1x15ml | URS | D | | | |
| 12582 | ALLERGOCROM | spr nas 1x15ml | URS | D | | | |
| 76418 | CROMOBENE | spr nas 1x15ml | MCK | D | | | |
| 83652 | CROMOHEXAL | spr nas 1x15ml | HEX | D | | | |
| 76418 | CROMOBENE NOSNÍ SPRAY | spr nas 1x15ml | MCK | D | | | |
| 83652 | CROMOHEXAL | nas spr sol 1x15ml | HEX | D | | | |
| 97615 | CROMOHEXAL | nas spr sol 1x15ml | SFS | D | | | |
| 53742 | ALLERGO-COMOD NOSNÍ SPREJ | spr nas 1x15ml | URS | D | | | |
| 449.2 | R01AC01 | natrium kromoglykát (nad 15 mililitrů v jednom balení) | lok. | 40 | MG | 13,09 | L/ALG,TRN, ORL |
| 449.2 | R01AC01 | natrium kromoglykát (nad 15 mililitrů v jednom balení) | lok. | 40 | MG | 13,09 | L/ALG,TRN,ORL |
| 86429 | CROMOHEXAL | nas spr sol 1x30ml | HEX | D | | | |
| 42545 | CROMOSOL | nas spr sol 1x28ml | ICN | PL | | | |
| 86429 | CROMOHEXAL | spr nas 1x30ml | HEX | D | | | |
| 449.3 | R01AC02 | levokabastin | lok. | 0.6 | MG | 10,80 | |
| | | | | | | | |
| 449.4 | R01AC03 | azelastin | lok. | 0.56 | MG | 10,80 | |
| 450 | R01AD | kortikosteroidy k lokálnímu podání | lok. | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 450.1 | R01AD01 | beclomethason dipropionát | lok. | 0.4 | MG | 4,30 | |
| 66006 | BECLOMET NASAL AQUA | spr nas 23ml/200dav | OKU | SF | | | |
| 66006 | BECLOMET NASAL AQUA | nas sprsus23ml/200d | OKU | SF | | | |
| 58408 | NASOBEC | spr nas 200x50rg | GNO | CZ | | | |
| 450.2 | R01AD04 | flunisolid | lok. | 0.15 | MG | 6,45 | |
| | | | | | | | |
| 450.3 | R01AD05 | budesonid lokálně do 50 rg v jedné dávce včetně | lok. | 0.3 | MG | 6,45 | |
| 55427 | TAFEN NASAL 50MCG | spr nas 1x10ml/200d | LEK | SLO | | | |
| 55427 | TAFEN NASAL 50 MCG | nas spr sus 200dÁv | LEK | SLO | | | |
| 450.4 | R01AD05 | budesonid lokálně nad 50 rg v jedné dávce | lok. | 0.3 | MG | 6,75 | |
| | | | | | | | |
| 450.5 | R01AD08 | flutikason - léková forma nosní kapky | lok. | 0.2 | MG | 8,60 | L/ALG,TRN, ORL |
| | | | | | | | |
| 450.6 | R01AD08 | flutikason - léková forma vodní nosní sprej | lok. | 0.2 | MG | 8,60 | |
| | | | | | | | |
| 450.7 | R01AD11 | triamcinolon acetonid | lok. | 220 | RG | 7,50 | L/ALG,TRN, ORL |
| | | | | | | | |
| 450.8 | R01AD09 | momethason | lok. | 200 | RG | 10,56 | L/ALG,TRN, ORL |
| | | | | | | | |
| 450.9 | R01AX03 | ipratropium bromid | lok. | 240 | RG | 8,60 | L/ALG,TRN, ORL |
| 450.5 | R01AD08 | flutikason – léková forma nosní kapky | lok. | 0.2 | MG | 8,60 | L/ALG,TRN,ORL |
| | | | | | | | |
| 450.6 | R01AD08 | flutikason – léková forma vodní nosní sprej | lok. | 0.2 | MG | 8,60 | |
| | | | | | | | |
| 450.7 | R01AD11 | triamcinolon acetonid | lok. | 220 | RG | 7,50 | L/ALG,TRN,ORL |
| | | | | | | | |
| 450.8 | R01AD09 | momethason | lok. | 200 | RG | 10,56 | L/ALG,TRN,ORL |
| | | | | | | | |
| 450.9 | R01AX03 | ipratropium bromid | lok. | 240 | RG | 8,60 | L/ALG,TRN,ORL |
| 451 | R03AC | inhalační selektivní beta-2 sympatomimetika | inhal. | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
@@ -7054,7 +7265,7 @@
| 451.2 | R03AC02 | bezfreonový salbutamol (lékové formy aerosolu) | inhal. | 0.8 | MG | 3,37 | |
| 10142 | ECOSAL INHALER | aer dos 200x100rg | IVX | CZ | | | |
| 451.3 | R03AC02 | salbutamol (lékové formy prášku k inhalaci) | inhal. | 0.8 | MG | 7,23 | |
| 83047 | VENTODISKS | inh plv 15x8x400rg | GLA | F | | | |
| 83047 | VENTODISKS 400 | inhplvdos15x8dÁvek | GWE | F | | | |
| 451.4 | R03AC02 | freonový salbutamol (lékové formy aerosolu k inhalaci vdechem aktivované) | inhal. | 0.8 | MG | 7,23 | |
| | | | | | | | |
| 451.5 | R03AC02 | bezfreonový salbutamol (lékové formy aerosolu k inhalaci vdechem aktivované) | inhal. | 0.8 | MG | 7,23 | |
@@ -7066,15 +7277,15 @@
| 451.8 | R03AC03 | terbutalin (lékové formy prášku k inhalaci) | inhal. | 2 | MG | 7,23 | |
| | | | | | | | |
| 451.9 | R03AC04 | fenoterol (lékové formy aerosolu) | inhal. | 0.6 | MG | 2,74 | |
| 02863 | BEROTEC 0.2MG | aer 1x15ml/300d | BGP | D | | | |
| 92588 | BEROTEC 0.2MG | aer 1x10ml/200d | BGP | D | | | |
| 92588 | BEROTEC 0.2 MG | aer dos 1x10ml/200d | BGP | D | | | |
| 02863 | BEROTEC 0.2 MG | aer dos 1x15ml/300d | BGP | D | | | |
| 451.10 | R03AC04 | fenoterol (lékové formy aerosolu bezfreonové) | inhal. | 0.6 | MG | 4,93 | |
| 64881 | BEROTEC N 100 MCG | inh sol pss200 dÁv | BGP | D | | | |
| 64881 | BEROTEC N 100 MCG | inh sol pss 200dÁv | BGP | D | | | |
| 451.11 | R03AC04 | fenoterol (lékové formy roztoku) | inhal. | 4 | MG | 24,64 | |
| | | | | | | | |
| 451.12 | R03AC04 | fenoterol (lékové formy prášku k inhalaci) | inhal. | 0.6 | MG | 7,23 | |
| | | | | | | | |
| 451.13 | R03AC06 | hexoprenalin (lékové formy aerosolu) | inhal. | 1.5 | MG | 2.74 | |
| 451.13 | R03AC06 | hexoprenalin (lékové formy aerosolu) | inhal. | 1.5 | MG | 2,74 | |
| | | | | | | | |
| 451.14 | R03AC12 | salmeterol (lékové formy aerosolu) | inhal. | 0.1 | MG | 20,63 | P |
| | | | | | | | |
@@ -7088,16 +7299,16 @@
| 452 | R03AK | inhalační sympatomimetika a jiná antiastmatika | inhal. | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 452.1 | R03AK03 | freonový fenoterol kombinace s ipratropiem (lékové formy aerosolu) | inhal. | 6 | DF | 4,83 | |
| 87899 | BERODUAL | aer dos 15ml/300df | BGP | D | | | |
| 87899 | BERODUAL | aer dos 15ml/300dÁv | BGP | D | | | |
| 452.2 | R03AK03 | bezfreonový fenoterol kombinace s ipratropiem (lékové formy aerosolu) | inhal. | 6 | DF | 6,00 | |
| | | | | | | | |
| 452.3 | R03AK03 | fenoterol kombinace s kromoglykátem (lékové formy aerosolu) | inhal. | 1 | DF | 1,25 | L/ALG,TRN |
| | | | | | | | |
| 452.4 | R03AK03 | fenoterol a jiná antiastmatika (lékové formy roztoku) | inhal. | 4 | ML | 20.63 | |
| 452.4 | R03AK03 | fenoterol a jiná antiastmatika (lékové formy roztoku) | inhal. | 4 | ML | 20,63 | |
| | | | | | | | |
| 452.5 | R03AK03 | fenoterol a jiná antiastmatika (lékové formy prášku k inhalaci) | inhal. | 3 | DF | 13,00 | |
| | | | | | | | |
| 452.6 | R03AK04 | salbutamol v kombinaci s bromidem ipratropia | inhal. | 6 | DF | 7.33 | L/ALG,TRN |
| 452.6 | R03AK04 | salbutamol v kombinaci s bromidem ipratropia | inhal. | 6 | DF | 7,33 | L/ALG,TRN |
| | | | | | | | |
| 452.7 | R03AK04 | salbutamol v kombinaci s kromoglykátem | inhal. | 8 | DF | 11,73 | L/ALG,TRN |
| | | | | | | | |
@@ -7107,23 +7318,23 @@
| | | | | | | | |
| 452.10 | R03AK06 | salmeterol a flutikason ve fixní kombinaci (léková forma prášku k inhalaci) 50/500 | inhal. | 2 | DF | 65,20 | L/ALG,TRN |
| | | | | | | | |
| 452.11 | R03AK07 | formoterol a budesonid v kombinaci (léková forma prášku k inhalaci), 100/6 | inhal. | 2 | DF | 22,40 | L/ALG,TRN |
| | | | | | | | |
| 452.12 | R03AK07 | formoterol a budesonid v kombinaci (léková forma prášku k inhalaci), 200/6 | inhal. | 2 | DF | 27,50 | L/ALG,TRN |
| 452.11 | R03AK07 | formoterol a budesonid v kombinaci (léková forma prášku k inhalaci), 100/6 | inhal. | 2 | DF | 23,60 | L/ALG,TRN |
| | | | | | | | |
| 452.12 | R03AK07 | formoterol a budesonid v kombinaci (léková forma prášku k inhalaci), 200/6 | inhal. | 2 | DF | 29,90 | L/ALG,TRN |
| | | | | | | | |
| 452.13 | R03AK07 | formoterol a budesonid v kombinaci (léková forma prášku k inhalaci), 400/12 | inhal. | 2 | DF | 54,00 | L/ALG,TRN |
| 453 | R03BA | inhalačni kortikosteroidy | inhal. | | | | |
| 453 | R03BA | inhalační kortikosteroidy | inhal. | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 453.1 | R03BA01 | beklomethason (lékové formy aerosolu freonové) do 100 rg včetně v jedné dávce | inhal. | 0.8 | MG | 6,35 | |
| | | | | | | | |
| 453.2 | R03BA01 | beklomethason (lékové formy aerosolu bezfreonové) do 100 rg včetně v jedné dávce | inhal. | 0.8 | MG | 10,80 | |
| 58792 | ECOBEC 100 MCG | aer dos 1x200dávek | IVX | CZ | | | |
| 58792 | ECOBEC 100 MCG | aer dos 1x200dÁvek | IVX | CZ | | | |
| 453.3 | R03BA01 | beklomethason (lékové formy aerosolu freonové) nad 100 rg v jedné dávce | inhal. | 0.8 | MG | 5,20 | |
| | | | | | | | |
| 453.4 | R03BA01 | beklomethason (lékové formy aerosolu bezfreonové) nad 100 rg v jedné dávce | inhal. | 0.8 | MG | 8,90 | |
| 58793 | ECOBEC 250 MCG | aer dos 1x200dávek | IVX | CZ | | | |
| 58793 | ECOBEC 250 MCG | aer dos 1x200dÁvek | IVX | CZ | | | |
| 453.5 | R03BA01 | beklomethason (lékové formy prášku k inhalaci) do 0,1 mg včetně v jedné dávce | inhal. | 0.8 | MG | 20,77 | |
| 83044 | BECODISKS 100 | inhplvdos 15x8dávek | GWE | F | | | |
| 83044 | BECODISKS 100 | inhplvdos15x8dÁvek | GWE | F | | | |
| 453.6 | R03BA01 | beklomethason (lékové formy prášku k inhalaci) více než 0,1 mg do 0,2 mg včetně v jedné dávce | inhal. | 0.8 | MG | 17,60 | |
| | | | | | | | |
| 453.7 | R03BA01 | beklomethason (lékové formy prášku k inhalaci) nad 0,2 mg v jedné dávce | inhal. | 0.8 | MG | 14,40 | |
@@ -7134,7 +7345,7 @@
| | | | | | | | |
| 453.10 | R03BA01 | beklomethason (lékové formy aerosolu vdechem freonové aktivované nad 200 rg v jedné dávce) balení obsahující 1 zásobník | inhal. | 0.8 | MG | 12,80 | |
| | | | | | | | |
| 453.11 | R03BA01 | beklomethason (lékové formy aerosolu vdechem bezfreonové aktivované nad 200 rg v jedné dávce) baleni obsahující 1 zásobník | inhal. | 0.8 | MG | 21,80 | |
| 453.11 | R03BA01 | beklomethason (lékové formy aerosolu vdechem bezfreonové aktivované nad 200 rg v jedné dávce) balení obsahující 1 zásobník | inhal. | 0.8 | MG | 21,80 | |
| | | | | | | | |
| 453.12 | R03BA01 | beklomethason (lékové formy aerosolu vdechem aktivované freonové do 200 rg včetně v jedné dávce) balení obsahující 3 zásobníky | inhal. | 0.8 | MG | 14,95 | |
| | | | | | | | |
@@ -7152,7 +7363,7 @@
| | | | | | | | |
| 453.19 | R03BA02 | budesonid (lékové formy prášku k inhalaci, nad 200 rg v 1 dávce) | inhal. | 0.8 | MG | 14,40 | |
| | | | | | | | |
| 453.20 | R03BA02 | (lékové formy suspense k inhalaci) do 0,25 mg včetně v 1 ml | inhal. | 0.8 | MG | 20,77 | |
| 453.20 | R03BA02 | budesonid (lékové formy suspense k inhalaci) do 0,25 mq včetně v 1 ml | inhal. | 0.8 | MG | 20,77 | |
| | | | | | | | |
| 453.21 | R03BA02 | budesonid (lékové formy suspense k inhalaci) nad 0,25 mg v 1 ml. | inhal. | 0.8 | MG | 16,81 | |
| | | | | | | | |
@@ -7170,12 +7381,17 @@
| 454 | R03BB | inhalační anticholinergika | inhal. | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 454.1 | R03BB01 | bromid ipratropia (lékové formy aerosolu) | inhal. | 0.12 | MG | 5,38 | |
| 80103 | ATROVENT | aer dos 15ml/300dav | BGP | D | | | |
| 80103 | ATROVENT | aer dos 300x20rg | BGP | D | | | |
| 454.2 | R03BB01 | bromid ipratropia (bezfreonové lékové formy) | inhal. | 0,12 | MG | 6,00 | |
| | | | | | | | |
| 454.3 | R03BB01 | bromid ipratropia (lékové formy prášku k inhalaci) | inhal. | 0.12 | MG | 2,16 | |
| 75847 | ATROVENT INHALETTEN | cps inh 100x0.2mg | BGP | D | | | |
| 454.4 | R03BB01 | bromid ipratropia (lékové formy roztoku) | inhal. | 4 | ML | 33,34 | L/ALG,TRN, ORL |
| 454.4 | R03BB01 | bromid ipratropia (lékové formy roztoku) | inhal. | 4 | ML | 33,34 | L/ALG,TRN,ORL |
| | | | | | | | |
| 454.5 | R03BB04 | tiotropium | inhal. | 18 | RG | 50,00 | P |
Léčbu tiotropiem indikuje pneumolog (TRN) u nemocných s diagnózou CHOPN stadia III. a IV. (podle dřívější verze GOLD stadium IIb a III), kteří dodržují léčebný režim včetně zákazu kouření.
| 455 | R03BC | inhalační protialergická léčiva | inhal. | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 455.1 | R03BC01 | natrium kromoglykát (lékové formy aerosolu) | inhal. | 40 | MG | 17,50 | |
@@ -7184,7 +7400,7 @@
| | | | | | | | |
| 455.3 | R03BC01 | natrium kromoglykát (lékové formy roztoku) | inhal. | 80 | MG | 13,49 | |
| | | | | | | | |
| 455.4 | R03BC01 | natrium kromoglykát (lékové formy prášku k insuflad) | lok. | 40 | MG | 19,11 | |
| 455.4 | R03BC01 | natrium kromoglykát (lékové formy prášku k insuflaci) | lok. | 40 | MG | 19,11 | |
| | | | | | | | |
| 455.5 | R03BC03 | nedokromil | inhal. | 8 | MG | 22,40 | L/ALG,TRN |
| | | | | | | | |
@@ -7194,7 +7410,7 @@
| 456.1 | R03CA02 | efedrin | p.o. | 50 | MG | 1,42 | |
| | | | | | | | |
| 456.2 | R03CB03 | orciprenalin | p.o. | 60 | MG | 6,55 | |
| 457 | R03CB | celkové podávaná neselektivní sympatomimetika | parent. | | | | |
| 457 | R03CB | celkově podávaná neselektivní sympatomimetika | parent. | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 457.1 | R03CA02 | efedrin | parent. | 50 | MG | 5,28 | O |
| 00447 | EPHEDRIN BIOTIKA | inj 10x1ml/50mg | HBS | SK | | | |
@@ -7202,7 +7418,7 @@
| 458 | R03CC | celkově podávaná selektivní sympatomimetika | p.o. | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 458.1 | R03CC02 | salbutamol (pevné lékové formy) | p.o. | 12 | MG | 6,19 | |
| 91085 | SALBUTAMOL POLFA | tbl 30x4mg | POL | PL | | | |
| 91085 | SALBUTAMOL WZF POLFA 4 MG | por tbl nob 30x4mg | WZF | PL | | | |
| 458.2 | R03CC02 | salbutamol (tekuté lékové formy) | p.o. | 12 | MG | 13,10 | |
| | | | | | | | |
| 458.3 | R03CC03 | terbutalin | p.o. | 15 | MG | 6,19 | |
@@ -7227,28 +7443,28 @@
| 99137 | SPOPHYLLIN RETARD 100MG | tbl ret 50x100mg | SLO | SK | | | |
| 98064 | SPOPHYLLIN RETARD 250MG | tbl ret 50x250mg | SLO | SK | | | |
| 460.2 | R03DA04 | teofylin (retardované lékové formy druhé skupiny do 250 mg včetně v jedné tabletě) | p.o. | 0.4 | GM | 4,79 | |
| 76650 | AFONILUM SR 250MG | cps 50x250mg | KNO | D | | | |
| 94192 | TEOTARD | cps ret 40x200mg | KRK | SLO | | | |
| 92644 | AFONILUM SR 125MG | cps 50x125mg | KNO | D | | | |
| 92644 | AFONILUM SR 125 MG | por cps pro50x125mg | AAW | D | | | |
| 76650 | AFONILUM SR 250 MG | por cps pro50x250mg | AAW | D | | | |
| 94192 | TEOTARD 200 | cps ret 40x200mg | ; KRK | SLO | | | |
| 460.3 | R03DA04 | teofylin (retardované lékové formy druhé skupiny nad 250 mg v jedné tabletě) | p.o. | 0.4 | GM | 4,27 | |
| 94191 | TEOTARD | cps ret 40x350mg | KRK | SLO | | | |
| 61238 | THEOPLUS | tbl ret 30x300mg | PFB | F | | | |
| 86720 | AFONILUM SR 375MG | cps 50x375mg | KNO | D | | | |
| 86720 | AFONILUM SR 375 MG | por cps pro50x375mg | AAW | D | | | |
| 94191 | TEOTARD 350 | cps ret 40x350mg | KRK | SLO | | | |
| 61238 | THEOPLUS 300 | tbl ret 30x300mg | PFG | F | | | |
| 460.4 | R03DA05 | aminofylin | p.o. | 0.6 | GM | 4,89 | |
| | | | | | | | |
| 460.5 | R03DA05 | aminofylin (retardované lékové formy do 150 mg včetně) | p.o. | 0.6 | GM | 9,92 | |
| | | | | | | | |
| 460.6 | R03DA05 | aminofylin (retardované lékové formy nad 150 do 250 mg včetně) | p.o. | 0.6 | GM | 4,79 | |
| 460.6 | R03DA05 | aminofylin (retardované lékové formy nad 150 do 250 mq včetně) | p.o. | 0.6 | GM | 4,79 | |
| | | | | | | | |
| 460.7 | R03DA05 | aminofylin (retardované lékové formy nad 250 mg) | p.o. | 0.6 | GM | 4,69 | |
| 91741 | AMINOPHYLLINUM RETARD LEK | tbl ret 20x350mg | LEK | SLO | | | |
| 91741 | AMINOPHYLLINUM RETARD LEK | por tbl ret20x350mg | LEK | SLO | | | |
| 460.8 | R03DC01 | zafirlukast | p.o. | 40 | MG | 41,50 | P |
| | | | | | | | |
| 460.9 | R03DC03 | montelukast (s obsahem 4 mg v jedné tabletě) | p.o. | 10 | MG | 143,00 | P |
| 460.9 | R03DC03 | montelukast (s obsahem 4 mg v jedné tabletě) | p.o. | 10 | MG | 124,85 | P |
Montelukast s obsahem 4 mg účinné látky v jedné tabletě předepisuje alergolog nebo pneumolog v následujících indikacích u pacientů od 3 do 5 let:
- a) nové diagnostikované nebo nově potvrzené lehké perzistující astma se zřetelnými pozátěžovými příznaky dosud neléčené inhalačními kortikosteroidy
- a) nově diagnostikované nebo nově potvrzené lehké perzistující astma se zřetelnými pozátěžovými příznaky dosud neléčené inhalačními kortikosteroidy
- b) námahou indukované astma
@@ -7256,7 +7472,7 @@
Nedojde-li během 3 měsíců léčby ke stabilizaci a kontrole perzistující formy astmatu, není další terapie montelukastem indikována.
| 460.10 | R03DC03 | montelukast (s obsahem 5 mg v jedné tabletě) | p.o. | 10 | MG | 114,52 | P |
| 460.10 | R03DC03 | montelukast (s obsahem 5 mg v jedné tabletě) | p.o. | 10 | MG | 100,00 | P |
| --- | --- | --- | --- | --- | --- | --- | --- |
Montelukast s obsahem 5 mg účinné látky v jedné tabletě předepisuje alergolog nebo pneumolog v následujících indikacích u pacientů od 6 do 12 let:
@@ -7265,39 +7481,38 @@
- b) námahou indukované astma
- c) aspirinové astma
- d) astma s prokázanou odpovídavostí na léčbu antileukotrieny v batolecím a předškolním věku
- c) aspirinové astma d) astma s prokázanou odpovídavostí na léčbu antileukotrieny v batolecím a předškolním věku
Nedojde-li během 3 měsíců léčby ke stabilizaci a kontrole perzistující formy astmatu, není další terapie montelukastem indikována.
U pacientů, kde léčba montelukastem s obsahem 5 mg účinné látky v jedné tabletě byla indikována již před 12 rokem věku a u nichž vykazuje zřetelný efekt, mohou výše uvedení specialisté pokračovat v léčbě až do 14 let věku pacienta.
| 460.11 | R03DC03 | montelukast (s obsahem 10 mg v jedné tabletě) | p.o. | 10 | MG | 48,16 | P |
| --- | --- | --- | --- | --- | --- | --- | --- |
Léčba antileukotrieny u dospělých je předepisována alergologem nebo pneumologem u perzistujících forem bronchiálního astmatu v následujících indikacích: a) aspirin – senzitivní (nesteroidními antiflogistiky indukované astma), b) astma v kombinací s nosní polypózou, c) námahou indukované astma, d) astma s prokázanou dobrou odpovídavostí na léčbu antileukotrieny v dětském věku, e) astma, kde nedostačuje dlouhodobá léčba inhalačními kortikosteroidy, beta2-mimetiky s prodlouženým účinkem, teofyliny s prodlouženým účinkem, nebo nelze tyto léky podávat pro prokázanou intoleranci. V případě neúspěchu kombinované terapie s antileukotrieny do třech měsíců po jejím zahájení, není další preskripce antileukotrienů indikována.
| 461 | R03DA | ostatní antiastmatika k celkovému podání ze skupiny xantinů | p.rect | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 461.1 | R03DA05 | aminofylin | p.rect. | 0.6 | GM | 6.35 | |
| 460.11 | R03DC03 | montelukast (s obsahem 10 mg v jedné tabletě) | p.o. | 10 | MG | 41,50 | P |
| --- | --- | --- | --- | --- | --- | --- | --- |
Léčba antileukotrieny u dospělých je předepisována alergologem nebo pneumologem u perzistujících forem bronchiálního astmatu v následujících indikacích: a) aspirin - senzitivní (nesteroidními antiflogistiky indukované astma), b) astma v kombinaci s nosní polypózou, c) námahou indukované astma, d) astma s prokázanou dobrou odpovídavostí na léčbu antileukotrieny v dětském věku, e) astma, kde nedostačuje dlouhodobá léčba inhalačními kortikosteroidy, beta2-mimetiky s prodlouženým účinkem, teofyliny s prodlouženým účinkem, nebo nelze tyto léky podávat pro prokázanou intoleranci. V případě neúspěchu kombinované terapie s antileukotrieny do třech měsíců po jejím zahájení, není další preskripce antileukotrienů indikována.
| 461 | R03DA | ostatní antiastmatika k celkovému podání ze skupiny xantinů | p.rect. | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 461.1 | R03DA05 | aminofylin | p.rect. | 0.6 | GM | 6,35 | |
| 462 | R03DA | ostatní antiastmatika k celkovému podání ze skupiny xantinů | parent. | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 462.1 | R03DA05 aminofylin | parent. | 0.6 | GM | 29,23 | O | |
| 96371 | AMINOPHYLLINUM I.V. | inj 50x10ml/250mg | LEK | SLO | | | |
| 462.1 | R03DA05 | aminofylin | parent. | 0.6 | GM | 29,23 | O |
| 93129 | AMINOPHYLLINUM LEK | inj 10x10ml/250mg | LEK | SLO | | | |
| 96371 | AMINOPHYLLINUM LEK | inj 50x10ml/250mg | LEK | SLO | | | |
| 463 | R05CB | mukolytika | p.o. | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 463.1 | R05CB01 | acetylcystein | p.o. | 0.5 | GM | 2,25 | |
| | | | | | | | |
| 463.2 | R05CB02 | bromhexin | p.o. | 24 | MG | 2,08 | |
| 42263 | FLEGAMINA | tbl 20x8mg | POL | PL | | | |
| 42263 | FLEGAMINA | tbl 20x8mg-lekov. | KRZ | PL. | | | |
| 463.3 | R05CB03 | karbocystein | p.o. | 1.5 | GM | 3,60 | |
| | | | | | | | |
| 463.4 | R05CB06 | ambroxol | p.o. | 0.15 | GM | 4,50 | |
| 94918 | AMBROBENE | tbl 20x30mg | MCK | D | | | |
| 94918 | AMBROBENE 30 MG | tbl 20x30mg | MCK | D | | | |
| 78278 | AMBROSAN | tbl 20x30mg | PMP | CZ | | | |
| 43950 | AMBROXOL AL 30 TABLETTEN | tbl 20x30mg | apa | D | | | |
| 59483 | AMBROSAN | tbl 500x30mg | PMP | CZ | | | |
| 43950 | AMBROXOL AL 30 | tbl 20x30mg | APA | D | | | |
| 463.5 | R05CB15 | erdostein | p.o. | 600 | MG | 3,12 | |
| 464 | R05CB | mukolytika | inhal. | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
@@ -7307,7 +7522,7 @@
| | | | | | | | |
| 464.3 | R05CB05 | mesna | inhal. | 600 | MG | 39,13 | |
| 03614 | MISTABRON | sol 6x3ml/600mg | UCB | B | | | |
| 464.4 | R05CB13 | alfadornáza | inhal. | 2.5 | MG | 1137,70 | P |
| 464.4 | R05CB13 | alfadornáza | inhal. | 2.5 | MG | 1069,40 | P |
Léčbu alfadornázou předepisuje ošetřující lékař na doporučení specializovaného pracoviště, které zajišťuje péči o pacienty s cystickou fibrózou, při zajištění dobré spolupráce pacienta:
@@ -7315,13 +7530,12 @@
- b) při častých respiračních infekcích vyžadujících antibiotickou léčbu.
| 77521 | PULMOZYME | inh sol 6x2.5ml | GCH | USA | | | |
| 464.5 | R05CB15 | erdostein | inhal. | 450 | MG | 8,31 | |
| 465 | R05CB | mukolytika | parent. | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 465.1 | R05CB01 | acetylcystein | parent. | 0.5 | GM | 16,76 | |
| 88939 | ACC INJEKT | inj 5x3ml/300mg | HEX | D | | | |
| 88941 | ACC INJEKT | inj 100x3ml/300mg | HEX | D | | | |
| 88939 | ACC INJEKT | inj sol 5x3ml/300mg HEX | D | | | | |
| 88941 | ACC INJEKT | injsol100x3ml/300mg HEX | D | | | | |
| 465.2 | R05CB02 | bromhexin | parent. | 24 | MG | 40,37 | |
| | | | | | | | |
| 465.3 | R05CB06 | ambroxol | parent. | 0.15 | GM | 226,02 | |
@@ -7336,11 +7550,11 @@
| 466.2 | R05DA01 | ethylmorfin nad 15 mg | p.o. | 50 | MG | 5,95 | |
| 44589 | DIOLAN 30MG | tbl 10x30mg(blistr) | SLO | SK | | | |
| 466.3 | R05DA04 | kodein | p.o. | 0.1 | GM | 12,80 | |
| 56992 | CODEIN SLOVAKOFARMA 15MG | tbl 10x15mg-blistr | SLO | SK | | | |
| 56993 | CODEIN SLOVAKOFARMA 30MG | tbl 10x30mg-blistr | SLO | SK | | | |
| 56992 | CODEIN SLOVAKOFARMA 15MG | tbl 10x15mg-blistr | SLO | SK | | | |
| 466.4 | R05DA08 | folkodin | p.o. | 50 | MG | 3,67 | |
| | | | | | | | |
| 466.5 | R05DA09 | dextromethor- phan | p.o. | 90 | MG | 3,67 | |
| 466.5 | R05DA09 | dextromethorphan | p.o. | 90 | MG | 3,67 | |
| | | | | | | | |
| 466.6 | R05DA20 | kombinace antitusik | p.o. | 3 | DF | 3,67 | |
| 467 | R05DB | antitusika chemicky blízká lokálním anestetikům | p.o., p.rect., parent. | | | | |
@@ -7350,7 +7564,7 @@
| 467.2 | R05DB03 | klobutinol | parent. | 120 | MG | 112,03 | H |
| | | | | | | | |
| 467.3 | R05DB05 | pentoxyverin (do 8 mg v jednom čípku včetně) | p.rect. | 100 | MG | 139,11 | L/PDD |
| 92252 | SEDOTUSSIN 8MG BABIES | sup 6x8mg | UCB | B | | | |
| | | | | | | | |
| 467.4 | R05DB05 | pentoxyverin (nad 8 mg v jednom čípku) | p.rect. | 100 | MG | 63,40 | L/PDD |
| | | | | | | | |
| 467.5 | R05DB13 | butamirát (pevné lékové formy) | p.o. | 25 | MG | 1,04 | |
@@ -7358,7 +7572,6 @@
| 467.6 | R05DB13 | butamirát (tekuté lékové formy-kapky) | p.o. | 25 | MG | 10,56 | |
| 94859 | TUSSIN | gtt 1x10ml | IVX | CZ | | | |
| 467.7 | R05DB13 | butamirát (tekuté lékové formy-sirup) | p.o. | 25 | MG | 3,83 | |
| | | | | | | | |
| 467.8 | R05DB18 | prednoxdiazin | p.o. | 300 | MG | 1,96 | |
| | | | | | | | |
| 467.9 | R05DB19 | dropropizin | p.o. | 25 | MG | 0,88 | |
@@ -7379,14 +7592,14 @@
| 468.4 | R06AA07 | difenylpyralin | p.o. | 10 | MG | 7,72 | |
| | | | | | | | |
| 468.5 | R06AA02 | difenhydramin (tekuté lékové formy) | p.o. | 0.2 | GM | 8,54 | |
| 469 | R06AA | antihistaminika ze sku | piny derivátů aminoalkyletherů | parent. | | | |
| 469 | R06AA | antihistaminika ze skupiny derivátů aminoalkyletherů | parent. | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 469.1 | R06AA04 | klemastin | parent. | 2 | MG | 32,44 | O |
| 470 | R06AB | antihistaminika ze skupiny derivátů alkylaminů | p.o. | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 470.1 | R06AB03 | dimetinden (pevné lékové formy) | p.o. | 4 | MG | 10,71 | |
| 12515 | FENISTIL 24 | cps ret 20x4mg | NCH | CH | | | |
| 12514 | FENISTIL 24 | cps ret 10x4mg | NCH | CH | | | |
| 12514 | FENISTIL 24 | por cps pro 10x4mg | NCH | CH | | | |
| 12515 | FENISTIL 24 | por cps pro 20x4mg | NCH | CH | | | |
| 470.2 | R06AB03 | dimetinden (tekuté lékové formy) | p.o. | 4 | MG | 8,54 | |
| | | | | | | | |
| 470.3 | R06AB56 | dexbromfeniramin, kombinace | p.o. | 2 | DF | 8,50 | |
@@ -7411,12 +7624,35 @@
| 473.1 | R06AE06 | oxatomid | p.o. | 60 | MG | 7,04 | |
| | | | | | | | |
| 473.2 | R06AE07 | cetirizin | p.o. | 10 | MG | 6,50 | |
| 02927 | LETIZEN | tbl obd 50x10mg | KRK | SLO | | | |
| 02926 | LETIZEN | tbl obd 20x10mg | KRK | SLO | | | |
Levocetirizin předepisuje alergolog/klinický imunolog nebo pneumolog u pacientů od 6 let věku v indikaci alergická rýma (AR) pacientům po selhání léčby antihistaminiky I. a II. generace v kombinaci s intranasálními kortikosteroidy při splnění následujících kritérií:
- 1. u pacienta s AR dochází v důsledku alergické rýmy v průběhu pylové sezóny k prokazatelnému zvýšení bronchiální reaktivity (průkaz bronchomotorickým testem) až k projevům lehkého intermitentního astmatu (vyžadujícího dle potřeby inhal.SABA)
| 43872 | ALERID | por tbl flm 10x10mg | CIA | IND | | | |
| 64867 | ALERID | por tbl flm 20x10mg | CIA | IND | | | |
| 64868 | ALERID | por tbl flm 50x10mg | CIA | IND | | | |
| 30900 | ANALERGIN | por tbl flm 10x10mg | IXP | CZ | | | |
| 31001 | ANALERGIN | por tbl flm 30x10mg | IXP | CZ | | | |
| 31007 | ANALERGIN | por tbl flm 50x10mg | IXP | CZ | | | |
| 03898 | CEREX | por tbl flm 20x10mg | SFS | D | | | |
| 03899 | CEREX | por tbl flm 50x10mg | SFS | D | | | |
| 03900 | CEREX | por tbl flm100x10mg | SFS | D | | | |
| 99586 | CETIRIZIN IREX | por tbl flm30x10mg | DGT | D | | | |
| 10637 | CETIRIZIN-RATIOPHARM 10 MG | por tbl flm 20x10mg | MCK | D | | | |
| 10638 | CETIRIZIN-RATIOPHARM 10 MG | por tbl flm 50x10mg | MCK | D | | | |
| 59538 | CETIRIZIN-SL | por tbl flm 10x10mg | SLO | SK | | | |
| 59539 | CETIRIZIN-SL | por tbl flm 20x10mg | SLO | SK | | | |
| 59540 | CETIRIZIN-SL | por tbl flm 30x10mg | SLO | SK | | | |
| 59541 | CETIRIZIN-SL | por tbl flm 50x10mg | SLO | SK | | | |
| 42481 | CETIRIZIN-SL | por tbl flm 7x10mg | SLO | SK | | | |
| 02926 | LETIZEN | por tbl flm 20x10mg | KRK | SLO | | | |
| 02927 | LETIZEN | por tbl flm 50x10mg | KRK | SLO | | | |
| 66029 | ZODAC | por tbl flm 10x10mg | LEX | CZ | | | |
| 66030 | ZODAC | por tbl flm 30x10mg | LEX | CZ | | | |
| 05496 | ZODAC | por tbl flm 60x10mg | LEX | CZ | | | |
| 99600 | ZODAC | por tbl flm 90x10mg | LEX | CZ | | | |
| 42882 | LETIZEN | por sol 1x120ml | KRK | SLO | | | |
| 58834 | ZODAC GTT | por gtt sol 1x20ml | LEX | CZ | | | |
Levocetirizin předepisuje alergolog/klinický imunolog nebo pneumolog u pacientů od 6 let věku v indikaci alergická rýma (AR) pacientům po selhání léčby antihistaminiky I. a II. generace v kombinací s intranasálními kortikosteroidy při splnění následujících kritérií:
- 1. u pacienta s AR dochází v důsledku alergické rýmy v průběhu pylové sezony k prokazatelnému zvýšení bronchiální reaktivity (průkaz bronchomotorickým testem) až k projevům lehkého intermitentního astmatu (vyžadujícího dle potřeby inhal.SABA)
- 2. u pacienta s AR a průduškovým astmatem, léčeným standardním způsobem, dochází v důsledku zhoršení alergické rýmy v průběhu pylové sezóny k prokazatelnému zhoršení příznaků astmatu.
@@ -7438,41 +7674,53 @@
| 473.10 | R06AX12 | terfenadin | p.o. | 0.12 | GM | 6,50 | |
| 56052 | TERIDIN | tbl 20x60mg | KRK | SLO | | | |
| 473.11 | R06AX13 | loratadin | p.o. | 10 | MG | 6,50 | |
| 31744 | EROLIN | por sir 1x120ml | EGI | H | | | |
| 03272 | EROLIN | por tbl nob 10x10mg | EGI | H | | | |
| 03273 | EROLIN | por tbl nob 30x10mg | EGI | H | | | |
| 01700 | FLONIDAN | por sus 1x120ml | LEK | SLO | | | |
| 88734 | FLONIDAN | por tbl nob 10x10mg | LEK | SLO | | | |
| 53639 | FLONIDAN | por tbl nob 30x10mg | LEK | SLO | | | |
| 58618 | LORANOL | por tbl nob 20x10mg | SFS | D | | | |
| 58619 | LORANOL | por tbl nob 50x10mg | SFS | D | | | |
| 58620 | LORANOL | por tbl nob100x10mg | SFS | D | | | |
| 58139 | LORATADIN 10-SL | tbl 10x10mg | SLO | SK | | | |
| 58140 | LORATADIN 10-SL | tbl 30x10mg | SLO | SK | | | |
| 40711 | LORATADIN-RATIOPHARM 10 MG | por tbl nob100x10mg | MCK | D | | | |
| 97393 | LORATADIN-RATIOPHARM 10 MG | por tbl nob30x10mg | MCK | D | | | |
| 473.12 | R06AX17 | ketotifen | p.o. | 2 | MG | 6,50 | |
| 66002 | KETOTIFEN AL | cps 100x1mg | APA | D | | | |
| 66004 | KETOTIFEN AL | cps 20x1mg | APA | D | | | |
| 66003 | KETOTIFEN AL | cps 50x1mg | APA | D | | | |
| 66004 | KETOTIFEN AL | cps 20x1mg | APA | D | | | |
| 87171 | KETOTIFEN TROM | cps 30x1mg | TRM | D | | | |
| 87171 | KETOTIFEN TROM | por cps dur 30x1mg | TRM | D | | | |
| 473.13 | R06AX18 | akrivastin | p.o. | 24 | MG | 6,50 | |
| | | | | | | | |
| 473.14 | R06AX25 | mizolastin | p.o. | 10 | MG | 6,50 | |
| | | | | | | | |
| 473.15 | R06AX26 | fexofenadin | p.o. | 120 | MG | 6,50 | |
Desloratadin předepisuje alergolog/klinický imunolog nebo pneumolog u pacientů od 12 let věku v indikaci alergická rýma (AR) pacientům po selhání léčby antihistaminiky I. a II. generace v kombinaci s intranasálními kortikosteroidy při splnění následujících kritérií:
- 1.u pacienta s AR dochází v důsledku alergické rýmy v průběhu pylové sezóny k prokazatelnému zvýšení bronchiální reaktivity (průkaz bronchomotorickým testem) až k projevům lehkého intermitentního astmatu (vyžadujícího dle potřeby inhal.SABA)
Desloratadin předepisuje alergolog/klinický imunolog nebo pneumolog u pacientů od 2 let věku v sirupové formě a od 12 let věku v indikaci alergická rýma (AR) pacientům po selhání léčby antihistaminiky I. a II. generace v kombinaci s intranasálními kortikosteroidy při splnění následujících kritérií:
- 1.u pacienta s AR dochází v důsledku alergické rýmy v průběhu pylové sezony k prokazatelnému zvýšení bronchiální reaktivity (průkaz bronchomotorickým testem) až k projevům lehkého intermitentního astmatu (vyžadujícího dle potřeby inhal.SABA)
- 2.u pacienta s AR a průduškovým astmatem, léčeným standardním způsobem, dochází v důsledku zhoršení alergické rýmy v průběhu pylové sezóny k prokazatelnému zhoršení příznaků astmatu.
| 473.16 | R06AX27 | desloratadin | p.o. | 5 | MG | 7,80 | P |
| 474 | R06AX | jiná antihistaminika k systémovému použití | parent. | | | | |
| 474 | R06AX | jiná antihistaminika k systémovému použiti | parent. | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 474.1 | R06AX | bisulepin | parent. | 4 | MG | 26,28 | O |
| 474.2 | R06AX | medosulepin/ vápník | parent. | 2 | DF | 30,79 | O |
| | | | | | | | |
| 474.2 | R06AX | medosulepin/vápník | parent. | 2 | DF | 30,79 | O |
| 475 | R07AA | plicní surfaktanty | parent. | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 475.1 | R07AA01 | kolfosceril palmitát | parent. | 160 | MG | 20087,47 | T |
| | | | | | | | |
| 475.2 | R07AA02 | přirozené fosfolipidy (zvířecího původu) | parent. | 160 | MG | 20087,47 | T |
| | | | | | | | |
| 475.3 | R07AA30 | beraktant | parent. | 160 | MG | 20087,47 | T |
| 44278 | SURVANTA | sus 1x8ml/200mg | ABN | USA | | | |
| 44277 | SURVANTA | sus 1x4ml/100mg | ABN | USA | | | |
| 475.1 | R07AA01 | kolfosceril palmitát | parent. | 160 | MG | 19083,10 | T |
| | | | | | | | |
| 475.2 | R07AA02 | přirozené fosfolipidy (zvířecího původu) | parent. | 160 | MG | 19083,10 | T |
| | | | | | | | |
| 475.3 | R07AA30 | beraktant | parent. | 160 | MG | 19083,10 | T |
| 476 | S01AA | antibiotika k lokálnímu podání | lok. | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 476.1 | S01AA | neomycin/poly- myxin/fenylefrin | lok. | 1 | ML | 19,55 | L/OPH |
| 476.1 | S01AA | neomycin/polymyxin/fenylefrin | lok. | 1 | ML | 19,55 | L/OPH |
| | | | | | | | |
| 476.2 | S01AA01 | chloramfenikol (lékové formy očních kapek) | lok. | 1 | ML | 2,79 | |
| | | | | | | | |
| 476.3 | S01AA01 | chloramfenikol (lékové formy očních mastí) | lok. | 1 | GM | 4,64 | |
@@ -7483,7 +7731,7 @@
| | | | | | | | |
| 476.6 | S01AA12 | tobramycin (lékové formy očních mastí) | lok. | 1 | GM | 3,21 | |
| | | | | | | | |
| 476.7 | S01AA20 | neomycin/ba- citracin/hydro- kortison | lok. | 1 | GM | 6,43 | |
| 476.7 | S01AA20 | neomycin/bacitracin/hydrokortison | lok. | 1 | GM | 6,43 | |
| | | | | | | | |
| 476.8 | S01AA20 | antibiotika v kombinaci s jinými léčivy | lok. | 1 | ML | 3,21 | |
| | | | | | | | |
@@ -7491,28 +7739,28 @@
| | | | | | | | |
| 476.10 | S01AA25 | azidamfenikol | lok. | 1 | ML | 3,21 | |
| | | | | | | | |
| 476.11 | S01AA30 | neomycin/ bacitracin | lok. | 1 | GM | 6,10 | |
| | | | | | | | |
| 476.12 | S01AA30 | neomycin/ polymyxin | lok. | 1 | ML | 19,55 | L/OPH |
| 476.11 | S01AA30 | neomycin/bacitracin | lok. | 1 | GM | 6,10 | |
| | | | | | | | |
| 476.12 | S01AA30 | neomycin/polymyxin | lok. | 1 | ML | 19,55 | L/OPH |
| 477 | S01AB | chemoteraputika k lokálnímu podání | lok. | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 477.1 | S01AB | sulfathiazol | lok. | 1 | GM | 3,42 | |
| | | | | | | | |
| 477.2 | S01AB04 | sulfacetamid | lok. | 1 | ML | 6,95 | |
| 93577 | SULPHACETAMID | gtt oph 12x0.5ml | POL | PL | | | |
| 93577 | SULPHACETAMIDE 10%-POLPHARMA | gtt oph 12x0.5ml | ZPF | PL | | | |
| 478 | S01AD | antivirotika k lokálnímu podání | lok. | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 478.1 | S01AD02 | trifluorothimidin (lékové formy očních mastí) | lok. | 1 | GM | 73,91 | L/OPH |
| | | | | | | | |
| 478.2 | S01AD02 | trifluorothimidin (lékové formy očních kapek) | lok. | 1 | ML | 53,23 | L/OPH |
| 65513 | TRIHERPINE | gtt oph 1x5ml | CBA | CH | | | |
| 65513 | TRIHERPINE | oph gtt sol 1x5ml | NAH | CH | | | |
| 478.3 | S01AD03 | acyklovir | lok. | 1 | GM | 73,91 | L/OPH |
| 53606 | XOROX | ung oph 1x4.5 gm | KWI | A | | | |
| 479 | S01AX | ostatní antiinfektiva | lok. | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 479.1 | S01AX | jiná antiinfektiva (lékové formy očních kapek) | lok. | 1 | ML | 2,62 | |
| | | | | | | | |
| 479.2 | S01AX | jiná antiinfektiva (lékové formy očních masti) | lok. | 1 | GM | 4,46 | |
| 479.2 | S01AX | jiná antiinfektiva (lékové formy očních mastí) | lok. | | GM | 4,46 | |
| | | | | | | | |
| 479.3 | S01AX11 | ofloxacin | lok. | 1 | ML | 14,40 | L/OPH |
| | | | | | | | |
@@ -7521,20 +7769,20 @@
| 479.5 | S01AX17 | lomefloxacin k lokálnímu podání | lok. | 1 | ML | 14,40 | L/OPH |
| 480 | S01BA | kortikosteroidy k lokálnímu podání | lok. | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 480.1 | S01BA01 | dexamethason (lékové formy očních kapek) | lok. | 1 | ML | 3.47 | |
| 480.1 | S01BA01 | dexamethason (lékové formy očních kapek) | lok. | 1 | ML | 3,47 | |
| | | | | | | | |
| 480.2 | S01BA01 | dexamethason (lékové formy očních mastí) | lok. | 1 | GM | 3,62 | |
| | | | | | | | |
| 480.3 | S01BA02 | hydrokortison | lok. | 1 | GM | 6,04 | |
| | | | | | | | |
| 480.4 | S01BA03 | kortison | lok. | 1 | ML | 19,55 | L/OPH |
| 00757 | CORTISON SPOFA | gtt oph 1x3ml | SPX | CZ | | | |
| 00757 | CORTISON SPOFA | gtt 1x3ml/15mg | SPX | CZ | | | |
| 480.5 | S01BA04 | prednizolon (lékové formy očních kapek) | lok. | 1 | ML | 17,00 | L/OPH |
| | | | | | | | |
| 480.6 | S01BA04 | prednizolon (lékové formy očních mastí) | lok. | 1 | GM | 17,00 | L/OPH |
| | | | | | | | |
| 480.7 | S01BA07 | fluorometholon | lok. | 1 | ML | 17,00 | L/OPH |
| 56868 | FLUMETOL S | gttoph1x10ml/0.02gm | FRM | I | | | |
| 56868 | FLUMETOL S | gttoph1 x10ml/0.02gm | FRM | I | | | |
| 481 | S01BC | nesteroidní protizánětlivá léčiva k lokálnímu podání | lok. | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 481.1 | S01BC02 | oxyfenbutazon | lok. | 1 | GM | 14,66 | |
@@ -7548,13 +7796,13 @@
| | | | | | | | |
| 482.2 | S01CA05 | gentamicin/betamethason (lékové formy očních kapek) | lok. | 1 | ML | 12,00 | L/OPH,ORL |
| 91712 | GARASONE | gtt oph/oto 1x5ml | SCH | B | | | |
| 482.3 | S01CA05 | gentamicin/betamethason (lékové formy očních mastí) | lok. | 1 GM | 15,40 | L/OPH,ORL | |
| 482.3 | S01CA05 | gentamicin/ betamethason (lékové formy očních mastí) | lok. | 1 | GM | 15,40 | L/OPH,ORL |
| 91711 | GARASONE | ung oph 1x5gm | SCH | B | | | |
| 482.4 | S01CA01 | dexamet./neomycin/polymyxin (lékové formy očních kapek) | lok. | 1 | ML | 12,00 | L/OPH |
| | | | | | | | |
| 482.5 | S01CA01 | dexamet./neomycin/polymyxin (lékové formy očních mastí) | lok. | 1 | GM | 15,40 | L/OPH |
| | | | | | | | |
| 482.6 | S01CA01 | oxytetracyklin/ dexamethason | lok. 1 GM | 17,60 | L/OPH | | |
| 482.5 | S01CA01 | dexamet./ neomycin/ polymyxin (lékové formy očních mastí) | lok. | 1 | GM | 15,40 | L/OPH |
| | | | | | | | |
| 482.6 | S01CA01 | oxytetracyklin/ dexamethason | lok. | 1 | GM | 17,60 | L/OPH |
| | | | | | | | |
| 482.7 | S01CA01 | dexamethason a tobramycin (lékové formy očních kapek) | lok. | 1 | ML | 12,00 | L/OPH |
| | | | | | | | |
@@ -7577,8 +7825,8 @@
| 54270 | OFTANEX | gtt oph 1x10ml | SOY | SF | | | |
| 59629 | OFTANEX | gtt oph 1x5ml | SOY | SF | | | |
| 483.3 | S01EA04 | klonidin | lok. | 1 | ML | 10,70 | L/OPH |
| 20766 | ARUCLONIN 1/8% | gtt oph 10ml | CHV | D | | | |
| 49501 | ARUCLONIN 1/16% | gtt oph 10ml | CHV | D | | | |
| 49501 | ARUCLONIN 1/16% | gttoph1x10ml/6.25mg | CHV | D | | | |
| 20766 | ARUCLONIN 1/8% | gttoph1x10ml/12.5mg | CHV | D | | | |
| 483.4 | S01EA05 | brimonidin | lok. | 1 | ML | 59,80 | P |
Léčbu brimonidinem indikuje oční lékař u pacientů s glaukomem při netoleranci nebo neúčinnosti betablokátorů.
@@ -7588,18 +7836,18 @@
| 484.1 | S01EB01 | pilokarpin (lékové formy gelu) | lok. | 1 | GM | 29,00 | |
| | | | | | | | |
| 484.2 | S01EB01 | pilokarpin (lékové formy olejových očních kapek) | lok. | 1 | ML | 9,70 | |
| 03865 | PILOCARPIN ANKERP.OCNI OLEJ 2% | gtt oph ole 1x10ml | CHV | D | | | |
| 01638 | PILOCARPIN ANKERP.OCNI OLEJ 2% | gtt oph ole 3x10ml | CHV | D | | | |
| 03865 | PILOCARPIN ANKERP.OČNÍ OLEJ 2% | gtt oph ole 1x10ml | CHV | D | | | |
| 01638 | PILOCARPIN ANKERP.OČNÍ OLEJ 2% | gtt oph ole 3x10ml | CHV | D | | | |
| 484.3 | S01EB01 | pilokarpin (lékové formy očních kapek, koncentrace do 1% včetně) | lok. | 1 | ML | 5,80 | |
| 44445 | PILOPOS 1% | gtt oph 1x10ml | URS | D | | | |
| 484.4 | S01EB01 | pilokarpin (lékové formy očních kapek, koncentrace více než 1%) | lok. | 1 | ML | 6,50 | |
| 57337 | PILOCARPIN ANKERP.OCNI KAPKY 2% | gtt oph 3x10ml | CHV | D | | | |
| 04146 | PILOCARPIN ANKERP.2% OČNÍ KAPKY | gtt oph1x10ml/200mg | CHV | D | | | |
| 57337 | PILOCARPIN ANKERP.2% OČNÍ KAPKY | gtt oph3x10ml/200mg | CHV | D | | | |
| 44446 | PILOPOS 2% | gtt oph 1x10ml | URS | D | | | |
| 56673 | PILOTONINA 2% | gtt oph 1x10ml | FRM | I | | | |
| 44446 | PILOPOS 2% | gtt oph 1x10ml | URS | D | | | |
| 04146 | PILOCARPIN ANKERP.OCNI KAPKY 2% | gtt oph 1x10ml | CHV | D | | | |
| 484.5 | S01EB02 | karbachol (koncentrace do 1 % včetně) | lok. | 1 | ML | 8,50 | L/OPH |
| | | | | | | | |
| 484.6 | S01EB02 | karbachol (koncentrace nad 1% do 1,5% včetně) | lok. | 1 | ML | 6,06 | L/OPH |
| 484.6 | S01EB02 | karbachol (koncentrace nad 1 % do 1,5% včetně) | lok. | 1 | ML | 6,06 | L/OPH |
| | | | | | | | |
| 484.7 | S01EB02 | karbachol (koncentrace nad 1,5%) | lok. | 1 | ML | 6,60 | L/OPH |
| | | | | | | | |
@@ -7626,111 +7874,114 @@
| 486 | S01ED | lokální beta-blokátory k léčbě glaukómu | lok. | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 486.1 | S01ED01 | timolol (koncentrace do 0,25% včetně) | lok. | 1 | ML | 14,25 | |
| 12732 | TIMOHEXAL 0.1% | gtt oph 3x5ml/5mg | HEX | D | | | |
| 96022 | OFTENSIN 0.25% | gtt oph 1x10ml | ZPF PL | | | | |
| 87113 | TIMOLOL-POS 0.25% | gtt oph 1x5ml | URS | D | | | |
| 76186 | ARUTIMOL 0.25% | gtt oph 1x5ml | CHV | D | | | |
| 12729 | TIMOHEXAL 0.1% | gtt oph 1x5ml/5mg | HEX | D | | | |
| 01760 | TIMOLOL-POS 0.25% | gtt oph 3x5ml | URS | D | | | |
| 70474 | ARUTIMOL 0.25% | gtt oph 3x5ml | CHV | D | | | |
| 12730 | TIMOHEXAL 0.25% | gtt oph1x5ml/12.5mg | HEX | D | | | |
| 96021 | OFTENSIN 0,25% | gtt oph 1x5ml | ZPF | PL | | | |
| 12733 | TIMOHEXAL 0.25% | gtt oph3x5ml/12.5mg | HEX | D | | | |
| 98210 | TIMOPTOL(LAHV.PE) | gtt oph 5ml 0.25% | LEX | CZ | | | |
| 44546 | TIMO-COMOD 0.25% | gtt oph 1x10ml/25mg | URS | D | | | |
| 76186 | ARUTIMOL 0.25% | oph gtt sol 1x5ml | CHV | D | | | |
| 70474 | ARUTIMOL 0.25% | oph gtt sol 3x5ml | CHV | D | | | |
| 54476 | OFTAN TIMOLOL 0.25% | gtt oph 1x5ml | SOY | SF | | | |
| 54494 | OFTAN TIMOLOL 0.25% | gtt oph 3x5ml | SOY | SF | | | |
| 96022 | OFTENSIN 0.25% | gtt oph 1x10ml | ZPF | PL | | | |
| 96021 | OFTENSIN 0.25% | gtt oph 1x5ml | ZPF | PL | | | |
| 44546 | TIMO-COMOD 0.25% | gtt oph 1x10ml/25mg | URS | D | | | |
| 12729 | TIMOHEXAL 0.1% | gtt oph 1x5ml/5mg | HEX | D | | | |
| 12732 | TIMOHEXAL 0.1% | gtt oph 3x5ml/5mg | HEX | D | | | |
| 12730 | TIMOHEXAL 0.25% | gtt oph1x5ml/12.5mg | HEX | D | | | |
| 12733 | TIMOHEXAL 0.25% | gtt oph3x5ml/12.5mg | HEX | D | | | |
| 87113 | TIMOLOL-POS 0.25% | gtt oph 1x5ml | URS | D | | | |
| 01760 | TIMOLOL-POS 0.25% | gtt oph 3x5ml | URS | D | | | |
| 98210 | TIMOPTOL 0.25% | oph gtt sol 1x5ml | LEX | CZ | | | |
| 486.2 | S01ED01 | timolol (koncentrace nad 0,25%) | lok. | 1 | ML | 16,60 | |
| 70475 | ARUTIMOL 0.5% | gtt oph 3x5ml | CHV | D | | | |
| 76187 | ARUTIMOL 0.50% | oph gtt sol 1x5ml | CHV | D | | | |
| 70475 | ARUTIMOL 0.50% | oph gtt sol 3x5ml | CHV | D | | | |
| 54477 | OFTAN TIMOLOL 0.50% | gtt oph 1x5ml | SOY | SF | | | |
| 59928 | OFTAN TIMOLOL 0.50% | gtt oph 3x5ml | SOY | SF | | | |
| 96019 | OFTENSIN 0.5% | gtt oph 1x5ml | ZPF | PL | | | |
| 44547 | TIMO-COMOD 0.5% | gtt oph 1x10ml/50mg | URS | D | | | |
| 76187 | ARUTIMOL 0.5% | gtt oph 1x5ml | CHV | D | | | |
| 12731 | TIMOHEXAL 0.5% | gtt oph 1x5ml/25mg | HEX | D | | | |
| 12734 | TIMOHEXAL 0.5% | gtt oph 3x5ml/25mg | HEX | D | | | |
| 59928 | OFTAN TIMOLOL 0,50% | gtt oph 3x5ml | SOY | SF | | | |
| 12731 | TIMOHEXAL 0.5% | gtt oph 1x5ml/25mg | HEX | D | | | |
| 56123 | TIMOLOL 0.5% UNIMED PHARMA | gtt oph 1x10ml | UPA | SK | | | |
| 87114 | TIMOLOL-POS 0.5% | gtt oph 1x5ml | URS | D | | | |
| 54477 | OFTAN TIMOLOL 0.50% | gtt oph 1x5ml | SOY | SF | | | |
| 01759 | TIMOLOL-POS 0.5% | gtt oph 3x5ml | URS | D | | | |
| 98211 | TIMOPTOL(LAHV.PE) | gtt oph 5ml 0.50% | LEX | CZ | | | |
| 96019 | OFTENSIN 0.5% | gtt oph 1x5ml | ZPF | PL | | | |
| 98211 | TIMOPTOL 0.5% | oph gtt sol 1x5ml | LEX | CZ | | | |
| 486.3 | S01ED02 | betaxolol | lok. | 1 | ML | 20,00 | L/OPH |
| | | | | | | | |
| 486.4 | S01ED03 | levobunolol | lok. | 1 | ML | 20,00 | L/OPH |
| | | | | | | | |
| 486.5 | S01ED04 | metipranolol | lok. | 1 | ML | 13,20 | |
| | | | | | | | |
| 486.6 | S01ED05 | Carteolol | lok. | 1 | ML | 20,00 | L/OPH |
Latanoprost včetně kombinací, unoproston, bimatoprost: indikuje oční lékař u pacientů, kteří trpí glaukomem s otevřeným úhlem a okulární hypertenzí při netoleranci nebo neúčinnosti betablokátorů a není-li operační výkon indikován
| 486.6 | S01ED05 | carteolol | lok. | 1 | ML | 20,00 | L/OPH |
| | | | | | | | |
| 486.7 | S01EE01 | latanoprost | lok. | 1 | ML | 184,00 | P |
- 1.Latanoprost indikuje oční lékař u nemocných, kteří trpí glaukomem s otevřeným úhlem a oční hypertenzí vedle beta-blokátorů, alfa agonistů a inhibitorů karboanhydrázy a není-li operační výkon indikován.
- 2.Latanoprost/timolol v kombinaci indikuje oční lékař u nemocných, kteří trpí glaukomem s otevřeným úhlem a oční hypertenzí, při neúčinnosti beta-blokátorů a není-li operační výkon indikován.
Unoproston, bimatoprost: indikuje oční lékař u pacientů, kteří trpí glaukomem s otevřeným úhlem a okulární hypertenzí při netoleranci nebo neúčinnosti betablokátorů a není-li operační výkon indikován.
Travoprost indikuje oční lékař u pacientů, kteří trpí glaukomem s otevřeným úhlem a okulární hypertenzí a nesnášejí jiné léky na nitrooční tlak a není-li operační výkon indikován.
| 486.7 | S01EX03 | latanoprost | lok. | 1 | ML | 204,00 | P |
| | | | | | | | |
| 486.8 | S01EX04 | unoproston | lok. | 1 | ML | 105,30 | P |
| | | | | | | | |
| 486.9 | S01EX | bimatoprost | lok. | 1 | ML | 170,00 | P |
| | | | | | | | |
| 486.10 | S01EX | travoprost | lok. | | ML | 204,00 | P |
| 486.8 | S01EE02 | unoproston | lok. | 1 | ML | 105,30 | P |
| | | | | | | | |
| 486.9 | S01EE03 | bimatoprost | lok. | 1 | ML | 170,00 | P |
| | | | | | | | |
| 486.10 | S01EE04 | travoprost | lok. | 1 | ML | 204,00 | P |
| | | | | | | | |
| 486.11 | S01ED51 | timolol v kombinaci s dorzolamidem | lok. | 1 | ML | 74,05 | P |
| | | | | | | | |
| 486.12 | S01ED51 | timolol v kombinaci s latanoprostem | lok. | 1 | ML | 220,60 | P |
| 486.12 | S01ED51 | timolol v kombinaci s latanoprostem | lok. | 1 | ML | 200,60 | P |
| 487 | S01F | mydriatika a cykloplegika | lok. | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 487.1 | S01FA01 | atropin (koncentrace do 0,5% včetně) | lok. | 1 | ML | 5,00 | |
| 83770 | ATROPIN-POS 0.5% | gtt oph 1x10ml | URS | D | | | |
| 83770 | ATROPIN-POS 0.5% | oph gtt sol1x10ml | URS | D | | | |
| 487.2 | S01FA01 | atropin (koncentrace nad 0,5%) | lok. | 1 | ML | 5,66 | |
| 83771 | ATROPIN-POS 1% | gtt oph 1x10ml | URS | D | | | |
| 83771 | ATROPIN-POS 1% | oph gtt sol 1x10ml | URS | D | | | |
| 487.3 | S01FA04 | cyklopentolát | lok. | 1 | ML | 35,10 | O/OPH |
| 45558 | CYCLOGYL 1% | gtt oph 1x15ml 1% | ACU | B | | | |
| 487.4 | S01FA06 | tropikamid | lok. | 1 | ML | 8,52 | O/OPH |
| 21155 | MYDRUM | gtt oph 1x10ml 0.5% | CHV | D | | | |
| 21155 | MYDRUM | oph gtt sol 1x10ml | CHV | D | | | |
| 487.5 | S01FB01 | fenylefrin (koncentrace 10% nebo více) | lok. | 1 | ML | 40,33 | O/OPH |
| 488 | S01G | dekongestanty a antialergika | lok. | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 488.1 | S01GA52 | antazolin/tetry- zolin | lok. | 1 | ML | 6,06 | L/OPH,ALG |
| 488.1 | S01GA52 | antazolin/tetryzolin | lok. | 1 | ML | 6,06 | L/OPH,ALG |
| | | | | | | | |
| 488.2 | S01GX01 | natrium kromoglykát (lékové formy očních kapek) | lok. | 1 | ML | 4,06 | |
| | | | | | | | |
| 488.3 | S01GX01 | natrium kromoglykát (lékové formy očních a nosních kapek) | lok. | 1 | ML | 5,23 | L/OPH,ALG,ORL |
| 54241 | ALLERGOCROM EYE+NAS.KOMBI-PACK | oph 10ml+nas 15ml | URS | D | | | |
| 54241 | ALLERGOCROM KOMBI (OČNÍ+NOSNÍ) | oph 10ml+nas 15ml | URS | D | | | |
| 83651 | CROMOHEXAL COMBI | oph 10ml+nas 15ml | HEX | D | | | |
| 57944 | CROMOHEXAL COMBI | oph10ml+nas15ml sol | SFS | D | | | |
| 488.4 | S01GX02 | levokabastin | lok. | 1 | ML | 17,60 | L/OPH,ALG |
| | | | | | | | |
| 488.5 | S01GX03 | kyselina spaglumová | lok. | 1 | ML | 14,66 | L/OPH,ALG |
| | | | | | | | |
| 488.6 | S01GX05 | lodoxamid | lok. | 1 | ML | 14,66 | L/OPH,ALG |
| | | | | | | | |
| 488.7 | S01GX06 | emedastin | lok. | 1 | ML | 17,60 | L/OPH, ALG |
| | | | | | | | |
| 488.8 | S01GX07 | azelastin | lok. | 1 | ML | 17,60 | L/OPH, ALG |
| | | | | | | | |
| 488.9 | S01GX08 | ketotifen | lok. | 1 | ML | 27,14 | L/OPH, ALG |
| | | | | | | | |
| 488.10 | S01GA52 | tetryzolin/anti-histaminikum | lok. | 1 | ML | 4,06 | L/OPH,ALG |
| 488.10 | S01GA52 | tetryzolin/antihistaminikum | lok. | 1 | ML | 4,06 | L/OPH,ALG |
| 489 | S01HA | lokální místní anestetika | lok. | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 489.1 | S01HA | místní anestetika | lok. | 1 | ML | 11,83 | L/OPH |
| | | | | | | | |
| 489.2 | S01HA02 | oxybuprokain | lok. | 1 | ML | 11,83 | L/OPH |
| 66524 | NOVESIN 0.4% | gtt oph 1x10ml | CBV | CH | | | |
| 66524 | NOVESIN 0.4% | oph gtt sol 1x10ml | NAH | CH | | | |
| 490 | S01 | jiná oftalmologika | lok. | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 490.1 | S01XA | tolazolin (koncentrace 10%) | lok. | 1 | GM | 14,91 | L/OPH |
| | | | | | | | |
| 490.2 | S01XA | jodid draselný a sodný | lok. | 1 | ML | 4,89 | |
| 56119 | JODID DRASELNY+SODNY 2% UNIM.PH | gtt oph 1x10ml | UPA | SK | | | |
| 56119 | JODID DRASELNY+SODNY 2% UNIM.PH | oph gtt sol 1x10ml | UPA | SK | | | |
| 490.3 | S01XA01 | guajazulen | lok. | 1 | GM | 3,98 | |
| 00874 | OPHTHALMO-AZULEN | ung oph 1x5gm | LEX | CZ | | | |
| 00874 | OPHTHALMO-AZULEN | ung oph 1x5gm/7.5mg | LEX | CZ | | | |
| 490.4 | S01XA02 | retinol | lok. | 1 | GM | 2,93 | |
| | | | | | | | |
| 490.5 | S01XA04 | jodid draselný | lok. | 1 | ML | 4,89 | |
| 56118 | JODID DRASELNY 2% UNIMED PHARMA | gtt oph 1x10ml | UPA | SK | | | |
| 56118 | JODID DRASELNY 2% UNIMED PHARMA | oph gtt sol 1x10ml | UPA | SK | | | |
| 490.6 | S01XA11 | nandrolon | lok. | 1 | ML | 11,20 | |
| | | | | | | | |
| 490.7 | S01XA20 | umělé slzy a jiné indiferentní přípravky | lok. | 1 | ML | 3,03 | |
| | | | | | | | |
| 04179 | LACRISYN | gtt oph 1x10ml | GNO | CZ | | | |
| 490.8 | S01XA20 | umělé slzy a jiné indiferentní přípravky (v lékové formě gelu) | lok. | 1 | GM | 3,03 | |
| | | | | | | | |
| 490.9 | S01KA01 | kyselina hyaluronová | lok. | 1 | ML | 1376,58 | Z |
@@ -7743,29 +7994,29 @@
| 491.2 | S02AA11 | polymyxin B | lok. | 1 | ML | 2,64 | L/ORL |
| | | | | | | | |
| 491.3 | S02BA | kortikosteroidy a antiinfektiva v kombinaci | lok. | 1 | GM | 22,92 | L/ORL, PDD |
| 84575 | OTOBACID N | gtt oto 1x6gm | ASH | D | | | |
| 84575 | OTOBACID N | aur gtt sol 1x6gm | ASH | D | | | |
| 492 | V01AA | extrakty alergenů | p.o. | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 492.1 | V01AA | I. generace (PNU), úvodní dávka | p.o. | 1 | DF | 88,46 | L/ALG |
| | | | | | | | |
| 492.2 | V01AA | I. generace (PNU), udržovací dávka | p.o. | 1 | DF | 415,47 | L/ALG |
| 492.3 | V01AA | II. generace (IC,IR,JSA,JSK,SQ,SU), úvodní dávka | p.o. | 1 | DF | 228,70 | L/ALG |
| | | | | | | | |
| 492.4 | V01AA | II. generace (IC,IR,JSA,JSK,SQ,SU), udržovací dávka | p.o. | 1 | DF | 498,16 | L/ALG |
| | | | | | | | |
| 492.5 | V01AA | II. generace (IC,IR,JSA,JSK,SQ,SU, STU), pro sublng. podání, úvodní dávka | p.o. | 1 | DF | 308,40 | L/ALG |
| | | | | | | | |
| 492.3 | V01AA | II. generace (IC,IR,JSA,JSK, SQ,SU), úvodní dávka | p.o. | 1 | DF | 228,70 | L/ALG |
| | | | | | | | |
| 492.4 | V01AA | II. generace (IC,IR,JSA,JSK, SQ,SU), udržovací dávka | p.o. | 1 | DF | 498,16 | L/ALG |
| | | | | | | | |
| 492.5 | V01AA | II. generace (IC,IR,JSA,JSK, SQ,SU, STU), pro sublng. podání, úvodní dávka | p.o. | 1 | DF | 308,40 | L/ALG |
| | | | | | | | |
| 492.6 | V01AA | II. generace (IC,IR,JSA,JSK, SQ,SU,STU),pro sublng. podání, udržovací dávka | p.o. | 1 | DF | 616,52 | L/ALG |
| 493 | V01AA | extrakty alergenů | intrader. | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 493.1 | V01AA | extrakty alergenů (diagnostické, jedna lahvička) | intrader. | 1 | BA | 134,61 | O/ALG |
| 494 | V01AA | extrakty alergenů | PRICK tes | O/ALG | | | |
| 494 | V01AA extrakty alergenů | PRICK test | O/ALG | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 494.1 | V01AA | extrakty alergenů (diagnostické, jedna lahvička) | PRICK test | 1 | BA | 522,52 | O/ALG |
| | | | | | | | |
| 494.2 | V01AA | extrakty alergenů (diagnostické, kontrola) | PRICK test | 1 | BA | 363,86 | O/ALG |
| 495 | V01AA | extrakty alergenů | parent. | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 495.1 | V01AA | I. generace (PNU), vodné, úvodní dávka | parent. | 1 | DF | 69,48 | L/ALG |
| | | | | | | | |
| 495.2 | V01AA | I. generace (PNU), vodné, udržovací dávka | parent. | 1 | DF | 442,69 | L/ALG |
@@ -7773,13 +8024,13 @@
| 495.3 | V01AA | II. generace (IC,IR,JSA,JSK, SQ,SU,RG), vodné, úvodní dávka | parent. | 1 | DF | 228,70 | L/ALG |
| | | | | | | | |
| 495.4 | V01AA | II. generace (IC,IR,JSA,JSK, SQ,SU,RG), vodné, udržovací dávka | parent. | 1 | DF | 749,06 | L/ALG |
| 47701 | ALBEY 120MCG(APIS MELLIF) | inj sic 1x120rg | HST | USA | | | |
| 47699 | ALBEY 120MCG(VESPULA) | inj sic 1x120rg | HST | USA | | | |
| 47701 | ALBEY 120MCG(APIS MELLIF) | inj sic 1x120rg+sol | HST | USA | | | |
| 47699 | ALBEY 120MCG(VESPULA) | inj sic 1x12org+sol | HST | USA | | | |
| 495.5 | V01AA | I. generace (PNU), depotní, úvodní dávka | parent. | 1 | DF | 38,50 | L/ALG |
| 83562 | H-AL POL.SEVAC DEP.SMES TRAV I | inj 250pnu/1ml | SEV | CZ | | | |
| 83558 | H-AL POL.SEVAC DEP.JAR.SM.CAS. | inj 250pnu/1 ml | SEV | CZ | | | |
| 83560 | H-AL POL.SEVAC DEP.SM.PODZIMNI | inj 250pnu/1ml | SEV | CZ | | | |
| 83554 | H-AL POL.SEVAC DEP.POLLIN.MIXT. | inj 250pnu/1ml | SEV | CZ | | | |
| 83558 | H-AL POLLENS(JAR.SM.CAS.) DEPOT | inj 250pnu-1ml | SVF | CZ | | | |
| 83554 | H-AL POLLENS(POLLIN.MIXT.) DEPOT | inj 250pnu-1ml | SVF | CZ | | | |
| 83560 | H-AL POLLENS(SM.PODZIMNI) DEPOT | inj 250pnu-1ml | SVF | CZ | | | |
| 83562 | H-AL POLLENS(SMĚS TRAV I)DEPOT | inj 250pnu-1 ml | SVF | CZ | | | |
| 495.6 | V01AA | I. generace (PNU), depotní, udržovací dávka | parent. | 1 | BA | 265,93 | L/ALG |
| | | | | | | | |
| 495.7 | V01AA | II. generace (IC,IR,JSA,JSK, SQ,SU), depotní, úvodní dávka | parent. | 1 | BA | 1233,60 | L/ALG |
@@ -7792,7 +8043,7 @@
- a) hyperfosfatémie vyšší než 2,5mmol/l a hyperkalcémie (Ca více než 2,7mmol/l) při terapii kalcium karbonátem a to i přes použití dialyzačního roztoku s obsahem kalcia 1,25 mmol/l,
- b) nekontrolovatelná hyperfosfatemie (více než 3,2 mmol/l); čí opakované zjišťovaná hodnota více než 2,5 mmol/l při prokázané diet s omezením fosforu do 1200 mg/d, adekvátní dialyzační léčbě - Kt/V dle Daugirdase II více než 1,2 a spolupráci pacienta,
- b) nekontrolovatelná hyperfosfatemie (více než 3,2 mmol/l); či opakovaně zjišťovaná hodnota více než 2,5 mmol/l při prokázané dietě s omezením fosforu do 1200 mg/d, adekvátní dialyzační léčbě - Kt/V dle Daugirdase II více než 1,2 a spolupráci pacienta,
- c) parathyreoidektomie - k překlenutí období od indikace do operačního výkonu,
@@ -7802,13 +8053,15 @@
Kontroly účinnosti podávání sevelameru jsou prováděny nejméně jednou za 3 měsíce léčby. Podávání je ukončeno pokud je při kontrole zjištěna hyperfosfatemie vyšší než 2,5mmol/l.
| 496.1 | V03AE02 | sevelamer | p.o. | 1 | DF | 23,33 | P |
| | | | | | | | |
| 496.2 | V03AX | antistafylokokový fág. lyzát | lok. | 20 | ML | 321,60 | |
| 496.1 | V03AE02 | sevelamer do 403 mg v jedné tabletě včetně | p.o. | 400 | MG | 20,70 | P |
| | | | | | | | |
| 496.2 | V03AE02 | sevelamer nad 403 mg v jedné tabletě | p.o. | 400 | MG | 18,60 | P |
| | | | | | | | |
| 496.3 | V03AX | antistafylokokový fág. lyzát | lok. | 20 | ML | 321,60 | |
| 497 | V03AB | antidota | parent. | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 497.1 | V03AC01 | deferoxamin | parent. | 1 | GM | 386,74 | K |
| 01445 | DESFERAL | inj sic 10x500mg | CGC | CH | | | |
| 01445 | DESFERAL | inj plv sol10x500mg | NPA | CH | | | |
| 497.2 | V03AB | trimedoxim + atropin | parent. | | | Plně | K |
| | | | | | | | |
| 497.3 | V03AB | obedoxim | parent. | | | Plně | K |
@@ -7822,8 +8075,8 @@
| 497.7 | V03AB14 | protamin | parent. | 1 | ML | 6,01 | K |
| | | | | | | | |
| 497.8 | V03AB15 | naloxon | parent. | 0.4 | MG | 11,83 | K |
| 88866 | INTRENON | inj 10x1ml/400rg | LEX | CZ | | | |
| 94763 | NALOXONE POLFA | inj 10x1ml/0.4mg | POL | PL | | | |
| 88866 | INTRENON | inj | 10x1ml/0.4mg | LEX | CZ | | |
| 94763 | NALOXONE WZF POLFA | inj | 10x1ml/0.4mg | WZF | PL | | |
| 497.9 | V03AB16 | ethanol (koncentrace 10%) | parent. | 100 | ML | 20,43 | K |
| | | | | | | | |
| 497.10 | V03AB19 | fysostigmin | parent. | 1 | MG | 10,31 | K |
@@ -7837,97 +8090,100 @@
| 498.1 | V03AF01 | mesna | p.o. | 1,2 | GM | 290,85 | B/ONK,HEM |
| 05883 | UROMITEXAN TABLETS 400MG | tbl obd 10x400mg | HOD | D | | | |
| 498.2 | V03AF03 | kalcium folinát (do 15 mg v jedné tabletě včetně) | p.o. | 60 | MG | 111,91 | |
| 96963 | CALCIUMFOLINAT EBEWE 15MG | por cps dur 20x15mg | EBP | A | | | |
| 54518 | LEUCOVORIN CA LACHEMA 15 | por tbl nob 30x15mg | PVL | CZ | | | |
| 96963 | CALCIUMFOLINAT-EBEWE | cps 20x15mg | EBW | A | | | |
| 498.3 | V03AF03 | kalcium folinát (nad 15 mg v jedné tabletě) | p.o. | 60 | MG | 115,42 | |
| 96964 | CALCIUMFOLINAT-EBEWE | cps 20x100mg | EBW | A | | | |
| 96964 | CALCIUMFOLINAT EBEWE 100MG | por cps dur20x100mg | EBP | A | | | |
| 01671 | LEUCOVORIN CA LACHEMA 25 | por tbl nob 30x25mg | PVL | CZ | | | |
| 499 | V03AF | antidota užívaná při léčbě cytostatiky | parent. | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 499.1 | V03AF01 | mesna (do 200 mg v jedné ampuli včetně) | parent. | 0.2 | GM | 29,72 | B/ONK,HEM |
| | | | | | | | |
| 499.2 | V03AF01 | mesna (nad 200 mg v jedné ampuli) | parent. | 0.4 | GM | 48,39 | B/ONK,HEM |
| 05954 | UROMITEXAN 400MG | inj 15x4ml/400mg | HOD | D | | | |
| 05954 | UROMITEXAN 400MG | inj sol15x4ml/400mg | BXH | D | | | |
| 499.3 | V03AF02 | dexrazoxan | parent. | 0.5 | GM | 4329,50 | B/ONK,HEM |
| | | | | | | | |
| 499.4 | V03ZAF03 | kalcium folinát | parent. | 60 | MG | 234,23 | B/ONK,HEM |
| 11186 | LEUCOVORIN-TEVA | inj 5x10ml/100mg | PHM | NL | | | |
| 11184 | LEUCOVORIN-TEVA | inj 1x5ml/50mg | PHM | NL | | | |
| 12442 | LEUCOVORIN CA LACHEMA 50 | inj sol 5x5ml/50mg | PVL | CZ | | | |
| 57614 | LEUCOVORIN CA LACHEMA 150 INJ. | inj 1x15ml/150mg | PVL | CZ | | | |
| 57615 | LEUCOVORIN CA LACHEMA 150 INJ. | inj 10x15ml/150mg | PVL | CZ | | | |
| 12441 | LEUCOVORIN CA LACHEMA 20 | inj sol 10x2ml/20mg | PVL | CZ | | | |
| 88636 | LEUCOVORIN CA LACHEMA 10 | inj plv sol 10x10mg | PVL | CZ | | | |
| 96966 | CALCIUMFOLINAT EBEWE 30MG | inj 5x3ml/30mg | EBP | A | | | |
| 11190 | LEUCOVORIN-TEVA | inj 1x50ml/500mg | PHM | NL | | | |
| 12440 | LEUCOVORIN CA LACHEMA 10 | inj sol 10x1ml/10mg | PVL | CZ | | | |
| 10791 | LEUCOVORIN-TEVA | inj sic 1x50mg | PHM | NL | | | |
| 11189 | LEUCOVORIN-TEVA | inj 1x35ml/350mg | PHM | NL | | | |
| 11187 | LEUCOVORIN-TEVA | inj 1x20ml/200mg | PHM | NL | | | |
| 91561 | LEUCOVORIN CA LACHEMA 25 | inj plv sol 10x25mg | PVL | CZ | | | |
| 75004 | LEUCOVORIN CA LACHEMA 25 | inj plv sol 1x25mg | PVL | CZ | | | |
| 75005 | LEUCOVORIN CA LACHEMA 10 | inj plv sol 1x10mg | PVL | CZ | | | |
| 11188 | LEUCOVORIN-TEVA | inj 1x30ml/300mg | PHM | NL | | | |
| 01668 | LEUCOVORIN CA LACHEMA 450 | inj sol 1x45ml | PVL | CZ | | | |
| 58033 | CALCIUMFOLINAT EBEWE 100MG | inj 1x10ml/100mg | EBP | A | | | |
| 01669 | LEUCOVORIN CA LACHEMA 450 | inj sol 5x45ml | PVL | CZ | | | |
| 11185 | LEUCOVORIN-TEVA | inj 1x10ml/100mg | PHM | NL | | | |
| 499.5 | V03AF05 | amifostin | parent. | 1,7 | GM | 19500,00 | X |
| | | | | | | | |
| 499.4 | V03AF03 | kalcium folinát | parent. | 60 | MG | 234,23 | B/ONK,HEM |
| 58033 | CALCIUMFOLINAT EBEWE 100MG | inj | sol1x10ml/100mg | EBP | A | | |
| 96966 | CALCIUMFOLINAT EBEWE 30MG | inj | sol 5x3ml/30mg | EBP | A | | |
| 88636 | LEUCOVORIN CA LACHEMA 10 | inj | plv sol 10x10mg | PVL | CZ | | |
| 75005 | LEUCOVORIN CA LACHEMA 10 | inj | plv sol 1x10mg | PVL | CZ | | |
| 12440 | LEUCOVORIN CA LACHEMA 10 | inj | sol 10x1ml/10mg | PVL | CZ | | |
| 57615 | LEUCOVORIN CA LACHEMA 150 INJ. | inj | sol 10x15ml | PVL | CZ | | |
| 57614 | LEUCOVORIN CA LACHEMA 150 INJ. | inj | sol 1x15ml | PVL | CZ | | |
| 12441 | LEUCOVORIN CA LACHEMA 20 | inj | sol 10x2ml/20mg | PVL | CZ | | |
| 91561 | LEUCOVORIN CA LACHEMA 25 | inj | plv sol 10x25mg | PVL | CZ | | |
| 75004 | LEUCOVORIN CA LACHEMA 25 | inj | plv sol 1x25mg | PVL | CZ | | |
| 01668 | LEUCOVORIN CA LACHEMA 450 | inj | sol 1x45ml | PVL | CZ | | |
| 01669 | LEUCOVORIN CA LACHEMA 450 | inj | sol 5x45ml | PVL | CZ | | |
| 12442 | LEUCOVORIN CA LACHEMA 50 | inj | sol 5x5ml/50mg | PVL | CZ | | |
| 11185 | LEUCOVORIN-TEVA | inj | 1x10ml/100mg | PHM | NL | | |
| 11187 | LEUCOVORIN-TEVA | inj | 1x20ml/200mg | PHM | NL | | |
| 11188 | LEUCOVORIN-TEVA | inj | 1x30ml/300mg | PHM | NL | | |
| 11189 | LEUCOVORIN-TEVA | inj | 1x35ml/350mg | PHM | NL | | |
| 11190 | LEUCOVORIN-TEVA | inj | 1x50ml/500mg | PHM | NL | | |
| 11184 | LEUCOVORIN-TEVA | inj | 1x5ml/50mg | PHM | NL | | |
| 11186 | LEUCOVORIN-TEVA | inj | 5x10ml/100mg | PHM | NL | | |
| 499.5 | V03AF05 | amifostin | parent. | 1.7 | GM | 19500,00 | X |
| 31540 | ETHYOL | inj sic 3x500mg | SCH | B | | | |
| 499.6 | V03AF07 | rasburikaza | parent. | 1 | DF | 2500,00 | H |
| 500 | V03AK | tkáňová lepidla | lok. | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 500.1 | V03AK | tkáňová lepidla | lok. | 1 | ml | 3219,90 | X |
| 90503 | TISSUCOL KIT | kit 1x1ml | IMM | A | | | |
| 90504 | TISSUCOL KIT | kit 1x2ml | IMM | A | | | |
| 90505 | TISSUCOL KIT | kit 1x5ml | IMM | A | | | |
| 90502 | TISSUCOL KIT | kit 1x0.5ml | IMM | A | | | |
| 500.1 | V03AK | tkáňová lepidla | lok. | 1 | ML | 3219,90 | X |
| 90502 | TISSUCOL KIT | glu 0.5ml(3x+2xsol) | BXG | A | | | |
| 90503 | TISSUCOL KIT | glu 1ml(3x+2xsolv.) | BXG | A | | | |
| 90504 | TISSUCOL KIT | glu 2ml(3x+2xsolv.) | BXG | A | | | |
| 90505 | TISSUCOL KIT | glu 5ml(3x+2xsolv.) | BXG | A | | | |
| 500.2 | V03AK | tkáňová lepidla | lok. | 1 | C2 | 177,24 | X |
| 89822 | TACHOCOMB (2.5X3X0.5CM) | spn 1x1ks | HNP | A | | | |
| 74980 | TACHOCOMB (9.5X4.8X0.5CM) | spn 1x1ks | HNP | A | | | |
| 89822 | TACHOCOMB COAT.DRY-FOAM FLEECE | spn 1/2.5x3x0.5cm | NYC | A | | | |
| 74980 | TACHOCOMB COAT.DRY-FOAM FLEECE | spn 1/9.5x4.8x0.5cm | NYC | A | | | |
| 501 | V04CD | testy sekrece hormonů hypofýzy | p.o. | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 501.1 | V04CD01 | metyrapon | p.o. | 3 | GM | 386,77 | K/END |
| 01359 | METOPIRONE | cps 50x250mg | CGC | CH | | | |
| 01359 | METOPIRONE | cps 50x250mg | NPA | CH | | | |
| 502 | V04CF | tuberkulinový test | parent. | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 502.1 | V04CF01 | tuberkulin | parent. | 0.6 | RG | 277,44 | H |
| 68920 | TUBERCULIN PPD RT 23,SSI | inj 10x5ml/2rg | SST | DK | | | |
| 68918 | TUBERCULIN PPD RT 23,SSI | inj 10x1.5ml/0.6rg | SST | DK | | | |
| 68919 | TUBERCULIN PPD RT 23,SSI | inj 1x5ml/2rg | SST | DK | | | |
| 68918 | TUBERCULIN PPD RT 23 SSI | inj 10x1.5ml/0.6rg | SST | DK | | | |
| 68920 | TUBERCULIN PPD RT 23 SSI | inj 10x5ml/2rg | SST | DK | | | |
| 68919 | TUBERCULIN PPD RT 23 SSI | inj 1x5ml/2rg | SST | DK | | | |
| 503 | V04CL | testy pro alergické choroby | intrader. | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 503.1 | V04CL | testy pro alergické choroby (diagnostické alergeny, 1 lahvička) | intrader. | 1 | BA | 134,61 | O/ALG |
| 47433 | D-AL(MIT,MYCO,DMX, BACTO) INJ | 1x5ml-pnu 1000 | SVF | CZ | | | |
| 54551 | D-AL POLLENS INJ | 1x5ml-jsk 100 | SVF | CZ | | | |
| 47427 | D-AL POLLENS INJ | 1x5ml-jsk 1000 | SVF | CZ | | | |
| 47428 | D-AL POLLENS INJ | 1x5ml-pnu 100 | SVF | CZ | | | |
| 47431 | D-AL FOODS INJ | 1x5ml-pnu 1000 | SVF | CZ | | | |
| 47434 | D-AL DUSTS INJ | 1x5ml-pnu 1000 | SVF | CZ | | | |
| 47432 | D-AL DUSTS INJ | 1x5ml-pnu 100 | SVF | CZ | | | |
| 47429 | D-AL POLLENS INJ | 1x5ml-pnu 1000 | SVF | CZ | | | |
| 47430 | D-AL INSECTS INJ | 1x5ml-pnu 0.5-500 | SVF | CZ | | | |
| 47432 | D-AL DUSTS | inj sol 1x5ml-pnu | SVF | CZ | | | |
| 47434 | D-AL DUSTS | inj sol 1x5ml-pnu | SVF | CZ | | | |
| 47431 | D-AL FOODS | inj sol 1x5ml-pnu | SVF | CZ | | | |
| 47430 | D-AL INSECTS | inj sol 1x5ml-pnu | SVF | CZ | | | |
| 47427 | D-AL POLLENS | inj sol 1x5ml-jsk | SVF | CZ | | | |
| 54551 | D-AL POLLENS | inj sol 1x5ml-jsk | SVF | CZ | | | |
| 47428 | D-AL POLLENS | inj sol 1x5ml-pnu | SVF | CZ | | | |
| 47429 | D-AL POLLENS | inj sol 1x5ml-pnu | SVF | CZ | | | |
| 47433 | D-AL(MIT,MYCO,DMX, BACTO) | inj sol 1x5ml-pnu | SVF | CZ | | | |
| 503.2 | V04CL | testy pro alergické choroby (diagnostické alergeny, souprava) | intrader. | 1 | BA | 495,05 | O/ALG |
| | | | | | | | |
| 503.3 | V04CL | testy pro alergické choroby (diagnostické alergeny, 1 lahvička) | prick test | 1 | BA | 522,52 | O/ALG |
| 53626 | ALYOSTAL PRICK | sol 1x3ml | SLG | F | | | |
| 84304 | D-AL PRICK TEST | 1x3ml-pnu | SVF | CZ | | | |
| 84296 | D-AL PRICK TEST | 1x3ml-jsk | SVF | CZ | | | |
| 503.3 | V04CL | testy pro alergické choroby (diagnostické alergeny, 1 lahvička) | PRICK test | 1 | BA | 522,52 | O/ALG |
| 84296 | D-AL PRICK TEST | sol 1x3ml-jsk | SVF | CZ | | | |
| 84304 | D-AL PRICK TEST | sol 1x3ml-pnu | SVF | CZ | | | |
| 84296 | D-AL PRICK TEST | sol 1x3ml-jsk | SVF | CZ | | | |
| 84304 | D-AL PRICK TEST | sol 1x3ml-pnu | SVF | CZ | | | |
| 70500 | SOLUPRICK SQ | sol 1x3ml | AAS | DK | | | |
| 69225 | SOLUPRICK SQ (DIAG.) | sol 1x3ml | EAS | A | | | |
| 69224 | SOLUPRICK SQ (DIAG.)-KONTROLA | sol 2x3ml | EAS | A | | | |
| 503.4 | V04CL | testy pro alergické choroby (diagnostické alergeny, kontrola) | PRICK test | 1 | BA | 363,86 | O/ALG |
| 504 | V04CX | jiná diagnostika | p.o. | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 504.1 | V04CX | jiná diagnostika (přípravky uvolňující CO2) | p.o. | 1 | DF | 20,73 | |
| 46684 | CO2 GRANULAT GUERBET | gra 10x2.938gm | GMG | F | | | |
| 504.1 | V04CX | jiná diagnostika (přípravky uvolňující C02) | p.o. | 1 | DF | 20,73 | |
| 46684 | CO2 GRANULAT GUERBET | gra 10 (sÁČky) | GMG | F | | | |
| 505 | V04CX | jiná diagnostika | intrader. | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 505.1 | V04CX | jiná diagnostika (diagnostika buněčné imunity) | intrader. | 1 | ML | 114,51 | O |
| 45918 | IMUNOSKINTEST | inj 2x1.5+6x1.3ml | SVF | CZ | | | |
| 45918 | IMUNOSKINTEST | inj 2x1.5ml+6x1.3ml | SVF | CZ | | | |
| 505.2 | V04CX | jiná diagnostika (sulfanum ceruleum) | subkut. | 50 | MG | 251,00 | O |
| 506 | V04CX | jiná diagnostika | parent. | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 506.1 | V04CG03 | histamin | parent. | 10 | MG | 10,07 | O |
| | | | | | | | |
| 506.2 | V04CG30 | kofein a benzoát sodný | parent. | 0.1 | GM | 5.47 | O |
| 506.2 | V04CG30 | kofein a benzoát sodný | parent. | 0.1 | GM | 5,47 | O |
| | | | | | | | |
| 506.3 | V04CH01 | inulin | parent. | 5 | GM | 489,33 | O |
| | | | | | | | |
@@ -7951,11 +8207,11 @@
| 507.1 | V06CA | výživa bez fenylalaninu (suplementovaný bílkovinný hydrolyzát) | p.o. | 1 | GM | 5,33 | L/J4 |
| 94078 | SINFEMIX | plv 1x250gm | IMA | SK | | | |
| 507.2 | V06CA | výživa bez fenylalaninu (bílkovinný hydrolyzát) | p.o. | 1 | GM | 5,08 | L/J4 |
| 88063 | SINFENAL | plv 1x250gm | IMA | SK | | | |
| 88063 | SINFENAL | por plv sol1x250gm | IMA | SK | | | |
| 507.3 | V06CA | výživa bez fenylalaninu (definované směsi aminokyselin) | p.o. | 1 | GM | 12,45 | L/J4 |
| 93089 | MILUPA PKU 3 | plv po 1x500gm | MLP | D | | | |
| 93088 | MILUPA PKU 2 | plv po 1x500gm | MLP | D | | | |
| 93087 | MILUPA PKU 1 | plv po 1x500gm | MLP | D | | | |
| 93087 | MILUPA PKU 1 | por plv 1x500gm | MLP | D | | | |
| 93088 | MILUPA PKU 2 | por plv 1x500gm | MLP | D | | | |
| 93089 | MILUPA PKU 3 | por plv 1x500gm | MLP | D | | | |
| 507.4 | V06CA | výživa bez fenylalaninu (definované směsi aminokyselin, pro děti mladší 18 měsíců) | p.o. | 1 | GM | 25,27 | L/J4 |
| | | | | | | | |
| 507.5 | V06CA | výživa bez fenylalaninu (definované směsi aminokyselin, pro těhotné) | p.o. | 1 | GM | 14,17 | L/J4 |
@@ -7967,32 +8223,32 @@
| 509 | V06DB | kombinace tuk/sacharidy/proteiny/minerály/vitamíny | p.o. | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 509.1 | V06DB | tuk/sacharidy/proteiny/minerály/vitamíny, komb. | p.o. | 100 | GM | 44,87 | H |
| 61454 | NUTRISON | plv 1x430gm | NUT | NL | | | |
| 61454 | NUTRISON POWDER | plv 1x430gm | NUT | NL | | | |
| 509.2 | V06DB | tuk/sacharidy/proteiny/minerály/vitamíny, komb. | p.o. | 500 | ML | 79,38 | H |
| | | | | | | | |
| 509.3 | V06DC | kombinace sacharidů | p.o. | 100 | GM | 44,87 | H |
| 510 | V06DD | aminokyseliny včetně kombinaci s polypeptidy | p.o. | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 510.1 | V06DD | aminokyseliny včetně kombinací s polypeptidy | p.o. | 5 | DF | 88,01 | L/J7 |
| 88115 | KETOSTERIL | tbl obd 100 | FRE | D | | | |
| 88116 | KETOSTERIL | tbl obd 300(3x100) | FRE | D | | | |
| 88117 | KETOSTERIL | tbl obd 1500=15x100 | FRE | D | | | |
| 511 | V06DE | kombinace aminokyseliny/sacharidy/minerály/vitamíny | p.o. | | | | |
| 88116 | KETOSTERIL | tbl obd 300=3x100 | FRE | D | | | |
| 511 | V06DE | kombinace aminokyseliny/sacharidy/minerály/vitaminy | p.o. | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 511.1 | V06DE | kombinace aminokyseliny/sacharidy/minerály/vitamíny (mléčné bílkoviny kravského mléka) | p.o. | 100 | GM | 26,88 | |
| | | | | | | | |
| 511.2 | V06DE | kombinace aminokyseliny/sacharidy/minerály/vitamíny (mléčné bílkoviny kravského mléka s nízkým obsahem laktózy) | p.o. | 100 | GM | 13,83 | L/J11 |
| | | | | | | | |
| 511.3 | V06DE | kombinace aminokyseliny/sacharidy/minerály/vitamíny (mléčné proteinové hydrolyzáty) | p.o. | 100 | GM | 29,33 | L/J11 |
| 511.3 | V06DE | kombinace aminokyseliny/sacharidy/minerály/vitamíny (mléčné proteinové hvdrolyzáty) | p.o. | 100 | GM | 29,33 | L/J11 |
| | | | | | | | |
| 511.4 | V06DE | kombinace aminokyseliny/sacharidy/minerály/vitamíny (mléčné proteinové hydrolyzáty s nízkým obsahem laktózy) | p.o. | 100 | GM | 63,54 | L/J11 |
| | | | | | | | |
| 511.5 | V06 | kombinace aminokyseliny/ sacharidy/ minerály/ vitamíny (jednotlivé aminokyseliny) | p.o. | 100 | GM | 302,25 | P |
Přípravky obsahující kombinace aminokyseliny/sacharidy/minerály/vitamíny (jednotlivé aminokyseliny) jsou ordinovány pacientům s těžkou potravinovou alergií, zvláště na bílkovinu kravského mléka (těžké reakce anafylaktického charakteru, neúspěch tera extensivně hydrolyzovanými přípravky, potravinová alergie s projevy poškození střevní sliznice), s multiproteinovou alregií syndromu krátkého střeva, u malabsorpce při přechodu z parenterální na enterální výživu. Ve výše uvedených případech ordir dětem do 3 let věku lékař s atestací II. stupně v oboru pediatrie nebo s atestací I. stupně v oboru pediatrie a zároveň s nástavbou specializací v oboru gastroenterologie nebo alergologie a klinické imunologie. Po 6 měsících by měl být proveden pokus o reexpo proteinovým hydrolyzátem.
| 511.5 | V06 | kombinace aminokyseliny/sacharidy/minerály/vitamíny (jednotlivé aminokyseliny) | p.o. | 100 | GM | 302,25 | P |
Přípravky obsahující kombinace aminokyseliny/sacharidy/minerály/vitamíny (jednotlivé aminokyseliny) jsou ordinovány pacientům s těžkou potravinovou alergií, zvláště na bílkovinu kravského mléka (těžké reakce anafylaktického charakteru, neúspěch terapie extensivně hydrolyzovanými přípravky, potravinová alergie s projevy poškození střevní sliznice), s multiproteinovou alregií, u syndromu krátkého střeva, u malabsorpce při přechodu z parenterální na enterální výživu. Ve výše uvedených případech ordinuje dětem do 3 let věku lékař s atestací II. stupně v oboru pediatrie nebo s atestací I. stupně v oboru pediatrie a zároveň s nástavbovou specializací v oboru gastroenterologie nebo alergologie a klinické imunologie. Po 6 měsících by měl být proveden pokus o reexpozici proteinovým hydrolyzátem.
| 512 | V06DF | náhrady mléka obsahující sojovou bílkovinu | p.o. | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 512.1 | IV06DF | náhrady mléka obsahující sojovou bílkovinu | p.o. | 100 | GM | 27,96 | L/J11 |
| 512.1 | V06DF | náhrady mléka obsahující sojovou bílkovinu | p.o. | 100 | GM | 27,96 | L/J11 |
| 513 | V06DX | jiné kombinace přípravků pro výživu | p.o. | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 513.1 | V06DX | MCT olej | p.o. | 100 | ML | 103,13 | L/J11 |
@@ -8000,51 +8256,55 @@
| 513.2 | V06DX | kombinace s vysokým obsahem mléčné bílkoviny a kalcia | p.o. | 100 | GM | 44,87 | L/J11 |
| 514 | V07AB | rozpouštědla a ředidla, včetně irigačních roztoků | parent. | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 514.1 | V07AB | voda pro injekci (do 2 ml v jedné ampuli včetně) | parent. | 1 | ML | 2,69 | |
| 514.1 | V07AB | voda pro Injekci (do 2 ml v jedné ampuli včetně) | parent. | 1 | ML | 2,69 | |
| | | | | | | | |
| 514.2 | V07AB | voda pro injekci (nad 2 do 10 ml v jedné ampuli včetně) | parent. | 10 | ML | 3,32 | |
| 00387 | AQUA PRO INJECTIONE BIOTIKA | inj 10x10ml | BTA | SK | | | |
| 00388 | AQUA PRO INJECTIONE BIOTIKA | inj 50x10ml | BTA | SK | | | |
| 55807 | AQUA PRO INJECTIONE BIOTIKA | inj 100x10ml | BTA | SK | | | |
| 00387 | AQUA PRO INJECTIONE BIOTIKA | inj 10x10ml-amp.pl. | BTA | SK | | | |
| 00388 | AQUA PRO INJECTIONE BIOTIKA | inj 50x10ml-amp.pl. | BTA | SK | | | |
| 55807 | AQUA PRO INJECTIONE BIOTIKA | inj100x10ml-amp.pl. | BTA | SK | | | |
| 514.3 | V07AB | voda pro injekci nad 10 ml v jedné ampuli nebo lahvi | parent. | 100 | ML | 13,98 | |
| 44559 | STERILE WATER F.INJ.U.S.P.SIFRA | inf 16x250ml | SFR | I | | | |
| 31427 | STERILE WATER F.INJ. FRESENIUS | inf 12x500ml | FKI | I | | | |
| 44560 | STERILE WATER F.INJ.U.S.P.SIFRA | inf 12x500ml | SFR | I | | | |
| 89244 | AQUA PRO INJECTIONE ARDEAPHARMA | inf 1x250ml | ARD | CZ | | | |
| 69789 | AQUA PRO INJECTIONE ARDEAPHARMA | inf 1x500ml | ARD | CZ | | | |
| 53363 | AQUA PRO INJECTIONE INFUSIA | sol 1x250ml(sklo) | IHO | CZ | | | |
| 91876 | AQUA PRO INJECTIONE INFUSIA | sol 1x500ml(plast) | IHO | CZ | | | |
| 53364 | AQUA PRO INJECTIONE INFUSIA | sol 1x500ml(sklo) | IHO | CZ | | | |
| 80486 | AQUA PRO INJECTIONE MEDICAMENTA | par Iqf 1x250ml | MVM | CZ | | | |
| 70528 | AQUA PRO INJECTIONE MEDICAMENTA | par Iqf 1x500ml | MVM | CZ | | | |
| 92782 | AQUA PRO INJECTIONE MEDIEKOS | sol 1x1000ml(vak) | INK | CZ | | | |
| 92783 | AQUA PRO INJECTIONE MEDIEKOS | sol 1x2000ml(vak) | INK | CZ | | | |
| 83943 | AQUA PRO INJECTIONE MEDIEKOS | sol 1x500ml(vak) | INK | CZ | | | |
| 95565 | STERILE WATER F.INJ.FRESENIUS | par Iqf 1x1000ml-pe | FKI | I | | | |
| 31424 | STERILE WATER F.INJ.FRESENIUS | par Iqf 1x250ml-skl | FKI | I | | | |
| 95564 | STERILE WATER F.INJ.FRESENIUS | par Iqf 1x500ml-pe | FKI | I | | | |
| 31426 | STERILE WATER F.INJ.FRESENIUS | par Iqf 1x500ml-skl | FKI | I | | | |
| 95566 | STERILE WATER F.INJ.FRESENIUS | par Iqf 20x500ml-pe | FKI | I | | | |
| 95567 | STERILE WATER F.INJ.FRESENIUS | par Iqf12x1000ml-pe | FKI | I | | | |
| 31427 | STERILE WATER F.INJ.FRESENIUS | par Iqf12x500ml-skl | FKI | I | | | |
| 31425 | STERILE WATER F.INJ.FRESENIUS | par Iqf16x250ml-skl | FKI | I | | | |
| 31428 | STERILE WATER F.INJ.FRESENIUS | par Iqf1x1000ml-skl | FKI | I | | | |
| 31429 | STERILE WATER F.INJ.FRESENIUS | par lqf6x1000ml-skl | FKI | I | | | |
| 43759 | STERILE WATER F.INJ.U.S.P.SIFRA | par Iqf 1x250ml-skl | SFR | I | | | |
| 43760 | STERILE WATER F.INJ.U.S.P.SIFRA | par Iqf 1x500ml-skl | SFR | I | | | |
| 44560 | STERILE WATER F.INJ.U.S.P.SIFRA | par Iqf12x500ml-skl | SFR | I | | | |
| 44559 | STERILE WATER F.INJ.U.S.P.SIFRA | par Iqf16x250ml-skl | SFR | I | | | |
| 43761 | STERILE WATER F.INJ.U.S.P.SIFRA | par Iqf1x1000ml-skl | SFR | I | | | |
| 44557 | STERILE WATER F.INJ.U.S.P.SIFRA | par Iqf6x1000ml-skl | SFR | I | | | |
| 99814 | VODA NA INJEKCI VIAFLO | par Iqf 20x500ml | BFH | E | | | |
| 99208 | VODA NA INJEKCI VIAFLO | par Iqf 30x250ml | BFH | E | | | |
| 98539 | VODA NA INJEKCI VIAFLO | par Iqf 35x150ml | BFH | E | | | |
| 99826 | VODA NA INJEKCI VIAFLO | par Iqf10x1000ml | BFH | E | | | |
| 57776 | WATER FOR INJECTIONS BIEFFE | inf 1x1000ml(vak) | BFH | E | | | |
| 53363 | AQUA PRO INJECTIONE INFUSIA | sol 1x250ml(sklo) | IHO | CZ | | | |
| 70484 | WATER FOR INJECTIONS BIEFFE | inf 1x1000ml(vak) | BFF | I | | | |
| 97726 | WATER FOR INJECTIONS BIEFFE | inf 1x250ml(sklo) | BFF | I | | | |
| 57773 | WATER FOR INJECTIONS BIEFFE | inf 1x250ml(vak) | BFH | E | | | |
| 85557 | WATER FOR INJECTIONS BIEFFE | inf 1x250ml(vak) | BFF | I | | | |
| 97727 | WATER FOR INJECTIONS BIEFFE | inf 1x500ml(sklo) | BFF | I | | | |
| 57775 | WATER FOR INJECTIONS BIEFFE | inf 1x500ml(vak) | BFH | E | | | |
| 57773 | WATER FOR INJECTIONS BIEFFE | inf 1x250ml(vak) | BFH | E | | | |
| 92782 | AQUA PRO INJECTIONE MEDIEKOS | sol 1x1000ml(vak) | MKS | CZ | | | |
| 31426 | STERILE WATER F.INJ. FRESENIUS | inf 1x500ml | FKI | I | | | |
| 43759 | STERILE WATER F.INJ.U.S.P.SIFRA | inf 1x250ml | SFR | I | | | |
| 97727 | WATER FOR INJECTIONS BIEFFE | inf 1x500ml(sklo) | BFF | I | | | |
| 95566 | STERILE WATER F.INJ.FRESENIUS | par Iqf 20x500ml-pe | FKI | I | | | |
| 70528 | AQUA PRO INJECTIONE MEDICAMENTA | inf 1x500ml | MVM | CZ | | | |
| 70484 | WATER FOR INJECTIONS BIEFFE | inf 1x1000ml(plast) | BFF | I | | | |
| 53364 | AQUA PRO INJECTIONE INFUSIA | sol 1x500ml(sklo) | IHO | CZ | | | |
| 43760 | STERILE WATER F.INJ.U.S.P.SIFRA | inf 1x500ml | SFR | I | | | |
| 31424 | STERILE WATER F.INJ. FRESENIUS | inf 1x250ml | FKI | I | | | |
| 69789 | AQUA PRO INJECTIONE ARDEAPHARMA | inf 1x500ml | ARD | CZ | | | |
| 31429 | STERILE WATER F.INJ. FRESENIUS | inf 6x1000ml | FKI | I | | | |
| 31428 | STERILE WATER F.INJ. FRESENIUS | inf 1x1000ml | FKI | I | | | |
| 91876 | AQUA PRO INJECTIONE INFUSIA | i sol 1x500ml | IHO | CZ | | | |
| 44557 | STERILE WATER F.INJ.U.S.P.SIFRA | inf 6x1000ml | SFR | I | | | |
| 95565 | STERILE WATER F.INJ.FRESENIUS | par Iqf 1x1000ml-pe | FKI | I | | | |
| 85557 | WATER FOR INJECTIONS BIEFFE | inf 1x250ml(plast) | BFF | I | | | |
| 89244 | AQUA PRO INJECTIONE ARDEAPHARMA | inf 1x250ml | ARD | CZ | | | |
| 95564 | STERILE WATER F.INJ.FRESENIUS | par Iqf 1x500ml-pe | FKI | I | | | |
| 80486 | AQUA PRO INJECTIONE MEDICAMENTA | inf 1x250ml | MVM | CZ | | | |
| 85558 | WATER FOR INJECTIONS BIEFFE | inf 1x500ml(plast) | BFF | I | | | |
| 31425 | STERILE WATER F.INJ. FRESENIUS | inf 16x250ml | FKI | I | | | |
| 95567 | STERILE WATER F.INJ.FRESENIUS | par Iqf12x1000ml-pe | FKI | I | | | |
| 83943 | AQUA PRO INJECTIONE MEDIEKOS | sol 1x500ml(vak) | MKS | CZ | | | |
| 43761 | STERILE WATER F.INJ.U.S.P.SIFRA | inf 1x1000ml | SFR | I | | | |
| 92783 | AQUA PRO INJECTIONE MEDIEKOS | sol 1x2000ml(vak) | MKS | CZ | | | |
| 97726 | WATER FOR INJECTIONS BIEFFE | inf 1x250ml(sklo) | BFF | I | | | |
| 85558 | WATER FOR INJECTIONS BIEFFE | inf 1x500ml(vak) | BFF | I | | | |
| 515 | V08A | rozpustné nefrotropní RTG kontrastní látky | p.o. | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 515.1 | V08AA05 | kyselina ioxitalamová | p.o. | 10 | ML | 59,19 | K |
| 59497 | TELEBRIX GASTRO | sol 10x100ml/30gm | GUT | F | | | |
| 59497 | TELEBRIX GASTRO | sol 10x100ml/30gm i | GUT | F | | | |
| 515.2 | V08AB04 | iopamidol | p.o. | 10 | ML | 59,19 | K |
| 516 | V08AA | rozpustné nefrotropní hyperosmolární RTG kontrastní látky | parent. | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
@@ -8059,7 +8319,7 @@
| 516.5 | V08AA05 | kyselina ioxitalamová (koncentrace 300 mg l/ml) | parent. | 10 | ML | 54,73 | K |
| 92350 | TELEBRIX N 380 | inj 6x20ml | LEX | CZ | | | |
| 516.6 | V08AA05 | kyselina ioxitalamová (koncentrace 350 mg l/ml a více) | parent. | 10 | ML | 66,00 | K |
| 517 | V08AB | rozpustné nefrotropní nízkoosmolání RTG kontrastní látky | parent. | K | | | |
| 517 | V08AB | rozpustné nefrotropní nízkoosmolání RTG kontrastní látky | parent. | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
Vyšetření iotrolanem ordinuje rentgenolog:
@@ -8087,15 +8347,14 @@
| 517.9 | V08AB02 | iohexol (koncentrace 350 mg l/ml, nad 50 ml v ampuli) | parent. | 10 | ML | 159,40 | K |
| | | | | | | | |
| 517.10 | V08AB03 | kyselina ioxagliková (koncentrace 320 mg l/ml, do 30 ml v ampuli včetně) | parent. | 10 | ML | 236,91 | K |
| 59544 | HEXABRIX 320 | inj sol 1x50ml | GUT | F | | | |
| 59545 | HEXABRIX 320 | inj sol 25x50ml | GUT | F | | | |
| 59544 | HEXABRIX 320 | inj sol 1x50ml | GUT | F | | | |
| 517.11 | V08AB03 | kyselina ioxagliková (koncentrace 320 mg l/ml, nad 50 ml v ampuli) | parent. | 10 | ML | 186,90 | K |
| | | | | | | | |
| 517.12 | V08AB04 | iopamidol (koncentrace 200 mg l/ml, do 15 ml v ampuli včetně) | parent. | 10 | ML | 242,54 | K |
| | | | | | | | |
| 517.13 | V08AB04 | iopamidol (koncentrace 300 mg l/ml, do 15 ml v ampuli včetně) | parent. | 10 | ML | 299,78 | K |
| | | | | | | | |
| 517.14 | V08AB04 | iopamidol (koncentrace 300 mg l/ml, nad 15 do 30 ml v ampuli včetně) | parent. | 10 | ML | 185,92 | K |
| 517.14 | V08AB04 | opamidol (koncentrace 300 mg l/ml, nad 15 do 30 ml v ampuli včetně) | parent. | 10 | ML | 185,92 | K |
| | | | | | | | |
| 517.15 | V08AB04 | iopamidol (koncentrace 300 mg l/ml, nad 50 ml v ampuli) | parent. | 10 | ML | 169,67 | K |
| | | | | | | | |
@@ -8108,6 +8367,7 @@
| 517.19 | V08AB05 | iopromid (koncentrace 240 mg l/ml, nad 50 ml v ampuli) | parent. | 10 | ML | 122,70 | K |
| | | | | | | | |
| 517.20 | V08AB05 | iopromid (koncentrace 300 mg l/ml, do 30 ml v ampuli včetně) | parent. | 10 | ML | 185,40 | K |
| | | | | | | | |
| 517.21 | V08AB05 | iopromid (koncentrace 300 mg l/ml, nad 50 ml v ampuli) | parent. | 10 | ML | 142,60 | K |
| | | | | | | | |
| 517.22 | V08AB05 | iopromid (koncentrace 370 mg l/ml, nad 50 ml v ampuli) | parent. | 10 | ML | 165,80 | K |
@@ -8118,7 +8378,7 @@
| | | | | | | | |
| 517.25 | V08AB07 | ioversol (koncentrace 160 mg l/ml, nad 50 ml v ampuli) | parent. | 10 | ML | 95,60 | K |
| | | | | | | | |
| 517.26 | V08AB07 | ioversol (koncentrace 240 mg l/ml, nad 50 ml v ampuli) | parent. | 10 | ML | 122,70 | K |
| 517.26 | V08AB07 | ioversol (koncentrace 240 mg l/ml, nad 50 ml v ampuli) parent. | 10 | ML | 122,70 | K | |
| | | | | | | | |
| 517.27 | V08AB07 | ioversol (koncentrace 300 mg l/ml, do 15 ml v ampuli včetně) | parent. | 10 | ML | 256,70 | K |
| | | | | | | | |
@@ -8126,89 +8386,50 @@
| | | | | | | | |
| 517.29 | V08AB07 | ioversol (koncentrace 300 mg l/ml, nad 50 ml v ampuli) | parent. | 10 | ML | 142,65 | K |
| | | | | | | | |
| 517.30 | V08AB07 | ioversol (koncentrace 320 mg l/ml, nad 50 ml v ampuli) | parent. | 10 | ML | 149,50 | K |
| 517.30 | V08AB07 | ioversol (koncentrace 320 mg l/ml, nad 50 ml v ampuli) | parent. | 10 | ML 149,50 | K | |
| | | | | | | | |
| 517.31 | V08AB07 | ioversol (koncentrace 350 mg l/ml, do 30 ml v ampuli včetně) | parent. | 10 | ML | 207,20 | K |
| | | | | | | | |
| 517.32 | V08AB07 | ioversol (koncentrace 350 mg l/ml, nad 50 ml v ampuli) | parent. | 10 | ML | 159,42 | K |
| | | | | | | | |
| 517.33 | V08AB09 | iodixanol (koncentrace 150 mg l/ml, od 50 ml v jedné ampuli) | parent. | 10 | ML | 215,46 | K |
| 42405 | VISIPAQUE 150 MG l/ML | inj sol 10x50ml-amp | NRI | IRL | | | |
| 84340 | VISIPAQUE 150MG l/ML | inj 6x200ml | NYI | N | | | |
| 42401 | VISIPAQUE 150 MG l/ML | inj sol 10x100ml-pp | NRI | IRL | | | |
| 42404 | VISIPAQUE 150 MG l/ML | inj sol 10x50ml-amp | NYI | N | | | |
| 45114 | VISIPAQUE 150MG l/ML | inj 10x50ml | NRI | IRL | | | |
| 42402 | VISIPAQUE 150 MG l/ML | inj sol 10x200ml-pp | NYI | N | | | |
| 42400 | VISIPAQUE 150 MG l/ML | inj sol 10x100ml-pp | NYI | N | | | |
| 42398 | VISIPAQUE 150 MG l/ML | inj sol 6x500ml-skl | NYI | N | | | |
| 42399 | VISIPAQUE 150 MG l/ML | inj sol 6x500ml-skl | NRI | IRL | | | |
| 84339 | VISIPAQUE 150MG l/ML | inj 10x50ml | NYI | N | | | |
| 45115 | VISIPAQUE 150MG l/ML | inj 6x200ml | NRI | IRL | | | |
| 42403 | VISIPAQUE 150 MG l/ML | inj sol 10x200ml-pp | NRI | IRL | | | |
| 517.34 | V08AB09 | iodixanol (koncentrace 270 mg l/ml, do 30 ml včetně v jedné ampuli ) | parent. | 10 | ML | 336,60 | K |
| 42423 | VISIPAQUE 270 MG l/ML | inj sol 10x20ml-amp | NRI | IRL | | | |
| 45118 | VISIPAQUE 270MG l/ML | inj 10x20ml | NRI | IRL | | | |
| 42420 | VISIPAQUE 270 MG l/ML | inj sol 10x10ml-amp | NYI | N | | | |
| 84341 | VISIPAQUE 270MG l/ML | inj 10x20ml | NYI | N | | | |
| 42422 | VISIPAQUE 270 MG l/ML | inj sol 10x20ml-amp | NYI | N | | | |
| 42421 | VISIPAQUE 270 MG l/ML | inj sol 10x10ml-amp | NRI | IRL | | | |
| 517.35 | V08AB09 | iodixanol (koncentrace 270 mg l/ml, od 50 ml v jedné ampuli) | parent. | 10 | ML | 282,14 | K |
| 42409 | VISIPAQUE 270 MG l/ML | inj sol 10x75ml-pp | NRI | IRL | | | |
| 84343 | VISIPAQUE 270MG l/ML | inj 10x100ml | NYI | N | | | |
| 42424 | VISIPAQUE 270 MG l/ML | inj sol 10x40ml-amp | NYI | N | | | |
| 84344 | VISIPAQUE 270MG I/ML | inj 6x200ml | NYI | N | | | |
| 42425 | VISIPAQUE 270 MG I/ML | inj sol 10x40ml-amp | NRI | IRL | | | |
| 45120 | VISIPAQUE 270MG I/ML | inj 10x100ml | NRI | IRL | | | |
| 45119 | VISIPAQUE 270MG I/ML | inj 10x50ml | NRI | IRL | | | |
| 42426 | VISIPAQUE 270 MG I/ML | inj sol 10x50ml-amp | NYI | N | | | |
| 42427 | VISIPAQUE 270 MG I/ML | inj sol 10x50ml-amp | NRI | IRL | | | |
| 45121 | VISIPAQUE 270MG I/ML | inj 6x200ml | NRI | IRL | | | |
| 42415 | VISIPAQUE 270 MG l/ML | inj sol 10x175ml-pp | NRI | IRL | | | |
| 42410 | VISIPAQUE 270 MG I/ML | inj sol 10x100ml-pp | NYI | N | | | |
| 42411 | VISIPAQUE 270 MG I/ML | inj sol 10x100ml-pp | NRI | IRL | | | |
| 42412 | VISIPAQUE 270 MG I/ML | inj sol 10x150ml-pp | NYI | N | | | |
| 84342 | VISIPAQUE 270MG I/ML | inj 10x50ml | NYI | N | | | |
| 42414 | VISIPAQUE 270 MG I/ML | inj sol 10x175ml-pp | NYI | N | | | |
| 42416 | VISIPAQUE 270 MG I/ML | inj sol 10x200ml-pp | NYI | N | | | |
| 42417 | VISIPAQUE 270 MG I/ML | inj sol 10x200ml-pp | NRI | IRL | | | |
| 42418 | VISIPAQUE 270 MG I/ML | inj sol 6x500ml-pp | NYI | N | | | |
| 42419 | VISIPAQUE 270 MG I/ML | inj sol 6x500ml-pp | NRI | IRL | | | |
| 42408 | VISIPAQUE 270 MG I/ML | inj sol 10x75ml-pp | NYI | N | | | |
| 42407 | VISIPAQUE 270 MG I/ML | inj sol 6x500ml-skl | NRI | IRL | | | |
| 42406 | VISIPAQUE 270 MG I/ML | inj sol 6x500ml-skl | NYI | N | | | |
| 42413 | VISIPAQUE 270 MG I/ML | inj sol 10x150ml-pp | NRI | IRL | | | |
| 517.36 | V08AB09 | iodixanol (koncentrace 320 mg l/ml, do 30 ml včetně v jedné ampuli) | parent. | 10 | ML | 357,46 | K |
| 42442 | VISIPAQUE 320 MG I/ML | inj sol 10x10ml-amp | NYI | N | | | |
| 42444 | VISIPAQUE 320 MG I/ML | inj sol 10x20ml-amp | NYI | N | | | |
| 45122 | VISIPAQUE 320MG I/ML | inj 10x20ml | NRI | IRL | | | |
| 84345 | VISIPAQUE 320MG I/ML | inj 10x20ml | NYI | N | | | |
| 42445 | VISIPAQUE 320 MG I/ML | inj sol 10x20ml-amp | NRI | IRL | | | |
| 42443 | VISIPAQUE 320 MG I/ML | inj sol 10x10ml-amp | NRI | IRL | | | |
| 517.37 | V08AB09 | iodixanol (koncentrace 320 mg l/ml, od 50 ml v jedné ampuli) | parent. | 10 | ML | 287,25 | K |
| 42432 | VISIPAQUE 320 MG I/ML | inj sol 10x100ml-pp | NYI | N | | | |
| 42439 | VISIPAQUE 320 MG I/ML | inj sol 10x200ml-pp | NRI | IRL | | | |
| 45125 | VISIPAQUE 320MG I/ML | inj 6x200ml | NRI | IRL | | | |
| 45124 | VISIPAQUE 320MG I/ML | inj 10x100ml | NRI | IRL | | | |
| 45123 | VISIPAQUE 320MG I/ML | inj 10x50ml | NRI | IRL | | | |
| 42449 | VISIPAQUE 320 MG I/ML | inj sol 10x50ml-amp | NRI | IRL | | | |
| 42448 | VISIPAQUE 320 MG I/ML | inj sol 10x50ml-amp | NYI | N | | | |
| 42447 | VISIPAQUE 320 MG I/ML | inj sol 10x40ml-amp | NRI | IRL | | | |
| 42446 | VISIPAQUE 320 MG I/ML | inj sol 10x40ml-amp | NYI | N | | | |
| 42430 | VISIPAQUE 320 MG I/ML | inj sol 10x75ml-pp | NYI | N | | | |
| 42440 | VISIPAQUE 320 MG I/ML | inj sol 6x500ml-pp | NYI | N | | | |
| 84348 | VISIPAQUE 320MG I/ML | inj 6x200ml | NYI | N | | | |
| 42438 | VISIPAQUE 320 MG I/ML | inj sol 10x200ml-pp | NYI | N | | | |
| 42429 | VISIPAQUE 320 MG I/ML | inj sol 6x500ml-skl | NRI | IRL | | | |
| 42436 | VISIPAQUE 320 MG I/ML | inj sol 10x175ml-pp | NYI | N | | | |
| 42435 | VISIPAQUE 320 MG I/ML | inj sol 10x150ml-pp | NRI | IRL | | | |
| 42434 | VISIPAQUE 320 MG I/ML | inj sol 10x150ml-pp | NYI | N | | | |
| 42433 | VISIPAQUE 320 MG I/ML | inj sol 10x100ml-pp | NRI | IRL | | | |
| 84347 | VISIPAQUE 320MG I/ML | inj 10x100ml | NYI | N | | | |
| 42431 | VISIPAQUE 320 MG I/ML | inj sol 10x75ml-pp | NRI | IRL | | | |
| 42437 | VISIPAQUE 320 MG I/ML | inj sol 10x175ml-pp | NRI | IRL | | | |
| 84346 | VISIPAQUE 320MG l/ML | inj 10x50ml | NYI | N | | | |
| 42441 | VISIPAQUE 320 MG l/ML | inj sol 6x500ml-pp | NRI | IRL | | | |
| 42428 | VISIPAQUE 320 MG l/ML | inj sol 6x500ml-skl | NYI | N | | | |
| 517.33 | V08AB09 | iodixanol (koncentrace 150 mg l/ml, od 50 ml v jedné ampuli) | parent. | 10 | ML | 193,90 | K |
| 42400 | VISIPAQUE 150 MG l/ML | inj sol 10x100ml-pp | ABH | N | | | |
| 42401 | VISIPAQUE 150 MG l/ML | inj sol 10x100ml-pp | AHC | IRL | | | |
| 42402 | VISIPAQUE 150 MG l/ML | inj sol 10x200ml-pp | ABH | N | | | |
| 42403 | VISIPAQUE 150 MG l/ML | inj sol 10x200ml-pp | AHC | IRL | | | |
| 45115 | VISIPAQUE 150 MG l/ML | inj sol 6x200ml-skl | AHC | IRL | | | |
| 84340 | VISIPAQUE 150 MG l/ML | inj sol 6x200ml-skl | ABH | N | | | |
| 42398 | VISIPAQUE 150 MG l/ML | inj sol 6x500ml-skl | ABH | N | | | |
| 42399 | VISIPAQUE 150 MG l/ML | inj sol 6x500ml-skl | AHC | IRL | | | |
| 517.34 | V08AB09 | iodixanol (koncentrace 270 mg l/ml, do 30 ml včetně v jedné ampuli) | parent. | 10 | ML | 302,90 | K |
| | | | | | | | |
| 517.35 | V08AB09 | iodixanol (koncentrace 270 mg l/ml, od 50 ml v jedné ampuli) | parent. | 10 | ML | 253,90 | K |
| 42410 | VISIPAQUE 270 MG l/ML | inj sol 10x100ml-pp | ABH | N | | | |
| 42411 | VISIPAQUE 270 MG l/ML | inj sol 10x100ml-pp | AHC | IRL | | | |
| 45120 | VISIPAQUE 270 MG l/ML | inj sol 10x100ml-sk | AHC | IRL | | | |
| 84343 | VISIPAQUE 270 MG l/ML | inj sol 10x100ml-sk | ABH | N | | | |
| 42412 | VISIPAQUE 270 MG l/ML | inj sol 10x150ml-pp | ABH | N | | | |
| 42413 | VISIPAQUE 270 MG l/ML | inj sol 10x150ml-pp | AHC | IRL | | | |
| 42414 | VISIPAQUE 270 MG l/ML | inj sol 10x175ml-pp | ABH | N | | | |
| 42415 | VISIPAQUE 270 MG l/ML | inj sol 10x175ml-pp | AHC | IRL | | | |
| 42416 | VISIPAQUE 270 MG l/ML | inj sol 10x200ml-pp | ABH | N | | | |
| 42417 | VISIPAQUE 270 MG l/ML | inj sol 10x200ml-pp | AHC | IRL | | | |
| 45121 | VISIPAQUE 270 MG l/ML | inj sol 6x200ml-skl | AHC | IRL | | | |
| 84344 | VISIPAQUE 270 MG l/ML | inj sol 6x200ml-skl | ABH | N | | | |
| 42418 | VISIPAQUE 270 MG l/ML | inj sol 6x500ml-pp | ABH | N | | | |
| 42419 | VISIPAQUE 270 MG l/ML | inj sol 6x500ml-pp | AHC | IRL | | | |
| 42406 | VISIPAQUE 270 MG l/ML | inj sol 6x500ml-skl | ABH | N | | | |
| 42407 | VISIPAQUE 270 MG l/ML | inj sol 6x500ml-skl | AHC | IRL | | | |
| 517.36 | V08AB09 | iodixanol (koncentrace 320 mg l/ml, do 30 ml včetně v jedné ampuli) | parent. | 10 | ML | 321,70 | K |
| | | | | | | | |
| 517.37 | V08AB09 | iodixanol (koncentrace 320 mg l/ml, od 50 ml v jedné ampuli) | parent. | 10 | ML | 258,50 | K |
| 42438 | VISIPAQUE 320 MG l/ML | inj sol 10x200ml-pp | ABH | N | | | |
| 42439 | VISIPAQUE 320 MG l/ML | inj sol 10x200ml-pp | AHC | IRL | | | |
| 45125 | VISIPAQUE 320 MG l/ML | inj sol 6x200ml-skl | AHC | URL | | | |
| 84348 | VISIPAQUE 320 MG l/ML | inj sol 6x200ml-skl | ABH | N | | | |
| 42440 | VISIPAQUE 320 MG l/ML | inj sol 6x500ml-pp | ABH | N | | | |
| 42441 | VISIPAQUE 320 MG l/ML | inj sol 6x500ml-pp | AHC | IRL | | | |
| 42428 | VISIPAQUE 320 MG l/ML | inj sol 6x500ml-skl | ABH | N | | | |
| 517.38 | V08AB10 | iomeprol (koncentrace 150 mg l/ml, nad 50 ml v ampuli) | parent. | 10 | ML | 92,70 | K |
| | | | | | | | |
| 517.39 | V08AB10 | iomeprol (koncentrace 200 mg l/ml, nad 50 ml v ampuli) | parent. | 10 | ML | 109,70 | K |
@@ -8223,7 +8444,7 @@
| | | | | | | | |
| 517.44 | V08AB10 | iomeprol (koncentrace 350 mg l/ml, nad 50 ml v ampuli) | parent. | 10 | ML | 159,40 | K |
| | | | | | | | |
| 517.45 | V08AB10 | iomeprol (koncentrace 400 mg l/ml, do 30 ml v ampuli včetně) | parent. | 10 | ML | 228,70 | K |
| 517.45 | V08AB10 | iomeprol (koncentrace 400 mg l/ml, do 30 ml v ampuli vöetne) | parent. | 10 | ML | 228,70 | K |
| | | | | | | | |
| 517.46 | V08AB10 | iomeprol (koncentrace 400 mg l/ml, nad 50 ml v ampuli) | parent. | 10 | ML | 175,90 | K |
| | | | | | | | |
@@ -8241,22 +8462,25 @@
| --- | --- | --- | --- | --- | --- | --- | --- |
| 519.1 | V08AD | iopydol + iopyron | parent. | 10 | ML | 300,70 | K |
| | | | | | | | |
| 519.2 | V08AD01 | ethylestery jodovaných mastných kyselin | parent. | 10 | ML | 462,54 | K |
| 59494 | LIPIODOL ULTRA-FLUIDE | inj 1x10ml/4.8gm i | GUT | F | | | |
| 519.2 | V08AD01 | ethylestery jodovaných mastných kyselin | parent. | 10 ML | 462,54 | K | |
| 59494 | LIPIODOL ULTRA-FLUIDE | inj sol 1x10ml | GUT | F | | | |
| 520 | V08BA | RTG kontrastní přípravky obsahující síran barnatý | p.o. | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 520.1 | V08BA01 | síran barnatý | p.o. | 100 | GM | 32,15 | K |
| 59062 | MICROPAQUE | sus 1x2000ml | DEF | F | | | |
| 95607 | MICROPAQUE | sus 1x2000ml | GUT | F | | | |
| 520.2 | V08BA01 | síran barnatý (lékové formy pro CT) | p.o. | 7.5 | GM | 147,52 | K |
| 62399 | E-Z-CAT | sus 1x225ml | EZE | USA | | | |
| 78269 | E-Z-CAT | sus 1x225ml | EZE | CND | | | |
| 46675 | MICROPAQUE CT | sus 1x2000ml/100gm | DEF | F | | | |
| 78269 | E-Z-CAT | sus 1x225ml | EZE | CND | | | |
| 95609 | MICROPAQUE CT | sus 1x2000ml/100gm | GUT | F | | | |
| 520.3 | V08BA01 | RTG kontrastní přípravky obsahující síran barnatý (lékové formy kolon) | p.rect. | 100 | GM | 45,00 | K |
| | | | | | | | |
| 20926 | MICROPAQUE COLON | rct plv sus 1x800gm | GUE | F | | | |
| 520.4 | V08BA01 | síran barnatý (lékové formy pasty) | p.o. | 100 | GM | 94,58 | K |
| | | | | | | | |
| 520.5 | V08BA01 | síran barnatý (lékové formy HD) | p.o. | 100 | GM | 36,73 | K |
| 59063 | MICROPAQUE H.D. ORAL | plv 1x416gm | DEF | F | | | |
| 95610 | MICROPAQUE H.D. ORAL | plv 1x416gm | GUT | F | | | |
| 521 | V08CA | paramagnetické kontrastní látky | parent. | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 521.1 | V08CA01 | dimeglumin gadopentetat (do 10 ml v 1 ampuli včetně) | parent. | 10 | ML | 1582,80 | K |
@@ -8272,7 +8496,6 @@
| 521.6 | V08CA03 | gadodiamid (nad 10 ml v 1 ampuli) | parent. | 10 | ML | 1472,10 | K |
| | | | | | | | |
| 521.7 | V08CA04 | gadoteridol (do 10 ml v 1 ampuli včetně) | parent. | 10 | ML | 1582,80 | K |
| | | | | | | | |
| 521.8 | V08CA04 | gadoteridol (nad 10 ml v 1 ampuli) | parent. | 10 | ML | 1472,10 | K |
| | | | | | | | |
| 521.9 | V08CA05 | mangafodipir | parent. | 10 | ML | 916,70 | K |
@@ -8287,7 +8510,7 @@
| | | | | | | | |
| 521.14 | V08CB03 | oxid železa, nanočástice, s obsahem do 0,9 ml včetně | parent. | 1 | DF | 5780,78 | H |
| | | | | | | | |
| 521.15 | V08CB03 | oxid železa, nanočástice, s obsahem nad 0,9 mi | parent. | 1 | DF | 6700,00 | H |
| 521.15 | V08CB03 | oxid železa, nanočástice, s obsahem nad 0,9 ml | parent. | 1 | DF | 6700,00 | H |
| | | | | | | | |
| 521.16 | V08DA01 | mikročástice albuminu s oktafluoropanem | parent. | 1 | DF | 2857,50 | H |
| | | | | | | | |
2003-06-30
Vyhláška Ministerstva zdravotnictví č. 57/1997 Sb.
Zobrazit změny Text k tomuto datu
2002-12-31
Vyhláška Ministerstva zdravotnictví č. 57/1997 Sb.
Zobrazit změny Text k tomuto datu
2002-06-30
Vyhláška Ministerstva zdravotnictví č. 57/1997 Sb.
Zobrazit změny Text k tomuto datu
2001-12-31
Vyhláška Ministerstva zdravotnictví č. 57/1997 Sb.
Zobrazit změny Text k tomuto datu
2001-06-30
Vyhláška Ministerstva zdravotnictví č. 57/1997 Sb.
Zobrazit změny Text k tomuto datu
2000-12-31
Vyhláška Ministerstva zdravotnictví č. 57/1997 Sb.
Zobrazit změny Text k tomuto datu
2000-06-30
Vyhláška Ministerstva zdravotnictví č. 57/1997 Sb.
Zobrazit změny Text k tomuto datu
2000-03-31
Vyhláška Ministerstva zdravotnictví č. 57/1997 Sb.
Zobrazit změny Text k tomuto datu
1999-12-31
Vyhláška Ministerstva zdravotnictví č. 57/1997 Sb.
Zobrazit změny Text k tomuto datu
1999-09-30
Vyhláška Ministerstva zdravotnictví č. 57/1997 Sb.
Zobrazit změny Text k tomuto datu
1999-06-30
Vyhláška Ministerstva zdravotnictví č. 57/1997 Sb.
Zobrazit změny Text k tomuto datu
1999-04-30
Vyhláška Ministerstva zdravotnictví č. 57/1997 Sb.
Zobrazit změny Text k tomuto datu
1998-12-31
Vyhláška Ministerstva zdravotnictví č. 57/1997 Sb.
Zobrazit změny Text k tomuto datu
1998-09-30
Vyhláška Ministerstva zdravotnictví č. 57/1997 Sb.
Zobrazit změny Text k tomuto datu
1998-06-30
Vyhláška Ministerstva zdravotnictví č. 57/1997 Sb.
Zobrazit změny Text k tomuto datu
1998-04-30
Vyhláška Ministerstva zdravotnictví č. 57/1997 Sb.
Zobrazit změny Text k tomuto datu
1997-12-31
Vyhláška Ministerstva zdravotnictví č. 57/1997 Sb.
Zobrazit změny Text k tomuto datu
1997-09-30
Vyhláška Ministerstva zdravotnictví č. 57/1997 Sb.
Zobrazit změny Text k tomuto datu
1997-06-30
Vyhláška Ministerstva zdravotnictví č. 57/1997 Sb.
Zobrazit změny Text k tomuto datu
1997-05-13
Vyhláška Ministerstva zdravotnictví č. 57/1997 Sb.
Zobrazit změny Text k tomuto datu
1997-03-31
Vyhláška Ministerstva zdravotnictví č. 57/1997 Sb. — versión origina
původní verze Text k tomuto datu